Citrus Sinensis ID: 005007
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | 2.2.26 [Sep-21-2011] | |||||||
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.336 | 0.398 | 0.456 | 8e-56 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.340 | 0.367 | 0.424 | 9e-54 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.390 | 0.431 | 0.385 | 2e-53 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.338 | 0.259 | 0.407 | 3e-53 | |
| Q99759 | 626 | Mitogen-activated protein | yes | no | 0.316 | 0.364 | 0.411 | 2e-51 | |
| Q61084 | 626 | Mitogen-activated protein | yes | no | 0.316 | 0.364 | 0.411 | 5e-51 | |
| Q9SZ67 | 1895 | Probable WRKY transcripti | no | no | 0.316 | 0.120 | 0.430 | 1e-50 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.325 | 0.359 | 0.426 | 2e-50 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | no | no | 0.330 | 0.384 | 0.409 | 4e-49 | |
| Q10407 | 1116 | MAP kinase kinase kinase | yes | no | 0.329 | 0.212 | 0.406 | 6e-49 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 219 bits (557), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 125/274 (45%), Positives = 170/274 (62%), Gaps = 32/274 (11%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-- 404
P + WQKG+L+GRG+FGSVY G + + G A+KEV ++ ++ ECI+QLE
Sbjct: 324 PDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGE 382
Query: 405 -------------------QVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRH 444
+ +LYI+LE V GS+ + Y R RD S+V +TR
Sbjct: 383 IKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQ 439
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 504
IL+GL YLH IHRDIK AN+LVDA+G VKLADFG+AK ++ + S KG+P WMAP
Sbjct: 440 ILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAP 498
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 563
EVI +KD + + A DIWSLGCTV+EM TG+ P+S+ E QA+F++ T P +P+
Sbjct: 499 EVIN---RKDSDGYGSPA-DIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPD 554
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
LS + + F+L+C NP ERP+A ELL HPF+R
Sbjct: 555 TLSLDARLFILKCLKVNPEERPTAAELLNHPFVR 588
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 9e-54, Method: Compositional matrix adjust.
Identities = 120/283 (42%), Positives = 167/283 (59%), Gaps = 38/283 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQV------ 406
W+KG+LIGRG FG+VY+G N ++G A+K+V I + K+ I++LE+
Sbjct: 69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128
Query: 407 ---------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
DD L I LE+V GSI+ + E ES+VR +TR +L GL Y
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEY 187
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIK 508
LH+ +HRDIKGAN+LVD G +KLADFG +K L ++ S+KG+P WMAPEVI
Sbjct: 188 LHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVIL 247
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKV--LNRTPPIPEML 565
+ + DIWS+GCTVIEM+TGK PWS +++ A+F + PPIP+ L
Sbjct: 248 QTGH-------SFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTL 300
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 608
SS+ KDFLL+C P RP+A ELL+HPF+ + ++ S +
Sbjct: 301 SSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDL 343
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 128/332 (38%), Positives = 182/332 (54%), Gaps = 51/332 (15%)
Query: 319 HPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS---------QWQKGKLIGRGTFGS 369
HP P P S +TS + ++ S SP + +W+KG+LIGRG FG+
Sbjct: 26 HPPPFP----SLLADKITSCIRKSMVFAKSQSPPNNSTVQIKPPIRWRKGQLIGRGAFGT 81
Query: 370 VYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQV-------------------- 406
VY+G N ++G A+K+V I + K+ I++LE+
Sbjct: 82 VYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVR 141
Query: 407 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
D+ L I LE+V GSI+ + E ES+VR +T +L GL YLH+ +HRDIKGA
Sbjct: 142 EDETLNILLEFVPGGSISSLL-EKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGA 200
Query: 466 NLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
N+LVD G +KLADFG +K L +S S+KG+P WMAPEVI + +
Sbjct: 201 NILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVILQTGH-------SFS 253
Query: 523 VDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKV--LNRTPPIPEMLSSEGKDFLLRCFLR 579
DIWS+GCTVIEM+TGK PWS +++ A+F + PPIP+ +SS+ DFLL+C +
Sbjct: 254 ADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLLKCLQQ 313
Query: 580 NPVERPSAVELLEHPFIRNANYQNLSVPMRVF 611
P RP+A ELL+HPF+ ++ S + F
Sbjct: 314 EPNLRPTASELLKHPFVTGKQKESASKDLTSF 345
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 114/280 (40%), Positives = 173/280 (61%), Gaps = 36/280 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECI----KQLEQV-- 406
+WQKG+++GRG +GSVY+G N++TG A+K+++I I DPK I K++E +
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228
Query: 407 ---------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
L ++LEY+ GSI+ + + +E++++ +T+ IL GL++
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 287
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 510
LH+ + IHRDIKGAN+L+D G+VKL+DFG +K +G+ + S++G+P WMAPEVIK
Sbjct: 288 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK-- 345
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL--NRTPPIPEMLSS 567
+ G+ + + DIWSLGC ++EM T +PPWS E M+ + N P IP +S
Sbjct: 346 --QTGHGR---SSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQ 400
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 607
E DFL CF R+P ERP A +LL+HPFI N + N+ +P
Sbjct: 401 EAFDFLNLCFKRDPKERPDANQLLKHPFIMNLD-DNIQLP 439
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 112/272 (41%), Positives = 161/272 (59%), Gaps = 44/272 (16%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------ECIKQL------ 403
W++GKL+G+G FG VY+ + +TG A K+V PD P+++ EC QL
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 404 -----------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
++ + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 505
HS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR---SVTGTPYWMSPE 537
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 563
VI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 590
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+S G+DFL R F+ +RPSA ELL H F
Sbjct: 591 HISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 112/272 (41%), Positives = 161/272 (59%), Gaps = 44/272 (16%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------ECIKQL------ 403
W++GKL+G+G FG VY+ + +TG A K+V PD P+++ EC QL
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 404 -----------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
++ + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 505
HS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMSPE 537
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 563
VI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 590
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+S G+DFL R F+ +RPSA ELL H F
Sbjct: 591 HISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 114/265 (43%), Positives = 159/265 (60%), Gaps = 37/265 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------- 404
WQKG+L+GRG+ GSVY G + + G A KEV ++ ++ E I+Q+E
Sbjct: 1626 WQKGQLLGRGSLGSVYEGISAD-GDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684
Query: 405 ----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+ + +LYI+LE V GS+ + + + + +S+V +TR IL+GL YLH
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRN--QLGDSVVSLYTRQILDGLKYLHD 1742
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP--NWMAPEVIKAVMQ 512
IHR+IK AN+LVDA+G VKLADFG+AK +SL +P NWMAPEVI
Sbjct: 1743 KGFIHRNIKCANVLVDANGTVKLADFGLAK-------VMSLWRTPYWNWMAPEVILNPKD 1795
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKD 571
DG DIWSLGCTV+EMLTG+ P+S+ E A++ + + P IP++LS + +D
Sbjct: 1796 YDG---YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARD 1852
Query: 572 FLLRCFLRNPVERPSAVELLEHPFI 596
F+L C NP ERP+A ELL HPF+
Sbjct: 1853 FILTCLKVNPEERPTAAELLNHPFV 1877
|
Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 116/272 (42%), Positives = 155/272 (56%), Gaps = 38/272 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQV----- 406
+W+KG+LIG G FG VY+G N ++G AIK+V I P K+ I++LE+
Sbjct: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126
Query: 407 ----------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
D L I +E+V GSI+ + E E ++ +T+ +L GL
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLL-EKFGSFPEPVIIMYTKQLLLGLE 185
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVI 507
YLH+ +HRDIKGAN+LVD G ++LADFG +K + L+ S+KG+P WMAPEVI
Sbjct: 186 YLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI 245
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEM 564
+ + DIWS+GCTVIEM TGKPPWSE A + RT PPIPE
Sbjct: 246 LQTGH-------SFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPED 298
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
LS E KDFL++C + P R SA ELL+HPF+
Sbjct: 299 LSPEAKDFLMKCLHKEPSLRLSATELLQHPFV 330
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 4e-49, Method: Compositional matrix adjust.
Identities = 116/283 (40%), Positives = 166/283 (58%), Gaps = 45/283 (15%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------EC 399
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P+++ EC
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 405
Query: 400 IKQL------EQVDDH-----------LYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
QL E++ + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 464
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSL 495
R IL G+ YLHS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+
Sbjct: 465 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMK---SV 521
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 555
G+P WM+PEVI +G + A DIWS+ CTV+EMLT KPPW+EFE A+FK+
Sbjct: 522 TGTPYWMSPEVISG----EGYGRKA---DIWSVACTVVEMLTEKPPWAEFEAMAAIFKIA 574
Query: 556 NR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ P +P +S +DFL R F+ + RPSA ELL H F+
Sbjct: 575 TQPTNPKLPPHVSDYTRDFLKRIFVEAKL-RPSADELLRHMFV 616
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 113/278 (40%), Positives = 153/278 (55%), Gaps = 41/278 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--------------IPD-------- 392
+W KG+LIG GT+G V++ N TG A+K+V+I I D
Sbjct: 824 KWMKGELIGNGTYGKVFLAMNINTGELIAVKQVEIPQTINGRHDQLRKDIVDSINAEISM 883
Query: 393 --DPKSAECIKQL--EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
D ++ L E+ + + I+LEYV GSI R +R + E +VR +R +L G
Sbjct: 884 IADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYG-PFEEQLVRFVSRQVLYG 942
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAPE 505
L+YLHS IHRD+K NLL+D GV K++DFG++KH + LS++GS WMAPE
Sbjct: 943 LSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDNDANLSMQGSIFWMAPE 1002
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV--LNRTPPIPE 563
VI + + + VD+WSLGC V+EML G+ PWS E QAMFK+ + PPIP
Sbjct: 1003 VI-----HNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAMFKLGTEKKAPPIPS 1057
Query: 564 MLSS----EGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
L S E FL CF N RP+A ELL HPF++
Sbjct: 1058 ELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095
|
May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| 255538424 | 692 | conserved hypothetical protein [Ricinus | 0.786 | 0.817 | 0.555 | 1e-155 | |
| 225470467 | 707 | PREDICTED: uncharacterized protein LOC10 | 0.861 | 0.876 | 0.476 | 1e-148 | |
| 449470172 | 709 | PREDICTED: uncharacterized protein LOC10 | 0.836 | 0.849 | 0.492 | 1e-140 | |
| 225458499 | 782 | PREDICTED: uncharacterized protein LOC10 | 0.590 | 0.543 | 0.584 | 1e-138 | |
| 449448516 | 760 | PREDICTED: uncharacterized protein LOC10 | 0.875 | 0.828 | 0.423 | 1e-130 | |
| 449521088 | 604 | PREDICTED: uncharacterized protein LOC10 | 0.656 | 0.783 | 0.501 | 1e-128 | |
| 255562635 | 709 | conserved hypothetical protein [Ricinus | 0.583 | 0.592 | 0.559 | 1e-128 | |
| 356565641 | 637 | PREDICTED: uncharacterized protein LOC10 | 0.551 | 0.623 | 0.548 | 1e-125 | |
| 357465415 | 700 | Mitogen-activated protein kinase kinase | 0.723 | 0.744 | 0.446 | 1e-123 | |
| 224136678 | 379 | predicted protein [Populus trichocarpa] | 0.430 | 0.817 | 0.650 | 1e-121 |
| >gi|255538424|ref|XP_002510277.1| conserved hypothetical protein [Ricinus communis] gi|223550978|gb|EEF52464.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1432), Expect = e-155, Method: Compositional matrix adjust.
Identities = 347/625 (55%), Positives = 408/625 (65%), Gaps = 59/625 (9%)
Query: 21 NNRKLTRVRKLRHVPDDELGLLMT-DRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLP 79
N ++LTR RK+RH +LGL + DR SP ASPDSAR SP S SS A+P+PLP
Sbjct: 21 NTKRLTRQRKIRHETQQDLGLQFSQDRLNSPPASPDSARKPRSPPCSSSSSSPALPQPLP 80
Query: 80 LPDLASLFRKPES----SGHGF-ESPEGRPHR--GRKSTNQ----TAKGSAGFLSHFHKG 128
LP+ + R+ E GH SPE RP R S +Q +A GS+ F F
Sbjct: 81 LPE-SHFTRRLEPFGFIPGHAVPASPEERPIYLLRRNSADQVDINSATGSSNFQWRFSPQ 139
Query: 129 DSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNP----KSISTRR 184
D N+++ + LR ++ RS P SS VSP+RSN + N K T
Sbjct: 140 DP---NVDTANHGLRLNIAPRSAP----SSPLVSPRRSNAGEFSTTFNAADSTKCSKTCC 192
Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
+G +DLNIEC NY P+SAPTS FSSP VSPQ S T + SF A
Sbjct: 193 KGQLNDLNIECVNYKLSWIDSPRSAPTSGFSSPNVSPQRSYTIDFLPSFVA--------- 243
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
EVPDLGR G TS S K D S + P +QS N + P K F L +K
Sbjct: 244 REVPDLGRHAGHTSRKSLVKTG-NGLDRSAI-YPSQQSPTPNKKPPHKFSFQLHNKMFVG 301
Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
SKE E+N+ +AHPLPLPPGA SP +S + S A++ H +EKP+ S +K+QW KGKLI
Sbjct: 302 KSKEWPETNSQFSAHPLPLPPGAASP-QSFIPSPPAILHHTIEKPNVSLRKTQWLKGKLI 360
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----------------- 405
GRGT+GSVY+GTNRETGA CA+KEVDIIP D KS ECIKQLEQ
Sbjct: 361 GRGTYGSVYVGTNRETGALCAMKEVDIIPGDSKSVECIKQLEQEIRLLQHLEHPNIVQYY 420
Query: 406 ----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
VDDH YIYLEYV+PGSI++YVREHC +TESIVRNFTRHIL+GLAYLHS TIHRD
Sbjct: 421 SCEIVDDHFYIYLEYVYPGSISKYVREHCGAMTESIVRNFTRHILSGLAYLHSKKTIHRD 480
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
IKGANLLV++SG+VKLADFGMAKHL+GLSYELSLKGSP+WMAPEVI+AVMQ + NP LAL
Sbjct: 481 IKGANLLVNSSGIVKLADFGMAKHLSGLSYELSLKGSPHWMAPEVIQAVMQNNANPDLAL 540
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 581
AVDIWSLGCT+IEM TGKPPW E EGPQAMFK LN+TPPIPE +S E KDFL C RNP
Sbjct: 541 AVDIWSLGCTIIEMFTGKPPWGELEGPQAMFKALNKTPPIPEAMSPEAKDFLCCCLRRNP 600
Query: 582 VERPSAVELLEHPFIRNANYQNLSV 606
ERPSA LLEHPF+RN++ NLS
Sbjct: 601 AERPSASMLLEHPFLRNSSELNLST 625
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470467|ref|XP_002263088.1| PREDICTED: uncharacterized protein LOC100245919 [Vitis vinifera] gi|296084711|emb|CBI25853.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1373), Expect = e-148, Method: Compositional matrix adjust.
Identities = 329/690 (47%), Positives = 411/690 (59%), Gaps = 70/690 (10%)
Query: 25 LTRVRKLRHVPDDELGLLMTDRACS-PSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDL 83
LTR RKLRHV + + L+ R+ + P S S S SS VP PLP P+L
Sbjct: 25 LTRARKLRHVRGNHIDALVRSRSSAEPKDLLPLPSSSSSFDHSSERLSSVVPHPLPRPEL 84
Query: 84 ASLFRKPESSGHGF--ESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKND 141
A LFR+ S + P P G S GF KG+S V D
Sbjct: 85 ALLFRRNGGSNSNLNCDRPLPSPKEGL---------SRGFEDR-DKGNSFV-------GD 127
Query: 142 LRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPL------HNPKSISTRRRGFSHDLNIEC 195
V V ST T S + R +++ L S+ R F
Sbjct: 128 GNGEVAVSSTATG--SKVGYNEARKSMEQFDTLSSRYLPQGQNSVKNNRVNF-------- 177
Query: 196 ANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF-SSFWAPKEIQDWSTAEVPDLGRFV 254
+ D+ +SAPTS SSPAVSPQ + GN+F S +P+ Q WS E+P
Sbjct: 178 -----KLDVPTRSAPTSSLSSPAVSPQRTSPGNLFLSQNVSPQVFQGWSAPEMPVFDMVT 232
Query: 255 GCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNN 314
G T +SP ++ ++S D+SPL SP +S N RSP PL K + S E+N+
Sbjct: 233 GFTPQMSP-EQTMFSTDNSPLHSPTVKSPHVNPRSPSGPASPLHPKISLETSTARRENNS 291
Query: 315 HLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
H N H LPLPPG ++PP++S ++ P ++ K + P +QWQKGKLIGRGTFGSVY+ T
Sbjct: 292 HANVHRLPLPPGVVAPPQAS---SIHP-VIAKTESFPMTTQWQKGKLIGRGTFGSVYVAT 347
Query: 375 NRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------------VDDHLYIY 413
NRETGA CA+KEV+++PDDPKSAE IKQLEQ V+D LYIY
Sbjct: 348 NRETGALCAMKEVELLPDDPKSAESIKQLEQEIKILSQLKHPNIVQYFGSETVEDRLYIY 407
Query: 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 473
LEYVHPGSIN+YVREHC ITES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVDASG
Sbjct: 408 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDASG 467
Query: 474 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 533
VVKLADFGM+KHLTG + +LSLKGSP WMAPE+++AVMQKD + LA AVDIWSLGCT+I
Sbjct: 468 VVKLADFGMSKHLTGAAADLSLKGSPYWMAPELMQAVMQKDHSSDLAFAVDIWSLGCTII 527
Query: 534 EMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
EML GKPPWSE+EG AMFKV+ +PPIP+ LSSEGKDFL CF RNP ERP A++LLEH
Sbjct: 528 EMLNGKPPWSEYEGAAAMFKVMRESPPIPKTLSSEGKDFLRCCFRRNPAERPPAIKLLEH 587
Query: 594 PFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEV 653
F++N+ ++ + + FS + L DK++ E++ + + +P SP R + K S
Sbjct: 588 RFLKNSTQLDVPLLTQAFSGMKLPDKANKSREKSNDRVDPVPISP--RKKTSKGKKASGT 645
Query: 654 CPQCHAGTFNCATASRHSSCSTFGVHISLS 683
Q H T + AS HS ST SLS
Sbjct: 646 GQQSHRETSDLTVASHHSPRSTLEALPSLS 675
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470172|ref|XP_004152792.1| PREDICTED: uncharacterized protein LOC101219854 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 330/670 (49%), Positives = 406/670 (60%), Gaps = 68/670 (10%)
Query: 20 FNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSP----GTSDHWSSSAVP 75
F R+LTR RKLRH+ D ++G P + PDS +S P G S+ WSSS P
Sbjct: 38 FIQRRLTRQRKLRHLTDQDVGFEH------PRSLPDSPDISAKPKSPLGGSERWSSSPSP 91
Query: 76 KPLPLPDLASLFRKPESSGHGFESPEGRPHRG--RKSTNQTAKGSAGFLSHFHKGDSQVL 133
+PLPLP+L + R PE + + G P RK ++ + H + + L
Sbjct: 92 QPLPLPELFPV-RSPEFGSNYGQGRVGSPVETSVRKCSDHATTNVSRSFGHNQRRVATDL 150
Query: 134 NIESVKNDLRPSVPVRSTPTSLSS-SHAVSPQRSNL---QNPTPLHNPKSISTRRRGFSH 189
+E V + R ++P SLS+ S ++P + L + TP + + RG
Sbjct: 151 TLEVVDGNSRTGATAFTSPQSLSANSGKLNPNKEFLFGCSDQTP-------NNKGRGSPT 203
Query: 190 DLNIECANYSSRADIIPK-----SAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
+ E NY ++ PK SAPTS+ SP VSP+ S GN F + E Q+ +
Sbjct: 204 HPSAERGNY----NLTPKKSSSKSAPTSILPSPVVSPRKSYNGNHFVPGLSHHEHQESPS 259
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
SP P + S+ PL SP +SS SN RS + FPL K
Sbjct: 260 N-----------NSPKVPPLKTALSSQPFPLHSPTARSSISNSRSHNDMTFPLHTKLQKD 308
Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
NS + ES+ H+NAHPLPLPP ++ ++S S + + H++EKP S K QWQKGKLI
Sbjct: 309 NSIDRSESHAHVNAHPLPLPPPLVASSQASAQSLPSNVHHVIEKPFISSMKGQWQKGKLI 368
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----------------- 405
GRGTFGSVY+ TNRETGA CA+KEVD+IPDDPKSAECIKQLEQ
Sbjct: 369 GRGTFGSVYLATNRETGALCAMKEVDLIPDDPKSAECIKQLEQEIEVLSHLKHPNIVQYY 428
Query: 406 ----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
+ D YIYLEYV+PGSIN+YVRE C ITESIVRNFTRHIL+GLAYLHST TIHRD
Sbjct: 429 GSEIIGDCFYIYLEYVYPGSINKYVRERCGAITESIVRNFTRHILSGLAYLHSTKTIHRD 488
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
IKGANLLVD+SGVVKLADFGMAKHLTG Y+LSLKGSP WMAPEVIKA M KD NP LAL
Sbjct: 489 IKGANLLVDSSGVVKLADFGMAKHLTG-QYDLSLKGSPYWMAPEVIKAAMLKDANPDLAL 547
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 581
AVDIWSLGCT+IEML GKPPW EFEG Q MFKVLN+TPPIPE LS EGKDFL CF RNP
Sbjct: 548 AVDIWSLGCTIIEMLNGKPPWCEFEGHQVMFKVLNKTPPIPEKLSPEGKDFLQCCFQRNP 607
Query: 582 VERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETR 641
+RP+A+ LL+HPF+R+++ N S+P FS +NL +K + K + +S T
Sbjct: 608 ADRPTAMVLLDHPFLRSSSDSNASIPTSAFSTMNLLEKLLSPKDPLNPKGDQAQNSSGTL 667
Query: 642 VRNRKLPCNS 651
N L C S
Sbjct: 668 TSNDYLSCRS 677
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458499|ref|XP_002282240.1| PREDICTED: uncharacterized protein LOC100257467 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 500 bits (1287), Expect = e-138, Method: Compositional matrix adjust.
Identities = 272/465 (58%), Positives = 323/465 (69%), Gaps = 40/465 (8%)
Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
RGFS DLN E Y+ R +I +SAPTS FSSPA+SPQ G S +A IQD+ +
Sbjct: 228 RGFSQDLNDEACPYNLRVNIPARSAPTSGFSSPALSPQRFSPGERLPSSYA--AIQDFQS 285
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNL----RSPRKVYFPLRHK 300
P R GC+S +SP K ++ D+SPL SP QS + +SP + F L K
Sbjct: 286 ---PGFDRLPGCSSQMSPLK-TPHTPDYSPLHSPTVQSPCISPCLSPKSPTGIAFSLYPK 341
Query: 301 SLPQNSKELLESNNHLNAHPLPLPPGALSP-----PKSSVT---SAVMPHIMEKPSASPK 352
LP + E N H+ HPLPLPP AL P P ++T SA+ H EKP+
Sbjct: 342 LLPGSHVTWPEKNGHVTVHPLPLPPIALMPSELPLPPKALTPSESAISHHTAEKPNVPSM 401
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------- 405
KSQWQKGKLIGRGTFGSVY+ TNRETGA CA+KEVDIIPDDPKS+ECIKQLEQ
Sbjct: 402 KSQWQKGKLIGRGTFGSVYVATNRETGALCAMKEVDIIPDDPKSSECIKQLEQEIKVLHH 461
Query: 406 --------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
VDDH YIYLEYVHPGSIN+YV +H +TE++VRNFTRHIL+GLAY
Sbjct: 462 LKHPNIVQYYGSEIVDDHFYIYLEYVHPGSINKYV-DHFGAMTENVVRNFTRHILSGLAY 520
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
LHST TIHRDIKGANLLVD+ GVVKLADFG+AK LTG + +LSLKGSP+WMAPEV++AV+
Sbjct: 521 LHSTKTIHRDIKGANLLVDSFGVVKLADFGLAKFLTGQACDLSLKGSPHWMAPEVMQAVL 580
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571
+KD NP LA AVDIWSLGCT+IEML G+PPWSEF P AMFKVL+ +PP+PE LSSEGKD
Sbjct: 581 RKDANPDLAFAVDIWSLGCTIIEMLNGRPPWSEFAAPAAMFKVLHESPPLPETLSSEGKD 640
Query: 572 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 616
FL CF RNP ERPSA LL+H F+R++ QN+S + FS + L
Sbjct: 641 FLQHCFRRNPAERPSAAMLLDHSFVRSSQDQNVSGFSQAFSGMQL 685
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448516|ref|XP_004142012.1| PREDICTED: uncharacterized protein LOC101219486 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1218), Expect = e-130, Method: Compositional matrix adjust.
Identities = 308/728 (42%), Positives = 405/728 (55%), Gaps = 98/728 (13%)
Query: 5 GKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPG 64
G A N ++ V F + +R RKLR++ E + + A +P+ +S SP
Sbjct: 36 GSAENNYRGIVWR--FGASRYSRHRKLRNLSGREH--VDSSLAKWSDTAPEPVSLSRSPS 91
Query: 65 TSDHWSSSAVPKPLPLPDLASLFRKPE------SSGHGFESPEGRPHRGRKSTNQTAKGS 118
TSDH AVP LPLP+++ LF+ E S+G + P P KGS
Sbjct: 92 TSDH---PAVP--LPLPEVSPLFQPRERISTSNSAGGEGDCPLPSP-----------KGS 135
Query: 119 AGFLSHFHKGDSQVLNI------ESVKNDLRPSVPVRSTPTSLSSSHA----VSPQRSNL 168
G GD + ++ + + + P+ ++S S+ H + + S
Sbjct: 136 RG-----RAGDERDVDRDRNAPPQKIGGGISPNASIKSVSDSVGERHKKEGQIEARLSGR 190
Query: 169 QNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGN 228
N P++ R GF D+ +SAPTS ++SP SPQ + +GN
Sbjct: 191 ANQDARRYPEN---SRNGF-------------WIDVPSRSAPTSPYTSPTPSPQRNISGN 234
Query: 229 VFS-SFWAPKEIQDWSTAEVPD-------LGRFVGCTS--PVSPFKRNV---------YS 269
+ + + +P Q WS E+P+ +G V P S R V S
Sbjct: 235 ISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHVWSAPELPSSAMMRGVPPAFFDCSTLS 294
Query: 270 ADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALS 329
+ SP+ SP +S + RSP PL K + E + H++ HPLPLPPG
Sbjct: 295 TESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISHETHAMRREGSGHVSVHPLPLPPGVPM 354
Query: 330 PPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI 389
P SS ++ + + S S K+QWQKGKLIGRGTFGSVY+ +NR+ GA CA+KEV++
Sbjct: 355 PSASSPSTPISQANTKSESIS-MKNQWQKGKLIGRGTFGSVYVASNRQNGALCAMKEVEL 413
Query: 390 IPDDPKSAECIKQLEQ---------------------VDDHLYIYLEYVHPGSINRYVRE 428
DDPKSAE IKQLEQ +DD LYIYLEYVHPGSIN+YVRE
Sbjct: 414 FHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYGSDIIDDRLYIYLEYVHPGSINKYVRE 473
Query: 429 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488
HC +TES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVD+ GVVKLADFGMAKHLTG
Sbjct: 474 HCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDSCGVVKLADFGMAKHLTG 533
Query: 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548
+LSLKGSP WMAPE++ +VMQKD P LALAVDIWSLGCT+IEM TGKPPWSE+EG
Sbjct: 534 QVADLSLKGSPYWMAPELLLSVMQKDNTPDLALAVDIWSLGCTIIEMFTGKPPWSEYEGA 593
Query: 549 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 608
AMFKV+ TPP+PE LS E +DFL CF RNP ERP+A LLEHPF++N Y + S
Sbjct: 594 AAMFKVMKDTPPMPESLSYEARDFLKCCFQRNPAERPTAAMLLEHPFMKNLQYTDASSCS 653
Query: 609 RVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCPQCHAGTFNCATAS 668
+V + +L DK + ++ + K++ P + KL ++ + P H T + S
Sbjct: 654 QVVAGASLMDKCYSPSKQYSSKSDQSSMLPSPQNSKGKLAADNVIGPLSHHETSDLTVMS 713
Query: 669 RHSSCSTF 676
R+S ST
Sbjct: 714 RYSPRSTL 721
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521088|ref|XP_004167563.1| PREDICTED: uncharacterized protein LOC101228290 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1193), Expect = e-128, Method: Compositional matrix adjust.
Identities = 258/514 (50%), Positives = 324/514 (63%), Gaps = 41/514 (7%)
Query: 203 DIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDWSTAEVPD-------LGRFV 254
D+ +SAPTS ++SP SPQ + +GN+ + + +P Q WS E+P+ +G V
Sbjct: 53 DVPSRSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHV 112
Query: 255 GCTS--PVSPFKRNV---------YSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLP 303
P S R V S + SP+ SP +S + RSP PL K
Sbjct: 113 WSAPELPSSAMMRGVPPAFFDCSTLSTESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISH 172
Query: 304 QNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIG 363
+ E + H++ HPLPLPPG P SS ++ + + S S K+QWQKGKLIG
Sbjct: 173 ETHAMRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQANTKSESIS-MKNQWQKGKLIG 231
Query: 364 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------------ 405
RGTFGSVY+ +NR+ GA CA+KEV++ DDPKSAE IKQLEQ
Sbjct: 232 RGTFGSVYVASNRQNGALCAMKEVELFHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYG 291
Query: 406 ---VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+DD LYIYLEYVHPGSIN+YVREHC +TES+VRNFTRHIL+GLAYLHST TIHRDI
Sbjct: 292 SDIIDDRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDI 351
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
KGANLLVD+ GVVKLADFGMAKHLTG +LSLKGSP WMAPE++ +VMQKD P LALA
Sbjct: 352 KGANLLVDSCGVVKLADFGMAKHLTGQVADLSLKGSPYWMAPELLLSVMQKDNTPDLALA 411
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPV 582
VDIWSLGCT+IEM TGKPPWSE+EG AMFKV+ TPP+PE LS E +DFL CF RNP
Sbjct: 412 VDIWSLGCTIIEMFTGKPPWSEYEGAAAMFKVMKDTPPMPESLSYEARDFLKCCFQRNPA 471
Query: 583 ERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRV 642
ERP+A LLEHPF++N Y + S +V + +L DK + ++ + K++ P +
Sbjct: 472 ERPTAAMLLEHPFMKNLQYTDASSCSQVVAGASLMDKCYSPSKQYSSKSDQSSMLPSPQN 531
Query: 643 RNRKLPCNSEVCPQCHAGTFNCATASRHSSCSTF 676
KL ++ + P H T + SR+S ST
Sbjct: 532 SKGKLAADNVIGPLSHHETSDLTVMSRYSPRSTL 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562635|ref|XP_002522323.1| conserved hypothetical protein [Ricinus communis] gi|223538401|gb|EEF40007.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1193), Expect = e-128, Method: Compositional matrix adjust.
Identities = 255/456 (55%), Positives = 305/456 (66%), Gaps = 36/456 (7%)
Query: 190 DLNIE-CANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWA--PKEIQDWSTAE 246
D +++ CA+YS R + +SAPTS FSSP Q T F ++ K Q WS E
Sbjct: 216 DFSVDHCADYS-RINAPIRSAPTSPFSSP----QKLTTAADFLPYYQMIAKGNQVWSAPE 270
Query: 247 VPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNS 306
+ L + P + F +S D SPL SPP +S + N +SP L + + S
Sbjct: 271 MATLD--IPGLPPPAFFDYTAFSTDTSPLHSPPSRSPRRNPKSPTGGPASLNARLSIETS 328
Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGT 366
+E N +L HPLPLPPGA S S+ +P ++ K + P KSQWQKGKLIGRGT
Sbjct: 329 REC---NANLEVHPLPLPPGASS--SRPSISSSVPQVISKAESIPLKSQWQKGKLIGRGT 383
Query: 367 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ--------------------- 405
FGSVY+ +NRETGA CA+KEVD+ PDDPKSAE IKQLEQ
Sbjct: 384 FGSVYVASNRETGALCAMKEVDMFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI 443
Query: 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
V DH YIYLEYVHPGSIN+YVREHC ITE++VR+F+RHIL+GLAYLHS TIHRDIKGA
Sbjct: 444 VGDHFYIYLEYVHPGSINKYVREHCGAITENVVRSFSRHILSGLAYLHSMKTIHRDIKGA 503
Query: 466 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525
NLLVDASGVVKLADFGM+KHLTG + ELSLKGSP WMAPE+++AVMQKD + LALAVDI
Sbjct: 504 NLLVDASGVVKLADFGMSKHLTGQAAELSLKGSPYWMAPELMQAVMQKDTSSDLALAVDI 563
Query: 526 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP 585
WSLGCT+IEM TGKPPWS++EG AMFKVL PPIPE LS EGKDFL CF RNP +RP
Sbjct: 564 WSLGCTIIEMFTGKPPWSDYEGAAAMFKVLRDIPPIPETLSPEGKDFLHCCFQRNPADRP 623
Query: 586 SAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSH 621
SA LLEH ++RN+ + R + I L D +H
Sbjct: 624 SASMLLEHRWLRNSQQLDFPSSTRSINGIKLMDLTH 659
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565641|ref|XP_003551047.1| PREDICTED: uncharacterized protein LOC100790701 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1176), Expect = e-125, Method: Compositional matrix adjust.
Identities = 244/445 (54%), Positives = 298/445 (66%), Gaps = 48/445 (10%)
Query: 212 SVFSSPAVSPQSSKTGNVFSSFWA-PKEIQDWSTAEVP--DLGRFVGCTSPVSPFKRNVY 268
S+ SP++SPQ ++ G+ ++A PK Q WST E+P D G P + F +
Sbjct: 161 SISGSPSMSPQKTRNGDFVPYYYACPKGNQFWSTPEMPTCDAGLL-----PPAFFDLSAL 215
Query: 269 SADHSPLP----SPPRQSSQSNLRS---PRKVYFPLRHKSLPQNSKELLESNNH--LNAH 319
S + S P SP R+S Q + R+ P P+ +P E NN + H
Sbjct: 216 STETSLSPNSHQSPQRKSPQKHTRTFSGPPSPIHPMLSLEIPTVRHE----NNAPPVAVH 271
Query: 320 PLPLPP--GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRE 377
PLPLPP G SPP +A H M K + P KSQW+KGKLIGRGTFGSVY+ TNRE
Sbjct: 272 PLPLPPRAGLTSPP----AAATFSHAMVKSESLPMKSQWKKGKLIGRGTFGSVYVATNRE 327
Query: 378 TGASCAIKEVDIIPDDPKSAECIKQLEQ---------------------VDDHLYIYLEY 416
TGA CA+KEV++ PDDPKSAECIKQLEQ V+D YIYLEY
Sbjct: 328 TGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEY 387
Query: 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476
VHPGSIN+YVR+HC ITES++RNFTRHIL+GLAYLHS TIHRDIKGANLLVD++GVVK
Sbjct: 388 VHPGSINKYVRDHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVK 447
Query: 477 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 536
LADFGMAKHLTG LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+IEM
Sbjct: 448 LADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTIIEMF 507
Query: 537 TGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
TGKPPWSE+EG A+FKV+ TPPIPE LSSEGKDFL CF RNP ERP+A LLEH F+
Sbjct: 508 TGKPPWSEYEGAAALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLEHRFL 567
Query: 597 RNANYQNLSVPMRVFSRINLGDKSH 621
+N+ + P ++++ + DK H
Sbjct: 568 KNSQQPDAISPTQLYNGTSFMDKPH 592
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465415|ref|XP_003602992.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355492040|gb|AES73243.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1156), Expect = e-123, Method: Compositional matrix adjust.
Identities = 278/622 (44%), Positives = 359/622 (57%), Gaps = 101/622 (16%)
Query: 20 FNNRKLTRVRKLRHVPDDELG--LLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKP 77
R+LTR ++L + D ++G TD A S S SP +SDHWS+SAVP+P
Sbjct: 23 IQQRRLTRQKRLCYPNDQDVGESFHSTDVAVSFSLP-----TSPYRTSSDHWSTSAVPQP 77
Query: 78 LPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIES 137
LPLP+ R+P+ H P R T ++ + S+ HF + +
Sbjct: 78 LPLPESPLTTRRPDH--HAAALPFSRK-SADHDTVRSLRSSSNLGRHFFNTVTG-----N 129
Query: 138 VKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECAN 197
K+DLR ++P P R L + S R SHD + E +
Sbjct: 130 AKSDLRVNIP---------------PTRG-------LVSSNSSCKDTRKHSHDNDCEGIS 167
Query: 198 YSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDW------STAEVPDL 250
+S+ KSAP S+FSSP SP+ + ++ S P++ D TA PDL
Sbjct: 168 -NSKLQFAAKSAPNSIFSSPVTSPRRLSSVDLLDPSIILPQDFNDMFRVLPAKTAHSPDL 226
Query: 251 G--RFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKE 308
R G SP + + + SQ + + +V+
Sbjct: 227 SPRRSFGNHSPANHHRHTIQGG------------SQQHSKFCTRVW-------------- 260
Query: 309 LLESNNHLNAHPLPLPPGALSPPKSS---VTSAVMPHIMEKPSASPKKSQWQKGKLIGRG 365
NNHL+AHPLPLPP A P+ S +S M H E + K WQKGKLIGRG
Sbjct: 261 --PENNHLDAHPLPLPPRASPQPQQSPAHQSSVTMNHSTENIHS--MKGHWQKGKLIGRG 316
Query: 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-------------------- 405
+FGSVY TN ETGASCA+KEVD++PDDPKS +CIKQL+Q
Sbjct: 317 SFGSVYHATNLETGASCALKEVDLVPDDPKSTDCIKQLDQEIRILGQLHHPNIVEYYGSE 376
Query: 406 -VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
V D L IY+EYVHPGS+ +++++HC +TES+VRNFTRHIL+GLAYLHST TIHRDIKG
Sbjct: 377 VVGDRLCIYMEYVHPGSLQKFMQDHCGVMTESVVRNFTRHILSGLAYLHSTKTIHRDIKG 436
Query: 465 ANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
ANLLVDASG+VKLADFG++K LT SYELSLKGSP WMAPE++ A M+ + NP +A+AVD
Sbjct: 437 ANLLVDASGIVKLADFGVSKILTEKSYELSLKGSPYWMAPELMMAAMKNETNPTVAMAVD 496
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER 584
IWSLGCT+IEMLTGKPPWSEF G QAMFKVL+R+P IP+ LS EG+DFL +CF RNP +R
Sbjct: 497 IWSLGCTIIEMLTGKPPWSEFPGHQAMFKVLHRSPDIPKTLSPEGQDFLEQCFQRNPADR 556
Query: 585 PSAVELLEHPFIRNANYQNLSV 606
PSA LL HPF++N + Q++ V
Sbjct: 557 PSAAVLLTHPFVQNLHEQDVIV 578
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136678|ref|XP_002326918.1| predicted protein [Populus trichocarpa] gi|222835233|gb|EEE73668.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-121, Method: Compositional matrix adjust.
Identities = 216/332 (65%), Positives = 250/332 (75%), Gaps = 22/332 (6%)
Query: 338 AVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
++ + +EK + +K+QW KGKLIG GT+G VY+GTNR TGASCA+KEVDIIPDDPKSA
Sbjct: 6 TIIHNTLEKLNEPLRKNQWVKGKLIGSGTYGRVYMGTNRVTGASCAMKEVDIIPDDPKSA 65
Query: 398 ECIKQLEQ---------------------VDDHLYIYLEYVHPGSINRYVREHCRDITES 436
ECIKQLEQ VDD YIYLEY++PGSIN+YVREHC +TES
Sbjct: 66 ECIKQLEQEIRVLRDLKHPNIVQYYGCEIVDDQFYIYLEYINPGSINKYVREHCGHMTES 125
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496
IVRNFTRHIL+GLAYLHS T+HRDIKGANLLVDASGVVKL DFG AKHLTGLSYELSLK
Sbjct: 126 IVRNFTRHILSGLAYLHSKKTVHRDIKGANLLVDASGVVKLTDFGTAKHLTGLSYELSLK 185
Query: 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 556
GSP+WMAPEVIKAVM K GNP+LA AVD WSLGCT+IEM TGKPPW + +G QAMFK+LN
Sbjct: 186 GSPHWMAPEVIKAVMLKSGNPELAFAVDTWSLGCTIIEMFTGKPPWGDLQGAQAMFKILN 245
Query: 557 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 616
+ PP+PE LS EGKDFL RCF RNP ERPSA+ LLEHPF+ A+ N+S +NL
Sbjct: 246 KDPPMPETLSPEGKDFLRRCFRRNPAERPSAMMLLEHPFVCKASDLNVSASREAIPAVNL 305
Query: 617 GDKSHDQVERATRKTESLPDSPETRVRNRKLP 648
D S +R T + + P SP R+RN +LP
Sbjct: 306 EDNSQSLRDR-TAENDVSPTSPGMRMRNHRLP 336
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| TAIR|locus:2174969 | 716 | MAPKKK5 "mitogen-activated pro | 0.319 | 0.321 | 0.652 | 1.5e-120 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.261 | 0.212 | 0.604 | 2.2e-81 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.273 | 0.323 | 0.550 | 2.9e-60 | |
| UNIPROTKB|Q40541 | 690 | Q40541 "Protein kinase" [Nicot | 0.297 | 0.310 | 0.440 | 7e-49 | |
| UNIPROTKB|F1MH06 | 626 | MAP3K3 "Uncharacterized protei | 0.258 | 0.297 | 0.438 | 6.4e-47 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.262 | 0.149 | 0.440 | 5.5e-46 | |
| TAIR|locus:2080394 | 651 | NP3 "NPK1-related protein kina | 0.251 | 0.278 | 0.482 | 7.6e-46 | |
| TAIR|locus:2133529 | 560 | MEKK3 "MAPK/ERK kinase kinase | 0.252 | 0.325 | 0.484 | 1e-45 | |
| UNIPROTKB|K7GPY0 | 612 | MAP3K3 "Uncharacterized protei | 0.258 | 0.303 | 0.438 | 1e-45 | |
| UNIPROTKB|J3KRN4 | 622 | MAP3K3 "Mitogen-activated prot | 0.258 | 0.299 | 0.438 | 1.5e-45 |
| TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 807 (289.1 bits), Expect = 1.5e-120, Sum P(3) = 1.5e-120
Identities = 154/236 (65%), Positives = 187/236 (79%)
Query: 404 EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
E V+D +IYLEYVHPGSIN+Y+R+HC +TES+VRNFTRHIL+GLAYLH+ T+HRDIK
Sbjct: 415 ETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRNFTRHILSGLAYLHNKKTVHRDIK 474
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
GANLLVDASGVVKLADFGMAKHLTG +LSLKGSP WMAPE+++AVMQKD NP LA AV
Sbjct: 475 GANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQKDSNPDLAFAV 534
Query: 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE 583
DIWSLGCT+IEM TGKPPWSEFEG AMFKV+ +PPIPE +S EGKDFL CF RNP E
Sbjct: 535 DIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPPIPESMSPEGKDFLRLCFQRNPAE 594
Query: 584 RPSAVELLEHPFIRNA----NYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLP 635
RP+A LLEH F++N+ + N V ++F+ +N+ + S + E+ K + +P
Sbjct: 595 RPTASMLLEHRFLKNSLQPTSPSNSDVS-QLFNGMNITEPSSRR-EKPNFKLDQVP 648
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 2.2e-81, Sum P(3) = 2.2e-81
Identities = 119/197 (60%), Positives = 147/197 (74%)
Query: 404 EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
E VDD LYIYLEYV GSI + ++E+ + E+ +RN+T+ IL+GLAYLH+ NT+HRDIK
Sbjct: 469 ETVDDKLYIYLEYVSGGSIYKLLQEYGQ-FGENAIRNYTQQILSGLAYLHAKNTVHRDIK 527
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
GAN+LVD G VK+ADFGMAKH+T S LS KGSP WMAPEVIK +G+ LAV
Sbjct: 528 GANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIK---NSNGSN---LAV 581
Query: 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNP 581
DIWSLGCTV+EM T KPPWS++EG AMFK+ N P IP+ LS EGKDF+ +C RNP
Sbjct: 582 DIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNP 641
Query: 582 VERPSAVELLEHPFIRN 598
RP+A +LL+H F+RN
Sbjct: 642 ANRPTAAQLLDHAFVRN 658
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 2.9e-60, Sum P(2) = 2.9e-60
Identities = 114/207 (55%), Positives = 149/207 (71%)
Query: 404 EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
E ++ L +YLEYV GSI++ ++++ TE +++N+TR IL GLAYLH NT+HRDIK
Sbjct: 283 ELSEETLSVYLEYVSGGSIHKLLKDY-GSFTEPVIQNYTRQILAGLAYLHGRNTVHRDIK 341
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
GAN+LVD +G +KLADFGMAKH+T S LS KGSP WMAPEV VM ++G AV
Sbjct: 342 GANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEV---VMSQNGYTH---AV 395
Query: 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNP 581
DIWSLGCT++EM T KPPWS+FEG A+FK+ N TP IP+ LS++ K+F+ C RNP
Sbjct: 396 DIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCLQRNP 455
Query: 582 VERPSAVELLEHPFIRNAN-YQNLSVP 607
RP+A +LLEHPF+RN + S+P
Sbjct: 456 TVRPTASQLLEHPFLRNTTRVASTSLP 482
|
|
| UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)] | Back alignment and assigned GO terms |
|---|
Score = 443 (161.0 bits), Expect = 7.0e-49, Sum P(2) = 7.0e-49
Identities = 103/234 (44%), Positives = 144/234 (61%)
Query: 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469
L I LE+V GSI+ + + ES++R +T+ +L GL YLH +HRDIKGAN+LV
Sbjct: 158 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV 216
Query: 470 DASGVVKLADFGMAK---HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 526
D G +KLADFG +K L ++ S+KG+P WMAPEVI +Q G+ + + DIW
Sbjct: 217 DNKGCIKLADFGASKKVVELATMTGAKSMKGTPYWMAPEVI---LQT-GH---SFSADIW 269
Query: 527 SLGCTVIEMLTGKPPWSE-FEGPQAMFKV--LNRTPPIPEMLSSEGKDFLLRCFLRNPVE 583
S+GCT+IEM TGKPPWS+ ++ A+F + PPIPE LS+E KDFLL+C + P
Sbjct: 270 SVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKDFLLKCLQKEPHL 329
Query: 584 RPSAVELLEHPFIRNANYQNLSVPMRVFSRIN-LGDKSHDQVERATRKTESLPD 636
R SA LL+HPF+ A +Q R F R + +G+ + +R +T +PD
Sbjct: 330 RHSASNLLQHPFV-TAEHQEA----RPFLRSSFMGNPENMAAQRMDVRTSIIPD 378
|
|
| UNIPROTKB|F1MH06 MAP3K3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 6.4e-47, Sum P(3) = 6.4e-47
Identities = 89/203 (43%), Positives = 129/203 (63%)
Query: 399 CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
C++ ++ + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YLHS +
Sbjct: 430 CLR--DRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSNMIV 486
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIKAVMQKD 514
HRDIKGAN+L D++G VKL DFG +K L + S+ G+P WM+PEVI +
Sbjct: 487 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVISG----E 542
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 572
G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P +S G+DF
Sbjct: 543 GYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDF 599
Query: 573 LLRCFLRNPVERPSAVELLEHPF 595
L R F+ +RPSA ELL H F
Sbjct: 600 LRRIFVEAR-QRPSAEELLTHHF 621
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 5.5e-46, Sum P(3) = 5.5e-46
Identities = 89/202 (44%), Positives = 133/202 (65%)
Query: 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469
L ++LEY+ GSI+ + + +E++++ +T+ IL GL++LH+ + IHRDIKGAN+L+
Sbjct: 572 LSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSFLHANSIIHRDIKGANILI 630
Query: 470 DASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 528
D G+VKL+DFG +K +G+ + S++G+P WMAPEVIK + G+ + + DIWSL
Sbjct: 631 DTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK----QTGHGRSS---DIWSL 683
Query: 529 GCTVIEMLTGKPPWSEF-EGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERP 585
GC ++EM T +PPWS E M+ + N P IP +S E DFL CF R+P ERP
Sbjct: 684 GCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERP 743
Query: 586 SAVELLEHPFIRNANYQNLSVP 607
A +LL+HPFI N + N+ +P
Sbjct: 744 DANQLLKHPFIMNLD-DNIQLP 764
|
|
| TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 7.6e-46, Sum P(2) = 7.6e-46
Identities = 94/195 (48%), Positives = 124/195 (63%)
Query: 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 467
D L I +E+V GSI+ + E E ++ +T+ +L GL YLH+ +HRDIKGAN+
Sbjct: 144 DSLNILMEFVPGGSISSLL-EKFGSFPEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANI 202
Query: 468 LVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
LVD G ++LADFG +K + L+ S+KG+P WMAPEVI +Q G+ + + D
Sbjct: 203 LVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI---LQT-GH---SFSAD 255
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEGKDFLLRCFLRNP 581
IWS+GCTVIEM TGKPPWSE A + RT PPIPE LS E KDFL++C + P
Sbjct: 256 IWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKDFLMKCLHKEP 315
Query: 582 VERPSAVELLEHPFI 596
R SA ELL+HPF+
Sbjct: 316 SLRLSATELLQHPFV 330
|
|
| TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 424 (154.3 bits), Expect = 1.0e-45, Sum P(3) = 1.0e-45
Identities = 92/190 (48%), Positives = 123/190 (64%)
Query: 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469
LYI+LE V GS+ + + ++ ++V +TR IL GL YLH +HRDIK AN+LV
Sbjct: 377 LYIFLELVTQGSVQKLYERY--QLSYTVVSLYTRQILAGLNYLHDKGFVHRDIKCANMLV 434
Query: 470 DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG 529
DA+G VKLADFG+A+ + + +S KG+ WMAPEVI DGN A DIWSLG
Sbjct: 435 DANGTVKLADFGLAE-ASKFNDIMSCKGTLFWMAPEVINR-KDSDGNGSPA---DIWSLG 489
Query: 530 CTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAV 588
CTV+EM TG+ P+S+ + QA FK+ T P +P+ LS + + F+L C NP ERP+A
Sbjct: 490 CTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARHFILTCLKVNPEERPTAA 549
Query: 589 ELLEHPFIRN 598
ELL HPF+ N
Sbjct: 550 ELLHHPFVIN 559
|
|
| UNIPROTKB|K7GPY0 MAP3K3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 1.0e-45, Sum P(2) = 1.0e-45
Identities = 89/203 (43%), Positives = 129/203 (63%)
Query: 399 CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
C++ ++ + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YLHS +
Sbjct: 416 CLR--DRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSNMIV 472
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIKAVMQKD 514
HRDIKGAN+L D++G VKL DFG +K L + S+ G+P WM+PEVI +
Sbjct: 473 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVISG----E 528
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 572
G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P +S G+DF
Sbjct: 529 GYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDF 585
Query: 573 LLRCFLRNPVERPSAVELLEHPF 595
L R F+ +RPSA ELL H F
Sbjct: 586 LRRIFVEAR-QRPSAEELLTHHF 607
|
|
| UNIPROTKB|J3KRN4 MAP3K3 "Mitogen-activated protein kinase kinase kinase 3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 1.5e-45, Sum P(2) = 1.5e-45
Identities = 89/203 (43%), Positives = 129/203 (63%)
Query: 399 CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
C++ ++ + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YLHS +
Sbjct: 426 CLR--DRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSNMIV 482
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIKAVMQKD 514
HRDIKGAN+L D++G VKL DFG +K L + S+ G+P WM+PEVI +
Sbjct: 483 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVISG----E 538
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 572
G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P +S G+DF
Sbjct: 539 GYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDF 595
Query: 573 LLRCFLRNPVERPSAVELLEHPF 595
L R F+ +RPSA ELL H F
Sbjct: 596 LRRIFVEAR-QRPSAEELLTHHF 617
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00009700001 | SubName- Full=Chromosome undetermined scaffold_245, whole genome shotgun sequence; (592 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 720 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-111 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-103 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-82 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-79 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-75 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-73 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-72 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-67 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-66 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-63 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-61 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-61 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-58 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-55 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-55 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-55 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-54 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-52 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-51 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-51 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-51 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-50 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-49 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-43 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-42 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-42 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-40 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-39 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-39 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-39 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-39 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-38 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-38 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-38 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-37 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-37 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-37 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-37 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-37 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-35 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-35 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-35 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-35 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-34 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-34 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-33 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-33 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-33 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-32 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-32 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-32 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-31 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-31 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-31 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-31 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-30 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-30 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-29 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-29 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-28 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-28 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-27 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-26 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-26 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-25 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-25 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-24 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-23 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-23 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-19 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-19 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 8e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.001 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 337 bits (865), Expect = e-111
Identities = 134/264 (50%), Positives = 170/264 (64%), Gaps = 30/264 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------- 405
W+KG+L+G G+FGSVY G N + G A+KEV + D E +KQLEQ
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 406 -----------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+D+LYI+LE V GS+ + ++++ E ++R +TR IL GL YLH
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
NT+HRDIKGAN+LVD +GVVKLADFGMAK + S+ S KGSP WMAPEVI Q+
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI---AQQG 177
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 572
G LA DIWSLGCTV+EM TGKPPWS+ EG A+FK+ PPIP+ LS E KDF
Sbjct: 178 GY---GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 573 LLRCFLRNPVERPSAVELLEHPFI 596
+L+C R+P RP+A ELLEHPF+
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 315 bits (809), Expect = e-103
Identities = 120/268 (44%), Positives = 167/268 (62%), Gaps = 34/268 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------------ 402
+W +G+L+GRG+FGSVY+ +++TG A+K V++ D + E +++
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 403 --------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
++ + L I+LEYV GS+ + + + E ++R +TR IL GLAYLHS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVM 511
+HRDIKGAN+LVD+ GVVKLADFG AK L + S++G+P WMAPEVI+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-- 177
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRT--PPIPEMLSSE 568
++ G A DIWSLGCTVIEM TGKPPWSE P A++K+ + P IPE LS E
Sbjct: 178 EEYG-----RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPFI 596
KDFL +C R+P +RP+A ELL+HPF+
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 2e-82
Identities = 114/262 (43%), Positives = 155/262 (59%), Gaps = 28/262 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-------LE--- 404
+Q G LIGRG FG VY G N ETG AIK++ + ++ + I Q L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 405 --------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ D LYI LEY GS+ + +++ ES+V + +L GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQG 119
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDG 515
IHRDIK AN+L GVVKLADFG+A L +S + S+ G+P WMAPEVI + G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI----EMSG 175
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFLL 574
+ A DIWSLGCTVIE+LTG PP+ + A+F+ V + PP+PE +S E KDFL+
Sbjct: 176 ---ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232
Query: 575 RCFLRNPVERPSAVELLEHPFI 596
+CF ++P RP+A +LL+HP+I
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 5e-79
Identities = 88/262 (33%), Positives = 139/262 (53%), Gaps = 29/262 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSA----ECIKQL------ 403
++ + +G G+FG VY+ +++TG AIK + I D + + +K+L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 404 -----EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ +D LY+ +EY G + +++ R ++E R + R IL+ L YLHS +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHSKGIV 119
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
HRD+K N+L+D G VKLADFG+A+ L + G+P +MAPEV+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-------GKG 172
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPE---MLSSEGKDFLL 574
AVDIWSLG + E+LTGKPP+ + +FK + PP P +S E KD +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 575 RCFLRNPVERPSAVELLEHPFI 596
+ +++P +R +A E L+HPF
Sbjct: 233 KLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 2e-75
Identities = 117/269 (43%), Positives = 153/269 (56%), Gaps = 32/269 (11%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD--- 407
+WQ+G IG GTFG VY N +TG A+KE+ I +DPK+ + I LE +
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 408 -----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ +YI++EY G++ + EH R + E ++R +T +L GLAYLHS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSPNWMAPEVIKAVM 511
+HRDIK AN+ +D +GV+KL DFG A L T SL G+P +MAPEVI
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT--- 176
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV-LNRTPPIPE--MLSS 567
A DIWSLGC V+EM TGK PWSE + Q MF V PPIP+ LS
Sbjct: 177 -GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFI 596
EGKDFL RC +P +RP+A ELL+HPF+
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (605), Expect = 8e-73
Identities = 109/271 (40%), Positives = 161/271 (59%), Gaps = 41/271 (15%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------- 404
W++GKL+G+G FG VY+ + +TG A+K+V PD P++ + + LE
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 405 ----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+ D+ L I++EY+ GS+ ++ + +TE++ R +TR IL G+ YLHS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS 122
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPEVI 507
+HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PEVI
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWMSPEVI 179
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEML 565
+G + A D+WS+GCTV+EMLT KPPW+EFE A+FK+ P +P +
Sbjct: 180 SG----EGYGRKA---DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV 232
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
S + ++FL R F+ N +RPSA ELL H F+
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 5e-72
Identities = 116/276 (42%), Positives = 154/276 (55%), Gaps = 41/276 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQL------- 403
W KG+LIG+GT+G VY+ N TG A+K+V++ D + + +K L
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 404 --------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
E +++L I+LEYV GSI +R + R E +VR FT +L GL
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGL 121
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEV 506
AYLHS +HRD+K NLLVDA G+ K++DFG++K + +S++GS WMAPEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE- 563
I + Q + VDIWSLGC V+EM G+ PWS+ E AMFK+ N PPIP
Sbjct: 182 IHSYSQ-----GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 564 ---MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
LS DFL CF NP RP+A ELL+HPFI
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 4e-68
Identities = 97/260 (37%), Positives = 141/260 (54%), Gaps = 28/260 (10%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------- 404
++ + IG+G FG VY ++ TG AIK + + K + I +++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-ESKEKKEKIINEIQILKKCKHPNIV 60
Query: 405 ------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
D L+I +E+ GS+ ++ + +TES + + +L GL YLHS I
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
HRDIK AN+L+ + G VKL DFG++ L+ ++ G+P WMAPEVI K + K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN---GKPYDYK 177
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDFLLR 575
DIWSLG T IE+ GKPP+SE +A+FK+ PP PE S E KDFL +
Sbjct: 178 ----ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 576 CFLRNPVERPSAVELLEHPF 595
C +NP +RP+A +LL+HPF
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 1e-67
Identities = 87/269 (32%), Positives = 131/269 (48%), Gaps = 37/269 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL------------ 403
++ + +G G+FG+VY ++ TG A+K + KS +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTARREIRILRRLSHP 58
Query: 404 --------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
+ DHLY+ +EY G + Y+ ++E + IL GL YLHS
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHSN 117
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKD 514
IHRD+K N+L+D +GVVK+ADFG+AK L S L + G+P +MAPEV+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL------ 171
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-------MLSS 567
G VD+WSLG + E+LTGKPP+S + + P E S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFI 596
E KD + +C ++P +RP+A E+L+HP+
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 5e-66
Identities = 98/257 (38%), Positives = 142/257 (55%), Gaps = 31/257 (12%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------------- 404
+G G++GSVY ++ETG AIK V + + E IK++
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV---EEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 405 -QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+ L+I +EY GS++ ++ + +TE + L GL YLHS IHRDIK
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126
Query: 464 GANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
N+L++ G KLADFG++ LT ++ ++ G+P WMAPEVI + N K
Sbjct: 127 AGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYNNK---- 179
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDFLLRCFLR 579
DIWSLG T IEM GKPP+S+ +A+F + N+ PP PE S E DF+ +C ++
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVK 239
Query: 580 NPVERPSAVELLEHPFI 596
+P ERPSA++LL+HPFI
Sbjct: 240 DPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 95/270 (35%), Positives = 133/270 (49%), Gaps = 37/270 (13%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQVDD-- 408
+ + IG+G+FG VY ++ T AIK +D+ + + + ++ L Q
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 409 ------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
L+I +EY GS ++ + E+ + R +L GL YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAVM 511
IHRDIK AN+L+ G VKLADFG++ LT K G+P WMAPEVIK
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPFWMAPEVIK--- 171
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEG 569
Q + K DIWSLG T IE+ G+PP S+ + +F + PP E S
Sbjct: 172 QSGYDEK----ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227
Query: 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
KDF+ C ++P ERPSA ELL+H FI+ A
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 3e-61
Identities = 105/263 (39%), Positives = 145/263 (55%), Gaps = 29/263 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA--------EC-----IKQ 402
+K IG G G VY T+R TG AIK++ + + + +C +
Sbjct: 24 LEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 403 LEQ--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
+ V D L++ +EY+ GS+ + ++ + E + R +L GL YLHS N IHR
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
DIK N+L+ G VKLADFG A LT S S+ G+P WMAPEVIK +KD PK
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK---RKDYGPK- 196
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEMLSSEGKDFLLRC 576
VDIWSLG IEM G+PP+ +A+F + PP+ PE S E KDFL +C
Sbjct: 197 ---VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253
Query: 577 FLRNPVERPSAVELLEHPFIRNA 599
+++P +RPSA ELL+HPF++ A
Sbjct: 254 LVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 4e-61
Identities = 116/275 (42%), Positives = 155/275 (56%), Gaps = 41/275 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV-----DIIPDDPKSA---------ECI 400
+W KG LIG G+FGSVY+G N +G A+K+V D K + +
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 401 KQLEQVD-----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
K+L+ + DHL I+LEYV GS+ + + E++VRNF R IL GL
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGL 119
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWM 502
YLH+ IHRDIKGAN+LVD G +K++DFG++K L S SL+GS WM
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI 561
APEV+K K DIWSLGC V+EMLTGK P+ + QA+FK+ N +P I
Sbjct: 180 APEVVKQTSY---TRK----ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P +SSE DFL + F + +RP+A ELL+HPF+
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 2e-58
Identities = 110/272 (40%), Positives = 158/272 (58%), Gaps = 44/272 (16%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------ECIKQL------ 403
W++GKL+G+G FG VY+ + +TG A K+V P+ P+++ EC QL
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 404 -----------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
++ + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYL 122
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 505
HS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PE
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMSPE 179
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 563
VI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P
Sbjct: 180 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+S +DF L C RPSA ELL HPF
Sbjct: 233 HISEHARDF-LGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 96/275 (34%), Positives = 151/275 (54%), Gaps = 43/275 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIG-TNRETGASCAIKEVDIIPDDPKSAE-----------CIKQ 402
+W KG+++G+G +G+VY G TN G A+K+V++ + +AE +K
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 403 LEQV-----------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
L+ V D+ + I++E+V GSI+ + + E + +T+ IL+G+AY
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAY 117
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWMAP 504
LH+ +HRDIKG N+++ +G++KL DFG A+ L + S+ G+P WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPI 561
EVI + G + + DIWS+GCTV EM TGKPP + + AMF + P +
Sbjct: 178 EVIN----ESGYGRKS---DIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P+ S+ DF+ C R+ ERPSA++LL H F+
Sbjct: 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 2e-55
Identities = 108/272 (39%), Positives = 159/272 (58%), Gaps = 38/272 (13%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------ECIKQL---- 403
+ W+ GKL+G+G FG VY+ + +TG A+K+V P+ P+++ EC QL
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 404 -------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
+ ++ L I++E++ GSI ++ + +TE++ R +TR IL G++
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVS 120
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEV 506
YLHS +HRDIKGAN+L D+ G VKL DFG +K L + S+ G+P WM+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 564
I +G + A DIWS+GCTV+EMLT KPPW+EFE A+FK+ + P +P
Sbjct: 181 ISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+S +DFL R F+ + RPSA ELL H F+
Sbjct: 234 VSDHCRDFLKRIFVEAKL-RPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 102/259 (39%), Positives = 143/259 (55%), Gaps = 28/259 (10%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAE-------CIKQLEQ----- 405
++G+GT+G VY + T AIKE+ P E + + Q
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 406 -VDDHLYIYLEYVHPGSINRYVREHCRDIT--ESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+ I++E V GS++ +R + E + +T+ IL GL YLH +HRDI
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 463 KGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
KG N+LV+ SGVVK++DFG +K L G++ + G+ +MAPEVI + G P
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAP--- 191
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKV--LNRTPPIPEMLSSEGKDFLLRCF 577
DIWSLGCT++EM TGKPP+ E PQA MFKV P IPE LS+E K+F+LRCF
Sbjct: 192 --ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249
Query: 578 LRNPVERPSAVELLEHPFI 596
+P +R SA +LL+ PF+
Sbjct: 250 EPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 1e-54
Identities = 107/273 (39%), Positives = 158/273 (57%), Gaps = 44/273 (16%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------ECIKQLEQVDDH 409
W+ GKL+GRG FG VY+ + +TG A+K+V PD +++ EC QL + H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 410 -----------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
L I++EY+ GSI ++ + +TE++ R +TR IL G++YL
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYL 122
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 505
HS +HRDIKGAN+L D++G VKL DFG +K + TG+ S+ G+P WM+PE
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK---SVTGTPYWMSPE 179
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 563
VI +G + A D+WS+ CTV+EMLT KPPW+E+E A+FK+ + P +P+
Sbjct: 180 VISG----EGYGRKA---DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+S +DFL + F+ RP+A LL HPF+
Sbjct: 233 GVSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-52
Identities = 95/270 (35%), Positives = 137/270 (50%), Gaps = 31/270 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---------------- 399
++ ++IG GT+G VY +++TG AIK +DII D+ + +
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIAT 67
Query: 400 -----IKQLEQV-DDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRHILNGLA 450
IK+ DD L++ +E GS+ V R+ + + E + R L GLA
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKA 509
YLH IHRDIKG N+L+ + VKL DFG++ L + G+P WMAPEVI A
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI-A 186
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLS 566
++ + D+WSLG T IE+ GKPP + +A+FK+ PP PE S
Sbjct: 187 CDEQP-DASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWS 245
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ DF+ C ++N +RP ELLEHPFI
Sbjct: 246 KKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 6e-52
Identities = 78/252 (30%), Positives = 121/252 (48%), Gaps = 56/252 (22%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQV------------ 406
+G G FG+VY+ +++TG AIK + E I+ L+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 407 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
++HLY+ +EY GS+ ++E+ ++E + IL GL YLHS IHRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 465 ANLLVDA-SGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
N+L+D+ +G VKLADFG++K LT L ++ G+P +MAPEV+ G +
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL------GKGYYSEK 174
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPV 582
DIWSLG + E+ E KD + + ++P
Sbjct: 175 SDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPE 203
Query: 583 ERPSAVELLEHP 594
+RPSA E+LEH
Sbjct: 204 KRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 94/257 (36%), Positives = 133/257 (51%), Gaps = 28/257 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------AEC----IKQL---EQ 405
IG GT+G VY + TG AIK + + P D EC I
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
D L+I +EY GS+ + ++E + R L GLAYLH T IHRDIKGA
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGA 130
Query: 466 NLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
N+L+ G VKLADFG++ LT ++ S G+P WMAPEV AV +K G D
Sbjct: 131 NILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-AVERKGGYDGKC---D 186
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK------DFLLRCFL 578
IW+LG T IE+ +PP + +A+F +++++ P L + K DF+ +C
Sbjct: 187 IWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPPKLKDKEKWSPVFHDFIKKCLT 245
Query: 579 RNPVERPSAVELLEHPF 595
++P +RP+A +LL+HPF
Sbjct: 246 KDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 88/273 (32%), Positives = 140/273 (51%), Gaps = 36/273 (13%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----SAECIKQLEQVDD 408
S ++ K++G+G+ G VY ++ TG A+K++ + D + E +K L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRE-LKTLRSCES 58
Query: 409 H--------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+ I LEY+ GS+ +++ I E ++ R IL GL YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT 117
Query: 455 T-NTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQ 512
+ IHRDIK +NLL+++ G VK+ADFG++K L L + G+ +M+PE I+ +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG--E 175
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--AMFKVLNRTPPI---PEMLSS 567
DIWSLG T++E GK P+ P + + + PP E S
Sbjct: 176 SYSYAA-----DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
E +DF+ C ++P +RPSA ELL+HPFI+ A+
Sbjct: 231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 4e-51
Identities = 89/276 (32%), Positives = 144/276 (52%), Gaps = 41/276 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV----DIIPDDPKSAECIKQ-------- 402
+W KG+ +G G F S Y + +TG A+K+V + + + E +++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 403 ----------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
D H +++E++ GS++ + ++ E+++ N+T +L GL+YL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL 119
Query: 453 HSTNTIHRDIKGANLLVDASG-VVKLADFG----MAKHLTGLS-YELSLKGSPNWMAPEV 506
H IHRD+KGANLL+D++G +++ADFG +A TG ++ L G+ +MAPEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKV--LNRTPPI 561
++ G + D+WS+GC +IEM T KPPW+ + +FK+ P I
Sbjct: 180 LR------GEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
PE LS +D LRC P +RP + ELL+HP R
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 4e-51
Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 44/267 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQV------ 406
K IG+G+FG VY+ + G +KE+D+ K + +K+L
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 407 -----DDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTNTI 458
L I +EY G +++ +++ ++ E + ++ + L YLHS +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGN 516
HRDIK N+ + ++G+VKL DFG++K L+ + +L ++ G+P +++PE+ +
Sbjct: 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGTPYYLSPELCQ------NK 178
Query: 517 P---KLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRT-PPIPEMLSSEG 569
P K DIWSLGC + E+ T K P FEG + K+L PPIP SSE
Sbjct: 179 PYNYK----SDIWSLGCVLYELCTLKHP---FEGENLLELALKILKGQYPPIPSQYSSEL 231
Query: 570 KDFLLRCFLRNPVERPSAVELLEHPFI 596
++ + ++P ERPS ++L+ PFI
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 96/264 (36%), Positives = 141/264 (53%), Gaps = 22/264 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------AEC----IKQ 402
W+ +G G FG VY ++ETG A K + I ++ +EC I
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 403 LEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
L + ++ L+I +E+ G+++ + E R +TE +R R +L L +LHS IH
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 460 RDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L+ G VKLADFG+ AK+ + L + G+P WMAPEV+ KD NP
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD-NPY 185
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLR 575
A DIWSLG T+IE+ +PP E + + K+L PP P SS DFL
Sbjct: 186 DYKA-DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244
Query: 576 CFLRNPVERPSAVELLEHPFIRNA 599
C +++P +RP+A ELL+HPF+ +
Sbjct: 245 CLVKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 5e-49
Identities = 97/285 (34%), Positives = 140/285 (49%), Gaps = 31/285 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDP-----KSAECIKQLEQ-- 405
S +Q+ +LIGRG +G+VY G + TG A+K +++ PDD + + QL Q
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 406 ------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
L+I +EY GS+ ++ I E + R +L L Y+H
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIH 118
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQ 512
IHRDIK AN+LV +G VKL DFG+A L S + G+P WMAPEVI
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPE-MLSSEGK 570
D DIWSLG T+ EM TG PP+S+ + +AM + PP + + S +
Sbjct: 179 YD------TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLR 232
Query: 571 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 615
+F+ C P ER SA ELL+ +I+ + +S+ + SR
Sbjct: 233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISRYQ 277
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 7e-44
Identities = 95/265 (35%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------AEC-----IK 401
W+ +G G FG VY N+ETGA A K ++ ++ A C +K
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 402 QLEQV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
L D L+I +E+ G+++ + E R +TE ++ R +L L YLHS IH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 460 RDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L+ G +KLADFG+ AK++ L S G+P WMAPEV+ KD
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT--P 191
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLR 575
DIWSLG T+IEM +PP E + + K+ PP P S E +DFL
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251
Query: 576 CFLRNPVERPSAVELLEHPFIRNAN 600
++P RPSA +LLEHPF+ +
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 82/293 (27%), Positives = 142/293 (48%), Gaps = 65/293 (22%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA--E--CIKQLEQ---- 405
+K + +G GT+G VY +++TG A+K++ + ++ P +A E +K+L+
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIV 61
Query: 406 -------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ LY+ EY + +Y+ + ++ +++++ +L GLAY HS +
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM------APEVIKAVMQ 512
HRD+K N+L++ GV+KLADFG+A+ ++ + L+ + + APE++
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEILL---- 171
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-------------- 555
G+ + AVDIWS+GC EM+TGKP + SE + +F++L
Sbjct: 172 --GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 556 ----NRTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P P L EG D L + NP +R SA E L+HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 100/270 (37%), Positives = 142/270 (52%), Gaps = 32/270 (11%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL------- 403
PKK ++ + + IG+G G+VY + TG AIK++++ PK I ++
Sbjct: 17 PKK-KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENK 74
Query: 404 ----------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
V D L++ +EY+ GS+ V E C D E + R L L +LH
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLH 132
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQ 512
S IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV V +
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---VTR 189
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEMLSSEG 569
K PK VDIWSLG IEM+ G+PP+ +A++ + N TP + PE LS+
Sbjct: 190 KAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245
Query: 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+DFL RC + +R SA ELL+HPF++ A
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 1e-42
Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 33/263 (12%)
Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKS------AECIKQLE-- 404
+ GK +G G FG VY GT T A+K + + + A +K+L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 405 ---------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
+ LYI EY+ G + ++R+H +T + I G+ YL S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQ 512
N +HRD+ N LV + VVK++DFG+++ + Y G WMAPE +K
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK---- 177
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 570
+ K D+WS G + E+ T G+ P+ + + + + P PE E
Sbjct: 178 ---DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY 234
Query: 571 DFLLRCFLRNPVERPSAVELLEH 593
+ +L+C+ +P +RP+ EL+E
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 88/267 (32%), Positives = 136/267 (50%), Gaps = 29/267 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDI--------------IPDDPKSAECIKQLEQ-- 405
IG G+ G V I T++ TG A+K++D+ I D + ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
V D L++ +E++ G++ V H R + E + +L L++LH+ IHRDIK
Sbjct: 87 VGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSD 144
Query: 466 NLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
++L+ + G VKL+DFG ++ + SL G+P WMAPEVI + VD
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-------PYGTEVD 197
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLRCFLRNP 581
IWSLG VIEM+ G+PP+ QAM ++ + PP +S + FL R +R+P
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257
Query: 582 VERPSAVELLEHPFIRNANYQNLSVPM 608
+R +A ELL HPF+ A + VP+
Sbjct: 258 AQRATAAELLNHPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 84/264 (31%), Positives = 127/264 (48%), Gaps = 45/264 (17%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAEC--IK 401
+G+G+FG V + ++TG A+K E +I+ I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNIL----SRINHPFIV 56
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+L Q ++ LY+ LEY G + ++ + +E R + I+ L YLHS I
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+L+DA G +KL DFG+AK L + S + G+P ++APEV+ K
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL---GKGYGK 172
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFLL 574
AVD WSLG + EMLTGKPP F + ++ K+L PE LS E +D +
Sbjct: 173 ----AVDWWSLGVLLYEMLTGKPP---FYAEDRKEIYEKILKDPLRFPEFLSPEARDLIS 225
Query: 575 RCFLRNPVER---PSAVELLEHPF 595
++P +R A E+ HPF
Sbjct: 226 GLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 90/261 (34%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------AEC-----IK 401
W+ +G G FG VY N+ETG A K +D ++ A C +K
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 402 QLEQV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
L+ +++L+I +E+ G+++ + E R +TE +R + L L YLH IH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 460 RDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L G +KLADFG+ AK+ + S G+P WMAPEV+ KD
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD--RP 184
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLR 575
D+WSLG T+IEM +PP E + + K+ PP P SSE KDFL +
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244
Query: 576 CFLRNPVERPSAVELLEHPFI 596
C +N R + +LL+HPF+
Sbjct: 245 CLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 82/266 (30%), Positives = 121/266 (45%), Gaps = 38/266 (14%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------- 405
IG G VY AIK +D+ E K+++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 406 -VDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
V D L++ + Y+ GS+ ++ + E+I+ + +L GL YLHS IHRDI
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDI 128
Query: 463 KGANLLVDASGVVKLADFGMAKHL--TGLSYELSLK---GSPNWMAPEVIKAVMQKDG-N 516
K N+L+ G VK+ADFG++ L G K G+P WMAPEV++ Q G +
Sbjct: 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME---QVHGYD 185
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM------LSSEGK 570
K DIWS G T IE+ TG P+S++ + + L PP E S +
Sbjct: 186 FK----ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR 241
Query: 571 DFLLRCFLRNPVERPSAVELLEHPFI 596
+ C ++P +RP+A ELL+H F
Sbjct: 242 KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 89/269 (33%), Positives = 135/269 (50%), Gaps = 30/269 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---------------- 399
W+ + IG+GT+G V+ N++ G+ A+K +D I D + E
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 400 -----IKQLEQVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAY 451
K+ + D L++ LE + GS+ V+ + + E I+ L GL +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 510
LH TIHRD+KG N+L+ G VKL DFG++ LT + G+P WMAPEVI
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSS 567
Q D D+WSLG T IE+ G PP ++ +A+FK+ PP PE+ S+
Sbjct: 200 QQLDST--YDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSN 257
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFI 596
E DF+ +C ++ +RP+ +LL+H FI
Sbjct: 258 EFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-39
Identities = 96/255 (37%), Positives = 130/255 (50%), Gaps = 30/255 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVDD--------- 408
IG+G+FG VY G + T AIK +D+ + E I+Q L Q D
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 409 -----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
L+I +EY+ GS ++ + E+ + R IL GL YLHS IHRDIK
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
AN+L+ G VKLADFG+A LT + + G+P WMAPEVIK
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-------QSAYDFK 181
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFLRNP 581
DIWSLG T IE+ G+PP S+ + +F + +PP E S K+F+ C ++P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 582 VERPSAVELLEHPFI 596
RP+A ELL+H FI
Sbjct: 242 RFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 8e-39
Identities = 100/293 (34%), Positives = 151/293 (51%), Gaps = 29/293 (9%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--------------IPDD 393
S K ++ + + IG+G G+VY + TG AIK++++ + +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 394 PKSAECIKQLEQ--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
K+ + L+ V D L++ +EY+ GS+ V E C D E + R L L +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDF 130
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAV 510
LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV V
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---V 187
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEMLSS 567
+K PK VDIWSLG IEM+ G+PP+ +A++ + N TP + PE LS+
Sbjct: 188 TRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA 243
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 620
+DFL RC + R SA ELL+HPF++ A + P+ + ++ + + S
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 9e-39
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 48/269 (17%)
Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQ------- 405
GK +G G FG VY G + A+K + + S + I++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRK 57
Query: 406 --------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
++ LYI +EY+ G + Y+R++ ++ S + +F I G+ Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WMAPEVI 507
L S N IHRD+ N LV + VVK++DFG+++ L + K WMAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY--DDDYYRKRGGKLPIRWMAPESL 175
Query: 508 KAVMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 563
K+G K D+WS G + E+ T G+ P+ + + + N P P
Sbjct: 176 -----KEGKFTSK----SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLE 592
E D +L+C+ +P +RP+ EL+E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 33/265 (12%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
+G G G V +R TG A+K + + ++ + +++L+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 405 QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIK 463
+ + I +EY+ GS+++ ++E I E I+ +L GL YLH IHRD+K
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
+N+LV++ G +KL DFG++ L S + G+ ++MAPE I+ ++
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQG-------NDYSVKS 180
Query: 524 DIWSLGCTVIEMLTGK-PPWSEFEGPQAMF----KVLNRTPP-IP-EMLSSEGKDFLLRC 576
DIWSLG ++IE+ TG+ P E + P +F ++N PP +P S + +DF+ C
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240
Query: 577 FLRNPVERPSAVELLEHPFIRNANY 601
+++P ERPS ELLEHPFI+
Sbjct: 241 LIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 103/282 (36%), Positives = 147/282 (52%), Gaps = 35/282 (12%)
Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
IMEK S K ++ + + IG+G G+V+ + TG AIK++++ PK
Sbjct: 4 IMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKEL 62
Query: 399 CI------KQLEQ-----------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 441
I K+L+ V D L++ +EY+ GS+ V E C D E+ +
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQIAAV 120
Query: 442 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPN 500
R L L +LH+ IHRDIK N+L+ G VKL DFG +T S ++ G+P
Sbjct: 121 CRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTP 559
WMAPEV V +K PK VDIWSLG IEM+ G+PP+ +A++ + N TP
Sbjct: 181 WMAPEV---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 560 PI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+ PE LS +DFL RC + +R SA ELL+HPF++ A
Sbjct: 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 37/263 (14%)
Query: 358 KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDP------KSAECIKQLE--- 404
GK +G G FG VY GT A+K + + + A +++L+
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 405 --------QVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHST 455
++ L I +EY+ G + Y+R++ ++++ S + +F I G+ YL S
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKAVMQK 513
N IHRD+ N LV + VVK++DFG+++ L Y G P WMAPE + K
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL-----K 177
Query: 514 DG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569
+G K D+WS G + E+ T G+ P+ + + + P P E
Sbjct: 178 EGKFTSK----SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 570 KDFLLRCFLRNPVERPSAVELLE 592
+L+C+ +P +RP+ EL+E
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 7e-38
Identities = 99/258 (38%), Positives = 131/258 (50%), Gaps = 29/258 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDI------IPDDPKSAECIKQLEQ---------- 405
IG+G+FG V+ G + T AIK +D+ I D + + Q +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 406 -VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
D L+I +EY+ GS + D E+ + R IL GL YLHS IHRDIK
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 465 ANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
AN+L+ G VKLADFG+A LT + + G+P WMAPEVIK Q + K
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSK----A 182
Query: 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFLRNPV 582
DIWSLG T IE+ G+PP SE + +F + PP E S K+F+ C + P
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242
Query: 583 ERPSAVELLEHPFI-RNA 599
RP+A ELL+H FI R A
Sbjct: 243 FRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-37
Identities = 96/272 (35%), Positives = 142/272 (52%), Gaps = 29/272 (10%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--------------IPDD 393
S K ++ + + IG+G G+VY + TG AI+++++ + +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 394 PKSAECIKQLEQ--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
K+ + L+ V D L++ +EY+ GS+ V E C D E + R L L +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEF 131
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAV 510
LHS IHRDIK N+L+ G VKL DFG +T + S + G+P WMAPEV V
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---V 188
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEMLSS 567
+K PK VDIWSLG IEM+ G+PP+ +A++ + N TP + PE LS+
Sbjct: 189 TRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+DFL RC + +R SA ELL+H F++ A
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 90/263 (34%), Positives = 126/263 (47%), Gaps = 41/263 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV------------DIIPDDPKSAECIKQLEQ---- 405
IG G+FG+VY + T AIK++ DII K ++QL
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII----KEVRFLQQLRHPNTI 78
Query: 406 ------VDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ +H ++ +EY GS + + H + + E + L GLAYLHS I
Sbjct: 79 EYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGN 516
HRDIK N+L+ G VKLADFG A + +S S G+P WMAPEVI A+ Q DG
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLL 574
VD+WSLG T IE+ KPP A++ + P S ++F+
Sbjct: 195 ------VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248
Query: 575 RCFLRNPVERPSAVELLEHPFIR 597
C + P +RPS+ ELL+H F+
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 88/270 (32%), Positives = 130/270 (48%), Gaps = 30/270 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------- 405
W+ + IG+GT+G VY TN++ G+ A+K +D I D + E + Q
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 406 -----------VDDHLYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAY 451
V L++ LE + GS+ V+ + E+++ L GL +
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 510
LH+ IHRD+KG N+L+ G VKL DFG++ LT + G+P WMAPEVI
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSS 567
Q D + D+WSLG T IE+ G PP + + +FK+ PP PE
Sbjct: 204 QQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCR 261
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
F+ +C +++ RPS LLEHPFI+
Sbjct: 262 SFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 40/270 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDP----KSAECIKQLE-------- 404
K I +G FGSVY+ R TG AIK + D+I + K+ I ++
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q D+LY+ +EY++ G ++ + E + + ++ G+ LH IH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
RDIK NLL+D +G +KL DFG+++ GL + G+P+++APE I + +
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSR--NGLENK-KFVGTPDYLAPETI---LGVGDDK-- 172
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-----VLNRTPPIPEMLSSEGKDFLL 574
D WSLGC + E L G PP+ E P A+F +N + E S E D +
Sbjct: 173 --MSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 575 RCFLRNPVERPSA---VELLEHPFIRNANY 601
R +P +R A E+ HPF ++ N+
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 96/255 (37%), Positives = 131/255 (51%), Gaps = 30/255 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVDD--------- 408
IG+G+FG V+ G + T AIK +D+ + E I+Q L Q D
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 409 -----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
L+I +EY+ GS +R D E + + IL GL YLHS IHRDIK
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
AN+L+ G VKLADFG+A LT + + G+P WMAPEVI+ Q + K
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDSK---- 181
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEMLSSEGKDFLLRCFLRNP 581
DIWSLG T IE+ G+PP S+ + +F + PP + S K+F+ C ++P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241
Query: 582 VERPSAVELLEHPFI 596
RP+A ELL+H FI
Sbjct: 242 SFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 77/273 (28%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----AEC--IKQLE-----QVD 407
+ IG+G+FG+V + G KE+D K +E +++L+ +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 408 DH--------LYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYLH-- 453
D LYI +EY G I + +E I E + +L L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYECHNR 124
Query: 454 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKA 509
+HRD+K AN+ +DA+ VKL DFG+AK L S+ + G+P +M+PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL-- 182
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------RTPPIPE 563
+ K DIWSLGC + E+ PP F L + IP
Sbjct: 183 -NHMSYDEK----SDIWSLGCLIYELCALSPP---FTA--RNQLQLASKIKEGKFRRIPY 232
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
SSE + + +P +RPS ELL+ P I
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 93/267 (34%), Positives = 138/267 (51%), Gaps = 36/267 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQV------------ 406
+++G GT+G VY G + +TG AIK +D+ D+ + + I L++
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 407 ---------DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN 456
DD L++ +E+ GS+ V+ + E + R IL GLA+LH+
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDG 515
IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI D
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC----DE 197
Query: 516 NPKLALAV--DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK--- 570
NP DIWSLG T IEM G PP + +A+F ++ R PP P++ S +
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPP-PKLKSKKWSKKF 255
Query: 571 -DFLLRCFLRNPVERPSAVELLEHPFI 596
DF+ C ++N + RPS +LL+HPFI
Sbjct: 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 81/295 (27%), Positives = 119/295 (40%), Gaps = 79/295 (26%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDHLYIYLE--- 415
GK+IG G+F +V + +ET AIK +D +QL + Y+ +E
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILD-----------KRQLIKEKKVKYVKIEKEV 54
Query: 416 ----YVHPGSINRY-----------VREHCRD------------ITESIVRNFTRHILNG 448
HPG I Y V E+ + + E R + IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK------------ 496
L YLHS IHRD+K N+L+D +K+ DFG AK L S S K
Sbjct: 115 LEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 497 ---------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547
G+ +++PE++ +K + D+W+LGC + +MLTGKPP F G
Sbjct: 175 NRRRFASFVGTAEYVSPELLN---EKPAGK----SSDLWALGCIIYQMLTGKPP---FRG 224
Query: 548 P---QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP----SAVELLEHPF 595
K+L P + KD + + + +P +R EL HPF
Sbjct: 225 SNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 140 bits (352), Expect = 4e-36
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 50/285 (17%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---------------- 399
++ + +G G+FG VY+ +R+ A+K + +
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 400 ----IKQLEQVDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLH 453
+ Q + LY+ +EYV GS+ +++ ++ES IL+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 454 STNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYEL-------SLKGSPNWMAPE 505
S IHRDIK N+L+D G VVKL DFG+AK L + G+P +MAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---------- 555
V+ + + DIWSLG T+ E+LTG PP+ + A + L
Sbjct: 179 VLLGLSLAYASSS----SDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 556 ---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+P PE++S D L + ++P R S+ L H +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 78/294 (26%), Positives = 121/294 (41%), Gaps = 73/294 (24%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-------KQLEQV------- 406
++G G +G V N+ TG AIK+ DD + +QL
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 407 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
LY+ EYV ++ + + VR++ +L +AY HS N IHRDI
Sbjct: 68 AFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDI 126
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--------WM-APEVIKAVMQK 513
K N+LV SGV+KL DFG A+ L + + W APE++
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRA-------RPASPLTDYVATRWYRAPELLV----- 174
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFE---------GP--QAMFKVLN--- 556
G+ VD+W++GC + E+L G+P + S+ + GP + ++ +
Sbjct: 175 -GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233
Query: 557 -----RTPPIPEMLSSEGK----------DFLLRCFLRNPVERPSAVELLEHPF 595
P + S E + DFL C +P ER + ELL+HP+
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 68/267 (25%), Positives = 110/267 (41%), Gaps = 40/267 (14%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDP------KSAECIKQLEQ----- 405
K +G G FG VY G A+K + + K A +K+L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 406 ------VDDHLYIYLEYVHPGSINRYVREHCRD--------ITESIVRNFTRHILNGLAY 451
++ LY+ LEY+ G + Y+R+ ++ + +F I G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIK 508
L S +HRD+ N LV VVK++DFG+++ + Y G WMAPE +K
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLS 566
+ D+WS G + E+ T G P+ + + + P PE
Sbjct: 181 -------DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593
E + +L C+ +P +RP+ EL+E
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 40/271 (14%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ----LEQVD------- 407
+G G FG V + + + A+K V I+ + E I LE+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV--ETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 408 -----DHLYIY--LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
D YIY +EY G + +R+ E R + ++ YLH+ I+R
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
D+K NLL+D++G VKL DFG AK L + G+P ++APE+I K +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL---NKGYD---- 170
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFK-VLNRTPPI--PEMLSSEGKDFLLRC 576
+VD WSLG + E+LTG+PP+ E E P ++ +L + P + KD + +
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230
Query: 577 FLRNPVER-----PSAVELLEHPFIRNANYQ 602
RNP ER ++ +H + +++
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 102/292 (34%), Positives = 142/292 (48%), Gaps = 53/292 (18%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV------------DIIPDDPKSAECIKQLEQ---- 405
IG G+FG+VY TN T A+K++ DII K + ++QL+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII----KEVKFLQQLKHPNTI 84
Query: 406 ------VDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ +H ++ +EY GS + + H + + E + T L GLAYLHS N I
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGN 516
HRDIK N+L+ G VKLADFG A + + S G+P WMAPEVI A+ Q DG
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD----F 572
VD+WSLG T IE+ KPP A++ + P + S+E D F
Sbjct: 201 ------VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNEWTDSFRGF 252
Query: 573 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 624
+ C + P ERP++ ELL H F+R P RV I+L ++ D V
Sbjct: 253 VDYCLQKIPQERPASAELLRHDFVRRDR------PARVL--IDLIQRTKDAV 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 49/277 (17%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--------LEQV------- 406
I +G +G V++ + TG AIK +I + L Q
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 407 -------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+LY+ +EY+ G + + E+ + E + R + I+ L YLHS IH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 460 RDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLK--------GSPNWMAPEVIKAV 510
RD+K N+L+D++G +KL DFG++K L L+ G+P+++APEVI
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG- 175
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPE--MLSS 567
+ + VD WSLGC + E L G PP+ E P+ +F +LN PE +S
Sbjct: 176 --QGHSK----TVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSD 228
Query: 568 EGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANY 601
E D + + + +P +R S E+ HPF + ++
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 77/267 (28%), Positives = 133/267 (49%), Gaps = 30/267 (11%)
Query: 360 KLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------- 404
K++G+G+FG V + GTN K+V + DD + +++
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q +HL+ +EY++ G + +++ E+ R + I+ GL +LH I+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 460 RDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L+D G +K+ADFGM K ++ G + G+P+++APE++K K
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-------K 172
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578
+VD WS G + EML G+ P+ + + +LN P P +S E KD L + F
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232
Query: 579 RNPVER-PSAVELLEHPFIRNANYQNL 604
R+P +R ++ +HPF R +++ L
Sbjct: 233 RDPTKRLGVDGDIRQHPFFRGIDWERL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 70/292 (23%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----------------EVDIIPDDPKSAECIKQL 403
K +G GTFGSVY+ N+ETG AIK EV + + +K
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 404 E--QVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
E + +D LY EY+ G++ + +++ + +ES++R+ IL GLA++H HR
Sbjct: 65 EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR 123
Query: 461 DIKGANLLVDASGVVKLADFGMAKHL------TGLSYELSLKGSPNWM-APEVIKAVMQK 513
D+K NLLV VVK+ADFG+A+ + T Y S W APE++
Sbjct: 124 DLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--DYV-----STRWYRAPEILLR---- 172
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKP------------------------PWSE-FEGP 548
+ + VDIW+LGC + E+ T +P W E ++
Sbjct: 173 --STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 549 QAM-FKVLNRTP-PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+ F+ P + +++ S E D + +P +RP+A + L+HP+
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-35
Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 32/265 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ------------- 405
+L+G GT+G VY G + +TG AIK +D+ D+ + + I L++
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 406 --------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN 456
+DD L++ +E+ GS+ ++ + E + R IL GL++LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDG 515
IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI D
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC----DE 187
Query: 516 NPKLA--LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP--IPEMLSSEGKD 571
NP D+WSLG T IEM G PP + +A+F + P + S + +
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQS 247
Query: 572 FLLRCFLRNPVERPSAVELLEHPFI 596
F+ C ++N +RP+ +L++HPFI
Sbjct: 248 FIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 86/267 (32%), Positives = 129/267 (48%), Gaps = 29/267 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVD--------------IIPDDPKSAECIKQLEQ-- 405
IG G+ G V I + +G A+K +D +I D + ++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
V + L++ +E++ G++ V + + E + +L L YLHS IHRDIK
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146
Query: 466 NLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
++L+ G VKL+DFG ++ + SL G+P WMAPEVI VD
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-------YGTEVD 199
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE---MLSSEGKDFLLRCFLRNP 581
IWSLG VIEM+ G+PP+ QAM ++ + PP + +S +DFL R R P
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP 259
Query: 582 VERPSAVELLEHPFIRNANYQNLSVPM 608
ER +A ELL+HPF+ VP+
Sbjct: 260 QERATAQELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 86/272 (31%), Positives = 143/272 (52%), Gaps = 30/272 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
+G+G +GSVY +R TG + A+KE+ + D+ K + I +L+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 405 QVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST-NTIHRD 461
++ +Y+ +EY+ GS+++ I E ++R T ++ GL +L N IHRD
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K N+LV+ +G VKL DFG++ +L S + G ++MAPE IK + NP +
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIK-SGGPNQNPTYTV 186
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPP-IPEMLSSEGKDFLLRC 576
D+WSLG +++EM G+ P+ E +F L+ PP +P S + +DF+ +C
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKC 245
Query: 577 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 608
+ P RP+ +LLEHP++ Y+N V M
Sbjct: 246 LNKIPNRRPTYAQLLEHPWLV--KYKNADVDM 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 44/276 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECI----KQLE-------- 404
K++G+G+FG V + + T A+K + I+ DD EC + L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECTMTEKRVLALAGKHPFL 58
Query: 405 -------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
Q D L+ +EYV+ G + +++ E R + I+ GL +LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGI 117
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
I+RD+K N+L+D+ G +K+ADFGM K G+ ++ G+P+++APE++
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKE--GILGGVTTSTFCGTPDYIAPEILSYQ---- 171
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 573
AVD W+LG + EML G+ P+ E + +F+ +L P LS E K L
Sbjct: 172 ---PYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSIL 227
Query: 574 LRCFLRNPVERPSAV-----ELLEHPFIRNANYQNL 604
+NP +R + ++ HPF R ++ L
Sbjct: 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKL 263
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 74/295 (25%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQVDDH------ 409
IG GT+G VY N++TG A+K+ I ++ K + IK L+++ H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLR-HPNIVRL 63
Query: 410 -----------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+Y+ EY+ + + TES ++ + + +L GL YLHS +
Sbjct: 64 KEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WM-APEVIKAVMQK 513
HRDIKG+N+L++ GV+KLADFG+A+ T S + W PE++
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTK---RNSADYTNRVITLWYRPPELLL----- 174
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPP------------------------WSEFEGPQ 549
G + VD+WS+GC + E+ GKP W
Sbjct: 175 -GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233
Query: 550 AMFKVLNRTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
F+ L P ++ D L + +P +R SA + L+H +
Sbjct: 234 -WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 73/254 (28%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQ---LEQVD-DH------- 409
IG+G+FG V+ + A+K++D+ + + E I + L ++D +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 410 ------LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
L I +EY G +++ ++ R + E V F IL GLA+LHS +HRDI
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDI 127
Query: 463 KGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
K NL +DA VK+ D G+AK L ++ ++ G+P +++PE+ + K N K
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE---DKPYNEK--- 181
Query: 522 AVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRN 580
D+W+LG + E TGK P+ + +G + + PP+ +M S + + +C ++
Sbjct: 182 -SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 581 PVERPSAVELLEHP 594
+RP +LL +P
Sbjct: 241 YRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 109/353 (30%), Positives = 168/353 (47%), Gaps = 56/353 (15%)
Query: 273 SPLPSPPRQSSQSNLRS-PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPP 331
P P +++ +S PR+ P LPQ L A PLPLPP + S
Sbjct: 6 PPPGVPLPSTARHTTKSRPRRR--PDLTLPLPQRDPSL--------AVPLPLPPPSSSSS 55
Query: 332 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------ 385
SS +SA PSA+ S+ ++ IG G G+VY +R TG A+K
Sbjct: 56 SSSSSSA----SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 386 ----------EVDIIPD--DPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDI 433
E++I+ D P +C + + + + LE++ GS+ E
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGGSL-----EGTHIA 165
Query: 434 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYE 492
E + + R IL+G+AYLH + +HRDIK +NLL++++ VK+ADFG+++ L +
Sbjct: 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 493 LSLKGSPNWMAPEVIKAVMQK---DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ 549
S G+ +M+PE I + DG A DIWSLG +++E G+ P+ G Q
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDG-----YAGDIWSLGVSILEFYLGRFPFG--VGRQ 278
Query: 550 AMFKVL------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ L ++ P P S E + F+ C R P +R SA++LL+HPFI
Sbjct: 279 GDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-33
Identities = 89/257 (34%), Positives = 133/257 (51%), Gaps = 29/257 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIP--------------DDPKSAECIKQLEQV- 406
IG GT+G VY N TG AIK + + P D K + +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 407 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
D L+I +E+ GS+ + ++ES + +R L GL YLHS +HRDIKGA
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGA 135
Query: 466 NLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
N+L+ +G VKLADFG++ +T ++ S G+P WMAPEV AV +K G +L D
Sbjct: 136 NILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV-AAVERKGGYNQLC---D 191
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK------DFLLRCFL 578
IW++G T IE+ +PP + +A+F ++ ++ P L + K F+
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPPKLKDKMKWSNSFHHFVKMALT 250
Query: 579 RNPVERPSAVELLEHPF 595
+NP +RP+A +LL+HPF
Sbjct: 251 KNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 4e-33
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 78/300 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------ECIKQLE 404
K IG G +G V ++ TG AIK++ + DD A E I L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 405 QV--------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ + +YI E + +++ ++ + +T+ ++ F IL GL YLHS N
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN 123
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------APEV 506
IHRD+K +N+LV+++ +K+ DFG+A+ + E ++ APE+
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE------KGFLTEYVVTRWYRAPEL 177
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE-- 544
+ + + A+DIWS+GC E+LT KP P E
Sbjct: 178 LLSSSRYT------KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231
Query: 545 --FEGPQAMFKVLNRTP----PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+A + + P+ ++ S E D L + + +P +R +A E L HP+
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 88/267 (32%), Positives = 136/267 (50%), Gaps = 29/267 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVD--------------IIPDDPKSAECIKQLEQ-- 405
IG G+ G V I T + TG A+K++D +I D +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
V D L++ +E++ G++ V H R + E + +L L+YLH+ IHRDIK
Sbjct: 90 VGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 466 NLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
++L+ + G +KL+DFG ++ + SL G+P WMAPEVI + VD
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-------PYGTEVD 200
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEM--LSSEGKDFLLRCFLRNP 581
IWSLG VIEM+ G+PP+ QAM ++ + PP + + +SS + FL +R P
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260
Query: 582 VERPSAVELLEHPFIRNANYQNLSVPM 608
+R +A ELL+HPF++ A + VP+
Sbjct: 261 SQRATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 80/292 (27%), Positives = 136/292 (46%), Gaps = 60/292 (20%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII---PDDPKSA--ECIKQLEQVD--- 407
+QK IG GT+G VY ++ TG AIK++ + PK+A E IK L++++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE-IKLLKELNHPN 59
Query: 408 -----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
LY+ E++ + + +++ R + ES+++++ +L GLA+ HS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDG 515
+HRD+K NLL++ GV+KLADFG+A+ + W APE++
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP------------- 559
VDIWS+GC E+L+ +P + SE + +F+ L TP
Sbjct: 179 P------VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG-TPDPEVWPKFTSLAR 231
Query: 560 ------------PIPEM---LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P+P++ S + D L + +P +R +A + L HP+
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 46/275 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV------------- 406
K +G G+FG V + ++ +G A+K I K + +KQ+E V
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALK----ILSKAKIVK-LKQVEHVLNEKRILQSIRHP 61
Query: 407 -----------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
D +LY+ +EYV G + ++R+ E + R + ++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
+ ++RD+K NLL+D+ G +K+ DFG AK + G +Y L G+P ++APE+I G
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEII----LSKG 174
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 574
K AVD W+LG + EML G PP+ + + P ++ K+L P S + KD +
Sbjct: 175 YGK---AVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKVRFPSFFSPDAKDLIR 230
Query: 575 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
+ +R ++ HP+ ++ L
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 89/311 (28%), Positives = 140/311 (45%), Gaps = 75/311 (24%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPK 395
++ K+IGRG FG V++ +++TG A+K E DI+ D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--A 58
Query: 396 SAECIKQLE---QVDDHLYIYLEYVHPGS--INRYVREHCRDITESIVRNFTRHILNGLA 450
+ I +L Q ++HLY+ +EY+ PG +N +R+ E R + ++ L
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYM-PGGDLMNLLIRKDV--FPEETARFYIAELVLALD 115
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLK---------- 496
+H IHRDIK N+L+DA G +KLADFG+ K + Y
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 497 ----------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540
G+P+++APEV++ L D WSLG + EML G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGT-------PYGLECDWWSLGVILYEMLYGFP 228
Query: 541 PWSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVE-LLEH 593
P+ + Q + K++N R PP P +S E D + R L +P +R + E + H
Sbjct: 229 PFYS-DTLQETYNKIINWKESLRFPPDPP-VSPEAIDLICR-LLCDPEDRLGSFEEIKSH 285
Query: 594 PFIRNANYQNL 604
PF + +++NL
Sbjct: 286 PFFKGIDWENL 296
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 90/308 (29%), Positives = 136/308 (44%), Gaps = 83/308 (26%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---------IKQLEQ 405
+++KGK +G GT+ VY ++ETG AIK+ I + K A+ IK L++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKK--IKLGERKEAKDGINFTALREIKLLQE 58
Query: 406 VDDHLYIYLE--YVHPGSINRYVREHC--------RD----ITESIVRNFTRHILNGLAY 451
+ I L + H +IN V E +D +T + ++++ L GL Y
Sbjct: 59 LKHPNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEVI--- 507
LHS +HRD+K NLL+ + GV+KLADFG+A+ S+ GSPN M +V+
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----SF-----GSPNRKMTHQVVTRW 167
Query: 508 -KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL- 555
+A P+L VD+WS+GC E+L P S+ + +F+ L
Sbjct: 168 YRA-------PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG 220
Query: 556 -------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELL 591
PP P S + D L R NP +R +A + L
Sbjct: 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280
Query: 592 EHPFIRNA 599
EHP+ N
Sbjct: 281 EHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 59/285 (20%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV------DIIPDDP-KSAECIKQLEQ--------- 405
IG G G V+ +RETG + A+K+V IP+ + + ++ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 406 --VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+ +EY+ P ++ +R+ R + E+ V+++ R +L G+AY+H+ +HRD+K
Sbjct: 68 FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126
Query: 464 GANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW-MAPEVIKAVMQKDGNPKLAL 521
ANLL+ A GV+K+ADFG+A+ S + + W APE++ G K
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY------GARKYDP 180
Query: 522 AVDIWSLGCTVIEMLTGKP--------------------P----WSEFEG-PQAMFKVLN 556
VD+W++GC E+L G P P W P
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240
Query: 557 RTPPIP--EML---SSEGKDFLLRCFLR-NPVERPSAVELLEHPF 595
+ PIP E+ S E D LL+ L +P +R SA E L HP+
Sbjct: 241 ESKPIPLEEIFPDASPEALD-LLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 80/260 (30%), Positives = 123/260 (47%), Gaps = 36/260 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC----IKQLEQVDDH------ 409
K +G+G++GSVY A+KEVD+ K E I+ L V+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 410 --------LYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTI 458
L I +EY G +++ + + + I E + +L GL LH +
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
HRD+K AN+L+ A+ +VK+ D G++K L + + G+P++MAPEV K G P
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK------GRP- 177
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLN-RTPPIPEMLSSEGKDFLL 574
+ DIWSLGC + EM T PP FE +KV + PPIP + S + ++F+
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234
Query: 575 RCFLRNPVERPSAVELLEHP 594
P RP+ ++L P
Sbjct: 235 SMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 84/274 (30%), Positives = 131/274 (47%), Gaps = 45/274 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIKQL 403
+G+G +G V++ ++TG A+K E DI+ KS +K L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLL 67
Query: 404 E--QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
Q D++LY+ +EYV PG R + + ++E R + + + LH IHRD
Sbjct: 68 YAFQDDEYLYLAMEYV-PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K N L+DASG +KL DFG++K ++Y S+ GSP++MAPEV++
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRG-------KGYDF 177
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-------KVLNR---TPPIPEMLSSEGKD 571
VD WSLGC + E L G PP+S P + + L R P LS E D
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFN-LSDEAWD 235
Query: 572 FLLRCFLRNPVERPSAVE-LLEHPFIRNANYQNL 604
+ + + +P R ++E + HPF + ++ L
Sbjct: 236 LITKL-INDPSRRFGSLEDIKNHPFFKEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 91/257 (35%), Positives = 130/257 (50%), Gaps = 29/257 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------AECIKQLEQV------ 406
+G GT+G VY N TG A+K + + P D S EC K V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSY 75
Query: 407 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
+ L+I +EY GS+ + ++E + R L GLAYLHS +HRDIKG
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKG 134
Query: 465 ANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
AN+L+ +G VKLADFG+A +T ++ S G+P WMAPEV AV + G +L
Sbjct: 135 ANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNGGYNQLC--- 190
Query: 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPPIPEML--SSEGKDFLLRCFL 578
DIW++G T IE+ +PP + +A+F K + P + + SS +F+
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLT 250
Query: 579 RNPVERPSAVELLEHPF 595
+NP +RP+A LL H F
Sbjct: 251 KNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 36/261 (13%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKE---VDIIPDDP-----KSAECIKQLE--------- 404
IG+G FG V I R+T A+K + +++L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 405 --QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
Q ++++Y+ ++ + G + RY +E V+ + I+ L YLHS IHRDI
Sbjct: 68 SFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDI 126
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
K N+L+D G V + DF +A +T + S G+P +MAPEV+ Q +A
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--QGYS-----VA 179
Query: 523 VDIWSLGCTVIEMLTGKPPW-----SEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
VD WSLG T E L GK P+ + + +A + P S+E D + +
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDAINKLL 237
Query: 578 LRNPVERPSAV--ELLEHPFI 596
R+P +R +L HP+
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/173 (38%), Positives = 93/173 (53%), Gaps = 14/173 (8%)
Query: 433 ITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491
I E I+ T I+ L YL IHRD+K +N+L+DASG VKL DFG++ L
Sbjct: 111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170
Query: 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEG 547
+ G +MAPE I D NPK + D+WSLG +++E+ TG+ P+ +EFE
Sbjct: 171 KTRSAGCAAYMAPERIDP---PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE- 226
Query: 548 PQAMFKVLNRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ K+L PP E S + F+ C ++ +RP ELL+HPFIR
Sbjct: 227 --VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 87/267 (32%), Positives = 134/267 (50%), Gaps = 29/267 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVD--------------IIPDDPKSAECIKQLEQ-- 405
IG G+ G V I T + +G A+K++D +I D + ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
V D L++ +E++ G++ V H R + E + +L L+ LH+ IHRDIK
Sbjct: 88 VGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 466 NLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
++L+ G VKL+DFG ++ + SL G+P WMAPE+I + VD
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-------PYGPEVD 198
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRCFLRNP 581
IWSLG VIEM+ G+PP+ +AM + + PP + L S K FL R +R+P
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 582 VERPSAVELLEHPFIRNANYQNLSVPM 608
+R +A ELL+HPF+ A + VP+
Sbjct: 259 AQRATAAELLKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 81/279 (29%), Positives = 129/279 (46%), Gaps = 58/279 (20%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
+G G GSV + TG A+K + P+ + +++LE
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 405 --QVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ + I +EY GS++ V++ I E ++ +L GL+YLHS IH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH 128
Query: 460 RDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
RDIK +N+L+ G VKL DFG +A TG S+ +MAPE I+
Sbjct: 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---------YMAPERIQ--- 176
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNR--TPPIPEMLSSE 568
G P ++ D+WSLG T++E+ + P+ E E P ++L+ P PE+
Sbjct: 177 ---GKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232
Query: 569 G---------KDFLLRCFLRNPVERPSAVELLEHPFIRN 598
G KDF+ +C ++P RP+ ++LEHP+I+
Sbjct: 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 67/189 (35%), Positives = 103/189 (54%), Gaps = 9/189 (4%)
Query: 424 RYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGM 482
+ V + I E I+ I+ L YLHS + IHRD+K +N+L++ +G VKL DFG+
Sbjct: 91 KKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI 150
Query: 483 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK-LALAVDIWSLGCTVIEMLTGKPP 541
+ +L + G +MAPE I + N K + D+WSLG T+IE+ TG+ P
Sbjct: 151 SGYLVDSVAKTIDAGCKPYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFP 206
Query: 542 WSEFEGP-QAMFKVLNRTPP-IP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ ++ P Q + +V+ P +P E S E +DF+ +C +N ERP+ ELL+HPF
Sbjct: 207 YDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
Query: 599 ANYQNLSVP 607
+N V
Sbjct: 267 HLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 32/268 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLE----------- 404
K++G+G+FG V + + G A+K +V +I DD + K++
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTI 458
Q +HL+ +E+++ G + ++++ R D+ + + I+ GL +LHS I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQFLHSKGII 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+++D G +K+ADFGM K ++ G + + G+P+++APE+++ +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL------- 171
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
K +VD WS G + EML G+ P+ + + + TP P ++ E KD L + F
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLF 231
Query: 578 LRNPVERPSAV-ELLEHPFIRNANYQNL 604
R+P R V + HPF + N+ L
Sbjct: 232 ERDPTRRLGVVGNIRGHPFFKTINWTAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 80/317 (25%), Positives = 117/317 (36%), Gaps = 100/317 (31%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----------------SAECIK 401
GKL G GTFG VY +TG A+K+ I+ + K +
Sbjct: 14 GKL-GEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 402 QLEQVDDHLYIYLEYVHPGSINR----------YVREHCRDI-----------TESIVRN 440
L I + P R Y+ D+ TES ++
Sbjct: 71 PL--------IDMAVERPDKSKRKRGSVYMVTPYM---DHDLSGLLENPSVKLTESQIKC 119
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 500
+ +L G+ YLH + +HRDIK AN+L+D G++K+ADFG+A+ G G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 501 -----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP-------- 540
W PE++ G + AVDIW +GC EM T +P
Sbjct: 180 TRKYTNLVVTRWYRPPELLL------GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
Query: 541 ------------P-------WSEFEGPQAMFKVLNRTPPIPEM---LSSEGKDFLLRCFL 578
P W G + + N + E L EG D L +
Sbjct: 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 579 RNPVERPSAVELLEHPF 595
+P +R +A + LEHP+
Sbjct: 294 LDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 76/301 (25%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA----ECIKQLEQVDD 408
+++ IG G +G+VY + TG A+K+V + + P S +KQLE +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 409 -------------------HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILN 447
L + E+V + Y+ C + +++ R +L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDLMRQLLR 118
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WM- 502
G+ +LHS +HRD+K N+LV + G VK+ADFG+A+ S+E++L + W
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMAL--TSVVVTLWYR 173
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP 559
APEV+ +Q A VD+WS+GC E+ +P + SE + +F V+
Sbjct: 174 APEVL---LQS----SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226
Query: 560 -------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 594
+PE+ EG D L + NP +R SA E L+HP
Sbjct: 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEI-CEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 595 F 595
+
Sbjct: 286 Y 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 75/212 (35%), Positives = 113/212 (53%), Gaps = 21/212 (9%)
Query: 405 QVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
Q D L++ L+YV+ G + + Y REH TES VR + I+ L +LH I+RDI
Sbjct: 75 QTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQLGIIYRDI 131
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
K N+L+D+ G V L DFG++K E S G+ +MAPEVI+ G+
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG-----GSGGHD 186
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-----VLNRTPPIPEMLSSEGKDFLLR 575
AVD WSLG E+LTG P++ +G Q +L PP P+ +S+E +DF+ +
Sbjct: 187 KAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQK 245
Query: 576 CFLRNPVER---PSAVELLEHPFIRNANYQNL 604
++P +R A E+ HPF + ++ +L
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 92/267 (34%), Positives = 129/267 (48%), Gaps = 51/267 (19%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDII--PDDPKSAECIKQLEQVDDHLYIYLEYV-H 418
IG G+FG+VY + T AIK++ + K + IK+++ +L+ + H
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK--------FLQRIKH 84
Query: 419 PGSINR---YVREHC--------------------RDITESIVRNFTRHILNGLAYLHST 455
P SI Y+REH + + E + T L GLAYLHS
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQK 513
N IHRDIK N+L+ G VKLADFG A + + S G+P WMAPEVI A+ Q
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQY 201
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD-- 571
DG VD+WSLG T IE+ KPP A++ + P + S+E D
Sbjct: 202 DGK------VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYF 253
Query: 572 --FLLRCFLRNPVERPSAVELLEHPFI 596
F+ C + P +RP++ ELL+H F+
Sbjct: 254 RNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 88/285 (30%), Positives = 131/285 (45%), Gaps = 57/285 (20%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC----IKQLEQV---------- 406
L+G G++G V ++ETG AIK+ DD + I+ L+Q+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 407 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
LY+ E+V ++ + ++ + ES VR + IL G+ + HS N IHRDI
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLAL 521
K N+LV SGVVKL DFG A+ L + + W APE++ G+ K
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV------GDTKYGR 180
Query: 522 AVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-----------NRTPP-----IP 562
AVDIW++GC V EMLTG+P + S+ + + K L + P +P
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240
Query: 563 EM------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
E+ LS D +C +P +RPS+ +LL H F
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 39/213 (18%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV------- 406
++ K +G GTFG V++ +R + A+K + I P+ + +KQ + V
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI-PEVIR----LKQEQHVHNEKRVL 55
Query: 407 -----------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
LY+ +EYV G + Y+R + S + I+ L
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCAL 114
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 509
YLHS ++RD+K N+L+D G +KL DFG AK L ++ +L G+P ++APEVI
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVI-- 170
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542
Q G+ K AVD W+LG + EML G PP+
Sbjct: 171 --QSKGHNK---AVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 40/263 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAE-CIKQ---LEQVD------- 407
K IG+G F VY G A+K+V I D K+ + C+K+ L+Q+D
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 408 -------DHLYIYLEYVHPGSINR---YVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+ L I LE G ++R + ++ R I E + + + + L ++HS
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGN 516
+HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I ++G
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----HENG- 182
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVLNRT-----PPIP-EMLSSEG 569
DIWSLGC + EM + P F G + ++ + + PP+P + S E
Sbjct: 183 --YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237
Query: 570 KDFLLRCFLRNPVERPSAVELLE 592
+D + RC +P +RP +L+
Sbjct: 238 RDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 77/269 (28%), Positives = 139/269 (51%), Gaps = 34/269 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLE----------- 404
K++G+G+FG V++ + T AIK +V ++ DD + K++
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTI 458
Q ++L+ +EY++ G + +++ H D+ + + I+ GL +LHS +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIV 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+L+D G +K+ADFGM K ++ G + + G+P+++APE++ + QK
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL--LGQKYNT- 175
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
+VD WS G + EML G+ P+ + + + P P L+ E KD L++ F
Sbjct: 176 ----SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF 231
Query: 578 LRNPVERPSAV--ELLEHPFIRNANYQNL 604
+R P ER V ++ +HPF R ++ L
Sbjct: 232 VREP-ERRLGVKGDIRQHPFFREIDWSAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 93/340 (27%), Positives = 152/340 (44%), Gaps = 70/340 (20%)
Query: 344 MEKPSASP-KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-- 400
KP S K S ++ G+ +G G+FG V I ++ TG AIK + K E +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-------KKREILKM 59
Query: 401 KQLEQV------------------------DDHLYIYLEYVHPGSINRYVREHCRDITES 436
KQ++ V ++ +Y LE+V G + ++R+ R
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPND 118
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496
+ + + ++ YLHS + I+RD+K NLL+D G VK+ DFG AK + ++ +L
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLC 176
Query: 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVL 555
G+P ++APEVI Q G+ K AVD W++G + E + G PP+ + + P ++ K+L
Sbjct: 177 GTPEYLAPEVI----QSKGHGK---AVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKIL 228
Query: 556 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV-----ELLEHPFIRNANYQNL------ 604
P +D + + +R + ++ HP+ AN+ L
Sbjct: 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 605 -SVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVR 643
+P+RV S GD T E PDSP R+
Sbjct: 289 APIPVRVKSP---GD---------TSNFEKYPDSPVDRLP 316
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 81/271 (29%), Positives = 124/271 (45%), Gaps = 37/271 (13%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV---DIIP-DDPKSAECIKQLE------------- 404
+GRG FG V + ++TG AIK + DII D+ +S C K++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q +DH+ +EY G + ++ H +E + ++ GL YLH ++
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENKIVY 124
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K NLL+D G VK+ADFG+ K G S G+P ++APEV+
Sbjct: 125 RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT-------ETS 177
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578
AVD W LG + EML G+ P+ + + ++N P LS E + R
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237
Query: 579 RNPVER-----PSAVELLEHPFIRNANYQNL 604
RNP R A ++ + PF R+ N+ +L
Sbjct: 238 RNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 87/279 (31%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV------------DIIPDDPKSAECIKQLEQ---- 405
IG G+FG+VY + AIK++ DII K +++L
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII----KEVRFLQKLRHPNTI 78
Query: 406 ------VDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ +H ++ +EY GS + + H + + E + T L GLAYLHS N I
Sbjct: 79 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGN 516
HRD+K N+L+ G+VKL DFG A + + G+P WMAPEVI A+ Q DG
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEGKDFLL 574
VD+WSLG T IE+ KPP A++ + P + S ++F+
Sbjct: 195 ------VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 575 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSR 613
C + P +RP++ LL+H F+ + +V M + R
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRE--RPPTVIMDLIQR 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSA---------------ECI 400
KL+G+GTFG V + + TG A+K EV I D+ +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
K Q D L +EY + G + ++ R +E R + I++ L YLHS + ++R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNP 517
D+K NL++D G +K+ DFG+ K G+S ++K G+P ++APEV++ +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE-------DN 170
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
AVD W LG + EM+ G+ P+ + + +L P LS E K L
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL 230
Query: 578 LRNPVER-----PSAVELLEHPFIRNANYQNL 604
++P +R A E++EH F + N+Q++
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 84/284 (29%), Positives = 121/284 (42%), Gaps = 57/284 (20%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ---VDDH-- 409
IG G++G V+ NRETG AIK+ DDP + +KQL+ V+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 410 ------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
L++ EY +N + + R + E +++ L + + H N IHRD+K
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLALA 522
N+L+ G +KL DFG A+ LTG + + + W APE++ Q G P
Sbjct: 128 PENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY-GPP----- 181
Query: 523 VDIWSLGCTVIEMLTGKPPW------------------------SEFEGPQAMFKVLNRT 558
VD+W++GC E+LTG+P W F Q +
Sbjct: 182 VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE 241
Query: 559 PPIPEML-------SSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
P E L SS FL C +P ER S ELLEHP+
Sbjct: 242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 79/274 (28%), Positives = 124/274 (45%), Gaps = 32/274 (11%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV---DDHLYI---YL 414
IGRG FG+V ++ +G A+K + D+ + + L+ V D YI Y
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 415 EYVHPG---------SIN-----RYVREHCRD-ITESIVRNFTRHILNGLAYLHST-NTI 458
G I+ +YV E + I E I+ + L YL I
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
HRD+K +N+L+D +G +KL DFG++ L + G +MAPE I
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI----DPSARDG 186
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI-----PEMLSSEGKDF 572
+ D+WSLG T+ E+ TGK P+ ++ + +V+ PPI S +F
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNF 246
Query: 573 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 606
+ C +++ +RP ELLEHPFI++ +N+ V
Sbjct: 247 INLCLIKDESKRPKYKELLEHPFIKDYEERNVDV 280
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 79/295 (26%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------ECIKQLEQV 406
IG GT+G VY G N++TG A+K++ + ++ P +A I L+ V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 407 ---DDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTIHRD 461
+ LY+ E++ + +Y+ + + +V+++ IL G+ + HS +HRD
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 462 IKGANLLVDASGVVKLADFGMAK-----------HLTGLSYELSLKGSPNWMAPEVIKAV 510
+K NLL+D GV+KLADFG+A+ + L Y APEV+
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR----------APEVLL-- 174
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP-------- 559
G+P+ + VDIWS+G EM T KP + SE + +F++L TP
Sbjct: 175 ----GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG-TPTEDVWPGV 229
Query: 560 -PIPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+P+ L +G D L + + +P +R SA + L HP+
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 80/295 (27%), Positives = 137/295 (46%), Gaps = 68/295 (23%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA----ECIKQLE---- 404
+QK + IG GT+G VY N+ TG A+K++ + + P +A +K+L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 405 -------QVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 456
++ LY+ E++H + +++ I +++++ +L GLA+ HS
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------WMAPEVIKAV 510
+HRD+K NLL++ G +KLADFG+A+ ++ + ++ + + APE++
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEILL-- 173
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVLNRTP-------- 559
G + AVDIWSLGC EM+T + P SE + +F+ L TP
Sbjct: 174 ----GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGV 228
Query: 560 -PIPE------------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+P+ L +G+D L + +P +R SA L HPF
Sbjct: 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 71/263 (26%), Positives = 132/263 (50%), Gaps = 28/263 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI---IPDDPKSA--EC--IKQLEQ-- 405
+++K +++GRG FG V++ + IK++ + D+ +A EC +K L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 406 ---------VDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHST 455
D L I +EY G++ Y+++ C + E + +F IL L ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 456 NTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
+HRD+K N+L+D VVK+ DFG++K L+ S ++ G+P +++PE+ + K
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG---KP 177
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFL 573
N K DIW+LGC + E+ + K + P + K+++ T PI + S + + +
Sbjct: 178 YNQK----SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI 233
Query: 574 LRCFLRNPVERPSAVELLEHPFI 596
L +P +RP +++ P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 70/259 (27%), Positives = 130/259 (50%), Gaps = 30/259 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ------- 405
+++G+G FG + E + KEV++ K + L+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 406 ---VDDH-LYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
+DD+ L I +EY + G++ ++ VR+ + E +V + I++ ++Y+H +HR
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 461 DIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
DIK N+ + +G++KL DFG++K L + S ++ G+P +M+PE+ + V K
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV-------KY 178
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCF 577
DIW+LGC + E+LT K + + K++ N T P+ + SSE +
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLL 237
Query: 578 LRNPVERPSAVELLEHPFI 596
++P +RP+A E+L+ P +
Sbjct: 238 QQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 6e-27
Identities = 85/273 (31%), Positives = 133/273 (48%), Gaps = 39/273 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSA---------------ECI 400
KL+G+GTFG V + + TG A+K EV I D+ +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
K Q D L +EY + G + ++ RE R TE R + I++ L YLHS + ++
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGN 516
RDIK NL++D G +K+ DFG+ K G+S ++K G+P ++APEV++ +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE-------D 169
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 576
AVD W LG + EM+ G+ P+ + + +L P LS E K L
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 229
Query: 577 FLRNPVER----PS-AVELLEHPFIRNANYQNL 604
++P +R PS A E++EH F + N+Q++
Sbjct: 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 78/296 (26%), Positives = 138/296 (46%), Gaps = 70/296 (23%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------ECI 400
+QK + IG GT+G VY ++ TG A+K++ + +D P +A I
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 401 KQLEQV---DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 456
+L V ++ LY+ E++ + +Y+ + +++++ +L G+AY HS
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WM-APEVIKAV 510
+HRD+K NLL+D G +KLADFG+A+ ++ + ++ + W APE++
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEILL-- 172
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP-------- 559
G+ + + VDIWS+GC EM+ +P + SE + +F+ L TP
Sbjct: 173 ----GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG-TPDEDVWPGV 227
Query: 560 --------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+P L +G D L + + +P +R SA L+HP+
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 32/265 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV-------- 406
++ K K IG G+FG + ++E G IKE++I PK E ++ V
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 407 ----------DDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHS 454
+ +LYI ++Y G + + + R + E + ++ I L ++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD 119
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKAVMQ 512
+HRDIK N+ + G +KL DFG+A+ L + EL+ G+P +++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICE---N 175
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKD 571
+ N K DIW+LGC + EM T K + + K++ + PP+ S + ++
Sbjct: 176 RPYNNK----SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRN 231
Query: 572 FLLRCFLRNPVERPSAVELLEHPFI 596
+ + F RNP +RPS +LE FI
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 84/282 (29%), Positives = 132/282 (46%), Gaps = 45/282 (15%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIKQ 402
L+GRG FG V + + TG A+K E DI+ ++ I Q
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI--SNSPWIPQ 65
Query: 403 LE---QVDDHLYIYLEYVHPGS-----INRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
L+ Q D+LY+ +EY PG +NRY + E + + + ++ + +H
Sbjct: 66 LQYAFQDKDNLYLVMEY-QPGGDLLSLLNRYEDQ----FDEDMAQFYLAELVLAIHSVHQ 120
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQ 512
+HRDIK N+L+D +G +KLADFG A LT + G+P+++APEV+ M
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT-MN 179
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSS 567
DG + D WSLG EM+ G+ P+ E + ++N + P P+ +SS
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-VSS 238
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL--SVP 607
+ D L++ L ER L HPF ++ N+ S+P
Sbjct: 239 DFLD-LIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLP 279
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 78/281 (27%), Positives = 142/281 (50%), Gaps = 41/281 (14%)
Query: 360 KLIGRGTFGSVYIG---TNRETGASCAIKEVD--IIPDDPKSAECIKQLEQVDDH----- 409
K++G G +G V++ + ++G A+K + I K+ E + QV +H
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 410 --------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
L++ L+Y++ G + ++ + R E V+ ++ I+ L +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLHKL 124
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQK 513
I+RDIK N+L+D++G V L DFG++K E S G+ +MAP++++
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG--GD 182
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWS----EFEGPQAMFKVLNRTPPIPEMLSSEG 569
G+ K AVD WS+G + E+LTG P++ + + ++L PP P+ +S+
Sbjct: 183 GGHDK---AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 570 KDFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNLS 605
KD + R +++P +R PS A E+ +HPF + N+ +L+
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LE----------- 404
K IG G+FG +Y+ + C IKE+D+ K E K+ L
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 405 ---QVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
Q + L+I +EY G + R R+ +E + ++ I GL ++H +HR
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHR 125
Query: 461 DIKGANLLVDASGVV-KLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKAVMQKDGNP 517
DIK N+ + +G+V KL DFG+A+ L S EL+ G+P +++PE+ + + N
Sbjct: 126 DIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQ---NRPYNN 181
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRC 576
K DIWSLGC + E+ T K P+ Q + K+ PI S + + + +
Sbjct: 182 K----TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQL 237
Query: 577 FLRNPVERPSAVELLEHPFI 596
F +P +RPS +L+ PF+
Sbjct: 238 FKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 96/330 (29%), Positives = 153/330 (46%), Gaps = 57/330 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIK 401
K+IGRG FG V + ++ + A+K E DI+ ++E I
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH--ANSEWIV 106
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
QL Q D +LY+ +EY+ G + + + DI E R +T ++ L +HS I
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 459 HRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
HRD+K N+L+D SG +KLADFG M G+ + G+P++++PEV+K+ + G+
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS---QGGD 221
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEGKD 571
D WS+G + EML G P+ K+++ P E+ S + KD
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI-SKQAKD 280
Query: 572 FLLRCFL--------RNPVERPSAVELLEHPFIRNA--NYQNL--SVPMRVFSRINLGDK 619
L+ FL RN V+ E+ HPF +N + N+ +V V + D
Sbjct: 281 -LICAFLTDREVRLGRNGVD-----EIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDT 334
Query: 620 SH-DQVERATRKTESLPDSPETRVRNRKLP 648
S+ D +E + E+ P P+ N +LP
Sbjct: 335 SNFDDIEDDDKNEETFP-LPKAFAGN-QLP 362
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 43/280 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQ------- 405
Q +++G G G+VY + T A+K + DI + K + + +LE
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSP 59
Query: 406 ----------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
V++ + I E++ GS++ Y R I E ++ ++ GL YL S
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
+HRD+K +N+LV+ G VKL DFG++ L S + G+ +MAPE I
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISG------ 167
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-------VLNRTPPI-PEMLSS 567
+ + D+WSLG + +E+ G+ P+ + + Q +++ PP+ P S
Sbjct: 168 -EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226
Query: 568 EG-KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 606
E F+ +C + P ERP+ L++HPFI N N V
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 75/274 (27%), Positives = 127/274 (46%), Gaps = 38/274 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLE----------- 404
K++G+G+FG V + + T AIK +V + DD K++
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q D L+ +EYV+ G + + + R E R + + L +LH I+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 460 RDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L+DA G KLADFGM K + + G+P+++APE+++ + +
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL-------E 172
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFLLRCF 577
+VD W+LG + EM+ G+PP+ E + +F+ +L+ P LS E L
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFM 231
Query: 578 LRNPVERPSAV-------ELLEHPFIRNANYQNL 604
+NP +R V + +HPF + ++ L
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 24/215 (11%)
Query: 405 QVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
Q + L++ L+YV G + + Y R++ +E VR ++ I+ L +LH ++RDI
Sbjct: 75 QTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLGIVYRDI 131
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
K N+L+D+ G V L DFG++K E S G+ +MAPE+I+ K G+ K
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG---KGGHGK-- 186
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEFEG-----PQAMFKVLNRTPPIPEMLSSEGKDFLLR 575
AVD WSLG + E+LTG P++ EG + ++L PP P + E +D L +
Sbjct: 187 -AVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244
Query: 576 CFLRNPVER-----PSAVELLEHPFIRNANYQNLS 605
++P +R A E+ EHPF + +++ L+
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 78/244 (31%), Positives = 122/244 (50%), Gaps = 19/244 (7%)
Query: 405 QVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
Q LY+ LEY+ G + ++ RE E + I L +LH I+RD+K
Sbjct: 70 QTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLK 127
Query: 464 GANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
N+L+DA G VKL DFG+ K + + + G+ +MAPE++ + G+ K A
Sbjct: 128 PENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL----MRSGHGK---A 180
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPV 582
VD WSLG + +MLTG PP++ + + K+L +P L+ E +D L + RNP
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240
Query: 583 ER----PS-AVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVER-ATRKTESLP- 635
R P A E+ HPF R+ N+ +L + +V +S + V + ++ T P
Sbjct: 241 SRLGAGPGDAAEVQSHPFFRHVNWDDL-LARKVEPPFKPLLQSEEDVSQFDSKFTRQTPV 299
Query: 636 DSPE 639
DSP+
Sbjct: 300 DSPD 303
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 80/274 (29%), Positives = 133/274 (48%), Gaps = 40/274 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAEC----------------I 400
++G+G+FG V + + T AIK + II DD EC +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECTMVEKRVLALPGKPPFL 63
Query: 401 KQLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
QL Q D LY +EYV+ G + ++++ + E + I GL +LHS
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
I+RD+K N+++DA G +K+ADFGM K ++ G + G+P+++APE+I Q G
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPYGK 180
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFLLR 575
+VD W+ G + EML G+PP+ + E +F+ ++ P+ LS E
Sbjct: 181 -----SVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234
Query: 576 CFLRNPVER----PSAV-ELLEHPFIRNANYQNL 604
++P +R P+ ++ EH F R +++ L
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 92/304 (30%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------ECIKQLEQV 406
I GT+G VY +++TG A+K++ + + P ++ I +++V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 407 -----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFT--------RHILNGLAYL 452
D +Y+ +EYV EH + + E++ + F +L+G+A+L
Sbjct: 73 VVGSNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMA-------KHLTGLSYELSLKGSPNWM-AP 504
H +HRD+K +NLL++ G++K+ DFG+A K T L L W AP
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL-------WYRAP 175
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------P--- 541
E++ G + + A+D+WS+GC E+LT KP P
Sbjct: 176 ELLL------GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229
Query: 542 -WSEF-EGPQAMFKVLNRTPP------IPE-MLSSEGKDFLLRCFLRNPVERPSAVELLE 592
W F E P A K + P P LS G D L R +P +R SA + L+
Sbjct: 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289
Query: 593 HPFI 596
HP+
Sbjct: 290 HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 41/275 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAEC----------------IK 401
+++G+G+FG V + +E+G A+K + D+I D EC +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLT 59
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
QL Q D L+ +E+V+ G + ++++ R E+ R + I + L +LH I
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
+RD+K N+L+D G KLADFGM K G + + G+P+++APE+++ ++
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS-TFCGTPDYIAPEILQEML----- 172
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFLLR 575
+VD W++G + EML G P+ E E +F+ +LN P LS + D L
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 576 CFLRNPVERPSAVEL------LEHPFIRNANYQNL 604
+NP R ++ L L HPF + +++ L
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSA---------------ECI 400
KL+G+GTFG V + + +G A+K EV I D+ +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
K Q D L +EYV+ G + ++ R +E R + I++ L YLHS ++R
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNP 517
D+K NL++D G +K+ DFG+ K G++ ++K G+P ++APEV++ +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLE-------DN 170
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
AVD W LG + EM+ G+ P+ + + +L P LS++ K L
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL 230
Query: 578 LRNPVER-----PSAVELLEHPFIRNANYQNL 604
+++P +R A E++ H F N+Q++
Sbjct: 231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 45/277 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIK-----------EVDIIPDDPKSAECIKQLE------ 404
IG+GTFG VY ++T A+K EV + E
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q D LY+ +Y+ G + ++++ R +E + + ++ L +LH + ++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 460 RDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L+DA+G + L DFG++K +LT + G+ ++APEV+ + + G K
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL---LDEKGYTK 176
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLN----RTPPIPEMLSSEGKDF 572
VD WSLG V EM G WS F Q M++ + R P +LS EG+ F
Sbjct: 177 H---VDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFP--KNVLSDEGRQF 228
Query: 573 LLRCFLRNPVER----PSAVELLEHPFIRNANYQNLS 605
+ RNP R AVEL EHPF + ++ LS
Sbjct: 229 VKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLS 265
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 91/296 (30%), Positives = 135/296 (45%), Gaps = 68/296 (22%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAE---CI-KQLEQVD 407
+++K + IG GT+G+V+ NRET A+K V + DD P SA C+ K+L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 57
Query: 408 DHLYIYLEY--VHPGSINRYVREHCR------------DITESIVRNFTRHILNGLAYLH 453
H I Y +H V E+C DI IV++F +L GLA+ H
Sbjct: 58 -HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQ 512
S N +HRD+K NLL++ +G +KLADFG+A+ S + W P+V+
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF---- 172
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QAMFKVLNR--------- 557
G + ++D+WS GC E+ P F G + +F++L
Sbjct: 173 --GAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 558 --------TPPIPEM---------LSSEGKDFLLRCFLR-NPVERPSAVELLEHPF 595
P P L+S G+D LL+ L NPV+R SA E L+HP+
Sbjct: 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRD-LLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-----KQLEQVD--------- 407
+G+G FG V + TG A K++D + E + K LE+V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 408 -----DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
D L + + ++ G + ++ E+ + I+ GL +LH ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K N+L+D G V+++D G+A L G G+P +MAPEV++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-------GEVYDF 173
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEF----EGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
+VD ++LGCT+ EM+ G+ P+ + E + + L P+ S E KD
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233
Query: 578 LRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 608
++P +R SA E+ EHP ++ N++ L M
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGM 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 82/303 (27%), Positives = 133/303 (43%), Gaps = 75/303 (24%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA-----------ECIK 401
++K + IG GT+G VY ++ TG A+K+ + D+ P +A E I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 402 -----QLEQVDDH-----LYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHILNG 448
+E V++ LY+ EY+ ++ R R + +++F +L G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 449 LAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPN------W 501
+A+ H +HRD+K NLLVD G++K+AD G+ + + + +K + +
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIVTLWY 177
Query: 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRT 558
APEV+ G+ + VDIWS+GC EM +P + SE + +FK+L T
Sbjct: 178 RAPEVLL------GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-T 230
Query: 559 P-----------------PI--PEMLSS-------EGKDFLLRCFLRNPVERPSAVELLE 592
P P P+ LS EG D L + +P +R SA L
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290
Query: 593 HPF 595
HP+
Sbjct: 291 HPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 63/192 (32%), Positives = 92/192 (47%), Gaps = 49/192 (25%)
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----- 499
+L L Y+HS N IHRD+K +N+L+++ VKLADFG+A+ L+ L +P
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP---ENPVLTDY 172
Query: 500 ---NWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWS---------- 543
W APE++ G+ + VD+WS+GC + EML GKP P +
Sbjct: 173 VATRWYRAPEILL------GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226
Query: 544 EFEGP--------------QAMFKVLNRTP--PIPEML---SSEGKDFLLRCFLRNPVER 584
E GP M L P P+ E+L S + D L + + NP +R
Sbjct: 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286
Query: 585 PSAVELLEHPFI 596
+A E LEHP++
Sbjct: 287 LTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 79/301 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQV------------ 406
KLI G +G+VY+ ++ET A+K+++ K ++ Q++QV
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKIN------KQNLILRNQIQQVFVERDILTFAEN 60
Query: 407 ------------DDHLYIYLEYVHPGSINRYVREHCRDITESI-------VRNFTRHILN 447
HL + +EYV G C + ++I R + +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGD--------CATLLKNIGALPVDMARMYFAETVL 112
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLK------- 496
L YLH+ +HRD+K NLL+ + G +KL DFG++K LT YE ++
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 497 -----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQA 550
G+P ++APEVI + Q G P VD W++G + E L G P+ F + P+
Sbjct: 173 DKQVCGTPEYIAPEVI--LRQGYGKP-----VDWWAMGIILYEFLVGCVPF--FGDTPEE 223
Query: 551 MF-KVLNRT---PPIPEMLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQN 603
+F +V++ P E L ++ +D + R +NP+ER A E+ +H F ++
Sbjct: 224 LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283
Query: 604 L 604
L
Sbjct: 284 L 284
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 41/267 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
+G G GSV + TG A K V I + +++L+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 405 QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-HRDIK 463
++++ + +E++ GS++R ++ I I+ ++ GL YL++ + I HRDIK
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK 131
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
+N+LV++ G +KL DFG++ L S + G+ +M+PE I+ K +
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQG-------GKYTVKS 183
Query: 524 DIWSLGCTVIEMLTGKPPWSEFE-------GPQAMFKVLNR-----TPPIP-EMLSSEGK 570
D+WSLG ++IE+ GK P++ P + +L + P +P + +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 571 DFLLRCFLRNPVERPSAVELLE-HPFI 596
DF+ C L++P ERP+ +L PFI
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 68/252 (26%), Positives = 122/252 (48%), Gaps = 27/252 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI------IPDDPKSAECIKQLE--------- 404
+++G G+FG + + + A+KE+ + + D K A + +++
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 405 --QVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
+ D HLYI +EY G + + ++ + + E + + + G+ ++H +HRD
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRD 125
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
IK N+ + +G VKL DFG A+ LT +Y + G+P ++ PE+ + + + +
Sbjct: 126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKS---- 181
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLR 579
DIWSLGC + E+ T K P+ + KV + P+P S E + + + F R
Sbjct: 182 ---DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238
Query: 580 NPVERPSAVELL 591
NP RPSA +L
Sbjct: 239 NPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 86/317 (27%), Positives = 135/317 (42%), Gaps = 88/317 (27%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIK 401
K+IGRG FG V + ++TG A+K E DI+ + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE--ADNPWVV 64
Query: 402 QLE---QVDDHLYIYLEYVHPGS--INRYVREHCRDI-TESIVRNFTRHILNGLAYLHST 455
+L Q +++LY+ +EY+ PG + ++ +D TE R + + + +H
Sbjct: 65 KLYYSFQDENYLYLIMEYL-PGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKL 120
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAK-----HLT----------------------- 487
IHRDIK NLL+DA G +KL+DFG+ H T
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 488 -------------GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 534
L+Y S G+P+++APEV +Q N D WSLG + E
Sbjct: 181 SKRKAETWKRNRRALAY--STVGTPDYIAPEVF---LQTGYNK----ECDWWSLGVIMYE 231
Query: 535 MLTGKPPWSEFEGPQAMF-KVLN--RTPPIPE--MLSSEGKDFLLR--CFLRNPVERPSA 587
ML G PP+ + PQ + K++N T P+ LS E KD + R C +
Sbjct: 232 MLVGYPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGV 290
Query: 588 VELLEHPFIRNANYQNL 604
E+ HPF + +++++
Sbjct: 291 NEIKSHPFFKGVDWEHI 307
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 362 IGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQ--LEQVD--------- 407
IG+G+FG V R+T A I++ I+ + ++ L QV+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 408 -----DHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
+ LY+ L +++ G + ++ RE D++ + R +T +L L LH N I+RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHKFNVIYRD 118
Query: 462 IKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
+K N+L+D G + L DFG+ K ++ + G+P ++APE++ G K
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH----GYTK-- 172
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRN 580
AVD W+LG + EMLTG PP+ + + K+L P+ + KD L+ R+
Sbjct: 173 -AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231
Query: 581 PVER---PSAVELLEHPFIRNANYQNL 604
P R A E+ HPF +++ L
Sbjct: 232 PTRRLGYNGAQEIKNHPFFSQLSWKKL 258
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 79/256 (30%), Positives = 121/256 (47%), Gaps = 40/256 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQV----------- 406
K IGRG F VY T G A+K+V I + D A+CIK+++ +
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 407 ------DDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHSTNT 457
D+ L I LE G ++R ++ + R I E V + + + L ++HS
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGN 516
+HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I ++G
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----HENG- 182
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------PPIP-EMLSSEG 569
DIWSLGC + EM + P F G + L + PP+P + S E
Sbjct: 183 --YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 570 KDFLLRCFLRNPVERP 585
+ + C +P +RP
Sbjct: 238 RQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 70/262 (26%), Positives = 109/262 (41%), Gaps = 49/262 (18%)
Query: 362 IGRGTFGSVYIGTNRETGAS---CAIKEV--DIIPDDPKS----AECIKQLEQVDDHLYI 412
+G G FGSV G A+K + + I K A + QL DH I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL----DHPCI 58
Query: 413 Y--------------LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+E G + +Y+++ R+I S ++ + G+AYL S + +
Sbjct: 59 VRLIGVCKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGS--P-NWMAPEVIKAVMQKD 514
HRD+ N+L+ K++DFGM++ L G Y + P W APE I
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG---- 173
Query: 515 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSE 568
K + D+WS G T+ E + G P+ E +G + + + L R PE E
Sbjct: 174 ---KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR----PEECPQE 226
Query: 569 GKDFLLRCFLRNPVERPSAVEL 590
+L C+ P +RP+ EL
Sbjct: 227 IYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 8e-23
Identities = 85/322 (26%), Positives = 144/322 (44%), Gaps = 37/322 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETG------------------ASCAIKEVDIIPDDPKSAECIK 401
K+IGRG FG V + + TG +C +E D++ + + I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR--RWIT 64
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
L Q +++LY+ ++Y G + + + + E + R + ++ + +H +
Sbjct: 65 NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A+ +DG
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM--EDGK 182
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEGKD 571
+ D WSLG + EML G+ P+ + K++N PP +S E KD
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKD 242
Query: 572 FLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL--SVPMRVFSRINLGDKSH-DQVER 626
+ R C + R + +HPF ++ N+ S V + D S+ D +
Sbjct: 243 LIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDD 302
Query: 627 ATRKTESLPDSPETRVRNRKLP 648
R TESLP S LP
Sbjct: 303 DLRNTESLPPSSHGAFSGNHLP 324
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-23
Identities = 76/261 (29%), Positives = 124/261 (47%), Gaps = 38/261 (14%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQ---LEQV-- 406
+ +Q K IGRG F VY T A+K+V I D +C+K+ L+Q+
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 407 ------------DDHLYIYLEYVHPGSIN---RYVREHCRDITESIVRNFTRHILNGLAY 451
D+ L I LE G ++ +Y ++ R I E V + + + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 510
+HS +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--- 178
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIP-EM 564
++G DIWSLGC + EM + P+ + +F + + PP+P E
Sbjct: 179 -HENG---YNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTEH 232
Query: 565 LSSEGKDFLLRCFLRNPVERP 585
S + ++ + C +P +RP
Sbjct: 233 YSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 56/290 (19%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSA----ECIKQLE---- 404
+++ + +G GT+ +VY G NR TG A+KE+ + ++ P +A +K+L+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 405 -------QVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHST 455
++ L + EY+ + +Y+ + + V++FT +L G+A+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 514
+HRD+K NLL++ G +KLADFG+A+ S + W AP+V+
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL------ 173
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPP---------IPE 563
G+ + ++DIWS+GC + EM+TG+P + + K+ TP +PE
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 564 M------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
G D L R NP R SA + L+HP+
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 48/232 (20%)
Query: 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-HRDIKGA 465
D + I +E++ GS+++ +++ R I E+I+ + +L GL YL + I HRD+K +
Sbjct: 71 DGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 466 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525
N+LV++ G +KL DFG++ L S S G+ ++M+PE ++ G + DI
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ------GT-HYTVQSDI 181
Query: 526 WSLGCTVIEMLTGK----------------PPWSEFEG----------------PQAMFK 553
WSLG +++EM G+ P SE E P A+F+
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241
Query: 554 VL----NRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+L N PP S E +DF+ +C +NP ER EL +HPFI+ A
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 73/260 (28%), Positives = 114/260 (43%), Gaps = 40/260 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDP----KSAECIKQLEQVDDH---- 409
+ IG+G FG VY G + A+K + PD + AE +KQ DH
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY----DHPNIV 55
Query: 410 -----------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+YI +E V GS+ ++R+ +T + + G+ YL S N I
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKDG 515
HRD+ N LV + V+K++DFGM++ G Y +S LK P W APE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY------ 169
Query: 516 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDF 572
+ D+WS G + E + G P+ Q ++ + R P P++ E
Sbjct: 170 -GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPEEIYRL 227
Query: 573 LLRCFLRNPVERPSAVELLE 592
+L+C+ +P RPS E+
Sbjct: 228 MLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 90/329 (27%), Positives = 133/329 (40%), Gaps = 116/329 (35%)
Query: 362 IGRGTFGSVY--IGTNRETGASCAIKEVDIIPDD----PKSA------------ECIKQL 403
IGRGT+G VY N + G AIK+ + +SA E + L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 404 EQV-----DDHLYIYLEYV-HP-GSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHST 455
+V D +Y+ +Y H I ++ R+ R I S+V++ ILNG+ YLHS
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 456 NTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
+HRD+K AN+LV GVVK+ D G+A+ + AP +K +
Sbjct: 128 WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL---------------FNAP--LKPLA 170
Query: 512 QKDG--------NPKLAL-------AVDIWSLGCTVIEMLTGKPPWSEFEGPQA------ 550
D P+L L A+DIW++GC E+LT +P F+G +A
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI---FKGREAKIKKSN 227
Query: 551 ---------MFKVLNRTPP---------IPEM--------------------------LS 566
+F+VL TP +PE
Sbjct: 228 PFQRDQLERIFEVLG-TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEHPF 595
S+G D L + +P +R +A E LEHP+
Sbjct: 287 SQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 70/264 (26%), Positives = 108/264 (40%), Gaps = 49/264 (18%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------------KQLE 404
+ G IG+G FG V +G R G A+K + DD +A+ L
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKC---LKDDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 405 QV------DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 457
Q+ + LYI EY+ GS+ Y+R R IT + F + G+ YL N
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKD 514
+HRD+ N+LV V K++DFG+AK W APE ++
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALR------ 172
Query: 515 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG---- 569
K + D+WS G + E+ + G+ P+ P V+ M + EG
Sbjct: 173 -EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLK--DVVPHVEKGYRMEAPEGCPPE 227
Query: 570 -KDFLLRCFLRNPVERPSAVELLE 592
+ C+ +P +RP+ +L E
Sbjct: 228 VYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-22
Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 35/271 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKS---AE---CIKQLE------ 404
K+IG+G+FG V + ++ G A+K + I+ + AE +K ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
Q D LY L+YV+ G + ++ RE R E R + I + L YLHS N I
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+L+D+ G V L DFG+ K + + G+P ++APEV++ K
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR----KQPYD 174
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
+ VD W LG + EML G PP+ + + +LN+ + +S + L
Sbjct: 175 R---TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLL 231
Query: 578 LRNPVERPSA----VELLEHPFIRNANYQNL 604
++ +R A +E+ H F + N+ +L
Sbjct: 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 52/277 (18%)
Query: 360 KLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQVD--DHLYIY 413
K +G G FG V + TG A+K ++ ++ ++ +++E + DH I
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 414 -----------------LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+EY+ GS+ Y++ H I + F+ I G+ YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSYELSLKGSP-NWMAPEVIKAVMQ 512
IHRD+ N+LV++ +VK++DFG+AK L Y SP W APE ++
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR---- 185
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLT-GKP---PWSEF-------EGPQAMFKVLN----- 556
K + A D+WS G T+ E+ T G P P +EF +G + ++L
Sbjct: 186 ---TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 557 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
R P P E D + C+ P +RPS +L+
Sbjct: 243 ERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 38/273 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSA---------------ECI 400
KL+G+GTFG V + + TG A+K EV + D+ +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIH 459
K Q D L +EY + G + ++ R +E R + I++ L YLHS N ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGN 516
RD+K NL++D G +K+ DFG+ K G+ ++K G+P ++APEV++ +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLE-------D 170
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 576
AVD W LG + EM+ G+ P+ + + +L P LS E K L
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL 230
Query: 577 FLRNPVER-----PSAVELLEHPFIRNANYQNL 604
++P +R A E+++H F +Q++
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 66/260 (25%), Positives = 126/260 (48%), Gaps = 31/260 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI---IPDDPKSAECIKQL------------- 403
+++G+G++G V + +R G IK++++ + K+AE QL
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 404 ---EQVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 459
E D LYI + + G + ++E + + E+ V + I L YLH + +H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNP 517
RD+K N+ + + ++K+ D G+A+ L ++ +L G+P +M+PE+ N
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFS-------NK 177
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRC 576
D+W+LGC V EM T K ++ + +++++ + PP+P+ S E + +
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 577 FLRNPVERPSAVELLEHPFI 596
+ P +RPS +L P+I
Sbjct: 238 LSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 41/275 (14%)
Query: 360 KLIGRGTFGSVYIG---TNRETGASCAIK-----------------EVDIIPDDPKSAEC 399
K++G+G+FG V++ T + G A+K E DI+ + +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPF 59
Query: 400 IKQLE---QVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
I +L Q + LY+ L+++ G + R +E TE V+ + + L +LHS
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL 117
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
I+RD+K N+L+D G +KL DFG++K + S G+ +MAPEV+ +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV----NRR 173
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574
G+ + D WS G + EMLTG P+ + + M +L +P+ LS E + L
Sbjct: 174 GH---TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230
Query: 575 RCFLRNPVER----PSAVELLE-HPFIRNANYQNL 604
F RNP R P VE ++ HPF ++ L
Sbjct: 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAEC----------------IK 401
++G+G+FG V + + T AIK + +I DD EC +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVECTMVEKRVLALQDKPPFLT 64
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
QL Q D LY +EYV+ G + ++++ + E + I GL +LH I
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 459 HRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+++D+ G +K+ADFGM K H+ + G+P+++APE+I Q G
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPYG-- 179
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
+VD W+ G + EML G+PP+ + + ++ P+ LS E
Sbjct: 180 ---KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236
Query: 578 LRNPVER-----PSAVELLEHPFIRNANYQNLS 605
++P +R ++ EH F R ++ L
Sbjct: 237 TKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 65/255 (25%), Positives = 111/255 (43%), Gaps = 30/255 (11%)
Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIK--EVDIIPDDPK----SAECIKQLEQ---- 405
G+ IG G FG VY G + A+K + P + A ++Q +
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 406 ------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
++ ++I +E G + Y++ + + + + ++ + LAYL S +H
Sbjct: 71 KLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNP 517
RDI N+LV + VKL DFG++++L SY + KG P WMAPE I
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-------R 183
Query: 518 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLR 575
+ A D+W G + E+L G P+ + + ++ N P+P + +
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 243
Query: 576 CFLRNPVERPSAVEL 590
C+ +P +RP EL
Sbjct: 244 CWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 81/281 (28%), Positives = 124/281 (44%), Gaps = 56/281 (19%)
Query: 357 QKGKLIGRGTFGSV----YIGTNRETGASCAIK----------------EVDIIP----- 391
+K +++G G FG V Y N TG A+K E++I+
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 392 DDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
+ K C EQ L + +EYV GS+ Y+ +H ++ + ++ F + I G+AY
Sbjct: 67 NIVKYKGCCS--EQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQICEGMAY 122
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TG-LSYELSLKG-SPN-WMAPEVI 507
LHS + IHRD+ N+L+D +VK+ DFG+AK + G Y + G SP W A E +
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEFE---GP-QAMFKVLNRTP 559
K K + A D+WS G T+ E+LT + P +FE GP Q V+
Sbjct: 183 KEN-------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235
Query: 560 --------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P P+ E + C+ RP+ L+
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 74/300 (24%), Positives = 124/300 (41%), Gaps = 80/300 (26%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE------------------CIKQL 403
IG G +G V + +G AIK++ D P A+ I+ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 404 EQVDD----HLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTI 458
+ +Y+ ++ + ++ + H +TE +R F +L GL Y+HS N I
Sbjct: 73 LRPPGADFKDVYVVMDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSANVI 129
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------APEVIK 508
HRD+K +NLLV+ +++ DFGMA+ L+ E +M APE++
Sbjct: 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-----YFMTEYVATRWYRAPELLL 184
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEML---------------------TGKPPWSEF-- 545
++ P+ A+D+WS+GC EML G P E
Sbjct: 185 SL------PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-EEVLN 237
Query: 546 ----EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ + + L R P+P ++ S E D L + +P ER + + L+HPF+
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 91/318 (28%), Positives = 135/318 (42%), Gaps = 69/318 (21%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-EQV 406
S S + QKG +G GT+G V + TG AIK+V II + +QL
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMC 61
Query: 407 DDH------LYIYLEYVHP---GSINRYVREHCRDI-------------------TESIV 438
H L I E H G ++ YV ++ TES V
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQV 121
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498
+ ILNGL LH +HRD+ AN+ +++ G+ K+ADFG+A+ Y +L
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 499 PNW-----MAPEVI----KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFE 546
M +V+ +A G K AVD+WS+GC E+LTGKP + +E +
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241
Query: 547 GPQAMFKVLNRTP---PIPEMLS---------SEGKDF-------------LLRCFLR-N 580
+F++L TP P+ + KD LL+ L+ N
Sbjct: 242 QLGRIFELLG-TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300
Query: 581 PVERPSAVELLEHPFIRN 598
P+ER SA E L+H + ++
Sbjct: 301 PLERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 8e-21
Identities = 92/336 (27%), Positives = 151/336 (44%), Gaps = 53/336 (15%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------------------EVDII--P 391
K ++ K+IGRG FG V + ++ T A+K E DI+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 392 DDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
+ P + Q D +LY+ +EY+ G + + + D+ E R +T ++ L
Sbjct: 101 NSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDA 157
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKA 509
+HS IHRD+K N+L+D SG +KLADFG M + G+ + G+P++++PEV+K+
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEML 565
+ G+ D WS+G + EML G P+ K++N T P +
Sbjct: 218 ---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274
Query: 566 SSEGKDFLLRCFL--------RNPVERPSAVELLEHPFIRN-----ANYQNLSVPMRVFS 612
S E K+ L+ FL RN VE E+ H F +N ++ P+
Sbjct: 275 SKEAKN-LICAFLTDREVRLGRNGVE-----EIKRHLFFKNDQWAWETLRDTVAPVVPDL 328
Query: 613 RINLGDKSHDQVERATRKTESLPDSPETRVRNRKLP 648
++ + D +E + E+ P P+ V N +LP
Sbjct: 329 SSDIDTSNFDDIEEDKGEEETFP-IPKAFVGN-QLP 362
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 77/275 (28%), Positives = 130/275 (47%), Gaps = 42/275 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAEC----------------I 400
++G+G+FG V + + T AIK + +I DD EC +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVECTMVEKRVLALSGKPPFL 63
Query: 401 KQLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
QL Q D LY +EYV+ G + +++ R E + I GL +LHS
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
I+RD+K N+++D+ G +K+ADFGM K G++ + + G+P+++APE+I Q G
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-TFCGTPDYIAPEIIA--YQPYG 179
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFLL 574
+VD W+ G + EML G+ P+ E E +F+ ++ P+ +S E
Sbjct: 180 K-----SVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 233
Query: 575 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
++P +R ++ EH F R +++ L
Sbjct: 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 69/301 (22%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------EC 399
Q++K + IG GT+G VY +R T + A+K++ + +D P +A
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 400 IKQLEQV---DDHLYIYLEYV------HPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
I +L+ V + LY+ EY+ H S + + +++ + IL G+A
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQILRGIA 116
Query: 451 YLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIK 508
Y HS +HRD+K NLL+D +KLADFG+A+ + + W APE++
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP------ 559
G+ + VDIWS+GC EM+ KP + SE + +F++L TP
Sbjct: 177 ------GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TPNEETWP 229
Query: 560 ---PIPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+P+ L G D L + +P +R +A LEH + ++
Sbjct: 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 599 A 599
Sbjct: 290 L 290
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 46/222 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-------ECIKQLEQV 406
S+++K IG+GTFG V+ +++T A+K+ ++ ++ K E IK L+ +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITALRE-IKILQLL 68
Query: 407 DDHLYIYLE---YVHPGSINRY------VREHCR------------DITESIVRNFTRHI 445
+ L NRY V E C T S ++ + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 505
LNGL Y+H +HRD+K AN+L+ G++KLADFG+A+ ++ LS PN
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-----AFSLSKNSKPNRYTNR 183
Query: 506 VIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 540
V+ + P+L L +D+W GC + EM T P
Sbjct: 184 VVTLWYRP---PELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 73/319 (22%), Positives = 122/319 (38%), Gaps = 97/319 (30%)
Query: 361 LIGRGTFG--SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------- 405
LIG+ V++ ++ T A+K++++ D S E +K L+Q
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 406 -------VDDH-LYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 456
+ D LY+ + GS ++ H + + E + + +LN L Y+HS
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----------KGSP------- 499
IHR +K +++L+ G V L+GL Y +S+ P
Sbjct: 122 FIHRSVKASHILLSGDGKV---------VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 500 NWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 558
W++PEV++ +Q G N K DI+S+G T E+ G P+ + Q + + + T
Sbjct: 173 PWLSPEVLQQNLQ--GYNEK----SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226
Query: 559 PP-------IPEMLSSEGKD---------------------------FLLRCFLRNPVER 584
P P S + F+ C R+P R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 585 PSAVELLEHPF---IRNAN 600
PSA +LL H F + N
Sbjct: 287 PSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 73/264 (27%), Positives = 112/264 (42%), Gaps = 42/264 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGAS---------CAIKEVDIIPDDPKSAECIKQLEQ----- 405
K +G G+FG V G +G + K DI+ D K A + L+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 406 -----VDDHLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNTIH 459
+ L + E GS+ +R+ S + ++ I NG+ YL S IH
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHL--TGLSY--ELSLKGSPNWMAPEVIKAVMQKDG 515
RD+ N+L+ + VK+ DFG+ + L Y E LK W APE ++
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR----- 175
Query: 516 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV------LNRTPPIPEMLSSE 568
+ A D+W G T+ EM T G+ PW+ G Q + K+ L R PE +
Sbjct: 176 --TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER----PEACPQD 229
Query: 569 GKDFLLRCFLRNPVERPSAVELLE 592
+ +L+C+ NP +RP+ L E
Sbjct: 230 IYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 54/286 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIK--QLE----------- 404
++IGRG++ V + ++T A+K + +++ DD E I Q E
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHP 56
Query: 405 ---------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
Q + L+ +E+V G + +++ R + E R ++ I L +LH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER 115
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 514
I+RD+K N+L+DA G +KL D+GM K S G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPW--------SEFEGPQAMFKV-LNRTPPIPEML 565
+VD W+LG + EM+ G+ P+ + +F+V L + IP L
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228
Query: 566 SSEGKDFLLRCFL-RNPVER------PSAVELLEHPFIRNANYQNL 604
S + +L+ FL ++P ER ++ HPF RN ++ L
Sbjct: 229 SVKASS-VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL 273
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-20
Identities = 80/281 (28%), Positives = 132/281 (46%), Gaps = 48/281 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK------------------EVDII--PDDPKSAEC 399
K+IGRG FG V + ++ + A+K E DI+ + P +
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 400 IKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q D +LY+ +EY+ G + + + D+ E + +T ++ L +HS IH
Sbjct: 109 FCAF-QDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIH 165
Query: 460 RDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
RD+K N+L+D G +KLADFG M TG+ + G+P++++PEV+K+ + G+
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS---QGGDG 222
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PE--MLSSEGKDFL 573
D WS+G + EML G P+ K+++ + PE +S K+ L
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN-L 281
Query: 574 LRCFL--------RNPVERPSAVELLEHPFIRNA--NYQNL 604
+ FL RN VE E+ +HPF +N N+ N+
Sbjct: 282 ICAFLTDREVRLGRNGVE-----EIKQHPFFKNDQWNWDNI 317
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 70/283 (24%), Positives = 113/283 (39%), Gaps = 46/283 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQ-LEQVDDHLYIYL 414
+++G+G FG V R TG A K+++ + E + KQ LE+V+ + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 415 EYVHP--------------GSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 459
Y + G + ++ E + I GL LH ++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
RD+K N+L+D G ++++D G+A + G+ +MAPEV+K N +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK-------NERY 178
Query: 520 ALAVDIWSLGCTVIEMLTGKPP---------WSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570
+ D W LGC + EM+ GK P E E +V E S +
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-----RVKEDQEEYSEKFSEAAR 233
Query: 571 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 608
+ ++P R A E+ HPF R AN++ L M
Sbjct: 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 45/223 (20%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQV 406
K+++ +K K++G G FG+VY G G AIK + + K +++
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-------REETSPKANKEI 56
Query: 407 DDHLYIYLEYVHP-----------------------GSINRYVREHCRDITESIVRNFTR 443
D Y+ HP G + YVR H +I + N+
Sbjct: 57 LDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV 116
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---N 500
I G++YL +HRD+ N+LV VK+ DFG+AK L E +G
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 542
WMA E I + D+WS G TV E++T G P+
Sbjct: 177 WMALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-19
Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETG---------ASCAI---KEVDIIPDDPKSAECIKQLEQV- 406
+ +G G+FG V + T + I K+VD + + K I V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 407 -------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ +LY+ LE+V G ++R + R + + I+ YL S N ++
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
RD+K NLL+D G +K+ DFG AK + +Y +L G+P ++APE++ V G+ K
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNV----GHGK- 207
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 579
A D W+LG + E+L G PP+ E K+L P+ L + K + +
Sbjct: 208 --AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSH 265
Query: 580 NPVER-----PSAVELLEHPFIRNANYQNL 604
+ +R A + EHP+ N ++ +L
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295
|
Length = 340 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 46/279 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQ----LEQVDDH---- 409
++IGRG++ V + ++T A+K V +++ DD + + ++ EQ +H
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLV 59
Query: 410 -----------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
L+ +EYV+ G + +++ R + E R ++ I L YLH I
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGII 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+L+D+ G +KL D+GM K L + G+PN++APE+++
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-------E 171
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWS---EFEGPQA-----MFKV-LNRTPPIPEMLSSE 568
+VD W+LG + EM+ G+ P+ + P +F+V L + IP LS +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231
Query: 569 GKDFLLRCFLRNPVERPSAV------ELLEHPFIRNANY 601
L ++P ER ++ HPF RN ++
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 42/265 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQ------LEQVD------- 407
+G+G+FG+VY+ +++ A +K + IP + E ++ L ++D
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 408 -------DHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTNT 457
D I EY ++ + E ++E+ V + +L G+ Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 515
+HRD+K N+ + + ++K+ DFG+++ L G S +L + G+P +M+PE +K +
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALK---HQGY 182
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----RTPPIPEMLSSEGKD 571
+ K DIWSLGC + EM FEG + VL TP +PE S +
Sbjct: 183 DSK----SDIWSLGCILYEMCCLA---HAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235
Query: 572 FLLRCFLRNPVERPSAVELLEHPFI 596
+ ++P RPSA E+L +PFI
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 49/272 (18%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEV----DIIPDDPK-----SAECIKQLEQVD--- 407
+G G FG V++G + E + V + +D + AE + + +
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 408 --------DHLYIYLEYVHPGSINRYVREHCRD-------------ITESIVRNFTRHIL 446
D + EY+ G +N+++R H D +T S + I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWM 502
+G+ YL S + +HRD+ N LV VVK+ DFGM++ + Y + G WM
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRWM 191
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 561
PE ++M + K D+WS G + E+ T GK PW + + +
Sbjct: 192 PPE---SIMYR----KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244
Query: 562 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P SE D +L C+ R+P +R + ++ E
Sbjct: 245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 74/303 (24%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV------DIIPDDPKSAECIKQLEQVD 407
++++K IG GT+G VY + +G A+K+V D IP S I L +
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIP--ISSLREITLLLNLR 64
Query: 408 DHLYIYLEYV----HPGSINRYVREHC------------RDITESIVRNFTRHILNGLAY 451
+ L+ V H SI V E+C +ES V+ +L GL Y
Sbjct: 65 HPNIVELKEVVVGKHLDSI-FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SPN----WM-APE 505
LH IHRD+K +NLL+ G +K+ADFG+A+ +Y L K +P W APE
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMTPKVVTLWYRAPE 178
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL------- 555
++ G A+D+W++GC + E+L KP SE E + ++L
Sbjct: 179 LLL------GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 556 ---------------------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 594
N P LS G L + +P +R +A E LE
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEALESS 291
Query: 595 FIR 597
+ +
Sbjct: 292 YFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 29/247 (11%)
Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDD-PKSAECIKQLEQ----------V 406
K +G G FG V++G A ++K+ + P+ A +KQL+
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 407 DDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
+ +YI EY+ GS+ +++ +T + + + I G+A++ N IHRD++ A
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAA 131
Query: 466 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALA 522
N+LV + K+ADFG+A+ + Y + +G+ W APE I +
Sbjct: 132 NILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY-------GTFTIK 183
Query: 523 VDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLR 579
D+WS G + E++T G+ P+ P+ + + L R P P+ E + + C+
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGYRMPRPDNCPEELYELMRLCWKE 242
Query: 580 NPVERPS 586
P ERP+
Sbjct: 243 KPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 70/260 (26%), Positives = 115/260 (44%), Gaps = 43/260 (16%)
Query: 360 KLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDD-------------PKSAE----CI 400
K +G G FG V++G R A AI E + +D PK + C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
+Q LYI E++ G + Y+R+ +++ ++ + + + G+ YL + IHR
Sbjct: 70 QQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPK 518
D+ N LV ++GVVK++DFGM +++ Y S K W PEV K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-------SK 177
Query: 519 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSEGKDF 572
+ D+WS G + E+ T GK P+ + + + + L R P++ S +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLASMTVYEV 233
Query: 573 LLRCFLRNPVERPSAVELLE 592
+ C+ P RP+ ELL
Sbjct: 234 MYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 405 QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
Q L++ +EYV+ G + +++ R + E R + I L +LH I+RD+K
Sbjct: 66 QTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKL 124
Query: 465 ANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
N+L+DA G +KL D+GM K G S G+PN++APE+++ + +V
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-------EEYGFSV 177
Query: 524 DIWSLGCTVIEMLTGKPPWS------EFEGPQAMFKVLNRTP-PIPEMLSSEGKDFLLRC 576
D W+LG + EM+ G+ P+ + +F+V+ P IP LS + L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 577 FLRNPVERPSA------VELLEHPFIRNANYQNL 604
++P ER ++ H F R+ ++ L
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 74/291 (25%), Positives = 118/291 (40%), Gaps = 66/291 (22%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLE--------- 404
+ +G G++ +VY G +R G A+K + + ++ + A +K L+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 405 --QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+ L EY+H + +Y+ +H + VR F +L GLAY+H + +HRD+
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
K NLL+ G +KLADFG+A+ + S S + W P ++ G + A
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP--DVLL---GATDYSSA 184
Query: 523 VDIWSLGCTVIEMLTG--------------------------------------KPPWSE 544
+DIW GC IEML G KP W
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244
Query: 545 FEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
PQ + V R P + +D + + P +R SA + L HP+
Sbjct: 245 PCKPQQLRVVWKRLSRPP-----KAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 73/304 (24%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ--LE---------- 404
KL+G+G G V++ + TG A+K +D +I + +Q L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 405 ----QVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHSTNT 457
Q + +L + ++Y G + R ++ C ++E + R + +L L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYLHLLGI 124
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPN-------------- 500
++RD+K N+L+ SG + L+DF ++K + KGS
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 501 -------------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547
++APEVI DG+ AVD W+LG + EML G P F+G
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISG----DGH---GSAVDWWTLGILLYEMLYGTTP---FKG 234
Query: 548 P---QAMFKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVER----PSAVELLEHPFIRN 598
+ +L + P +SS +D + + +++P +R A E+ +HPF R
Sbjct: 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
Query: 599 ANYQ 602
N+
Sbjct: 295 VNWA 298
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 36/278 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQ-LEQVDDHLYIYL 414
+++G+G FG V R TG A K ++ + E + KQ LE+V+ + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 415 EYVHP--------------GSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 459
Y + G + ++ E + IL GL LH NT++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
RD+K N+L+D G ++++D G+A + G+ +MAPEV+ N +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN-------NQRY 178
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS----EGKDFLLR 575
L+ D W LGC + EM+ G+ P+ + +V R E+ S+ E K
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238
Query: 576 CFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 608
++P +R A E+ HPF RN N++ L M
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 30/255 (11%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDD-PKSAECIKQLEQVDDH 409
+ + + +G G FG V++GT T A +K + P+ + A+ +K+L D
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH--DK 62
Query: 410 L-------------YIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHST 455
L YI EY+ GS+ +++ + + + + I G+AYL S
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQK 513
N IHRD+ N+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY---- 178
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKD 571
+ + D+WS G + E++T G+ P+ + + +V P P E D
Sbjct: 179 ---GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235
Query: 572 FLLRCFLRNPVERPS 586
+L+C+ ++P ERP+
Sbjct: 236 LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 81/311 (26%), Positives = 129/311 (41%), Gaps = 87/311 (27%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAEC------IKQLEQVD 407
++ K +G+G +G V N ET + AIK++ + K +K L
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFR 59
Query: 408 DHLYIY----LEYVHPGSINR-YVREHCRD------------ITESIVRNFTRHILNGLA 450
H I ++ V PG+ N Y+ E + +T++ ++F IL GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-------- 502
Y+HS N +HRD+K NLLV+A +K+ DFG+A+ + + + +M
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSENPGENAGFMTEYVATRW 174
Query: 503 --APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNR 557
APE++ + A+D+WS+GC + E+L KP F+G + ++L
Sbjct: 175 YRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKP---VFKGKDYVDQLNQILQV 225
Query: 558 --TPPIPEMLSS----------------EGKDF-------------LLRCFLR-NPVERP 585
TP E LS K F LL L +P +R
Sbjct: 226 LGTPD-EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284
Query: 586 SAVELLEHPFI 596
S E LEHP++
Sbjct: 285 SVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 57/274 (20%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQL------EQVDDH- 409
+G+G+FG VY G + E AIK V+ ++ E I+ L ++ + H
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 410 -------------LYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRHILN 447
+ +E + G + Y+R + T I +
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGS-P-NWMAP 504
G+AYL + +HRD+ N +V VK+ DFGM + + Y KG P WMAP
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-F----KVLNRT 558
E + KDG D+WS G + EM T + P+ + + F L+
Sbjct: 191 ESL-----KDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL- 242
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
PE + + + C+ NP RP+ +E++
Sbjct: 243 ---PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 69/225 (30%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV--------------------------------DI 389
IG GT+G VY +++TG A+K+V +I
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 390 IPDDPKSAECIKQ-------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
+ D + + K E +D L LE G + +E +++F
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE---SGLV---------HFSEDHIKSFM 122
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 502
+ +L GL Y H N +HRDIK +N+L++ G +KLADFG+A+ L
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--------LYNSEESRPY 174
Query: 503 APEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 540
+VI + P+L L A+D+WS GC + E+ T KP
Sbjct: 175 TNKVITLWYRP---PELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-18
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 34/219 (15%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----------------- 392
SP KS ++ G +IG G+FG VY +T AIK+V P
Sbjct: 63 SPNKS-YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINI 121
Query: 393 ----DPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHI 445
D EC K+ E+ + L + +E++ P ++++Y++ + R+ + +V+ ++ +
Sbjct: 122 IFLKDYYYTECFKKNEK-NIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 504
LAY+HS HRD+K NLL+D + +KL DFG AK+L +S S + AP
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 543
E++ G +D+WSLGC + EM+ G P +S
Sbjct: 240 ELML------GATNYTTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 39/273 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKS---AE---CIKQLE------ 404
K+IG+G+FG V + + G+ A+K + I+ ++ AE +K L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
Q + LY L+YV+ G + ++ RE C E R + + + + YLHS N I
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNII 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDG 515
+RD+K N+L+D+ G V L DFG+ K G+ E + G+P ++APEV++
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLR------- 169
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLR 575
VD W LG + EML G PP+ + Q +L++ +P + D L+
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG 229
Query: 576 CFLRNPVERPSA----VELLEHPFIRNANYQNL 604
++ R A +E+ H F N+ +L
Sbjct: 230 LLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 33/270 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLE------------- 404
K+IG+G+FG V + + G A+K + I+ + + + +
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q + LY L++V+ G + +++ R E R + I + L YLHS N ++
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L+D+ G V L DFG+ K S + G+P ++APEVI+ Q N
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--QPYDN-- 175
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPPIPEMLSSEGKDFLL 574
VD W LG + EML G PP+ + + + K L P S ++ L
Sbjct: 176 ---TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLE 232
Query: 575 RCFLRNPVERPSAVELLEHPFIRNANYQNL 604
+ R + +E+ EHPF + ++ +L
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 19/190 (10%)
Query: 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469
+YI EY+ G + Y+REH + S + + + G+AYL S IHRD+ N LV
Sbjct: 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133
Query: 470 DASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 527
D G VK++DFG+++++ Y S+ K W PEV+ K + D+W+
Sbjct: 134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-------KFSSKSDVWA 186
Query: 528 LGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSEGKDFLLRCFLRNP 581
G + E+ + GK P+ F + + KV L R P + S + + C+
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----PHLASEKVYAIMYSCWHEKA 242
Query: 582 VERPSAVELL 591
ERP+ +LL
Sbjct: 243 EERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 77/299 (25%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQV----DDHLYIYLEY 416
IG G FG V+ T+ G A+K++ + + S + ++L+ + D++ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 417 VHPGSINRYVREHCRDITE--------SIVRN----------FTRHILNGLAYLHSTNTI 458
+ P I+ + E +TE IV F IL GL YLHS +
Sbjct: 68 LQPPHIDPF--EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125
Query: 459 HRDIKGANLLVDASGVVKLADFGMA--------KHLTGLSYELSLKGSPNWMAPEVIKAV 510
HRDIK NLLV+++ V+K+ DFG+A KH+T E+ + + APE++
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT---QEVV---TQYYRAPEILM-- 177
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGK---------------------PPWSEFEGP- 548
G+ AVDIWS+GC E+L + P
Sbjct: 178 ----GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233
Query: 549 QAMFKVLNRTPPIPEMLSS----------EGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ + R P P L E L R + +P +R SA + L HP++
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 65/273 (23%), Positives = 126/273 (46%), Gaps = 30/273 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETG------------------ASCAIKEVDIIPD-DPKSAECI 400
K+IGRG FG V + + T +C +E +++ + D + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
Q +++LY+ ++Y G + + + + E + R + ++ + +H + +HR
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR 126
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
DIK N+L+D +G ++LADFG + G G+P++++PE+++A+ +DG K
Sbjct: 127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM--EDGMGK 184
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEGKDFL 573
D WSLG + EML G+ P+ + K++N P +S E KD +
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244
Query: 574 LR--CFLRNPVERPSAVELLEHPFIRNANYQNL 604
R C + + + +H F +++N+
Sbjct: 245 QRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 66/273 (24%), Positives = 126/273 (46%), Gaps = 30/273 (10%)
Query: 360 KLIGRGTFGSVYI------------------GTNRETGASCAIKEVDIIPD-DPKSAECI 400
K+IGRG FG V + + +C +E D++ + D + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 401 KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
Q +++LY+ ++Y G + + + + E + R + ++ + +H + +HR
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
DIK N+L+D +G ++LADFG L G G+P++++PE+++A+ +DG K
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM--EDGKGK 184
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEGKDFL 573
D WSLG + EML G+ P+ + K++N P +S + KD +
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244
Query: 574 LR--CFLRNPVERPSAVELLEHPFIRNANYQNL 604
R C + + + + +HPF ++ N+
Sbjct: 245 RRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 62/297 (20%)
Query: 352 KKSQWQKGKLIGRGTFGSVY---------------IGTNRETGASC-AIKEVDIIPDDPK 395
K ++K +G G++ +VY I E GA AI+E ++ D K
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLL-KDLK 61
Query: 396 SAE--CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
A + + L + EY+ + +Y+ + ++ VR F +L GLAY H
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQ 512
+HRD+K NLL+ G +KLADFG+A+ + S S + W P+V+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL---- 176
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQ--AMFKVLNRTP--------- 559
G+ + + ++D+W +GC EM TG+P P S Q +F+VL TP
Sbjct: 177 --GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG-TPTEETWPGVS 233
Query: 560 ------------PIPEML---------SSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
P L G++ L+ P +R SA E ++HP+
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 32/249 (12%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKS----AECIKQLEQ--------- 405
+ +G G FG V+ G N T A+K + DPK A+ +K+L
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 406 --VDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+++ +YI E + GS+ Y++ R + + + + +G+AYL + N IHRD+
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDL 129
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
N+LV + + K+ADFG+A+ + YE K W APE + +
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-------NRFS 182
Query: 521 LAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCF 577
+ D+WS G + E++T G+ P+ + + +V R P P E D +L C+
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKELYDIMLDCW 241
Query: 578 LRNPVERPS 586
+P +RP+
Sbjct: 242 KEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 27/253 (10%)
Query: 359 GKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDD-PKSAECIKQLEQ---------V 406
K +G G FG V++G + A I+E + DD + A+ + +L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 407 DDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
++I EY+ G + Y+RE + + + + + YL S IHRD+
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAA 128
Query: 465 ANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKDGNPKLALA 522
N LV VVK++DFG+A+++ Y S K W PEV + +
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD-------YSRFSSK 181
Query: 523 VDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLR 579
D+WS G + E+ + GK P+ F + + V R P++ +E + C+
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTEVYTIMYSCWHE 240
Query: 580 NPVERPSAVELLE 592
P +RP+ +LL
Sbjct: 241 KPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 46/225 (20%)
Query: 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 467
+ +YI EY+ V E ++E R F +L GL Y+HS N +HRD+K AN+
Sbjct: 89 NSVYIVQEYMETDL--ANVLEQGP-LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145
Query: 468 LVDASG-VVKLADFGMAK----HLTGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLAL 521
++ V+K+ DFG+A+ H + Y LS W +P + ++ + K
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGY-LSEGLVTKWYRSPRL---LLSPNNYTK--- 198
Query: 522 AVDIWSLGCTVIEMLTGKPPWS---EFEGPQAMFK------------VLNRTP------- 559
A+D+W+ GC EMLTGKP ++ E E Q + + +LN P
Sbjct: 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDG 258
Query: 560 -----PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P+ ++L + E DFL + NP++R +A E L HP++
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 38/272 (13%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------------------- 398
+IGRG FG VY +TG A+K +D K E
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 399 CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
C+ D L L+ ++ G ++ ++ +H +E+ +R + I+ GL ++H+ +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
+RD+K AN+L+D G V+++D G+A + S+ G+ +MAPEV++ + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS--- 175
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIPEMLSSEGKDFLLR 575
+ D +SLGC + ++L G P+ + + L +P+ S E + L
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232
Query: 576 CFLRNPVER-----PSAVELLEHPFIRNANYQ 602
R+ R A E+ EHPF R+ ++Q
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 80/303 (26%), Positives = 122/303 (40%), Gaps = 90/303 (29%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ--------- 405
IG G +G+VY + +G A+K V + ++ + +K+LE
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 406 ---------------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 444
VD L YL+ V P + +++ R
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL-----------PAETIKDLMRQ 116
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNW 501
L GL +LH+ +HRD+K N+LV + G VKLADFG+A+ S +++L + +
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWY 173
Query: 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLN-- 556
APEV+ +Q A VD+WS+GC EM KP + SE + +F ++
Sbjct: 174 RAPEVL---LQS----TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
Query: 557 ------------------RTP-PI----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
R P P+ PE+ G LL NP +R SA L+H
Sbjct: 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI-EESGAQLLLEMLTFNPHKRISAFRALQH 285
Query: 594 PFI 596
PF
Sbjct: 286 PFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 35/261 (13%)
Query: 358 KGKLIGRGTFGSVYIGTNRETG---ASCAIK----------EVDIIPDDPK----SAECI 400
K K+IG G FG V+ G + G + AIK D + + S I
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 401 KQLEQVDD---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+LE V I EY+ G++++Y+R+H + + + R I G+ YL N
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSP-NWMAPEVIKAVMQK 513
+HRD+ N+LV+++ K++DFG+++ L +Y S P W APE I
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI------ 182
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT--PPIPEMLSSEGK 570
K A D+WS G + E+++ G+ P+ + + M K +N P P S
Sbjct: 183 -AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-KAINDGFRLPAPMDCPSAVY 240
Query: 571 DFLLRCFLRNPVERPSAVELL 591
+L+C+ ++ RP V+++
Sbjct: 241 QLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 74/302 (24%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQ-------LEQV 406
++Q +G G +G V + +TG AIK++ P +SA K+ L+ +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHM 71
Query: 407 DDHLYIYLEYV-HPGS------------------INRYVREHCRDITESIVRNFTRHILN 447
D I L V P S +N V+ C+ +++ ++ IL
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILR 129
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEV 506
GL Y+HS IHRD+K +N+ V+ +K+ DFG+A+H E++ + W APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEI 186
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF- 545
+ M + VDIWS+GC + E+LTGK P E
Sbjct: 187 MLNWMHYNQ------TVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 546 -----EGPQAMFKVLNRTP-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
E + + L + P + + D L + + +P +R +A E L HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 596 IR 597
+
Sbjct: 301 LA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQ-LEQVDDHLYIYL 414
+++G+G FG V R TG A K+++ + E + KQ LE+V+ + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 415 EYVHP-------------GSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTIH 459
Y + G ++ H + E + I GL LH ++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
RD+K N+L+D G ++++D G+A H+ G+ +MAPEV+K N +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-------NERY 178
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS----EGKDFLLR 575
+ D W+LGC + EM+ G+ P+ + + +V + E S + +
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238
Query: 576 CFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 608
++P ER A E+ EHP + N++ L M
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 67/252 (26%), Positives = 119/252 (47%), Gaps = 39/252 (15%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIK-------EVDIIPDDPKSAECIKQLEQVDDH-- 409
K +G G FG V++ T N+ T A+K V+ + + ++ + V H
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 410 -----LYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+YI E++ GS+ +++ + + +F+ I G+A++ N IHRD++
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDGNPKLA 520
AN+LV AS V K+ADFG+A+ + Y + +G+ W APE I
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINF-------GSFT 181
Query: 521 LAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSEGKDFLL 574
+ D+WS G ++E++T G+ P+ P+ + + + R PE L + ++
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY----NIMM 237
Query: 575 RCFLRNPVERPS 586
RC+ P ERP+
Sbjct: 238 RCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 35/271 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLE------ 404
K+IG+G+FG V + ++ A+K + K E +K ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 405 -----QVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
Q D LY L+Y++ G + ++ RE C E R + I + L YLHS N +
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIV 118
Query: 459 HRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+RD+K N+L+D+ G + L DFG+ K ++ + G+P ++APEV+
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-------KQ 171
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577
VD W LG + EML G PP+ + +LN+ + +++ + L
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231
Query: 578 LRNPVERPSA----VELLEHPFIRNANYQNL 604
++ +R A +E+ H F N+ +L
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 72/256 (28%), Positives = 124/256 (48%), Gaps = 30/256 (11%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ- 405
P++S + KL G+G FG V++GT T AIK + P++ A+ +K+L
Sbjct: 4 PRESLRLEVKL-GQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 406 ---------VDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHST 455
++ +YI EY+ GS+ +++ E + + + + I +G+AY+
Sbjct: 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQK 513
N +HRD++ AN+LV + V K+ADFG+A+ + Y K W APE A +
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG 178
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 570
+ + D+WS G + E+ T G+ P+ + + +V R P PE S
Sbjct: 179 ----RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-H 233
Query: 571 DFLLRCFLRNPVERPS 586
D + +C+ + P ERP+
Sbjct: 234 DLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 17/178 (9%)
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSP 499
+T I++GL +LH I+RD+K N+L+D G V+++D G+A L G S G+P
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVL 555
+MAPE+++ + +VD ++LG T+ EM+ + P+ + E + ++L
Sbjct: 162 GFMAPELLQ-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214
Query: 556 NRTPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 608
N + P+ S K F ++P +R + L HP R+ N++ L M
Sbjct: 215 NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGM 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 67/225 (29%), Positives = 95/225 (42%), Gaps = 55/225 (24%)
Query: 403 LEQVDDHLYIYLEYV-HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
E VD L YL+ V PG + +++ +L GL +LHS +HRD
Sbjct: 88 FEHVDQDLTTYLDKVPEPG------------VPTETIKDMMFQLLRGLDFLHSHRVVHRD 135
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K N+LV +SG +KLADFG+A+ + S+ + + APEV+ +Q A
Sbjct: 136 LKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL---LQS----SYAT 188
Query: 522 AVDIWSLGCTVIEMLTGKP------------------------PWSEFEG-PQAMFK--- 553
VD+WS+GC EM KP W P+ F
Sbjct: 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 248
Query: 554 ---VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+ I E+ GKD LL+C NP +R SA L HP+
Sbjct: 249 AQPIEKFVTDIDEL----GKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 79/307 (25%), Positives = 133/307 (43%), Gaps = 55/307 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR---------------ETGASC-AIKEVDIIPDDPK 395
K + K + +G GT+ +V+ G ++ E GA C AI+EV ++ D K
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL-KDLK 62
Query: 396 SAECIK--QLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
A + + D L + EY+ + +Y+ + ++ V+ F IL GLAY H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
+HRD+K NLL++ G +KLADFG+A+ + + S + W P +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL---- 177
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTP------------ 559
G+ + + +D+W +GC EM +G+P P S E + L TP
Sbjct: 178 -GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 560 -----------PIPEM-----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603
P P + L +EG + L + +R SA E ++H + R+ +
Sbjct: 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI 296
Query: 604 LSVPMRV 610
S+P +
Sbjct: 297 HSLPESI 303
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 86/310 (27%), Positives = 131/310 (42%), Gaps = 77/310 (24%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIK 401
K+IGRG FG V + ++TG A+K E DI+ + A +K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-ADGAWVVK 65
Query: 402 QLEQVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
D +LY+ +E++ PG + ++E + + + + +H IH
Sbjct: 66 MFYSFQDKRNLYLIMEFL-PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHL-----------------TGLSYE---------- 492
RDIK NLL+DA G VKL+DFG+ L + S++
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 493 ---------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 543
S G+P+++APEV MQ G KL D WSLG + EML G PP+
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVF---MQT-GYNKLC---DWWSLGVIMYEMLIGYPPFC 237
Query: 544 EFEGPQAMF-KVLNRT------PPIPEMLSSEGKDFLLRCFL--RNPVERPSAVELLEHP 594
E PQ + KV+N P +P +S + KD +LR N + E+ HP
Sbjct: 238 S-ETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHP 294
Query: 595 FIRNANYQNL 604
F ++ ++
Sbjct: 295 FFEGVDWGHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-17
Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 38/286 (13%)
Query: 340 MPHIMEKP-SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
+P E P S +P++ + L+GR + ++ T + + ++ D+ ++A
Sbjct: 52 LPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAY 111
Query: 399 CIKQLE-----------------QVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIV 438
+L + DD L + +EY G +N+ +++ ++ E V
Sbjct: 112 ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSYELSL 495
I+ L +HS +HRD+K AN+ + +G++KL DFG +K + L S
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMF 552
G+P ++APE+ + + + D+WSLG + E+LT P F+GP + M
Sbjct: 232 CGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRP---FKGPSQREIMQ 281
Query: 553 KVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+VL + P P +SS K L +NP RP+ +LL F++
Sbjct: 282 QVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 56/261 (21%)
Query: 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-HRDIKGA 465
D + I +E++ GS+++ +++ R I E I+ + ++ GL YL + I HRD+K +
Sbjct: 75 DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133
Query: 466 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525
N+LV++ G +KL DFG++ L S S G+ ++M+PE ++ ++ DI
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGT-------HYSVQSDI 185
Query: 526 WSLGCTVIEMLTGK-----PPWSEFE---------------------------------- 546
WS+G +++EM G+ P E E
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDS 245
Query: 547 -GPQAMFKVL----NRTPP-IPE-MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
P A+F++L N PP +P + +E +DF+ +C ++NP ER +L+ H FI+ +
Sbjct: 246 RPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305
Query: 600 NYQNLSVPMRVFSRINLGDKS 620
+ + + S I L S
Sbjct: 306 EAEEVDFAGWLCSTIGLNQPS 326
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 43/256 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS------AECIKQLEQ---------- 405
IG+G FG V +G R G A+K I +D + A + QL
Sbjct: 14 IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 406 VDDH--LYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNTIHRDI 462
V++ LYI EY+ GS+ Y+R R + + F+ + + YL + N +HRD+
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
N+LV V K++DFG+ K + S + + K W APE ++ K +
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EKKFSTK 179
Query: 523 VDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG-----KDFLLRC 576
D+WS G + E+ + G+ P+ + V+ R +M + +G D + +C
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235
Query: 577 FLRNPVERPSAVELLE 592
+ + RPS ++L E
Sbjct: 236 WHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 72/267 (26%), Positives = 117/267 (43%), Gaps = 48/267 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASC---AIKEVDIIPDDPKSAECIKQ----------LEQV 406
K+IG G FG V G + G AIK + K+ KQ + Q
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-------KAGSSDKQRLDFLTEASIMGQF 62
Query: 407 DDHLYIYL--------------EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
D I L EY+ GS+++++RE+ T + R I +G+ YL
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG--SP-NWMAPEVIKA 509
N +HRD+ N+LV+++ V K++DFG+++ L + KG P W APE I
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI-- 180
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 566
K A D+WS G + E+++ G+ P+ + + V + R PP P
Sbjct: 181 -----AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMDCP 234
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593
S +L C+ ++ ERP+ +++
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 57/295 (19%)
Query: 362 IGRGTFGSVYIGTNR---------------ETGASC-AIKEVDIIPDDPKSAECIK--QL 403
+G GT+ +VY G ++ E GA C AI+EV ++ D K A + +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL-KDLKHANIVTLHDI 72
Query: 404 EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+ L + EY+ + +Y+ + I V+ F +L GL Y H +HRD+K
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
NLL++ G +KLADFG+A+ + + S + W P I G+ + +
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL-----GSTDYSTQI 186
Query: 524 DIWSLGCTVIEMLTGKP--PWSEFEGP-QAMFKVLNRTP---PIPEMLSSE--------- 568
D+W +GC EM TG+P P S E +F++L TP P +LS+E
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGILSNEEFKSYNYPK 245
Query: 569 ----------------GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 607
G + L + +R SA E ++HP+ + +P
Sbjct: 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-17
Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 77/310 (24%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIK 401
K+IGRG FG V + ++TG A+K E DI+ + S +K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVK 65
Query: 402 QLEQVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
D +LY+ +E++ PG + +TE + + + + +H IH
Sbjct: 66 MFYSFQDKLNLYLIMEFL-PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLT---------GLSYEL----------------- 493
RDIK NLL+D+ G VKL+DFG+ L L++ L
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 494 ----------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 543
S G+P+++APE V + G KL D WSLG + EML G PP+
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPE----VFMQTGYNKLC---DWWSLGVIMYEMLIGYPPFC 237
Query: 544 EFEGPQAMF-KVLNRT------PPIPEMLSSEGKDFLLR--CFLRNPVERPSAVELLEHP 594
E PQ + KV+N P +P +S + KD +LR C + + P E+ +P
Sbjct: 238 S-ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294
Query: 595 FIRNANYQNL 604
F +++++
Sbjct: 295 FFEGVDWEHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 68/252 (26%), Positives = 109/252 (43%), Gaps = 29/252 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPK-----SAECIKQLEQVD------ 407
+L+G+G FG V+ GT ++ A+K + +P + K A +KQ + +
Sbjct: 1 ELLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 408 -----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+YI +E V G ++R+ ++ + F G+AYL S N IHRD+
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSP-NWMAPEVIKAVMQKDGNPKLA 520
N LV + V+K++DFGM++ Y S LK P W APE + + +
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-------GRYS 172
Query: 521 LAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFLLRCFL 578
D+WS G + E + G P+ QA +V P+ + + RC+
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232
Query: 579 RNPVERPSAVEL 590
P RP EL
Sbjct: 233 YKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-17
Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 51/288 (17%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI---IPDDPKSAE--- 398
E + K W +++G G G+V G A+K VD+ D A+
Sbjct: 24 EATAKEQAKKYWIS-RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEV 82
Query: 399 -------------CIKQLEQVDDH-------LYIYLEYVHPGSINRYVREHCRDITESIV 438
C + + D + + L+Y + G + + ++ +
Sbjct: 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK-----TN 137
Query: 439 RNFTRH--------ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-L 489
R F H +L + ++HS + IHRDIK AN+L+ ++G+VKL DFG +K +
Sbjct: 138 RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV 197
Query: 490 SYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547
S ++ + G+P ++APE+ + +K + K D++SLG + E+LT K P+
Sbjct: 198 SDDVGRTFCGTPYYVAPEIWR---RKPYSKK----ADMFSLGVLLYELLTLKRPFDGENM 250
Query: 548 PQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 594
+ M K L R P+P +S E ++ + +P RPS+ +LL P
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ 405
K ++K + +G G++ +VY G ++ G A+K + + ++ + A +K L+
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 406 VD-----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+ + L + EYVH + +Y+ +H + V+ F +L GL+Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
+HRD+K NLL+ +G +KLADFG+A+ + S+ S + W P +
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL----- 176
Query: 515 GNPKLALAVDIWSLGCTVIEMLTG 538
G+ + + +D+W +GC +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 65/246 (26%), Positives = 116/246 (47%), Gaps = 27/246 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ---------- 405
K +G G FG V++GT A+K + P+S A+ +K+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 406 VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
++ +YI EY+ GS+ ++++ R + + + + G+AY+ N IHRD++
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRS 130
Query: 465 ANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
AN+LV V K+ADFG+A+ + Y K W APE A + + +
Sbjct: 131 ANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG----RFTIK 183
Query: 523 VDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFLLRCFLRN 580
D+WS G + E++T G+ P+ + + +V P P+ + +L+C+ ++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243
Query: 581 PVERPS 586
P ERP+
Sbjct: 244 PEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 73/291 (25%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV------DDHLYI--Y 413
IG GTF V +R+TG AIK + KS E + L ++ H I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKC---MKKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 414 LEYVH---PGS---------INRY--VREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+E + G +N Y ++ R + E V+++ +L L ++H H
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM-APEVIKAVMQKDG-- 515
RDIK N+L+ ++KLADFG + + Y + S W APE + DG
Sbjct: 124 RDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYI--STRWYRAPE----CLLTDGYY 176
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKP--PWS-EFEGPQAMFKVLNRTPP------------ 560
PK +DIW++GC E+L+ P P + E + + VL TP
Sbjct: 177 GPK----MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG-TPDAEVLKKFRKSRH 231
Query: 561 ----------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+P S+EG D L + +P ER +A + L HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNA-SAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 9e-17
Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 50/285 (17%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV------DIIPDDP-KSAECIKQL-- 403
+++ K +G G +G+V +R TGA AIK++ ++ + +K +
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 404 -------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
+D YL G+ + +H + ++E ++ +L GL
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQMLKGLK 132
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKA 509
Y+H+ IHRD+K NL V+ +K+ DFG+A+ E++ W APEVI
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS---EMTGYVVTRWYRAPEVILN 189
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPP---IPEM 564
M VDIWS+GC + EMLTGKP + + + +++ TP + ++
Sbjct: 190 WMH------YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243
Query: 565 LSSEGKDFL----------LRCFLRNPVERPSAVELLEHPFIRNA 599
S + K+++ R L N P AV +LE + +A
Sbjct: 244 QSEDAKNYVKKLPRFRKKDFRSLLPNA--NPLAVNVLEKMLVLDA 286
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 68/273 (24%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-----KQLEQVDD-------- 408
+G+G FG V + TG A K++D KS E + + LE+V+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 409 ------HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
HL + + ++ G + ++ R + V +++ I G+ +LHS + ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K N+L+D G +L+D G+A L G+ +MAPE++K +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK-------EEPYSY 173
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP-----EMLSSEGKDFLLRC 576
VD +++GC++ EM+ G+ P+ + + A ++ RT + + E KD + R
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKD-ICRL 232
Query: 577 FL-RNPVERPSAVEL----LEHPFIRNANYQNL 604
FL + P +R + E +H F + N+ L
Sbjct: 233 FLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 58/278 (20%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQVD 407
K+++++K K++G G FG+VY G G AIKE+ + A K +++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------REATSPKANKEIL 57
Query: 408 DHLYIYLEYVHP-----------------------GSINRYVREHCRDITESIVRNFTRH 444
D Y+ +P G + YVREH +I + N+
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NW 501
I G+ YL +HRD+ N+LV VK+ DFG+AK L E +G W
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGPQAMFKVL 555
MA E I + + D+WS G TV E++T KP P SE +L
Sbjct: 178 MALESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASEISS------IL 224
Query: 556 NRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 591
+ P P + + + +++C++ + RP EL+
Sbjct: 225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 41/236 (17%)
Query: 384 IKEVDIIP--DDPKS----AECIKQLEQVDDHLYIYLEYVHPGSINRYVREH-------- 429
+KE+ I+ DP A CI D L + EY+ G +N+++ H
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 430 --CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL- 486
I+ S + I +G+ YL S N +HRD+ N LV + +K+ADFGM+++L
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 487 TGLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPW 542
+G Y + + WM+ E I K A D+W+ G T+ E+LT + P+
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCKEQPY 234
Query: 543 SEFEGPQAM------FKVLNRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
S+ Q + F+ R P P + +L C+ RN ERPS E+
Sbjct: 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 86/330 (26%), Positives = 128/330 (38%), Gaps = 97/330 (29%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPK 395
S + K K IG G FG V + +T A A+K E DI+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE--A 58
Query: 396 SAECIKQLE---QVDDHLYIYLEYVHPGS------INRYVREHCRDITESIVRNFTRHIL 446
E + +L Q D+LY ++Y+ PG I + E E + R + +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRLGIFE------EDLARFYIAELT 111
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSY 491
+ +H IHRDIK N+L+D G +KL DFG+ H S
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 492 EL-----------------------------SLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
E SL G+PN++APEV+ + G +L
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL----LRTGYTQLC-- 225
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKDFLLRCF 577
D WS+G + EML G+PP+ + KV+N P + LS E D +LR
Sbjct: 226 -DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK-LSREASDLILR-L 282
Query: 578 LRNPVER---PSAVELLEHPFIRNANYQNL 604
+R A E+ HPF + ++ +L
Sbjct: 283 CCGAEDRLGKNGADEIKAHPFFKGIDFASL 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 82/308 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVD-----D 408
++Q IG G +G V T++ TG AIK+ I P + C + L ++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFE-HQTFCQRTLREIKILRRFK 61
Query: 409 HLYI--YLEYVHPGSINRY-----VREH-----CRDITESIVRN-----FTRHILNGLAY 451
H I L+ + P S + V+E + I + N F IL GL Y
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------- 500
+HS N +HRD+K +NLL++ + +K+ DFG+A+ ++ +
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR--------IADPEHDHTGFLTEYVATR 173
Query: 501 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------------- 540
W APE++ + G K A+DIWS+GC + EML+ +P
Sbjct: 174 WYRAPEIM---LNSKGYTK---AIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227
Query: 541 -PWSE----FEGPQAM--FKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAV 588
P E +A K L P +P ++ + D L + NP +R +
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287
Query: 589 ELLEHPFI 596
E L HP++
Sbjct: 288 EALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 62/290 (21%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQ- 405
+ + GK +G G FG V N ++ A+K + + ++ + ++E
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 406 --VDDH---------------LYIYLEYVHPGSINRYVREH-----------CRDITESI 437
+ H LY+ +EY G++ ++R R E++
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 438 ----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 491
+ +F + G+ +L S IHRD+ N+LV V+K+ADFG+A+ + + Y
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 492 -----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545
L +K WMAPE + + D+WS G + E+ T G P+
Sbjct: 190 KTTNGRLPVK----WMAPEALFDRV-------YTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
Query: 546 EGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ +FK+L R P+ + E + C+ P +RP+ +L+E
Sbjct: 239 PVEE-LFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 38/274 (13%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------------------- 398
+IGRG FG VY +TG A+K +D K E
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 399 CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
C+ D L L+ ++ G ++ ++ +H +E +R + I+ GL ++H+ +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
+RD+K AN+L+D G V+++D G+A + S+ G+ +MAPEV++ D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDS--- 175
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLLR 575
+ D +SLGC + ++L G P+ + + + L +P+ S E K L
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232
Query: 576 CFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
R+ +R A E+ EH F + ++Q +
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 64/275 (23%), Positives = 104/275 (37%), Gaps = 71/275 (25%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVD-------------- 407
+G G FG V++ A C +++P+ K +K L++
Sbjct: 13 LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 408 ------------------DHLYIYLEYVHPGSINRYVREH--------------CRDITE 435
L + EY+ G +NR++R H +T
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 436 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495
+ I +G+ YL S + +HRD+ N LV VVK+ DFGM++ + Y +
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 180
Query: 496 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 550
G WM PE +++ + K DIWS G + E+ T GK PW + +A
Sbjct: 181 GGRTMLPIRWMPPE---SILYR----KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233
Query: 551 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVER 584
+ + R P E + C+ R P +R
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 71/277 (25%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDHL------ 410
++IG+G FG VY GT + CA+K ++ I D LE+V+ L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----------LEEVEQFLKEGIIM 50
Query: 411 ----------------------YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+ L Y+ G + ++R + T + F + G
Sbjct: 51 KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG 110
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---------ELSLKGSP 499
+ YL S +HRD+ N ++D S VK+ADFG+A+ + Y +L +K
Sbjct: 111 MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK--- 167
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-- 556
WMA E ++ K D+WS G + E++T G PP+ + + F +
Sbjct: 168 -WMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYL 215
Query: 557 ---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
R PE + +L C+ P RP+ EL
Sbjct: 216 LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 52/275 (18%)
Query: 360 KLIGRGTFGSV----YIGTNRETGASCAIKEV-----DIIPDDPKSAECIKQLEQVDD-- 408
+ +G+G FGSV Y TG A+K++ + + D + E +K L Q D+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIV 68
Query: 409 ------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+L + +EY+ GS+ Y+++H + + + I G+ YL S
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG-SP-NWMAPEVIKAVMQ 512
+HRD+ N+LV++ VK+ DFG+ K L Y++ G SP W APE +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT---- 184
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL----- 555
K ++A D+WS G + E+ T P +EF +G ++ ++
Sbjct: 185 ---ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 556 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
N P P +E + C+ +P +RPS EL
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 39/265 (14%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDP--KSAECIK--------QLEQ 405
K KL G G +G VY G ++ + A+K + D + + K A +K QL
Sbjct: 11 KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 406 VDDH---LYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLHSTNTIHRD 461
V YI E++ G++ Y+RE R ++V + I + + YL N IHRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
+ N LV + +VK+ADFG+++ +TG +Y K W APE + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-------AYNKF 182
Query: 520 ALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSEGKDFL 573
++ D+W+ G + E+ T G P+ + Q + + R P + + +
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP----KVYELM 238
Query: 574 LRCFLRNPVERPSAVEL---LEHPF 595
C+ NP +RPS E+ E F
Sbjct: 239 RACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 47/201 (23%)
Query: 431 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HL 486
R + + ++ F IL GL Y+HS +HRD+K +N+L++ + +K+ DFG+A+ +
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162
Query: 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------ 540
TG + + APE++ QK + VDIWS GC EML GKP
Sbjct: 163 TGYV------STRYYRAPEIM-LTWQKYD-----VEVDIWSAGCIFAEMLEGKPLFPGKD 210
Query: 541 --------------PWSEF------EGPQAMFKVLNRTPPIP-----EMLSSEGKDFLLR 575
P + E + L + P+P + D L +
Sbjct: 211 HVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEK 270
Query: 576 CFLRNPVERPSAVELLEHPFI 596
+ +P +R SA E L HP++
Sbjct: 271 MLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 63/247 (25%), Positives = 117/247 (47%), Gaps = 58/247 (23%)
Query: 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-HRDIKGA 465
D + I +E++ GS+++ ++E + I E I+ + +L GLAYL + I HRD+K +
Sbjct: 75 DGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 133
Query: 466 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525
N+LV++ G +KL DFG++ L S S G+ ++M+PE ++ ++ DI
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGT-------HYSVQSDI 185
Query: 526 WSLGCTVIEMLTG-----------------------------------KPPWSEFEG--- 547
WS+G +++E+ G +PP G
Sbjct: 186 WSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGM 245
Query: 548 ----PQAMFKVL----NRTPP-IPE-MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
A+F++L N PP +P + + + ++F+ +C ++NP ER L+ H FI+
Sbjct: 246 DSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305
Query: 598 NANYQNL 604
+ + +
Sbjct: 306 RSEVEEV 312
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 52/266 (19%)
Query: 362 IGRGTFGSVYIG--------TNRETGASCAIKEVDIIP--DDPKSAECIKQLEQ------ 405
+G G FG V++ ++ A A+K+ + D + AE + L+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 406 ----VD-DHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTRHI 445
D D L + EY+ G +N+++R H D + S + + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NW 501
+G+ YL S + +HRD+ N LV A+ +VK+ DFGM++ + Y + G W
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRW 191
Query: 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RT 558
M PE ++M + K D+WS G + E+ T GK PW + + + + R
Sbjct: 192 MPPE---SIMYR----KFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECITQGRV 243
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVER 584
P + E D +L C+ R P +R
Sbjct: 244 LERPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 70/274 (25%), Positives = 113/274 (41%), Gaps = 50/274 (18%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEV------DIIPDDPKSAECIKQL-------- 403
+G G FG V Y TG A+K + + I D K E ++ L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 404 -----EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
E + + + +E++ GS+ Y+ + I + I G+ YL S +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV 131
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPN-WMAPEVIKAVMQKD 514
HRD+ N+LV++ VK+ DFG+ K + ++K SP W APE + +Q
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL---IQS- 187
Query: 515 GNPKLALAVDIWSLGCTVIEMLT----GKPPWSEFE---GPQA-------MFKVLN--RT 558
K +A D+WS G T+ E+LT P + F GP + +VL +
Sbjct: 188 ---KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P P E + +C+ P +R + L+E
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 34/199 (17%)
Query: 408 DHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTRHILNGLAYLHST 455
D L + EY+ G +N+++R H D +T+S + + + I G+ YL S
Sbjct: 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVM 511
+ +HRD+ N LV + +VK+ DFGM++ + Y + G WM PE ++M
Sbjct: 140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPE---SIM 195
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-----FKVLNRTPPIPEML 565
+ K D+WSLG + E+ T GK PW + + + +VL R P
Sbjct: 196 YR----KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR----PRTC 247
Query: 566 SSEGKDFLLRCFLRNPVER 584
E D +L C+ R P R
Sbjct: 248 PKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 67/283 (23%), Positives = 112/283 (39%), Gaps = 46/283 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-----KQLEQVDDHLYIYL 414
+++G+G FG V R TG A K+++ + E + + LE+V+ + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILN--------------------GLAYLHS 454
Y + C +T + HI N GL L
Sbjct: 66 AYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
++RD+K N+L+D G ++++D G+A + G+ +MAPEVI
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN------ 174
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGK 570
N K + D W LGC + EM+ G+ P+ + + + +V E S + K
Sbjct: 175 -NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233
Query: 571 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 608
+NP ER A + +HP +N N++ L M
Sbjct: 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 27/244 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ----------VD 407
+G+G FG V++GT T AIK + P++ A+ +K+L +
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 408 DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 466
+ +YI E++ GS+ +++E + + + + I +G+AY+ N IHRD++ AN
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAAN 132
Query: 467 LLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
+LV + V K+ADFG+A+ + Y K W APE A + + + D
Sbjct: 133 ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG----RFTIKSD 185
Query: 525 IWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFLLRCFLRNPV 582
+WS G + E++T G+ P+ + + +V P P+ + + C+ ++P
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPD 245
Query: 583 ERPS 586
ERP+
Sbjct: 246 ERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 410 LYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 467
+YI EY+ GS+ +++ E + + ++ +F+ I G+AY+ N IHRD++ AN+
Sbjct: 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKNYIHRDLRAANV 134
Query: 468 LVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525
LV S + K+ADFG+A+ + Y K W APE I + D+
Sbjct: 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDV 187
Query: 526 WSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPV 582
WS G + E++T GK P+ M L R P E E D + C+
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDVM-SALQRGYRMPRMENCPDELYDIMKTCWKEKAE 246
Query: 583 ERPS 586
ERP+
Sbjct: 247 ERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 26/253 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIG--TNRETGASCAIKEVDIIP--DDPKSAECIKQLEQ--- 405
+ ++ + +G G FG V+ G NR A +K D++ D K + +K+L
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 406 --------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN 456
V + +YI E + GS+ ++R + + + + + + G+AYL N
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP-NWMAPEVIKAVMQKDG 515
+IHRD+ N+LV V K+ADFG+A+ + Y S K P W APE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA-------S 177
Query: 516 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKDFL 573
+ + D+WS G + EM T G+ P+ + ++ P P E +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237
Query: 574 LRCFLRNPVERPS 586
L C+ P +RPS
Sbjct: 238 LECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 406 VDDHLYIYLEYVHPGSINRYVREH----------CRDITESIVRNFTRHILNGLAYLHST 455
VD L + +EY+ G +N+++++H + ++ S + I +G+ YL S
Sbjct: 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL 149
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVM 511
N +HRD+ N LV + +K+ADFGM+++L Y ++G WMA E +V+
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWE---SVL 205
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSE------------FEGPQAMFKVLNR 557
K D+W+ G T+ E+LT + P+ F L R
Sbjct: 206 LG----KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPR 261
Query: 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
P P+ + + +L C+ R+ +RP+ E+ H F++
Sbjct: 262 PPNCPKDIY----ELMLECWRRDEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 63/286 (22%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
+G GT+ +V+ G ++ T A+KE+ + ++ I+++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 405 QVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+ L + EY+ + +Y+ ++C ++ + V+ F +L GL+Y H +HRD+K
Sbjct: 73 HTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
NLL++ G +KLADFG+A+ + + S + W P + G+ + + +
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-----GSTEYSTPI 185
Query: 524 DIWSLGCTVIEMLTGKP------------------------PW------SEFEG---PQA 550
D+W +GC + EM TG+P W EF PQ
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQY 245
Query: 551 MFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+ L N P L ++G D L L R SA L H +
Sbjct: 246 RAQPLINHAP----RLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 56/279 (20%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD-----IIPDDPKSAEC---------- 399
++Q +G G +GSV + +TG A+K++ II E
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 400 ----------IKQLEQVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+ LE+ +D +YL ++ +N V+ C+ +T+ V+ IL G
Sbjct: 78 VIGLLDVFTPARSLEEFND---VYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 132
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVI 507
L Y+HS + IHRD+K +NL V+ +K+ DFG+A+H E++ + W APE++
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 189
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTPPIPEML 565
M + VDIWS+GC + E+LTG+ P ++ + L TP E+L
Sbjct: 190 LNWMHYN------QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELL 242
Query: 566 ---SSEGKDFLLRCFLRNPV---------ERPSAVELLE 592
SSE ++ + P P AV+LLE
Sbjct: 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 58/218 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV----DIIPDDPKSAECIKQLEQVD-------- 407
K IGRG +G V N ET AIK++ D D ++ IK L +D
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 408 -----------DHLYIYLEYVHPGSINRYVR-------EHCRDITESIVRNFTRHILNGL 449
+ +YI E + +++ +R +HC+ F +L GL
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQ--------YFLYQLLRGL 121
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 509
Y+HS N +HRD+K +NLL++A+ +K+ DFG+A+ + ++M V
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGDFMTEYV--- 169
Query: 510 VMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 540
V + P+L L A+D+WS+GC E+L KP
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 35/259 (13%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPD---DPKSA------ECIKQ 402
+ G++IG G FG+V G TG A+K + D+ + + + + +
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 403 LEQVDDH--LYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAYLHSTNTIH 459
L V H LYI +E + G++ ++R R + I + F+ + G+ YL S +H
Sbjct: 64 LLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 460 RDIKGANLLVDASGVVKLADFGMAK-HLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNP 517
RD+ N+LV GV K++DFG+A+ G+ + +L +K W APE +K +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALK-------HK 172
Query: 518 KLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPEMLSSEGKDFL 573
K + D+WS G + E+ + G+ P+ + E + + K P PE ++ +
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP--PEGCPADVYVLM 230
Query: 574 LRCFLRNPVERPSAVELLE 592
C+ P +RPS +L E
Sbjct: 231 TSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 75/295 (25%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-----------IKQLEQVDD 408
K +G G +GSV ++ TG AIK++ P +E +K ++ +
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQH--E 74
Query: 409 HLYIYLEYVHPGSINR----------YVREHCRDI-----TESIVRNFTRHILNGLAYLH 453
++ L+ Y++ + I +E V+ +L GL Y+H
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQ 512
S IHRD+K NL V+ +K+ DFG+A+H E++ W APEVI M
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMH 191
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF------E 546
+ VDIWS+GC + EMLTGK P EF +
Sbjct: 192 YNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 547 GPQAMFKVLNRTPP------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
++ K L + P P+ S + D L + + +R +A E LEHP+
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKA-SPQAVDLLEKMLELDVDKRLTATEALEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 46/271 (16%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDHLY 411
K+++ ++ K++G G FG+VY G G + I I ++ + +E +D+ L
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA--NVEFMDEAL- 61
Query: 412 IYLEYVHP-----------------------GSINRYVREHCRDITESIVRNFTRHILNG 448
I HP G + YV EH +I ++ N+ I G
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPE 505
+ YL +HRD+ N+LV + VK+ DFG+A+ L G E + G WMA E
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGPQAMFKVLNRTP 559
I K D+WS G T+ E++T GKP P E P + K
Sbjct: 182 CIHY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--PDLLEK--GERL 230
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
P P + + + +++C++ + RP EL
Sbjct: 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 64/264 (24%), Positives = 110/264 (41%), Gaps = 41/264 (15%)
Query: 361 LIGRGTFGSVYIGTNRETGAS-CAIKEVDII-PDDPKS------------AECIKQLEQV 406
+G G FG VY + G + A+KE+++ P K +E EQ+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 407 --------------DDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 449
+D LYI ++ + + + ++E + TE + N ++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 450 AYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 508
YLH I HRD+ N+++ V + DFG+AK S S+ G+ + PE++K
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK 186
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMFKVLNRTPPIPEMLSS 567
N D+W+ GC + +M T +PP +S A V P+PE + S
Sbjct: 187 -------NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 568 EGKDFLL-RCFLRNPVERPSAVEL 590
E ++ C + RP +++
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 68/271 (25%), Positives = 108/271 (39%), Gaps = 56/271 (20%)
Query: 360 KLIGRGTFGSVYIGTNRE-----TGAS-CAIKEVDIIPDDPKSAECIKQ----------- 402
+G G FG VY GT + +G A+K + D + E +K+
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 403 -LEQV-----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR------HILNGLA 450
++ + ++ YI +E + G + Y+R+ + + + G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 451 YLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWM 502
YL + IHRD+ N LV DA VVK+ DFG+A+ + Y E WM
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN----- 556
APE + DG K D+WS G + E+LT G+ P+ +VL
Sbjct: 181 APESL-----LDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTAG 229
Query: 557 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 586
R PE + + C+ ++P ERP+
Sbjct: 230 GRLQK-PENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 60/297 (20%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
E P + + GK +G G FG V +G +++ V ++ DD +
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65
Query: 398 ECIKQLEQV------------------DDHLYIYLEYVHPGSINRYVR-------EHCRD 432
+ + ++E + D LY+ +EY G++ Y+R E+ D
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 433 ITE--------SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484
I + + T + G+ YL S IHRD+ N+LV + V+K+ADFG+A+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 485 HLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 537
+ + Y K + N WMAPE + + + D+WS G + E+ T
Sbjct: 186 DVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEIFTL 235
Query: 538 GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
G P+ + +FK+L + P ++E + C+ P RP+ +L+E
Sbjct: 236 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKS-----AECIKQLEQVD-------- 407
IGRG FG V+ G R A+K + +P D K+ A +KQ +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 408 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
+YI +E V G ++R + + + G+ YL S + IHRD+
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122
Query: 465 ANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKDGNPKLAL 521
N LV V+K++DFGM++ Y + +K P W APE + + +
Sbjct: 123 RNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-------GRYSS 175
Query: 522 AVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFL 578
D+WS G + E + G P++ Q + R P PE+ + RC+
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC-PELCPDAVYRLMERCWE 234
Query: 579 RNPVERPS 586
+P +RPS
Sbjct: 235 YDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 65/253 (25%), Positives = 107/253 (42%), Gaps = 35/253 (13%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKS-AECIKQLEQ-----------VD 407
IG G FG V++G + A I+E + +D A+ + +L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 467
+ + E++ G ++ Y+R ++ + + G+AYL S+N IHRD+ N
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNC 131
Query: 468 LVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525
LV + VVK++DFGM + + Y S K W +PEV K + D+
Sbjct: 132 LVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-------SKYSSKSDV 184
Query: 526 WSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578
WS G + E+ + GK P+ E A F++ P + S + + C+
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-----PRLASQSVYELMQHCWK 239
Query: 579 RNPVERPSAVELL 591
P +RPS LL
Sbjct: 240 ERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-14
Identities = 56/224 (25%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 403 LEQVDDHLYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHS----- 454
L + + LYI +E+ G ++R +++ + I E + + TR +L+ LAY H+
Sbjct: 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGP 141
Query: 455 --TNTIHRDIKGANLLV-----------------DASGVVKLADFGMAKHLTGLSYELSL 495
+HRD+K N+ + + + K+ DFG++K++ S S
Sbjct: 142 NGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC 201
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 555
G+P + +PE++ + + D+W+LGC + E+ +GK P+ + + L
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKS-----DMWALGCIIYELCSGKTPFHKANNFSQLISEL 256
Query: 556 NRTPPIPEMLSSEGKDFLLRCFLR-NPVERPSAVELLEHPFIRN 598
R P +P S+ + L++ L + ERPSA++ L + I+N
Sbjct: 257 KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-14
Identities = 81/326 (24%), Positives = 127/326 (38%), Gaps = 87/326 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPK 395
S + K K +G G FG V + +T A A+K E DI+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE--A 58
Query: 396 SAECIKQLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
E + +L Q D+LY ++Y+ PG + E + R + + + +
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYELS--- 494
H IHRDIK N+L+D G +KL DFG+ H+ S + S
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 495 ------------------------------LKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
L G+PN++APEV + + G +L D
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV----LLRTGYTQLC---D 230
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----PIPEMLSSEGKDFLLRCFLRN 580
WS+G + EML G+PP+ + KV+N P LS E D +++ R
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRG 289
Query: 581 PVER---PSAVELLEHPFIRNANYQN 603
P +R A E+ HPF + ++ +
Sbjct: 290 PEDRLGKNGADEIKAHPFFKTIDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 50/226 (22%)
Query: 407 DDHLYIYLEYVHPGSINRYVREHCRD------------------ITESIVRNFTRHILNG 448
+D L + EY+ G +N+++ H D I+ S + + I +G
Sbjct: 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAP 504
+ YL S N +HRD+ N LV + +K+ADFGM+++L Y ++G WMA
Sbjct: 151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAW 209
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSEFEGPQAM------FK--- 553
E I +M K A D+W+ G T+ E+L + P+ E Q + F+
Sbjct: 210 ECI--LMG-----KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG 262
Query: 554 ---VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
L R PP P+ L + +L+C+ R+ ERPS ++ H F+
Sbjct: 263 RQVYLFRPPPCPQGLY----ELMLQCWSRDCRERPSFSDI--HAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 49/281 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK-EVDIIPDD--PKSAE---------- 398
K+++ +K K++G G FG+VY G G + I + ++ ++ PK+ +
Sbjct: 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64
Query: 399 -------------CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 445
C+ Q+ L Y G + YVRE+ I + N+ I
Sbjct: 65 GVGSPYVCRLLGICLTSTVQLVTQLMPY------GCLLDYVRENKDRIGSQDLLNWCVQI 118
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWM 502
G++YL +HRD+ N+LV + VK+ DFG+A+ L E G WM
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRT 558
A E I + + D+WS G TV E++T G P+ E P + K
Sbjct: 179 ALESIL-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--GER 229
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
P P + + + +++C++ + RP EL+ F R A
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 78/320 (24%), Positives = 129/320 (40%), Gaps = 85/320 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPKSAECIK 401
K+IG+G FG V + ++TG A+K E D++ + S +
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVS 65
Query: 402 QLEQVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
D Y+YL E++ G + + ++ +E + R + + + +H IH
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIH 124
Query: 460 RDIKGANLLVDASGVVKLADFGMA-------------KHLTG-----------------L 489
RDIK N+L+D G +KL+DFG++ K L G +
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 490 SYELSLK------------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 531
+ +S K G+P+++APE+ + Q G D WSLG
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF--LQQGYGQ-----ECDWWSLGAI 237
Query: 532 VIEMLTGKPPWSEFEGPQAMF-KVLN--RTPPIPE--MLSSEGKDFLLR--CFLRNPVER 584
+ E L G PP+ E + K++N T P+ LS E +D + R N + R
Sbjct: 238 MFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGR 296
Query: 585 PSAVELLEHPFIRNANYQNL 604
A E+ HPF R ++ +
Sbjct: 297 GGAHEIKSHPFFRGVDWDTI 316
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 81/305 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-------KQLEQVD----- 407
++IG+G++G V + TG AIK+++ + + A I + L D
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 408 -----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+Y+ E + S V + D+T + F +L L Y+H+ N
Sbjct: 66 HIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN 123
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------------WMAP 504
HRD+K N+L +A +K+ DFG+A+ ++ +P + AP
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLAR--------VAFNDTPTAIFWTDYVATRWYRAP 175
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW------------SEFEG---PQ 549
E+ + K A+DIWS+GC E+LTGKP + ++ G P+
Sbjct: 176 ELCGSFFSK-----YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230
Query: 550 AMFKVLN-----------RTPPIPEMLSSEGKDFLLRCFLR-----NPVERPSAVELLEH 593
+ +V N + P+P D L L +P +RP+A E L
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290
Query: 594 PFIRN 598
P+ +
Sbjct: 291 PYFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 407 DDHLYIYLEYVHPGSINRYV--RE------HCRDITESIVRNF---TRHILNGLAYLHST 455
DD L + EY+ G +N+++ RE H +I + N I +G+ YL S
Sbjct: 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL 148
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVM 511
N +HRD+ N LV +K+ADFGM+++L Y ++G WMA E I
Sbjct: 149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILL-- 205
Query: 512 QKDGNPKLALAVDIWSLGCTVIEM--LTGKPPWS------------EFEGPQAMFKVLNR 557
K A D+W+ G T+ EM L + P+S EF Q L++
Sbjct: 206 -----GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQ 260
Query: 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
TP P + ++RC+ R+ +RP+ ++ H F+R
Sbjct: 261 TPLCPSPVF----KLMMRCWSRDIKDRPTFNKI--HHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 77/322 (23%), Positives = 133/322 (41%), Gaps = 69/322 (21%)
Query: 349 ASPK----KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
A PK +++ GK +G G FG V IG +++ V ++ DD +
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62
Query: 398 ECIKQLEQV------------------DDHLYIYLEYVHPGSINRYVR-----------E 428
+ + ++E + D LY+ +EY G++ Y+R +
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 429 HCRDITESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484
C+ E + + + + G+ YL S IHRD+ N+LV V+K+ADFG+A+
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 485 HLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 537
+ + Y K + N WMAPE + + + D+WS G + E+ T
Sbjct: 183 DVHNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEIFTL 232
Query: 538 GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH-- 593
G P+ + +FK+L + P + E + C+ P +RP+ +L+E
Sbjct: 233 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
Query: 594 ---PFIRNANYQNLSVPMRVFS 612
Y +LSVP +S
Sbjct: 292 RVLTVTSTDEYLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 83/325 (25%), Positives = 126/325 (38%), Gaps = 85/325 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------------------EVDIIPDDPK 395
S + K K +G G FG V + +T A A+K E DI+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE--A 58
Query: 396 SAECIKQLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
E + +L Q D+LY ++Y+ PG + E + R + + + +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYE----- 492
H IHRDIK N+L+D G +KL DFG+ H+ S E
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 493 ----------------------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
SL G+PN++APEV + + G +L D
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV----LLRKGYTQLC---D 230
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEM--LSSEGKDFL--LRCFL 578
WS+G + EML G+PP+ + KV+N T IP LS E D + L C
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290
Query: 579 RNPVERPSAVELLEHPFIRNANYQN 603
+ R A ++ HPF ++ +
Sbjct: 291 EERLGRNGADDIKAHPFFSEVDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-------IKQLEQVD------ 407
++G G +G V ++ET AIK+ ++ + E ++ L+Q +
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 408 -----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
LY+ EYV + + E + VR++ ++ + + H + +HRDI
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 463 KGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLA 520
K NLL+ + V+KL DFG A++L+ G + + + W +PE++ G P
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL------GAP-YG 179
Query: 521 LAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 560
AVD+WS+GC + E+ G+P + SE + + KVL P
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 37/257 (14%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQV------ 406
+G G FG+V G +++ + A+K + +DP + A ++QL+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 407 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+ + +E G +N++++++ + +TE + + G+ YL TN +HRD+
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQKDGNPK 518
N+L+ K++DFG++K L Y+ G P W APE + K
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY-------K 174
Query: 519 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKDFLLR 575
+ D+WS G + E + G+ P+ +G + M + R P+ E D +
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-ECPQRCPPEMYDLMKL 233
Query: 576 CFLRNPVERP--SAVEL 590
C+ ERP + VEL
Sbjct: 234 CWTYGVDERPGFAVVEL 250
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 64/307 (20%)
Query: 359 GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQ---VDD 408
GK +G G FG V G ++ V ++ D D A+ I ++E +
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 409 H---------------LYIYLEYVHPGSINRYVR-------EHCRDITESIVRNFT---- 442
H LY+ +EY G++ ++R ++ DIT+ +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 443 ----RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498
+ G+ YL S IHRD+ N+LV V+K+ADFG+A+ + + Y K +
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY---YKKT 193
Query: 499 PN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 551
N WMAPE + + + D+WS G + E+ T G P+ + +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGILMWEIFTLGGSPYPGIP-VEEL 245
Query: 552 FKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----NYQNLS 605
FK+L + P + E + C+ P +RP+ +L+E A Y +LS
Sbjct: 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLS 305
Query: 606 VPMRVFS 612
+P +S
Sbjct: 306 MPFEQYS 312
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 42/269 (15%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK-EVDIIPDDPKSAECIKQLEQVDDH- 409
K+++ +K KL+G G FG+V+ G G S I + I D +S + +++ DH
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGR--QTFQEITDHM 60
Query: 410 ----------------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 447
L + + GS+ +VR+H + + N+ I
Sbjct: 61 LAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAP 504
G+ YL +HR++ N+L+ + +V++ADFG+A L + K WMA
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PI 561
E I + D+WS G TV EM++ G P++ P + +L +
Sbjct: 181 ESILF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLLEKGERLAQ 232
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
P++ + + +++C++ + RP+ EL
Sbjct: 233 PQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 67/298 (22%)
Query: 351 PKKSQWQK-------GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS--- 396
P+ +W+ GK +G G FG V IG ++E V ++ D
Sbjct: 8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL 67
Query: 397 AECIKQLEQV------------------DDHLYIYLEYVHPGSINRYVR-------EHCR 431
++ I ++E + D LY+ +EY G++ Y+R E+C
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127
Query: 432 DITESIVRNFT--------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483
+ T+ + + G+ YL S IHRD+ N+LV V+K+ADFG+A
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187
Query: 484 KHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 537
+ + + Y K + N WMAPE + + + D+WS G + E+ T
Sbjct: 188 RDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWEIFT 237
Query: 538 -GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
G P+ + +FK+L + P ++E + C+ P +RP+ +L+E
Sbjct: 238 LGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 415 EYVHPGSINRYVREHCRDITESIVRNFTR---------------------HILNGLAYLH 453
EY+ G +N ++R S+ + + + G+AYL
Sbjct: 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------WMAPEVI 507
+HRD+ N LV + VVK+ADFG+++++ Y K S N WM PE I
Sbjct: 148 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKASENDAIPIRWMPPESI 204
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI---PE 563
+ D+W+ G + E+ + G P+ + ++ V R + P+
Sbjct: 205 FY-------NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPD 255
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVEL 590
E + + C+ + P +RPS +
Sbjct: 256 NCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 64/269 (23%), Positives = 108/269 (40%), Gaps = 39/269 (14%)
Query: 362 IGRGTFGSVYIG-----------TNRETGASCAIKEVDI---------IPDDPKSAECIK 401
IG G FG V +G +E AS E + + P +C+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 402 QLEQVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRH-ILNGLAYLHSTNT 457
Q + +L + LE+ G + Y+R + + V + +GL +LH +
Sbjct: 63 QCIESIPYLLV-LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKD 514
IH D+ N + A VK+ D+G+A Y ++ P W+APE+++ Q
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 515 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR------TPPIPEMLSS 567
+IWSLG T+ E+ T P+ + Q + +V+ P + S
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSD 241
Query: 568 EGKDFLLRCFLRNPVERPSAVE---LLEH 593
+ + C+L +P RP+A E LL +
Sbjct: 242 RWYEVMQFCWL-DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 60/201 (29%)
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 500
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ + +P
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM----TPYVVTR 181
Query: 501 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-------------------- 539
+ APEVI + K+ VDIWS+GC + EM+ G
Sbjct: 182 YYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234
Query: 540 PPWSEFE---GPQAMFKVLNRT--PPIP-EML-----------------SSEGKDFLLRC 576
P EF P V NR E L +S+ +D L +
Sbjct: 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294
Query: 577 FLRNPVERPSAVELLEHPFIR 597
+ +P +R S + L+HP+I
Sbjct: 295 LVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471
I E++ G+++ ++R++ T + R I G+ YL N +HRD+ N+LV++
Sbjct: 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS 141
Query: 472 SGVVKLADFGMAKHL----TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDI 525
+ V K++DFG+++ L + +Y SL G P W APE I K A D+
Sbjct: 142 NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-------RKFTSASDV 194
Query: 526 WSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPV 582
WS G + E+++ G+ P+ + + + R PP + + +L C+ ++
Sbjct: 195 WSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD-CPTALHQLMLDCWQKDRN 253
Query: 583 ERP 585
RP
Sbjct: 254 ARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 46/278 (16%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSA 397
P+ P +W GK +G G FG V T S A+ +V + + S+
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 398 EC------IKQLEQVDDHL---------------YIYLEYVHPGSINRYVREHCRD-ITE 435
E +K + + +H + EY G + ++R +T
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 436 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495
+ +F+ + G+A+L S N IHRD+ N+L+ +VK+ DFG+A+ + S +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV- 199
Query: 496 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 550
KG+ WMAPE I N D+WS G + E+ + G P+
Sbjct: 200 KGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 551 MFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS 586
+K++ + PE +E D + C+ +P++RP+
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 362 IGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLE---QVDD-------- 408
+G G FG V G R+ AIK + + E +++ E Q+D+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 409 -----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
L + +E G +N+++ +IT S V + G+ YL N +HRD+
Sbjct: 63 VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122
Query: 464 GANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP---NWMAPEVIKAVMQKDGNPKL 519
N+L+ K++DFG++K L SY + W APE I K
Sbjct: 123 ARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-------RKF 175
Query: 520 ALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-FKVLNRTPPIPEMLSSEGKDFLLRCF 577
+ D+WS G T+ E + G+ P+ + +GP+ M F + P E + C+
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235
Query: 578 LRNPVERP 585
+ +RP
Sbjct: 236 IYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 41/198 (20%)
Query: 430 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489
C+ +++ V+ +L GL Y+HS IHRD+K +N+ V+ +++ DFG+A+
Sbjct: 112 CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170
Query: 490 SYELSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEF- 545
E++ + W APE++ M + VDIWS+GC + E+L GK P +++
Sbjct: 171 --EMTGYVATRWYRAPEIMLNWMHYNQ------TVDIWSVGCIMAELLKGKALFPGNDYI 222
Query: 546 ------------EGPQAMFKV--------LNRTPPIPEMLSSE--------GKDFLLRCF 577
P+ + K+ + P +P+ + D L +
Sbjct: 223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKML 282
Query: 578 LRNPVERPSAVELLEHPF 595
+ + +R SA E L HP+
Sbjct: 283 VLDSDKRISASEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 50/202 (24%), Positives = 73/202 (36%), Gaps = 55/202 (27%)
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 502
+ IL GL YLH+ IHRD+K N+ ++ V + D G A+ L L G+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA------------ 550
APEV+ K DIWS G + EML P + FE P +
Sbjct: 224 APEVL-------ARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEYVKSCHSH 274
Query: 551 MFKVLNRTPPIPEMLSSEGKDFLLRCFLR------------------------------- 579
+ K+++ PE + L+R F+
Sbjct: 275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKM 334
Query: 580 ---NPVERPSAVELLEHPFIRN 598
+ RPSA E+L +P
Sbjct: 335 LTFDAAMRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 17/182 (9%)
Query: 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471
I EY+ GS++ ++R+H T + R I +G+ YL +HRD+ N+LV++
Sbjct: 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS 141
Query: 472 SGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVMQKDGNPKLALAVDIWS 527
+ V K++DFG+++ L +Y P W APE I K A D+WS
Sbjct: 142 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-------RKFTSASDVWS 194
Query: 528 LGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVE 583
G + E+++ G+ P+ E Q + K + R P P + +L C+ ++ E
Sbjct: 195 YGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPA-PMDCPAALHQLMLDCWQKDRNE 252
Query: 584 RP 585
RP
Sbjct: 253 RP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 67/289 (23%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAEC------IKQLEQV-- 406
GK +G G FG V T V + + ++ S+E L+QV
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 407 ------------DDHLYIYLEYVHPGSINRYVREH-----------------------CR 431
D L + +EY GS+ ++RE R
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 432 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491
+T + +F I G+ YL +HRD+ N+LV +K++DFG+++ + Y
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV----Y 178
Query: 492 ELS--LKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 543
E +K S WMA E + + + D+WS G + E++T G P+
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPYP 231
Query: 544 EFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
P+ +F +L + PE S E + +L C+ + P +RP+ ++
Sbjct: 232 GI-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 40/169 (23%), Positives = 56/169 (33%), Gaps = 29/169 (17%)
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 505
L L LH + + L+ G V + P +MAPE
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKLDGSV------------AFKTPEQSRPDPYFMAPE 74
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVLNRTPPIPEM 564
VI+ DI+SLG T+ E L + P++ E E + +LN P
Sbjct: 75 VIQGQSY-------TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR 127
Query: 565 LSSEG---------KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604
S +DF+ C R P R +A L H A L
Sbjct: 128 DRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 68/289 (23%), Positives = 106/289 (36%), Gaps = 75/289 (25%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSA----------------- 397
+ +G G FG VY G R +V + +P+
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 398 ECIKQLEQVD-DHL--YIYLEYVHPGSINRYVREHCRD-------ITESIVRNFTRHILN 447
+ I +L V + L +I LE + G + ++RE R +T + R +
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLTMKDLLFCARDVAK 127
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYE-------LSLKG 497
G YL + IHRDI N L+ G V K+ADFGMA+ + SY L +K
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186
Query: 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556
WM PE A + K D+WS G + E+ + G P+ + M
Sbjct: 187 ---WMPPE---AFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM----- 231
Query: 557 RTPPIPEMLSSEGK------------DFLLRCFLRNPVERPSAVELLEH 593
E ++ G+ + C+ P +RP+ +LE
Sbjct: 232 ------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 440 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499
+F+ + G+++L S N IHRD+ N+L+ + K+ DFG+A+ + S +KG+
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNA 276
Query: 500 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554
WMAPE I N D+WS G + E+ + G P+ +K+
Sbjct: 277 RLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 555 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS---AVELLE 592
+ + PE SE D + C+ +P++RP+ V+L+E
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 64/282 (22%)
Query: 359 GKLIGRGTFGSVYIGT-NRETGAS--CAIK--EVDI-----IPDDPKSAECIKQLEQVDD 408
GK++G G FGSV G +++ G+ A+K ++DI I + A C+K D
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF----D 59
Query: 409 HLYIY---------------------LEYVHPGSINRY-----VREHCRDITESIVRNFT 442
H + L ++ G ++ + + + + F
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-------ELSL 495
I G+ YL + N IHRD+ N ++ V +ADFG++K + Y ++ +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554
K W+A I+++ + K D+W+ G T+ E+ T G+ P+ E + ++
Sbjct: 180 K----WIA---IESLADRVYTSK----SDVWAFGVTMWEIATRGQTPYPGVENHE-IYDY 227
Query: 555 L---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
L NR PE E D + C+ +P +RP+ +L E
Sbjct: 228 LRHGNRLKQ-PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 499
F+ + NG+ +L S N +HRD+ N+L+ +VK+ DFG+A+ + S +S KGS
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302
Query: 500 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 555
WMAPE I N D+WS G + E+ T G P+ E + + +
Sbjct: 303 LPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355
Query: 556 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELL 591
R + P S E + + +C+ RP +L+
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 20/179 (11%)
Query: 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 466
H+ I ++Y+ G + +++ ++E+ V+ R ++ L LH N IH DIK N
Sbjct: 82 KGHVLI-MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLEN 139
Query: 467 LLVD-ASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
+L D A + L D+G+ K + T Y+ G+ ++ +PE IK ++ D
Sbjct: 140 VLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIK----GHNY---DVSFD 188
Query: 525 IWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 579
W++G E+LTGK P+ E E +++ K + P + +S DF ++ L+
Sbjct: 189 WWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF-VQSMLK 246
|
Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 51/196 (26%)
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 503
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ + + A
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190
Query: 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPWS 543
PEVI + K+ VDIWS+GC + E++ G P +
Sbjct: 191 PEVILGMGYKEN-------VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 544 EFEG---PQAMFKVLNRTPPIP--------------------EMLSSEGKDFLLRCFLRN 580
EF P V NR P P ++ +S+ +D L + + +
Sbjct: 244 EFMNRLQPTVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302
Query: 581 PVERPSAVELLEHPFI 596
P +R S E L HP+I
Sbjct: 303 PDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 493
++ + G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552
LK WMAPE I + + D+WS G + E+ + G P+ + +
Sbjct: 244 PLK----WMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 553 KVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ L + P+ + E +L C+ P +RP+ EL+EH
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 52/279 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS-----CAIKEVDIIPDDPKSAECIKQLE--- 404
+S Q+ +GRG FG V++ + +K + D+ +E ++L+
Sbjct: 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR 63
Query: 405 ---------------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHILN- 447
+ + H Y+ LEY G + +++R + T+ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 448 ------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSP 499
G+ +L + +HRD+ N LV + VK++ ++K + Y +
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT 558
W+APE AV + D + K D+WS G + E+ T G+ P+ + VLNR
Sbjct: 183 RWLAPE---AVQEDDFSTK----SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRL 231
Query: 559 P------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 591
P+PE S + RC+ NP +RPS EL+
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 359 GKLIGRGTFGSVYIG--TNRETGASCAIKEVDI-------IPDDPKSAECIKQ------- 402
GK +G G FGSV G ++ A+K + I + D A C+K+
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 403 ------LEQVDDHLY----IYLEYVHPGSINRYV-REHCRDI-----TESIVRNFTRHIL 446
L+ V+ Y + L ++ G ++ ++ D T+ +V+ F I
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIA 122
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS---LKGSPNWMA 503
+G+ YL S + IHRD+ N +++ + V +ADFG++K + Y K W+A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL---NRTP 559
E + + D+WS G T+ E+ T G+ P+ E + ++ L NR
Sbjct: 183 IESL-------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLK 234
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P+ L + C+L NP +RPS L
Sbjct: 235 QPPDCLDGL-YSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 24/158 (15%)
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 500
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y KG
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185
Query: 501 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 554
WM+PE + KDG D+WS G + E+ T + P+ Q + V
Sbjct: 186 RWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 555 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 591
L++ P+ML + + C+ NP RPS +E++
Sbjct: 239 LLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 51/196 (26%)
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWM 502
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ + +
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPW 542
APEVI + K+ VDIWS+GC + EM+ K P
Sbjct: 186 APEVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 543 SEFEG---PQAMFKVLNR------TPP--IPEML-----------SSEGKDFLLRCFLRN 580
EF P V NR T P P+ L +S+ +D L + + +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 581 PVERPSAVELLEHPFI 596
P +R S E L+HP+I
Sbjct: 299 PAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 51/196 (26%)
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM- 502
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ +
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 192
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPW 542
APEVI + K+ VDIWS+GC + EM+ G P
Sbjct: 193 APEVILGMGYKEN-------VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 543 SEFEG---PQAMFKVLNR--------TPPIPEML-----------SSEGKDFLLRCFLRN 580
EF P V NR P++L +S+ +D L + + +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 581 PVERPSAVELLEHPFI 596
+R S E L+HP+I
Sbjct: 306 ASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 500
I G++YLH IH+DI N ++D VK+ D +++ L + Y L + N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CLGDNENRPV 183
Query: 501 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT 558
WMA E + N + + A D+WS G + E++T G+ P+ E + P M L
Sbjct: 184 KWMALESLV-------NKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAAYLKDG 235
Query: 559 PPIPEMLSSEGKDF--LLRCFLRNPVERPSAVELL 591
+ + ++ + F + C+ +P ERPS +L+
Sbjct: 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 25/158 (15%)
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYELSLKGSPN 500
G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ L LK
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 240
Query: 501 WMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 557
WMAPE I K + D+WS G + E+ + G P+ + + + L
Sbjct: 241 WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291
Query: 558 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ PE + E +L C+ NP +RP+ EL+E
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 64/279 (22%)
Query: 359 GKLIGRGTFGSV---YIGTNRETGASCAIK--EVDI-----IPDDPKSAECIKQLEQVDD 408
G+++G+G FGSV + + + A+K + DI I + + A C+K+ D
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF----D 59
Query: 409 HLYI---------------------YLEYVHPGSINRY-----VREHCRDITESIVRNFT 442
H + L ++ G ++ + + E + + F
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSL 495
I +G+ YL S N IHRD+ N +++ + V +ADFG++K + G + +L +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554
K W+A E + + D+W+ G T+ E++T G+ P++ E + ++
Sbjct: 180 K----WLALESL-------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNY 227
Query: 555 L---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
L NR P+ L + + + +C+ P RPS L
Sbjct: 228 LIKGNRLKQPPDCL-EDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 15/153 (9%)
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 499
F+ + G+ +L S N IHRD+ N+L+ V K+ DFG+A+ + S +KG+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNAR 275
Query: 500 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 555
WMAPE I + + D+WS G + E+ + GK P+ +K++
Sbjct: 276 LPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328
Query: 556 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS 586
R + P+ E + C+ P ERP+
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 493
++ + G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ S L
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 494 SLKGSPNWMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 550
LK WMAPE I K + D+WS G + E+ + G P+ + +
Sbjct: 239 PLK----WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPYPGVQINEE 285
Query: 551 MFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ L + PE + E +L C+ +P ERP+ L+E
Sbjct: 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 358 KGKLIGRGTFGSVYIGTNRE--------------TGAS-CAIKEVDIIPD--DPKSAECI 400
+G +GRGT+G VY ++ TG S A +E+ ++ + P
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 401 KQ-LEQVDDHLYIYLEYV-----HPGSINRYVREHCRDIT--ESIVRNFTRHILNGLAYL 452
K L D +++ +Y H +R + + + + +V++ IL+G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 453 HSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS----LKGSPNWMAP 504
H+ +HRD+K AN+LV G VK+AD G A+ L+ + + + AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540
E++ G A+DIW++GC E+LT +P
Sbjct: 185 ELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 39/216 (18%)
Query: 358 KGKLIGRGTFGSVYIGTNRE--------------TGAS-CAIKEVDIIPD--DPKSAECI 400
+G +GRGT+G VY ++ TG S A +E+ ++ + P
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 401 KQ-LEQVDDHLYIYLEYV-----HPGSINRYVREHCR--DITESIVRNFTRHILNGLAYL 452
K L D +++ +Y H +R + + + + S+V++ IL+G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 453 HSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS----LKGSPNWMAP 504
H+ +HRD+K AN+LV G VK+AD G A+ L+ + + + AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540
E++ G A+DIW++GC E+LT +P
Sbjct: 185 ELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 389 IIPDDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
IIP + C+ + +D +++ L++ G + ++ + I E V+ + ++
Sbjct: 39 IIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVA 97
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNWMAPE 505
L LH + RD+ N+L+D G ++L F + E S G + APE
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENMYCAPE 152
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP-PWSEFEGPQAMFKVLNRTPPIPEM 564
V G + A D WSLG + E+LTGK G + T IPE
Sbjct: 153 V-------GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----HTTLNIPEW 200
Query: 565 LSSEGKDFLLRCFLRNPVERPSA-----VELLEHPF 595
+S E + L + NP ER A ++ HPF
Sbjct: 201 VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----- 499
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y KG
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 554
WMAPE + KDG + D+WS G + E+ + + P+ Q + V
Sbjct: 186 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238
Query: 555 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
L++ PE ++ D + C+ NP RP+ +E++
Sbjct: 239 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 440 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499
+FT + G+ +L S N +HRD+ N+L+ +VK+ DFG+A+ + S +S KGS
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGST 299
Query: 500 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554
WMAPE I N L+ D+WS G + E+ + G P+ +
Sbjct: 300 FLPVKWMAPESIF------DNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352
Query: 555 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ + P+ + E D +++C+ P +RPS + L +
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 60/277 (21%)
Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKE--VDIIPDD---------PKSA-------EC 399
K IG G FG V +G + T A +KE V + P + +C
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 400 IKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESI------VRNFTRHILNGLAYLH 453
+ Q +V +L + +E+ G + Y+R CR E + ++ I GL +LH
Sbjct: 61 LGQCTEVTPYLLV-MEFCPLGDLKGYLRS-CR-KAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-------WMAPEV 506
N IH D+ N L+ A VK+ D+G++ Y+ +P+ W+APE+
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSH----NKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 507 IKAVMQKDGNPKLALAVD------IWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP 559
+ V GN L VD +WSLG T+ E+ G P+ Q + +
Sbjct: 174 VDEV---HGN---LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 560 ---PIPEM---LSSEGKDFLLRCFLRNPVERPSAVEL 590
P P + LS + + C+L+ P +RPSA E+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKHLTG--------LSYEL 493
+L+ LA H+ +HRD+K N++V +GV K+ DFG+ L G L+
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 553
+ G+P + APE Q G P D+++ G +E LTG+ + +++
Sbjct: 148 EVLGTPTYCAPE------QLRGEPVTP-NSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
Query: 554 VLNRTP-PIPEMLSSEGKDFLLRCFLR-NPVERPSAVELLEHPF 595
L+ +P ++ +LR L +P +R ++ L F
Sbjct: 201 QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPK----------SAECIKQLEQ---- 405
+G+GTF ++ G RE G + + +++ D +A + QL
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 406 --------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
D+ + + EYV GS++ Y++++ I S + + L +L
Sbjct: 63 LNYGVCVCGDESIMVQ-EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 458 IHRDIKGANLLV-----DASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 509
H ++ N+L+ +G +KL+D G++ +T L E+ L+ P W+ PE I+
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPECIE- 177
Query: 510 VMQKDGNPK-LALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPIPEMLSS 567
NP+ L+LA D WS G T+ E+ +G P S + Q + +P +
Sbjct: 178 ------NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQFYEDRHQLPAPKWT 230
Query: 568 EGKDFLLRCFLRNPVERPS 586
E + + +C P RPS
Sbjct: 231 ELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 55/269 (20%)
Query: 362 IGRGTFGSVYIG-----TNRETGASCAIK------EVDIIPDDPKSAECIKQL------- 403
+G G FG VY G R + S AIK E + + + AE + L
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 404 -------EQVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILN------- 447
EQ L+ YL + G ++ ++ + D+ + L+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAH---GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 448 ------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP-- 499
G+ YL S + +HRD+ N LV VK++DFG+++ + Y S
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 500 -NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 557
WM PE A++ K DIWS G + E+ + G P+ F + + + +R
Sbjct: 190 VRWMPPE---AILYG----KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242
Query: 558 TP-PIPEMLSSEGKDFLLRCFLRNPVERP 585
P PE + ++ C+ P RP
Sbjct: 243 QLLPCPEDCPARVYALMIECWNEIPARRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 62/247 (25%)
Query: 407 DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
D+ L++ ++ GS + H D ++E + + +L L Y+H +HR +K +
Sbjct: 71 DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKAS 130
Query: 466 NLLVDASGVVKL----ADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGN 516
++L+ G V L ++ M H L + S+K P W++PEV++ +Q
Sbjct: 131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDA 189
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-------IP------- 562
DI+S+G T E+ G P+ + Q + + LN T P IP
Sbjct: 190 KS-----DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMK 244
Query: 563 --------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVEL 590
S F+ +C RNP RPSA L
Sbjct: 245 PSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL 304
Query: 591 LEHPFIR 597
L H F +
Sbjct: 305 LNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471
+ EYV G ++ ++ +++ + + + + L YL +H ++ G N+LV
Sbjct: 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR 136
Query: 472 SGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
G+ +KL+D G+ +T LS E ++ P W+APE I ++G L +A D
Sbjct: 137 YGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP-WIAPECI-----RNGQASLTIAAD 188
Query: 525 IWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE 583
WS G T++E+ + G+ P S + +P +E + + +C+ +P +
Sbjct: 189 KWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTK 247
Query: 584 RPS 586
RPS
Sbjct: 248 RPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 41/175 (23%)
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK------- 496
I + Y+HS +HRD+K N+L+ G V + D+G A L +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 497 -----------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 545
G+P++MAPE + G P + + DI++LG + +MLT P+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLL------GVPA-SESTDIYALGVILYQMLTLSFPYRRK 234
Query: 546 EGPQAMFKVLNRTPP---------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 591
+G + ++ + IP LS ++ +P ER S+V+ L
Sbjct: 235 KGRKISYR--DVILSPIEVAPYREIPPFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 35/262 (13%)
Query: 362 IGRGTFGSV-----YIGTN------RETGASCAIKEVD---------IIPDDPKSAECIK 401
IG G FG V Y T +E A+ + KE + I P +C+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 402 QLEQVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
Q + +L ++ EY G + Y+ H R+ +++ I G+ ++H N +
Sbjct: 63 QCVEAIPYLLVF-EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDG 515
H D+ N + + VK+ D+G+ Y E W+APE++
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181
Query: 516 NPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLNR------TPPIPEMLSSE 568
+ ++W+LG T+ E+ P+S + + V+ P + S
Sbjct: 182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241
Query: 569 GKDFLLRCFLRNPVERPSAVEL 590
+ L C+L +P +R +A E+
Sbjct: 242 WYEVLQFCWL-SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 12/112 (10%)
Query: 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VL 555
G+P+++APE++ + K P AVD W+LG + E LTG PP+++ E PQ +F+ +L
Sbjct: 542 GTPDYLAPELL---LGKPHGP----AVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNIL 593
Query: 556 NRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604
NR P P E LS ++ + +P +R EL +HP +++NL
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENL 645
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 409 HLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLH 453
+LY+ +EY G++ ++R+ ++ + +F + G+ YL
Sbjct: 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 141
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
IHRD+ N+LV + V K+ADFG+++ + + WMA E + +
Sbjct: 142 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 201
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKD 571
+ D+WS G + E+++ G P+ + K+ P E D
Sbjct: 202 TNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYD 254
Query: 572 FLLRCFLRNPVERPSAVELL 591
+ +C+ P ERPS ++L
Sbjct: 255 LMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 40/182 (21%), Positives = 80/182 (43%), Gaps = 13/182 (7%)
Query: 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469
+ I EY+ G+++ ++R+H + + + +G+ YL +H+ + +LV
Sbjct: 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV 140
Query: 470 DASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 527
++ V K++ F + + +S K W APE I+ + A D+WS
Sbjct: 141 NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-------HHFSSASDVWS 193
Query: 528 LGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVER 584
G + E+++ G+ P+ + G + V + R P P + +L C+ + ER
Sbjct: 194 FGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCPNLLHQLMLDCWQKERGER 252
Query: 585 PS 586
P
Sbjct: 253 PR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/107 (32%), Positives = 47/107 (43%), Gaps = 9/107 (8%)
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPN 500
R +L + YLH IHRDIK N+ ++ G V L DFG A ++ G+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547
APE++ AVDIWS G + EM T E +G
Sbjct: 249 TNAPELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 474
E+V G ++ +R+ + + + + + L+YL N +H ++ N+L+ G+
Sbjct: 96 EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155
Query: 475 -------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 527
+KL+D G++ T LS E ++ P W+APE + GN L+ A D WS
Sbjct: 156 AEGTSPFIKLSDPGVS--FTALSREERVERIP-WIAPECV-----PGGN-SLSTAADKWS 206
Query: 528 LGCTVIEM-LTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPS 586
G T++E+ G+ P E P + + +PE E + +C P +RPS
Sbjct: 207 FGTTLLEICFDGEVPLKE-RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 50/236 (21%), Positives = 92/236 (38%), Gaps = 39/236 (16%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECI--KQLEQVD--- 407
+W+ KLIG G FG VY + A+ +++ + ++ E + + +D
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72
Query: 408 --------DHL-------------------YIYLEYVHPGSINRYVREHCRDITESIVRN 440
DHL +I LE + + + R C++ + +++N
Sbjct: 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN--KKLIKN 130
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGS 498
+ +L L Y+H H DIK N++VD + + D+G+A H + G E S K
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS-KEQ 189
Query: 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 554
+ + A + + D+ SLG +++ K PW F +
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245
|
Length = 294 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 58/263 (22%), Positives = 106/263 (40%), Gaps = 46/263 (17%)
Query: 361 LIGRGTFGSVYIGTNRETG--ASCAIK----------------EVDIIPDDPKSAECIKQ 402
+IG G FG V ++ G + AIK E++++ I
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 403 LEQVDD--HLYIYLEYVHPGSINRYVR-------------EH--CRDITESIVRNFTRHI 445
L ++ +LYI +EY G++ ++R EH +T + F +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 505
G+ YL IHRD+ N+LV + K+ADFG+++ + + WMA E
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIE 188
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--P 562
+ + + D+WS G + E+++ G P+ + +++ L + + P
Sbjct: 189 SLNYSVYTTKS-------DVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKP 240
Query: 563 EMLSSEGKDFLLRCFLRNPVERP 585
E + + +C+ P ERP
Sbjct: 241 RNCDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 32/78 (41%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 431 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGL 489
RDI ++++ R +L GL LH +HRDIK NLLV G VK+ DFG A + TG+
Sbjct: 306 RDI--NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI 363
Query: 490 SYELSLKG--SPNWMAPE 505
++ L G P + PE
Sbjct: 364 NFN-PLYGMLDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 52/250 (20%), Positives = 101/250 (40%), Gaps = 63/250 (25%)
Query: 410 LYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468
L++ ++ GS N ++ + + ++E+++ N L GL YLH IHR+IK +++L
Sbjct: 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL 133
Query: 469 VDASGVVKLAD----FGMAKH--LTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKL 519
+ G+V L+ + + ++ + Y+ S P W++PE+++ +
Sbjct: 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLY-----GY 187
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------------------- 559
+ DI+S+G T E+ TG+ P+ + Q + + L P
Sbjct: 188 NVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ 247
Query: 560 ---------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P + S ++ + C ++P +RPSA LL
Sbjct: 248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307
Query: 593 HPFIRNANYQ 602
H F + Q
Sbjct: 308 HAFFKQVKEQ 317
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 18/150 (12%)
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 500
I G+ YL S +H+D+ N+L+ VK++D G+++ + Y + P
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY---YRVQPKSLL 188
Query: 501 ---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556
WM PE I K + DIWS G + E+ + G P+ F + + V
Sbjct: 189 PIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
Query: 557 RT-PPIPEMLSSEGKDFLLRCFLRNPVERP 585
R P E + C+ P RP
Sbjct: 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 499
I G+ +L S + +H+D+ N+LV VK++D G+ + + Y L G+
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY-YKLMGNSLLPI 190
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR- 557
WM+PE A+M K ++ DIWS G + E+ + G P+ + + + NR
Sbjct: 191 RWMSPE---AIMYG----KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 558 TPPIPEMLSSEGKDFLLRCFLRNPVERP 585
P P+ + +L C+ P RP
Sbjct: 244 VLPCPDDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 43/200 (21%), Positives = 85/200 (42%), Gaps = 26/200 (13%)
Query: 409 HLYIYLEYVHPGSI-------------NRYVREH--CRDITESIVRNFTRHILNGLAYLH 453
+LY+ +EY G++ + + ++ + +F + G+ YL
Sbjct: 70 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
IHRD+ N+LV + V K+ADFG+++ + + WMA E + +
Sbjct: 130 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 189
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGK 570
+ D+WS G + E+++ G P+ + +++ L + + P E
Sbjct: 190 TNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVY 241
Query: 571 DFLLRCFLRNPVERPSAVEL 590
D + +C+ P ERPS ++
Sbjct: 242 DLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 44/151 (29%), Positives = 64/151 (42%), Gaps = 34/151 (22%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQVDD--------- 408
K I RG FG VY+G + A+K V K A+ I + + QV
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVV-------KKADMINKNMVHQVQAERDALALSK 62
Query: 409 -----HLY--------IYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
HLY +YL EY+ G + + + E + + + L YLH
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH 121
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAK 484
IHRD+K N+L+ G +KL DFG++K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 37/119 (31%), Positives = 51/119 (42%), Gaps = 22/119 (18%)
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSY--- 491
I++ R IL L LHST +HRD+K N++ SG K+ D G A L G++Y
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV---------------DIWSLGCTVIEM 535
E L P + APE Q P +A DI+S G ++M
Sbjct: 316 EFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 32/104 (30%), Positives = 40/104 (38%), Gaps = 14/104 (13%)
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 502
R +L LAYLH IHRD+K N+ +D L DFG A L G W
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG---WS 248
Query: 503 APEVIKAVMQKDGNPKLAL-----AVDIWSLGCTVIEMLTGKPP 541
++ + LAL DIWS G + EM
Sbjct: 249 ------GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 46/203 (22%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 399 CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
C++ +E + + E+V G ++ ++ +T + + + L+YL + +
Sbjct: 73 CVRDVENI-----MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLV 127
Query: 459 HRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
H ++ N+L+ G+ +KL+D G+ +T LS + ++ P W+APE ++
Sbjct: 128 HGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-WIAPECVE--- 181
Query: 512 QKDGNPKLALAVDIWSLGCTVIEM-LTGKPPWSE--------FEGPQAMFKVLNRTPPIP 562
+ L++A D WS G T+ E+ G+ P + F Q M TP
Sbjct: 182 ---DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV----TPSCK 234
Query: 563 EMLSSEGKDFLLRCFLRNPVERP 585
E+ D + C +P +RP
Sbjct: 235 EL-----ADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 425 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484
Y+ R + + V R +L+ + Y+H IHRDIK N+LV+ + L DFG A
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308
Query: 485 HLTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 534
G + + G+ + APEV+ G+P +VDIWS G + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLA------GDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYELSLK 496
R + +L + Y+H IHRDIK N+ ++ G + L DFG A +++
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329
Query: 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 537
G+ +PE ++ DG ++ DIWS G +++ML+
Sbjct: 330 GTVATNSPE----ILAGDGYCEIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 43/200 (21%), Positives = 90/200 (45%), Gaps = 25/200 (12%)
Query: 403 LEQVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIH 459
++ VDD L + LEY G + + + +D++ + GL L+ TN +
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA---PEVIKAVMQKDGN 516
+++ + LV + +K+ G+ K L+ ++ + N+M +++ + +
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMVYFSYKMLNDIFSE--- 198
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVL---NRTPPIPEMLSSEGKD 571
+ DI+SLG + E+ TGK P FE + ++ ++ N + +P E K
Sbjct: 199 --YTIKDDIYSLGVVLWEIFTGKIP---FENLTTKEIYDLIINKNNSLKLPLDCPLEIKC 253
Query: 572 FLLRCFLRNPVERPSAVELL 591
+ C + ++RP+ E+L
Sbjct: 254 IVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 20/86 (23%)
Query: 406 VDDHLY-IYLEYVHPG-----SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
VD I +EY+ G I E R+I + + LH +H
Sbjct: 67 VDPDNKTIVMEYIE-GKPLKDVIEEGNDELLREIGRLVGK------------LHKAGIVH 113
Query: 460 RDIKGANLLVDASGVVKLADFGMAKH 485
D+ +N++V + L DFG+ K+
Sbjct: 114 GDLTTSNIIVRDDKLY-LIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.001
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 10/74 (13%)
Query: 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471
I +EY+ G + V E +VR + A LH +H D+ +N +V
Sbjct: 413 IVMEYIG-GKDLKDVLEG----NPELVRKVGEIV----AKLHKAGIVHGDLTTSNFIVRD 463
Query: 472 SGVVKLADFGMAKH 485
+ L DFG+ K+
Sbjct: 464 DRLY-LIDFGLGKY 476
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.61 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.99 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.58 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.38 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.16 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.0 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.9 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.49 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.42 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.01 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.71 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.66 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.01 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.17 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.15 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.98 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.9 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.25 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 89.21 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 88.97 | |
| PTZ00384 | 383 | choline kinase; Provisional | 88.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 88.61 | |
| PLN02236 | 344 | choline kinase | 88.56 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 88.22 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=430.34 Aligned_cols=245 Identities=33% Similarity=0.537 Sum_probs=211.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC------------hhHHHHHHHHhh-----------cCC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------------PKSAECIKQLEQ-----------VDD 408 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~------------~~~~~~ik~L~~-----------~~~ 408 (720)
..+.|.+.+.||+|+||.|.+|+.+.||+.||||++...... .+++++++.|.+ ..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567899999999999999999999999999999998643211 244555555543 356
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC---CCeeeeccccchh
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKH 485 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~---g~VKL~DFGlA~~ 485 (720)
..||||||++||+|.+.+..+ +.+.|..-+.+++|||.||.|||++||+||||||+||||..+ ..+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 789999999999999999775 779999999999999999999999999999999999999765 6899999999999
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH-HHHHHhccCCCC---
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTPPI--- 561 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~-~i~ki~~~~~~i--- 561 (720)
......+.++||||.|.|||++.+ .|...+..++||||||||||-+|+|.+||.+.-... ....|..+.+.+
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~----kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLAS----KGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred cccceehhhhcCCccccChhheec----CCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 988889999999999999999974 234556679999999999999999999998765555 667777665433
Q ss_pred -CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 562 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 562 -P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
...+++++++||.+||..||++|||+.|+|+||||+....
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 3568999999999999999999999999999999987653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=416.90 Aligned_cols=245 Identities=33% Similarity=0.550 Sum_probs=214.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-----HHHHHHHHh--------------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----SAECIKQLE--------------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-----~~~~ik~L~--------------~~~~~lyL 412 (720)
..++|+++++||+|+||+||+++.++|++.||+|+++......+ ...+...|. |..+++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35699999999999999999999999999999998864321111 111112222 34788999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~~ 491 (720)
|+||+.||+|..+|++. +.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+|+|+||||++.. .....
T Consensus 103 Vld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 99999999999999765 78999999999999999999999999999999999999999999999999999965 44456
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 570 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~ 570 (720)
..++|||+.|||||++.+ ..|+.++|+|||||++||||+|.+||...+....+.+|+.+. ...|..++.+++
T Consensus 182 t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred cccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 678999999999999984 578999999999999999999999999999999999999887 666777999999
Q ss_pred HHHHHhhhcCCCCCC----CHHHHHcCcccccccccCC
Q 005007 571 DFLLRCFLRNPVERP----SAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 571 dLI~~cL~~dP~kRP----Ta~ELL~Hpff~~~~~~~l 604 (720)
+||+++|++||++|. .+++|-+||||...+|..+
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 999999999999995 7899999999999887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=414.68 Aligned_cols=243 Identities=32% Similarity=0.587 Sum_probs=212.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHh---h--------------cCC-EEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---Q--------------VDD-HLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~---~--------------~~~-~lyLVm 414 (720)
..+.+.++.||+|..|+||+|+++.|++.+|+|+|....+.....+++++|+ . .++ .++|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4578889999999999999999999999999999965554444334444433 2 245 599999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+||+|.++++.. +.++|..+..++.+|++||.|||+ ++||||||||+||||+..|+|||||||.++.+.+. ...
T Consensus 158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~ 235 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IAN 235 (364)
T ss_pred hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcc
Confidence 999999999999776 779999999999999999999995 99999999999999999999999999999988776 667
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC-----CcHHHHHHHhc-cCCCCCcc-CC
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-----EGPQAMFKVLN-RTPPIPEM-LS 566 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~-----~~~~~i~ki~~-~~~~iP~~-ls 566 (720)
+++||..|||||.+.+ ..|+.++||||||++|+||++|+.||... ...+.+..|+. ..+.+|+. ++
T Consensus 236 tfvGT~~YMsPERi~g-------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISG-------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred cccccccccChhhhcC-------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 8999999999999984 57899999999999999999999999874 56678888887 56678886 99
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccCC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~l 604 (720)
+++++||.+||++||.+|+++.|||+|||++.....++
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 99999999999999999999999999999987765544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=433.95 Aligned_cols=240 Identities=35% Similarity=0.642 Sum_probs=214.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-----CCh---hHHHHHHHHhh-----------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDP---KSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-----~~~---~~~~~ik~L~~-----------~~~~ly 411 (720)
+...+|.++++||+|||++||.+++..+|+.||+|+|.... ... .++++...|.+ ..+++|
T Consensus 15 ~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 15 PRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred CCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 33478999999999999999999999999999999986421 111 22333333332 467899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-c
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~ 490 (720)
||+|+|+.++|..+++. .+.++|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+... .
T Consensus 95 ivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999999974 478999999999999999999999999999999999999999999999999999988744 7
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
...+.||||.|+|||++. ...+++.+||||+|||||-||+|++||...+-.+.+.+|....+.+|..++.+++
T Consensus 174 rk~TlCGTPNYIAPEVl~-------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~ 246 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLN-------KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAK 246 (592)
T ss_pred ccceecCCCcccChhHhc-------cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHH
Confidence 778999999999999998 3568899999999999999999999999998999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+||.+||+.||.+|||++++|.|+||..
T Consensus 247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 247 DLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 9999999999999999999999999943
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=427.11 Aligned_cols=245 Identities=29% Similarity=0.595 Sum_probs=217.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC--------CCChhHHHHHHHHh------------hcCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII--------PDDPKSAECIKQLE------------QVDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~--------~~~~~~~~~ik~L~------------~~~~~ly 411 (720)
...+|..++.||+|+|++||+|+++.+++.||||++... ..-..+.+.+.+|. +.+..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346899999999999999999999999999999987531 11122333444442 2467899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+|+||+++|+|.++|++. +.|+|..++.|+.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999876 8899999999999999999999999999999999999999999999999999987743211
Q ss_pred --------------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc
Q 005007 492 --------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR 557 (720)
Q Consensus 492 --------------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~ 557 (720)
..+++||..|.+||+|. +...+..+|||+||||||.|+.|.+||.+.+..-.+.+|+..
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-------~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLN-------DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhc-------CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 14589999999999997 457888999999999999999999999999999999999999
Q ss_pred CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccCC
Q 005007 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 558 ~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~l 604 (720)
.+.+|+.+++.++|||+++|.+||.+|+|+.||.+||||....|+++
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 99999999999999999999999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=396.93 Aligned_cols=239 Identities=29% Similarity=0.539 Sum_probs=202.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-----------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-----------~~~~lyLVmE 415 (720)
++|+++.++|+|+||+||+|++++||+.||||++....+++.. ++.+++|.+ ....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4789999999999999999999999999999999776665543 223333332 3678999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t 494 (720)
||+. ++.+.|......+++..++.|++|++.|+.|||++++|||||||+||||+..|.+||||||+|+.+. .+.....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9984 5555566667789999999999999999999999999999999999999999999999999999987 5566677
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------------- 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--------------- 559 (720)
++.|.||+|||++.| +..|+..+|||++||++.||++|.+.|.+.++.+.+..|.....
T Consensus 161 YVATRWYRaPELLvG------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 161 YVATRWYRAPELLVG------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred hhhhhhccChhhhcc------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 899999999999985 67899999999999999999999999999988888776643111
Q ss_pred ----CCCc------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 560 ----PIPE------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 560 ----~iP~------------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+|+ .++.-+.||++.||.+||.+|++.+|+|.|+||...
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1121 245678899999999999999999999999999543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=409.43 Aligned_cols=242 Identities=29% Similarity=0.559 Sum_probs=214.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----C---Ch---hHHHHHHHHh-h-----------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----D---DP---KSAECIKQLE-Q-----------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~---~~---~~~~~ik~L~-~-----------~~~ 408 (720)
.....|.+++.||+|+||+||+|.+..+|..||||+++... . .. .++..++.+. + ...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34569999999999999999999999999999999776531 1 11 1222333333 1 256
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhc-
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL- 486 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~- 486 (720)
.+|||||||.||+|.++|.+ .+.+.|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 69999999999999999988 5889999999999999999999999999999999999999999 99999999999988
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCC-CCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccC
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP-KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 565 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~-~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~l 565 (720)
.......+.+||+.|+|||++.+ .. +.+.++||||+||+||.|++|+.||.+.+....+.+|..+...+|..+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSG------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCC------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence 46677789999999999999985 23 446899999999999999999999999888889999999999999999
Q ss_pred -CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 566 -SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 566 -s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+.++++||.+||..||.+|+|+.+|++|+||+..
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 9999999999999999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=419.47 Aligned_cols=240 Identities=33% Similarity=0.549 Sum_probs=219.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--------CChhHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--------DDPKSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--------~~~~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
.-|++|+.||.|+-|.|.+|++.+||+.+|||+|.... ....++.+++.+.+ .+.++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 46999999999999999999999999999999986542 22334445555443 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||++||.|+++|..+ +.|+|.++..|++||+.||.|||..+|+||||||+|+|||..+++||+|||+|..-.++....+
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 999999999999876 7899999999999999999999999999999999999999999999999999998888888889
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.||+|.|.|||++.| .++.+.++||||+|||||.||||++||.+.+...++.++..+.+.+|..++.++++||.
T Consensus 171 SCGSPHYA~PEIV~G------~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSG------RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred cCCCcccCCchhhcC------CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 999999999999985 56778999999999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||..||++|+|.+||++|||+....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999999997543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=388.46 Aligned_cols=243 Identities=30% Similarity=0.570 Sum_probs=215.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--------ChhHHHHHHHHh-----------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--------DPKSAECIKQLE-----------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--------~~~~~~~ik~L~-----------~~~~~lyL 412 (720)
...+|++++.||.|+||+|.+++++.+|..+|+|+++...- ..++..+++.+. +..+++||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34689999999999999999999999999999998864221 111222233222 13678999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||++||.|+.++++. +.|+|..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+...+. .
T Consensus 122 vmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 99999999999999774 78999999999999999999999999999999999999999999999999999988765 5
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
.+.||||.|+|||++.. ..|+.++|+|+|||++|||+.|.+||...+...++.+|+.+...+|..++.+++||
T Consensus 199 ~TlCGTPeYLAPEii~s-------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQS-------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDL 271 (355)
T ss_pred EEecCCccccChHHhhc-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHH
Confidence 68899999999999983 67889999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCC-----CCHHHHHcCcccccccccCC
Q 005007 573 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 573 I~~cL~~dP~kR-----PTa~ELL~Hpff~~~~~~~l 604 (720)
|+++|+.|-.+| ...++|.+||||+...|..+
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 999999999999 35789999999998776543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=402.07 Aligned_cols=242 Identities=49% Similarity=0.883 Sum_probs=204.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----ChhHHHHHHHHhh------------cCC-EEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPKSAECIKQLEQ------------VDD-HLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~~~~~~ik~L~~------------~~~-~lyLVm 414 (720)
..+|..++.||+|+||.||++.+.++|..+|||.+..... ...++.++..|.. .++ .++|+|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4579999999999999999999999999999999987521 1223333444331 122 699999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchhccC----c
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG----L 489 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~----~ 489 (720)
||+.||+|.+++.+.++.|+|..++.|++||++||+|||++|||||||||+||||+. +|.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999999999887658999999999999999999999999999999999999999 79999999999987764 2
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC-CCcHHHHHHHhcc--CCCCCccCC
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKVLNR--TPPIPEMLS 566 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~-~~~~~~i~ki~~~--~~~iP~~ls 566 (720)
.....+.||+.|||||++.. ......++|||||||++.||+||++||.+ ....+.+..+... .+.+|..++
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 23446889999999999973 11223589999999999999999999998 5666666666543 478999999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+++++||.+||++||++||||+++|+|||.+...
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999999999997644
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=409.90 Aligned_cols=249 Identities=31% Similarity=0.531 Sum_probs=208.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHH-Hh--------------hcCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQ-LE--------------QVDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~-L~--------------~~~~~ly 411 (720)
..-++|+++++||+|+||.||+|+-+.||..||+|+++....... .+...+. |. +..+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 345799999999999999999999999999999999975332111 1111111 11 2467899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC---
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--- 488 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~--- 488 (720)
|||||++|||+..+|... +.|+|..++.|+.+++.||+.||+.|||||||||+|+|||..|++||+||||+.-+..
T Consensus 218 LiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999765 7899999999999999999999999999999999999999999999999999842100
Q ss_pred ----------------------c-----------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccc
Q 005007 489 ----------------------L-----------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523 (720)
Q Consensus 489 ----------------------~-----------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~as 523 (720)
. ....+.+|||.|||||++.+ ..|+..+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-------kgY~~~c 369 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-------KGYGKEC 369 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-------CCCCccc
Confidence 0 01113679999999999985 4589999
Q ss_pred cccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCc--cCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCccc
Q 005007 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFI 596 (720)
Q Consensus 524 DVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~--~ls~el~dLI~~cL~~dP~kRP---Ta~ELL~Hpff 596 (720)
|+|||||||||||.|.+||...+..+...+|++.. ..+|. .++++++|||.+||. ||++|. .++||.+||||
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 99999999999999999999999999999998654 55554 578999999999999 999997 59999999999
Q ss_pred ccccccCCCCcc
Q 005007 597 RNANYQNLSVPM 608 (720)
Q Consensus 597 ~~~~~~~l~~~~ 608 (720)
+...|..+....
T Consensus 449 ~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 449 KGVDWDHLREMP 460 (550)
T ss_pred ccCCcchhhcCC
Confidence 999998876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=408.73 Aligned_cols=241 Identities=28% Similarity=0.502 Sum_probs=206.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-------------------ChhHHHHHHHHhhcCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-------------------DPKSAECIKQLEQVDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-------------------~~~~~~~ik~L~~~~~~lyLV 413 (720)
.++|.+.++||.|+||.||+|+.+++|..||||.++.... +++.+.+.+.+.+.+..+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4689999999999999999999999999999997764321 222222222222233489999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
||||+ -.|+++++++.+.|+|..|+.||.||++||+|+|.+|+.||||||+||||.....|||+|||+|+.+.......
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT 167 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT 167 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc
Confidence 99997 78999999988899999999999999999999999999999999999999989999999999999998877778
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--c--------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--R-------------- 557 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~-------------- 557 (720)
.++.|+||+|||+|.. ...|+.++|||++|||++|+++-++.|.+.++.+.+.+|.. +
T Consensus 168 eYVSTRWYRAPEvLLr------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLR------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred hhhhcccccchHHhhh------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 8999999999999986 57899999999999999999999999999999888888742 0
Q ss_pred ---CCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 ---TPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 ---~~~iP-----------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
...+| ..++.++.+||.+||.+||.+||||.|+|+||||+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11111 12678999999999999999999999999999998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=395.13 Aligned_cols=242 Identities=32% Similarity=0.608 Sum_probs=210.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-----------cCCEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-----------~~~~lyL 412 (720)
....+|.+.+.||+|+||+||+|+++.++..||||.|....-..+. +.+++.+.+ .++++||
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 3456899999999999999999999999999999999765433332 333333332 3678999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC------CCeeeeccccchhc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS------GVVKLADFGMAKHL 486 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~------g~VKL~DFGlA~~~ 486 (720)
|||||.||||.+||+.+ +.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 87 VMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999876 689999999999999999999999999999999999999764 36899999999999
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCCCc
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPE 563 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~iP~ 563 (720)
.......+.||++.|||||++. ..+|+.++|+||+|+|||+|++|++||......+.+..+..+. +.++.
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~-------~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIM-------SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred CchhHHHHhhCCccccCHHHHH-------hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 9988889999999999999997 3578899999999999999999999999888888777666543 34556
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.++..+.+|+...|++++.+|.+..+.+.|+++....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 7888889999999999999999999999999997544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=412.66 Aligned_cols=245 Identities=31% Similarity=0.540 Sum_probs=215.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChhHHHHHHHHh----------------hcCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLE----------------QVDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~~~~~ik~L~----------------~~~~~l 410 (720)
....+|+++++||+|.||+|++|..+.+++.||||+++... ++-+...+.+.+. |.++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44568999999999999999999999999999999997543 2222222222211 347899
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Cc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GL 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~ 489 (720)
|+||||+.||++..++ +.+.|+|..++.|+..|+.||.|||++|||+||||.+|||||.+|++||+||||++... .+
T Consensus 445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999944443 34779999999999999999999999999999999999999999999999999999865 55
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHH
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 569 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el 569 (720)
....++||||.|||||++.+ ..|+.++|+|+|||+|||||.|..||.+.+.++....|+...+.+|..++.++
T Consensus 523 ~~TsTfCGTpey~aPEil~e-------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea 595 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTE-------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEA 595 (694)
T ss_pred CccccccCChhhcChhhhcc-------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHH
Confidence 67789999999999999984 57999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHcCcccccccccCC
Q 005007 570 KDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 604 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~~l 604 (720)
.++|+++|.+||++|.- +++|.+||||+..+|..+
T Consensus 596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L 635 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL 635 (694)
T ss_pred HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence 99999999999999975 589999999999887644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=371.33 Aligned_cols=241 Identities=26% Similarity=0.479 Sum_probs=205.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHhhc--------------CCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQV--------------DDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~~~--------------~~~lyLVmE 415 (720)
.+|.+.++||+|.||+||+|++.+||+.||||+|+.... .....++++.|++. .+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 479999999999999999999999999999999986542 23345566666543 467899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc-
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS- 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t- 494 (720)
||+ .+|+..|++....|+..+++.|+.|+++||+|||++.|+||||||+|+||+.+|.+||+|||+|+.+.......+
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 997 999999999888999999999999999999999999999999999999999999999999999998865443333
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-----CCC------Cc
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPI------PE 563 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-----~~i------P~ 563 (720)
-+.|.||+|||++.| ...|+..+||||+|||+.||+-|.+.|.+.++.+++..|+... ..+ |+
T Consensus 161 ~V~TRWYRAPELLfG------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFG------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ceeeeeccChHHhcc------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 368999999999996 4678889999999999999999999999998888887775310 011 11
Q ss_pred -----------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 564 -----------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 564 -----------------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
..++++.|||.+||..||.+|+|+.|+|+|+||.....
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 24678899999999999999999999999999986543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=396.43 Aligned_cols=241 Identities=28% Similarity=0.510 Sum_probs=204.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh----------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ----------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~----------------~~~~lyL 412 (720)
...|+++++||+|+||.||+|++..||+.||+|+|.....+.. .+++|+.|.. ....+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4579999999999999999999999999999999987654332 2334444433 1357999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|+|||+ -||..++......|++.+|+.||+||++||+|||.+||+|||||..|||||.+|++||+|||||+.+....
T Consensus 196 VFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 999997 89999998766789999999999999999999999999999999999999999999999999999776543
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc----------CCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------TPP 560 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~----------~~~ 560 (720)
.....+.|+||+|||+|.| ...|+.++|+||+||||.||++|++.|.+....+.+.+|... ...
T Consensus 275 ~~T~rVvTLWYRpPELLLG------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLG------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred ccccceEEeeccChHHhcC------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 3455678999999999996 567999999999999999999999999998888877777531 112
Q ss_pred CC-------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 561 IP-------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 561 iP-------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+| ..+++.+.+|+..||..||.+|.||.++|+|+||....
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 22 12578889999999999999999999999999995433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=393.83 Aligned_cols=240 Identities=39% Similarity=0.668 Sum_probs=207.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH--------------HHHHHHHhh--cCCEEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--------------AECIKQLEQ--VDDHLYIYL 414 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~--------------~~~ik~L~~--~~~~lyLVm 414 (720)
.....|...++||+|+.|.||.|+...+++.||||.+++...-.++ .++++.++. .++.+++||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3456899999999999999999999999999999998765433221 112222221 368899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~ 493 (720)
|||+||+|.+++.+. .++|.+|..|++++|+||+|||.+||+|||||.+|||++.+|.|||+|||++..+.... ...
T Consensus 350 Eym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred eecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 999999999999664 49999999999999999999999999999999999999999999999999998876554 667
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cCC--CCCccCCHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTP--PIPEMLSSEGK 570 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~~--~iP~~ls~el~ 570 (720)
+.+|||+|||||++.. ..|+.++||||||++++||+-|.+||-..+....+..|.. +.+ ..|+.++.+++
T Consensus 428 TmVGTPYWMAPEVvtr-------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTR-------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred cccCCCCccchhhhhh-------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHH
Confidence 8899999999999984 5789999999999999999999999998777777777764 333 45788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|||.+||+.|+++|++|.|||+||||+..
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=385.52 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=207.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------------------hhHHHHHHHHhh------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------------PKSAECIKQLEQ------ 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------------------~~~~~~ik~L~~------ 405 (720)
..-++|++++.||+|.||+|.+|++..+++.||||++...... ..++.+++.+.+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457999999999999999999999999999999988532210 112333343332
Q ss_pred -------cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 406 -------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 406 -------~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
..+.+|||+|||..|.+...-.+ +..+++.+++.|+++++.||+|||.+|||||||||.|+||+.+|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 25789999999999987654322 2339999999999999999999999999999999999999999999999
Q ss_pred ccccchhccCc------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH
Q 005007 479 DFGMAKHLTGL------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 552 (720)
Q Consensus 479 DFGlA~~~~~~------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ 552 (720)
|||.+..+... ......+|||.|||||.+.+.. .....+.+.|||||||+||.|+.|+.||-+....+.+.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~---~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN---SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC---CccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999766221 1223467999999999987522 13567889999999999999999999999999999999
Q ss_pred HHhccCCCCCcc--CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 553 KVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 553 ki~~~~~~iP~~--ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
+|++....+|+. +.++++|||++||++||++|+++.+|..|||........
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 999999999876 799999999999999999999999999999997654333
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=375.11 Aligned_cols=234 Identities=29% Similarity=0.514 Sum_probs=198.0
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Chh------HHHHHHHHhh-----------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPK------SAECIKQLEQ-----------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~------~~~~ik~L~~-----------~~~~lyLVmEy~~gG 420 (720)
++||+|+||+||+|+++.+|+.||||+++.... ... +.++++.+.+ .++.+||||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999874211 111 1112222211 356789999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP 499 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GTp 499 (720)
+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||+
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 999999764 6799999999999999999999999999999999999999999999999999976432 22334567999
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhc
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 579 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~ 579 (720)
.|||||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||+.
T Consensus 160 ~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 160 EYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cccChhhhcC-------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence 9999999863 457889999999999999999999998877777777777788888999999999999999999
Q ss_pred CCCCCC-----CHHHHHcCcccccccc
Q 005007 580 NPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 580 dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
||++|| ++.++|+|+||....+
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=372.82 Aligned_cols=242 Identities=28% Similarity=0.447 Sum_probs=204.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh----------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ----------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~----------------~~~~lyL 412 (720)
.+.|+++..|++|+||+||+|+|+.|++.||+|.+++..... ...++|..|.. .-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 358999999999999999999999999999999998765322 12333333332 1356999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-c
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~ 491 (720)
|||||+ -||..+|......|.+.+++.++.|+|+||+|||.+.|+|||||++|+|++..|.+||+|||+|+.+.... .
T Consensus 155 VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 999998 89999998887789999999999999999999999999999999999999999999999999999987653 3
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-----------C--
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-----------T-- 558 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-----------~-- 558 (720)
....+.|.||+|||++.| ...|+.++||||+|||+.||+++++.|.+....+.+.+|+.. .
T Consensus 234 ~T~lVVTLWYRaPELLLG------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLG------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CcceEEEeeecCHHHhcC------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 345678999999999996 567899999999999999999999999998888877776531 0
Q ss_pred ------CC------------CCcc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 559 ------PP------------IPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 559 ------~~------------iP~~-ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.. ++.. +++...+||..+|..||++|.||+|.|+|.||.....
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 00 1111 5689999999999999999999999999999987543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=369.16 Aligned_cols=238 Identities=30% Similarity=0.503 Sum_probs=203.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-C-------hhHHHHHHHHh-----------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-D-------PKSAECIKQLE-----------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~-------~~~~~~ik~L~-----------~~~~~lyLVm 414 (720)
++|++.+.||+|+||+||+|.+..+|+.||||++..... . .++.++++.+. ..++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999998864211 0 11112222211 2356799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||+.+|+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 999999999999765 67999999999999999999999999999999999999999999999999999876442 234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+......+|..++.++++||+
T Consensus 158 ~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 230 (291)
T cd05612 158 LCGTPEYLAPEVIQS-------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIK 230 (291)
T ss_pred ccCChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHH
Confidence 679999999999863 4567899999999999999999999998888788888888888889999999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHcCcccccccc
Q 005007 575 RCFLRNPVERPS-----AVELLEHPFIRNANY 601 (720)
Q Consensus 575 ~cL~~dP~kRPT-----a~ELL~Hpff~~~~~ 601 (720)
+||+.||.+|++ ++|+++|+||+...+
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 999999999995 999999999976554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=373.47 Aligned_cols=241 Identities=28% Similarity=0.520 Sum_probs=205.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----C----hhHHHHHHHHhh-----------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----D----PKSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~----~~~~~~ik~L~~-----------~~~~ly 411 (720)
....+|++.+.||+|+||+||+|+++.+++.||||+++.... . ..+..++..+.+ .++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 345789999999999999999999999999999998864211 0 111222222221 357799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+||||+.||+|.+++.+. +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 95 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999999999765 679999999999999999999999999999999999999999999999999998664432
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+......+|..++.++++
T Consensus 173 -~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 244 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244 (329)
T ss_pred -ceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHH
Confidence 34679999999999863 4567899999999999999999999998887778888888888889999999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 005007 572 FLLRCFLRNPVERPS-----AVELLEHPFIRNANY 601 (720)
Q Consensus 572 LI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~ 601 (720)
||.+||+.||.+|++ ++++++||||+...+
T Consensus 245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 999999999999997 799999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=369.88 Aligned_cols=228 Identities=32% Similarity=0.525 Sum_probs=196.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-------------~~~~lyL 412 (720)
..+|+++++||+|.||.||++.+..+|+.||.|.++....+.+. +.++++|.+ ....++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35899999999999999999999999999999998855443332 222333222 2334899
Q ss_pred EEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHh--CC--CcccccCCCceeecCCCCeeeeccccchh
Q 005007 413 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS--TN--TIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs--~g--IVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
|||||.+|||..+|+. ..+.++|..+|+|+.||+.||..||. .. |+||||||.||+|+.+|.|||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999963 34679999999999999999999998 44 89999999999999999999999999998
Q ss_pred ccCc-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-CCC-
Q 005007 486 LTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIP- 562 (720)
Q Consensus 486 ~~~~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-~iP- 562 (720)
+... ....+++|||+||+||++.+ ..|++++|||||||++|||+.-.+||.+.+-.+.-.+|.++.. ++|
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~-------~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHE-------SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhc-------CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 8654 34567899999999999984 6799999999999999999999999999988888888887655 488
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCH
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSA 587 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa 587 (720)
+.+|.++..+|..|+..|++.||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 7899999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=370.75 Aligned_cols=251 Identities=28% Similarity=0.539 Sum_probs=212.3
Q ss_pred CCCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh-----------------cCCE
Q 005007 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----------------VDDH 409 (720)
Q Consensus 347 ~~~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-----------------~~~~ 409 (720)
.......+.|++.+.||.|.-++||+|+.+.++..||||++++.........+.++... .+..
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 34566778999999999999999999999999999999999877655443333333321 3678
Q ss_pred EEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
+|+||.||.+|++.++|+.. ...+.|..|..|++++|+||.|||.+|.||||||+.||||+.+|.|||+|||.+-.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999999999865 34599999999999999999999999999999999999999999999999998755432
Q ss_pred cc----cc-ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc
Q 005007 489 LS----YE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 563 (720)
Q Consensus 489 ~~----~~-~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~ 563 (720)
.. .. .+++||++|||||++... ...|+.++||||||++..||.+|..||......+.+...+++.++.+.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~-----~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQ-----LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhc-----ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 21 12 567899999999997642 245899999999999999999999999999999888887777665433
Q ss_pred ----------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 564 ----------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 564 ----------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
.++..++.+|..||++||.+|||++++|+|+||+.....
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 256788999999999999999999999999999876543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=368.82 Aligned_cols=239 Identities=27% Similarity=0.454 Sum_probs=202.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhH---HHHHHHHh---------------hcCCEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKS---AECIKQLE---------------QVDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~---~~~ik~L~---------------~~~~~lyLVm 414 (720)
+|++.+.||+|+||+||+|++..+++.||||++..... .... ......+. +.++.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999874321 1111 11111111 1246689999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Cccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~ 493 (720)
||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 999999999999764 679999999999999999999999999999999999999999999999999997543 222334
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+......+|..++.++.+||
T Consensus 160 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 232 (323)
T cd05616 160 TFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 232 (323)
T ss_pred cCCCChhhcCHHHhcC-------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 5679999999999863 457889999999999999999999999888888888888888888999999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 005007 574 LRCFLRNPVERPS-----AVELLEHPFIRNANY 601 (720)
Q Consensus 574 ~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~ 601 (720)
.+||++||.+|++ ..++++|+||+...+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999997 489999999987554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.84 Aligned_cols=239 Identities=28% Similarity=0.494 Sum_probs=201.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChh------HHHHHHHHhh------------cCCEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPK------SAECIKQLEQ------------VDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~------~~~~ik~L~~------------~~~~lyLVm 414 (720)
+|++.+.||+|+||+||+|++..+++.||||++.... .... +.+.+..+.+ .++.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999886421 1111 1111111111 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Cccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~ 493 (720)
||++||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 999999999999764 679999999999999999999999999999999999999999999999999987532 222334
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+......+|..++.++.++|
T Consensus 160 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 232 (324)
T cd05587 160 TFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232 (324)
T ss_pred eecCCccccChhhhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 5679999999999873 457789999999999999999999999888888888888888888999999999999
Q ss_pred HHhhhcCCCCCCCH-----HHHHcCcccccccc
Q 005007 574 LRCFLRNPVERPSA-----VELLEHPFIRNANY 601 (720)
Q Consensus 574 ~~cL~~dP~kRPTa-----~ELL~Hpff~~~~~ 601 (720)
.+||.+||.+|+++ +++++||||+...+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999976 89999999987554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.64 Aligned_cols=241 Identities=24% Similarity=0.426 Sum_probs=196.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--h------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--P------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.|++.+.||+|+||+||+|.+..+|+.||||++...... . .+..++..+.. .++.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378999999999999999999999999999988643211 1 11222222221 3567899999
Q ss_pred eccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 999999998886532 4689999999999999999999999999999999999999999999999999987654444455
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH----HHHHHhccCCCCCccCCHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~----~i~ki~~~~~~iP~~ls~el~ 570 (720)
..||..|||||++.+ ..++.++|||||||++|||++|+.||....... ....+......++..++.++.
T Consensus 161 ~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 161 RVGTVGYMAPEVINN-------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred CCCCCCccCHhhhcC-------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 679999999999963 457889999999999999999999998654322 222233444566778999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 005007 571 DFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQ 602 (720)
Q Consensus 571 dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~ 602 (720)
+||++||+.||++|++ ++++++||||....+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 9999999999999997 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=367.92 Aligned_cols=240 Identities=30% Similarity=0.551 Sum_probs=199.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----Ch----hHHHHHHHHh-----------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DP----KSAECIKQLE-----------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~----~~~~~ik~L~-----------~~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|.+..+|+.||||+++.... .. .+.+.+..+. +.++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 479999999999999999999999999999999864211 10 1111121111 2367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
||+.|++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999775 679999999999999999999999999999999999999999999999999997654332
Q ss_pred --------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC
Q 005007 491 --------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 544 (720)
Q Consensus 491 --------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~ 544 (720)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCCCC
Confidence 2234569999999999874 3678899999999999999999999998
Q ss_pred CCcHHHHHHHhc--cCCCCCcc--CCHHHHHHHHHhhhcCCCCCCC-HHHHHcCccccccccc
Q 005007 545 FEGPQAMFKVLN--RTPPIPEM--LSSEGKDFLLRCFLRNPVERPS-AVELLEHPFIRNANYQ 602 (720)
Q Consensus 545 ~~~~~~i~ki~~--~~~~iP~~--ls~el~dLI~~cL~~dP~kRPT-a~ELL~Hpff~~~~~~ 602 (720)
....+...++.. ....+|.. +++++.+||.+||. ||.+|++ ++|+|+||||+...+.
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 887777777765 44444443 59999999999997 9999999 9999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=377.42 Aligned_cols=237 Identities=20% Similarity=0.372 Sum_probs=186.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh------------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ------------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~------------------~~~~ 409 (720)
...+|+++++||+|+||+||+|.+..+++.||||+++...... .++.+++.+.. ..++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3578999999999999999999999999999999986432211 12222222221 1356
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCC---------------
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG--------------- 473 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g--------------- 473 (720)
+|||||++ |++|.+++.+. +.+++..++.|+.||+.||+|||+ .|||||||||+||||+.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 89999998 78899988765 679999999999999999999998 5999999999999998765
Q ss_pred -CeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH
Q 005007 474 -VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 552 (720)
Q Consensus 474 -~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ 552 (720)
.+||+|||++.... ......+||+.|||||++.+ ..|+.++|||||||+||||++|++||...+..+.+.
T Consensus 285 ~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 285 CRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-------LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ceEEECCCCccccCc--cccccccCCccccCcHHhhc-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999886432 22345789999999999974 457889999999999999999999998766554433
Q ss_pred HHhccCCCCCc------------------------------------------cCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 005007 553 KVLNRTPPIPE------------------------------------------MLSSEGKDFLLRCFLRNPVERPSAVEL 590 (720)
Q Consensus 553 ki~~~~~~iP~------------------------------------------~ls~el~dLI~~cL~~dP~kRPTa~EL 590 (720)
.+......+|. ...+.+.|||.+||++||++|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 33211111110 013567799999999999999999999
Q ss_pred HcCcccccc
Q 005007 591 LEHPFIRNA 599 (720)
Q Consensus 591 L~Hpff~~~ 599 (720)
|+||||...
T Consensus 436 L~Hp~~~~~ 444 (467)
T PTZ00284 436 TTHPYVLKY 444 (467)
T ss_pred hcCcccccc
Confidence 999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=383.06 Aligned_cols=237 Identities=31% Similarity=0.562 Sum_probs=210.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH-------HHHHHHh-----------hcCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-------ECIKQLE-----------QVDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~-------~~ik~L~-----------~~~~~lyLVmE 415 (720)
++|.+.+.||+|+||+||+|+.+.|.+.||||.+.......++. ++...+. +...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47999999999999999999999999999999997655443222 2222221 23678999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+.| +|+.+|.+. +.++|+.++.++.|++.||.|||+++|+|||+||.||||+..|.+||||||+|+.+.... ....
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9985 999999765 789999999999999999999999999999999999999999999999999999876543 3346
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
+.|||.|||||++.+ ..|+..+|+||||||+|||++|++||...+..+.+..|+......|..++.+++.||+
T Consensus 160 ikGtPlYmAPElv~e-------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEE-------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQ 232 (808)
T ss_pred ccCcccccCHHHHcC-------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHH
Confidence 789999999999973 6789999999999999999999999999888899999999999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCcccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+|.+||.+|+|-.+++.|||++..
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999999754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=372.09 Aligned_cols=241 Identities=29% Similarity=0.488 Sum_probs=194.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-h----h---HHHHHHHHh-----------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-P----K---SAECIKQLE-----------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~----~---~~~~ik~L~-----------~~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|.++.+++.||||++...... . . +..++..+. +.++.+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999999999999999998642110 0 1 111122211 1256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
|||+||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999999999764 679999999999999999999999999999999999999999999999999987543210
Q ss_pred --------------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC
Q 005007 491 --------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 538 (720)
Q Consensus 491 --------------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG 538 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-------CCCCCchhhhhhHHHHHHHHhC
Confidence 1124579999999999863 4578899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhcc--CCCCCc--cCCHHHHHHHHHhhhcCCC---CCCCHHHHHcCcccccccccC
Q 005007 539 KPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPV---ERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 539 k~PF~~~~~~~~i~ki~~~--~~~iP~--~ls~el~dLI~~cL~~dP~---kRPTa~ELL~Hpff~~~~~~~ 603 (720)
+.||.+....+.+.++... ...+|. .+++++++||.+|+. +|+ .||+++||++||||+...+..
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 9999987777777777653 334453 478999999999775 444 458999999999998776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=366.22 Aligned_cols=240 Identities=29% Similarity=0.537 Sum_probs=194.8
Q ss_pred CeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCC--C-------hhHHHHHHHHhh------------cCCEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPD--D-------PKSAECIKQLEQ------------VDDHL 410 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~--~-------~~~~~~ik~L~~------------~~~~l 410 (720)
+|++++.||+|+||+||+|++. .+++.||||++..... . ..+.+++..+.. .++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 5789999998863211 1 111222222211 25668
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 9999999999999999764 579999999999999999999999999999999999999999999999999998653322
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHHHhccCCCCCcc
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPEM 564 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~ki~~~~~~iP~~ 564 (720)
.....+||+.|||||++.+ ...++.++|||||||++|||++|+.||.... .......+....+.+|..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233 (332)
T ss_pred CCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 2335679999999999863 2346789999999999999999999996432 223344455667778888
Q ss_pred CCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
++.++++||.+||+.||++|| +++++++||||+...+
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999999999999999 8899999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=368.93 Aligned_cols=235 Identities=30% Similarity=0.518 Sum_probs=197.3
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hh------HHHHHHHHh-----------hcCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PK------SAECIKQLE-----------QVDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~------~~~~ik~L~-----------~~~~~lyLVmEy~~gG 420 (720)
++||+|+||+||+|++..+|+.||||++...... .. +.++++.+. +.++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999998643211 11 111222221 1356789999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP 499 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GTp 499 (720)
+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+||+
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 999998654 6799999999999999999999999999999999999999999999999999876432 22334567999
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhc
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 579 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~ 579 (720)
.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+......+|..++.++.+||.+||++
T Consensus 160 ~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 160 EYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CccChhhhcC-------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCC
Confidence 9999999863 457889999999999999999999998877777777777777888999999999999999999
Q ss_pred CCCCCC-----CHHHHHcCccccccccc
Q 005007 580 NPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 580 dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
||++|+ ++.|+++|+||....+.
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=359.50 Aligned_cols=242 Identities=27% Similarity=0.454 Sum_probs=208.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----h---HHHHHHHHhh-----------cCCEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----K---SAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~---~~~~ik~L~~-----------~~~~lyL 412 (720)
...++|++.+.||+|.|++||+|.+..||+.+|+|+|+...... + ++++-..|++ .++..||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34568999999999999999999999999999999886543211 1 1222222221 3678899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~ 489 (720)
|+|+|.|++|..-|-.+ -.++|..+..+++|||++|.|||.+||||||+||+|+||.. ..-|||+|||+|..+.++
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999998777655 45899999999999999999999999999999999999954 346999999999999877
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccC
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML 565 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~l 565 (720)
.....++|||.|||||++. ...|+..+|||+.|||||.||.|.+||.+.+...++..|+.+...+| ..+
T Consensus 167 ~~~~G~~GtP~fmaPEvvr-------kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred cccccccCCCcccCHHHhh-------cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcC
Confidence 7778899999999999998 36789999999999999999999999999999999999998776665 468
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
++++++||++||..||.+|+|+.|+|+|||+.+..
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 99999999999999999999999999999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=370.95 Aligned_cols=240 Identities=30% Similarity=0.525 Sum_probs=196.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Ch-------hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DP-------KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~-------~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|++..+|+.||||++..... .. .+..++..+.+ .++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999999999999999864311 01 11222222221 356799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
||+.||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999999999764 579999999999999999999999999999999999999999999999999987542211
Q ss_pred -----------------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHH
Q 005007 491 -----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 535 (720)
Q Consensus 491 -----------------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyEL 535 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-------TGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-------CCCCCeeeeecchhHHHHh
Confidence 1113569999999999863 4578899999999999999
Q ss_pred hcCCCCCCCCCcHHHHHHHhccC--CCCCc--cCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccccc
Q 005007 536 LTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQ 602 (720)
Q Consensus 536 LTGk~PF~~~~~~~~i~ki~~~~--~~iP~--~ls~el~dLI~~cL~~dP~kRPT---a~ELL~Hpff~~~~~~ 602 (720)
++|.+||......+.+.+++... ..+|. .+++++++||.+||. +|.+|++ +.|+|+||||+...+.
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 99999999887777766666432 33343 478999999999997 8999997 9999999999876654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=359.62 Aligned_cols=241 Identities=24% Similarity=0.477 Sum_probs=190.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.++|++.+.||+|+||+||+|+++.+++.||||++....... +++.+++.+.+ .++.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999999999999999987543221 12222333221 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 996 7888888776677999999999999999999999999999999999999999999999999998754322 22234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH-HHHHHh---ccCC--------C--
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVL---NRTP--------P-- 560 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~-~i~ki~---~~~~--------~-- 560 (720)
..||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+..... .+..+. .... .
T Consensus 163 ~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 163 EVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 568999999999863 3457889999999999999999999998754432 222221 1000 0
Q ss_pred ----------CC---------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 561 ----------IP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 561 ----------iP---------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+ ..+++++++||.+||+.||++|||+.|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 01356889999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=365.94 Aligned_cols=234 Identities=29% Similarity=0.517 Sum_probs=197.3
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CCh---hHHHHHHHHh---------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDP---KSAECIKQLE---------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~---~~~~~ik~L~---------------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|+++.+++.||||+++... ... ....++..+. ...+.+||||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999886321 111 1111111111 125678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-CccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t~~GT 498 (720)
|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........||
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 9999998765 679999999999999999999999999999999999999999999999999987542 22233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++++||.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 160 PDYIAPEILQE-------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred ccccCHHHHcC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999863 45788999999999999999999999988888888888888888899999999999999999
Q ss_pred cCCCCCCCH------HHHHcCcccccccc
Q 005007 579 RNPVERPSA------VELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa------~ELL~Hpff~~~~~ 601 (720)
+||++|+++ +++++||||+...+
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999998 99999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=372.77 Aligned_cols=246 Identities=27% Similarity=0.461 Sum_probs=210.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--------hhHHHHHHHHhh-----------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--------~~~~~~ik~L~~-----------~~~~ly 411 (720)
...+.|++++.||.|.-|+||+|+.+.++..+|+|+++..... ..+.+++..+.+ .++.+|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 3456899999999999999999999999999999999743221 112223333222 367899
Q ss_pred EEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc---
Q 005007 412 IYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--- 487 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~--- 487 (720)
+|||||+||+|..+.+++ .+.|+|..++.|+.+++.||+|||-.|||+|||||+||||.++|+|.|+||.|+....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999765 5679999999999999999999999999999999999999999999999999874220
Q ss_pred -------------------------------C-c----------------------cccccccCCCCCCChHHHHHhhhc
Q 005007 488 -------------------------------G-L----------------------SYELSLKGSPNWMAPEVIKAVMQK 513 (720)
Q Consensus 488 -------------------------------~-~----------------------~~~~t~~GTp~YmAPEvl~g~~~~ 513 (720)
. . ...++++||-.|+|||+|.|
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G---- 309 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG---- 309 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec----
Confidence 0 0 11235789999999999985
Q ss_pred CCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc--cCCHHHHHHHHHhhhcCCCCCCC----H
Q 005007 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPS----A 587 (720)
Q Consensus 514 ~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~--~ls~el~dLI~~cL~~dP~kRPT----a 587 (720)
...+.++|+|.|||+|||||+|+.||.+.+..+.+.+|+.....+|+ .++..++|||+++|.+||.+|.. |
T Consensus 310 ---~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 310 ---EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred ---CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 44678999999999999999999999999999999999999988886 46889999999999999999998 9
Q ss_pred HHHHcCcccccccccC
Q 005007 588 VELLEHPFIRNANYQN 603 (720)
Q Consensus 588 ~ELL~Hpff~~~~~~~ 603 (720)
+||.+||||+..+|.-
T Consensus 387 ~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 387 AEIKRHPFFEGVNWAL 402 (459)
T ss_pred HHhhcCccccCCChhh
Confidence 9999999999999873
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=382.62 Aligned_cols=240 Identities=40% Similarity=0.634 Sum_probs=204.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~lyLVm 414 (720)
....|...++||+|.||.||+|.+..+++.||||++++........ +.+..|.+ .+..++|+|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3457888899999999999999999999999999998765444321 12222222 144578999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~ 493 (720)
|||.||++.++++- +..+.|..+..++++++.||.|||.++.+|||||+.||||..+|.|||+|||.+..+.... ...
T Consensus 91 ey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999964 3556999999999999999999999999999999999999999999999999998876544 337
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
+++|||+||||||+.+ ..|+.++||||||++.|||++|.+||.....+..++.|-+. .+.+...+++.+++|
T Consensus 170 tfvGTPfwMAPEVI~~-------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ-------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred cccccccccchhhhcc-------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence 8999999999999983 46888999999999999999999999998887666666544 444556789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|..||++||+.||+|.+||+|.|++..
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 999999999999999999999999873
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.68 Aligned_cols=241 Identities=27% Similarity=0.526 Sum_probs=221.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.-|.+.+.||+|-|++|.+|++..||..||||+|+..+.+. .+++|++.+++ ....+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 46899999999999999999999999999999998655332 34555555443 2567999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee-cCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-DASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL-d~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
+-++|+|++||.++...+.|+.+++|++||+.|+.|||+..||||||||+|+++ .+-|.|||.|||++..+..+....+
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 999999999999998899999999999999999999999999999999999876 5679999999999999999999999
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.||+..|-|||++.| +.+..+++||||||||||.|++|++||...++-+.+..|+...+.+|..++.+++|||.
T Consensus 178 sCGSLAYSAPEILLG------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLG------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ 251 (864)
T ss_pred ccchhhccCchhhhc------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence 999999999999996 56778899999999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.||..||++|.+.+||..|+|++...
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999999999999998765
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=364.53 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=200.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhH-HHHHHHHh--------------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKS-AECIKQLE--------------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~-~~~ik~L~--------------~~~~~lyLVm 414 (720)
++|++.+.||+|+||+||+|.++.+|+.||||+++.... .... .+++..+. ..++.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999874321 1111 11111111 1256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
||++||+|.+++.+....+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99999999999987657899999999999999999999999999999999999999999999999999986643322 2
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCc--cCCHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSE 568 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~--~ls~e 568 (720)
....||+.|+|||++...... +...++.++|||||||++|||++|+.||........+.+++.. ...+|. .++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred ecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 235699999999998642211 1345788999999999999999999999887777777766543 233343 57899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
+.+||.+||. +|.+|||++++++||||....+..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 9999999998 999999999999999998765543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=362.66 Aligned_cols=230 Identities=30% Similarity=0.505 Sum_probs=195.1
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCC--CChh------HHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPK------SAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~------~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
||+|+||+||+|.+..+++.||||+++... .... +..++..+.+ .++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986321 1111 1112222211 25678999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCCCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNW 501 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GTp~Y 501 (720)
.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 9999764 6799999999999999999999999999999999999999999999999999976432 2233456799999
Q ss_pred CChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCC
Q 005007 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 581 (720)
Q Consensus 502 mAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP 581 (720)
+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+......+|..+++++++||.+||..||
T Consensus 160 ~aPE~~~~-------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 160 LAPELLLG-------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred CCHHHHcC-------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCH
Confidence 99999863 45788999999999999999999999988877888888888888899999999999999999999
Q ss_pred CCCC---CHHHHHcCcccccc
Q 005007 582 VERP---SAVELLEHPFIRNA 599 (720)
Q Consensus 582 ~kRP---Ta~ELL~Hpff~~~ 599 (720)
++|| ++.|+|+||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.34 Aligned_cols=237 Identities=25% Similarity=0.455 Sum_probs=190.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
..+|++.++||+|+||+||+|++..++..||||+++...... +++.++..+.+ .++.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999999999999999987533211 22233333322 2457899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 997 59999987765668999999999999999999999999999999999999999999999999997643222 2234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..|++.|+|||++.+ ...++.++|||||||++|||++|++||.+....+.+..+....
T Consensus 163 ~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 163 EVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 568999999999863 3457889999999999999999999998776655544432110
Q ss_pred ---CCC-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 ---PPI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ---~~i-----------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..+ ...++.++++||.+||+.||.+|||++|+|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001 12467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=363.57 Aligned_cols=234 Identities=29% Similarity=0.554 Sum_probs=195.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChh-HHHHHHHHh---------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK-SAECIKQLE---------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~-~~~~ik~L~---------------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|+++.+|+.||||+++... .... ...+...+. +.++++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999986421 1111 111111111 135678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-CccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t~~GT 498 (720)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 9999999764 679999999999999999999999999999999999999999999999999987532 22233457799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....+.+|..++.++++||.+||.
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 160 PDYIAPEILQG-------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred cCccCHHHHcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999873 45788999999999999999999999887777777777777788888999999999999999
Q ss_pred cCCCCCCCH-HHHHcCcccccccc
Q 005007 579 RNPVERPSA-VELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa-~ELL~Hpff~~~~~ 601 (720)
.||++|+++ +++++||||+...+
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCCCCH
Confidence 999999998 58999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=363.92 Aligned_cols=234 Identities=29% Similarity=0.496 Sum_probs=197.5
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Ch------hHHHHHHHHh------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DP------KSAECIKQLE------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~------~~~~~ik~L~------------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|++..+++.||||+++.... .. .+.+++..+. +.++.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999864211 11 1111111111 125678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|..++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 9999999765 6799999999999999999999999999999999999999999999999999875432 2233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++.+||.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 160 PDYIAPEILQE-------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred ccccCHHHHcC-------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999863 45788999999999999999999999988888888888888888888999999999999999
Q ss_pred cCCCCCC-------CHHHHHcCcccccccc
Q 005007 579 RNPVERP-------SAVELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRP-------Ta~ELL~Hpff~~~~~ 601 (720)
+||++|+ ++.++++||||....+
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 9999999 9999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=365.25 Aligned_cols=235 Identities=30% Similarity=0.496 Sum_probs=196.7
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Chh---HHHHHHHHhh--------------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPK---SAECIKQLEQ--------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~---~~~~ik~L~~--------------~~~~lyLVmEy~~gG 420 (720)
++||+|+||+||+|.+..+|+.||||+++.... ... ...+++.+.. .++.+||||||+.||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999864211 111 1111122211 256799999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
+|..++... ..+++..++.|+.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.... ........||
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 999988654 679999999999999999999997 7999999999999999999999999999875432 2233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|||||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 160 PEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cccCCHHHHcc-------CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999863 45788999999999999999999999887777777777777888899999999999999999
Q ss_pred cCCCCCC-----CHHHHHcCccccccccc
Q 005007 579 RNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 579 ~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
.||++|+ ++.++|+|+||....+.
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999997 99999999999875443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.01 Aligned_cols=237 Identities=30% Similarity=0.533 Sum_probs=200.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChh-H---HHHHHHHh--------------hcCCEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK-S---AECIKQLE--------------QVDDHLYIY 413 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~-~---~~~ik~L~--------------~~~~~lyLV 413 (720)
|++.+.||+|+||+||+|.+..+|+.||||+++... .... . .+++..+. ...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999986421 1111 1 11111111 125678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-cccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~ 492 (720)
|||+.||+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999988854 5699999999999999999999999999999999999999999999999999875432 2233
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
...+||+.|||||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 231 (324)
T cd05589 159 STFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISI 231 (324)
T ss_pred cccccCccccCHhHhcC-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 45779999999999863 45788999999999999999999999988877788888888888899999999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 573 LLRCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 573 I~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
|.+||+.||.+|| ++.++++|+||++..+
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999999999999 7999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=368.96 Aligned_cols=240 Identities=27% Similarity=0.475 Sum_probs=202.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCC-cEEEEEEeccCCC----C-h---hHHHHHHHHhh-----------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPD----D-P---KSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg-~~VAVK~l~~~~~----~-~---~~~~~ik~L~~-----------~~~~ly 411 (720)
..++|++.+.||+|+||.||+|.+..++ ..||||++..... . . .+..++..+.+ .++.+|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3458999999999999999999877655 6899998853211 1 1 11222222221 256789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999999999765 67999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
....+||+.|||||++.+ ..++.++|||||||++|||++|++||...+....+.++......+|..+++++++
T Consensus 185 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257 (340)
T ss_pred cceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 245679999999999973 4567899999999999999999999998877777888888888889999999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 572 FLLRCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 572 LI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
+|++||+.||++|+ +++|+++||||++..+
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999999995 8999999999987654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=352.30 Aligned_cols=235 Identities=25% Similarity=0.449 Sum_probs=187.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHh-----------hcCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLE-----------QVDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~-----------~~~~~lyLVmE 415 (720)
++|++.+.||+|+||+||+|+++.+++.||||+++...... .+++.+..+. ..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999887543211 1222222221 13567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YEL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~ 493 (720)
|+.++.|..+. +....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99987666554 444679999999999999999999999999999999999999999999999999998764322 223
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------------- 560 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~------------- 560 (720)
...||+.|+|||++.+ ..++.++|||||||++|||++|++||......+....+......
T Consensus 160 ~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 160 EYVATRWYRSPELLLG-------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccccccccCCcHHHcC-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 4578999999999863 34788999999999999999999999876654443332211100
Q ss_pred ------C-------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 561 ------I-------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 561 ------i-------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
. ...++.++++||++||++||++|||++|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=363.08 Aligned_cols=233 Identities=32% Similarity=0.576 Sum_probs=195.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChh-HHHHHHHHh---------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK-SAECIKQLE---------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~-~~~~ik~L~---------------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|++..+++.||||+++... .... .......+. +.++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999886421 1111 111111111 135678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 9999999764 6799999999999999999999999999999999999999999999999999976432 2333456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....+.+|..++.++.+||.+||.
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 160 PDYIAPEILKG-------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred ccccCHHHHcC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999863 45788999999999999999999999988877777788788888899999999999999999
Q ss_pred cCCCCCCCH-HHHHcCccccccc
Q 005007 579 RNPVERPSA-VELLEHPFIRNAN 600 (720)
Q Consensus 579 ~dP~kRPTa-~ELL~Hpff~~~~ 600 (720)
.||.+|+++ .++++|+||....
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCHHHcCCChHHHHcCcccCCCC
Confidence 999999986 5899999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=362.17 Aligned_cols=242 Identities=31% Similarity=0.598 Sum_probs=201.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhhc------------CC-----
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQV------------DD----- 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~~------------~~----- 408 (720)
...|..+++||+|+||+||+|+++.+|+.||+|++....++ ..++-+++.|.+. ++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34688889999999999999999999999999999876553 2233344444331 22
Q ss_pred -EEEEEEEeccCCCHHHHHHHhc---CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 409 -HLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 409 -~lyLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.+|+||||++ .+|.+++.... ..++...++.|++||+.||+|||+++|+||||||+||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 7899999997 89999998764 368889999999999999999999999999999999999999999999999999
Q ss_pred hcc-CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CC--
Q 005007 485 HLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TP-- 559 (720)
Q Consensus 485 ~~~-~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~-- 559 (720)
.+. +.......++|.||+|||++.| ...|+..+||||+|||++||+++++-|.+....+.+..|... .+
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlG------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLG------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcC------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 776 4444566789999999999986 456889999999999999999999999998888888777531 00
Q ss_pred --------------CCCc------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 560 --------------PIPE------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 560 --------------~iP~------------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.++. ....++.+++.+||+.+|.+|.+++.+|+|+||.....
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 1111 12358899999999999999999999999999987643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=364.99 Aligned_cols=235 Identities=31% Similarity=0.514 Sum_probs=197.5
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Ch------hHHHHHHHHh-----------hcCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DP------KSAECIKQLE-----------QVDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~------~~~~~ik~L~-----------~~~~~lyLVmEy~~gG 420 (720)
++||+|+||+||+|.+..+|+.||||+++.... .. .+.++++.+. ..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 479999999999999999999999999864211 11 1112222221 1356799999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP 499 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GTp 499 (720)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 999988664 6799999999999999999999999999999999999999999999999999876432 22234567999
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhc
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 579 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~ 579 (720)
.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..+++++++||.+||+.
T Consensus 160 ~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 160 EYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CcCCcccccC-------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence 9999999863 457889999999999999999999998877777777777777888999999999999999999
Q ss_pred CCCCCC-----CHHHHHcCccccccccc
Q 005007 580 NPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 580 dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
||++|+ ++.++++|+||....+.
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999998 89999999999875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=364.48 Aligned_cols=243 Identities=29% Similarity=0.473 Sum_probs=215.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--------H-----------HHHHHHHhhcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--------S-----------AECIKQLEQVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--------~-----------~~~ik~L~~~~~~lyLVm 414 (720)
++|..+++||+|.||+|.+|+.+.+|+.||||+++......+ + ...++.-.+.++++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 578999999999999999999999999999998864321110 0 112333445689999999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~~~~ 493 (720)
||..||.|+.+|.. .+.++|..++.|..+|+.||.|||+++||.||||.+|+|||++|++||+|||+++.- ..+....
T Consensus 248 eyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 248 EYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred EEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 99999999999965 478999999999999999999999999999999999999999999999999999864 4556778
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
++||||.|+|||++. +..|+.++|+|.+|||||||++|++||...+....+..|+.....+|..++++++.||
T Consensus 327 TFCGTPEYLAPEVle-------DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLE-------DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred cccCChhhcCchhhc-------cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 999999999999997 4679999999999999999999999999988888888999999999999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHcCcccccccccCC
Q 005007 574 LRCFLRNPVERP-----SAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 574 ~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~~l 604 (720)
..+|.+||.+|. .+.||.+|+||...+|+.+
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 999999999996 5899999999999887643
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=361.61 Aligned_cols=239 Identities=27% Similarity=0.477 Sum_probs=201.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChh------HHHHHHHHh------------hcCCEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPK------SAECIKQLE------------QVDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~------~~~~ik~L~------------~~~~~lyLVm 414 (720)
+|+..+.||+|+||+||+|+++.+|+.||||++.... .... +..++..+. +.++.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999886421 1111 111111111 1256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~ 493 (720)
||++||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 999999999999764 67999999999999999999999999999999999999999999999999998764322 2334
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+..+......+|..++.++.++|
T Consensus 160 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 232 (323)
T cd05615 160 TFCGTPDYIAPEIIAY-------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232 (323)
T ss_pred CccCCccccCHHHHcC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 5679999999999863 357889999999999999999999999888878888888888888999999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 005007 574 LRCFLRNPVERPS-----AVELLEHPFIRNANY 601 (720)
Q Consensus 574 ~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~ 601 (720)
.+||+++|.+|++ .+++++|+||+...+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 9999999999997 589999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=369.40 Aligned_cols=238 Identities=29% Similarity=0.488 Sum_probs=190.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Ch------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.|++++.||+|+||+||+|++..+++.||||++..... .. .+.+++..+.. .++++|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999864221 11 11122222221 2567999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc------
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL------ 489 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~------ 489 (720)
|++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999764 67999999999999999999999999999999999999999999999999997533100
Q ss_pred ------------------------------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccc
Q 005007 490 ------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 527 (720)
Q Consensus 490 ------------------------------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWS 527 (720)
......+||+.|||||++.+ ..++.++||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DiwS 233 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-------KGYTQLCDWWS 233 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-------CCCCCccceee
Confidence 01124579999999999863 45788999999
Q ss_pred hhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCc--cCCHHHHHHHHHhhh--cCCCCCCCHHHHHcCccccccc
Q 005007 528 LGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE--MLSSEGKDFLLRCFL--RNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 528 LG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~--~ls~el~dLI~~cL~--~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|||++|||++|+.||......+...++.. ....+|. .+++++++||.+||. .++..|+++.|+++||||+...
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 99999999999999988776666666553 2334443 579999999999654 4555699999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=360.71 Aligned_cols=238 Identities=29% Similarity=0.502 Sum_probs=196.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++++.||+|+||.||+|.+..+++.||||+++..... .....++..+.. .++.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998643110 111112222221 256799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||++||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 999999999999754 6799999999999999999999999999999999999999999999999999976544 3345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCc------cCC
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE------MLS 566 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~------~ls 566 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+.... ...|. .++
T Consensus 158 ~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 158 VVGSPDYMAPEVLRG-------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred cccCccccChhHhcC-------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 679999999999873 367889999999999999999999998877666655554321 12222 468
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
+++.+||.+||..+|.+|+++.|+++||||....+
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 99999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=377.75 Aligned_cols=242 Identities=27% Similarity=0.504 Sum_probs=194.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhhc-------------------CCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQV-------------------DDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~~-------------------~~~lyL 412 (720)
..+|+++++||+|+||+||+|.+..+++.||||++...... ..++.+++.+.+. ...+++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 45899999999999999999999999999999988543221 2233344443221 124679
Q ss_pred EEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccC
Q 005007 413 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTG 488 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~ 488 (720)
||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.+..
T Consensus 145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 999997 577777643 346799999999999999999999999999999999999998665 799999999988765
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------- 558 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------- 558 (720)
........||+.|||||++.+ ...|+.++|||||||+||||++|.+||.+....+.+.+++...
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred CCCcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 555566789999999999864 3457889999999999999999999998876655554443210
Q ss_pred -------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 559 -------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 559 -------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
..+|...++++++||.+||++||.+|+|+.|+|+||||+....
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0134457889999999999999999999999999999986543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=364.49 Aligned_cols=241 Identities=29% Similarity=0.515 Sum_probs=197.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHhhc-------------------C
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQV-------------------D 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~~~-------------------~ 407 (720)
....+|...+.||+|+||+|+.|.++.||+.||||++..... ..+..++++.|.+. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344577778999999999999999999999999998863222 22233444444331 2
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
+.+|+|+|+|+ .||..+|+.. ..|++..++.++.|||+||+|+|+.+|+||||||.|||++.+..+||||||+|+...
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 45899999994 8999999764 559999999999999999999999999999999999999999999999999999875
Q ss_pred C---ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--------
Q 005007 488 G---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-------- 556 (720)
Q Consensus 488 ~---~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-------- 556 (720)
. ......++.|.||+|||++.. ...|+.++||||+||||.|||+|++-|.+.+....+..|+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLN------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhc------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 3 444566788999999999974 35689999999999999999999999988766555554432
Q ss_pred ---------------cCCCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 557 ---------------RTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 557 ---------------~~~~iP--------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
..+..| ...++++.|||.+||..||.+|+|++|+|+|||+...
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 111111 2468999999999999999999999999999999754
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=357.22 Aligned_cols=234 Identities=29% Similarity=0.512 Sum_probs=194.7
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhH---HHH----HHHHh-----------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKS---AEC----IKQLE-----------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~---~~~----ik~L~-----------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|++..+++.||||++..... .... ... ++.+. ...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999863211 1111 111 11111 125678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|..++... ..+.+..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .......+||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 9999988654 6799999999999999999999999999999999999999999999999999875422 2233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+......+|...+.++.++|.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 160 PEYLAPEVLRK-------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cccCCHHHhcC-------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999863 45788999999999999999999999988777777888888888888899999999999999
Q ss_pred cCCCCCCCH----HHHHcCcccccccc
Q 005007 579 RNPVERPSA----VELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa----~ELL~Hpff~~~~~ 601 (720)
+||.+|+++ .|+++|+||....+
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 999999875 59999999976544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=369.07 Aligned_cols=238 Identities=30% Similarity=0.509 Sum_probs=192.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Ch-------hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DP-------KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~-------~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|+++++||+|+||+||+|++..+++.||||++..... .. .+.+++..+.. .++.+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 369999999999999999999999999999998864211 00 11122222211 256799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL----- 489 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~----- 489 (720)
|||+||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 81 DYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999999999764 67999999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCcccccc
Q 005007 490 -------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 526 (720)
Q Consensus 490 -------------------------------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVW 526 (720)
......+||+.|||||++.+ ..++.++|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Diw 232 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWW 232 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-------CCCCCeeeEE
Confidence 01123579999999999863 4578899999
Q ss_pred chhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCcccccc
Q 005007 527 SLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNA 599 (720)
Q Consensus 527 SLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP--~~ls~el~dLI~~cL~~dP~kRPT---a~ELL~Hpff~~~ 599 (720)
||||+||||++|++||...+..+...++... ...+| ..++++++++|.+|+ .+|++|++ ++|+++||||+..
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999999999999987776666666543 23333 457999999999976 59999987 9999999999765
Q ss_pred c
Q 005007 600 N 600 (720)
Q Consensus 600 ~ 600 (720)
.
T Consensus 312 ~ 312 (382)
T cd05625 312 D 312 (382)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=361.24 Aligned_cols=234 Identities=29% Similarity=0.517 Sum_probs=196.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHH---HHH----HHHhh-----------cCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSA---ECI----KQLEQ-----------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~---~~i----k~L~~-----------~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|++..+|+.||||++..... ..... ... +.+.+ .++.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999864211 11111 111 11111 25678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .......+||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 9999999764 6799999999999999999999999999999999999999999999999999876432 2233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......++..++.++.++|.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 160 PEYLAPEVLRK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred hhhcChhhhcC-------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999863 45788999999999999999999999988777778888888778888899999999999999
Q ss_pred cCCCCCCCH----HHHHcCcccccccc
Q 005007 579 RNPVERPSA----VELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa----~ELL~Hpff~~~~~ 601 (720)
.||.+||++ .|+++||||....+
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999987 69999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=360.33 Aligned_cols=243 Identities=32% Similarity=0.514 Sum_probs=190.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHh-----------hcCCEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLE-----------QVDDHLYIY 413 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~-----------~~~~~lyLV 413 (720)
....+|++++.||+|+||+||+|.+..+++.||||++........ ++++++.+. ..++.+|+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 345689999999999999999999999999999999864432211 112222221 135678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~ 492 (720)
|||+++|+|... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... ..
T Consensus 151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 999999998643 346788889999999999999999999999999999999999999999999998664322 22
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH---HHHHHH-hccCCCCCccCCHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKV-LNRTPPIPEMLSSE 568 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---~~i~ki-~~~~~~iP~~ls~e 568 (720)
....||..|+|||++..... ....++.++|||||||+||||++|+.||...... ..+..+ .......+..++.+
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLN--HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccCccccCccccccccc--cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 35679999999998753211 1234567899999999999999999999743221 222222 23344566788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+++||.+||..||++|||+.|+|+|+||....
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999999999999998653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=368.51 Aligned_cols=240 Identities=28% Similarity=0.506 Sum_probs=192.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Chh-------HHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPK-------SAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~-------~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|.+..+++.||||++..... ... +.+++..+.+ .++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999998853211 011 1111111111 256799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
||++||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999999999764 679999999999999999999999999999999999999999999999999986432100
Q ss_pred --------------------------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCcccccc
Q 005007 491 --------------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 526 (720)
Q Consensus 491 --------------------------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVW 526 (720)
.....+||+.|+|||++.+ ..++.++|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Diw 232 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-------QGYGQECDWW 232 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-------CCCCCceeeE
Confidence 0012569999999999863 4578899999
Q ss_pred chhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCc--cCCHHHHHHHHHhhhcCCCCC---CCHHHHHcCcccccc
Q 005007 527 SLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE--MLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNA 599 (720)
Q Consensus 527 SLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~--~ls~el~dLI~~cL~~dP~kR---PTa~ELL~Hpff~~~ 599 (720)
||||+||||++|++||......+.+..+.. ....+|. .++.++++||.+||. +|.+| +++.|+|+||||+..
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999999999988776666666654 2334454 478999999999998 77765 599999999999876
Q ss_pred ccc
Q 005007 600 NYQ 602 (720)
Q Consensus 600 ~~~ 602 (720)
.+.
T Consensus 312 ~~~ 314 (377)
T cd05629 312 DWD 314 (377)
T ss_pred CHH
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.63 Aligned_cols=235 Identities=30% Similarity=0.516 Sum_probs=189.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCCCCh-------hHHHHHHHHhh-------------------c
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDP-------KSAECIKQLEQ-------------------V 406 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~-tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-------------------~ 406 (720)
.+|++.+.||+|+||+||+|.+.. +++.||||.++...... .+..+++.+.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 46889999887543221 12223333321 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 407 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
+..+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 245899999996 6899998654 24589999999999999999999999999999999999999999999999999987
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-----C
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----P 560 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-----~ 560 (720)
...........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+.+.+++.... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ccCCcccccccccccccChHHHhC-------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 655444455679999999999863 4577899999999999999999999998777666666543110 0
Q ss_pred ----------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 561 ----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 561 ----------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+...+++.+++||.+||+.||++|||+.|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112367888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=366.00 Aligned_cols=238 Identities=31% Similarity=0.503 Sum_probs=192.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----Ch---hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DP---KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~---~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|++..+++.||||++..... .. .+++++..+.. .++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999998853211 01 11222222221 357899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL----- 489 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~----- 489 (720)
|||+||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999999999765 67999999999999999999999999999999999999999999999999997532100
Q ss_pred ---------------------------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhh
Q 005007 490 ---------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 530 (720)
Q Consensus 490 ---------------------------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~ 530 (720)
......+||+.|||||++.+ ..++.++|||||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGv 232 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWWSVGV 232 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-------CCCCcceeeeeccc
Confidence 00123579999999999863 45788999999999
Q ss_pred hHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCccccccc
Q 005007 531 TVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNAN 600 (720)
Q Consensus 531 vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP--~~ls~el~dLI~~cL~~dP~kRP---Ta~ELL~Hpff~~~~ 600 (720)
++|||++|+.||......+...++... ...+| ..++.++.+||.+|+ .+|.+|+ ++.|+++||||+...
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999999999887766665555532 22333 357899999999976 5999999 999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.68 Aligned_cols=234 Identities=27% Similarity=0.502 Sum_probs=190.9
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh-------HHHHHHHHhh------------cCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK-------SAECIKQLEQ------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~-------~~~~ik~L~~------------~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|++..+++.||||+++..... .. +..++..+.. .++.+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999998743211 11 1111222211 25678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~~~~t~~GT 498 (720)
|+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.. .........+||
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 9999998664 67999999999999999999999999999999999999999999999999998753 223334457899
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC--------c-HHHHHHHhccCCCCCccCCHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------G-PQAMFKVLNRTPPIPEMLSSEG 569 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~--------~-~~~i~ki~~~~~~iP~~ls~el 569 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||.... . ......+......+|..++.++
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 232 (329)
T cd05588 160 PNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232 (329)
T ss_pred ccccCHHHHcC-------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999863 457789999999999999999999996321 1 1234445666778899999999
Q ss_pred HHHHHHhhhcCCCCCCC------HHHHHcCcccccccc
Q 005007 570 KDFLLRCFLRNPVERPS------AVELLEHPFIRNANY 601 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPT------a~ELL~Hpff~~~~~ 601 (720)
.++|.+||+.||.+|++ ++++++||||....+
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999999999987 799999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=363.98 Aligned_cols=241 Identities=29% Similarity=0.507 Sum_probs=195.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----Ch-h---HHHHHHHHh-----------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DP-K---SAECIKQLE-----------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~-~---~~~~ik~L~-----------~~~~~lyLVm 414 (720)
++|++.+.||+|+||+||+|.++.+++.||||+++.... .. . +..++..+. +.++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999863211 00 1 111122221 1256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
|||+||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999999999764 679999999999999999999999999999999999999999999999999987542110
Q ss_pred --------------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC
Q 005007 491 --------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 538 (720)
Q Consensus 491 --------------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG 538 (720)
.....+||+.|||||++.+ ..++.++|||||||++|||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-------CCCCCcceeccccceeeecccC
Confidence 0124579999999999863 4578899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhcc--CCCCCc--cCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCcccccccccC
Q 005007 539 KPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANYQN 603 (720)
Q Consensus 539 k~PF~~~~~~~~i~ki~~~--~~~iP~--~ls~el~dLI~~cL~~dP~kRP---Ta~ELL~Hpff~~~~~~~ 603 (720)
++||........+.++... ...+|. .+++++++||.+|+. ||.+|+ +++|+++||||+...+..
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 9999987777777776642 233443 378999999999874 999998 589999999999876554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=358.79 Aligned_cols=234 Identities=30% Similarity=0.574 Sum_probs=195.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChh-HHHHHHHHh---------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK-SAECIKQLE---------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~-~~~~ik~L~---------------~~~~~lyLVmEy~~g 419 (720)
+.||+|+||+||+|++..+++.||||+++... .... .......+. ..++.+||||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999986431 1111 111111111 125678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-CccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t~~GT 498 (720)
|+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 9999999764 679999999999999999999999999999999999999999999999999987532 22233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....+.+|..++.++++||.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 160 PDYIAPEILLG-------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred ccccCHHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhc
Confidence 99999999863 45788999999999999999999999887777777777666677888899999999999999
Q ss_pred cCCCCCCCHH-HHHcCcccccccc
Q 005007 579 RNPVERPSAV-ELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa~-ELL~Hpff~~~~~ 601 (720)
.||++|+++. ++++||||+...+
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred cCHhhcCCChHHHHcCcccCCCCH
Confidence 9999999996 9999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=364.84 Aligned_cols=245 Identities=29% Similarity=0.492 Sum_probs=200.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CCh------hHHHHHHHHh-----------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDP------KSAECIKQLE-----------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~------~~~~~ik~L~-----------~~~~~lyL 412 (720)
...+|++.++||+|+||+||+|++..+++.||||++.... ... .+..+++.+. ..++.+||
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999999999999999986321 111 1122222222 12567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 9999999999999865 358999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCc--cCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~--~ls 566 (720)
.....+||+.|||||++.+.. ....++.++|||||||++|||++|++||........+.+++... ..+|. .++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred cCCCCCCCcCeECHHHhccCC---CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 223567999999999986421 12357889999999999999999999999887777777776532 34454 579
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccccc
Q 005007 567 SEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY 601 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~~ 601 (720)
.++++||.+||+.+|.+ |++++|+++||||+...+
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 99999999999999987 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.62 Aligned_cols=234 Identities=29% Similarity=0.509 Sum_probs=189.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh-------------------cCC
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ-------------------VDD 408 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~-------------------~~~ 408 (720)
+|++.+.||+|+||+||+|.++.+|+.||||+++..... ..+.++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999999999999999998753221 123333443321 023
Q ss_pred EEEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 409 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5799999997 58988886542 358999999999999999999999999999999999999999999999999998765
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-----C---
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----P--- 559 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-----~--- 559 (720)
.........||..|+|||++.+ ..++.++|||||||++|||++|++||........+.++.... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CcccCCCccccccccCchHhhC-------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 4444445678999999999863 457889999999999999999999998776655554443210 0
Q ss_pred -------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 -------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 -------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+...++.++++||.+||+.||++|||+.|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=357.53 Aligned_cols=235 Identities=31% Similarity=0.520 Sum_probs=196.8
Q ss_pred eeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCC---CCh------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 359 GKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIP---DDP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~---~~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
+++||+|+||+||+|++. .+++.||||+++... ... .+.++++.+.+ .++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 578999999986421 111 11222222221 3567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-cccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t 494 (720)
|+.||+|.+++... +.+.+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 99999999999764 6789999999999999999999999999999999999999999999999999875432 233345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
..||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+....+.++......+|..+++++.+||.
T Consensus 160 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 232 (323)
T cd05584 160 FCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK 232 (323)
T ss_pred cCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 679999999999863 3467899999999999999999999998888788888888888889999999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 575 RCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 575 ~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
+||++||++|+ +++++++||||....+
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999 8999999999976543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=360.48 Aligned_cols=232 Identities=30% Similarity=0.485 Sum_probs=191.6
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhH------HHHHHHHh--------------hcCCEEEEEEEeccC
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKS------AECIKQLE--------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~------~~~ik~L~--------------~~~~~lyLVmEy~~g 419 (720)
||+|+||+||+|++..+++.||||++..... .... ..++..+. +.++.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999853211 1111 11111111 124678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-CccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t~~GT 498 (720)
|+|.+++.+. +.+++..++.|+.||++||.|||++||+||||||+||||+.++.+||+|||+++... ........+||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 9999998764 679999999999999999999999999999999999999999999999999987543 23334467799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc-cCCHHHHHHHHHhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCF 577 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~-~ls~el~dLI~~cL 577 (720)
+.|||||++.+ ...++.++|||||||++|||++|+.||...+..+.+..+......+|. .+++++++||++||
T Consensus 160 ~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 160 TEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred ccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 99999999863 234788999999999999999999999887777777777766666664 47999999999999
Q ss_pred hcCCCCCC----CHHHHHcCccccccc
Q 005007 578 LRNPVERP----SAVELLEHPFIRNAN 600 (720)
Q Consensus 578 ~~dP~kRP----Ta~ELL~Hpff~~~~ 600 (720)
..||.+|| ++.++++||||....
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 99999998 799999999997644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.58 Aligned_cols=239 Identities=26% Similarity=0.493 Sum_probs=186.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhhc----------------CCEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQV----------------DDHLY 411 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~~----------------~~~ly 411 (720)
+|++.++||+|+||.||+|.+..+|..||||++....... .+++.+..+.+. ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999886432111 122222222210 12479
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
+|||||. ++|.+++... ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999995 7899998654 569999999999999999999999999999999999999999999999999997643221
Q ss_pred ---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh------------
Q 005007 491 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL------------ 555 (720)
Q Consensus 491 ---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~------------ 555 (720)
......||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+....+..+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcc-----ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 12345799999999998631 2457889999999999999999999997655433221110
Q ss_pred --------------ccCCCCC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 556 --------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 556 --------------~~~~~iP-----~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
......+ ..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0001111 13578899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.38 Aligned_cols=234 Identities=29% Similarity=0.519 Sum_probs=190.6
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHHHHHhh---------------cCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECIKQLEQ---------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~ik~L~~---------------~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|.+..+++.||||+++.... .... ..++..+.. .++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999875321 1111 111111111 25678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 9999988664 6799999999999999999999999999999999999999999999999999975422 2233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---------CcHHHHHHHhccCCCCCccCCHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---------EGPQAMFKVLNRTPPIPEMLSSEG 569 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---------~~~~~i~ki~~~~~~iP~~ls~el 569 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+......+|..++.++
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 232 (329)
T cd05618 160 PNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232 (329)
T ss_pred ccccCHHHHcC-------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHH
Confidence 99999999863 45778999999999999999999999521 111233445566778899999999
Q ss_pred HHHHHHhhhcCCCCCCC------HHHHHcCcccccccc
Q 005007 570 KDFLLRCFLRNPVERPS------AVELLEHPFIRNANY 601 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPT------a~ELL~Hpff~~~~~ 601 (720)
.+||.+||+.||++|++ +.++++||||+...+
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999999999998 589999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.55 Aligned_cols=245 Identities=32% Similarity=0.509 Sum_probs=205.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhh-------------cCC---EEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQ-------------VDD---HLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~-------------~~~---~lyLVmEy 416 (720)
-.|.-.+++|.|+||+||.|...++++.||||++-..... ..+.+++..+.+ .++ .+.+||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 3688999999999999999999999999999988655432 334444444432 122 46789999
Q ss_pred ccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhccCcccc
Q 005007 417 VHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 417 ~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~~~~~~~ 492 (720)
|+ .+|..+++.. +..++.-.++-|++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+..+...
T Consensus 104 mP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 104 MP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred ch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 97 8999999753 5679999999999999999999999999999999999999976 99999999999999888888
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc---c------------
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---R------------ 557 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~---~------------ 557 (720)
.++..|++|+|||++.| ...|+.+.||||.||||.||+.|++-|.+.+..+++..|++ .
T Consensus 183 iSYicSRyYRaPELifg------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred eeEEEeccccCHHHHcC------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 99999999999999996 46789999999999999999999999999877766655532 0
Q ss_pred --CCC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccCCC
Q 005007 558 --TPP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLS 605 (720)
Q Consensus 558 --~~~------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~l~ 605 (720)
... +...+++++.+|+.++|+.+|.+|.++.|+|.||||......+..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~ 318 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTK 318 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCcc
Confidence 011 123468999999999999999999999999999999876554443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=357.25 Aligned_cols=234 Identities=28% Similarity=0.501 Sum_probs=195.3
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHH-------HHHh-----------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECI-------KQLE-----------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~i-------k~L~-----------~~~~~lyLVmEy~~g 419 (720)
+.||+|+||+||+|++..+++.||||++..... .......+ +.+. +.++.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999864211 11111111 1111 125678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|.+++... ..+.+..++.++.||++||.|||++||+||||||+||||+.++.+||+|||+++.... .......+||
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 9999999764 6689999999999999999999999999999999999999999999999999976432 2233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|||||++.+ ..++.++|||||||++|||++|++||...+..+.+..+......++..++.++.++|.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 160 PEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred ccccCHHHHcC-------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcc
Confidence 99999999863 45778999999999999999999999988777777777777777778899999999999999
Q ss_pred cCCCCCCCHH----HHHcCcccccccc
Q 005007 579 RNPVERPSAV----ELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa~----ELL~Hpff~~~~~ 601 (720)
+||.+|+++. ++++|+||....+
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 9999999865 8999999976554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.16 Aligned_cols=242 Identities=29% Similarity=0.516 Sum_probs=210.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--------hhHHHHHHHHh-h-----------cCCE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLE-Q-----------VDDH 409 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--------~~~~~~ik~L~-~-----------~~~~ 409 (720)
......|++++.||+|.||+||+|+++.||+.+|+|.+...... .+++.+++.+. + ..+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34566899999999999999999999999999999998654321 22334444443 1 2567
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC----CCeeeeccccchh
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMAKH 485 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~----g~VKL~DFGlA~~ 485 (720)
+|+|||+|.||+|++.|... .++|..+..+++||+.|+.|||+.||+||||||+|||+... +.+|++|||++..
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 89999999999999999876 39999999999999999999999999999999999999543 4799999999999
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC---
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 562 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP--- 562 (720)
..........+||++|+|||++.+ ..|+..+||||+||++|.|++|.+||.+........++....+.++
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~-------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGG-------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred ccCCceEeeecCCccccCchhhcC-------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC
Confidence 888667788999999999999973 5789999999999999999999999999998888888888766543
Q ss_pred -ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 -~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++..+++||++||..||.+|+|+.++|+|||++...
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 45799999999999999999999999999999998753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=395.97 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=215.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEecc---CC----------------CChhHHHHHHHHhhcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI---IP----------------DDPKSAECIKQLEQVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~---~~----------------~~~~~~~~ik~L~~~~~~lyL 412 (720)
...+|.++++||+|+||.|.+++++.|++.||+|++.. .. .+..-+..+.+-.+.++++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 45689999999999999999999999999999998864 11 111122234444567899999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|||||+||||..++.+.. .++|+.++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-.+...+
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999999999998875 89999999999999999999999999999999999999999999999999987765333
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP--~~ls 566 (720)
.....+|||.|++||++..... +...|+..+|+|||||++||||+|..||....-.+.+-+|++- ...+| ..+|
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~--~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGD--GKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcC--CccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 2345689999999999986432 3468999999999999999999999999999999999999864 56677 4589
Q ss_pred HHHHHHHHHhhhcCCCCCCC---HHHHHcCcccccccccCCCC
Q 005007 567 SEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQNLSV 606 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPT---a~ELL~Hpff~~~~~~~l~~ 606 (720)
+++++||.++|. +|+.|.. ++++..||||.+..|.++..
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE 351 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence 999999999888 5899988 99999999999999976654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=355.99 Aligned_cols=234 Identities=30% Similarity=0.538 Sum_probs=197.0
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChh----HHHHHHHHh------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK----SAECIKQLE------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~----~~~~ik~L~------------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|++..+++.||||+++... .... +.+++..+. ...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987421 1111 111122111 125679999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-CccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t~~GT 498 (720)
|+|..++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 9999998764 579999999999999999999999999999999999999999999999999987532 22233456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..++.++.+||.+||.
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 160 PDYIAPEILSY-------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred ccccCHHHhcC-------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcc
Confidence 99999999863 45788999999999999999999999988877777778888888888999999999999999
Q ss_pred cCCCCCCCH-----HHHHcCcccccccc
Q 005007 579 RNPVERPSA-----VELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa-----~ELL~Hpff~~~~~ 601 (720)
.||.+||++ .++++||||+...+
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999 99999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=357.56 Aligned_cols=234 Identities=29% Similarity=0.498 Sum_probs=194.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHH---H----HHHHh-----------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAE---C----IKQLE-----------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~---~----ik~L~-----------~~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|.++.+|+.||||++..... ...... + ++.+. +.++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 479999999999999999999999999864211 111111 1 11111 125679999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t~~GT 498 (720)
|+|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .......+||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 9999988654 6799999999999999999999999999999999999999999999999999875432 2333456799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+.|||||++.+ ..++.++|||||||++|||++|+.||...+..+.+.+++.....++..++.++.++|.+||+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 160 PEYLAPEVIRK-------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLE 232 (325)
T ss_pred hhhCCHHHHcC-------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhc
Confidence 99999999863 45778999999999999999999999988777777778777777777899999999999999
Q ss_pred cCCCCCCCH----HHHHcCcccccccc
Q 005007 579 RNPVERPSA----VELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPTa----~ELL~Hpff~~~~~ 601 (720)
+||.+||++ .++++||||....+
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 999999876 59999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.81 Aligned_cols=247 Identities=25% Similarity=0.442 Sum_probs=197.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----Chh-HHHHHHHHh--------------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPK-SAECIKQLE--------------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~-~~~~ik~L~--------------~~~~~lyLVm 414 (720)
++|++.++||+|+||+||+++++.+++.||||++..... ... ..+++..+. +.++.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999999999999998853210 000 111111111 1256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
||+.||+|.+++.+....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987667799999999999999999999999999999999999999999999999999876533221 2
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCC---ccCCH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP---EMLSS 567 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP---~~ls~ 567 (720)
...+||+.|||||++.+... +...++.++|||||||++|||++|+.||...+..+.+.++.... ..+| ..++.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 161 SVAVGTPDYISPEILQAMED--GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred cccccCccccCHHHHhcccc--CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 23579999999999974321 23457889999999999999999999999887777777776543 2233 35799
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHcCccccccccc
Q 005007 568 EGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 568 el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~~~ 602 (720)
++++||.+||..++.+ |++++|+++||||....+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 9999999999765443 6899999999999876544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.13 Aligned_cols=246 Identities=26% Similarity=0.467 Sum_probs=194.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Ch-------hHHHHHHHHh-----------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DP-------KSAECIKQLE-----------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~-------~~~~~ik~L~-----------~~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|++..+++.||||++..... .. .+..++..+. ..++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999863211 00 1111111111 1356799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
||+.||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999977667799999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCC---ccCCH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP---EMLSS 567 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP---~~ls~ 567 (720)
...+||+.|||||++.+... +...++.++|||||||++|||++|+.||......+.+.++.... ..++ ..+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 161 NVAVGTPDYISPEILQAMED--GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cceeccccccCHHHHhhccc--cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 23469999999999974211 12457789999999999999999999998877666666665432 2233 34799
Q ss_pred HHHHHHHHhhhcCCC--CCCCHHHHHcCcccccccc
Q 005007 568 EGKDFLLRCFLRNPV--ERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 568 el~dLI~~cL~~dP~--kRPTa~ELL~Hpff~~~~~ 601 (720)
++++||++||..+++ .|++++++|+||||....+
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 999999999875443 3789999999999976543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=371.18 Aligned_cols=235 Identities=43% Similarity=0.793 Sum_probs=201.8
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----ChhHH---------HHHHHHhh--cCCEEEEEEEeccCCCHHH
Q 005007 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPKSA---------ECIKQLEQ--VDDHLYIYLEYVHPGSINR 424 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~~~~---------~~ik~L~~--~~~~lyLVmEy~~gGsL~~ 424 (720)
+||+|+||+||.|+|+.|...+|||+|..... ..+++ +++++|.. .++++-|+||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999999999999999864321 11122 22333322 3678999999999999999
Q ss_pred HHHHhcCCC--cHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec-CCCCeeeeccccchhccCcc-ccccccCCCC
Q 005007 425 YVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLS-YELSLKGSPN 500 (720)
Q Consensus 425 ~L~~~~~~L--se~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd-~~g~VKL~DFGlA~~~~~~~-~~~t~~GTp~ 500 (720)
+|+...+++ .|..+..|.+|||+||+|||++.|||||||.+|+||+ -.|.+||.|||-++++.+.. ...++.||..
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQ 741 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ 741 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchh
Confidence 999998998 8999999999999999999999999999999999997 46999999999999987654 4457899999
Q ss_pred CCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHH--hccCCCCCccCCHHHHHHHHHhh
Q 005007 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV--LNRTPPIPEMLSSEGKDFLLRCF 577 (720)
Q Consensus 501 YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki--~~~~~~iP~~ls~el~dLI~~cL 577 (720)
|||||+|.. |...|+.++|||||||++.||.||++||.+.... ..++++ .+..+++|+.++.+++.||.+|+
T Consensus 742 YMAPEvIDq-----G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 742 YMAPEVIDQ-----GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhChHhhcc-----CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999974 4567999999999999999999999999876554 444444 35678999999999999999999
Q ss_pred hcCCCCCCCHHHHHcCccccccc
Q 005007 578 LRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 578 ~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..||.+||+|.++|+.||++..+
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred CCCcccCccHHHhccCcccccCC
Confidence 99999999999999999998763
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=361.97 Aligned_cols=244 Identities=28% Similarity=0.490 Sum_probs=197.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----Ch----hHHHHHHHHh-----------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DP----KSAECIKQLE-----------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~----~~~~~ik~L~-----------~~~~~lyL 412 (720)
...+|++.+.||+|+||+||+|.+..+++.||+|++..... .. .+..++..+. ..++.+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 44689999999999999999999999999999999863211 11 1111111111 13567999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 121 VMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 9999999999999965 358999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCc--cCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~--~ls 566 (720)
...+.+||+.|||||++.+. .....++.++|||||||+||||++|+.||...+....+.+++.. ...+|. .++
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~---~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred ecccCCCCcccCCHHHHhcc---CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22356799999999999742 11235788999999999999999999999988777777777653 344554 469
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 005007 567 SEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNAN 600 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~ 600 (720)
..++++|.+||..++.+ |+++.|+++||||+...
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 99999999999865543 89999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.11 Aligned_cols=241 Identities=25% Similarity=0.435 Sum_probs=196.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--------hhHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--------~~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.|++.++||+|+||+||+|.+..+++.||||++...... ..++.++..+.+ .++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999999999999999988642211 112223333322 2467999999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988654 24699999999999999999999999999999999999999999999999999987654444445
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHH----HHHhccCCCCCccCCHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM----FKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i----~ki~~~~~~iP~~ls~el~ 570 (720)
..|++.|+|||++.+ ..++.++||||+||++|||++|+.||.+....... ..+......++..++..+.
T Consensus 161 ~~~~~~y~aPE~~~~-------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 161 RVGTVGYMAPEVVKN-------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred ccCCCCccCcHHhcC-------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 679999999999863 45778999999999999999999999875543322 2233444556777899999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 571 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 571 dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+||.+||..||++|| +++++++|+||....+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 999999999999999 99999999999865543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.16 Aligned_cols=241 Identities=26% Similarity=0.478 Sum_probs=192.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
..+|++.+.||+|+||+||+|+++.+++.||||+++...... .+.+.++.+.+ .++.+|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 358999999999999999999999999999999987543221 12223333321 3567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ....
T Consensus 85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 997 58988887765668999999999999999999999999999999999999999999999999997643322 2234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..+|+.|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+....
T Consensus 164 ~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 164 EVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 568999999999863 3457889999999999999999999998766544443332110
Q ss_pred ---CCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 ---PPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 ---~~iP-----------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
...+ ..++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0011 24688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.30 Aligned_cols=234 Identities=29% Similarity=0.505 Sum_probs=196.7
Q ss_pred eeEEeecCCeEEEEEEE---CCCCcEEEEEEeccCCCC----h---hHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 359 GKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDD----P---KSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d---~~tg~~VAVK~l~~~~~~----~---~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
++.||+|+||+||++++ ..+|+.||||+++..... . .+.+++..+.+ .++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36899999999999986 357899999998643211 1 11222222221 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~~ 496 (720)
.+|+|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .......
T Consensus 81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 81 RGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 999999999664 57999999999999999999999999999999999999999999999999999765433 2334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 576 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~c 576 (720)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..+++++++||++|
T Consensus 160 g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 160 GTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred CChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 356789999999999999999999999888777888888888888999999999999999
Q ss_pred hhcCCCCCCC-----HHHHHcCccccccc
Q 005007 577 FLRNPVERPS-----AVELLEHPFIRNAN 600 (720)
Q Consensus 577 L~~dP~kRPT-----a~ELL~Hpff~~~~ 600 (720)
|+.||++||+ ++++++|+||....
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999999999 78899999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=369.49 Aligned_cols=239 Identities=29% Similarity=0.522 Sum_probs=212.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-----------cCCE-EEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-----------VDDH-LYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-----------~~~~-lyLV 413 (720)
.++|..+++||+|+||.+++++++.+++.|++|+|......... ...+..+.+ .++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35899999999999999999999999999999999876533222 222332221 2444 9999
Q ss_pred EEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-c
Q 005007 414 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 491 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~ 491 (720)
|+||+||+|.+.|.+.. ..++|+.+..|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+.+.... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999998765 679999999999999999999999999999999999999999999999999999988765 7
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 570 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~ 570 (720)
..+++||++||.||++. +-.|+.++|||||||++|||++-+++|...+....+.+|.... .++|..++.+++
T Consensus 163 a~tvvGTp~YmcPEil~-------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILS-------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELR 235 (426)
T ss_pred hheecCCCcccCHHHhC-------CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHH
Confidence 78899999999999997 4678999999999999999999999999999999999998765 789999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
.+|+.||.++|+.||++.+||.+|.+..
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999988863
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=375.18 Aligned_cols=237 Identities=27% Similarity=0.483 Sum_probs=196.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh-----------------cCCEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ-----------------VDDHLYI 412 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~-----------------~~~~lyL 412 (720)
.+|.+.++||+|+||.|.+|++..|++.||||+|+...... .++.+++.|.+ ..+++||
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 48999999999999999999999999999999998665432 23334444442 2567999
Q ss_pred EEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC--CCeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~--g~VKL~DFGlA~~~~~~ 489 (720)
|+|.+. .+|+++|+.+ ...|+...++.|+.|||.||.+||+.||||+|||||||||... ..|||+|||.+......
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 999995 8999999864 4669999999999999999999999999999999999999654 47999999999877655
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc------------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------ 557 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------------ 557 (720)
-+ +++.++.|+|||+|.| ..|+.+.||||||||++||++|.+.|.+.+..+.+..|+.-
T Consensus 345 vy--tYiQSRfYRAPEVILG-------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 345 VY--TYIQSRFYRAPEVILG-------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ce--eeeeccccccchhhcc-------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 44 7889999999999996 56889999999999999999999999988877776655320
Q ss_pred --------C-CC-------------------------------CC-c----------cCCHHHHHHHHHhhhcCCCCCCC
Q 005007 558 --------T-PP-------------------------------IP-E----------MLSSEGKDFLLRCFLRNPVERPS 586 (720)
Q Consensus 558 --------~-~~-------------------------------iP-~----------~ls~el~dLI~~cL~~dP~kRPT 586 (720)
. .. .| . .-...+.|||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0 00 11 0 01245689999999999999999
Q ss_pred HHHHHcCccccccc
Q 005007 587 AVELLEHPFIRNAN 600 (720)
Q Consensus 587 a~ELL~Hpff~~~~ 600 (720)
+.|+|+||||+...
T Consensus 496 p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 PAQALNHPFLTGTS 509 (586)
T ss_pred HHHHhcCccccccc
Confidence 99999999998544
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.19 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=196.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHHHHHh--------------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECIKQLE--------------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~ik~L~--------------~~~~~lyLVm 414 (720)
++|++.+.||+|+||+||+|.++.+++.||||++..... .... .+++..+. +.++.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999998864211 1111 11111111 1356789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
||+.||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999987556799999999999999999999999999999999999999999999999999976643322 1
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCc---cCCH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE---MLSS 567 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~---~ls~ 567 (720)
...+||+.|||||++.+... +...++.++|||||||+||||++|+.||...+..+.+.++.... .++|. .+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 161 SVAVGTPDYISPEILQAMED--GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred ccccCCcccCCHHHHhcccc--CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 23569999999999874221 11357789999999999999999999998877767666665432 33343 4689
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHcCccccccccc
Q 005007 568 EGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 568 el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~~~ 602 (720)
++++||.+||..++++ |++++++++|+||+...+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999875544 4799999999999865543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.33 Aligned_cols=235 Identities=27% Similarity=0.499 Sum_probs=191.0
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--h------hHHHHHHHHhh------------cCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--P------KSAECIKQLEQ------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~------~~~~~ik~L~~------------~~~~lyLVmEy~~g 419 (720)
++||+|+||+||+|.+..+++.||||+++..... . .+...+..+.. ..+.+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999743211 1 11111122211 25678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-CccccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~~t~~GT 498 (720)
|+|..++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 9999988654 679999999999999999999999999999999999999999999999999997532 22333457899
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC------CcH-HHHHHHhccCCCCCccCCHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF------EGP-QAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~------~~~-~~i~ki~~~~~~iP~~ls~el~d 571 (720)
+.|+|||++.+ ..++.++|||||||+||||++|+.||... ... .....+......+|..++..+.+
T Consensus 160 ~~y~aPE~~~~-------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 232 (327)
T cd05617 160 PNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232 (327)
T ss_pred cccCCHHHHCC-------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999863 45788999999999999999999999532 222 23344455666788899999999
Q ss_pred HHHHhhhcCCCCCCC------HHHHHcCccccccccc
Q 005007 572 FLLRCFLRNPVERPS------AVELLEHPFIRNANYQ 602 (720)
Q Consensus 572 LI~~cL~~dP~kRPT------a~ELL~Hpff~~~~~~ 602 (720)
+|.+||..||++|++ ++++++|+||+...+.
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 999999999999997 5799999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.97 Aligned_cols=234 Identities=25% Similarity=0.449 Sum_probs=188.8
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
||+|+||+||+|.++.+++.||||++....... .+.+++..+.. .++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999886422111 11222222221 25678999999999999
Q ss_pred HHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccccCC
Q 005007 423 NRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGS 498 (720)
Q Consensus 423 ~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~GT 498 (720)
..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988753 23569999999999999999999999999999999999999999999999999997654332 23346799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......++..++.++.++|.
T Consensus 161 ~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 161 PGFMAPELLQG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233 (280)
T ss_pred cCccCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH
Confidence 99999999873 4577899999999999999999999976433 223333444555667789999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 575 RCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 575 ~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+||+.||++|+ |++++++||||+...+.
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 99999999999 89999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.08 Aligned_cols=241 Identities=39% Similarity=0.657 Sum_probs=215.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhc--------------CCEEEEEEEeccC
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV--------------DDHLYIYLEYVHP 419 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~--------------~~~lyLVmEy~~g 419 (720)
.-|.++.+||+|+||.||+|.++++|+.||||.+.+..+..+.+.++..+++. ...++||||||..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 35889999999999999999999999999999998887777777776666653 3458999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~~GT 498 (720)
|++.++++-+.+.|+|.++..+++..|.||+|||...-||||||..||||+.+|..||+|||.|..+.+. ...+++.||
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGT 192 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGT 192 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccC
Confidence 9999999988899999999999999999999999999999999999999999999999999999877653 345688999
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dLI~~ 575 (720)
|.|||||++.. -.|...+||||||++..||..|++||.+......++.|-...+ ..|+.+++++-|||+.
T Consensus 193 PFWMAPEVI~E-------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 193 PFWMAPEVIEE-------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred cccccHHHHHH-------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 99999999985 3578899999999999999999999999888887777655433 3478899999999999
Q ss_pred hhhcCCCCCCCHHHHHcCcccccccc
Q 005007 576 CFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
||.++|++|-|+.+|++|+|+++...
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 99999999999999999999987653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=349.87 Aligned_cols=245 Identities=28% Similarity=0.510 Sum_probs=211.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hhH-----HHHHHHHhh---------------cCC
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKS-----AECIKQLEQ---------------VDD 408 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~~-----~~~ik~L~~---------------~~~ 408 (720)
..|.-.++||+|..++|.+|.++.||+.+|+|++...... ... ..++..|.+ .+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677788999999999999999999999999999764321 111 112222332 244
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+++|+|.|+.|.|+|+|... ..++|+..+.||+||++|++|||.++||||||||+|||++++-++||+|||+++.+..
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 578999999999999999765 6799999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC--C--cc
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--P--EM 564 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i--P--~~ 564 (720)
+......||||+|+|||.+...+. ++.+.|+..+|+|++|||||-||.|.+||......-.+..|+.+.+.+ | ..
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~-e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMY-ENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred chhHHHhcCCCcccChhheeeecc-cCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 888899999999999999986554 457889999999999999999999999998877777777788776655 2 45
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
++.+.+|||.+||+.||.+|+|++|+|.||||....
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 889999999999999999999999999999996543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=349.68 Aligned_cols=238 Identities=26% Similarity=0.529 Sum_probs=191.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
.++|++.+.||+|+||+||+|++..+|..||+|.+....... ...++++.+.+ .++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 568999999999999999999999999999999987542211 11222222222 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|++||+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 161 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 161 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cccc
Confidence 99999999999764 5699999999999999999999986 6999999999999999999999999999766432 2345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc------------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------------------ 556 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~------------------ 556 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+. ..++.
T Consensus 162 ~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 162 FVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred CCCCcCcCCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCccccCccc
Confidence 679999999999863 4578899999999999999999999975443222 11111
Q ss_pred -----------------------------c-CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 557 -----------------------------R-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 557 -----------------------------~-~~~iP-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
. .+..+ ..+++++++||.+||++||++|||+.|||+|+||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 11111 23678999999999999999999999999999997644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=356.65 Aligned_cols=238 Identities=25% Similarity=0.491 Sum_probs=209.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChhHH------HHHHH-----------HhhcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSA------ECIKQ-----------LEQVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~~~------~~ik~-----------L~~~~~~lyL 412 (720)
.+-+|++.+.||+|+||+|-+|++...|+.||||.|+... +....+ +++.. +.+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 4568999999999999999999999999999999886543 222221 21111 1234678999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||..+|+|++||.+. +.|+|.+++.|++||..|+.|||.++++|||||.+|||||.++++||+||||+..+......
T Consensus 131 vMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999999999999775 78999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
.++||+|.|.+||++.| .++-++.+|-|||||+||.|+.|..||.+.+....+.+|..+.+.-|+. +.++.-|
T Consensus 210 qTFCGSPLYASPEIvNG------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNG------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCC------CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHH
Confidence 99999999999999985 5667889999999999999999999999999888888888887777764 5678999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
|++||..||++|.|+++|-.|-|+.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999999999999996663
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.04 Aligned_cols=236 Identities=25% Similarity=0.396 Sum_probs=185.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhhc--------------------C
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQV--------------------D 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~~--------------------~ 407 (720)
..++|++.+.||+|+||+||+|.+..+|+.||||++........ ..+++..+... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34699999999999999999999999999999999864322111 11222222211 1
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 35799999997 56666664 348999999999999999999999999999999999999999999999999998665
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-----------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----------- 556 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~----------- 556 (720)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cCccCCCCcccCCCCCchhccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 4444455678999999999863 4577899999999999999999999987654333222211
Q ss_pred -----------cCCCC--------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 557 -----------RTPPI--------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 557 -----------~~~~i--------------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..+.. ....++++++||.+||+.||++|||+.|+|+||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 11111 1124678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.93 Aligned_cols=239 Identities=27% Similarity=0.507 Sum_probs=208.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--------------------CChhHHHHHHHHhhcCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--------------------DDPKSAECIKQLEQVDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--------------------~~~~~~~~ik~L~~~~~~l 410 (720)
..-++|.+++.||+|-||.||+|+.++++-.||+|++.... .+++..+... +...+..+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~-~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG-YFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh-heecccee
Confidence 34468999999999999999999999999999999875321 1111111111 12246789
Q ss_pred EEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 411 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
||++||..+|+|+..|++. ...++|...+.|++|++.||.|||.++||||||||+|+|++..|.+||+|||.+.... .
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence 9999999999999999743 4569999999999999999999999999999999999999999999999999997655 5
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHH
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 569 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el 569 (720)
....+.|||..|.+||+..+ ..++..+|+|++|++.||+|.|.+||......+.+.+|..-...+|..++.++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~-------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a 249 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEG-------RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA 249 (281)
T ss_pred CCceeeecccccCCHhhcCC-------CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence 66789999999999999874 45778999999999999999999999998888999999999999999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+|+|.+||.++|.+|.+..|+++|||+..
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.92 Aligned_cols=245 Identities=29% Similarity=0.468 Sum_probs=196.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--C--h----hHHHHHHHHh-----------hcCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--D--P----KSAECIKQLE-----------QVDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~--~----~~~~~ik~L~-----------~~~~~ly 411 (720)
...++|++.+.||+|+||+||+|.++.+++.||+|++..... . . ++..++..+. ..++.+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 345799999999999999999999999999999999863211 1 0 1111111111 1256799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 120 lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999999999999965 358999999999999999999999999999999999999999999999999998664322
Q ss_pred -ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCc--cC
Q 005007 491 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--ML 565 (720)
Q Consensus 491 -~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~--~l 565 (720)
.....+||+.|||||++.+. .+...++.++|||||||+||||++|+.||...+....+.+++... ..+|. .+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred ccccCcccCccccCHHHHhcc---CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence 22356799999999998742 112347889999999999999999999999877777777776532 33443 58
Q ss_pred CHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 005007 566 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNAN 600 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~ 600 (720)
+.++++||.+||..++.+ |++++|+++|+||++..
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 999999999999844433 78999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.85 Aligned_cols=236 Identities=25% Similarity=0.373 Sum_probs=187.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh--------------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ--------------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~--------------------~~ 407 (720)
..++|++++.||+|+||+||+|++..+++.||||++........ ..+++..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35689999999999999999999999999999999865322211 1112222111 11
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 35799999997 577777743 48899999999999999999999999999999999999999999999999998765
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------- 558 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--------- 558 (720)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+.+++...
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhC-------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 5444455679999999999973 457889999999999999999999998776655544443210
Q ss_pred -------------CC--------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 559 -------------PP--------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 559 -------------~~--------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+. .....+.++++||.+||+.||.+|||+.|+|+||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00113467899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.98 Aligned_cols=242 Identities=26% Similarity=0.422 Sum_probs=200.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhhc--------------------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQV-------------------- 406 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~~-------------------- 406 (720)
....+|++.++||+|+||+||+|.+..+|+.||||++.......... .++..+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34569999999999999999999999999999999987543322211 122222110
Q ss_pred --CCEEEEEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccc
Q 005007 407 --DDHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 481 (720)
Q Consensus 407 --~~~lyLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFG 481 (720)
...+++||||+.+|+|.++|... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 01368999999999999999653 3468999999999999999999999999999999999999999999999999
Q ss_pred cchhccCc---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-
Q 005007 482 MAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR- 557 (720)
Q Consensus 482 lA~~~~~~---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~- 557 (720)
+++.+... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||......+.+.+++..
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 99865432 22345679999999999863 45788999999999999999999999987776777766654
Q ss_pred CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 558 ~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
...+|..+++++.+||.+||..||.+||++.++|+|||++..
T Consensus 262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 345778899999999999999999999999999999998753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.02 Aligned_cols=245 Identities=28% Similarity=0.493 Sum_probs=213.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC---C-Chh----H------------HHHHHHHhhcCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---D-DPK----S------------AECIKQLEQVDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~---~-~~~----~------------~~~ik~L~~~~~~ly 411 (720)
...+|..+.+||+|+||+|.+|..+.|.+.||||+++..- + +.+ + ...+.-..+.-+++|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4468999999999999999999999999999999886421 1 111 1 111222234568899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCcc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~ 490 (720)
+||||+.||+|--.|++. +.+.|..+..|+.+|+-||-|||++|||.||||.+|||||.+|+|||+|||+++.. .+..
T Consensus 427 FVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred eEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999999999999999775 78999999999999999999999999999999999999999999999999999864 4556
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
...++||||.|+|||++. ...|+.++|+||+||+|||||.|.+||.+.+..+++..|+.....+|..++.++.
T Consensus 506 TTkTFCGTPdYiAPEIi~-------YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv 578 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV 578 (683)
T ss_pred ceeeecCCCcccccceEE-------ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence 677899999999999986 3568999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHcCcccccccccCC
Q 005007 571 DFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 604 (720)
Q Consensus 571 dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~~l 604 (720)
++++..|.+.|.+|.. -.+|-.||||+...|..+
T Consensus 579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 9999999999999964 368999999998877643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=357.26 Aligned_cols=233 Identities=31% Similarity=0.554 Sum_probs=193.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcE-EEEEEeccCCCChhH-------HHHHHHHhh----------cCC--EEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDDPKS-------AECIKQLEQ----------VDD--HLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~-VAVK~l~~~~~~~~~-------~~~ik~L~~----------~~~--~lyL 412 (720)
..+..+.+.||+|+||+||+|.++ |.. ||||++......... +.++..+.+ .+. .++|
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 345566777999999999999987 666 999999765433221 222222222 122 5899
Q ss_pred EEEeccCCCHHHHHHH-hcCCCcHHHHHHHHHHHHHHHHHHHhCC-CcccccCCCceeecCCC-CeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLVDASG-VVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIL~gL~yLHs~g-IVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~ 489 (720)
||||+++|+|.+++.. ..+.++...+..|+.||++||+|||+++ |||||||++||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999987 3688999999999999999999999999 99999999999999998 9999999999877654
Q ss_pred c-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh--ccCCCCCccCC
Q 005007 490 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLS 566 (720)
Q Consensus 490 ~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~--~~~~~iP~~ls 566 (720)
. ......||+.|||||++.+. ...|+.++||||||++||||+||+.||.+....+....+. +..+.+|..++
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred cccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 2 23337899999999999842 3579999999999999999999999999988866666664 45677888899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.+..||.+||..||.+||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999975
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=349.91 Aligned_cols=237 Identities=25% Similarity=0.375 Sum_probs=186.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------------~~ 407 (720)
..++|++.+.||+|+||+||+|++..+++.||||++........ +...++.+.+ ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 34699999999999999999999999999999999875332221 1112222211 11
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+|+||||++ ++|.+.+.. .+++..++.++.||++||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 35799999997 567776643 48899999999999999999999999999999999999999999999999998765
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc----------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---------- 557 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---------- 557 (720)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++..
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred CccccCCccccCCccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 5444456779999999999863 45788999999999999999999999876544333322110
Q ss_pred ------------CC--------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 558 ------------TP--------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 558 ------------~~--------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+ ..+...+.++++||.+||+.||++|||+.|+|+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 0112235678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=368.21 Aligned_cols=246 Identities=35% Similarity=0.630 Sum_probs=210.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHH---------HHHHHHh--hcCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSA---------ECIKQLE--QVDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~---------~~ik~L~--~~~~~lyLVmEy 416 (720)
.+.|.|+..||.|+||+||+|.+++++...|.|+|....... .++ .+++.|. -.++.++|+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 357999999999999999999999999999999886432111 111 1222222 247889999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~~~~t~ 495 (720)
|.||-...++-+.++.|+|.+|..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+... .......++
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 9999999999888899999999999999999999999999999999999999999999999999987543 333455689
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC---CCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~---iP~~ls~el~dL 572 (720)
.|||||||||++.....+ +..|++++||||||++|.||.-+.+|-...+.+..+.+|....++ .|..++..+.||
T Consensus 191 IGTPYWMAPEVvmCET~K--D~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFK--DQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cCCcccccchheeecccc--CCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 999999999998754433 467999999999999999999999999999999999999876554 478899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|++||.+||+.||++.+||+||||++..
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 9999999999999999999999998654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=330.05 Aligned_cols=235 Identities=45% Similarity=0.850 Sum_probs=194.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh--------------cCCEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~--------------~~~~lyL 412 (720)
+.|++++.||+|+||.||+|.+..+++.||||++......... ..++..+.. .++.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999988654322111 111222211 2567999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999999765 56999999999999999999999999999999999999999999999999998765432111
Q ss_pred ----ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCccCC
Q 005007 493 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 566 (720)
Q Consensus 493 ----~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~~ls 566 (720)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+.. ....+|..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred cccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCC
Confidence 23568899999999874 3477899999999999999999999988766666555543 3456778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.++.++|.+||..+|.+|||+.|+|+|+||
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.90 Aligned_cols=239 Identities=24% Similarity=0.452 Sum_probs=192.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.|++.++||+|+||+||+|.+..+++.||||.+....... .+..++..+.+ .++.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788899999999999999999999999999886432111 11222222221 2467899999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+.|++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999999998643 23599999999999999999999999999999999999999999999999999976544333344
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH---HHHHHHh-ccCCCCCccCCHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVL-NRTPPIPEMLSSEGK 570 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---~~i~ki~-~~~~~iP~~ls~el~ 570 (720)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+. .....++..++++++
T Consensus 161 ~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05630 161 RVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDAR 233 (285)
T ss_pred CCCCccccChHHHcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHH
Confidence 579999999999863 45788999999999999999999999864322 2222222 123345677899999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 005007 571 DFLLRCFLRNPVERPS-----AVELLEHPFIRNAN 600 (720)
Q Consensus 571 dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~ 600 (720)
+||.+||+.||++||| ++|+++||||....
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 9999999999999999 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.66 Aligned_cols=237 Identities=26% Similarity=0.437 Sum_probs=187.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------cCC-----EEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------VDD-----HLY 411 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------~~~-----~ly 411 (720)
+|++++.||+|+||+||+|.+..+|+.||||++........ +.+++..+.+ ..+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999998864322211 1112222211 122 689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc--
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-- 489 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-- 489 (720)
+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9999996 6888888654 67999999999999999999999999999999999999999999999999999765332
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-------------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------------- 556 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~------------- 556 (720)
.......+|+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 12234568999999999874 34578899999999999999999999987665544433321
Q ss_pred ----------cCC---------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 557 ----------RTP---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 557 ----------~~~---------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
... .+....++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223467899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=337.32 Aligned_cols=242 Identities=25% Similarity=0.459 Sum_probs=193.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---h---HHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---K---SAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~---~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.++|++.+.||+|+||.||+|.++.+++.||||.++...... . +...+..+.+ .++.+|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 468999999999999999999999999999999987543221 1 2222333222 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+. ++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 997 68999987766679999999999999999999999999999999999999999999999999997643222 2233
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------------- 557 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~----------------- 557 (720)
..+++.|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+...
T Consensus 164 ~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 164 EVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 457899999999863 345778999999999999999999999876654444332210
Q ss_pred --CCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 558 --TPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 558 --~~~iP-----------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
...+| ..+++++++||.+||+.||.+|||+.|+|+|+||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00111 246889999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=338.54 Aligned_cols=242 Identities=27% Similarity=0.423 Sum_probs=202.2
Q ss_pred CCCCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHH----------------HHHHhhcCCEEEEEE
Q 005007 352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC----------------IKQLEQVDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~-k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~----------------ik~L~~~~~~lyLVm 414 (720)
..++|++- ++||-|-.|+|..|.++.||+.+|+|++.......++++. .+...+....+.|||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 34567664 6899999999999999999999999987543332222221 122223456789999
Q ss_pred EeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCcc
Q 005007 415 EYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~ 490 (720)
|.|+||+|+..|++++ ..|+|.++..|++||..||.|||+.+|.||||||+|+|... +..+||+|||+|+......
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 9999999999998763 45999999999999999999999999999999999999964 4589999999999887777
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCCc---
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE--- 563 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP~--- 563 (720)
...+.|.||+|.|||++. ..+|+...|+||+||+||.||+|.+||....+ ...-.+|..+.+.+|+
T Consensus 219 ~L~TPc~TPyYvaPevlg-------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred cccCCcccccccCHHHhC-------chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 778899999999999985 46789999999999999999999999976543 2344566777777774
Q ss_pred -cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 564 -MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 564 -~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+|++++|+|+++|..+|.+|.|++|+++|||+....
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 4789999999999999999999999999999997543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.16 Aligned_cols=240 Identities=22% Similarity=0.324 Sum_probs=188.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh-----------cCCEEEEEEEeccC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----------VDDHLYIYLEYVHP 419 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-----------~~~~lyLVmEy~~g 419 (720)
....+|++++.||+|+||.||+|.+..+++.||||..... ....++++++.+.+ .+...++||||+.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~-~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh-hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 3456899999999999999999999999999999976432 22334445555443 2567899999995
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc--cccccccC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--SYELSLKG 497 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~--~~~~t~~G 497 (720)
++|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++..... .......|
T Consensus 167 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 245 (391)
T PHA03212 167 TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245 (391)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccC
Confidence 7899888664 57999999999999999999999999999999999999999999999999999754322 22335679
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-------cHHHHHHHhc--------------
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-------GPQAMFKVLN-------------- 556 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-------~~~~i~ki~~-------------- 556 (720)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+..++.
T Consensus 246 t~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 246 TIATNAPELLAR-------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccCCCChhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 999999999863 457889999999999999999998764321 1111111110
Q ss_pred ------------cCCCCC---------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 557 ------------RTPPIP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 557 ------------~~~~iP---------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.....+ ..++.++.+||.+||++||++|||++|+|+||||+...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 000001 12466899999999999999999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.14 Aligned_cols=237 Identities=23% Similarity=0.423 Sum_probs=188.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------------cCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------------VDD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------------~~~ 408 (720)
.++|++++.||+|+||+||+|.+..+++.||||++....... .+.+.++.+.+ ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999999999999999886432111 11222222211 013
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|++||++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 479999998 7899888754 5699999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-----------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------- 557 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~----------- 557 (720)
. .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||...+..+.+..+...
T Consensus 171 ~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 171 E--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred C--cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 2 345679999999999863 245788999999999999999999999876554444333211
Q ss_pred ------------CCCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 ------------TPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 ------------~~~iP--------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
....+ ...++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 01111 13466789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.42 Aligned_cols=234 Identities=36% Similarity=0.619 Sum_probs=189.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH-------HHHHHHhh-----------cCCEEEEEEEec
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-------ECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~-------~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
|++++.||+|+||+||+|.+..+++.||+|.+.......... ..++.+.. .+..+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999998664333221 22222321 267799999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCcccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~~~~t~~ 496 (720)
.+++|.+++... ..+++..+..++.||++||+|||++||+|+||||+|||++.++.++|+|||++... ..........
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999743 77999999999999999999999999999999999999999999999999998753 2223334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC---cHHHHHHHhccCC----CCCccCCHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRTP----PIPEMLSSEG 569 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~---~~~~i~ki~~~~~----~iP~~ls~el 569 (720)
++..|+|||++.. ...++.++||||||+++|+|++|..||.... ....+.+...... ........++
T Consensus 160 ~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 160 GTPEYMAPEVLQQ------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp SSGGGSCHHHHTT------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccc------cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 8999999999861 3568889999999999999999999999873 2233333332211 1111224899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.++|.+||+.||++||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.32 Aligned_cols=231 Identities=24% Similarity=0.470 Sum_probs=174.6
Q ss_pred eeEEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCChhHH---HHHHHHhh-------------cCCEEEEEEEeccCC
Q 005007 359 GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ-------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~-------------~~~~lyLVmEy~~gG 420 (720)
+++||+|+||+||+|+++ .+++.||||.++......... ..++.+.+ .+..+|+||||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 578999999999999966 467899999987543332222 33333321 2456899999996 6
Q ss_pred CHHHHHHHh--------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee----cCCCCeeeeccccchhccC
Q 005007 421 SINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 421 sL~~~L~~~--------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL----d~~g~VKL~DFGlA~~~~~ 488 (720)
+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 888887532 1258999999999999999999999999999999999999 4567999999999986543
Q ss_pred cc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---------HHHHHHHh
Q 005007 489 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---------PQAMFKVL 555 (720)
Q Consensus 489 ~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---------~~~i~ki~ 555 (720)
.. ......||+.|+|||++.+ ...++.++|||||||++|||++|++||..... ...+..+.
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred CCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 21 2234678999999999874 34578899999999999999999999964321 11111111
Q ss_pred cc---C--------CCC---------------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 556 NR---T--------PPI---------------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 556 ~~---~--------~~i---------------------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.. . ..+ ....+.++.+||.+||+.||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 10 0 000 01134678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.82 Aligned_cols=235 Identities=26% Similarity=0.538 Sum_probs=193.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhh---------------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ---------------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~---------------~~~~lyLVmE 415 (720)
.|++++.||+|+||.||+|.++.+++.||||++......... ..++..+.. .+..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999999999999999998654322211 111121111 1345899999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccc
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYEL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~ 493 (720)
|+++++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999764 345899999999999999999999999999999999999999999999999999766432 2223
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDF 572 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~dL 572 (720)
...|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.... ..++..+++++.+|
T Consensus 161 ~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd08223 161 TLIGTPYYMSPELFSN-------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233 (257)
T ss_pred cccCCcCccChhHhcC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHH
Confidence 4568999999999863 457789999999999999999999998766655555555443 35667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
|.+||+.||++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.40 Aligned_cols=241 Identities=27% Similarity=0.454 Sum_probs=195.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--------hhHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--------~~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.|+..+.||+|+||+||+|.+..+++.||||.+...... ..+.+++..+.+ .++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 478899999999999999999999999999988643211 112223333322 2567899999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999888654 24699999999999999999999999999999999999999999999999999976544333345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHH----hccCCCCCccCCHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV----LNRTPPIPEMLSSEGK 570 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki----~~~~~~iP~~ls~el~ 570 (720)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ......++..++.++.
T Consensus 161 ~~g~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 161 RVGTVGYMAPEVLNN-------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCCcCccChHHhcC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 679999999999863 45788999999999999999999999876544333222 2334455677899999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 005007 571 DFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQ 602 (720)
Q Consensus 571 dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~ 602 (720)
+||.+||+.||++||+ +.++++|+||+...+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 9999999999999999 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.30 Aligned_cols=234 Identities=24% Similarity=0.464 Sum_probs=183.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCChh------HHHHHHHH-hh------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPK------SAECIKQL-EQ------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~~~------~~~~ik~L-~~------------~~ 407 (720)
..++|+++++||+|+||+||+|.+ ..+++.||||+++....... +..++..+ .+ .+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456899999999999999999975 24567899999874332221 12222222 11 13
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc---------------------------------------------------------
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------------- 430 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~--------------------------------------------------------- 430 (720)
+.+|+||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45899999999999999996531
Q ss_pred ----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---cccccCCCCCCC
Q 005007 431 ----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMA 503 (720)
Q Consensus 431 ----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmA 503 (720)
..+++..+..|+.||++||+|||++||+||||||+|||++.++.+||+|||+++....... .....++..|||
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2377888999999999999999999999999999999999999999999999986533211 123345788999
Q ss_pred hHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHHHHHHhhhcC
Q 005007 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRN 580 (720)
Q Consensus 504 PEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el~dLI~~cL~~d 580 (720)
||++.+ ..++.++|||||||+||||++ |..||......+.+...+. .....|..+++++.+||.+||..|
T Consensus 245 PE~~~~-------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 245 PESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred cHHhhc-------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 999863 457889999999999999997 9999987654444433332 234557788999999999999999
Q ss_pred CCCCCCHHHHHc
Q 005007 581 PVERPSAVELLE 592 (720)
Q Consensus 581 P~kRPTa~ELL~ 592 (720)
|++|||+.||++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=361.19 Aligned_cols=239 Identities=34% Similarity=0.599 Sum_probs=204.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhhc--------------CCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQV--------------DDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~~--------------~~~lyLVm 414 (720)
..|.-++.||.|+||-||.|++..+.+.||||++.....-. ..+..+++|.++ +...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35888899999999999999999999999999987654322 223344444442 33458999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|||- |+-.|+|.-+.+++-|..|..|+.+.|.||.|||+++.||||||..||||++.|.|||+|||.|....+ ..+
T Consensus 106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---Ans 181 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANS 181 (948)
T ss_pred HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhc
Confidence 9995 899999988888999999999999999999999999999999999999999999999999999987654 368
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCC-ccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIP-EMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP-~~ls~el~dL 572 (720)
++|||+|||||||... ..+.|+-++||||||++..||...++|+-+.+.+..++.|.... +.++ ..+++.++.|
T Consensus 182 FvGTPywMAPEVILAM----DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred ccCCccccchhHheec----cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 8999999999999743 13568889999999999999999999999999998888887544 4444 4589999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|..||++-|.+|||.+++|.|+|+....
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999999997543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.38 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=209.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----Chh---HHHHHHHHh-----------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPK---SAECIKQLE-----------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~~---~~~~ik~L~-----------~~~~~lyL 412 (720)
..+.|+.-++||+||||.||-|+.+.||+.||+|.++.... ... +..++..+. +..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34578888999999999999999999999999997753211 111 111121111 24788999
Q ss_pred EEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 413 YLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||..|+||||.-+|.+.+ ..|+|..++.|+.+|+.||++||..+||.|||||+|||||+.|+|+|+|+|||..+.....
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 999999999999998763 4699999999999999999999999999999999999999999999999999999988887
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHHHhccCCCCCccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~ki~~~~~~iP~~ls~ 567 (720)
....+||.+|||||++. +..|+..+|+|+|||+||||+.|+.||.... ..++-..++.....+++.+++
T Consensus 343 ~~~rvGT~GYMAPEvl~-------ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQ-------NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred cccccCcccccCHHHHc-------CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 77779999999999998 3569999999999999999999999997532 234445566777788999999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccccCC
Q 005007 568 EGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~~l 604 (720)
++++|.+.+|++||.+|. .+.++.+||||++.+|+.+
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 999999999999999996 5789999999999887754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.56 Aligned_cols=239 Identities=28% Similarity=0.535 Sum_probs=203.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-C----h---hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-D----P---KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~----~---~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|++.+.||+|+||.||+|.+..+++.||||++..... . . .+.+.++.+.+ .++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999998864221 1 1 11222232221 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||.||||+.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 999999999999765 67999999999999999999999999999999999999999999999999999876544 345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
..|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+...++......+|..++..++++|.
T Consensus 158 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 158 LCGTPEYLAPEIILS-------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIR 230 (290)
T ss_pred CCCCccccChhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHH
Confidence 578999999998863 3467889999999999999999999988776666777777778888889999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 575 RCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 575 ~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+||..||.+|+ +++|+++||||+...+.
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 99999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.37 Aligned_cols=240 Identities=27% Similarity=0.543 Sum_probs=190.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVm 414 (720)
..++|++.++||+|+||.||+|.+..++..||+|.+........ +.+.++.+.+ .++.+||||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 34689999999999999999999999999999998875432211 1222222221 356799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
||+.||+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||++...... ...
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 160 (333)
T cd06650 83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (333)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccc
Confidence 999999999999764 5699999999999999999999975 7999999999999999999999999999765432 223
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHH--------------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-------------------- 553 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~k-------------------- 553 (720)
...||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 161 ~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 161 SFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred cCCCCccccCHHHhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 4579999999999863 4577899999999999999999999975433222110
Q ss_pred ------------------------Hhcc-CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 554 ------------------------VLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 554 ------------------------i~~~-~~~iP-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+... .+.++ ..++.++++||.+||++||++|||++|+|+|+||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0111 11111 13578899999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=359.13 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=198.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~------------~~~~ly 411 (720)
.....|+++++||+||-++||++... +...||+|++.....+.. ++..+..|+. .++.+|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34568999999999999999999865 456778887765554433 3333444332 378899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||||-+ .||..+|++....+....++.|..|||.||.++|++||||.||||.|+|+ -.|.+||+|||+|..+.....
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 9999986 89999999887777767999999999999999999999999999999999 779999999999998765432
Q ss_pred ---cccccCCCCCCChHHHHHhhhcCC----CCCCCccccccchhhhHHHHhcCCCCCCCCC-cHHHHHHHhccCC--CC
Q 005007 492 ---ELSLKGSPNWMAPEVIKAVMQKDG----NPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLNRTP--PI 561 (720)
Q Consensus 492 ---~~t~~GTp~YmAPEvl~g~~~~~g----~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-~~~~i~ki~~~~~--~i 561 (720)
..+-+||+.||+||.+........ .-+++.++||||||||||+|++|++||.... ....+..|..... ++
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 345789999999999986443311 2348899999999999999999999998765 3344444444433 45
Q ss_pred CccCCHH-HHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 562 PEMLSSE-GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 562 P~~ls~e-l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
|..-... +.++++.||++||++|||+.|||+|||++....+.
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~ 637 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV 637 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence 5544433 99999999999999999999999999998655443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=393.28 Aligned_cols=242 Identities=44% Similarity=0.758 Sum_probs=204.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhhc--------------CCEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQV--------------DDHLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~~--------------~~~lyLVm 414 (720)
.-+|+.+..||.|.||.||-|.+..||...|+|+++..... +...++++.|+.. ++.+||.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34899999999999999999999999999999999765433 2233444444432 35578999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
|||+||+|.++++ +++..+|...+.|..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+.+..
T Consensus 1314 EyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999999995 55788999999999999999999999999999999999999999999999999998776543
Q ss_pred -ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHH-HHHHh-ccCCCCCccCCH
Q 005007 491 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVL-NRTPPIPEMLSS 567 (720)
Q Consensus 491 -~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~-i~ki~-~~~~~iP~~ls~ 567 (720)
......||+.|||||++.+... .....++||||||||+.||+||+.||...+..-+ ++++. +..+++|+.++.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~----kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKG----KGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred HHHHhhcCCchhcCchhhccccc----CCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence 2235779999999999986432 2345699999999999999999999998766544 44443 568899999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+.+|||.+||..||++|+++.|||+|.|-+..
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999999999999999999999987643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.76 Aligned_cols=243 Identities=33% Similarity=0.624 Sum_probs=194.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHh-h-----------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLE-Q-----------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~-~-----------------~~~~ 409 (720)
....|++.+.||+|+||.||+|.+..+++.||||++........ +...+..+. + .+..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 34679999999999999999999999999999999875433222 122222221 1 0246
Q ss_pred EEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
+|+||||+.+++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 89999999999999999764 34689999999999999999999999999999999999999999999999999976543
Q ss_pred c-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCccC
Q 005007 489 L-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPEML 565 (720)
Q Consensus 489 ~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~~l 565 (720)
. .......|+..|+|||++.+... ....++.++|||||||++|||++|+.||...........+.... ...+..+
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241 (272)
T ss_pred ccccCCcccccccccCHhHhccccC--cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence 2 22345678999999999864221 13457889999999999999999999997765544444433221 2223457
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+.++.+||.+||..||.+|||+.|+++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.42 Aligned_cols=233 Identities=24% Similarity=0.443 Sum_probs=185.1
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCCC--------hhHHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--------~~~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
||+|+||+||++.++.+|+.||+|++...... ..+.+++..+.+ .+..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999988632111 112223333321 25678999999999999
Q ss_pred HHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCC
Q 005007 423 NRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 501 (720)
Q Consensus 423 ~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~Y 501 (720)
.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............|+..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 98886532 35899999999999999999999999999999999999999999999999999876544433456789999
Q ss_pred CChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCC-ccCCHHHHHHHHHh
Q 005007 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIP-EMLSSEGKDFLLRC 576 (720)
Q Consensus 502 mAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP-~~ls~el~dLI~~c 576 (720)
+|||++.+ ..++.++|||||||++|||++|+.||..... .+............+ ..++.++++||.+|
T Consensus 161 ~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 161 MAPEILKE-------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233 (277)
T ss_pred cCHHHHcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence 99999863 3478899999999999999999999976433 222233333332222 45899999999999
Q ss_pred hhcCCCCCCCH----HHHHcCcccccccc
Q 005007 577 FLRNPVERPSA----VELLEHPFIRNANY 601 (720)
Q Consensus 577 L~~dP~kRPTa----~ELL~Hpff~~~~~ 601 (720)
|+.||++||++ ++++.|+||+...+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 99999999999 67889999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.04 Aligned_cols=241 Identities=27% Similarity=0.457 Sum_probs=199.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC-CcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~t-g~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
....|.+.++||+|+||.||+|.+..+ +..||+|.+....... .++.++..+.+ .++++||||
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 344699999999999999999998887 7889999765432111 11222222221 357899999
Q ss_pred EeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 415 EYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
||++||+|.++|.+. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999999988642 3468999999999999999999999999999999999999999999999999998765432
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCH
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 567 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~ 567 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..++.+ ...+|..++.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~ 297 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWER-------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSS 297 (478)
T ss_pred cccccccCCCccccCHhHhCC-------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCH
Confidence 2345679999999999863 45788999999999999999999999887777777776654 3456778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||..||++||+++++|.|+|++..
T Consensus 298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999999999753
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.93 Aligned_cols=235 Identities=32% Similarity=0.541 Sum_probs=184.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHh-----------hcCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLE-----------QVDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~-----------~~~~~lyLVmEy 416 (720)
+|++.+.||+|+||+||+|.+..+|+.||+|+++..... ..+++.++.+. ...+.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 589999999999999999999999999999988653221 12223333222 135678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
+. ++|.+++....+.+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 97 68888887655779999999999999999999999999999999999999999999999999998654322 22334
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCC-CCCcHHHHHHHhcc-----------------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVLNR----------------- 557 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~-~~~~~~~i~ki~~~----------------- 557 (720)
.++..|+|||++.+ ...++.++|||||||++|||++|..||. ..+..+.+..+...
T Consensus 160 ~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 160 VVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred ccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 67899999999864 3456789999999999999999988854 33333332222110
Q ss_pred ---CC---------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 558 ---TP---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 558 ---~~---------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.. .....+++++++||.+||+.||.+|||++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.22 Aligned_cols=233 Identities=27% Similarity=0.475 Sum_probs=186.3
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--H---HHH---HHHHhh--------------cCCEEEEEEEecc
Q 005007 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--S---AEC---IKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--~---~~~---ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
+||+|+||.||+|.+..+++.||||++........ . .+. +..+.. .++..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999998864322111 1 111 111110 2467899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GT 498 (720)
||+|.+++... +.+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... .....||
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence 99999998765 569999999999999999999999999999999999999999999999999987554322 2345689
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc--HHHHHH-HhccCCCCCccCCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFK-VLNRTPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--~~~i~k-i~~~~~~iP~~ls~el~dLI~~ 575 (720)
..|+|||++.. ...++.++|||||||++|||++|..||..... ...+.. .......+|..++.+++++|.+
T Consensus 159 ~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 159 HGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 99999998752 23577899999999999999999999975432 222222 2234456778899999999999
Q ss_pred hhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 576 CFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 576 cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
||..||.+|+ ++.|+++||||+..++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 9999999999 6999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.44 Aligned_cols=245 Identities=29% Similarity=0.513 Sum_probs=201.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--h------HHHHHHHHh-----------hcCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--K------SAECIKQLE-----------QVDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~------~~~~ik~L~-----------~~~~~lyLVm 414 (720)
++|++.+.||+|+||+||+|.+..+++.||||.+....... . +.+.+..+. ..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999887543221 1 112222221 1356789999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc---
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--- 490 (720)
||+.|++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999753 3569999999999999999999999999999999999999999999999999986542211
Q ss_pred ---------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCC
Q 005007 491 ---------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 543 (720)
Q Consensus 491 ---------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~ 543 (720)
......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-------DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 1123468999999999863 356789999999999999999999998
Q ss_pred CCCcHHHHHHHhccCCCCCcc--CCHHHHHHHHHhhhcCCCCCCC----HHHHHcCcccccccccCCC
Q 005007 544 EFEGPQAMFKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPS----AVELLEHPFIRNANYQNLS 605 (720)
Q Consensus 544 ~~~~~~~i~ki~~~~~~iP~~--ls~el~dLI~~cL~~dP~kRPT----a~ELL~Hpff~~~~~~~l~ 605 (720)
..+....+.++......++.. ++.+++++|.+||..||++||| ++|+|+|+||+...+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 234 GSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred CCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 887777777777666555554 6899999999999999999999 9999999999887665443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.05 Aligned_cols=236 Identities=32% Similarity=0.585 Sum_probs=189.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
++|++.+.||+|+||.||+|.++.+|+.||||++...... ..++++++.+.+ ....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999999999999999988643221 122333333322 2457899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 99988888777543 569999999999999999999999999999999999999999999999999998765433 2234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..++..|+|||++.+ ...++.++|||||||++|||++|++||.+....+....+....
T Consensus 160 ~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 160 YVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 568899999999863 3457789999999999999999999998766555444332100
Q ss_pred ---CCCC------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 ---PPIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ---~~iP------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
...| ..++.++.+||.+||+.+|++|||+.|+|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0001 2357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.45 Aligned_cols=233 Identities=25% Similarity=0.420 Sum_probs=186.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHh-h-----------cC--CEEEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLE-Q-----------VD--DHLYIYLE 415 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~-~-----------~~--~~lyLVmE 415 (720)
|++.+.||+|+||.||+|.+..+++.||||+++....... +...+..+. + .+ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7789999999999999999999999999998875322211 122222221 1 12 67899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
|+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++...........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence 997 6888888765567999999999999999999999999999999999999999 99999999999876544444456
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc------------------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------------ 557 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------------------ 557 (720)
.++..|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+...
T Consensus 159 ~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 159 ISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 68999999998753 245678999999999999999999999876654444333210
Q ss_pred CCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 558 TPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 558 ~~~iP-----------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
...++ ..++.++.+||.+||..+|++|||++++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 01111 2467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.58 Aligned_cols=235 Identities=29% Similarity=0.549 Sum_probs=195.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-H------HHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-S------AECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~------~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|.+.+.||+|+||.||+|.+..+++.|++|++........ . .+.+..+.+ .++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58899999999999999999999999999999865322211 1 111222211 25678999999
Q ss_pred ccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 417 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
+.|++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999764 4578999999999999999999999999999999999999999999999999988664432 2234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
..|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ...++..++.++.++|
T Consensus 161 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08529 161 IVGTPYYLSPELCED-------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233 (256)
T ss_pred cccCccccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 568999999999863 44778999999999999999999999887766666666544 3456667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+||+.+|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=319.47 Aligned_cols=237 Identities=32% Similarity=0.607 Sum_probs=194.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
++|++++.||.|+||+||+|.+..++..||||++......... .++++.+.. .++..|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4799999999999999999999999999999988654322211 122222221 25678999999
Q ss_pred ccCCCHHHHHHHh--cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---
Q 005007 417 VHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--- 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--- 491 (720)
+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999764 24689999999999999999999999999999999999999999999999999977654322
Q ss_pred --cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-CC-----c
Q 005007 492 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IP-----E 563 (720)
Q Consensus 492 --~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~-iP-----~ 563 (720)
.....|+..|+|||++... ..++.++|||||||++|||++|+.||........+.++...... ++ .
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQV------HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred cccccccCChhhcChHHHccc------cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 2345689999999998741 35778999999999999999999999887766666665544321 22 2
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.++.+++++|.+||.+||++||++.+|++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 567899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.11 Aligned_cols=237 Identities=23% Similarity=0.343 Sum_probs=184.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh-----------cCCEEEEEEEeccCCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----------VDDHLYIYLEYVHPGS 421 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-----------~~~~lyLVmEy~~gGs 421 (720)
...|++++.||+|+||+||+|.+..+++.||+|+..... ...+..+++.+.+ ..+..|+||||+. ++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 357999999999999999999999999999999754322 2223333333322 3567899999995 78
Q ss_pred HHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCC
Q 005007 422 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 501 (720)
Q Consensus 422 L~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~Y 501 (720)
|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++............||+.|
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y 222 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccc
Confidence 99988776678999999999999999999999999999999999999999999999999999764443344456799999
Q ss_pred CChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCC-CCCCCCCcH---------HHHHHHhcc----CCCCC-----
Q 005007 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGP---------QAMFKVLNR----TPPIP----- 562 (720)
Q Consensus 502 mAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk-~PF~~~~~~---------~~i~ki~~~----~~~iP----- 562 (720)
+|||++.+ ..++.++|||||||++|||+++. ++|...... ..+..++.. ...++
T Consensus 223 ~aPE~~~~-------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 223 NAPEVLAR-------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred cCCeecCC-------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 99999863 45788999999999999999854 444432111 111111110 00111
Q ss_pred -------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 563 -------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 563 -------------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134667888999999999999999999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=325.75 Aligned_cols=245 Identities=30% Similarity=0.528 Sum_probs=193.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHH-------hh-----------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-------EQ-----------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L-------~~-----------~~~~lyLVmE 415 (720)
++|++.+.||+|+||.||+|.+..+|+.||||+++...........+..+ .. .++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999999999999999987543322222221111 10 2456899999
Q ss_pred eccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 416 YVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 416 y~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|++ |+|.+++... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 997 7888887642 34689999999999999999999998 999999999999999999999999999987654333
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-cHHHHHHHhcc-CCCCC-ccCCHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLNR-TPPIP-EMLSSE 568 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-~~~~i~ki~~~-~~~iP-~~ls~e 568 (720)
.....|+..|+|||++.+... ...++.++|||||||++|||++|+.||.... ..+.+..+... ...++ ..++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELN---QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred cccccCCccccChhhcCCccc---ccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 334568999999998864211 1346789999999999999999999997533 33444444432 33343 357899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
+.+||.+||..+|++||++.++++|+||+.....
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 9999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=318.50 Aligned_cols=235 Identities=54% Similarity=0.974 Sum_probs=194.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh--------------cCCEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~--------------~~~~lyLV 413 (720)
+|++.+.||+|+||+||+|.+..++..||||++....... ....++..+.. .++.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999999999999999886543211 11111222211 24678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999999999999765 568999999999999999999999999999999999999999999999999988765444345
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el~d 571 (720)
...|+..|++||.+.. ...++.++|+|||||++|+|++|+.||..........++.. ....++..++.++++
T Consensus 160 ~~~~~~~y~~pe~~~~------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 160 SFKGSPYWMAPEVIAQ------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred ccCCCcceeCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 5678999999999863 11378899999999999999999999987765555554443 344567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
||.+||..+|.+||++.++|.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.69 Aligned_cols=234 Identities=48% Similarity=0.824 Sum_probs=194.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--------------HHHHHHHHhh-----------cCCE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--------------SAECIKQLEQ-----------VDDH 409 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--------------~~~~ik~L~~-----------~~~~ 409 (720)
+|.+++.||+|+||.||+|.+..+++.||+|++........ +..++..+.+ .++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 58899999999999999999999999999998865432211 1112222221 2567
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 89999999999999999765 67999999999999999999999999999999999999999999999999999866521
Q ss_pred c-------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCC
Q 005007 490 S-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI 561 (720)
Q Consensus 490 ~-------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~i 561 (720)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+.++... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232 (267)
T ss_pred cccCCccccccccCCCcCccChhHhcc-------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence 1 1123468899999999863 35678899999999999999999999887666666655443 4567
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+..++.++.++|++||+.||.+||++.|+++|+||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 77899999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.36 Aligned_cols=234 Identities=28% Similarity=0.472 Sum_probs=189.4
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--h------hHHHHHHHHhh--------------cCCEEEEEEEecc
Q 005007 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--P------KSAECIKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~------~~~~~ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
+||+|+||+||+|.+..+++.||||.+...... . .+...+..+.. .++.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999988643211 1 01111112211 2467899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GT 498 (720)
||+|.+++... +.+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.... .....|+
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence 99999998654 679999999999999999999999999999999999999999999999999987654322 2345799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC---cHHHHHHHhccCCCCCccCCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRTPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~---~~~~i~ki~~~~~~iP~~ls~el~dLI~~ 575 (720)
..|+|||++.+ ...++.++||||+||++|||++|+.||.... .......+......+|..++.++.++|.+
T Consensus 159 ~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 159 HGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence 99999999863 2347789999999999999999999997652 22333333444567777889999999999
Q ss_pred hhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 576 CFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 576 cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
||..+|.+|+ ++.++++||||+...+.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 9999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.51 Aligned_cols=235 Identities=44% Similarity=0.814 Sum_probs=191.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hh-------HHHHHHHHhh-------------cCCEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PK-------SAECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~-------~~~~ik~L~~-------------~~~~l 410 (720)
.+|+++++||+|+||+||+|++..+|+.||||++...... .. +...+..+.+ .+..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999988643221 11 1122222211 12468
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~- 489 (720)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 8999999999999999765 56899999999999999999999999999999999999999999999999998765321
Q ss_pred ---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCcc
Q 005007 490 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 564 (720)
Q Consensus 490 ---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~~ 564 (720)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||........+.++... .+.+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233 (265)
T ss_pred ccccccccCCCCccccChhhhcC-------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence 11234568999999999863 34678999999999999999999999877666555554432 3456777
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
++..+.++|.+||. +|++||+++|+++|+|++
T Consensus 234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 88999999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.88 Aligned_cols=235 Identities=30% Similarity=0.553 Sum_probs=185.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
+|++.+.||+|+||+||+|++..+++.||||++....... ....++..+.. .++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999999999999986543221 11222222221 25678999999
Q ss_pred ccCCCHHHHHHHhc--CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccc
Q 005007 417 VHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~ 493 (720)
+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 68988886432 568999999999999999999999999999999999999999999999999987553221 122
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------------- 558 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--------------- 558 (720)
...+++.|+|||++.+ ...++.++|||||||++|||++|++||........+..+....
T Consensus 160 ~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 160 HEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 3457899999999863 2446789999999999999999999998765544333321100
Q ss_pred --------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 --------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 --------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
......+++++++||.+||+.||.+|||+.+||+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.05 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=191.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCChhHHHHHHHHhh-----------cCCEEEEEEEecc
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQ-----------VDDHLYIYLEYVH 418 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-----------~~~~lyLVmEy~~ 418 (720)
...+|++++.||+|+||+||+|... .++..||||.+........++++++.+.+ .++.+|+||||+.
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 3458999999999999999999754 45688999988754444455555555543 2467899999996
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---cccc
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSL 495 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~ 495 (720)
++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++....... ....
T Consensus 170 -~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~ 247 (392)
T PHA03207 170 -CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247 (392)
T ss_pred -CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccc
Confidence 789888843 46799999999999999999999999999999999999999999999999999976543322 2346
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhcc---------------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNR--------------- 557 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~--------------- 557 (720)
.||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+... ...+..++..
T Consensus 248 ~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 248 SGTLETNSPELLAL-------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccCccCHhHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 79999999999863 4578899999999999999999999965432 1122221110
Q ss_pred --------------CCCCC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccCC
Q 005007 558 --------------TPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 558 --------------~~~iP-----~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~l 604 (720)
...+| ..++.++++||.+||..||++|||+.|+|.||||.....+.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 01111 134678899999999999999999999999999987655443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.65 Aligned_cols=242 Identities=26% Similarity=0.439 Sum_probs=194.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh-------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~-------------~~~~lyL 412 (720)
..+|++.+.||+|+||+||+|.+..+|+.||||+++..... ..++.+++.+.+ ..+.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45899999999999999999999999999999998643321 123333444332 1246899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-c
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~ 491 (720)
||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 999997 58998887655679999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-------------
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------- 558 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------------- 558 (720)
.....+++.|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+....
T Consensus 165 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 165 MTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 223346888999999863 3457789999999999999999999998877766655544310
Q ss_pred ------CCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 559 ------PPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 559 ------~~iP-----------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
..++ ..+++++.+||.+||..||++|||+.|+|.|+||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0011 125788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.10 Aligned_cols=244 Identities=34% Similarity=0.633 Sum_probs=199.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
++|++.+.||.|+||+||+|.+..++..||+|.++...... .+++.+..+.+ .++.+|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 57999999999999999999999999999999987542111 11222222221 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
++++|.+++.+....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ......
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI 164 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceee
Confidence 9999999998766779999999999999999999999999999999999999999999999999987653322 223456
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDFL 573 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dLI 573 (720)
|++.|+|||++..... ....++.++|||||||++|||++|++||...+....+.++..... ..+..++.++.++|
T Consensus 165 ~~~~y~~PE~~~~~~~--~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (280)
T cd06611 165 GTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242 (280)
T ss_pred cchhhcCHHHHhhccc--CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHH
Confidence 8999999999864211 123467899999999999999999999988777666666655432 34567899999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+||+.+|.+||+++++|+|+||...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 243 KSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.80 Aligned_cols=244 Identities=35% Similarity=0.614 Sum_probs=194.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHh-h----------------cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLE-Q----------------VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~-~----------------~~~~ 409 (720)
...++|++.+.||+|+||+||+|.+..+++.||||+++....... +...+..+. + .++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 345799999999999999999999999999999998864332211 222333332 1 1346
Q ss_pred EEEEEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 410 LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
+|+||||++|++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 8999999999999998853 2356899999999999999999999999999999999999999999999999998765
Q ss_pred cCcc-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCCC
Q 005007 487 TGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIP 562 (720)
Q Consensus 487 ~~~~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~iP 562 (720)
.... ......|++.|+|||++...... ...++.++|||||||++|||++|+.||........+.++.... ...+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQL--DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhc--cccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCC
Confidence 4322 22345689999999998642211 2347889999999999999999999998766555544433221 2235
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..++.++.+||.+||+.||++|||+.|+|+|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 5678899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=320.51 Aligned_cols=233 Identities=39% Similarity=0.780 Sum_probs=190.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----------hHHHHHHHHhh-----------cCCEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----------KSAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----------~~~~~ik~L~~-----------~~~~lyL 412 (720)
+|++++.||.|+||+||+|.+ .+|+.+|||.++...... .+.+.++.+.+ .++.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 478999999887543211 11112222221 2457899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~--- 489 (720)
||||++|++|.+++.+. ..+++..+..++.||+.||+|||+.+|+|+||||+|||++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999999765 56899999999999999999999999999999999999999999999999998765321
Q ss_pred ----cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CCCCC
Q 005007 490 ----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIP 562 (720)
Q Consensus 490 ----~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~~iP 562 (720)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+... .+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE-------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231 (265)
T ss_pred ccccccccccCCCccccChhhhcC-------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence 11224568999999999863 44678999999999999999999999876655554444332 34567
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..++.++.++|++||..+|.+||++.|+|+||||
T Consensus 232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 7789999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=324.71 Aligned_cols=236 Identities=29% Similarity=0.527 Sum_probs=190.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|++++.||+|+||.||+|.+..+|+.||||++........ +..+++.+.. .++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999999999999999875432111 1122222211 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--cccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~t 494 (720)
+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 999999997766779999999999999999999999999999999999999999999999999998765432 1234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------------- 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--------------- 559 (720)
..|+.+|+|||++.+ ...++.++|||||||++|||++|.++|........+..++....
T Consensus 160 ~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 160 QVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 568999999998753 34567899999999999999999999977665554444332100
Q ss_pred ---------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 560 ---------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 560 ---------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
.+....+.++.+||++||..||.+|||++++|+||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01123568999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.39 Aligned_cols=247 Identities=35% Similarity=0.607 Sum_probs=198.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--h---HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--K---SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~---~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
.+.|++++.||.|+||.||+|.+..+++.||+|.+....... . +...+..+.+ .++.+|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999999999999999986432110 1 1111222221 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
+.|++|..++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 170 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF 170 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccccee
Confidence 9999999988766577999999999999999999999999999999999999999999999999998754332 222345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dL 572 (720)
.+++.|+|||++.+.... ...++.++|||||||++|||++|++||...+....+.++..... ..+..++.++.++
T Consensus 171 ~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 171 IGTPYWMAPEVVMCETMK--DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred cCCccccCceeecccccc--CCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 689999999998532211 23467899999999999999999999987766555555543322 2355688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
|.+||..||++||+++|+|+||||.....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 99999999999999999999999976553
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.46 Aligned_cols=235 Identities=44% Similarity=0.857 Sum_probs=190.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----------HHHHHHHHhh-------------cCCEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----------SAECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----------~~~~ik~L~~-------------~~~~l 410 (720)
..|+.++.||+|+||.||+|.+..++..||+|++........ +...+..+.+ .++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999998865432211 1122222221 13568
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~- 489 (720)
+++|||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999999999764 56899999999999999999999999999999999999999999999999998765321
Q ss_pred ---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCcc
Q 005007 490 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEM 564 (720)
Q Consensus 490 ---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~~ 564 (720)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........+.++.. ..+.+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISG-------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233 (266)
T ss_pred ccCCccccCCccccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchh
Confidence 11123558899999999863 4577899999999999999999999987766555554433 24556777
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
+++.++++| +||..+|++||+++|+++||||+
T Consensus 234 ~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 234 ISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred cCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 899999999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.74 Aligned_cols=225 Identities=32% Similarity=0.599 Sum_probs=196.9
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhc-----------CCEEEEEEEeccCCCHHHH
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV-----------DDHLYIYLEYVHPGSINRY 425 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~-----------~~~lyLVmEy~~gGsL~~~ 425 (720)
..++.||.|+.|.||+|+.. ++.||||+|+..+. ..++.+..|.+. .-.+|||||||..|.|..+
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elkE--TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELKE--TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhhhh--hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 44678999999999999876 78999998874321 223333333321 3458999999999999999
Q ss_pred HHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChH
Q 005007 426 VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 505 (720)
Q Consensus 426 L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPE 505 (720)
|+.. ..++......|..+|+.||.|||.++|||||||.-||||..+..|||+|||-++...+....+.++||..|||||
T Consensus 203 Lka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPE 281 (904)
T KOG4721|consen 203 LKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPE 281 (904)
T ss_pred Hhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHH
Confidence 9764 779999999999999999999999999999999999999999999999999999998888889999999999999
Q ss_pred HHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCC
Q 005007 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVE 583 (720)
Q Consensus 506 vl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~k 583 (720)
+|. +..++.++|||||||||||||||..||.+.+..+++.-+-.. ..++|..+++.++-||+.||+-+|..
T Consensus 282 vIr-------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 282 VIR-------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred Hhh-------cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 998 578999999999999999999999999998887777665544 35678999999999999999999999
Q ss_pred CCCHHHHHcC
Q 005007 584 RPSAVELLEH 593 (720)
Q Consensus 584 RPTa~ELL~H 593 (720)
||++.+||.|
T Consensus 355 RPSFrqil~H 364 (904)
T KOG4721|consen 355 RPSFRQILLH 364 (904)
T ss_pred CccHHHHHHH
Confidence 9999999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=347.12 Aligned_cols=237 Identities=28% Similarity=0.437 Sum_probs=189.9
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH----Hhh-------------cCCEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQ-------------VDDHLY 411 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~----L~~-------------~~~~ly 411 (720)
++...++..++..||+|.||+||+|.+-. .||||++++....+...+.++. |.+ .+..+.
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 34445677899999999999999999864 5999999877655544333322 222 134458
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc---C
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---G 488 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~---~ 488 (720)
||..+|+|.+|+.+|+.....|....++.|++||++||.|||.++|||||||..||||.+++.|||+||||+.... +
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 8999999999999998777789999999999999999999999999999999999999999999999999986543 2
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-----CCCCc
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPE 563 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-----~~iP~ 563 (720)
........|...|||||+++. + ....|++.+||||||||+|||++|..||.....+++++.+-.+. ..+-.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRm--q--d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRM--Q--DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred ccccCCCccchhhhcHHHHhh--c--ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 233344568889999999983 2 25679999999999999999999999999544444444433331 12234
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++.++++|+..||..++++||.+.+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 57789999999999999999999999986
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.23 Aligned_cols=235 Identities=31% Similarity=0.477 Sum_probs=194.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh----------------cCCEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ----------------VDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~----------------~~~~lyLVm 414 (720)
+|++.+.||.|+||.||+|.+..+++.||+|++.......... .++..+.. .+..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986543222211 11221211 134579999
Q ss_pred EeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHH-----hCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 415 EYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLH-----STNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLH-----s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999653 467999999999999999999999 999999999999999999999999999999877
Q ss_pred cCccc-cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 487 TGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 487 ~~~~~-~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
..... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+... ...++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNH-------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233 (265)
T ss_pred cCCcccccccccCCCccChhhhcC-------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccc
Confidence 55433 345678999999999863 34778999999999999999999999887655555554443 3456778
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
++.++.++|.+||..+|++|||+.+||+|||+
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 89999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=326.78 Aligned_cols=240 Identities=28% Similarity=0.502 Sum_probs=191.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---h-------hHHHHHHHHhh-----------cCCEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---P-------KSAECIKQLEQ-----------VDDHLYIY 413 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~-------~~~~~ik~L~~-----------~~~~lyLV 413 (720)
+|++.+.||+|+||.||+|.+..+|+.||||+++..... . .+.+.++.+.+ .++.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999999999999998754322 1 11222222221 24678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~ 492 (720)
|||+ +|+|.+++......+++..++.++.||++||.|||++||+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999997654479999999999999999999999999999999999999999999999999997664432 22
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-------------
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------- 559 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~------------- 559 (720)
....+++.|+|||++.+ ...++.++|||||||++|||++|.++|......+.+.++.....
T Consensus 160 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 160 THQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred cccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 23456889999998853 34567899999999999999999998887666555444432100
Q ss_pred ----------C-----CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 560 ----------P-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 560 ----------~-----iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
. +...++.++.+||.+||..||++|||+.|+|+|+||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 0 11235788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=318.30 Aligned_cols=236 Identities=41% Similarity=0.683 Sum_probs=194.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh--------------cCCEEEEEEEeccC
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ--------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~--------------~~~~lyLVmEy~~g 419 (720)
++|++.+.||+|+||.||+|.+..++..||+|.+..........+++..+.. .+..+|++|||+.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 5899999999999999999999999999999998754321111222222221 24678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccccCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGS 498 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~GT 498 (720)
++|.+++......+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++....... ......|+
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 162 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCC
Confidence 99999998766789999999999999999999999999999999999999999999999999998765433 22345588
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CCCCCccCCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~~iP~~ls~el~dLI~~ 575 (720)
..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ....+..++.++.++|.+
T Consensus 163 ~~y~~PE~~~~-------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 163 PFWMAPEVIQE-------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccccCHHHHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 99999999863 35788999999999999999999999876555544443322 223345678899999999
Q ss_pred hhhcCCCCCCCHHHHHcCccc
Q 005007 576 CFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~Hpff 596 (720)
||+.||.+|||+.|+|+|+||
T Consensus 236 ~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=324.33 Aligned_cols=243 Identities=35% Similarity=0.635 Sum_probs=193.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh------------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ------------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~------------------~~~~ 409 (720)
....|++.+.||.|+||.||+|.+..+++.||+|++........ +...+..+.. .++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 34689999999999999999999999999999998865432211 1122222211 1356
Q ss_pred EEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 89999999999999999764 34588999999999999999999999999999999999999999999999999876542
Q ss_pred c-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--CCCccC
Q 005007 489 L-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEML 565 (720)
Q Consensus 489 ~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--~iP~~l 565 (720)
. .......|++.|+|||++.... .....++.++|||||||++|||++|+.||........+..+..... .....+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDE--NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW 251 (282)
T ss_pred cccCCCcccccccccCHhhcCccc--CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccccc
Confidence 2 2234567899999999875311 1134578899999999999999999999987665555444433221 123457
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+.++.+||.+||..||.+|||+.|||+||||
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=325.58 Aligned_cols=245 Identities=31% Similarity=0.595 Sum_probs=194.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHh-----------hcCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLE-----------QVDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~-----------~~~~~lyLVmEy 416 (720)
++|++++.||+|+||+||+|.+..+|..||+|.+........ +.+.++.+. ..++.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 378999999999999999999999999999998875432221 111222111 136789999999
Q ss_pred ccCCCHHHHHHHh--cCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 417 VHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
++|++|..++... ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccc
Confidence 9999999998653 2369999999999999999999996 59999999999999999999999999999765432 223
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH---HHhc-cCCCCCccCCHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLN-RTPPIPEMLSSEG 569 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~---ki~~-~~~~iP~~ls~el 569 (720)
...|+..|+|||++.+.... ....++.++|||||||++|||++|+.||.......... .+.. ....++..++.++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPN-QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred cCCCccCccCcchhcCCCCC-ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 45688899999998642211 22356889999999999999999999997654433222 2222 3455677799999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+||.+||..+|++||++.++++|+||....
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.28 Aligned_cols=234 Identities=29% Similarity=0.480 Sum_probs=195.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHh--------------hcCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLE--------------QVDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~--------------~~~~~lyLVmE 415 (720)
+|++.+.||.|+||.||+|.+..+++.||+|++....... ...++++.+. +.++.+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999999999999886432111 1111112111 23667999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
|+.|++|.+++... ..+++..+..|+.||++||.|||++||+|+||||+|||++.++.++|+|||++............
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999999999765 67999999999999999999999999999999999999999999999999999876554444556
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc--HHHHHHHhc-cCCCCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--~~~i~ki~~-~~~~iP~~ls~el~dL 572 (720)
.|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+.+... ....+|..++.++.++
T Consensus 160 ~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 160 SGTPGYMAPEVLCR-------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232 (258)
T ss_pred CCChhhcCHHHHcc-------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH
Confidence 78999999999863 3477899999999999999999999987664 333333333 5667788899999999
Q ss_pred HHHhhhcCCCCCCCH--HHHHcCccc
Q 005007 573 LLRCFLRNPVERPSA--VELLEHPFI 596 (720)
Q Consensus 573 I~~cL~~dP~kRPTa--~ELL~Hpff 596 (720)
|.+||..||.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.39 Aligned_cols=243 Identities=37% Similarity=0.660 Sum_probs=195.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh------------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ------------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~------------------~~~~ 409 (720)
..++|++.+.||+|+||+||+|.++.+++.||+|++........ +.+.++.+.. ..+.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 34799999999999999999999999999999999875433221 2223333321 0234
Q ss_pred EEEEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 410 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 79999999999999998653 357999999999999999999999999999999999999999999999999998765
Q ss_pred cCc-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCC
Q 005007 487 TGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIP 562 (720)
Q Consensus 487 ~~~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP 562 (720)
... .......|+..|+|||++.+... ....++.++|||||||+||+|++|+.||........+..+..... ..+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQ--PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred ccchhhhcCccccccccCHhHhccccc--ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence 332 22234568999999999864322 134678899999999999999999999987666666666554322 223
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..++.++++||.+||..||.+|||+.|+++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.73 Aligned_cols=244 Identities=35% Similarity=0.608 Sum_probs=195.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh-----------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ-----------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~-----------------~~~~l 410 (720)
..++|.+.+.||+|+||+||+|.+..+++.||||++........ +...+..+.. ..+.+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 45789999999999999999999999999999998865322211 2222222311 02458
Q ss_pred EEEEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 411 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
|+||||+.|++|.++++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999999998863 33568999999999999999999999999999999999999999999999999988654
Q ss_pred Ccc-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCc
Q 005007 488 GLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPE 563 (720)
Q Consensus 488 ~~~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~ 563 (720)
... ......|+..|+|||++..... ....++.++|||||||++|||++|++||........+..+..... ..++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQ--YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccCccCCccccChhhhcCCCC--cccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 322 2234568999999999863211 122467899999999999999999999988766666665544322 2355
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
.+..++.+||.+||+.+|++||++.|+|+||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 6778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=334.41 Aligned_cols=237 Identities=24% Similarity=0.446 Sum_probs=183.4
Q ss_pred EeeEEeec--CCeEEEEEEECCCCcEEEEEEeccCCCChhHH-------HHHHHHhh-----------cCCEEEEEEEec
Q 005007 358 KGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-------ECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 358 i~k~LG~G--~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~-------~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
++++||+| +|++||++.++.+|+.||||+++......... ++++.+.+ .++.+|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999999999999999987643322211 12222221 256789999999
Q ss_pred cCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc------
Q 005007 418 HPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS------ 490 (720)
Q Consensus 418 ~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~------ 490 (720)
++|+|.+++..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999754 3458999999999999999999999999999999999999999999999998764432111
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---------
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------- 559 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--------- 559 (720)
......++..|+|||++.+. ...++.++|||||||++|||++|+.||........+........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccceecccChHHhhcc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 11223467889999998641 13478899999999999999999999986554443333222110
Q ss_pred -------------------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 560 -------------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 560 -------------------------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+....+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112346789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=314.95 Aligned_cols=235 Identities=27% Similarity=0.535 Sum_probs=194.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|++.+.||+|+||.||+|.+..+++.||||++......... .+.++.+.+ .++.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999999999999999998754322111 112222211 25678999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhccCcccccc
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~~~~~~~~t 494 (720)
+++++|.+++.+.. ..+++..+..++.||+.||+|||++||+|+||||+|||++.+ +.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997643 458999999999999999999999999999999999999865 4689999999987755444445
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
..|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+... ...++..++.+++++|
T Consensus 161 ~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (256)
T cd08220 161 VVGTPCYISPELCEG-------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI 233 (256)
T ss_pred cccCCcccCchhccC-------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHH
Confidence 678999999999863 34678999999999999999999999887766666665543 4456778999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+||..+|.+|||+.|+|+||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=322.41 Aligned_cols=239 Identities=38% Similarity=0.636 Sum_probs=197.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
++|++.+.||.|+||.||+|.+..+++.||||++........ +++.+..+.+ .+..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 478999999999999999999999999999999875432211 1122222222 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
+.+++|.+++... .+++..++.++.||+.||.|||+++|+||||+|+||+++.++.++|+|||+++..... ......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 9999999999753 7999999999999999999999999999999999999999999999999999876543 233456
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCcc-CCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEM-LSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~-ls~el~dLI 573 (720)
.|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+... .+.++.. ++.++.++|
T Consensus 159 ~~~~~y~~PE~~~~-------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 159 VGTPFWMAPEVIKQ-------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 78999999999873 34788999999999999999999999876655555554433 3344444 789999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.+||..+|++|||++++++|+||+....
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 9999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=322.80 Aligned_cols=238 Identities=34% Similarity=0.578 Sum_probs=189.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
.++|++.+.||+|+||.||+|.+..+++.||||.++...... ...+++..+.. .++.+|+||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 358999999999999999999999999999999987543221 11112222221 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
+.+++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... ......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 88 CGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 9999999999764 67999999999999999999999999999999999999999999999999998765432 122345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC-----ccCCHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP-----EMLSSEGK 570 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP-----~~ls~el~ 570 (720)
.|+..|+|||++... ....++.++|||||||++|||++|..||........+..........+ ..++..+.
T Consensus 167 ~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 167 IGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 789999999997421 123477899999999999999999999976555444443332222111 24678999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
+||.+||..+|++||+++++++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.84 Aligned_cols=243 Identities=33% Similarity=0.580 Sum_probs=196.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEEEecc
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYLEYVH 418 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVmEy~~ 418 (720)
.|++.+.||+|+||.||+|.+..++..+|+|.+....... .+++.+..+.+ .++..|+||||+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 4788999999999999999999999999999886432110 11122222221 2567899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccccC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKG 497 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~~G 497 (720)
+++|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .......|
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence 99999988765567999999999999999999999999999999999999999999999999998765432 22234568
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCCCccCCHHHHHHHH
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEGKDFLL 574 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~iP~~ls~el~dLI~ 574 (720)
+..|+|||++..... ....++.++|||||||++|||++|++||......+.+..+.... ...|..++.++++||.
T Consensus 166 ~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 166 TPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccCHhhccccCC--CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 999999999853211 12456789999999999999999999998877666666655432 2345678899999999
Q ss_pred HhhhcCCCCCCCHHHHHcCcccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+||..||.+||+++++++||||...
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=321.36 Aligned_cols=238 Identities=34% Similarity=0.545 Sum_probs=189.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..+|++++.||+|+||.||+|.+..+++.||||++....... ...+++..+.. .++.+|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 458999999999999999999999999999999987543211 11112222222 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 9999999998654 679999999999999999999999999999999999999999999999999998664322 22345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-----CCccCCHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-----IPEMLSSEGK 570 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~-----iP~~ls~el~ 570 (720)
.|+..|+|||++.+. ....++.++|||||||++|||++|+.||...........+...... .+..++.++.
T Consensus 167 ~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 167 IGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred ccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 689999999987531 1234678999999999999999999999765443333332222111 1234688999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
+||.+||..+|++|||+++||+|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=329.94 Aligned_cols=232 Identities=25% Similarity=0.462 Sum_probs=173.7
Q ss_pred EeeEEeecCCeEEEEEEECC--CCcEEEEEEeccCCCChhHHHH---HHHHhh-------------cCCEEEEEEEeccC
Q 005007 358 KGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAEC---IKQLEQ-------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~--tg~~VAVK~l~~~~~~~~~~~~---ik~L~~-------------~~~~lyLVmEy~~g 419 (720)
.+++||+|+||+||+|+++. ++..||+|.++.........++ ++.+.+ .+..+|+||||+.
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 45789999999999999654 6688999988754333333333 333321 2456899999996
Q ss_pred CCHHHHHHHh--------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee----cCCCCeeeeccccchhcc
Q 005007 420 GSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLT 487 (720)
Q Consensus 420 GsL~~~L~~~--------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL----d~~g~VKL~DFGlA~~~~ 487 (720)
++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 6788877532 1248899999999999999999999999999999999999 566799999999998654
Q ss_pred Ccc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH---------HHHHHH
Q 005007 488 GLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---------QAMFKV 554 (720)
Q Consensus 488 ~~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---------~~i~ki 554 (720)
... ......||+.|+|||++.+ ...++.++|||||||++|||++|++||...... ..+..+
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred CCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 322 2234568999999999863 345788999999999999999999999643211 111111
Q ss_pred h---c-----------cCC------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 555 L---N-----------RTP------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 555 ~---~-----------~~~------------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
. + ... ......+..+++||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.08 Aligned_cols=236 Identities=30% Similarity=0.532 Sum_probs=188.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
++|++.+.||+|+||.||+|.+..++..||+|.++....... +++++..+.+ .++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 379999999999999999999999999999998875422211 1222222221 35789999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
++|++|.+++... +.+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~ 158 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 158 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccC
Confidence 9999999999765 679999999999999999999997 69999999999999999999999999998765332 22456
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc------------------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------------ 557 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------------------ 557 (720)
.|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ..+...
T Consensus 159 ~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 159 VGTRSYMSPERLQG-------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred CCCcCccChhHhcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCC
Confidence 78999999998753 3477899999999999999999999965432221 111110
Q ss_pred --------------------CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 558 --------------------TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 558 --------------------~~~iP-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+.+| ..++.++++||.+||..||++|||+.|+++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 11112 1367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.22 Aligned_cols=235 Identities=37% Similarity=0.747 Sum_probs=189.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHH---hh-----------cCCEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQL---EQ-----------VDDHLYI 412 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L---~~-----------~~~~lyL 412 (720)
+|+.++.||+|+||.||+|.+..+++.||||++....... ....+++.+ .+ ..+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999987543211 111122222 21 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCcc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~- 490 (720)
||||+.|++|.+++.+. +.+++..++.|+.||+.||.|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999999999764 6799999999999999999999999999999999999998776 59999999987664321
Q ss_pred ----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH---HHHHHHh--ccCCCC
Q 005007 491 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVL--NRTPPI 561 (720)
Q Consensus 491 ----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---~~i~ki~--~~~~~i 561 (720)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+..+. .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232 (268)
T ss_pred cCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCC
Confidence 1223468899999999863 35678999999999999999999999754432 2222221 234566
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
+..++.++.++|.+||..+|.+||++.|+|+||||+
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 778899999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.05 Aligned_cols=237 Identities=29% Similarity=0.531 Sum_probs=186.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh------------cCC-----E
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ------------VDD-----H 409 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~------------~~~-----~ 409 (720)
++|++.+.||+|+||.||+|.+..+++.||||+++..... ..+..++..+.+ .++ .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3799999999999999999999999999999988654322 122233333321 122 2
Q ss_pred EEEEEEeccCCCHHHHHHHhc----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccch
Q 005007 410 LYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAK 484 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~ 484 (720)
+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999985 8988886532 35899999999999999999999999999999999999998 8999999999987
Q ss_pred hccCc-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-----
Q 005007 485 HLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----- 558 (720)
Q Consensus 485 ~~~~~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~----- 558 (720)
.+... .......+++.|+|||++.+ ...++.++|||||||++|||++|..||...+..+...++....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 65322 11223357889999999863 2456789999999999999999999998876666555443210
Q ss_pred ---------------CC--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 559 ---------------PP--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 559 ---------------~~--------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
.. .-..++.++.+||.+||..||.+||++.|+|.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0024788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.95 Aligned_cols=239 Identities=37% Similarity=0.607 Sum_probs=193.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
.++|++.+.||.|+||.||+|.+..+++.+|+|++....... ....++..+.. .++.+|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999999999999999987543221 11122222211 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 99999999998765789999999999999999999999999999999999999999999999999997665432 23445
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-----CCccCCHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-----IPEMLSSEGK 570 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~-----iP~~ls~el~ 570 (720)
.++..|+|||++.+.. ...++.++|||||||++|||++|++||...........+...... .+..++.+++
T Consensus 162 ~~~~~y~~Pe~~~~~~----~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 162 IGTPYWMAPEVAAVER----KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cCCccccCchhhcccc----cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 7899999999986311 125778999999999999999999999887665555544433211 2334678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
+||.+||..+|.+|||+.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.23 Aligned_cols=237 Identities=27% Similarity=0.524 Sum_probs=185.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.++|++.+.||+|+||+||+|.++.+++.||||++....... ++++.++.+.+ .++..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999999999999999986543221 23333333322 3567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+. ++|.+++......+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 998 5999999776567899999999999999999999999999999999999999999999999998754321 11122
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHhc---cC------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLN---RT------------ 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~~---~~------------ 558 (720)
..++..|+|||++.+ ...++.++|||||||++|||++|+.||..... .+.+..+.. ..
T Consensus 163 ~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 163 EVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 346889999999864 24467899999999999999999999976542 222221111 00
Q ss_pred ------CC---------CCccCC--HHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 ------PP---------IPEMLS--SEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ------~~---------iP~~ls--~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.. ....+. .++.++|.+||..+|++|||+.|+|+|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.66 Aligned_cols=238 Identities=36% Similarity=0.599 Sum_probs=193.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..+|++.+.||+|+||.||+|++..+++.||||++....... ...+++..+.. .+.+.|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 469999999999999999999999999999999887543221 11122222221 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
++|++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 999999999865 458999999999999999999999999999999999999999999999999987654322 22345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cC--CCCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~--~~iP~~ls~el~dL 572 (720)
.|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.. .. ...+..++..+.++
T Consensus 177 ~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 177 VGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 68999999999863 4467899999999999999999999987665444433332 22 23456688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||..+|++|||+.|+++|+||...
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=369.33 Aligned_cols=246 Identities=26% Similarity=0.497 Sum_probs=199.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-------------cCCE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-------------VDDH 409 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-------------~~~~ 409 (720)
+....+|++++.||+|+||+||+|.+..++..||+|++........ ++.++..|.+ ..+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445699999999999999999999999999999999875432221 1222222221 1356
Q ss_pred EEEEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhC-------CCcccccCCCceeecC--------
Q 005007 410 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-------NTIHRDIKGANLLVDA-------- 471 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~-------gIVHRDIKP~NILLd~-------- 471 (720)
+||||||+.+|+|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753 35699999999999999999999984 4999999999999964
Q ss_pred ---------CCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCC
Q 005007 472 ---------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542 (720)
Q Consensus 472 ---------~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF 542 (720)
.+.+||+|||++..+..........||+.|+|||++.+. ...++.++||||||||||||++|+.||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-----~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-----TKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-----CCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 235999999999876554444566799999999998641 235788999999999999999999999
Q ss_pred CCCCcHHHHHHHhccCCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 543 SEFEGPQAMFKVLNRTPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 543 ~~~~~~~~i~ki~~~~~~iP-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
........+...+...+.++ ...+.++.+||..||..+|.+||++.|+|.|+||....
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 87766666666655555544 35789999999999999999999999999999997553
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.11 Aligned_cols=232 Identities=29% Similarity=0.490 Sum_probs=192.7
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCCC-h----hHHHHHHHHhh--------------cCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-P----KSAECIKQLEQ--------------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~----~~~~~ik~L~~--------------~~~~lyLVmEy~~gGsL 422 (720)
||.|+||.||+|.+..+++.||||++...... . ....+++.+.. .++.+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999998643221 1 11112222221 24568999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 502 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~Ym 502 (720)
.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.............|+..|+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 9999764 568999999999999999999999999999999999999999999999999998776544444567899999
Q ss_pred ChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC--cHHHHHHHh--ccCCCCCccCCHHHHHHHHHhhh
Q 005007 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--GPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 503 APEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~--~~~~i~ki~--~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
+||++.+ ..++.++|||||||++|||++|..||.... ..+.+.++. .....+|..++++++++|.+||.
T Consensus 160 ~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 160 APEIILN-------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232 (262)
T ss_pred ChhHhcC-------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence 9999763 456789999999999999999999998766 555556665 45667777789999999999999
Q ss_pred cCCCCCCC-----HHHHHcCcccccccc
Q 005007 579 RNPVERPS-----AVELLEHPFIRNANY 601 (720)
Q Consensus 579 ~dP~kRPT-----a~ELL~Hpff~~~~~ 601 (720)
.||++|++ ++|+++||||.+..+
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred CChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 99999999 999999999986544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.27 Aligned_cols=232 Identities=29% Similarity=0.527 Sum_probs=191.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH------HHHHHHHhh-----------cCCEEEEEEEec
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS------AECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~------~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
+|++.+.||+|+||.||++.+..+++.||+|+++........ ...+..+.+ .++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 589999999999999999999999999999998654322211 112222211 356799999999
Q ss_pred cCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 418 HPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
++|+|.+++... ...+++..++.|+.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 999999998653 3458999999999999999999999999999999999999999999999999997664322 23346
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~ 574 (720)
.|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+... ...++..++.++++||.
T Consensus 161 ~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (255)
T cd08219 161 VGTPYYVPPEIWEN-------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233 (255)
T ss_pred cCCccccCHHHHcc-------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 78999999999863 35778999999999999999999999877666665555544 34567788999999999
Q ss_pred HhhhcCCCCCCCHHHHHcC
Q 005007 575 RCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~H 593 (720)
+||+.||++|||+.|+|.-
T Consensus 234 ~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 234 QMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhCCcccCCCHHHHhhc
Confidence 9999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.49 Aligned_cols=233 Identities=24% Similarity=0.398 Sum_probs=187.1
Q ss_pred CeEEeeEE--eecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHh------------hcCCEEEEEEEeccCC
Q 005007 355 QWQKGKLI--GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE------------QVDDHLYIYLEYVHPG 420 (720)
Q Consensus 355 ~Y~i~k~L--G~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~------------~~~~~lyLVmEy~~gG 420 (720)
.|.+.+.+ |+|+||.||+++++.++..+|+|++........+......+. ..++.+|+||||++++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 94 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDG 94 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCC
Confidence 55555555 999999999999999999999999865322221222111111 1256789999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCccccccccCCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSP 499 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~~~~t~~GTp 499 (720)
+|.+++... ..+++..++.|+.||++||.|||+.||+||||||+|||++.++ .++|+|||++...... ....|+.
T Consensus 95 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~ 170 (267)
T PHA03390 95 DLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTL 170 (267)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCC
Confidence 999999765 4799999999999999999999999999999999999999988 9999999998765432 3456899
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH----HHHHHhccCCCCCccCCHHHHHHHHH
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~----~i~ki~~~~~~iP~~ls~el~dLI~~ 575 (720)
.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..........+..++..+++||.+
T Consensus 171 ~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T PHA03390 171 DYFSPEKIKG-------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS 243 (267)
T ss_pred cccChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence 9999999863 346789999999999999999999997543322 22222234445566789999999999
Q ss_pred hhhcCCCCCCC-HHHHHcCccccc
Q 005007 576 CFLRNPVERPS-AVELLEHPFIRN 598 (720)
Q Consensus 576 cL~~dP~kRPT-a~ELL~Hpff~~ 598 (720)
||+.||.+|++ ++|+|+|+||.+
T Consensus 244 ~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 244 MLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HhccChhhCCchHHHHhcCCcccC
Confidence 99999999996 699999999963
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.57 Aligned_cols=233 Identities=21% Similarity=0.395 Sum_probs=187.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyL 412 (720)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++........ .+++..+.+ .++.+||
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 458999999999999999999865 45678999998764332221 122222221 2467899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999999876567999999999999999999999999999999999999999999999999987654322211
Q ss_pred c--cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 005007 493 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 568 (720)
Q Consensus 493 ~--t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~e 568 (720)
. ...++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ..+.|..++..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNL 236 (266)
T ss_pred cccCCCCceeecCHHHHhh-------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 1 2335678999999863 457889999999999999775 99999887776666655443 34567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.++|.+||+.+|.+||+++||++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=313.20 Aligned_cols=235 Identities=29% Similarity=0.530 Sum_probs=194.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
+|++.+.||+|+||+||++.+..+|+.||||++........ ..+++..+.. .++..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58999999999999999999999999999999875322211 1112222221 25678999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-ccc
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-ELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-~~t 494 (720)
+.+++|.+++.... ..+++..+..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999997642 3589999999999999999999999999999999999999999999999999976543322 223
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.+++.+ ....+..++.++.++|
T Consensus 161 ~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08218 161 CIGTPYYLSPEICEN-------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV 233 (256)
T ss_pred ccCCccccCHHHhCC-------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 458899999999863 34677999999999999999999999877766666666544 3456778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+||+.+|.+||++.++|+|+||
T Consensus 234 ~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 234 SQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.15 Aligned_cols=236 Identities=34% Similarity=0.555 Sum_probs=186.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHh-----------hcCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLE-----------QVDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~-----------~~~~~lyLVmE 415 (720)
++|++.++||+|+||+||+|.+..+++.||||.+....... .+.+.+..+. ..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999999999999999875432221 1122222221 13567999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+.++.|..++... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99999888877543 459999999999999999999999999999999999999999999999999987654332 2234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..++..|+|||++.+ ...++.++|||||||++|||++|++||......+....+....
T Consensus 160 ~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 160 YVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 568899999999863 3456789999999999999999999997655444333322100
Q ss_pred ---CC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 ---PP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ---~~------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.. ....++..+.+||.+||..+|++||++.++|+|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.54 Aligned_cols=240 Identities=35% Similarity=0.603 Sum_probs=196.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...+|++.+.||.|+||+||+|.+..+|+.||||++....... ...+++..+.. .++.+|+|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3467999999999999999999999999999999886543221 11112222221 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-ELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-~~t 494 (720)
|+.+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9999999999865 3589999999999999999999999999999999999999999999999999886644322 234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CCCCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~~iP~~ls~el~d 571 (720)
..|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+... ....+..+++.+++
T Consensus 175 ~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 175 MVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred cCCCccccCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 568999999998863 45678999999999999999999999887665555544332 22345678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||..||.+|||+.++++|+||+...
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.95 Aligned_cols=236 Identities=29% Similarity=0.528 Sum_probs=186.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
++|++.++||+|+||+||+|.+..+++.||||.+......... ..+++.+.+ .++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688999999999999999999999999999988654222111 122222222 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~ 496 (720)
+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence 999998654 34789999999999999999999999999999999999999999999999999765432 234467
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-------HHHHHHhcc-CCCC-CccCCH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------QAMFKVLNR-TPPI-PEMLSS 567 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-------~~i~ki~~~-~~~i-P~~ls~ 567 (720)
||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+... ...+ ....+.
T Consensus 155 ~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd06619 155 GTNAYMAPERISG-------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227 (279)
T ss_pred CChhhcCceeecC-------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence 9999999999863 35788999999999999999999999653221 111222222 1222 234788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
++++||.+||+.+|++||+++|+++|+||+..+..
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 99999999999999999999999999999766433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.65 Aligned_cols=237 Identities=32% Similarity=0.572 Sum_probs=192.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~lyLVmEy 416 (720)
++|+..+.||+|+||.||+|.++.+++.||+|.+.......... .+++.+.. .++.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36888899999999999999999999999999887653322211 12222221 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+.+++|.+++......+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcc
Confidence 99999999998765789999999999999999999999 9999999999999999999999999999876643222 226
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-----cHHHHHHHhcc-CCCCCcc-CCHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-----GPQAMFKVLNR-TPPIPEM-LSSE 568 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-----~~~~i~ki~~~-~~~iP~~-ls~e 568 (720)
.|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+... .+.++.. ++.+
T Consensus 160 ~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 160 VGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred cCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 78999999999864 357889999999999999999999997542 22233333332 3344444 8899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
++++|.+||..||++|||+.|++.||||+.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.03 Aligned_cols=238 Identities=22% Similarity=0.361 Sum_probs=186.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh-----------cCCEEEEEEEeccCC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-----------~~~~lyLVmEy~~gG 420 (720)
....|.+.+.||+|+||.||+|.+..+++.||||..... ....++++++.+.+ .++..||||||+. +
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 345899999999999999999999999999999965322 22344455555442 3567899999995 7
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc---ccccccC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKG 497 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---~~~t~~G 497 (720)
+|..++......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++...... ......|
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 324 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAG 324 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCC
Confidence 8999887665679999999999999999999999999999999999999999999999999997654322 1234679
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-------cHHHHHHHhcc----CCCCC----
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-------GPQAMFKVLNR----TPPIP---- 562 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-------~~~~i~ki~~~----~~~iP---- 562 (720)
|+.|||||++.+ ..++.++||||||||||||++|..++.... ....+.+++.. ...++
T Consensus 325 T~~Y~APE~~~~-------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 325 TVDTNAPEVLAG-------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred CcCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 999999999863 457889999999999999999876543211 11222222211 00111
Q ss_pred ---------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 563 ---------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 563 ---------------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 024568999999999999999999999999999974
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.52 Aligned_cols=237 Identities=24% Similarity=0.443 Sum_probs=183.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhhc-------------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQV------------------- 406 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~~------------------- 406 (720)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .+++.++.+.+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999999999999999886432111 122233332220
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
.+..|+||||+. ++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 134699999996 6888888765557999999999999999999999999999999999999999999999999999765
Q ss_pred cCccc-----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc---cC
Q 005007 487 TGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---RT 558 (720)
Q Consensus 487 ~~~~~-----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~---~~ 558 (720)
..... .....++..|+|||++.+ ...++.++|||||||++|||++|++||...+.......+.. ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 43221 123457889999999863 23467799999999999999999999987654433222211 00
Q ss_pred ----------------CCCC-------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 ----------------PPIP-------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ----------------~~iP-------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..++ ...+..+.+||.+||..||.+|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.04 Aligned_cols=231 Identities=31% Similarity=0.540 Sum_probs=187.2
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hH---HHHHHHHh---------------hcCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KS---AECIKQLE---------------QVDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~---~~~ik~L~---------------~~~~~lyLVmEy~~g 419 (720)
+.||+|+||.||+|.+..+|+.||||++....... .. ......+. ..++.+|+||||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999886432111 10 11111111 124678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp 499 (720)
++|.+++... ..+++..+..++.||+.||.|||+++|+||||+|+|||++.++.+||+|||+++.... .....|+.
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 9999999764 6799999999999999999999999999999999999999999999999999876433 23456889
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC----CCCccCCHHHHHHHHH
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----PIPEMLSSEGKDFLLR 575 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~----~iP~~ls~el~dLI~~ 575 (720)
.|+|||.+.+ ..++.++||||||+++|||++|..||...+.......+..... .....++.++.++|.+
T Consensus 158 ~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 158 DYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred CccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 9999999863 2367899999999999999999999988776665555544332 2334678999999999
Q ss_pred hhhcCCCCCC---CHHHHHcCcccccccc
Q 005007 576 CFLRNPVERP---SAVELLEHPFIRNANY 601 (720)
Q Consensus 576 cL~~dP~kRP---Ta~ELL~Hpff~~~~~ 601 (720)
||+.||++|| +++|+|.||||.+.++
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 9999999999 5589999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.82 Aligned_cols=240 Identities=37% Similarity=0.611 Sum_probs=194.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--HHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--SAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...+|++.+.||+|+||.||+|.+..+++.||||++........ ...++..+.. .++.+|+|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 34789999999999999999999999999999999875432211 1112222221 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-ELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-~~t 494 (720)
|+++++|.+++.+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ ...
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9999999999965 4589999999999999999999999999999999999999999999999999876543322 234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cC--CCCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~--~~iP~~ls~el~d 571 (720)
..|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.. .. ...+..++..+++
T Consensus 175 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 175 MVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCCccccCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 568999999999863 4567899999999999999999999977554443333222 21 2345678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||..+|++||+++++|+||||+...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.98 Aligned_cols=239 Identities=26% Similarity=0.489 Sum_probs=185.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh----------------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ----------------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~----------------~~~~l 410 (720)
.++|++.++||+|+||+||+|.+..+|+.||||++........ +...++.+.+ ....+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999999999999999999864322211 1112222211 11357
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+. ++|.+++.. ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99999996 688888754 469999999999999999999999999999999999999999999999999987654322
Q ss_pred ----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc---c------
Q 005007 491 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---R------ 557 (720)
Q Consensus 491 ----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~---~------ 557 (720)
......||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+....+..+.. .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 1223568999999998753 24578899999999999999999999976543322221110 0
Q ss_pred -----------------CCCC-----CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 -----------------TPPI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 -----------------~~~i-----P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.... ....+.++.+||.+||+.+|++|||+.|+++||||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 123578899999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=311.35 Aligned_cols=238 Identities=36% Similarity=0.617 Sum_probs=195.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
++|++.+.||+|+||.||+|.+..+++.||||++........ ...++..+.. ..+.+|+||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 378999999999999999999999999999999876533111 1122222221 24678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCcccc-cc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-LS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~-~t 494 (720)
+++++|.+++... ..+++..++.++.||++||.|||+ +|++||||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9999999999765 679999999999999999999999 99999999999999999999999999999876543322 24
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC---cHHHHHHHhc-cCCCCCcc-CCHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLN-RTPPIPEM-LSSEG 569 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~---~~~~i~ki~~-~~~~iP~~-ls~el 569 (720)
..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+....+.. ....++.. ++..+
T Consensus 160 ~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 160 FVGTVTYMSPERIQG-------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred eeecccccCHhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 568899999998763 367889999999999999999999998764 3333333332 23445555 88999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.++|.+||..+|++||++.|+|+||||+..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=344.41 Aligned_cols=235 Identities=29% Similarity=0.507 Sum_probs=199.4
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhhc-----------CCEEEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQV-----------DDHLYIY 413 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~~-----------~~~lyLV 413 (720)
+....+.+++++.||+|-||.||+|.+.. ...||+|.++..... ..++.+++.|.+. ++.+|||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34445567888999999999999999873 347999988764433 3455666666542 3569999
Q ss_pred EEeccCCCHHHHHHH-hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 414 LEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||..|+|.++|++ ....+...+...|+.||++||+||+++++|||||-..||||++++.|||+|||||+...+..+.
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999999999987 5577999999999999999999999999999999999999999999999999999965555544
Q ss_pred ccccC--CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHH
Q 005007 493 LSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSE 568 (720)
Q Consensus 493 ~t~~G--Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~e 568 (720)
....+ -.-|.|||.+. ...++.++|||||||+||||+| |+.||.+....+.+..+.. ...+-|+.++++
T Consensus 360 ~~~~~kfPIkWtAPEa~~-------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALN-------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred ecCCCCCCceecCHHHHh-------hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence 43333 34699999998 3579999999999999999999 9999999999999888865 466788999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHH
Q 005007 569 GKDFLLRCFLRNPVERPSAVELL 591 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL 591 (720)
+.++|+.||..+|++|||++.+.
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999775
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.82 Aligned_cols=238 Identities=37% Similarity=0.628 Sum_probs=192.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHh---h-----------cCCEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLE---Q-----------VDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~---~-----------~~~~lyLVm 414 (720)
.|++.+.||+|+||.||+|.+..+++.||||++........ +..+++.+. . .+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58889999999999999999999999999998865322211 222333333 1 245689999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~ 493 (720)
||++|++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 99999999999865 469999999999999999999999999999999999999999999999999997665432 233
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCc-cCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPE-MLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~-~ls~el~d 571 (720)
...|+..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+... ...++. .++.++.+
T Consensus 160 ~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 160 TFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 4568999999999863 244678999999999999999999999876655444333222 223333 37889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+|.+||+.||++||++.|+++|+||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.46 Aligned_cols=234 Identities=27% Similarity=0.490 Sum_probs=189.2
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCC-----C---hhHHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----D---PKSAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~---~~~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
||+|+||+||+|.+..+|+.||||++..... . ..+.+.+..+.. .++.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999999999999998864211 1 111222222221 25678999999999999
Q ss_pred HHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCC
Q 005007 423 NRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 501 (720)
Q Consensus 423 ~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~Y 501 (720)
.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997653 36999999999999999999999999999999999999999999999999999876543333445688899
Q ss_pred CChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCCccCCHHHHHHHHHhh
Q 005007 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 577 (720)
Q Consensus 502 mAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP~~ls~el~dLI~~cL 577 (720)
+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+......++..+++++.++|.+||
T Consensus 161 ~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 161 MAPEVLQG-------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred CCHHHhcC-------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 99999863 3377899999999999999999999976543 222233334455667778999999999999
Q ss_pred hcCCCCCC-----CHHHHHcCccccccccc
Q 005007 578 LRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 578 ~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+.||.+|| ++.++++||||...++.
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 99999999 89999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.99 Aligned_cols=235 Identities=33% Similarity=0.585 Sum_probs=198.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--C------hhHHHHHHHHh------------hcCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--D------PKSAECIKQLE------------QVDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~------~~~~~~ik~L~------------~~~~~lyLV 413 (720)
++|++.+.||+|+||.||+|.+..+|+.||||++..... . ..+.+.+..+. ..++.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 479999999999999999999999999999998864211 1 11112222222 235679999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc---
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--- 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--- 490 (720)
|||+.+++|.+++.+. +.+++..++.|+.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999999765 579999999999999999999999999999999999999999999999999987654322
Q ss_pred ------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH
Q 005007 491 ------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 552 (720)
Q Consensus 491 ------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ 552 (720)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC-------CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 1223557899999998763 347789999999999999999999999877666667
Q ss_pred HHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCccc
Q 005007 553 KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSA----VELLEHPFI 596 (720)
Q Consensus 553 ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa----~ELL~Hpff 596 (720)
.+......+|..+++.+.+||.+||+.+|.+||++ +++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 233 KILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 77777778888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=322.03 Aligned_cols=239 Identities=28% Similarity=0.472 Sum_probs=193.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh-------HHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK-------SAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~-------~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|++.+.||+|+||.||+|.+..+++.||||.+...... .. +.++++.+.+ .++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3799999999999999999999999999999988653211 11 1112222211 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL----- 489 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~----- 489 (720)
||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999999999765 67999999999999999999999999999999999999999999999999998642100
Q ss_pred -----------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC
Q 005007 490 -----------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 558 (720)
Q Consensus 490 -----------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~ 558 (720)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|..||.+....+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 01112457889999999763 457889999999999999999999998776666666665544
Q ss_pred CCCC---ccCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccc
Q 005007 559 PPIP---EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNAN 600 (720)
Q Consensus 559 ~~iP---~~ls~el~dLI~~cL~~dP~kRPT---a~ELL~Hpff~~~~ 600 (720)
...| ..++.++.++|.+||+.||++||+ +.++|+||||....
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 3333 357899999999999999999998 79999999997644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.17 Aligned_cols=235 Identities=27% Similarity=0.505 Sum_probs=194.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|+..+.||.|+||.||.+.+..+++.|++|++........ +.++++.+.+ .++.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58999999999999999999999999999999875432221 1222222221 25678999999
Q ss_pred ccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 417 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
+++++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 3568999999999999999999999999999999999999999999999999997664433 2344
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFL 573 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~dLI 573 (720)
..|++.|+|||++.+ ..++.++|||||||++|||++|..||......+....+.... ...+..++.++.++|
T Consensus 161 ~~~~~~y~ape~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08221 161 VVGTPYYMSPELCQG-------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233 (256)
T ss_pred cCCCccccCHhhcCC-------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 668999999999863 346778999999999999999999998877766666665443 334566889999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+||..+|.+||++.++|+|+|+
T Consensus 234 ~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 234 HSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHcccCcccCCCHHHHhhCcCC
Confidence 99999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.38 Aligned_cols=236 Identities=31% Similarity=0.552 Sum_probs=188.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
++|++.+.||+|+||.||+|.+..+++.||||+++...... .+.++++.+.+ .++.+|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 37999999999999999999999999999999886432211 12223333321 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YEL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~ 493 (720)
|+.++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9998777666544 3569999999999999999999999999999999999999999999999999998765443 233
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------------- 558 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--------------- 558 (720)
...++.+|+|||++.+ ...++.++|||||||++|+|++|++||......+.+..+....
T Consensus 160 ~~~~~~~~~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 160 DYVATRWYRAPELLVG------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred CcccccCCcCCchhcC------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 4668999999999874 2367889999999999999999999998765554443322100
Q ss_pred -----------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 -----------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 -----------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
...+..++.++++||++||..+|++|||++++++|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.99 Aligned_cols=237 Identities=29% Similarity=0.515 Sum_probs=183.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
..+|++.+.||+|+||.||+|.+..+|+.||||.+....... .+.+.+..+.+ .++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 368999999999999999999999999999999986543221 12222333222 2457899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+. ++|..++......+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 996 77777776555668899999999999999999999999999999999999999999999999987543221 2233
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhcc--------------CC
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--------------TP 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~--------------~~ 559 (720)
..+++.|+|||++.+ ...++.++|||||||++|||++|+.||...... +.+.++... .+
T Consensus 163 ~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 163 EVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred ccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 457899999998863 234677899999999999999999999765432 222222110 00
Q ss_pred C---------CC-------c--cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 P---------IP-------E--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 ~---------iP-------~--~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
. .+ . ..+.++.++|.+||+.||.+|||+.|+|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 0 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.83 Aligned_cols=236 Identities=25% Similarity=0.406 Sum_probs=186.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhhc-----------------C
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQV-----------------D 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~~-----------------~ 407 (720)
...+|++.+.||+|+||+||+|.+..+|+.||||++........ ++.+++.+.+. .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 35689999999999999999999999999999998864322211 12222222210 1
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
...|+||||+. ++|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 24799999996 6888887543 8999999999999999999999999999999999999999999999999998765
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------- 558 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--------- 558 (720)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCCCCCCcccccccCHHHHhC-------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 5444445678999999999863 457889999999999999999999998765444333332100
Q ss_pred -------------CC--------------C-------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 559 -------------PP--------------I-------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 559 -------------~~--------------i-------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
.. + +...++++++||.+||+.||++|||+.|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 0 1124567899999999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.38 Aligned_cols=235 Identities=31% Similarity=0.600 Sum_probs=196.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|++.+.||+|+||.||+|.+..++..||+|++......... .+.++.+.. .++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 589999999999999999999999999999998765432111 112222221 24678999999
Q ss_pred ccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cc
Q 005007 417 VHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 492 (720)
Q Consensus 417 ~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~ 492 (720)
+++++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999765 3679999999999999999999999999999999999999999999999999997664433 23
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
....|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..+........ ...++..++.++.+
T Consensus 161 ~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd08215 161 KTVVGTPYYLSPELCQN-------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233 (258)
T ss_pred cceeeeecccChhHhcc-------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 34568999999998763 34778999999999999999999999877665555555443 45567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+|.+||..+|++|||+.|+|+||||
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.27 Aligned_cols=236 Identities=28% Similarity=0.524 Sum_probs=190.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cC--CEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VD--DHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~--~~lyLV 413 (720)
++|++.+.||.|+||+||+|.+..+++.||||.++...... .+..++..+.+ .. +.+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47999999999999999999999999999999987543221 12222333321 12 779999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~ 492 (720)
|||+. ++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...... ...
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99997 5999998765556999999999999999999999999999999999999999999999999999876543 222
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--------------
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------- 558 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-------------- 558 (720)
....+++.|+|||++.+ ...++.++|||||||++|||++|++||......+.+.++....
T Consensus 164 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 164 TQLVVTLWYRAPELLLG------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ccccccccccCchhhcC------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 34557899999999863 2346789999999999999999999998776655544432110
Q ss_pred -----------------CCCCcc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 -----------------PPIPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 -----------------~~iP~~-ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..++.. +++.+++||++||+.||++|||+.|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112223 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=310.94 Aligned_cols=231 Identities=31% Similarity=0.552 Sum_probs=190.5
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHh--------------hcCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLE--------------QVDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~--------------~~~~~lyLVmEy~~gGsL 422 (720)
||.|+||.||+|++..+|+.||||++....... ...+++..+. ..++.+|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999999999999886432210 1111111111 135678999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc---------ccc
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---------YEL 493 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---------~~~ 493 (720)
.+++... +.+++..+..++.||++||.|||++||+|+||+|+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9999765 479999999999999999999999999999999999999999999999999987643321 223
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccC--CHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML--SSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~l--s~el~d 571 (720)
...++..|++||++.+ ..++.++|||||||++|||++|+.||......+....+.......+..+ +.++.+
T Consensus 160 ~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd05579 160 RIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID 232 (265)
T ss_pred CcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHH
Confidence 4568889999999863 3367899999999999999999999988777777766666666666665 999999
Q ss_pred HHHHhhhcCCCCCCCH---HHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSA---VELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa---~ELL~Hpff~~~~ 600 (720)
||.+||+.+|++|||+ .++|+||||.+..
T Consensus 233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 9999999999999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.95 Aligned_cols=234 Identities=43% Similarity=0.818 Sum_probs=192.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hh-------HHHHHHHHhh-------------cCCEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PK-------SAECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~-------~~~~ik~L~~-------------~~~~l 410 (720)
.+|++++.||+|+||.||+|.+..+++.||||++...... .. +++.++.+.+ ..+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999999999999999987543211 11 1122222221 13468
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~- 489 (720)
++||||+++++|.+++... ..+++..++.|+.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 8999999999999999764 56899999999999999999999999999999999999999999999999999865321
Q ss_pred ---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCcc
Q 005007 490 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 564 (720)
Q Consensus 490 ---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~~ 564 (720)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.+.++... ...+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~ 233 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233 (264)
T ss_pred ccCccccccCCcccccCHhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcc
Confidence 11224568999999999863 34678999999999999999999999887766666665533 3457888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+++++.++|.+||+ ++.+||++.++|.|||.
T Consensus 234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.01 Aligned_cols=238 Identities=38% Similarity=0.624 Sum_probs=194.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..|+..+.||.|+||.||+|.+..++..||||+++......... .+++.+.. .++.+|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999999999999999887543222111 12222221 25679999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
+.||+|.+++.. ..+++..+..++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++....... .....
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 999999999864 468999999999999999999999999999999999999999999999999997664432 22334
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI~ 574 (720)
.++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ..+.++..++.++.++|.
T Consensus 162 ~~~~~y~apE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 162 VGTPFWMAPEVIQQ-------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cCcccccCHhHhcc-------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 68899999999863 3467899999999999999999999987665555544432 244556678899999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||..+|++||++.++++|+||....
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHcccCcccCcCHHHHHhChHhhhcc
Confidence 99999999999999999999997554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.68 Aligned_cols=236 Identities=48% Similarity=0.855 Sum_probs=189.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hh----------HHHHHHHHhh-----------cCC
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PK----------SAECIKQLEQ-----------VDD 408 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~----------~~~~ik~L~~-----------~~~ 408 (720)
+|.+.+.||.|+||.||+|.+..+|+.||||+++..... .. +...+..+.+ ..+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999999999999988643211 00 1111222211 245
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+++||||+.+++|.+++.+. +.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 689999999999999999775 6799999999999999999999999999999999999999999999999999976543
Q ss_pred cc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCc
Q 005007 489 LS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 563 (720)
Q Consensus 489 ~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~ 563 (720)
.. ......|+..|+|||++... ...++.++|||||||++|||++|..||...+..+.+.++... ...++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred cccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 21 22345689999999998631 124678999999999999999999999776655555544322 223333
Q ss_pred ----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 564 ----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 564 ----~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.++.+++++|.+||..+|.+||+++++|+||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 358899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.44 Aligned_cols=234 Identities=50% Similarity=0.938 Sum_probs=195.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHH---HHHHhh-----------cC--CEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAEC---IKQLEQ-----------VD--DHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~---ik~L~~-----------~~--~~lyLVm 414 (720)
+|++.+.||+|+||.||+|.+..+++.|+||++........ ...+ ++.+.. .. +.+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999876543211 1122 222221 13 6799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--- 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--- 491 (720)
||+.+++|.+++.+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999765 4899999999999999999999999999999999999999999999999999987765443
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHh--ccCCCCCccCCHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVL--NRTPPIPEMLSSE 568 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~--~~~~~iP~~ls~e 568 (720)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ...+..+. .....+|..++.+
T Consensus 160 ~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232 (260)
T ss_pred ccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHH
Confidence 345678999999999863 3478899999999999999999999987662 33333333 2456678888999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+++||.+||..||.+||++.|+++||||
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.86 Aligned_cols=235 Identities=30% Similarity=0.571 Sum_probs=187.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
+|++.+.||.|+||+||+|.+..+|+.||||+++...... .+.+.++.+.+ ..+.++|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999999999999999987643221 12233333322 246689999999
Q ss_pred cCCCHHHHHHHhc--CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 418 HPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 418 ~gGsL~~~L~~~~--~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 8 58988886543 468999999999999999999999999999999999999999999999999997653321 1233
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..++..|++||++.+ ...++.++|||+|||++|+|++|+.||.+.+..+.+.++....
T Consensus 160 ~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 160 EVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 457899999999863 3456789999999999999999999998776655444432110
Q ss_pred --CC-----------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 --PP-----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 --~~-----------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.. +...++.+++++|.+||+.||.+||++.|+++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.03 Aligned_cols=237 Identities=47% Similarity=0.850 Sum_probs=190.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|++.+.||+|+||.||+|.+..+++.||||+++....... +.+.++.+.+ ..+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999876544311 1112222211 24678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-----
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----- 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~----- 491 (720)
+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999764 5689999999999999999999999999999999999999999999999999987644322
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHH-HHHHh-ccCCCCCccC--CH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVL-NRTPPIPEML--SS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~-i~ki~-~~~~~iP~~l--s~ 567 (720)
.....++..|+|||++.+.. ...++.++|||||||++|||++|+.||...+.... ...+. ...+.+|... +.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGK----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccCCcCCcCccChhhccCCC----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 12356789999999986421 13477899999999999999999999976543332 22222 2334455544 89
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+.+||++||+.+|.+|||+.|++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.34 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=218.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh-----------cCCEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~-----------~~~~ly 411 (720)
......|.+.+.||+|.|++|.+|++..|+..||||+++....+... +++++.|.+ .+..+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 44556899999999999999999999999999999999876544432 233333322 267899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+||||+.+|+|+++|.++ +.+.+..++.++.|++.||+|||+++|||||||.+||||+.+-++||+|||++..+.....
T Consensus 132 lV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 999999999999999887 5677799999999999999999999999999999999999999999999999999998888
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
..++||++.|.|||++.| ..+.++.+|+||+|++||-|+.|.+||.+..-.+.-...+.+...+|..++.++++
T Consensus 211 lqt~cgsppyAaPEl~~g------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~ 284 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNG------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCED 284 (596)
T ss_pred ccccCCCCCccChHhhcC------cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHH
Confidence 899999999999999986 45678899999999999999999999999887777788888899999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
+|+++|.++|.+|++.++++.|.|+.....
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999999965443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=322.64 Aligned_cols=241 Identities=33% Similarity=0.551 Sum_probs=192.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--HHHHHHHHh--------------hcCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--SAECIKQLE--------------QVDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--~~~~ik~L~--------------~~~~~lyLVmEy~ 417 (720)
+.|.....||+|+||.||++.+..++..||||++........ ..+++..+. ...+..|+||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 456667889999999999999999999999998864321111 111111111 1357789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 99999998854 468999999999999999999999999999999999999999999999999987653322 223456
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCCCccCCHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEGKDFL 573 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~iP~~ls~el~dLI 573 (720)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||........+..+.... ......++..+.++|
T Consensus 180 ~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 180 GTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 8999999999863 457789999999999999999999998766655555443322 122335788999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
.+||..||.+|||++|+|+|+||+......
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.32 Aligned_cols=233 Identities=27% Similarity=0.398 Sum_probs=179.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeccCCCChh---HHHHHHHHhh--------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPK---SAECIKQLEQ-------- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~----------------tg~~VAVK~l~~~~~~~~---~~~~ik~L~~-------- 405 (720)
..+|++.++||+|+||+||+|.+.. ++..||||.+........ ..++++.+..
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999998542 345799998875432211 1122222222
Q ss_pred ------cCCEEEEEEEeccCCCHHHHHHHhc------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccc
Q 005007 406 ------VDDHLYIYLEYVHPGSINRYVREHC------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRD 461 (720)
Q Consensus 406 ------~~~~lyLVmEy~~gGsL~~~L~~~~------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRD 461 (720)
.++.++|||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 2456899999999999999986431 2367788999999999999999999999999
Q ss_pred cCCCceeecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-
Q 005007 462 IKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 537 (720)
Q Consensus 462 IKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT- 537 (720)
|||+||||+.++.+||+|||+++....... .....++..|||||++.+ ..++.++|||||||++|||++
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-------GKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-------CCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999976543221 123345788999999863 457889999999999999986
Q ss_pred -CCCCCCCCCcHHHHHHHhc--------cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 538 -GKPPWSEFEGPQAMFKVLN--------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 538 -Gk~PF~~~~~~~~i~ki~~--------~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+..||......+.+..+.. .....+..++..+.+||.+||..||++|||+.||.+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 6788887665554443321 112335568899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.65 Aligned_cols=235 Identities=42% Similarity=0.746 Sum_probs=186.3
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEEEeccCC
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVmEy~~gG 420 (720)
.....||+|+||.||+|.+..++..||+|.+....... .+...++.+.+ .++.+++||||+.++
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 33468999999999999999999999999886542211 11222222221 356789999999999
Q ss_pred CHHHHHHHhcCCC--cHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchhccCcc-cccccc
Q 005007 421 SINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 421 sL~~~L~~~~~~L--se~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
+|.+++......+ ++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... ......
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 170 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence 9999998754556 88899999999999999999999999999999999976 6799999999987654322 223346
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHH-HHHH--hccCCCCCccCCHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKV--LNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~-i~ki--~~~~~~iP~~ls~el~dLI 573 (720)
|+..|+|||++.+ +...++.++|||||||++|+|++|+.||........ .... ......+|..+++++++||
T Consensus 171 ~~~~~~aPE~~~~-----~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 171 GTLQYMAPEVIDK-----GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred CCccccChhhhcc-----ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 8999999999853 123477899999999999999999999976543222 2221 2344567888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+||..+|.+|||+.|++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=316.28 Aligned_cols=233 Identities=24% Similarity=0.426 Sum_probs=187.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg-----~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~ly 411 (720)
.+|++.+.||+|+||.||+|.+...+ ..||+|.++........ .+++..+.. ..+..|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 47999999999999999999876555 68999988644322111 112222222 245689
Q ss_pred EEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCee
Q 005007 412 IYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VK 476 (720)
++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 9999999999999997531 4578899999999999999999999999999999999999999999
Q ss_pred eeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHH
Q 005007 477 LADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552 (720)
Q Consensus 477 L~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ 552 (720)
|+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+.
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-------GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhcc-------CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999997653322 1223456888999998863 457889999999999999998 999998877777666
Q ss_pred HHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 553 KVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 553 ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+... ....|..++.++.+||.+||+.||.+||++.||+++
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66544 345677899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.35 Aligned_cols=234 Identities=40% Similarity=0.707 Sum_probs=192.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh--------------cCCEEEEEEEecc
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
+|.+.+.||+|+||.||+|.+..+++.|++|++..... ......++..+.. .++..+++|||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58899999999999999999999999999999876442 1122222222222 2467899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GT 498 (720)
|++|.+++......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.............|+
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 160 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT 160 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecC
Confidence 99999999776567999999999999999999999999999999999999999999999999999876554334456789
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cCCCCCcc--CCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEM--LSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~~~iP~~--ls~el~dLI~~ 575 (720)
..|++||++.+ ..++.++|||||||++|+|++|+.||...+....+..+.. ....++.. ++.++.++|.+
T Consensus 161 ~~~~~PE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 161 PYWMAPEVING-------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred CcccCHHHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 99999999863 3367899999999999999999999987755555444433 22233333 48999999999
Q ss_pred hhhcCCCCCCCHHHHHcCcc
Q 005007 576 CFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~Hpf 595 (720)
||+.||++|||+.|+|+|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.03 Aligned_cols=237 Identities=28% Similarity=0.533 Sum_probs=186.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh-------------------c
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ-------------------V 406 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~-------------------~ 406 (720)
.++|++.++||+|+||.||+|.++.+++.||||++...... ..+.+.++.+.+ .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46999999999999999999999999999999988543211 122333333221 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
...+|+||||+. ++|...+......+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 235799999997 5787777665567999999999999999999999999999999999999999999999999999765
Q ss_pred cCccc------------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHH
Q 005007 487 TGLSY------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 554 (720)
Q Consensus 487 ~~~~~------------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki 554 (720)
..... .....|++.|+|||++.+ ...++.++|||||||++|||++|++||.+.+.......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 43211 123457889999999864 245778999999999999999999999876665544443
Q ss_pred hccCC-----------------------CCC-------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 555 LNRTP-----------------------PIP-------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 555 ~~~~~-----------------------~iP-------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..... ..+ ..+..++.+||.+||..||++|||+.|+|.|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 32100 000 1244788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=329.52 Aligned_cols=235 Identities=25% Similarity=0.468 Sum_probs=184.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChh------HHHHHHHHhh-------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPK------SAECIKQLEQ-------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-------------~~ 407 (720)
..++|++++.||+|+||.||+|.+. .+++.||+|+++....... +.+.+..+.. .+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3568999999999999999999754 3568899998874332211 2222222211 13
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc---------------------------------------------------------
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------------- 430 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~--------------------------------------------------------- 430 (720)
..++++|||+++++|.++|....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 45789999999999999985421
Q ss_pred ---CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---cccccCCCCCCCh
Q 005007 431 ---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAP 504 (720)
Q Consensus 431 ---~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAP 504 (720)
..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..... .....++..||||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2578899999999999999999999999999999999999999999999999987643221 1233457789999
Q ss_pred HHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCC
Q 005007 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNP 581 (720)
Q Consensus 505 Evl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP 581 (720)
|++.+ ..++.++|||||||+||||++ |..||.+....+.+...+.. ....+..+++++.++|.+||+.+|
T Consensus 245 E~~~~-------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 245 ESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred HHhcC-------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 99863 457889999999999999997 99999875544444444322 334567788999999999999999
Q ss_pred CCCCCHHHHHcC
Q 005007 582 VERPSAVELLEH 593 (720)
Q Consensus 582 ~kRPTa~ELL~H 593 (720)
++||++.|+++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=316.36 Aligned_cols=235 Identities=30% Similarity=0.555 Sum_probs=186.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHh-----------hcCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLE-----------QVDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~-----------~~~~~lyLVmEy 416 (720)
.|++.+.||.|+||.||+|++..+|+.||||+++...... .+++.++.+. ..++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4889999999999999999999999999999886432211 1222223222 135678999999
Q ss_pred ccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 417 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
+. ++|..++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 6898888653 3568999999999999999999999999999999999999999999999999987654321 2223
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------------- 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--------------- 559 (720)
..++..|+|||++.+ ...++.++|||||||++|||+||+.||...+....+.++.....
T Consensus 160 ~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 160 EVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 457889999998753 23467889999999999999999999987665554444332100
Q ss_pred --------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 --------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 --------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+...++.+++++|.+||+.||.+|||++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.73 Aligned_cols=244 Identities=25% Similarity=0.466 Sum_probs=199.5
Q ss_pred eEE-eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH--HHHH---------------HHHhhcCCEEEEEEEec
Q 005007 356 WQK-GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECI---------------KQLEQVDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i-~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~--~~~i---------------k~L~~~~~~lyLVmEy~ 417 (720)
|++ .++||+|+||.|--|....+|..||||+|+....+.+. .+++ ..+.+.+.++|||||.|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 443 46899999999999999999999999999876544321 1222 22334578899999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---CeeeeccccchhccC------
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTG------ 488 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~~~~~------ 488 (720)
.||.|...|+++ +.|+|.++..++++|+.||+|||.+||.||||||+|||....+ -||||||.|+..+..
T Consensus 159 ~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 159 RGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred cCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999999999887 7799999999999999999999999999999999999996554 589999998754321
Q ss_pred --ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC---------------cHHHH
Q 005007 489 --LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---------------GPQAM 551 (720)
Q Consensus 489 --~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~---------------~~~~i 551 (720)
.....+.+|+..|||||+..-... ....|+.+.|.||||||||.||.|.+||.+.- ....+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~--qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVD--QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhcc--ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 122346779999999999864322 23578999999999999999999999996531 12345
Q ss_pred HHHhccCCCCCc----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 552 FKVLNRTPPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 552 ~ki~~~~~~iP~----~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
..|..+.+.+|+ .++.+++|+|..+|.+|+.+|.++.++|+|||++.....
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 566778888886 589999999999999999999999999999999876543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.03 Aligned_cols=234 Identities=28% Similarity=0.476 Sum_probs=185.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcE----EEEEEeccCCCChhH---HHHHHHHhh-------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKS---AECIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~----VAVK~l~~~~~~~~~---~~~ik~L~~-------------~~~~ly 411 (720)
...+|++.+.||+|+||+||+|++..++.. ||||+++........ .+++..+.. ..+..+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~ 84 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 84 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCce
Confidence 346899999999999999999998766664 899988643322111 112222222 134568
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+|+||+.+|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 99999999999999987666799999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CCCCCccC
Q 005007 492 EL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEML 565 (720)
Q Consensus 492 ~~---t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~~iP~~l 565 (720)
.. ...++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+. ..++.. ..+.+..+
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPIC 236 (316)
T ss_pred ceeccCCccceeecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCC
Confidence 22 2234678999999863 457889999999999999997 9999987655443 333332 33456678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+.++.++|.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.88 Aligned_cols=234 Identities=27% Similarity=0.428 Sum_probs=185.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCCCChhHHH---HHHHHhh-------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAE---CIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~----~VAVK~l~~~~~~~~~~~---~ik~L~~-------------~~~~ly 411 (720)
...+|++.++||+|+||+||+|.+..++. .||||.++.........+ ++..+.. .....+
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ 84 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcE
Confidence 34689999999999999999999887776 489998865433222211 1111221 133467
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
++|||+++|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99999999999999987656799999999999999999999999999999999999999999999999999987643222
Q ss_pred c---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCC
Q 005007 492 E---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566 (720)
Q Consensus 492 ~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls 566 (720)
. ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+.. .....+..++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 165 EYHADGGKVPIKWMALESILH-------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICT 237 (279)
T ss_pred eeecCCCccchhhCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCC
Confidence 1 12234678999999863 357789999999999999998 9999987665444443333 2344566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++.++|.+||..||++||++.++++
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=317.67 Aligned_cols=238 Identities=39% Similarity=0.640 Sum_probs=192.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..|+..+.||+|+||.||+|.+..++..||||.++........ ..++..+.. .++.+|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4678889999999999999999999999999988744322211 111222111 35678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
+.+++|.+++.. ..+++..++.++.||++||.|||++||+|+||+|+||+++.++.+||+|||++....... .....
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999999864 568999999999999999999999999999999999999999999999999997665432 22335
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI~ 574 (720)
.|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ....++..++.++.++|.
T Consensus 162 ~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 162 VGTPFWMAPEVIKQ-------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred cCcccccCHHHhCc-------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 68899999999863 3577899999999999999999999986655444444332 233455668899999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||+.+|++||++.++++|+||....
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHccCCcccCcCHHHHHHhHHHHHHh
Confidence 99999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=334.01 Aligned_cols=235 Identities=25% Similarity=0.445 Sum_probs=184.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCCCCh------hHHHHHHHH-hh-----------cC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDP------KSAECIKQL-EQ-----------VD 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg-----~~VAVK~l~~~~~~~------~~~~~ik~L-~~-----------~~ 407 (720)
...++|++++.||+|+||+||+|++..+| ..||||.++...... .+.+++..+ .+ ..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44568999999999999999999865443 579999987543221 122233333 11 24
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc---------------------------------------------------------
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------------- 430 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~--------------------------------------------------------- 430 (720)
+.+|+|||||.+|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 56899999999999999986431
Q ss_pred ------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc---ccc
Q 005007 431 ------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE---LSL 495 (720)
Q Consensus 431 ------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~---~t~ 495 (720)
..+++..++.|+.||++||.|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 23788889999999999999999999999999999999999999999999999765432211 122
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CCCCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~~iP~~ls~el~dL 572 (720)
.++..|||||++.+ ..++.++|||||||++|||++ |+.||........+.++... ....|..++.+++++
T Consensus 275 ~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 275 RLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred CCccceeCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 34667999999863 457889999999999999997 99999876655555454433 344566789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHc
Q 005007 573 LLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~ 592 (720)
|.+||+.||++|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.56 Aligned_cols=242 Identities=24% Similarity=0.423 Sum_probs=188.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChhHHH---HHHHHhh--------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAE---CIKQLEQ--------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~~~~---~ik~L~~--------------~~~~ 409 (720)
..++|++.++||+|+||.||+|.++. .+..||||++........... ++..+.. ..+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997652 355899998864432222111 1111111 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecc
Q 005007 410 LYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 480 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DF 480 (720)
.|+||||+.+|+|.+++.+.. ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 899999999999999997532 22456788999999999999999999999999999999999999999999
Q ss_pred ccchhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc
Q 005007 481 GMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556 (720)
Q Consensus 481 GlA~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~ 556 (720)
|+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhcc-------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 998765332211 12235678999999863 457889999999999999998 8999988776665555543
Q ss_pred -cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc------Cccccccc
Q 005007 557 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE------HPFIRNAN 600 (720)
Q Consensus 557 -~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~------Hpff~~~~ 600 (720)
.....+..++++++++|.+||+.||++|||+.++++ ||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 344567778899999999999999999999999987 88887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=304.86 Aligned_cols=227 Identities=28% Similarity=0.515 Sum_probs=187.8
Q ss_pred eEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyLVmEy~~g 419 (720)
+.||+|+||.||+|.+... +..||||.+......... ...+..+.. .++.+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999866 899999998765443211 112222221 25678999999999
Q ss_pred CCHHHHHHHh--------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 420 GSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 420 GsL~~~L~~~--------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
++|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 4679999999999999999999999999999999999999999999999999998765432
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCC
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls 566 (720)
......++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+.. .....+..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233 (262)
T ss_pred cccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 2234557889999998863 357889999999999999999 6999998877666666653 3456678889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.++.++|.+||..+|++||++.|++++
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=300.65 Aligned_cols=238 Identities=30% Similarity=0.544 Sum_probs=199.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+|.+.++||+|+||+||+|+++++++.||+|.++...++.. ++-.++++.+ .++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 68889999999999999999999999999999988765543 2233344432 36789999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
|+ .+|..+...-++.++.+.++.++.|+++||.|||+++++||||||.|+||+.+|++||+|||+++.+.-.- .....
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 97 89999998888999999999999999999999999999999999999999999999999999999875432 33345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-----------CCCCCc
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-----------TPPIPE 563 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-----------~~~iP~ 563 (720)
+.|.||++|+++.| ..-|+...|+||.|||+.||.. |++.|.+.+..+.+.+|... ...+|+
T Consensus 162 vvtlwyrppdvlfg------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeeeccCcceeee------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 67999999999986 3568889999999999999987 88889998888777777531 011111
Q ss_pred ------------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 564 ------------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 564 ------------------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+....+|+++++|..+|.+|+++++.|+||||.+.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 134567899999999999999999999999999764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.06 Aligned_cols=234 Identities=28% Similarity=0.470 Sum_probs=188.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChhH------HHHHHHHhh-----------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKS------AECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~~------~~~ik~L~~-----------~~~~lyL 412 (720)
.++|++.+.||+|+||+||+|.++.+ ...||||.++........ ...+..+.+ .++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35799999999999999999998754 457999988754332221 122222211 2456899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~- 491 (720)
||||+.+++|.+++....+.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 9999999999999987666899999999999999999999999999999999999999999999999999987742111
Q ss_pred --cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCH
Q 005007 492 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 567 (720)
Q Consensus 492 --~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~ 567 (720)
.....++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ..+.+..+++
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPS 235 (266)
T ss_pred eeccCCCCCccccChhhhcc-------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 112234678999998863 457889999999999999998 99999877766666655543 3455677899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+.+||.+||+.+|++||++.|++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.92 Aligned_cols=235 Identities=29% Similarity=0.544 Sum_probs=190.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHh--------------hcCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLE--------------QVDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~--------------~~~~~lyLVmEy 416 (720)
+|.+++.||+|+||.||+|.++.+|..||+|++...... .....++..+. ..++.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 589999999999999999999999999999998653211 11111222121 135678999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCccc-cc
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY-EL 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~~-~~ 493 (720)
+.+++|.+++.... ..+++..+..|+.||++||.|||+++|+|+||||+|||++.++ .+||+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999997643 3589999999999999999999999999999999999998886 469999999976644321 22
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
...|++.|+|||++.+ ..++.++|||||||++|||++|..||......+.+..+... ...++..++.+++++
T Consensus 161 ~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (257)
T cd08225 161 TCVGTPYYLSPEICQN-------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233 (257)
T ss_pred ccCCCccccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHH
Confidence 3468999999998763 35778999999999999999999999876665555554433 334556688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
|.+||..+|++|||+.|+++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.67 Aligned_cols=236 Identities=28% Similarity=0.471 Sum_probs=198.1
Q ss_pred eEE--eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 356 WQK--GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 356 Y~i--~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
|++ .++||.|.||+||-|.++++|+.||||+|+...--. ....++..|+. ..+++++|||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 554 479999999999999999999999999997654222 12223333332 3578999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---CeeeeccccchhccCcccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~~~~~~~~~ 492 (720)
.+.|.-|+.+|....+.|+|...+.++.|||.||.|||-++|+|+||||+||||.... .|||||||+|+.+.+....
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 9997778888877778999999999999999999999999999999999999996543 7999999999999999999
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC----CCCccCCHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----PIPEMLSSE 568 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~----~iP~~ls~e 568 (720)
.+++|||.|+|||++. +..|...-||||+|||+|--|.|..||.+.++ +-.+|.+... .....++++
T Consensus 724 rsVVGTPAYLaPEVLr-------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLR-------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred hhhcCCccccCHHHHh-------hccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHH
Confidence 9999999999999998 36688899999999999999999999976543 2233333322 223568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+.|||..+|+.+-++|.++++.|.|+|+++..
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 99999999999999999999999999998754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.49 Aligned_cols=241 Identities=28% Similarity=0.518 Sum_probs=193.2
Q ss_pred CeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCC---------ChhHHHHHHHHhh------------cCCEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPD---------DPKSAECIKQLEQ------------VDDHL 410 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~---------~~~~~~~ik~L~~------------~~~~l 410 (720)
.|++.+.||.|+||.||+|.+. .+|..||+|.+..... ...++.++..+.+ .++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 4789999998864211 0112223333321 24568
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999999999764 679999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCCcc
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEM 564 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP~~ 564 (720)
......|+..|+|||.+.+. ...++.++|||||||++|+|++|+.||..... .+....+......+|..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGG-----DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234 (290)
T ss_pred ccccccccCCcccCChhhccCC-----CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence 22345689999999998631 23467789999999999999999999964322 23333444556677888
Q ss_pred CCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
++..+.+||.+||..||++|+ ++++++.|+||+...+
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 999999999999999999997 8999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.62 Aligned_cols=235 Identities=30% Similarity=0.518 Sum_probs=181.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECC--CCcEEEEEEeccCC-----CChh---HHHHHHHHhh-----------cC--CEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIP-----DDPK---SAECIKQLEQ-----------VD--DHLY 411 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~--tg~~VAVK~l~~~~-----~~~~---~~~~ik~L~~-----------~~--~~ly 411 (720)
+|++.++||+|+||.||+|.+.. +++.||||.+.... .... ++.++..+.+ .. +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987632 1111 2223333321 12 6799
Q ss_pred EEEEeccCCCHHHHHHHhc----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC----CCCeeeeccccc
Q 005007 412 IYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----SGVVKLADFGMA 483 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~----~g~VKL~DFGlA 483 (720)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999997 57777775332 36899999999999999999999999999999999999999 899999999999
Q ss_pred hhccCccc----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH---------H
Q 005007 484 KHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ---------A 550 (720)
Q Consensus 484 ~~~~~~~~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~---------~ 550 (720)
........ .....++..|+|||++.+ ...++.++|||||||++|||++|++||....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 86543221 234567899999999863 2456789999999999999999999997543321 1
Q ss_pred HHHH---hc-----------------------cCCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 551 MFKV---LN-----------------------RTPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 551 i~ki---~~-----------------------~~~~iP-----------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+..+ +. ....++ ...+.++.++|.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111 00 001111 1456789999999999999999999999999
Q ss_pred ccc
Q 005007 594 PFI 596 (720)
Q Consensus 594 pff 596 (720)
|||
T Consensus 314 ~~f 316 (316)
T cd07842 314 PYF 316 (316)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.49 Aligned_cols=234 Identities=31% Similarity=0.552 Sum_probs=186.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHh------------hcCCEEEEEEEec
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLE------------QVDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~------------~~~~~lyLVmEy~ 417 (720)
|++.+.||+|+||+||+|.+..+++.||||++........ +...+..+. ..++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999999999999998764322111 111122221 1367889999999
Q ss_pred cCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccccc
Q 005007 418 HPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~ 496 (720)
+|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.............
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 789999887653 468999999999999999999999999999999999999999999999999998765544444567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-----------------
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----------------- 559 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~----------------- 559 (720)
|+..|+|||++.+ ...++.++||||||+++|||++|++||......+.+.++.....
T Consensus 160 ~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 160 STRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 8999999998753 24577899999999999999999999987665554443321000
Q ss_pred --C-----------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 --P-----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 --~-----------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
. .....+.++.+||++||+.||++|||++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.46 Aligned_cols=236 Identities=24% Similarity=0.445 Sum_probs=185.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCCh------hHHHHHHHH-hh-----------cC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDP------KSAECIKQL-EQ-----------VD 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~~------~~~~~ik~L-~~-----------~~ 407 (720)
...++|++++.||+|+||+||+|.+ ..++..||||+++...... .++.++..+ .+ ..
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456899999999999999999964 3567789999987433221 122233333 11 24
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc---------------------------------------------------------
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------------- 430 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~--------------------------------------------------------- 430 (720)
+..|+|||||+||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 56899999999999999986431
Q ss_pred -----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc-
Q 005007 431 -----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE- 492 (720)
Q Consensus 431 -----------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~- 492 (720)
..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 14678889999999999999999999999999999999999999999999999765432211
Q ss_pred --ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CCCCCccCCH
Q 005007 493 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSS 567 (720)
Q Consensus 493 --~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~~iP~~ls~ 567 (720)
....++..|+|||++.+ ..++.++|||||||++|||++ |..||........+.+.+.. ....|...+.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~-------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (375)
T cd05104 272 VKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS 344 (375)
T ss_pred ccCCCCCCcceeChhHhcC-------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence 12234567999999863 457889999999999999998 99999876655555554433 2344667789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++++||.+||+.||++||++.||++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.00 Aligned_cols=223 Identities=19% Similarity=0.294 Sum_probs=183.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh-----------c----CCEEEEEEEe
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ-----------V----DDHLYIYLEY 416 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~-----------~----~~~lyLVmEy 416 (720)
..||+|++|.||+|.. +|+.||||.++...... ++...+..+.+ . ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6899999999999987 58999999987543322 12222222221 0 2368999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+.||+|.+++.+. ..+++.....++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~ 180 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKN 180 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccc
Confidence 9999999999765 579999999999999999999998 499999999999999999999999999998654322 245
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el~dLI 573 (720)
.|+..|+|||++.+. ...++.++|||||||++|||++|+.||.+....+.+..+.. ....+|..+++++++||
T Consensus 181 ~~~~~y~aPE~~~~~-----~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 255 (283)
T PHA02988 181 VNFMVYFSYKMLNDI-----FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255 (283)
T ss_pred cCcccccCHHHhhhc-----cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence 689999999998742 14578899999999999999999999998877666666643 34456667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHc
Q 005007 574 LRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||+.||++|||+.|+++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=346.20 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=179.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC----CcEEEEEEeccCCCChhHH-HHH------------HHHh-----hcCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRET----GASCAIKEVDIIPDDPKSA-ECI------------KQLE-----QVDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~t----g~~VAVK~l~~~~~~~~~~-~~i------------k~L~-----~~~~~ 409 (720)
..++|+++++||+|+||+||+|++..+ +..||||++.......... +.+ ..+. ..+..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 457899999999999999999999998 9999999876432111100 000 0000 23567
Q ss_pred EEEEEEeccCCCHHHHHHHhcCC-------------------CcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec
Q 005007 410 LYIYLEYVHPGSINRYVREHCRD-------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 470 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~-------------------Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd 470 (720)
++|||||+.+++|.+++...... ..+..++.|+.||+.||.|||+++|+||||||+||||+
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe
Confidence 99999999999999998653211 12345778999999999999999999999999999998
Q ss_pred C-CCCeeeeccccchhccCc--cccccccCCCCCCChHHHHHhhhcCC---------------CCCCCccccccchhhhH
Q 005007 471 A-SGVVKLADFGMAKHLTGL--SYELSLKGSPNWMAPEVIKAVMQKDG---------------NPKLALAVDIWSLGCTV 532 (720)
Q Consensus 471 ~-~g~VKL~DFGlA~~~~~~--~~~~t~~GTp~YmAPEvl~g~~~~~g---------------~~~~s~asDVWSLG~vL 532 (720)
. ++.+||+|||+++.+... .....+.||+.|||||.+....+... ...+..++|||||||||
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 5 589999999999865432 22345779999999997753221110 01245577999999999
Q ss_pred HHHhcCCCCCCCCCcHHHHHHHhcc-C---------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 005007 533 IEMLTGKPPWSEFEGPQAMFKVLNR-T---------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590 (720)
Q Consensus 533 yELLTGk~PF~~~~~~~~i~ki~~~-~---------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~EL 590 (720)
|||+++..++.. ....+..++.. . ..+.+.....+++||.+||++||++|||+.|+
T Consensus 370 ~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~ 447 (566)
T PLN03225 370 LQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447 (566)
T ss_pred HHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence 999998766542 11122211110 0 00111123456699999999999999999999
Q ss_pred HcCccccccccc
Q 005007 591 LEHPFIRNANYQ 602 (720)
Q Consensus 591 L~Hpff~~~~~~ 602 (720)
|+||||+.....
T Consensus 448 L~Hpff~~~~~~ 459 (566)
T PLN03225 448 LAHPYFDREGLL 459 (566)
T ss_pred hCCcCcCCCCcc
Confidence 999999876554
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.49 Aligned_cols=238 Identities=27% Similarity=0.493 Sum_probs=189.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
.++|++.+.||+|+||+||+|.+..+|+.||+|++........ +.+++..+.+ ..+.+|+|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 4689999999999999999999999999999998865432211 1222222221 2467899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+++++|.+++.+. +.+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++...... ....
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~ 161 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADT 161 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCc
Confidence 99999999998764 679999999999999999999997 69999999999999999999999999998654322 2234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-----------HHHHHHhcc-CCCCC
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-----------QAMFKVLNR-TPPIP 562 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-----------~~i~ki~~~-~~~iP 562 (720)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+..+... ...++
T Consensus 162 ~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 162 FVGTSTYMSPERIQG-------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred cccCcccCCHHHHcc-------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 678999999999863 35778999999999999999999999764431 222223222 22333
Q ss_pred cc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 563 EM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 563 ~~-ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.. ++.++.+||.+||+.||++|||+.|+++|+||...
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 33 78899999999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.74 Aligned_cols=233 Identities=26% Similarity=0.483 Sum_probs=188.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
..+|.+.+.||+|+||+||+|.++.+++.||+|+++....... +.+.+..+.+ .++.+++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4579999999999999999999999999999998864322211 1222222211 256689999999
Q ss_pred cCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc--c
Q 005007 418 HPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--S 494 (720)
Q Consensus 418 ~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~--t 494 (720)
.+++|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++.......... .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 9999999997542 458999999999999999999999999999999999999999999999999998765432221 2
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
..++..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+... ....+..++.++.++
T Consensus 165 ~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 165 AKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred CCCccccCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 234667999998863 457789999999999999998 99999887666555555443 456677889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHc
Q 005007 573 LLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~ 592 (720)
|.+||+.||++||++.++++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=309.86 Aligned_cols=233 Identities=29% Similarity=0.499 Sum_probs=187.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh--------------cCCE-----
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ--------------VDDH----- 409 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~--------------~~~~----- 409 (720)
|++.+.||+|+||.||+|.++.+++.||||+++...... .+..+++.+.. ..+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 788999999999999999999999999999997533221 12223333321 1223
Q ss_pred EEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 899999997 58999886542 3589999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-----C---
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----P--- 560 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-----~--- 560 (720)
........++..|+|||++.+ ..++.++|||||||++|||++|++||......+.+.++..... .
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred CcccccccccccccChHHhcc-------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 444445568899999999863 3467899999999999999999999988776665555542100 0
Q ss_pred --------C-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 561 --------I-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 561 --------i-----------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+ ...++.++.++|.+||+.||.+||++.|+|+|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.13 Aligned_cols=233 Identities=24% Similarity=0.414 Sum_probs=184.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCc--EEEEEEeccCCCChh------HHHHHHHHh-h-----------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPK------SAECIKQLE-Q-----------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~--~VAVK~l~~~~~~~~------~~~~ik~L~-~-----------~~~~lyLV 413 (720)
++|++.+.||+|+||+||+|++..++. .+|+|.++....... +.+.+..+. + ..+.+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 589999999999999999999988775 478888874322211 222222231 1 23457999
Q ss_pred EEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 414 LEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
|||+++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999996532 248899999999999999999999999999999999999999999999
Q ss_pred ccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc
Q 005007 479 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 557 (720)
Q Consensus 479 DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~ 557 (720)
|||++..............+..|+|||++.+ ..++.++|||||||++|||++ |..||......+...++...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 9999864322111112223557999998863 457889999999999999997 99999887776666666543
Q ss_pred -CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 558 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 558 -~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
....+..++.++++||.+||..+|.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345677799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.37 Aligned_cols=248 Identities=28% Similarity=0.484 Sum_probs=192.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCCC----ChhHHHHHH---------------HHhhcCCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPD----DPKSAECIK---------------QLEQVDDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~----~VAVK~l~~~~~----~~~~~~~ik---------------~L~~~~~~ 409 (720)
...|++.+.||+|+||.||+|..+.++. .+|||+++...+ .....+++. .+...+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3479999999999999999997666543 689999876532 122222222 22223788
Q ss_pred EEEEEEeccCCCHHHHHHHh----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC----CCeeeeccc
Q 005007 410 LYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFG 481 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~----g~VKL~DFG 481 (720)
++|++||.+ -||..+|+-+ .+.++...++.|++||+.||.|||++=|+||||||.||||..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999998 8999999643 3569999999999999999999999999999999999999877 899999999
Q ss_pred cchhccCcc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----------
Q 005007 482 MAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---------- 547 (720)
Q Consensus 482 lA~~~~~~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---------- 547 (720)
+++.+...- ....++.|.||+|||++.| ...|+.++|||++|||+.||||-++.|.+.+.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLG------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLG------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcc------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999886542 2234667999999999996 46799999999999999999999999865322
Q ss_pred --HHHHHHHhccC--------CCCCcc--------------------------CCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005007 548 --PQAMFKVLNRT--------PPIPEM--------------------------LSSEGKDFLLRCFLRNPVERPSAVELL 591 (720)
Q Consensus 548 --~~~i~ki~~~~--------~~iP~~--------------------------ls~el~dLI~~cL~~dP~kRPTa~ELL 591 (720)
...++++++-. ..+|++ -++.+.+||.+||+.||.+|+|++++|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 22333443311 112221 134578999999999999999999999
Q ss_pred cCcccccccccCCCCc
Q 005007 592 EHPFIRNANYQNLSVP 607 (720)
Q Consensus 592 ~Hpff~~~~~~~l~~~ 607 (720)
+|+||+..........
T Consensus 336 eh~yF~~d~lpp~pt~ 351 (438)
T KOG0666|consen 336 EHPYFTEDPLPPLPTS 351 (438)
T ss_pred cccccccCCCCCCccc
Confidence 9999998765544333
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=320.53 Aligned_cols=240 Identities=26% Similarity=0.482 Sum_probs=188.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----h---HHHHHHHHhhc----------------CCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----K---SAECIKQLEQV----------------DDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~---~~~~ik~L~~~----------------~~~ 409 (720)
..+|++.+.||+|+||+||+|++..+++.||||.++...... . +..++..+.+. ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 458999999999999999999999999999999886432111 1 11222222110 134
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+||||||+. ++|.+++... +.+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 799999996 7899988654 67999999999999999999999999999999999999999999999999999866443
Q ss_pred -cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc------------
Q 005007 490 -SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------------ 556 (720)
Q Consensus 490 -~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~------------ 556 (720)
.......++..|+|||++.+ ...++.++|||||||++|+|++|++||...+....+..+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 23345568999999999863 23477899999999999999999999976543322221110
Q ss_pred -----------cCC--------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 557 -----------RTP--------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 557 -----------~~~--------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
... .....+++++++||++||+.+|++|||++|+|+||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000 01235788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.82 Aligned_cols=234 Identities=24% Similarity=0.424 Sum_probs=183.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcE--EEEEEeccCCCChh------HHHHHHHH-hh-----------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPK------SAECIKQL-EQ-----------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~--VAVK~l~~~~~~~~------~~~~ik~L-~~-----------~~~~lyL 412 (720)
-++|++.+.||+|+||+||+|.++.++.. +|+|.++....... +++.+..+ .+ .++.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 45899999999999999999999888765 57776653322111 22223333 11 2456899
Q ss_pred EEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 413 YLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 999999999999997532 25789999999999999999999999999999999999999999999
Q ss_pred eccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc
Q 005007 478 ADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556 (720)
Q Consensus 478 ~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~ 556 (720)
+|||++.............++..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhc-------cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 99999864322111122234667999998863 347789999999999999998 9999987666555555443
Q ss_pred c-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 ~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
. ....+..++.++.+||.+||+.+|++||++.++|++
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 234566688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.76 Aligned_cols=234 Identities=47% Similarity=0.845 Sum_probs=195.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
+|.+.+.||+|+||.||+|.+..+++.||||++........ ..++++.+.. .++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58899999999999999999999999999999875532111 1122222221 24678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-cccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-ELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-~~t~ 495 (720)
+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 9999999999765 6799999999999999999999999999999999999999999999999999987654332 2345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh-ccCCCCCccCCHHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~-~~~~~iP~~ls~el~dLI~ 574 (720)
.++..|+|||.+.+ ..++.++|||+||+++|+|++|+.||..........++. .....++..++.++.++|.
T Consensus 160 ~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 160 VGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 68999999998863 236789999999999999999999998776655555544 4455677888999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+||..+|++|||+.+++.|+||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=313.15 Aligned_cols=240 Identities=28% Similarity=0.520 Sum_probs=188.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
++|++.+.||+|+||+||+|.++.+|+.||||++....... .+.+.++.+.+ .++..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47999999999999999999999999999999886532211 12222333321 2567899999
Q ss_pred eccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchhccCc-ccc
Q 005007 416 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGL-SYE 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~~-~~~ 492 (720)
|+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ...
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 996 68888875532 23688899999999999999999999999999999999985 557999999999765322 112
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--------------
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------- 558 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-------------- 558 (720)
....|++.|+|||++.+ ...++.++|||||||++|+|++|++||......+.+.++....
T Consensus 161 ~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 161 THEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred ccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 23457899999999863 2457789999999999999999999998776666655543210
Q ss_pred -------CC--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 -------PP--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 -------~~--------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.. ....+++++.++|.+||+.+|++||++.++|+|+||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 0124678899999999999999999999999999998754
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.04 Aligned_cols=236 Identities=39% Similarity=0.640 Sum_probs=192.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhh--------------cCCEEEEEEEec
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
-|++.+.||+|+||.||+|.+..++..||||++........ ..++++.+.. .++.+|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 57889999999999999999999999999998864332211 1112222221 246789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||.||+++.++.++|+|||++....... ......
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 99999999864 468999999999999999999999999999999999999999999999999987654322 223456
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~ 575 (720)
|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+... ...++..++.++.++|.+
T Consensus 163 ~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 163 GTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred CCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 8999999998863 34677899999999999999999999876655555544333 344566788999999999
Q ss_pred hhhcCCCCCCCHHHHHcCcccccc
Q 005007 576 CFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
||..+|.+||++.++++|+||...
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.14 Aligned_cols=235 Identities=24% Similarity=0.427 Sum_probs=184.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhH------HHHHHHHhh-----------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKS------AECIKQLEQ-----------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~------~~~ik~L~~-----------~~~~ 409 (720)
..++|++.+.||+|+||+||+|.+. .++..||||.+......... ...++.+.. .+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999864 24577999987643221111 111222211 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecc
Q 005007 410 LYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 480 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DF 480 (720)
.++||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 899999999999999997532 23567888999999999999999999999999999999999999999999
Q ss_pred ccchhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc
Q 005007 481 GMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556 (720)
Q Consensus 481 GlA~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~ 556 (720)
|+++........ ....++..|||||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 998765332211 12345778999999863 457889999999999999999 7999988766655555544
Q ss_pred c-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 ~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
. ...++..++..++++|.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 345677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.81 Aligned_cols=238 Identities=27% Similarity=0.489 Sum_probs=185.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhhc---------------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQV--------------------- 406 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~~--------------------- 406 (720)
..+|++.+.||.|+||+||+|.++.+|+.||||++....... ++++.++.+.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 479999999999999999999999999999999886543221 112222222110
Q ss_pred ----CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccc
Q 005007 407 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFG 481 (720)
Q Consensus 407 ----~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFG 481 (720)
...+|+||||+. ++|.+++.. ..+++..++.++.||++||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 135799999997 689888854 46999999999999999999999999999999999999974 5678999999
Q ss_pred cchhccCcc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc
Q 005007 482 MAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR 557 (720)
Q Consensus 482 lA~~~~~~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~ 557 (720)
+++...... ......|+..|+|||++.+ ...++.++|||||||++|||++|+.||......+....++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 997653221 1122357889999998763 234778999999999999999999999876554444433321
Q ss_pred CC-------------------------C-----CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 558 TP-------------------------P-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 558 ~~-------------------------~-----iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+ . +...++.++++||.+||+.||++|||+.|+|+|+||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 10 0 112467899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.56 Aligned_cols=234 Identities=29% Similarity=0.550 Sum_probs=188.0
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHh-----------hcCCEEEEEEEec
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLE-----------QVDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~-----------~~~~~lyLVmEy~ 417 (720)
|++.+.||+|++|.||+|.+..+++.+|+|++....... .+...++.+. ..++.+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677899999999999999999999999999887543321 1122222222 1356789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
. ++|.+++......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||.+....... ......
T Consensus 81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 7 58988887765789999999999999999999999999999999999999999999999999997665433 223355
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-----------------
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----------------- 559 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~----------------- 559 (720)
++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...+..+.+.++.....
T Consensus 160 ~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 160 VTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred CcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 8889999999863 23578899999999999999999999987766555544432100
Q ss_pred -------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 -------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 -------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+...++.++.+||.+||+.||.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.14 Aligned_cols=240 Identities=28% Similarity=0.516 Sum_probs=189.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh---------------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ---------------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~---------------~~~~l 410 (720)
..+|++.+.||+|+||.||+|.+..+|+.||||++....... .+..+++.+.+ ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999999999999999886532211 12222222221 12468
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 99999996 6899988654 569999999999999999999999999999999999999999999999999997654321
Q ss_pred -----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc---------
Q 005007 491 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--------- 556 (720)
Q Consensus 491 -----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--------- 556 (720)
......|+.+|+|||++.+ ...++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred cCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 1234578999999999863 23478899999999999999999999977654433322211
Q ss_pred -----------------cCCCC-----CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 557 -----------------RTPPI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 557 -----------------~~~~i-----P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..... ...++++++++|++||+.+|++||++.++|.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00111 133688999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.96 Aligned_cols=243 Identities=28% Similarity=0.493 Sum_probs=186.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH---HHHHHHhh---------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQ---------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~---------------~~~~lyLVmE 415 (720)
++|+..+.||+|+||.||++.+..+++.||||.+.......... .++..+.. .++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 36777889999999999999999999999999987543222111 11111211 1445789999
Q ss_pred eccCCCHHHHHH---H-hcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 416 YVHPGSINRYVR---E-HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 416 y~~gGsL~~~L~---~-~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+. ++|.++.. . ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 986 56655432 1 235699999999999999999999975 99999999999999999999999999998765544
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhcc-CCCC----Ccc
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR-TPPI----PEM 564 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~-~~~i----P~~ 564 (720)
......|+..|+|||++.+.. ...++.++|||||||++|||++|++||...... +.+.++... .+.+ +..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 444556899999999986411 135788999999999999999999999765421 222232222 1222 224
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
++.++.+||.+||+.||++|||++++++|+||+....
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 7899999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.79 Aligned_cols=239 Identities=34% Similarity=0.580 Sum_probs=192.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHh--------------hcCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLE--------------QVDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~--------------~~~~~lyLVmEy~ 417 (720)
..|.....||+|+||.||+|.+..+++.||||++....... ...+++..+. ..++..|+||||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 45666678999999999999999999999999986432221 1111222221 1357799999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 99999998855 468999999999999999999999999999999999999999999999999987654322 223467
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDFL 573 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dLI 573 (720)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+..... ..+..++.++.++|
T Consensus 179 ~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 179 GTPYWMAPEVISR-------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251 (297)
T ss_pred cCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence 8999999999863 3577899999999999999999999987665555554443322 22345788999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.+||+.+|++||++.++++|+||.....
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.96 Aligned_cols=226 Identities=26% Similarity=0.470 Sum_probs=179.5
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
+.||+|+||.||+|.++.+++.||+|.+....... .+.+.++.+.+ .++.+|+||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999999999999876432211 11222222221 24568999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc---cccCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSP 499 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~---t~~GTp 499 (720)
.+++......+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++.......... ...++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 99997665678999999999999999999999999999999999999999999999999987654321111 112245
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHHHHhh
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCF 577 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI~~cL 577 (720)
.|+|||.+.+ ..++.++|||||||++|||++ |..||...........+.. .....+..++..+.+||.+||
T Consensus 161 ~y~aPE~~~~-------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 161 KWTAPEALNY-------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred eecCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 6999999863 347789999999999999997 9999987665554444433 244567778999999999999
Q ss_pred hcCCCCCCCHHHHHc
Q 005007 578 LRNPVERPSAVELLE 592 (720)
Q Consensus 578 ~~dP~kRPTa~ELL~ 592 (720)
+.+|++|||+.|+++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.35 Aligned_cols=234 Identities=29% Similarity=0.572 Sum_probs=185.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
|++.+.||.|++|+||+|.+..+|..||||++....... .+++.+..+.. .++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999999999999999887543211 12222222221 356789999999
Q ss_pred cCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 418 HPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
. ++|.+++.... ..+++..+..++.||++||+|||+++++||||+|+|||++.++.+||+|||++....... .....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 78999987643 368999999999999999999999999999999999999999999999999997653221 11233
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc------------------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------------ 557 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------------------ 557 (720)
.++..|+|||++.+ ...++.++|||||||++|||++|++||...+....+.++...
T Consensus 160 ~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 160 VVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 56889999998753 234678999999999999999999999876655444443221
Q ss_pred ---C--------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 558 ---T--------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 558 ---~--------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
. ......++.++.++|.+||+.||.+|||++|+++|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=310.33 Aligned_cols=234 Identities=25% Similarity=0.426 Sum_probs=185.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChhHHH------HHHHHhh-----------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAE------CIKQLEQ-----------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~~~~------~ik~L~~-----------~~~~l 410 (720)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+........... ++..+.+ ..+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999987 788999998865443322221 1222211 23457
Q ss_pred EEEEEeccCCCHHHHHHHhc------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---Ceeeeccc
Q 005007 411 YIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFG 481 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFG 481 (720)
|+||||+.|++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 89999999999999997642 2589999999999999999999999999999999999998765 59999999
Q ss_pred cchhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-
Q 005007 482 MAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN- 556 (720)
Q Consensus 482 lA~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~- 556 (720)
+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+.+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLD-------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99876332211 12223567999999863 457889999999999999997 9999987666555554443
Q ss_pred cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 ~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.....|..++..+.++|.+||+.+|++||++.++|+|
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3445567789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=319.11 Aligned_cols=240 Identities=28% Similarity=0.496 Sum_probs=191.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----h---HHHHHHHHhh-----------cC-----CEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----K---SAECIKQLEQ-----------VD-----DHLY 411 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~---~~~~ik~L~~-----------~~-----~~ly 411 (720)
+|++.+.||+|+||.||+|.+..+++.||||++....... . +...++.+.. .. ..+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999999999999999886533211 1 1222222211 12 3689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999997 6899988654 579999999999999999999999999999999999999999999999999998765443
Q ss_pred ---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-------
Q 005007 491 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------- 560 (720)
Q Consensus 491 ---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~------- 560 (720)
......++.+|+|||++.+ ...++.++|||||||++|+|++|++||...+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLS------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccCcCCceeeec------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 2334568999999999874 225788999999999999999999999877665554444321110
Q ss_pred ------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 561 ------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 561 ------------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
+...++.++.+||.+||+++|.+|||++++|+||||+.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 112367889999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=312.56 Aligned_cols=241 Identities=32% Similarity=0.546 Sum_probs=199.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhc---CCEEEEE---------------EEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV---DDHLYIY---------------LEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~---~~~lyLV---------------mEy 416 (720)
+.+.+..||.|+.|+|++++.+.+|...|||.+.......+..+++..|... .+.-||| ||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4466788999999999999999999999999998766655556666555432 2333333 455
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
|. .-++.+++.-.+.++|..+-++..-++.||.||.+ +|||||||||+|||+|+.|+|||||||++..+.+......-
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs 251 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS 251 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccc
Confidence 52 34556666666889999999999999999999975 59999999999999999999999999999988877777777
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC-CcHHHHHHHhccCCC-CCc--cCCHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRTPP-IPE--MLSSEGKD 571 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~-~~~~~i~ki~~~~~~-iP~--~ls~el~d 571 (720)
.|.+.|||||.+.- .....|+.++||||||++++||.||..||.+. .+.+.+.++++..++ +|. .+++++++
T Consensus 252 AGC~~YMaPERidp----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~ 327 (391)
T KOG0983|consen 252 AGCAAYMAPERIDP----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS 327 (391)
T ss_pred cCCccccCccccCC----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence 89999999998863 33578999999999999999999999999874 455777788876553 332 37999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|+..||++|+.+||...+||+|||+...+
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999999999997654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=304.75 Aligned_cols=231 Identities=28% Similarity=0.484 Sum_probs=186.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-h---HHHHHHHHhh-----------cCCEEEEEEEecc
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-K---SAECIKQLEQ-----------VDDHLYIYLEYVH 418 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~---~~~~ik~L~~-----------~~~~lyLVmEy~~ 418 (720)
++|++.+.||+|+||.||+|.++. +..+|+|.+....... . +.+.++.+.+ .++.+++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 579999999999999999998764 5689999876433222 1 2222222221 2456899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--cccc
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLK 496 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~t~~ 496 (720)
+|+|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........ ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence 99999999765567899999999999999999999999999999999999999999999999998765432222 1223
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~ 574 (720)
++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ....|...+.++.++|.
T Consensus 163 ~~~~y~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 163 FPVKWSPPEVFNF-------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred CchhhCChhhccc-------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 5668999999863 357789999999999999999 99999887777777766654 33456778899999999
Q ss_pred HhhhcCCCCCCCHHHHHc
Q 005007 575 RCFLRNPVERPSAVELLE 592 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~ 592 (720)
+||+.+|++||++.|+++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.18 Aligned_cols=239 Identities=24% Similarity=0.455 Sum_probs=189.1
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeccCCCChh------HHHHHHHHh-h----------
Q 005007 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPK------SAECIKQLE-Q---------- 405 (720)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~VYla~d~~t-----g~~VAVK~l~~~~~~~~------~~~~ik~L~-~---------- 405 (720)
......++|++.+.||+|+||.||+|.+... ...||+|.+........ +.+.+..+. +
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455567899999999999999999987643 37899998875432221 122222221 1
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHh---------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
.++.+++||||+.+|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 245689999999999999999642 2468999999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-------CCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999999986644321 112234567999998753 457889999999999999997 99999887
Q ss_pred CcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 546 EGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 546 ~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+....+... ....+..++.++.+||.+||..||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 239 PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665555554433 345667788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.94 Aligned_cols=239 Identities=29% Similarity=0.501 Sum_probs=187.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhh----------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ----------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~----------------~~~~lyLVm 414 (720)
++|+..+.||.|+||.||+|.+..+++.||+|.+......... .++++.+.. ..+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3789999999999999999999999999999998754332211 122222221 134689999
Q ss_pred EeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 415 EYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||++|++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999988753 33568999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-----cHHHHHHHhc-cCCCCC---
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-----GPQAMFKVLN-RTPPIP--- 562 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-----~~~~i~ki~~-~~~~iP--- 562 (720)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+....+.. ....++
T Consensus 160 ~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 160 AGTFTGTSFYMAPERIQG-------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cccccCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 224567889999999863 457789999999999999999999997652 1223333222 111222
Q ss_pred ---ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 ---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 ---~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++.+||.+||..+|.+|||+.|+++|+||+...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 23467899999999999999999999999999996544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.47 Aligned_cols=234 Identities=24% Similarity=0.422 Sum_probs=186.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeccCCCChhHH---HHHHHHhh--------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~t-----g~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~ 409 (720)
..++|++.+.||+|+||.||+|.++.. +..||||.+.......... +.+..+.. ..+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 456899999999999999999988644 4889999986443222111 12222221 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecc
Q 005007 410 LYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 480 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DF 480 (720)
.|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 899999999999999996431 23678899999999999999999999999999999999999999999999
Q ss_pred ccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc
Q 005007 481 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556 (720)
Q Consensus 481 GlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~ 556 (720)
|+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhc-------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99976543321 123446788999999863 457889999999999999998 9999987766665555543
Q ss_pred c-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 557 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 557 ~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
. ...+|..++.++.++|.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3 45667888999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.40 Aligned_cols=242 Identities=29% Similarity=0.467 Sum_probs=189.4
Q ss_pred CCCeE-EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------------------hHHHHHHHHhh-------
Q 005007 353 KSQWQ-KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------------------KSAECIKQLEQ------- 405 (720)
Q Consensus 353 ~~~Y~-i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------------------~~~~~ik~L~~------- 405 (720)
.++|. +.+.||+|+||+||+|.+..+++.||||++....... .+.+.+..+.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 5688999999999999999999999999886432211 12222232221
Q ss_pred ----cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccc
Q 005007 406 ----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 481 (720)
Q Consensus 406 ----~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFG 481 (720)
.++.+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 2466899999997 6899998654 569999999999999999999999999999999999999999999999999
Q ss_pred cchhccCc---------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC
Q 005007 482 MAKHLTGL---------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 546 (720)
Q Consensus 482 lA~~~~~~---------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~ 546 (720)
++...... .......++..|+|||++.+ ...++.++|||||||++|||++|++||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765411 11122346889999999863 2346789999999999999999999998877
Q ss_pred cHHHHHHHhcc---CC-------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 547 GPQAMFKVLNR---TP-------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 547 ~~~~i~ki~~~---~~-------------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..+.+..+... .. ......+.++.++|.+||+.+|++|||++|+|.|+||+.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 66655444321 00 001235788999999999999999999999999999986
Q ss_pred cccc
Q 005007 599 ANYQ 602 (720)
Q Consensus 599 ~~~~ 602 (720)
....
T Consensus 319 ~~~~ 322 (335)
T PTZ00024 319 DPLP 322 (335)
T ss_pred CCCC
Confidence 5433
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.87 Aligned_cols=233 Identities=27% Similarity=0.498 Sum_probs=187.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~l 410 (720)
..+|.+.+.||+|+||+||+|.+.. ++..||||.++....... +++.+..+.+ ..+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4578999999999999999998753 468899998875433211 1222222221 24568
Q ss_pred EEEEEeccCCCHHHHHHHhc-------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 411 YIYLEYVHPGSINRYVREHC-------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~-------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
++||||+++++|.++|.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 99999999999999997542 34788999999999999999999999999999999999999999999
Q ss_pred eccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHH
Q 005007 478 ADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553 (720)
Q Consensus 478 ~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~k 553 (720)
+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhcc-------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999975432221 123345788999999863 457889999999999999998 9999988777777666
Q ss_pred HhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 554 VLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 554 i~~~~-~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.... ...+..++.+++++|.+||+.||++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66543 3446678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=310.02 Aligned_cols=233 Identities=25% Similarity=0.394 Sum_probs=183.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcE----EEEEEeccCCCChhHHHHHH---HHhh-------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIK---QLEQ-------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~----VAVK~l~~~~~~~~~~~~ik---~L~~-------------~~~~lyL 412 (720)
..+|++++.||+|+||+||+|.+..++.. |++|.+..........+... .+.. .....++
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL 85 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEE
Confidence 45899999999999999999999887764 67776653222111111111 1111 1345689
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~- 491 (720)
||||+.+|+|.+++......+++..+..|+.||+.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999999999987667899999999999999999999999999999999999999999999999999986543221
Q ss_pred --cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCH
Q 005007 492 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 567 (720)
Q Consensus 492 --~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~ 567 (720)
.....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+.. .....+..++.
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05111 166 YFYSEHKTPIKWMALESILF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTI 238 (279)
T ss_pred cccCCCCCcccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCH
Confidence 123456778999999863 357889999999999999998 9999987655443333332 23344566788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.++|.+||..||.+|||+.|+++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=304.82 Aligned_cols=229 Identities=27% Similarity=0.482 Sum_probs=184.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhh------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQ------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~------------~~~~lyLVmEy~ 417 (720)
..+|++.+.||+|+||.||+|... |..||+|.++....... +...++.+.+ .++.+|+||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 458999999999999999999765 88899998865432222 2222222221 235689999999
Q ss_pred cCCCHHHHHHHhcC-CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccccc
Q 005007 418 HPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~-~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~ 496 (720)
++++|.+++.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~ 160 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGK 160 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCc
Confidence 99999999976533 48899999999999999999999999999999999999999999999999987654322 2334
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~ 574 (720)
++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++..++++|.
T Consensus 161 ~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 161 LPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred cceeecCHHHHcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 5678999998863 457789999999999999997 99999876655555554433 34456778999999999
Q ss_pred HhhhcCCCCCCCHHHHHc
Q 005007 575 RCFLRNPVERPSAVELLE 592 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~ 592 (720)
+||..+|++|||+.++++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 234 QCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.28 Aligned_cols=238 Identities=35% Similarity=0.618 Sum_probs=192.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-----HHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----SAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-----~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
..|...+.||+|++|.||+|.+..+++.||||+++....... +...+..+.+ ..+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 467777899999999999999999999999998864332211 1112222211 246789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 99999999976 569999999999999999999999999999999999999999999999999887654322 223456
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC---CccCCHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFL 573 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i---P~~ls~el~dLI 573 (720)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+.++....... +..++..+.+||
T Consensus 177 ~~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 177 GTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred CCccccCHHHhcC-------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 8999999999863 347789999999999999999999998766655555555442222 233788999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+||..+|++|||+.++|+|+||+...
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.44 Aligned_cols=238 Identities=25% Similarity=0.453 Sum_probs=190.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cC------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VD------ 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~------ 407 (720)
..++|++.+.||+|+||+||+|++..+++.||||++....... .+..++..+.+ .+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999999999999999886432111 12222222211 12
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+|+|+||+ +++|.+++.. ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 2489999999 6899999865 469999999999999999999999999999999999999999999999999998664
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------- 560 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~------- 560 (720)
.. .....++..|+|||++.+ ...++.++|||||||++|||++|+.||...+..+.+..+......
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cc--ccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 32 334568999999999863 235678999999999999999999999876665555444321110
Q ss_pred ------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 561 ------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 561 ------------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+...++.++.+||.+||..||++|||+.|||+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 1123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.23 Aligned_cols=234 Identities=28% Similarity=0.533 Sum_probs=186.9
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-----------cC--CEEEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-----------VD--DHLYIYLE 415 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-----------~~--~~lyLVmE 415 (720)
|++.+.||+|+||.||+|.+..+++.||||.+....... .+.+.++.+.+ .+ +.+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999999999999997653111 12222332221 13 67999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YEL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~ 493 (720)
|+. ++|..++......+++..++.++.||++||+|||++|++|+||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 997 58999887655679999999999999999999999999999999999999999999999999998665432 123
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------------- 559 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-------------- 559 (720)
...++..|+|||.+.+ ...++.++|||||||++|||++|+.||........+..+.....
T Consensus 160 ~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 160 NRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred ccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3457889999998753 23467899999999999999999999987766555444432100
Q ss_pred -----------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 -----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 -----------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+...++.++.++|++||..+|.+||+++++++|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.31 Aligned_cols=234 Identities=31% Similarity=0.515 Sum_probs=193.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-H------HHHHHHHh-----------hcCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-S------AECIKQLE-----------QVDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~------~~~ik~L~-----------~~~~~lyLVmEy 416 (720)
+|++.+.||+|+||.||++.+..+++.||||.+........ . .+.++.+. ..++..|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999999999999998865322111 1 11112111 125678999999
Q ss_pred ccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 417 VHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
+++++|.+++.+. ...+++..++.++.||+.||.|||++|++|+||||.||+++.++.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 9999999998652 256899999999999999999999999999999999999999999999999999876554 333
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
...|+..|++||.+.+ ..++.++|+||||+++|||++|+.||...+..+....+... ...++..++.+++++
T Consensus 160 ~~~~~~~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08530 160 TQIGTPHYMAPEVWKG-------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF 232 (256)
T ss_pred cccCCccccCHHHHCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHH
Confidence 4568999999999863 45678999999999999999999999887765555555443 345667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
|.+||..+|++||++.|+|+||++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.34 Aligned_cols=237 Identities=25% Similarity=0.461 Sum_probs=186.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh--------------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-------------------- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-------------------- 405 (720)
.++|++.+.||+|+||+||+|.++.+|+.||||+++...... .+.+.+..+.+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 468999999999999999999999999999999987532111 12222332221
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
..+.+|+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 02368999999985 7877776655679999999999999999999999999999999999999999999999999998
Q ss_pred hccCccc--cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc---cCC
Q 005007 485 HLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---RTP 559 (720)
Q Consensus 485 ~~~~~~~--~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~---~~~ 559 (720)
....... .....++..|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+.. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccCCcccccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 6643321 122346788999998853 23467899999999999999999999987665554443322 110
Q ss_pred ---------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 560 ---------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 560 ---------------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.....++..+.++|.+||..||.+||++.++|.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.84 Aligned_cols=224 Identities=24% Similarity=0.453 Sum_probs=179.8
Q ss_pred EEeecCCeEEEEEEE--CCCCcEEEEEEeccCCCChhHH-------HHHHHHhh----------cCCEEEEEEEeccCCC
Q 005007 361 LIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSA-------ECIKQLEQ----------VDDHLYIYLEYVHPGS 421 (720)
Q Consensus 361 ~LG~G~fG~VYla~d--~~tg~~VAVK~l~~~~~~~~~~-------~~ik~L~~----------~~~~lyLVmEy~~gGs 421 (720)
.||+|+||+||+|.+ ..++..||||+++......... .++..+.+ .++..++||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 689999999999964 4678899999987544332221 11222211 1456789999999999
Q ss_pred HHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc----cccccC
Q 005007 422 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----ELSLKG 497 (720)
Q Consensus 422 L~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~----~~t~~G 497 (720)
|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++....... .....+
T Consensus 82 L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 82 LNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99999754 5799999999999999999999999999999999999999999999999999976543221 112234
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHH
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~ 575 (720)
+..|+|||++.. ..++.++|||||||++|||++ |+.||......+....+... ...+|..++.+++++|.+
T Consensus 161 ~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 161 PVKWYAPECMNY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred CccccCHhHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 678999998852 457789999999999999998 99999887666665555543 456778899999999999
Q ss_pred hhhcCCCCCCCHHHHHc
Q 005007 576 CFLRNPVERPSAVELLE 592 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~ 592 (720)
||+.||++||++.+|.+
T Consensus 234 ~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 234 CWTYGVDERPGFAVVEL 250 (257)
T ss_pred HhccCchhCcCHHHHHH
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=306.25 Aligned_cols=231 Identities=25% Similarity=0.415 Sum_probs=181.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCc--EEEEEEeccCCCChhHH-------HHHHHHhhc-----------------CCE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSA-------ECIKQLEQV-----------------DDH 409 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~--~VAVK~l~~~~~~~~~~-------~~ik~L~~~-----------------~~~ 409 (720)
|.++++||+|+||+||+|++..++. .||||.++......... +.++.+.+. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578899999999999999887775 59999887543222211 122222210 123
Q ss_pred EEEEEEeccCCCHHHHHHHh-----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 410 LYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++||||+.+|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 58999999999999987432 2348899999999999999999999999999999999999999999999999998
Q ss_pred hccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CC
Q 005007 485 HLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TP 559 (720)
Q Consensus 485 ~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~ 559 (720)
....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 7643221 112345778999998863 457889999999999999999 89999887666655555543 33
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 560 ~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+..++..++++|.+||+.||++|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.33 Aligned_cols=238 Identities=26% Similarity=0.475 Sum_probs=189.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhhc-----------C------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQV-----------D------ 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~~-----------~------ 407 (720)
..++|++.+.||+|+||+||+|.+..+|..||||++....... .+.++++.+.+. +
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999999999999999886432221 122223322210 1
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+++||||+ |++|.+++.. ..+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 2468999999 7899988864 569999999999999999999999999999999999999999999999999997654
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------- 559 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-------- 559 (720)
.. .....+++.|+|||++.+ ...++.++|||||||++|+|++|+.||........+.+++....
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 170 SE--MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cC--ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 32 234567999999999863 23477899999999999999999999987655444443322111
Q ss_pred -----------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 -----------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 -----------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+...++.++.++|.+||..||.+|||+.+++.|+||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.36 Aligned_cols=232 Identities=28% Similarity=0.533 Sum_probs=186.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh----------cCCEEEEEEEecc
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ----------VDDHLYIYLEYVH 418 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~----------~~~~lyLVmEy~~ 418 (720)
.++|++.+.||+|+||.||+|.+. ++..||+|.+........ ++.+++.+.+ .++..|+||||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 458999999999999999999866 567799999875433221 2222333322 2345799999999
Q ss_pred CCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--ccc
Q 005007 419 PGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSL 495 (720)
Q Consensus 419 gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~t~ 495 (720)
+++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 99999999764 345899999999999999999999999999999999999999999999999999765433221 123
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+... ..+.+...+.++.+||
T Consensus 164 ~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 164 KFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred CCCccccChHHHhc-------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 35667999998863 457789999999999999999 99999887766666665543 4456777899999999
Q ss_pred HHhhhcCCCCCCCHHHHHc
Q 005007 574 LRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||..+|++|||+.++++
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.67 Aligned_cols=231 Identities=25% Similarity=0.429 Sum_probs=183.4
Q ss_pred eEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChhH-------HHHHHHHhhc-----------C------C
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKS-------AECIKQLEQV-----------D------D 408 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~~-------~~~ik~L~~~-----------~------~ 408 (720)
|++++.||+|+||+||+|.+..+ +..||||+++........ .+.++.+.+. . .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 478999998754332221 1122222110 1 1
Q ss_pred EEEEEEEeccCCCHHHHHHHh-----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccc
Q 005007 409 HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
..++||||+++|+|..++... ...+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 368999999999999998542 135899999999999999999999999999999999999999999999999999
Q ss_pred hhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cC
Q 005007 484 KHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RT 558 (720)
Q Consensus 484 ~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~ 558 (720)
+........ ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-------RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 865433211 12234678999998752 457889999999999999999 9999988777666665554 34
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 559 ~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...|..++.++.++|.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.50 Aligned_cols=233 Identities=22% Similarity=0.414 Sum_probs=185.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~----~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyL 412 (720)
.+|++.+.||+|+||+||+|.+. .++..||||.+........ +.++++.+.+ .++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 57899999999999999999853 4567899998874332221 2222233321 2466899
Q ss_pred EEEeccCCCHHHHHHHhc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCee
Q 005007 413 YLEYVHPGSINRYVREHC----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~----------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VK 476 (720)
||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 999999999999985321 2478889999999999999999999999999999999999999999
Q ss_pred eeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHH
Q 005007 477 LADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552 (720)
Q Consensus 477 L~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ 552 (720)
|+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+......+.
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999998654322 1223446778999999863 357889999999999999998 999998776655555
Q ss_pred HHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 553 KVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 553 ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+... ....+..++++++++|.+||+.||++||++.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 54433 345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.28 Aligned_cols=234 Identities=28% Similarity=0.522 Sum_probs=187.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~l 410 (720)
.+.+|.+.+.||+|+||+||++.+. .++..||+|.+....... .+.+.+..+.+ ..+.+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3568999999999999999999853 356679999886432111 11222222221 25678
Q ss_pred EEEEEeccCCCHHHHHHHhc------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 411 YIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999997542 248999999999999999999999999999999999999999999999
Q ss_pred ccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHH
Q 005007 479 DFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554 (720)
Q Consensus 479 DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki 554 (720)
|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||......+.+..+
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999976533221 122335778999999863 457889999999999999998 99999887777776666
Q ss_pred hccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 555 LNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 555 ~~~~-~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.... ...+..++.++.+||.+||+.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6543 4556778999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.39 Aligned_cols=232 Identities=27% Similarity=0.450 Sum_probs=185.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHHHHHHHhh--------------cCCEEEEEEEecc
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~~ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
.+|++++.||+|+||.||+|.++ ++..+|||++....... ....++..+.. ..+.+|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 47899999999999999999876 46789999886432211 12222222222 2456899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc--ccc
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK 496 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~--t~~ 496 (720)
|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 162 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK 162 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence 999999997765678999999999999999999999999999999999999999999999999987654322111 112
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~ 574 (720)
++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++.++.++|.
T Consensus 163 ~~~~y~~Pe~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 163 FPVKWAPPEVFDY-------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred CCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 3457999999863 457789999999999999999 89999877666666555443 34556678999999999
Q ss_pred HhhhcCCCCCCCHHHHHcC
Q 005007 575 RCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~H 593 (720)
+||..+|++|||+.|+++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=313.71 Aligned_cols=239 Identities=37% Similarity=0.636 Sum_probs=191.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--HHHH---HHHHhh-----------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--SAEC---IKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--~~~~---ik~L~~-----------~~~~lyLVmEy 416 (720)
..+|.+.+.||+|+||+||+|.+..+++.||||.+........ ...+ ++.+.+ ..+..|+||||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 4689999999999999999999999999999999864322211 1111 222211 24578999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
+++++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .....
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence 999999999965 358899999999999999999999999999999999999999999999999987654332 22345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh-ccCC--CCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTP--PIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~-~~~~--~iP~~ls~el~dL 572 (720)
.|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+. ...+ ..+..++..++++
T Consensus 176 ~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 176 VGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cCChhhcCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 68999999999863 346789999999999999999999998765544433332 2222 2344578899999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|.+||..+|++||++.+++.|+||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.66 Aligned_cols=237 Identities=25% Similarity=0.450 Sum_probs=184.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeccCCCChh------HHHHHHHHhh-----------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPK------SAECIKQLEQ----------- 405 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~-------tg~~VAVK~l~~~~~~~~------~~~~ik~L~~----------- 405 (720)
.....+|.+++.||+|+||+||+|.+.. ++..||+|.++....... +.+.+..+..
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3445789999999999999999998643 335799998875432221 1122222211
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
.++.+|+||||+.+|+|.++|.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 2456899999999999999997542 247889999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-------CCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999998765432211 12234568999999863 457789999999999999998 89999876
Q ss_pred CcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 546 EGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 546 ~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+....+... ....+..++.++++||.+||..+|.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 654444444333 345677889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.32 Aligned_cols=232 Identities=28% Similarity=0.513 Sum_probs=185.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh----------cCCEEEEEEEecc
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ----------VDDHLYIYLEYVH 418 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~----------~~~~lyLVmEy~~ 418 (720)
..+|+++++||+|+||+||+|.+..+ ..||||+++....... +.+++..+.+ .++..|+||||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 45799999999999999999988765 4699999875332221 1222222221 2455789999999
Q ss_pred CCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--ccc
Q 005007 419 PGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSL 495 (720)
Q Consensus 419 gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~t~ 495 (720)
+|+|.+++.+. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 99999999764 345899999999999999999999999999999999999999999999999999765433221 123
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ....+..++..+.++|
T Consensus 164 ~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 164 KFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred cccceecCHhHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 46678999998753 457889999999999999999 89999877666666655443 2344566889999999
Q ss_pred HHhhhcCCCCCCCHHHHHc
Q 005007 574 LRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||+.||++||++.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.44 Aligned_cols=233 Identities=28% Similarity=0.483 Sum_probs=185.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
..++|++.++||+|+||.||+|.+. ++..||+|.+....... .+..+++.+.+ ..+..|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4568999999999999999999865 56789999876432221 12222222221 24568999999
Q ss_pred ccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--c
Q 005007 417 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--L 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~ 493 (720)
+.+++|.+++... ...+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++......... .
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 9999999999754 356889999999999999999999999999999999999999999999999999876432211 2
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...++..|+|||++.+ ..++.++|||||||++|||++ |+.||...........+... ..+.+..++.++.+
T Consensus 163 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 163 GAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred CCccceecCCHHHhcc-------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2345678999999863 457789999999999999998 99999877666655555433 23344568899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHc
Q 005007 572 FLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~ 592 (720)
+|.+||..+|++||+++++++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.84 Aligned_cols=246 Identities=31% Similarity=0.538 Sum_probs=193.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH---Hhh---------------cCCEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQ---------------VDDHLYI 412 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~---L~~---------------~~~~lyL 412 (720)
...++|++.+.||+|+||+||+|.+..+++.||||.++.........+.+.+ +.. .+..+|+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3456899999999999999999999999999999998754322222111111 111 2457899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||||+. +.|.+++......+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..+.....
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999995 68888876655679999999999999999999997 6999999999999999999999999999987654443
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHhccC-CCCC--ccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRT-PPIP--EMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~~~~-~~iP--~~ls~ 567 (720)
.....++..|+|||.+.+... ...++.++|||||||++|||++|+.||..... .+.+..++... ..++ ..++.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDP---NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred ccCCCCCccccCHhhcCCCCC---ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 344568889999999863210 23477899999999999999999999976433 33444444332 2233 24688
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
++.+||.+||..||.+||+++++++|+||+...
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.41 Aligned_cols=247 Identities=27% Similarity=0.472 Sum_probs=208.4
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--C--ChhHHHHHHHH----------------hhcCC
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--D--DPKSAECIKQL----------------EQVDD 408 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~--~~~~~~~ik~L----------------~~~~~ 408 (720)
......+|.++++||+|+|++|.+++.+.|.+.||+|+++... + +..-++..+.+ .+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3445579999999999999999999999999999999887432 1 12222222222 23477
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-c
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-T 487 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~ 487 (720)
++++|.||++||+|--.++.+ +.|+|+.++.|..+|+.||.|||++|||.||||.+|+|||..|++||+|+|+++.. .
T Consensus 325 rlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred eEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 899999999999998888665 78999999999999999999999999999999999999999999999999999875 4
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC-------CCcH-HHHHHHhccCC
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-------FEGP-QAMFKVLNRTP 559 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~-------~~~~-~~i~ki~~~~~ 559 (720)
++....++||||.|+|||++.| ..|++.+|+|+|||+|+||+.|+.||.- .+.+ ..+.-|+.+..
T Consensus 404 ~gd~tstfcgtpnyiapeilrg-------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CCcccccccCCCcccchhhhcc-------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 5567788999999999999985 5789999999999999999999999952 1222 34445667888
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCC------CHHHHHcCcccccccccC
Q 005007 560 PIPEMLSSEGKDFLLRCFLRNPVERP------SAVELLEHPFIRNANYQN 603 (720)
Q Consensus 560 ~iP~~ls~el~dLI~~cL~~dP~kRP------Ta~ELL~Hpff~~~~~~~ 603 (720)
.+|..++-.+..+|+..|++||++|. .+.++..|+||+...|..
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 99999999999999999999999995 578999999999877653
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.08 Aligned_cols=235 Identities=25% Similarity=0.472 Sum_probs=182.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCChh------HHHHHHHHhh-------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPK------SAECIKQLEQ-------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-------------~~ 407 (720)
..++|++++.||+|+||+||+|.+ ..+++.||||.++....... +...+..+.+ .+
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999984 35678999999875432221 1222222211 13
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc---------------------------------------------------------
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------------- 430 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~--------------------------------------------------------- 430 (720)
..+++|||||.+|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 45789999999999999986421
Q ss_pred ---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---cccccCC
Q 005007 431 ---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGS 498 (720)
Q Consensus 431 ---------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GT 498 (720)
..+++..+..|+.||++||.|||++||+||||||+|||++.++.+||+|||++........ .....++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 2367788889999999999999999999999999999999999999999999976533211 1123356
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el~dLI~~ 575 (720)
..|+|||++.+ ..++.++|||||||++|||++ |..||........+...+. .....|..+++++.++|.+
T Consensus 245 ~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 245 LKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 317 (343)
T ss_pred cceECcHHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 78999999863 457889999999999999996 9999987654443333332 2345567788999999999
Q ss_pred hhhcCCCCCCCHHHHHcC
Q 005007 576 CFLRNPVERPSAVELLEH 593 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~H 593 (720)
||+.||++|||+.||++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.01 Aligned_cols=234 Identities=26% Similarity=0.414 Sum_probs=189.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhhc-------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQV------------------- 406 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~~------------------- 406 (720)
..-++++.++|.+|||+.||+|++...|..||+|.+-.. +.. +++++++.|...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 345789999999999999999999998899999987554 222 233344444310
Q ss_pred CCEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCCeeeeccccc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
.-.++|.||||.||.|-+++.++ ...|+|.+|++|++|+++||.+||... |||||||-|||||+.+|..||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 12478999999999999999743 345999999999999999999999987 999999999999999999999999998
Q ss_pred hhccCcc----------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHH
Q 005007 484 KHLTGLS----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 553 (720)
Q Consensus 484 ~~~~~~~----------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~k 553 (720)
....... ......-|+.|+|||+|.-. .+..++.|+|||+|||+||.||....||++... ..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly----sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----la 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY----SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LA 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh----cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----ee
Confidence 6432111 11122369999999999731 245789999999999999999999999987432 45
Q ss_pred HhccCCCCCc--cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 005007 554 VLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHP 594 (720)
Q Consensus 554 i~~~~~~iP~--~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hp 594 (720)
|++..+.+|. .++..+++||+.||+.||++||++.|++.+-
T Consensus 266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 6777777775 6899999999999999999999999999763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=305.18 Aligned_cols=232 Identities=27% Similarity=0.467 Sum_probs=187.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..+|+++++||.|+||.||+|.+.. +..||+|++..... .......+..+.. ..+.+++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4579999999999999999999987 89999998865432 1111112222221 24568999999
Q ss_pred ccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc-cc
Q 005007 417 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-LS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~-~t 494 (720)
+++++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......... ..
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~ 163 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence 9999999999753 346899999999999999999999999999999999999999999999999999776433221 22
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||......+.+..+... ....+..+++++.++
T Consensus 164 ~~~~~~~~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 164 KKIPYKWTAPEAASH-------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred CCCceEecCHHHHcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 345678999998863 457789999999999999998 89999887766666665543 345567889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHc
Q 005007 573 LLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~ 592 (720)
|.+||+.||.+|||+.+|++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.33 Aligned_cols=227 Identities=34% Similarity=0.588 Sum_probs=191.0
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHh-----------hcCCEEEEEEEeccCCCH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLE-----------QVDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~-----------~~~~~lyLVmEy~~gGsL 422 (720)
||+|+||.||+|.+..+++.||+|++....... .+...++.+. +.++.+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999999899999999886532211 1111222221 236779999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccccCCCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKGSPNW 501 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~~GTp~Y 501 (720)
.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++...... .......|+..|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 9999765 46999999999999999999999999999999999999999999999999999776443 223445688999
Q ss_pred CChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCC
Q 005007 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 581 (720)
Q Consensus 502 mAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP 581 (720)
++||.+.+ ..++.++|+|+|||++|||++|+.||...+..+....+......++..++.++.++|++||..||
T Consensus 160 ~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 160 LAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred cChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 99999863 34677899999999999999999999877766666677777778888899999999999999999
Q ss_pred CCCCCH---HHHHcCccc
Q 005007 582 VERPSA---VELLEHPFI 596 (720)
Q Consensus 582 ~kRPTa---~ELL~Hpff 596 (720)
++||++ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.85 Aligned_cols=240 Identities=26% Similarity=0.422 Sum_probs=191.7
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh-----------------cCC
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ-----------------VDD 408 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~-----------------~~~ 408 (720)
+....+|.+.+.||+|+||+|-.|.+.+++..||||+++....-.+ +++.++.+.+ ..+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3447799999999999999999999999999999999875433222 2233333322 357
Q ss_pred EEEEEEEeccCCCHHHHHHH-hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC----------------
Q 005007 409 HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---------------- 471 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---------------- 471 (720)
++|||+|.+ |-+++++|.+ ....++...|+.+.+||+++|+|||+.+++|.||||+|||+-.
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 889999999 5799999976 4567999999999999999999999999999999999999831
Q ss_pred ----CCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc
Q 005007 472 ----SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547 (720)
Q Consensus 472 ----~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~ 547 (720)
.-.|||+|||.|+..... ..+++.|..|+|||++.| -.++..+||||+||||+||++|...|...++
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg-------LGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG-------LGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec-------cCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 236899999999765433 367789999999999996 3578899999999999999999999987776
Q ss_pred HH---HHHHHhccC------------------CCCCccC-------------------------CHHHHHHHHHhhhcCC
Q 005007 548 PQ---AMFKVLNRT------------------PPIPEML-------------------------SSEGKDFLLRCFLRNP 581 (720)
Q Consensus 548 ~~---~i~ki~~~~------------------~~iP~~l-------------------------s~el~dLI~~cL~~dP 581 (720)
.+ .+..|++.. ..+|+.. ..++.|||++||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 55 444443311 1111110 1357899999999999
Q ss_pred CCCCCHHHHHcCcccccc
Q 005007 582 VERPSAVELLEHPFIRNA 599 (720)
Q Consensus 582 ~kRPTa~ELL~Hpff~~~ 599 (720)
.+|+|+.|+|.||||...
T Consensus 395 ~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 395 ARRITLREALSHPFFARL 412 (415)
T ss_pred cccccHHHHhcCHHhhcC
Confidence 999999999999999754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.80 Aligned_cols=233 Identities=20% Similarity=0.282 Sum_probs=174.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChh-H------------HHHHHHHhhcC------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPK-S------------AECIKQLEQVD------ 407 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~-~------------~~~ik~L~~~~------ 407 (720)
....++|+++++||+|+||+||+|.+..+ +..+|+|+......... + ...+..+...+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557999999999999999999998887 67788886543322110 0 00111111110
Q ss_pred ------------CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCe
Q 005007 408 ------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 475 (720)
Q Consensus 408 ------------~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~V 475 (720)
...+++||++. .++.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 13467888874 5677776543 457889999999999999999999999999999999999999999
Q ss_pred eeeccccchhccCcc--------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc
Q 005007 476 KLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547 (720)
Q Consensus 476 KL~DFGlA~~~~~~~--------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~ 547 (720)
||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|++||.....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-------ACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999998653211 1123569999999999863 4578899999999999999999999987633
Q ss_pred HHH-H--------HHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 548 PQA-M--------FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 548 ~~~-i--------~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
... + ..+...... ...++.++.++|..||..+|++||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 239 NGNLIHAAKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred chHHHHHhHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 221 1 122222222 3356899999999999999999999999975
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.47 Aligned_cols=233 Identities=31% Similarity=0.503 Sum_probs=183.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++.+.||+|+||.||+|++..+++.||||++..... ..+. ..++..+.. ..+.+++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999999999999998864221 1111 112222221 246789999
Q ss_pred EeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 415 EYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999998853 234589999999999999999999999999999999999999999999999999876543221
Q ss_pred -cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc--HHHHHHHhc-cCCCC-CccCC
Q 005007 492 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPI-PEMLS 566 (720)
Q Consensus 492 -~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--~~~i~ki~~-~~~~i-P~~ls 566 (720)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.. ..+.. +..++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred HHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 224568899999999863 3467899999999999999999999965432 233333322 22222 34578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.++.++|.+||+.+|.+||++.++|+.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 899999999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.41 Aligned_cols=242 Identities=30% Similarity=0.525 Sum_probs=191.3
Q ss_pred CeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCCC---------hhHHHHHHHHh------------hcCCEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDD---------PKSAECIKQLE------------QVDDHL 410 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~~---------~~~~~~ik~L~------------~~~~~l 410 (720)
+|++.+.||+|+||.||+|.+. .+++.||||.++..... ..+..++..+. ..++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46789999988632110 11222222221 124568
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+.+|+|.+++... ..+++..++.++.||++||.|||+.|++||||||.|||++.++.++|+|||+++.+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999999764 569999999999999999999999999999999999999999999999999987654332
Q ss_pred c--cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCCcc
Q 005007 491 Y--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEM 564 (720)
Q Consensus 491 ~--~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP~~ 564 (720)
. .....|+..|+|||.+.+. ....+.++||||||+++|||++|..||..... .+....+.......|..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT 234 (288)
T ss_pred ccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc
Confidence 1 2235689999999998642 12367789999999999999999999964321 23333445556677888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQ 602 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPT---a~ELL~Hpff~~~~~~ 602 (720)
++.+++++|.+||+.||++||| +.++|+|+||+...+.
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 9999999999999999999998 5688999999877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.12 Aligned_cols=233 Identities=22% Similarity=0.384 Sum_probs=185.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChhHH---HHHHH---Hhh-----------cCCEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSA---ECIKQ---LEQ-----------VDDHLY 411 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~~~---~~ik~---L~~-----------~~~~ly 411 (720)
.+|++.+.||+|+||+||+|.+.. +++.||||+++......... +++.. +.+ ..+.++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 468889999999999999998754 35789999987543321111 11111 111 235688
Q ss_pred EEEEeccCCCHHHHHHHh---------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCee
Q 005007 412 IYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VK 476 (720)
+++||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 999999999999998532 13478889999999999999999999999999999999999999999
Q ss_pred eeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHH
Q 005007 477 LADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552 (720)
Q Consensus 477 L~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ 552 (720)
|+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+.
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999886543221 123345788999999863 347789999999999999998 999998877776666
Q ss_pred HHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 553 KVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 553 ki~~~~-~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+.... ..++..++.++.+||..||+.+|++||++.+|+..
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 666543 45678899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.30 Aligned_cols=240 Identities=28% Similarity=0.491 Sum_probs=189.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHH-hh-------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQL-EQ-------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L-~~-------------~~~~l 410 (720)
...+|++.+.||+|+||.||+|.+..+|+.||||++...... ..+...+..+ .+ ....+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456899999999999999999999999999999987532111 1223334444 21 12358
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+. ++|..++... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 99999997 6999988653 68899999999999999999999999999999999999999999999999998664322
Q ss_pred ------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC------
Q 005007 491 ------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 558 (720)
Q Consensus 491 ------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------ 558 (720)
....+.||..|+|||++.+ ...++.++|||||||++|||++|+.||......+...++....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 2224568999999998753 2456789999999999999999999997655444333221110
Q ss_pred -------------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 -------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 -------------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
......++.++.+||.+||+.||.+|||+.++|+|+||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 001122688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.94 Aligned_cols=233 Identities=28% Similarity=0.517 Sum_probs=187.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh----------cCCEEEEEEEec
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ----------VDDHLYIYLEYV 417 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~----------~~~~lyLVmEy~ 417 (720)
..++|+++++||+|+||.||+|.+. +++.||+|.+........ +...+..+.+ .++.+|+||||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence 4568999999999999999999865 578899998875433222 1222222221 145689999999
Q ss_pred cCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--ccc
Q 005007 418 HPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELS 494 (720)
Q Consensus 418 ~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~~t 494 (720)
.+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........ ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 999999998653 34689999999999999999999999999999999999999999999999999976653222 123
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
..++..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+... ....+..++.++.++
T Consensus 163 ~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 163 AKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred CcccccccCHHHhcc-------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 345678999999863 457789999999999999999 99999887766655555433 345667788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHc
Q 005007 573 LLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~ 592 (720)
|.+||..+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.79 Aligned_cols=237 Identities=24% Similarity=0.448 Sum_probs=180.8
Q ss_pred eEEeec--CCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHH-------HHHhh-----------cCCEEEEEEEeccC
Q 005007 360 KLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-------KQLEQ-----------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G--~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~i-------k~L~~-----------~~~~lyLVmEy~~g 419 (720)
..||+| +||+||+|++..+|+.||||++..........+.+ +.+.+ .++.+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999999999999999987644332222211 11211 24668999999999
Q ss_pred CCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-------
Q 005007 420 GSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY------- 491 (720)
Q Consensus 420 GsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~------- 491 (720)
++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999997642 3589999999999999999999999999999999999999999999999986543321110
Q ss_pred -cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC----------
Q 005007 492 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---------- 560 (720)
Q Consensus 492 -~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~---------- 560 (720)
.....++..|||||++.+. ...++.++|||||||++|||++|++||........+...+.....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112346679999998641 234778999999999999999999999876554444433322111
Q ss_pred -------------------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 561 -------------------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 561 -------------------------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.+..++.++++||++||+.||++|||+.|+|+|+||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 11235678999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.78 Aligned_cols=234 Identities=32% Similarity=0.587 Sum_probs=186.3
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----h---HHHHHHHHh-----------hcCCEEEEEEEec
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----K---SAECIKQLE-----------QVDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~---~~~~ik~L~-----------~~~~~lyLVmEy~ 417 (720)
|++.+.||+|+||.||+|.+..+++.||+|++....... . +...+..+. ...+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999887543111 1 112222211 1356799999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~ 496 (720)
. ++|.+++......+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||+++...... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 7 68999998764579999999999999999999999999999999999999999999999999997664332 222345
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC------------------
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------------ 558 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------------------ 558 (720)
++..|+|||++.+ ...++.++|||||||++|||++|++||........+.++....
T Consensus 160 ~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 160 VTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 6788999999863 2357889999999999999999999998776555544433210
Q ss_pred CCC-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 PPI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ~~i-----------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..+ -..++.++.++|.+||..||++||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 01247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=349.28 Aligned_cols=131 Identities=27% Similarity=0.508 Sum_probs=110.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Chh-------HHHHHHHHhh-----------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPK-------SAECIKQLEQ-----------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~-------~~~~ik~L~~-----------~~~~lyLV 413 (720)
.++|+++++||+|+||+||+|++..+++.||||+++.... ... +..++..+.. ..+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999864321 111 1111222211 25679999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
|||+.|++|.++|... +.+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 678999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.86 Aligned_cols=233 Identities=29% Similarity=0.466 Sum_probs=186.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHHHHHHHhh--------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
..+|++++.||+|+||+||+|.+.. +..||||.++...... ...+++..+.. .++.+|+||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3579999999999999999998754 4569999887432211 12222222222 234579999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc--cc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~--t~ 495 (720)
.+|+|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......... ..
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 9999999997755579999999999999999999999999999999999999999999999999987654332211 22
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.++..|++||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+...+..++++|
T Consensus 162 ~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 162 KFPVRWSPPEVLLY-------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred ccChhhCCHHHHhc-------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 35678999999863 347789999999999999998 99999887766666666554 3344666789999999
Q ss_pred HHhhhcCCCCCCCHHHHHcC
Q 005007 574 LRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~H 593 (720)
.+||..||.+||++.+|+++
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.71 Aligned_cols=232 Identities=27% Similarity=0.507 Sum_probs=184.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh----------cCCEEEEEEEecc
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ----------VDDHLYIYLEYVH 418 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~----------~~~~lyLVmEy~~ 418 (720)
..+|++.+.||+|+||.||+|.+..+ ..||+|.+....... .++++++.+.+ .++..|+||||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence 35799999999999999999988654 469999876433221 12223333222 1345789999999
Q ss_pred CCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--ccc
Q 005007 419 PGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSL 495 (720)
Q Consensus 419 gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~t~ 495 (720)
+++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++.+||+|||++......... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 999999997643 34889999999999999999999999999999999999999999999999999765432211 223
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+....+... ....+..++..++++|
T Consensus 164 ~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 164 KFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred ccchhhCCHHHhcc-------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 45678999998863 457789999999999999999 99999887666665555443 3445677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHc
Q 005007 574 LRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||.+||++||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=311.76 Aligned_cols=237 Identities=28% Similarity=0.496 Sum_probs=185.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCC--CcEEEEEEeccCCCCh-------hHHHHHHHHhh----------------cCCE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDP-------KSAECIKQLEQ----------------VDDH 409 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~t--g~~VAVK~l~~~~~~~-------~~~~~ik~L~~----------------~~~~ 409 (720)
+|++.+.||+|+||.||+|.+..+ +..||||.+....... .+.++++.+.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999988 9999999886432211 12223333311 0134
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+|++|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 788999996 7899988653 67999999999999999999999999999999999999999999999999999765432
Q ss_pred c-----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-------
Q 005007 490 S-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------- 557 (720)
Q Consensus 490 ~-----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------- 557 (720)
. ......||..|+|||++.+ ...++.++|||||||++|+|++|++||...+....+..++..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred cccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 1 1234578999999999863 245778999999999999999999999875543333322210
Q ss_pred -------------------C--CC---CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 558 -------------------T--PP---IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 558 -------------------~--~~---iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
. .. ....++.++.+||.+||+.||++|||+.|++.|||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 112357899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.04 Aligned_cols=237 Identities=24% Similarity=0.434 Sum_probs=186.1
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeccCCCChh------HHHHHHHHh-h---------
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPK------SAECIKQLE-Q--------- 405 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~-------tg~~VAVK~l~~~~~~~~------~~~~ik~L~-~--------- 405 (720)
......+|.+++.||+|+||.||+|.+.. ....||+|.++....... +.+.++.+. +
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 34455799999999999999999998642 345799998874432221 122222221 1
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCcee
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NIL 468 (720)
.++.+|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 2456899999999999999997532 34888999999999999999999999999999999999
Q ss_pred ecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCC
Q 005007 469 VDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 544 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~ 544 (720)
++.++.+||+|||+++....... .....++..|||||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-------CCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999986643221 112234567999999863 457889999999999999999 9999987
Q ss_pred CCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 545 FEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 545 ~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
....+.+..+... ....+..++.+++++|.+||..||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 IPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7665555555443 24567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.36 Aligned_cols=239 Identities=34% Similarity=0.587 Sum_probs=191.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh----HHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK----SAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~----~~~~ik~L~~--------------~~~~lyLV 413 (720)
...|++.+.||+|+||+||+|.+..+++.||||++...... .. ...++..+.. .++..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999988643221 11 1122222222 24668999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++...... .
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~ 169 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---N 169 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---C
Confidence 99997 6787877655567999999999999999999999999999999999999999999999999998765432 3
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCC-CccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI-PEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~i-P~~ls~el~d 571 (720)
...|+..|+|||++.+. ....++.++|||||||++|||++|+.||...+.......+... .+.+ +..++.++++
T Consensus 170 ~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 170 SFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred CccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 45688999999987531 1245778999999999999999999999877665555554432 2222 3457889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+|.+||..+|++||++.+++.|+||...
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.80 Aligned_cols=233 Identities=27% Similarity=0.471 Sum_probs=184.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~lyL 412 (720)
.++|+..+.||+|+||.||+|.+..++. .||||.++......... .++..+.. ..+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578999999999999999999887665 79999886543222111 11222221 2456899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+.+++|.+++.+..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999999876677999999999999999999999999999999999999999999999999998765432211
Q ss_pred ----ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 493 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 493 ----~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
.....+..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ..+.+..++
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 236 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236 (268)
T ss_pred ceeccCCCcCceecCHHHhhc-------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence 11123457999999863 457789999999999999997 99999877666655555433 334455678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++.++|.+||+.+|.+||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.50 Aligned_cols=238 Identities=25% Similarity=0.428 Sum_probs=186.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----h---HHHHHHHHhh-----------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----K---SAECIKQLEQ-----------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~---~~~~ik~L~~-----------------~~ 407 (720)
..++|++.+.||+|+||.||+|.+..+|+.||||+++...... . +++.+..+.+ ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4578999999999999999999999999999999886532211 1 1222222221 01
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+|+++|++ |++|.+++.. ..+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3468888887 7899888854 469999999999999999999999999999999999999999999999999987653
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------- 558 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--------- 558 (720)
. ......|+..|+|||++.+ ...++.++|||||||++|||++|++||........+..++...
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 172 D--EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred c--cccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 3 2234568999999999863 2346789999999999999999999997655444333322110
Q ss_pred --------------CCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 --------------PPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 --------------~~iP--------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++ ...++++++||.+||+.||.+|+++.++|.|+||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0111 13578899999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=300.01 Aligned_cols=233 Identities=28% Similarity=0.514 Sum_probs=186.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
...+|++.+.||+|+||.||+|.+.. ++.||||.++....... +...+..+.+ .++.+|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45689999999999999999999754 57899999875432221 1222222221 24568999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc--
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-- 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~-- 493 (720)
+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 99999999997643 468999999999999999999999999999999999999999999999999998765322111
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+......+..+... ....+..++..+.+
T Consensus 163 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 163 GAKFPIKWTAPEAALY-------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred CCcCceeccCcccccc-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1122457999998763 457889999999999999999 99999887766666655443 23456678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHc
Q 005007 572 FLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~ 592 (720)
+|.+||+.+|.+||++.+|++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.35 Aligned_cols=233 Identities=25% Similarity=0.435 Sum_probs=183.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCC----------------cEEEEEEeccCCCChh------HHHHHHHHhh-----
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETG----------------ASCAIKEVDIIPDDPK------SAECIKQLEQ----- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg----------------~~VAVK~l~~~~~~~~------~~~~ik~L~~----- 405 (720)
..+|++++.||+|+||.||+|.+..++ ..||+|.+........ +++++..+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876544 5689998875432211 1222333322
Q ss_pred ------cCCEEEEEEEeccCCCHHHHHHHhc----------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 406 ------VDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 406 ------~~~~lyLVmEy~~gGsL~~~L~~~~----------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
.++.+++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 2467899999999999999997642 268999999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc--CCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSE 544 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT--Gk~PF~~ 544 (720)
+.++.+||+|||+++...... ......++..|||||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-------GKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-------CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999999987654322 1223456788999999863 357889999999999999998 7889987
Q ss_pred CCcHHHHHHHhcc--------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 545 FEGPQAMFKVLNR--------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 545 ~~~~~~i~ki~~~--------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
....+.+..+... ....+..++.++.++|.+||+.||.+|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6665555544321 12234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=295.90 Aligned_cols=230 Identities=31% Similarity=0.543 Sum_probs=186.4
Q ss_pred eEEeeEEeecCCeEEEEEEECCCC----cEEEEEEeccCCCChh---HHHHHHHHhh--------------cCCEEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPK---SAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg----~~VAVK~l~~~~~~~~---~~~~ik~L~~--------------~~~~lyLVm 414 (720)
+++.+.||+|+||.||+|.+...+ ..||+|++........ ...++..+.. .++..|+||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357789999999999999998766 8999999875543211 1112222221 246789999
Q ss_pred EeccCCCHHHHHHHhcCC-CcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~-Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
||+++++|.+++...... +++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999999765444 9999999999999999999999999999999999999999999999999997665432222
Q ss_pred --cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 494 --SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 494 --t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
...++..|+|||.+. ...++.++|||||||++|||++ |.+||...........+... ....+..++.++
T Consensus 161 ~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T smart00219 161 KKGGKLPIRWMAPESLK-------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEI 233 (258)
T ss_pred cccCCCcccccChHHhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHH
Confidence 123678999999885 2457889999999999999998 89999887766666665543 345566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++|.+||..||++|||+.|+++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=304.40 Aligned_cols=241 Identities=41% Similarity=0.707 Sum_probs=196.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
....|+..+.||.|+||.||+|.+..++..||+|+++.... ......++..+.. .++..|+||||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 45679999999999999999999998999999999975443 1111222222222 24678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~ 495 (720)
++|++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .....
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 99999999998764479999999999999999999999999999999999999999999999999987654322 22345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCC--CccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI--PEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~i--P~~ls~el~dL 572 (720)
.++..|++||++.+ ..++.++|||||||++|+|++|+.||...........+... ...+ +..++.++++|
T Consensus 177 ~~~~~y~~PE~~~~-------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 177 VGTPYWMAPEVIKR-------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred cCCcccCCHhHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 58899999998763 34678999999999999999999999877665555544432 2222 23478999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||+.+|.+||++.++|+|+||...
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.95 Aligned_cols=225 Identities=28% Similarity=0.463 Sum_probs=179.4
Q ss_pred eEEeecCCeEEEEEEECCCC---cEEEEEEeccCCCChhH---HHHHHHHhh-------------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKS---AECIKQLEQ-------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg---~~VAVK~l~~~~~~~~~---~~~ik~L~~-------------~~~~lyLVmEy~~gG 420 (720)
++||+|+||.||+|.+..++ ..||+|.+......... ..++..+.. ..+..++||||+.+|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 47999999999999876554 78999988754432111 112222222 134579999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc----ccc
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLK 496 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~----t~~ 496 (720)
+|.+++... ..+++..+..++.||+.||.|||.++|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 81 PLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 999999765 479999999999999999999999999999999999999999999999999998664332211 112
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~ 574 (720)
++..|+|||.+.+ ..++.++|||||||++|||++ |.+||......+....+... ....+..++..++++|.
T Consensus 160 ~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 160 WPLKWYAPECINY-------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIML 232 (257)
T ss_pred ccccccCHHHhcC-------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 3467999998863 457889999999999999998 99999887766555555433 34567778999999999
Q ss_pred HhhhcCCCCCCCHHHHHc
Q 005007 575 RCFLRNPVERPSAVELLE 592 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~ 592 (720)
+||..+|++||++.++++
T Consensus 233 ~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 233 SCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=301.12 Aligned_cols=232 Identities=26% Similarity=0.469 Sum_probs=184.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLV 413 (720)
.+|++.+.||+|+||.||+|.++.+++ .||||.++....... +...++.+.+ .++.+++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 479999999999999999999887765 599998865322111 1122222221 24568999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+.+|+|.+++....+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 99999999999998766779999999999999999999999999999999999999999999999999987654322111
Q ss_pred ----cccC--CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccC
Q 005007 494 ----SLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 565 (720)
Q Consensus 494 ----t~~G--Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~l 565 (720)
...| +..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+... ..+.+..+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 236 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236 (269)
T ss_pred ccccccCCCcceeecCHhHhcc-------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccC
Confidence 1112 357999999863 457789999999999999886 99999887766655555432 33445678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.++.++|.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=339.95 Aligned_cols=246 Identities=35% Similarity=0.625 Sum_probs=214.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh---------------------cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------------VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------------~~~~ 409 (720)
.....|.+.+.||.|.||+||+++.+.+++.+|||+++...+...++++...+.. .++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3445799999999999999999999999999999999887776666554333221 2678
Q ss_pred EEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
++||||||.||+.-|++++. +..+.|..|..|++.++.||.+||.+.++|||||..|||++.+|.|||+|||++..+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999999753 56799999999999999999999999999999999999999999999999999877653
Q ss_pred -ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC---CCcc
Q 005007 489 -LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEM 564 (720)
Q Consensus 489 -~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~---iP~~ 564 (720)
.....+.+|||+|||||++....+. +..|+.++|+||||++..||.-|.+|+.+.-....+++|-...++ -|+.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~--d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESP--DATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccccccCcCCCcccccceeeecccCC--CCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 3455788999999999999865444 467889999999999999999999999999888888887655443 3678
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
++.++.+||..||.+|.++||+..++|+|||++.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8999999999999999999999999999999983
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=298.89 Aligned_cols=234 Identities=27% Similarity=0.544 Sum_probs=187.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC---C-hh------HHHHHHHHh-----------hcCCEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---D-PK------SAECIKQLE-----------QVDDHLYIY 413 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~---~-~~------~~~~ik~L~-----------~~~~~lyLV 413 (720)
+|.+.+.||+|+||+||+|.+..++..+++|.++.... . .. +..++..+. ..+...++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 68999999999999999999998887777777654221 1 11 111111111 135678999
Q ss_pred EEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-
Q 005007 414 LEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 489 (720)
Q Consensus 414 mEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~- 489 (720)
|||+.+++|.+++.+ ....+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||+++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999999864 2356999999999999999999999999999999999999964 67999999998766433
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 568 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~e 568 (720)
.......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+... .+.++..++.+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKH-------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232 (260)
T ss_pred ccccCCCCCcCccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence 23335668999999998753 34667899999999999999999999876665655555443 34556778899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+.++|.+||..||++||++.|+++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.56 Aligned_cols=218 Identities=24% Similarity=0.344 Sum_probs=175.8
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH-----------HhhcCCEEEEEEEeccCCCHHHHHHHhcCCC
Q 005007 365 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----------LEQVDDHLYIYLEYVHPGSINRYVREHCRDI 433 (720)
Q Consensus 365 G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~-----------L~~~~~~lyLVmEy~~gGsL~~~L~~~~~~L 433 (720)
|.||+||+|+++.+++.||+|.+........+...+.. ....++..|+||||+.||+|.+++.+. ..+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 82 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNI 82 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCC
Confidence 89999999999999999999998754322222221111 112357899999999999999999765 469
Q ss_pred cHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhc
Q 005007 434 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513 (720)
Q Consensus 434 se~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~ 513 (720)
++..+..|+.||++||+|||++||+||||||+|||++.++.++|+|||++...... .....++..|+|||.+.+
T Consensus 83 ~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~---- 156 (237)
T cd05576 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI---- 156 (237)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCC----
Confidence 99999999999999999999999999999999999999999999999988665432 223456788999998742
Q ss_pred CCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCH-----H
Q 005007 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSA-----V 588 (720)
Q Consensus 514 ~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa-----~ 588 (720)
..++.++||||+||++|||++|+.||...... +. ......+|..++.+++++|.+||+.||++|+++ +
T Consensus 157 ---~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 229 (237)
T cd05576 157 ---SEETEACDWWSLGAILFELLTGKTLVECHPSG--IN--THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE 229 (237)
T ss_pred ---CCCCchhhHHHHHHHHHHHHHCcchhhcCchh--cc--cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence 34678999999999999999999887643211 00 112235677889999999999999999999986 9
Q ss_pred HHHcCccc
Q 005007 589 ELLEHPFI 596 (720)
Q Consensus 589 ELL~Hpff 596 (720)
|+++||||
T Consensus 230 ~~~~h~~~ 237 (237)
T cd05576 230 DIKSHPFF 237 (237)
T ss_pred HHHcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.03 Aligned_cols=234 Identities=27% Similarity=0.493 Sum_probs=188.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...++|++.++||+|+||+||+|.+. .+..||||.+........ ..+++..+.. .+..+++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34679999999999999999999976 457899998875433221 1222222222 2467899999
Q ss_pred eccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--
Q 005007 416 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-- 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~-- 492 (720)
|+++++|.+++.+.. ..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 999999999997643 46899999999999999999999999999999999999999999999999998765432111
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 570 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~ 570 (720)
....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+......+.++... ....+...+.++.
T Consensus 162 ~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 162 EGAKFPIKWTAPEAANY-------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234 (261)
T ss_pred hccCCCccccCHHHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 12234568999998863 457789999999999999998 99999887776666666544 3455667789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHc
Q 005007 571 DFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++|.+||..+|++||+++++++
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=302.12 Aligned_cols=233 Identities=27% Similarity=0.438 Sum_probs=187.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCCCChhHH---HHHHHHhh-------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSA---ECIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~----~VAVK~l~~~~~~~~~~---~~ik~L~~-------------~~~~lyL 412 (720)
..+|++++.||+|+||+||+|.++.+|. .||+|.+.......... +++..+.. .....++
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQL 85 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEE
Confidence 4689999999999999999999887765 58999876543321111 12222222 1356789
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 99999999999999876667999999999999999999999999999999999999999999999999999876533221
Q ss_pred cc---ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCH
Q 005007 493 LS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 567 (720)
Q Consensus 493 ~t---~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~ 567 (720)
.. ..++..|+|||.+.. ..++.++|||||||++|||++ |+.||......+....+... ....|..++.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 166 YHAEGGKVPIKWMALESILH-------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred eecCCCcccccccCHHHhhc-------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 11 223567999998852 457789999999999999998 99999887665555555433 3455677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.++|.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.28 Aligned_cols=238 Identities=26% Similarity=0.458 Sum_probs=186.5
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeccCCCCh------hHHHHHHHHh-h---------
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDP------KSAECIKQLE-Q--------- 405 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~-------~tg~~VAVK~l~~~~~~~------~~~~~ik~L~-~--------- 405 (720)
......+|.+++.||+|+||.||+|++. .++..||||.++...... .+...+..+. +
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 4455679999999999999999999753 234579999886432211 1122222221 1
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCcee
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NIL 468 (720)
.++.+|+||||+.+|+|.++|.... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 2456899999999999999997531 24778889999999999999999999999999999999
Q ss_pred ecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCC
Q 005007 469 VDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 544 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~ 544 (720)
++.++.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999986643221 122345678999999863 457889999999999999998 8899987
Q ss_pred CCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 545 FEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 545 ~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
....+....+... ....+..++.++++||.+||..+|.+||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 243 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7666655555433 334567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=300.82 Aligned_cols=232 Identities=24% Similarity=0.421 Sum_probs=173.6
Q ss_pred eEEeecCCeEEEEEEECC--CCcEEEEEEeccCCCChhHH---HHHHH---Hhh-----------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSA---ECIKQ---LEQ-----------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~--tg~~VAVK~l~~~~~~~~~~---~~ik~---L~~-----------~~~~lyLVmEy~~gG 420 (720)
+.||+|+||+||+|.... ....+|+|.+.......... +++.. +.+ ..+.+|+||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996433 44578888776433222111 12222 211 245689999999999
Q ss_pred CHHHHHHHhc----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---cc
Q 005007 421 SINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---EL 493 (720)
Q Consensus 421 sL~~~L~~~~----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~ 493 (720)
+|.+++.... ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999997643 2346788899999999999999999999999999999999999999999999875433221 12
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-C-----CCCCccCC
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T-----PPIPEMLS 566 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~-----~~iP~~ls 566 (720)
...++..|+|||++...........++.++|||||||++|||++ |..||......+.+.++... . +.++..++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 23456789999998743222123457889999999999999999 88999887766655554432 1 23345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..+.+++..|| .||++|||++||++
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHH
Confidence 89999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=301.11 Aligned_cols=233 Identities=27% Similarity=0.462 Sum_probs=185.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChhH------HHHHHHHhh-----------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKS------AECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~~------~~~ik~L~~-----------~~~~lyL 412 (720)
..+|++++.||+|+||.||+|+++.++. .||||.++........ ...++.+.+ .++.+|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3589999999999999999999875544 7999988653322211 112222221 2466899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999999876667899999999999999999999999999999999999999999999999999866432211
Q ss_pred ----ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 493 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 493 ----~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+... ..+.+..++
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235 (267)
T ss_pred eeecCCCccceeecCHhHhcc-------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCC
Confidence 11223568999999863 457889999999999999886 99999877665555555543 234455678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++.++|.+||+.+|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=300.10 Aligned_cols=225 Identities=27% Similarity=0.464 Sum_probs=179.2
Q ss_pred EEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCCh------hHHHHHHHHhh----------cCCEEEEEEEeccCCCH
Q 005007 361 LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDP------KSAECIKQLEQ----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~----------~~~~lyLVmEy~~gGsL 422 (720)
.||+|+||.||+|.+. .++..||||++....... .+..+++.+.+ ..+..++||||+++++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999775 456679999886543211 11222222221 13567999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-c---ccccCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E---LSLKGS 498 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-~---~t~~GT 498 (720)
.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ . ....++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCC
Confidence 999976556799999999999999999999999999999999999999999999999999975533211 1 112235
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHHHHh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRC 576 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI~~c 576 (720)
..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+.. .....|..+++++.++|.+|
T Consensus 162 ~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 162 LKWYAPECINF-------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred cccCCHHHHcc-------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 78999999863 357789999999999999996 9999988777666655543 34566778899999999999
Q ss_pred hhcCCCCCCCHHHHHc
Q 005007 577 FLRNPVERPSAVELLE 592 (720)
Q Consensus 577 L~~dP~kRPTa~ELL~ 592 (720)
|..+|++||++.++++
T Consensus 235 ~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 235 WIYKWEDRPNFAKVEE 250 (257)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=332.95 Aligned_cols=243 Identities=24% Similarity=0.406 Sum_probs=197.4
Q ss_pred cccCCCCCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHHHHHHHh------------hcCC
Q 005007 342 HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLE------------QVDD 408 (720)
Q Consensus 342 ~~~~~~~~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~~ik~L~------------~~~~ 408 (720)
.++..........+|.+...||.|+|+.|..|.+..+++..++|++.....+. ++..+..... ....
T Consensus 310 ~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 310 GVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred HHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCc
Confidence 33343444456778999999999999999999999999999999998663322 2222222211 2356
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee-cCCCCeeeeccccchhcc
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-DASGVVKLADFGMAKHLT 487 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL-d~~g~VKL~DFGlA~~~~ 487 (720)
++|+|||++.|+.|.+.+... . ....++..|++||+.||.|||++|||||||||+|||+ +..|+++|+|||.++...
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~-~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSK-P-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeeehhccccHHHHHHHhc-c-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 799999999999998888654 2 3337888999999999999999999999999999999 589999999999998876
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCH
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~ 567 (720)
.. ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||........+...+ +.+++.+.+|+
T Consensus 468 ~~--~~tp~~t~~y~APEvl~-------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i-~~~~~s~~vS~ 537 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLA-------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI-QMPKFSECVSD 537 (612)
T ss_pred hh--hcccchhhcccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh-cCCccccccCH
Confidence 54 44556789999999997 3568999999999999999999999998766653333222 22334488999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+++|||.+||+.||.+|+++.+++.|+||
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999999
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.00 Aligned_cols=232 Identities=32% Similarity=0.537 Sum_probs=184.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Chh----HHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPK----SAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~----~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... +.. ..++++.+.. .++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 479999999999999999999999999999998864221 111 1122222222 246789999
Q ss_pred EeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 415 EYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
||+++|+|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999998642 3458999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc--HHHHHHHhc-cCCCCCc-cCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPIPE-MLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--~~~i~ki~~-~~~~iP~-~ls 566 (720)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+.. ....+|. .++
T Consensus 162 ~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred ccceecCCccccCHHHhcc-------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 2234568999999999863 4577899999999999999999999965432 222233322 2333444 688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++.++|.+||..+|.+|||+.+|++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=296.75 Aligned_cols=229 Identities=29% Similarity=0.485 Sum_probs=185.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh---HHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK---SAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~---~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
.++|++.+.||.|+||.||+|.+. |+.||||.++..... .. +..++..+.+ .++..|+||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 468999999999999999999875 899999998755431 11 1122222221 256789999999
Q ss_pred cCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccccc
Q 005007 418 HPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~ 496 (720)
.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~ 160 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGK 160 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cCC
Confidence 9999999997653 2699999999999999999999999999999999999999999999999999987633221 333
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~ 574 (720)
++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ....+..+++++.++|.
T Consensus 161 ~~~~~~ape~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 161 LPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred CcccccCchhhcC-------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence 5667999998863 356779999999999999997 99999877665555444433 34556778999999999
Q ss_pred HhhhcCCCCCCCHHHHHc
Q 005007 575 RCFLRNPVERPSAVELLE 592 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~ 592 (720)
+||..+|++||++.|+++
T Consensus 234 ~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 234 DCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=331.29 Aligned_cols=246 Identities=27% Similarity=0.450 Sum_probs=212.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHH----HH--------HHHHh---hcCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSA----EC--------IKQLE---QVDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~----~~--------ik~L~---~~~~~ly 411 (720)
..-.+++++..||-|+||.|-++........+|+|+++...- ..+++ ++ +-.|. ..+.++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 344577888999999999999998776556689987753211 11111 11 11111 2467899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
++||-|-||+|..+|+++ +.|++..++.|+..+++|++|||.+|||.|||||+|+||+.+|-+||.|||+|+.+..+..
T Consensus 497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999999999887 7899999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~~ls~el 569 (720)
..++||||.|.|||++. +...+.++|.|+||+++||||+|.+||.+.+.+..+..|+.+ ...+|..+...+
T Consensus 576 TwTFcGTpEYVAPEIIL-------nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIIL-------NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA 648 (732)
T ss_pred eeeecCCcccccchhhh-------ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence 99999999999999998 456788999999999999999999999999999999999876 456799999999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHcCcccccccccCC
Q 005007 570 KDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 604 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~~l 604 (720)
.+||+++...+|.+|.. +.+|-+|.||...+|+.+
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 99999999999999975 899999999999887754
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.27 Aligned_cols=238 Identities=33% Similarity=0.550 Sum_probs=189.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-----HHHHHHHHhh-----------cCCEEEEEEEecc
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----SAECIKQLEQ-----------VDDHLYIYLEYVH 418 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-----~~~~ik~L~~-----------~~~~lyLVmEy~~ 418 (720)
.|....+||+|+||.||++.+..+|+.||||++........ +...+..+.+ .++..|+||||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 34555789999999999999999999999998864322111 1111222211 3577999999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-ccccccC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKG 497 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t~~G 497 (720)
+++|.+++.. ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... ......|
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999998754 468999999999999999999999999999999999999999999999999987554322 2234568
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCCCccCCHHHHHHHH
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEGKDFLL 574 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~iP~~ls~el~dLI~ 574 (720)
+..|+|||.+.+ ..++.++|||||||++|||++|..||......+.+..+.... ......++.++.++|.
T Consensus 179 ~~~y~~pE~~~~-------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 179 TPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred CccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 999999998752 346789999999999999999999998766555444443222 1223457899999999
Q ss_pred HhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
+||+.||.+||++.++|+|+||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=305.13 Aligned_cols=233 Identities=26% Similarity=0.470 Sum_probs=184.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~ly 411 (720)
..+|.+.+.||+|+||.||+|.+. .++..||+|.++...... ...+++..+.. .++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 457999999999999999999854 355679999876432111 11112222221 245689
Q ss_pred EEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCee
Q 005007 412 IYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VK 476 (720)
+||||+++++|.+++..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999997532 3488999999999999999999999999999999999999999999
Q ss_pred eeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHH
Q 005007 477 LADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552 (720)
Q Consensus 477 L~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ 552 (720)
|+|||+++....... .....|+..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+.
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999976543221 123446788999998863 457789999999999999998 999998877766666
Q ss_pred HHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 553 KVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 553 ki~~~~-~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+.... ...+..++.++.++|.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 555433 3456678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=313.07 Aligned_cols=236 Identities=28% Similarity=0.473 Sum_probs=184.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhhc-----------------CC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQV-----------------DD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~~-----------------~~ 408 (720)
..+|.+.+.||+|+||+||+|.+..+|+.||||++...... ..+...+..+.+. ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 45899999999999999999999999999999988642211 1122222222210 13
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|+||||+. .+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 4699999996 57776652 4589999999999999999999999999999999999999999999999999876532
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-----------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------- 557 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~----------- 557 (720)
......|+..|+|||++.+ ...++.++|||||||++|||++|+.||...+....+..++..
T Consensus 170 --~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred --CCCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 2234567899999999863 234778999999999999999999999876654444433221
Q ss_pred ------------CCCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 ------------TPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 ------------~~~iP--------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
....+ ...+.++.+||.+||+.||++||++.|+|.|+||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00111 23577899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=299.62 Aligned_cols=235 Identities=26% Similarity=0.483 Sum_probs=187.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChh------HHHHHHHHhh----------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPK------SAECIKQLEQ----------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~------~~~~ik~L~~----------~~~~lyL 412 (720)
...+|++.++||+|+||.||+|.+... ...||||.......... +...++.+.+ .++..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~l 83 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWI 83 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEE
Confidence 346799999999999999999987654 35689998765432111 1122222221 1455789
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+++|+|.+++......+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 99999999999999775557999999999999999999999999999999999999999999999999999766443221
Q ss_pred c--cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 005007 493 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 568 (720)
Q Consensus 493 ~--t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~e 568 (720)
. ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ....+..++.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05056 164 KASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 236 (270)
T ss_pred ecCCCCccccccChhhhcc-------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 1 2234567999998753 457789999999999999986 99999887766666555543 44567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+.++|.+||..+|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=297.44 Aligned_cols=227 Identities=28% Similarity=0.515 Sum_probs=176.2
Q ss_pred eEEeecCCeEEEEEEECC---CCcEEEEEEeccCCCChhHHH---HH---HHHhh------------cCCEEEEEEEecc
Q 005007 360 KLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAE---CI---KQLEQ------------VDDHLYIYLEYVH 418 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~---tg~~VAVK~l~~~~~~~~~~~---~i---k~L~~------------~~~~lyLVmEy~~ 418 (720)
+.||+|+||+||+|.+.. .+..||||.+........... ++ +.+.+ .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998754 345799998754322211111 11 11111 2445789999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-----ccc
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-----YEL 493 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-----~~~ 493 (720)
+|+|.+++.+....+.+..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 999999997765667888889999999999999999999999999999999999999999999997654321 112
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...++..|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+... ....+..++..+.+
T Consensus 161 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 161 GAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred cCcCCccccChhHhcc-------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 3345778999998863 457889999999999999999 57778776665555555443 34456678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcC
Q 005007 572 FLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~H 593 (720)
+|.+||..+|++||++.|+++.
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=323.31 Aligned_cols=236 Identities=25% Similarity=0.457 Sum_probs=183.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChh------HHHHHHHHh-h-----------c
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPK------SAECIKQLE-Q-----------V 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~------~~~~ik~L~-~-----------~ 406 (720)
....++|+++++||+|+||+||+|.+.. ++..||||+++....... +++++..+. + .
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3446789999999999999999998743 345799999875433221 222233332 1 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhc--------------------------------------------------------
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHC-------------------------------------------------------- 430 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~-------------------------------------------------------- 430 (720)
.+.+|||||||++|+|.++|.+..
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 466899999999999999986421
Q ss_pred ---------------------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC
Q 005007 431 ---------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471 (720)
Q Consensus 431 ---------------------------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~ 471 (720)
..+++..+..++.||++||+|||+++|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 24778888999999999999999999999999999999999
Q ss_pred CCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCc
Q 005007 472 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 547 (720)
Q Consensus 472 ~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~ 547 (720)
++.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-------NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999976543221 123346788999999863 457889999999999999997 9999987554
Q ss_pred HHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 548 PQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 548 ~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+...+.. ....+..++.+++++|.+||+.||++||++.+|.+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4444433322 34556778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.63 Aligned_cols=233 Identities=27% Similarity=0.478 Sum_probs=185.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCC-----hhHHHHHHHHhh-----------cCCEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDD-----PKSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~~-----------~~~~ly 411 (720)
.++|++.++||+|+||+||+|... .++..+|+|.+...... ..+.+.+..+.+ ..+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467899999999999999999743 35678999987643211 111222222221 245689
Q ss_pred EEEEeccCCCHHHHHHHhc--------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 412 IYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~--------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 9999999999999997643 24889999999999999999999999999999999999999999999
Q ss_pred eccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHH
Q 005007 478 ADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553 (720)
Q Consensus 478 ~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~k 553 (720)
+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|||++ |++||......+.+..
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 99999875533221 122335778999998863 457889999999999999998 9999988776666666
Q ss_pred Hhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 554 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 554 i~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+... ....+..+++.+.+||.+||+.||.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5543 34566788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.38 Aligned_cols=233 Identities=26% Similarity=0.443 Sum_probs=186.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHHHHHHHhh--------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
..+|++.+.||+|+||.||+|.+. .+..+|||.+....... ....+++.+.+ .....|+||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 358999999999999999999886 47789999886433221 22222222222 245689999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--ccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~t~ 495 (720)
.+++|.+++......+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++......... ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 999999999776567899999999999999999999999999999999999999999999999998765332211 122
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.++..|+|||++.+ ..++.++|||||||++|||++ |+.||........+..+... ....|...+.++.+||
T Consensus 162 ~~~~~~~aPe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 162 KFPVKWSSPEVFSF-------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM 234 (256)
T ss_pred ccchhhcCHhHhcc-------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 34678999998863 357789999999999999998 99999876665555555433 3344666789999999
Q ss_pred HHhhhcCCCCCCCHHHHHcC
Q 005007 574 LRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~H 593 (720)
.+||+.+|++|||+.|++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHcccChhhCCCHHHHHHh
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.63 Aligned_cols=240 Identities=34% Similarity=0.561 Sum_probs=193.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-h----HHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-K----SAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~----~~~~ik~L~~--------------~~~~lyLV 413 (720)
...|...+.||+|+||+||+|.+..++..||||++....... + ...++..+.. .++..|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 345889999999999999999999999999999986432211 1 1112222221 24568999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 104 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~ 179 (317)
T cd06635 104 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---AN 179 (317)
T ss_pred EeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cc
Confidence 99997 588888876667799999999999999999999999999999999999999999999999999875432 23
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--CCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--~iP~~ls~el~d 571 (720)
...|+..|+|||++.... ...++.++|||||||++|||++|+.||........+..+..... .....++..+++
T Consensus 180 ~~~~~~~y~aPE~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 180 SFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred cccCCccccChhhhhcCC----CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 456899999999985311 23477899999999999999999999988776666666654322 223467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||+.+|.+||++.++++|+|+....
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=300.64 Aligned_cols=226 Identities=25% Similarity=0.446 Sum_probs=176.2
Q ss_pred eEEeecCCeEEEEEEECCCCc--EEEEEEeccCCCCh------hHHHHHHHHhh------------cCCEEEEEEEeccC
Q 005007 360 KLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDP------KSAECIKQLEQ------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~--~VAVK~l~~~~~~~------~~~~~ik~L~~------------~~~~lyLVmEy~~g 419 (720)
++||+|+||.||+|++..++. .+|+|.++...... .+++.+..+.. .++.+|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988876 46888876432211 12222333311 13457899999999
Q ss_pred CCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 420 GSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 420 GsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997532 247899999999999999999999999999999999999999999999999986
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCC
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 562 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP 562 (720)
.............+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233 (270)
T ss_pred ccchhhhccCCCCccccCChHHHcc-------CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence 4322111122234567999998852 457889999999999999997 99999876665555555433 33456
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..++.++.++|.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 234 LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.19 Aligned_cols=239 Identities=26% Similarity=0.455 Sum_probs=187.1
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCC-------CcEEEEEEeccCCCChh------HHHHHHHHh-h--------
Q 005007 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPK------SAECIKQLE-Q-------- 405 (720)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~VYla~d~~t-------g~~VAVK~l~~~~~~~~------~~~~ik~L~-~-------- 405 (720)
..+....+|++++.||+|+||.||+|++... +..||+|.++....... +.+.+..+. +
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 3455566899999999999999999986432 23689998874332221 222333331 1
Q ss_pred ---cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCce
Q 005007 406 ---VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 467 (720)
Q Consensus 406 ---~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NI 467 (720)
.++.+|+||||+.+|+|.++|.... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 2456899999999999999997532 2477788899999999999999999999999999999
Q ss_pred eecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCC
Q 005007 468 LVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 543 (720)
Q Consensus 468 LLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~ 543 (720)
|++.++.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-------CCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999976543221 112234567999999863 457789999999999999998 899998
Q ss_pred CCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 544 EFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 544 ~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.....+....+... ....+..++.++.+||.+||+.+|.+||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 87666665555443 345667788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.42 Aligned_cols=230 Identities=28% Similarity=0.445 Sum_probs=176.7
Q ss_pred CCe-EEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-------------cCCE
Q 005007 354 SQW-QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-------------VDDH 409 (720)
Q Consensus 354 ~~Y-~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-------------~~~~ 409 (720)
++| ++.+.||+|+||+||++. ...++..||+|.++...... .+++.+..+.+ .+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 355 999999999999998864 34578899999987543211 12222222221 1235
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+|+||||+.+++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 8999999999999999976 35999999999999999999999999999999999999999999999999999866432
Q ss_pred cc----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH--------------HHH
Q 005007 490 SY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--------------QAM 551 (720)
Q Consensus 490 ~~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~--------------~~i 551 (720)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 21 112345677999998863 35778999999999999999999998643211 001
Q ss_pred HHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 552 FKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 552 ~ki~--~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.... ......+..++.++.++|.+||+.+|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 1123346678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.98 Aligned_cols=231 Identities=25% Similarity=0.413 Sum_probs=180.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyL 412 (720)
+|++.+.||+|+||+||+|++.. ....+|+|.+......... ..++..+.. .++..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2357899987643322111 112222221 2456789
Q ss_pred EEEeccCCCHHHHHHHh-----------------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 413 YLEYVHPGSINRYVREH-----------------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~-----------------------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998642 1347889999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-------CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999976533221 122345778999998863 457889999999999999998 99999876
Q ss_pred CcHHHHHHHhc-cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 EGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~~~~~i~ki~~-~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+....+.. .....+..++.++.+||.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 65544443332 234457778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.97 Aligned_cols=225 Identities=28% Similarity=0.472 Sum_probs=179.4
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
++||+|+||.||+|... ++..||+|.+........ +.+.++.+.+ .++..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999864 688999998865432111 1222222221 24568999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc--cccCCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPN 500 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~--t~~GTp~ 500 (720)
.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... ...++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 99997665678999999999999999999999999999999999999999999999999987543322111 2234567
Q ss_pred CCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhh
Q 005007 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 501 YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~ 578 (720)
|+|||++.+ ..++.++|||||||++|||++ |..||...........+... ....+..++.++.++|.+||.
T Consensus 160 y~aPE~~~~-------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 160 WTAPEALNY-------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred ccCHHHhcc-------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 999999863 457789999999999999998 99999877666655555443 334566789999999999999
Q ss_pred cCCCCCCCHHHHHc
Q 005007 579 RNPVERPSAVELLE 592 (720)
Q Consensus 579 ~dP~kRPTa~ELL~ 592 (720)
.+|++||++.|+++
T Consensus 233 ~~p~~Rp~~~~l~~ 246 (250)
T cd05085 233 YKPENRPKFSELQK 246 (250)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.04 Aligned_cols=236 Identities=24% Similarity=0.458 Sum_probs=186.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCCh------hHHHHHHHHh-h-----------c
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDP------KSAECIKQLE-Q-----------V 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~-~-----------~ 406 (720)
....++|.+++.||+|+||.||+|.+ ..++..||||.++...... .+.+.++.+. + .
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 34456899999999999999999975 3456689999887543221 1223333331 1 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.+.+|+||||+.+|+|.+++.... ..+++.++..|+.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 456899999999999999997543 3389999999999999999999999999999999999999999999999999986
Q ss_pred ccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CC
Q 005007 486 LTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TP 559 (720)
Q Consensus 486 ~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~ 559 (720)
...... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+.+.+.... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 543221 112345788999999863 457889999999999999998 99999877665555554432 23
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 560 ~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..+...+.++.+||.+||..+|++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 345667899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=298.08 Aligned_cols=232 Identities=32% Similarity=0.538 Sum_probs=182.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Chh-------HHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPK-------SAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~-------~~~~ik~L~~-----------~~~~lyLVm 414 (720)
.+|++.+.||+|+||.||+|++..+++.||||.+..... +.. +...++.+.+ .++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 478999999999999999999999999999998764321 111 1122222221 256789999
Q ss_pred EeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 415 EYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999998642 3468999999999999999999999999999999999999999999999999987664322
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH--HHHHHHhcc-CCCC-CccCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLNR-TPPI-PEMLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~--~~i~ki~~~-~~~i-P~~ls 566 (720)
......|+..|+|||++.+ ..++.++|||||||++|||++|..||...... .....+... ...+ +..++
T Consensus 162 ~~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred ccccccCCcCccCHHHhcC-------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 2234568999999999863 34678999999999999999999999754321 222222221 2222 34678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+++++|.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=330.32 Aligned_cols=243 Identities=30% Similarity=0.474 Sum_probs=194.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--------HHHHHHHH-----------hhcCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--------SAECIKQL-----------EQVDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--------~~~~ik~L-----------~~~~~~lyLV 413 (720)
++-|.+++.||-|+||.|.++...+|...||+|.++...-..+ +..++.+- .+.++++|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4568999999999999999999999999999997753211100 01111111 1247889999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc------
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT------ 487 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~------ 487 (720)
|||++|||+-.+|.+. +-|.|..++.|+.+|..|+++.|..|+|||||||+|||||.+|+|||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999999999999776 779999999999999999999999999999999999999999999999999985321
Q ss_pred ---Cc----------------------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhh
Q 005007 488 ---GL----------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 530 (720)
Q Consensus 488 ---~~----------------------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~ 530 (720)
.+ ......+||+.|+|||+|. ...|+..+|+||.||
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-------r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-------RTGYTQLCDWWSVGV 859 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-------ccCccccchhhHhhH
Confidence 00 0112367999999999997 356888999999999
Q ss_pred hHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCcccccccccC
Q 005007 531 TVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANYQN 603 (720)
Q Consensus 531 vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP--~~ls~el~dLI~~cL~~dP~kRP---Ta~ELL~Hpff~~~~~~~ 603 (720)
|||||+.|++||......+...++++. ...+| ..++.++.+||.++.. ++++|. -++|+..||||+...+..
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence 999999999999877666666666543 33343 5689999999998655 588886 467899999999877654
Q ss_pred C
Q 005007 604 L 604 (720)
Q Consensus 604 l 604 (720)
+
T Consensus 939 l 939 (1034)
T KOG0608|consen 939 L 939 (1034)
T ss_pred h
Confidence 3
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.97 Aligned_cols=238 Identities=36% Similarity=0.603 Sum_probs=190.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh----HHHHHHHHhh--------------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK----SAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~----~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
.|...+.||+|+||+||+|.+..+|+.||||++...... .. ...++..+.. .++..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 477788999999999999999999999999998653321 11 1122222222 2456899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
|+. |+|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..... ....
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~ 177 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSF 177 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCc
Confidence 996 688888876667799999999999999999999999999999999999999999999999999865332 2346
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCC-CccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPI-PEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~i-P~~ls~el~dLI 573 (720)
.|+..|+|||++... ....++.++|||||||++|||++|..||...+....+..+.... +.. ...++..+++||
T Consensus 178 ~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 178 VGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred cccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 789999999998531 12357789999999999999999999998877666665554332 222 235678899999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+||+.+|.+||++.++|.||||+...
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.42 Aligned_cols=224 Identities=24% Similarity=0.404 Sum_probs=174.7
Q ss_pred eEEeecCCeEEEEEEECCCCcE-------EEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 360 KLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~-------VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
+.||+|+||+||+|.++.++.. ||+|.+...... ....+++..+.. .++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 3699999999999998765543 888877532211 011112222221 24668999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC--------eeeeccccchhccC
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--------VKLADFGMAKHLTG 488 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~--------VKL~DFGlA~~~~~ 488 (720)
+.+|+|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 9999999999876567899999999999999999999999999999999999987765 69999999865543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHHHhccCCCCCccCCH
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~ki~~~~~~iP~~ls~ 567 (720)
. ....++..|+|||++.+ ...++.++|||||||++|||++| .+||...+.... .........+|...+.
T Consensus 161 ~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 230 (258)
T cd05078 161 K---EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPAPKWT 230 (258)
T ss_pred c---hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCCCCcH
Confidence 2 23568899999999863 23467899999999999999998 466665444333 3344555677777889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++.+||.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.60 Aligned_cols=225 Identities=28% Similarity=0.517 Sum_probs=179.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
++||+|+||.||+|.+.. ++.||+|.+........ +.++++.+.. ..+..|+||||+.|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999987 99999998875433211 1122222221 24568999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc---cccCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSP 499 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~---t~~GTp 499 (720)
.+++.+....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.......... ...++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 99997755678999999999999999999999999999999999999999999999999997654222111 122356
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhh
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCF 577 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL 577 (720)
.|+|||++.+ ..++.++|||||||++|||++ |..||...........+... ....+..++.++.++|.+||
T Consensus 160 ~y~~PE~~~~-------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 160 KWTAPEALNY-------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred ccCChHhhcc-------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence 7999999863 357889999999999999998 89999877655555544433 34456788999999999999
Q ss_pred hcCCCCCCCHHHHHc
Q 005007 578 LRNPVERPSAVELLE 592 (720)
Q Consensus 578 ~~dP~kRPTa~ELL~ 592 (720)
..+|.+|||+.|+|+
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.34 Aligned_cols=233 Identities=26% Similarity=0.412 Sum_probs=180.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCC--------------cEEEEEEeccCCCCh------hHHHHHHHHhh-------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------------ASCAIKEVDIIPDDP------KSAECIKQLEQ------- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg--------------~~VAVK~l~~~~~~~------~~~~~ik~L~~------- 405 (720)
..+|++.+.||+|+||.||+|++..++ ..||||.+....... ++++.++.+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468999999999999999999875432 358999887542221 12222333322
Q ss_pred ----cCCEEEEEEEeccCCCHHHHHHHhc-----------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec
Q 005007 406 ----VDDHLYIYLEYVHPGSINRYVREHC-----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 470 (720)
Q Consensus 406 ----~~~~lyLVmEy~~gGsL~~~L~~~~-----------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd 470 (720)
.++.+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 2566899999999999999996532 1368889999999999999999999999999999999999
Q ss_pred CCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc--CCCCCCCC
Q 005007 471 ASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSEF 545 (720)
Q Consensus 471 ~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT--Gk~PF~~~ 545 (720)
.++.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-------CCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999976543221 122345678999998863 457889999999999999988 77899877
Q ss_pred CcHHHHHHHhc--------cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 EGPQAMFKVLN--------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~~~~~i~ki~~--------~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+.+..+.. .....+..+++.+.+||.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66555444321 112335567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.51 Aligned_cols=234 Identities=26% Similarity=0.431 Sum_probs=179.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------c--CCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------V--DDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d----~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~--~~~ 409 (720)
+.-|++.+.||+|+||.||+|.. ..++..||+|.++....... ++..++.+.+ . ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34689999999999999999974 46788999999864432211 1222222221 0 245
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+++||||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999999765556899999999999999999999999999999999999999999999999999866432
Q ss_pred cc----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC--------------cHHHH
Q 005007 490 SY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------------GPQAM 551 (720)
Q Consensus 490 ~~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~--------------~~~~i 551 (720)
.. .....|+..|+|||++.+ ..++.++|||||||++|||++++.|+.... .....
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ-------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc-------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 21 123456778999998863 457789999999999999999876643210 01111
Q ss_pred HHHhc--cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 552 FKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 552 ~ki~~--~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+. ...+.+..++.++.+||.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11111 2334566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.36 Aligned_cols=239 Identities=32% Similarity=0.578 Sum_probs=191.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Chh------HHHHHHHHhh-----------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPK------SAECIKQLEQ-----------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~------~~~~ik~L~~-----------~~~~lyLV 413 (720)
...|...+.||+|+||.||+|+++.++..||||.+..... ... +.+.+..+.+ .++..|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 4468889999999999999999999999999998864321 111 1112222221 24568999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+. |+|.+++......+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++...... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~ 169 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---c
Confidence 99996 6888887665567999999999999999999999999999999999999999999999999998765432 3
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CC-CCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PP-IPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~-iP~~ls~el~d 571 (720)
...|+..|+|||++.+.. ...++.++|||||||++|||++|+.||...+.......+.... +. .+..++..+.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 170 XFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred cccCCccccCHHHHhhcc----cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 456899999999986421 2346779999999999999999999998776655555554332 22 23467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
||.+||..+|++||++.++++|+|+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.06 Aligned_cols=237 Identities=25% Similarity=0.424 Sum_probs=176.0
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
|.+++.+|. +|.||++++..+++.||||++........ +++.++.+.+ .++.+|++|||+
T Consensus 4 ~~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 4 TLIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 334444444 45566666677899999999875422111 1112222211 256789999999
Q ss_pred cCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-----
Q 005007 418 HPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----- 491 (720)
Q Consensus 418 ~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~----- 491 (720)
.+|+|.+++... ...+++..+..++.||++||+|||+++|+||||||+|||++.+|.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999999764 34689999999999999999999999999999999999999999999999999875532211
Q ss_pred ---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------
Q 005007 492 ---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------- 558 (720)
Q Consensus 492 ---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------- 558 (720)
.....++..|+|||++.+. ...++.++|||||||++|||++|+.||........+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 1234578889999998631 1347789999999999999999999998765443332221110
Q ss_pred ------------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 559 ------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 559 ------------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
......++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111234688999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.70 Aligned_cols=233 Identities=28% Similarity=0.447 Sum_probs=179.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeccCCCCh------hHHHHHHHHhh-----
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDP------KSAECIKQLEQ----- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~----------------tg~~VAVK~l~~~~~~~------~~~~~ik~L~~----- 405 (720)
.++|++.+.||+|+||+||+|.+.. ++..||||.+....... .+++.+..+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999986432 34579999887543221 12222233322
Q ss_pred ------cCCEEEEEEEeccCCCHHHHHHHhc----------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 406 ------VDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 406 ------~~~~lyLVmEy~~gGsL~~~L~~~~----------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
.++.+++||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 2456899999999999999997642 236778899999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc--CCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSE 544 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT--Gk~PF~~ 544 (720)
+.++.+||+|||+++.+..... .....++..|++||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-------CCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999976533221 112234678999998763 357889999999999999998 7899987
Q ss_pred CCcHHHHHHHh--------ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 545 FEGPQAMFKVL--------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 545 ~~~~~~i~ki~--------~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
....+.+.... ....+.+..++..+.+||.+||+.||.+||++.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443321 1122345668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.64 Aligned_cols=234 Identities=21% Similarity=0.395 Sum_probs=185.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC----CCcEEEEEEeccCCCChhHH------HHHHHHhh------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSA------ECIKQLEQ------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~----tg~~VAVK~l~~~~~~~~~~------~~ik~L~~------------~~~~ 409 (720)
..++|++.++||+|+||+||+|.+.. ++..||+|.+.......... ..++.+.+ .+..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999999876 35789999876432221111 11222221 1356
Q ss_pred EEEEEEeccCCCHHHHHHHhc-------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecccc
Q 005007 410 LYIYLEYVHPGSINRYVREHC-------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 482 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~-------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGl 482 (720)
.++++||+.+++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 789999999999999996532 3589999999999999999999999999999999999999999999999999
Q ss_pred chhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-
Q 005007 483 AKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR- 557 (720)
Q Consensus 483 A~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~- 557 (720)
++.+...... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVN-------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhc-------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9865433221 22346778999999863 457889999999999999999 99999877665554444433
Q ss_pred CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 558 ~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
....+..+++++.++|.+||..||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.65 Aligned_cols=233 Identities=23% Similarity=0.435 Sum_probs=184.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~l 410 (720)
.++|++.+.||+|+||.||+|.+. .++..||||++........ ++..+..+.+ .++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 468999999999999999999875 3678999998864332111 1122222211 24568
Q ss_pred EEEEEeccCCCHHHHHHHhc---------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 411 YIYLEYVHPGSINRYVREHC---------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~---------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 99999999999999997532 247888899999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999875433221 112234667999999863 457889999999999999997 88999877
Q ss_pred CcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 EGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+....+... ....+..++.++.+||.+||+.+|.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 666666655543 33456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.14 Aligned_cols=228 Identities=27% Similarity=0.455 Sum_probs=181.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh-------------cCCEEEEEEEeccCC
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-------------~~~~lyLVmEy~~gG 420 (720)
++|++++.||+|+||.||++. .+++.||+|.++..........++..+.. ..+..|+||||+.++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 579999999999999999986 46889999988654322222222222221 134579999999999
Q ss_pred CHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCC
Q 005007 421 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499 (720)
Q Consensus 421 sL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp 499 (720)
+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... ......+.
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~ 161 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPV 161 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCc
Confidence 9999997643 35899999999999999999999999999999999999999999999999998754322 12233456
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhh
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCF 577 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL 577 (720)
.|+|||.+.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++.++.++|.+||
T Consensus 162 ~y~~pe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 162 KWTAPEALKH-------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred eecCHHHhcc-------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 7999998863 357789999999999999997 99999887665555544433 23345678899999999999
Q ss_pred hcCCCCCCCHHHHHc
Q 005007 578 LRNPVERPSAVELLE 592 (720)
Q Consensus 578 ~~dP~kRPTa~ELL~ 592 (720)
+.+|++||++.++++
T Consensus 235 ~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPSFHKLRE 249 (254)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=301.05 Aligned_cols=229 Identities=29% Similarity=0.537 Sum_probs=179.7
Q ss_pred EEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEEEEEEE
Q 005007 357 QKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~----~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~lyLVmE 415 (720)
.+.+.||.|.||.||+|.+. ..+..|+||.++......... +.++.+.. ..+.+++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 56789999999999999988 456789999996533222122 22222222 1455899999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc---c
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---Y 491 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---~ 491 (720)
|+++|+|.++|... ...+++..+..|+.||++||.|||+++|+|+||+++||||+.++.+||+|||++....... .
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999876 5679999999999999999999999999999999999999999999999999998763221 1
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
.....+...|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+...++... ....+..++..+
T Consensus 162 ~~~~~~~~~~~aPE~~~~-------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKD-------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDI 234 (259)
T ss_dssp STTSESGGGGS-HHHHHH-------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHH
T ss_pred cccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccceeccchhHHH
Confidence 223346678999999985 347889999999999999999 78999988777766666433 345677899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++|..||..||++||++.+|++
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.04 Aligned_cols=226 Identities=29% Similarity=0.482 Sum_probs=180.1
Q ss_pred eEEeecCCeEEEEEEECC-CCc--EEEEEEeccCCCChh---HHHHHHHHhh-------------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPK---SAECIKQLEQ-------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~-tg~--~VAVK~l~~~~~~~~---~~~~ik~L~~-------------~~~~lyLVmEy~~gG 420 (720)
++||+|+||+||+|.+.. .++ .||||.+........ ...++..+.. .+..+++||||++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999999865 333 699998875443211 1112222221 135789999999999
Q ss_pred CHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----ccccc
Q 005007 421 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS----YELSL 495 (720)
Q Consensus 421 sL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~----~~~t~ 495 (720)
+|.+++.+.. ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+.... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCC
Confidence 9999997754 568999999999999999999999999999999999999999999999999998764321 11234
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el~dL 572 (720)
.++..|+|||.+.+ ..++.++|||||||++|||++ |+.||......+....+.. .....+..++.++.++
T Consensus 161 ~~~~~y~~pE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 161 KVPFAWCAPESLRT-------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred CCCceecCHHHhcc-------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 57788999998863 457889999999999999998 9999987776666555543 2334556788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHc
Q 005007 573 LLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~ 592 (720)
|.+||..+|++||++.++++
T Consensus 234 i~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHCCCCcccCCCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.82 Aligned_cols=232 Identities=25% Similarity=0.373 Sum_probs=171.7
Q ss_pred eEEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCChhHHH---HHHHHhh--------------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAE---CIKQLEQ--------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~~~~~---~ik~L~~--------------~~~~lyLVmEy~~gG 420 (720)
+.||+|+||+||+|.+. .++..+|+|.++.......... ++..+.. ....+++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999764 3567899998875543222111 2222221 234578999999999
Q ss_pred CHHHHHHHhc----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---cc
Q 005007 421 SINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---EL 493 (720)
Q Consensus 421 sL~~~L~~~~----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~ 493 (720)
+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 9999997532 2456778889999999999999999999999999999999999999999999975433221 12
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCC-----CCCccCC
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTP-----PIPEMLS 566 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~-----~iP~~ls 566 (720)
...|+..|+|||++.+.........++.++|||||||++|||++ |+.||......+....... ... .+....+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 34578889999998632111011246789999999999999996 9999987665554433322 111 2223467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.+.++|.+|| .+|++|||++||+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 88999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.26 Aligned_cols=233 Identities=26% Similarity=0.452 Sum_probs=178.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCC-----hhHHHHHHHHhh-------------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDD-----PKSAECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~~-------------~~~~l 410 (720)
..+|++.+.||+|+||+||+|. +..++..||||++...... ..+.+.+..+.+ ....+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3589999999999999999997 4567899999998644221 112222233221 12357
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
++||||+++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 89999999999999997655679999999999999999999999999999999999999999999999999998764322
Q ss_pred cc----ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH---------------HHH
Q 005007 491 YE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---------------QAM 551 (720)
Q Consensus 491 ~~----~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---------------~~i 551 (720)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|..++...... ..+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cceeecCCCCCceEeeCHHHhcc-------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 11 11223456999999863 45778999999999999999987775432111 011
Q ss_pred HHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 552 FKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 552 ~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..++.. ....+..++.++.+||.+||..+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112222 23345678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.10 Aligned_cols=235 Identities=27% Similarity=0.470 Sum_probs=183.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCCCChhH------HHHHHHHhh----------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKS------AECIKQLEQ----------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~----~VAVK~l~~~~~~~~~------~~~ik~L~~----------~~~~ly 411 (720)
...+|+..+.||+|+||.||+|.+..+|. .||+|.+......... ...+..+.+ .....+
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 84 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ 84 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCce
Confidence 35689999999999999999999988776 4688877643322111 111122211 123467
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+|+||+++|+|.+++......+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 89999999999999987666799999999999999999999999999999999999999999999999999987643322
Q ss_pred c---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCC
Q 005007 492 E---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566 (720)
Q Consensus 492 ~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls 566 (720)
. ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.. .....+..++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 237 (303)
T ss_pred ccccCCCccccccCCHHHhcc-------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 1 12335778999998863 457889999999999999997 9999987654333322222 2334455678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.++.++|.+||..+|++||++.++++.
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=291.76 Aligned_cols=233 Identities=28% Similarity=0.521 Sum_probs=184.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-h---HHHHHHHHhh----------cCCEEEEEEEec
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-K---SAECIKQLEQ----------VDDHLYIYLEYV 417 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~---~~~~ik~L~~----------~~~~lyLVmEy~ 417 (720)
...+|++.+.||+|+||.||+|.+. .+..||+|++....... . +.++++.+.+ .+...|+||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeC
Confidence 4578999999999999999999865 45679999886432211 1 1222222221 135579999999
Q ss_pred cCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc--cc
Q 005007 418 HPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LS 494 (720)
Q Consensus 418 ~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--~t 494 (720)
++++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 999999999763 345788899999999999999999999999999999999999999999999999765432221 12
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+.......+... ....+..++.++.++
T Consensus 163 ~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 163 AKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred CcccccccCHhHhcc-------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 335677999999863 457789999999999999998 99999887666555555443 334456788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHc
Q 005007 573 LLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~ 592 (720)
|.+||+.+|++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.90 Aligned_cols=224 Identities=25% Similarity=0.434 Sum_probs=173.4
Q ss_pred eEEeecCCeEEEEEEECCCC----------cEEEEEEeccCCCC-hhHHHHHHHHhh-------------cCCEEEEEEE
Q 005007 360 KLIGRGTFGSVYIGTNRETG----------ASCAIKEVDIIPDD-PKSAECIKQLEQ-------------VDDHLYIYLE 415 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg----------~~VAVK~l~~~~~~-~~~~~~ik~L~~-------------~~~~lyLVmE 415 (720)
+.||+|+||.||+|.+..++ ..|++|.+...... ....+++..+.. ..+..++|||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 47999999999999998777 35888877644331 122222222221 1245789999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-------CeeeeccccchhccC
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-------VVKLADFGMAKHLTG 488 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-------~VKL~DFGlA~~~~~ 488 (720)
|+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~ 160 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc
Confidence 9999999999987655799999999999999999999999999999999999999887 799999999986543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhccCCCCCccCCH
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~~~~iP~~ls~ 567 (720)
.....++..|+|||++.+. ...++.++|||||||++|||++ |..||......+... ........+.....
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (259)
T cd05037 161 ---REERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHRLPMPDCA 231 (259)
T ss_pred ---ccccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcCCCCCCCCch
Confidence 2234567789999998741 1357889999999999999999 688887765333222 22233333333448
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.++|.+||..+|.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=330.85 Aligned_cols=240 Identities=20% Similarity=0.331 Sum_probs=170.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCC-cEEEEEEec---------------cCCCC-------hhHHHHHHHHhh----
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVD---------------IIPDD-------PKSAECIKQLEQ---- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg-~~VAVK~l~---------------~~~~~-------~~~~~~ik~L~~---- 405 (720)
..+|++++.||+|+||+||+|..+... ..+++|.+. ..... ..+++++..+.+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999999765432 223322111 00000 011222222221
Q ss_pred -------cCCEEEEEEEeccCCCHHHHHHHh----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC
Q 005007 406 -------VDDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 474 (720)
Q Consensus 406 -------~~~~lyLVmEy~~gGsL~~~L~~~----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~ 474 (720)
.++..|+|||++. ++|..++... ........++.|+.||+.||.|||++|||||||||+||||+.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 2467899999995 6777776532 122446778899999999999999999999999999999999999
Q ss_pred eeeeccccchhccCcc--ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCC-CCCC--CcHH
Q 005007 475 VKLADFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEF--EGPQ 549 (720)
Q Consensus 475 VKL~DFGlA~~~~~~~--~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~P-F~~~--~~~~ 549 (720)
+||+|||+++.+.... .....+||+.|+|||++.+ ..++.++|||||||+||||++|..+ |... ....
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999998765432 2234679999999999873 4578899999999999999998754 4322 1122
Q ss_pred HHHHHhccC----CCCC----------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 550 AMFKVLNRT----PPIP----------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 550 ~i~ki~~~~----~~iP----------------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
.+.+++... ..+| ..++.++.++|.+||+.||.+|||+.|+|.||||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 222222100 0000 12456788899999999999999999999999997
Q ss_pred ccc
Q 005007 598 NAN 600 (720)
Q Consensus 598 ~~~ 600 (720)
...
T Consensus 459 ~~~ 461 (501)
T PHA03210 459 AEE 461 (501)
T ss_pred cCC
Confidence 543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=327.96 Aligned_cols=233 Identities=32% Similarity=0.601 Sum_probs=190.2
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChh-------HHHHHHHHhh-------------cCCEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPK-------SAECIKQLEQ-------------VDDHLYIY 413 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~-------~~~~ik~L~~-------------~~~~lyLV 413 (720)
.+...+||+|+|-+||+|.|..+|..||--.++... ..++ +++.++-|.+ .++.+.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 355679999999999999999999999976554321 1221 2223333332 24568999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC--CCcccccCCCceeecC-CCCeeeeccccchhccCcc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~--gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~~~ 490 (720)
+|++..|+|..|++++ +.+....++.|++|||+||.|||++ -|||||||.+||||+. -|.|||+|+|||.......
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999999887 7799999999999999999999988 5999999999999985 4899999999998876644
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHH-HhccCCC--CCccCCH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPP--IPEMLSS 567 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~k-i~~~~~~--iP~~ls~ 567 (720)
. ..++|||.|||||++. ..|...+||||||++|+||+|+..||......+.+++ +..+..+ +-..-.+
T Consensus 201 a-ksvIGTPEFMAPEmYE--------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 201 A-KSVIGTPEFMAPEMYE--------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred c-ceeccCccccChHHHh--------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 4 3488999999999985 4688899999999999999999999988766665554 4444322 2233468
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||.. ..+|+|+.|||+|+||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 9999999999999999864
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=317.35 Aligned_cols=237 Identities=24% Similarity=0.434 Sum_probs=186.0
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChh------HHHHHHHHh-h-----------c
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPK------SAECIKQLE-Q-----------V 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~------~~~~ik~L~-~-----------~ 406 (720)
....++|.++++||+|+||.||+|.+. .+++.||||+++....... +.+++..+. + .
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344568999999999999999999864 3557899999975433221 122222222 1 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhc--------------------------------------------------------
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHC-------------------------------------------------------- 430 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~-------------------------------------------------------- 430 (720)
++.+|||||||.+|+|.++|....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 356899999999999999996431
Q ss_pred -----------------------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 431 -----------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 431 -----------------------------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
..+++..++.|+.||+.||+|||+++|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 135677788999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||+++...... ......++..|||||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-------NLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-------CCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999997653221 1123456788999999863 457889999999999999998 89999876
Q ss_pred CcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 546 EGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 546 ~~~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+.+...+.. ....|..++.++.+||.+||..+|.+||++.||++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 665555554433 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.74 Aligned_cols=238 Identities=27% Similarity=0.485 Sum_probs=185.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----h---hHHHHHHHHhh------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----P---KSAECIKQLEQ------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~---~~~~~ik~L~~------------~~~~lyL 412 (720)
..++|++.+.||+|+||+||+|++..+++.||||++...... . .+.+++..+.+ .....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 457899999999999999999999999999999987542211 1 12223333321 1356899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+ +++|..++.. ..+++..+..++.||++||.|||++||+||||||.|||++.++.+||+|||++..... ..
T Consensus 88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~ 162 (328)
T cd07856 88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QM 162 (328)
T ss_pred Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--Cc
Confidence 99999 5789988864 4588999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh-----------------
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----------------- 555 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~----------------- 555 (720)
....++..|+|||++.+ ...++.++|||||||++|||++|++||...+.......+.
T Consensus 163 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 163 TGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred CCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 34567899999998753 2457889999999999999999999997654322211110
Q ss_pred ---------ccCCCCC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 556 ---------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 556 ---------~~~~~iP-----~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
......| ..++.++.++|.+||+.+|++|||++++|.|+||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0011111 24678999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=295.03 Aligned_cols=234 Identities=23% Similarity=0.443 Sum_probs=185.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCC------hhHHHHHHHHhh-----------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDD------PKSAECIKQLEQ-----------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~------~~~~~~ik~L~~-----------~~~~l 410 (720)
.++|++.+.||+|+||+||+|+++. +.+.||+|.+...... ..+++.+..+.+ ..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4689999999999999999999764 3467999988654332 112222333321 23568
Q ss_pred EEEEEeccCCCHHHHHHHhc--------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecccc
Q 005007 411 YIYLEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 482 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~--------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGl 482 (720)
|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999997542 1589999999999999999999999999999999999999999999999999
Q ss_pred chhccCcc--ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhccCC
Q 005007 483 AKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP 559 (720)
Q Consensus 483 A~~~~~~~--~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~~~ 559 (720)
++...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQE-------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 87543221 1123346778999998863 346778999999999999998 8999987766666666554433
Q ss_pred --CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 560 --PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 560 --~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+..++..+.++|.+||..+|.+||++.|++..
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=294.81 Aligned_cols=239 Identities=25% Similarity=0.389 Sum_probs=186.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh----HHHHHHHHh-------------h---cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK----SAECIKQLE-------------Q---VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~----~~~~ik~L~-------------~---~~~~ 409 (720)
...++|++.++||+|||+-||+++...+++.||+|+|.....+ .+ +++..+.++ + -...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3467999999999999999999999999999999988765421 11 111111111 1 1346
Q ss_pred EEEEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCCeeeeccccch
Q 005007 410 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.||++.|...|+|.+.|... +..++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999999999999998643 346999999999999999999999998 9999999999999999999999999987
Q ss_pred hccC----c------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC--CcHHHHH
Q 005007 485 HLTG----L------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--EGPQAMF 552 (720)
Q Consensus 485 ~~~~----~------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~--~~~~~i~ 552 (720)
...- . ........|..|+|||++.- ..+...+.++|||||||+||+|+.|.-||... .+.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v----k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV----KSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheec----ccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 5421 1 11123346889999999863 23466889999999999999999999999642 1112222
Q ss_pred HHhccCCCCCc--cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 553 KVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 553 ki~~~~~~iP~--~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+.+....+|. .+++.+.+||+.||+.||.+||++.+++.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 33344445553 489999999999999999999999999864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=293.28 Aligned_cols=232 Identities=23% Similarity=0.448 Sum_probs=186.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCCC---------Chh---HHHHHHHHhh---------------c
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPD---------DPK---SAECIKQLEQ---------------V 406 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~-tg~~VAVK~l~~~~~---------~~~---~~~~ik~L~~---------------~ 406 (720)
.|++.+.||+|+||.||+|.+.. +++.+|||++..... ... ...++..+.. .
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999988 688999998764321 111 1112222211 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeecccc
Q 005007 407 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGM 482 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGl 482 (720)
++..++||||++|++|.+++.. ....+++..++.++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 5678999999999999998843 34569999999999999999999996 7899999999999999999999999999
Q ss_pred chhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-CC
Q 005007 483 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PI 561 (720)
Q Consensus 483 A~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-~i 561 (720)
+.............|+..|++||++.+ ..++.++|||||||++|||++|+.||...........+..... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKN-------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred eeecccccccccccCcccCcChhhhcC-------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 987655444445678999999999863 3468899999999999999999999987666555555544332 22
Q ss_pred C-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 562 P-EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 562 P-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+ ..++.++.++|.+||+.||++||++.|+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3 3678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=302.74 Aligned_cols=242 Identities=26% Similarity=0.457 Sum_probs=193.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHhh----------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQ---------------------- 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~~---------------------- 405 (720)
..+.|....+||+|.||.||+|+.+.+|+.||+|++-.... -....+.++.|+.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34688999999999999999999999999999996643211 1111222222211
Q ss_pred cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
....+|+||.+|+ -+|..+|.+....++..+|+.+|.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 1345999999997 899999988777899999999999999999999999999999999999999999999999999987
Q ss_pred ccCcc-----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---
Q 005007 486 LTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--- 557 (720)
Q Consensus 486 ~~~~~-----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--- 557 (720)
+.... .....+.|.||++||.+.| +..|+...|||..||||.||.+|.+-|.+......+..|..-
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLG------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhc------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 64321 1223456999999999996 577899999999999999999999999887776665554210
Q ss_pred -------------------CCCCCc-------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 -------------------TPPIPE-------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 -------------------~~~iP~-------------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++|+ .-.+++.|||.++|..||.+|+++.++|+|.||....
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 011121 1246888999999999999999999999999997543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.69 Aligned_cols=223 Identities=23% Similarity=0.373 Sum_probs=170.8
Q ss_pred EEeecCCeEEEEEEECCC------------------------CcEEEEEEeccCCCCh--hHHHHHHHHhh---------
Q 005007 361 LIGRGTFGSVYIGTNRET------------------------GASCAIKEVDIIPDDP--KSAECIKQLEQ--------- 405 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~~t------------------------g~~VAVK~l~~~~~~~--~~~~~ik~L~~--------- 405 (720)
.||+|+||.||+|....+ ...||+|+++...... ...++...+..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975322 2358888775322111 11111111211
Q ss_pred -----cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-------
Q 005007 406 -----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG------- 473 (720)
Q Consensus 406 -----~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g------- 473 (720)
.+...++||||+++|+|..++....+.+++..+..++.||++||+|||++||+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 24567999999999999999976667799999999999999999999999999999999999997654
Q ss_pred CeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHh-cCCCCCCCCCcHHHHH
Q 005007 474 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMF 552 (720)
Q Consensus 474 ~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELL-TGk~PF~~~~~~~~i~ 552 (720)
.+||+|||++...... ....++..|+|||.+.+ ...++.++|||||||++|||+ +|+.||......+. .
T Consensus 162 ~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~ 231 (274)
T cd05076 162 FIKLSDPGVSFTALSR---EERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-E 231 (274)
T ss_pred eeeecCCccccccccc---cccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-H
Confidence 4899999998654322 22357888999998863 245788999999999999994 79999987654333 3
Q ss_pred HHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 553 KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 553 ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
........+|.....++.++|.+||+.+|++|||+.++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33444455666677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.37 Aligned_cols=226 Identities=28% Similarity=0.504 Sum_probs=177.1
Q ss_pred eEEeecCCeEEEEEEECCCC------cEEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 360 KLIGRGTFGSVYIGTNRETG------ASCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg------~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+.||+|+||.||+|.+.... +.||||.+........ +...++.+.+ ..+..|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999886544 6899998754321111 1122222211 24568999999
Q ss_pred ccCCCHHHHHHHh------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-----Ceeeeccccchh
Q 005007 417 VHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAKH 485 (720)
Q Consensus 417 ~~gGsL~~~L~~~------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-----~VKL~DFGlA~~ 485 (720)
+++++|.+++.+. ...+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999653 23478899999999999999999999999999999999999887 899999999976
Q ss_pred ccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCC
Q 005007 486 LTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPP 560 (720)
Q Consensus 486 ~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~ 560 (720)
...... .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+.. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLD-------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233 (269)
T ss_pred cccccccccCcccCCCccccCHHHHcc-------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC
Confidence 543221 112345778999999863 457889999999999999998 9999987766655555443 3445
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 561 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 561 iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+..++.++.++|.+||..+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66778999999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=336.16 Aligned_cols=233 Identities=21% Similarity=0.354 Sum_probs=179.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--------HHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--------SAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--------~~~~ik~L~~-----------~~~~lyLVm 414 (720)
.+|+++++||+|+||+||+|++..+|+.||||++........ +.+.+..+.+ .++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 589999999999999999999999999999999875322111 1112222221 256789999
Q ss_pred EeccCCCHHHHHHHh----------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 415 EYVHPGSINRYVREH----------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~----------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
||++||+|.+++... ...++...+..++.||++||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 1235567788999999999999999999999999999999999999999999997
Q ss_pred hccCc-------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC
Q 005007 485 HLTGL-------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 545 (720)
Q Consensus 485 ~~~~~-------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~ 545 (720)
..... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-------~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-------VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-------CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 65210 01113569999999999863 45788999999999999999999999875
Q ss_pred CcHHHHHHHh-ccCCCC--CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 546 EGPQAMFKVL-NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 546 ~~~~~i~ki~-~~~~~i--P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.......... ...... ...+++.+.++|.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5443333221 111111 13578899999999999999999876665543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.49 Aligned_cols=232 Identities=21% Similarity=0.361 Sum_probs=171.2
Q ss_pred eEEeecCCeEEEEEEECCC--CcEEEEEEeccCCCChhHHHHHHH------Hhh-----------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQ------LEQ-----------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~t--g~~VAVK~l~~~~~~~~~~~~ik~------L~~-----------~~~~lyLVmEy~~gG 420 (720)
+.||+|+||+||+|..... ...+++|.+............+++ +.+ ....+|+||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 345667776544322111111111 111 235679999999999
Q ss_pred CHHHHHHHhc---CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---ccccc
Q 005007 421 SINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELS 494 (720)
Q Consensus 421 sL~~~L~~~~---~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---~~~~t 494 (720)
+|.+++.+.. ..+.+..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997532 34677788999999999999999999999999999999999999999999998643221 11234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhccC------CCCCccCCH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT------PPIPEMLSS 567 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~~------~~iP~~ls~ 567 (720)
..|+..|+|||++...........++.++|||||||++|||++ |..||......+.+.+++... +.++..+++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 5688999999998532211112346789999999999999996 688998777666666554331 233445788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+.++|..|| .+|++||++.|+++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 9999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.38 Aligned_cols=224 Identities=21% Similarity=0.352 Sum_probs=170.4
Q ss_pred eEEeecCCeEEEEEEECC------------CCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEE
Q 005007 360 KLIGRGTFGSVYIGTNRE------------TGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~------------tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~ly 411 (720)
+.||+|+||+||+|+... ....||+|.+....... ...+++..+.. .+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 22358888775432211 11112222221 245678
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC-------eeeeccccch
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------VKLADFGMAK 484 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~-------VKL~DFGlA~ 484 (720)
+||||+++|+|..++......+++..++.|+.||++||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999999998766567999999999999999999999999999999999999987664 8999999986
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHh-cCCCCCCCCCcHHHHHHHhccCCCCCc
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLNRTPPIPE 563 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELL-TGk~PF~~~~~~~~i~ki~~~~~~iP~ 563 (720)
..... ....|+..|+|||++.. ...++.++|||||||++|||+ +|..||......+. ............
T Consensus 161 ~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~~ 230 (262)
T cd05077 161 TVLSR---QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCMLVT 230 (262)
T ss_pred cccCc---ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccCCC
Confidence 55322 23457889999998752 245788999999999999997 69999876543332 233333333444
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..++++.+||.+||+.||.+||++.+||++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.70 Aligned_cols=233 Identities=29% Similarity=0.500 Sum_probs=180.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeccCCCC---h---hHHHHHHHHhh-----------c--CCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDD---P---KSAECIKQLEQ-----------V--DDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~----~tg~~VAVK~l~~~~~~---~---~~~~~ik~L~~-----------~--~~~ 409 (720)
..+|++.+.||+|+||.||+|... .+++.||||.+...... . .+++.++.+.. . +..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 457889999999999999999864 35889999998755442 1 11122222211 1 346
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
.++||||+++++|.+++......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999999999999876557999999999999999999999999999999999999999999999999999876532
Q ss_pred ccc----ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH--------------HHH
Q 005007 490 SYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--------------QAM 551 (720)
Q Consensus 490 ~~~----~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~--------------~~i 551 (720)
... ....++..|++||.+.+ ..++.++|||||||++|||++|..||...... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-------CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 211 12234567999998863 35778999999999999999999998643221 112
Q ss_pred HHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 552 FKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 552 ~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+.. ....+..++.++.+||.+||..+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222 22335567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=333.95 Aligned_cols=235 Identities=26% Similarity=0.531 Sum_probs=196.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCC-Cc----EEEEEEeccCCCChhHHHHHHH------Hhh-----------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-GA----SCAIKEVDIIPDDPKSAECIKQ------LEQ-----------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~t-g~----~VAVK~l~~~~~~~~~~~~ik~------L~~-----------~~~ 408 (720)
.....-++++.||+|.||.||.|....- |. .||||.++...+..+..+.+++ +.+ ...
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4456788999999999999999986543 32 4999999877655544433332 222 145
Q ss_pred EEEEEEEeccCCCHHHHHHHh------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecccc
Q 005007 409 HLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 482 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGl 482 (720)
..+|++|||+||||..+|++. ...|+..+...++.||++|++||+++++|||||-..|+||+....|||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 678999999999999999886 56799999999999999999999999999999999999999999999999999
Q ss_pred chhccCcccc-ccccC--CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHh-cc
Q 005007 483 AKHLTGLSYE-LSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NR 557 (720)
Q Consensus 483 A~~~~~~~~~-~t~~G--Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~-~~ 557 (720)
|+.+....+. ....+ -..|||||.+. +..++.++|||||||+|||+++ |..||.+.++.+.+..++ ++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~-------d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLK-------DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHh-------hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9955443332 22222 24799999998 3678999999999999999999 999999999988888554 56
Q ss_pred CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 558 ~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..+.|.++++.+.++|..||+.+|++||++..|++
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 78889999999999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=315.63 Aligned_cols=247 Identities=18% Similarity=0.243 Sum_probs=175.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC----------------CCCcEEEEEEeccCCCC-----------------hhHHH
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR----------------ETGASCAIKEVDIIPDD-----------------PKSAE 398 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~----------------~tg~~VAVK~l~~~~~~-----------------~~~~~ 398 (720)
..++|++.++||+|+||+||+|.+. ..++.||||.++..... ....+
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 34567999998643211 00011
Q ss_pred H--HHHHhh------------------------cCCEEEEEEEeccCCCHHHHHHHhcC---------------------
Q 005007 399 C--IKQLEQ------------------------VDDHLYIYLEYVHPGSINRYVREHCR--------------------- 431 (720)
Q Consensus 399 ~--ik~L~~------------------------~~~~lyLVmEy~~gGsL~~~L~~~~~--------------------- 431 (720)
. +..+.+ .++..+|||||+.+++|.++|....+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 1 111100 13467999999999999999864211
Q ss_pred --CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc--ccCCCCCCChHHH
Q 005007 432 --DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 507 (720)
Q Consensus 432 --~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t--~~GTp~YmAPEvl 507 (720)
.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........... ..+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 235677899999999999999999999999999999999999999999999976543322222 2348999999998
Q ss_pred HHhhhcCC---------------CCCCCccccccchhhhHHHHhcCCC-CCCCCCcHH-----------HHHHHhccCCC
Q 005007 508 KAVMQKDG---------------NPKLALAVDIWSLGCTVIEMLTGKP-PWSEFEGPQ-----------AMFKVLNRTPP 560 (720)
Q Consensus 508 ~g~~~~~g---------------~~~~s~asDVWSLG~vLyELLTGk~-PF~~~~~~~-----------~i~ki~~~~~~ 560 (720)
........ ........||||+|||+|+|++|.. ||....... ....+......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 53211000 0011235799999999999999886 775422111 11111122222
Q ss_pred --CCccCCHHHHHHHHHhhhcCC---CCCCCHHHHHcCccccc
Q 005007 561 --IPEMLSSEGKDFLLRCFLRNP---VERPSAVELLEHPFIRN 598 (720)
Q Consensus 561 --iP~~ls~el~dLI~~cL~~dP---~kRPTa~ELL~Hpff~~ 598 (720)
....+++.++|||.+||.++| .+|+|++|+|+||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 234578999999999999876 68999999999999953
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=286.87 Aligned_cols=231 Identities=23% Similarity=0.425 Sum_probs=178.6
Q ss_pred eEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCCCChhH-------HHHHHHHhhc--------------C---C
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKS-------AECIKQLEQV--------------D---D 408 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~---tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~~--------------~---~ 408 (720)
|++.+.||+|+||+||+|.++. +++.||||++......... .+.+..+.+. . .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998653 5789999988754333221 1222222210 0 1
Q ss_pred EEEEEEEeccCCCHHHHHHHh-----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccc
Q 005007 409 HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
..++++||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 237889999999999887432 124788999999999999999999999999999999999999999999999999
Q ss_pred hhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-C
Q 005007 484 KHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T 558 (720)
Q Consensus 484 ~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~ 558 (720)
+....... .....+++.|++||.+.+ ..++.++|||||||++|||++ |++||...+..+....+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 86543221 122345678999998863 456789999999999999999 99999877665555444432 3
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 559 ~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+..++..+.++|.+||+.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34456678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=309.88 Aligned_cols=239 Identities=26% Similarity=0.421 Sum_probs=191.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChhHHHHHHHHhh-----------------cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQ-----------------VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~~~~~ik~L~~-----------------~~~~ 409 (720)
....+|.+....|+|-|++|..|.+..-|..||||+|.... .-..++++++.|.. ..++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34568889999999999999999999999999999996432 22233444444432 3688
Q ss_pred EEEEEEeccCCCHHHHHHHhcC--CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhc
Q 005007 410 LYIYLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~--~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~ 486 (720)
+|||+|-+. ..|.++|++.+. .|....++.|+.||+.||..|-..||+|.||||.||||++. ..+||||||.|...
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999999996 899999987643 58889999999999999999999999999999999999875 57999999999766
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCcc--
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM-- 564 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~-- 564 (720)
..... ..+..+..|.|||+|.| -.|+...|+||+||+||||+||+..|.+..+..++...+....++|..
T Consensus 588 ~enei-tPYLVSRFYRaPEIiLG-------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 588 SENEI-TPYLVSRFYRAPEIILG-------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccc-cHHHHHHhccCcceeec-------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 55433 34456778999999996 467889999999999999999999999877666554443222221110
Q ss_pred ----------------------------------------------------------CCHHHHHHHHHhhhcCCCCCCC
Q 005007 565 ----------------------------------------------------------LSSEGKDFLLRCFLRNPVERPS 586 (720)
Q Consensus 565 ----------------------------------------------------------ls~el~dLI~~cL~~dP~kRPT 586 (720)
+-.++++||.+||.+||++|+|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 0146789999999999999999
Q ss_pred HHHHHcCccccc
Q 005007 587 AVELLEHPFIRN 598 (720)
Q Consensus 587 a~ELL~Hpff~~ 598 (720)
..++|.||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999974
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=334.90 Aligned_cols=181 Identities=29% Similarity=0.493 Sum_probs=142.8
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCC-cHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~L-se~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
.+||-||||+...|.++|+.. ... ....+|++++||++||.|+|++|||||||||.||+|++++.|||+|||+|+...
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N-~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRN-HFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK 748 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhc-ccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence 479999999988888888653 222 478899999999999999999999999999999999999999999999998621
Q ss_pred -------------------CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC-CCc
Q 005007 488 -------------------GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEG 547 (720)
Q Consensus 488 -------------------~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~-~~~ 547 (720)
+.......+||.-|+|||++.+.. ...|+.++|||||||||+||+. ||.. .+.
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~----~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER 821 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS----SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER 821 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc----cccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence 011334578999999999997521 1368999999999999999996 4643 344
Q ss_pred HHHHHHHhccCCCCCcc----CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 548 PQAMFKVLNRTPPIPEM----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 548 ~~~i~ki~~~~~~iP~~----ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
...+.++..+..+.+.. --+.-..+|++||+.||.+||||.|||++.||.
T Consensus 822 a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 822 ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 44444444444443321 124557899999999999999999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.92 Aligned_cols=243 Identities=27% Similarity=0.458 Sum_probs=198.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh------------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~------------------~~~~lyLV 413 (720)
...+.+-+..||.|+||+|++..++.+|+..|||.|.....+.+..+.+..++. .++..+|.
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 344667778999999999999999999999999999876665444444443332 26778999
Q ss_pred EEeccCCCHHHHHHH----hcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 414 LEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 414 mEy~~gGsL~~~L~~----~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
||+|+ .+|..+.+. ....++|..+-.|..-++.||+||-+ .+||||||||+||||+..|.|||||||++..+.+
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99997 777665431 23579999999999999999999975 5999999999999999999999999999987766
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHhccCCCCC---c-
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRTPPIP---E- 563 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~~~~~~iP---~- 563 (720)
.-....-.|...|||||.+... ...|+.++||||||++|||+.||+.||...+. .+.+..+..+.+++- .
T Consensus 221 SiAkT~daGCrpYmAPERi~p~-----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPS-----DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHHhhhccCCccccChhccCCc-----cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence 5444556799999999998631 23588999999999999999999999987543 456666666655432 2
Q ss_pred --cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 564 --MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 564 --~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+..+..||..||.+|-.+||...+|++++|++...
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 3788999999999999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.67 Aligned_cols=237 Identities=27% Similarity=0.508 Sum_probs=192.4
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCc---E-EEEEEeccCCC--------ChhHHHHHHHHhh-----------
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---S-CAIKEVDIIPD--------DPKSAECIKQLEQ----------- 405 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~-VAVK~l~~~~~--------~~~~~~~ik~L~~----------- 405 (720)
+...-++-.++++||+|+||.||+|..+..+. . ||||..+.... ...+++++..|.+
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444566777999999999999998775432 3 89998875221 1123333444433
Q ss_pred cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.+..+|||||+|.||+|.++|++....++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+||||++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 35678999999999999999998766799999999999999999999999999999999999999999999999999876
Q ss_pred ccCccccccc-cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc--cCCCC
Q 005007 486 LTGLSYELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPI 561 (720)
Q Consensus 486 ~~~~~~~~t~-~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~--~~~~i 561 (720)
.......... .--..|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|+. ...+.
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~-------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNT-------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred CcceeeccccccCcceecChhhhcc-------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 5422111111 13457999999973 478999999999999999999 8999999999988888853 34566
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
|...+.++..++.+||..||++|+|+.++.+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 7788999999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.65 Aligned_cols=232 Identities=27% Similarity=0.448 Sum_probs=176.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh--------------cCC-EEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ--------------VDD-HLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~--------------~~~-~lyLVmE 415 (720)
.+.|....+||+|+||.||+|.... |..||||++..... ..+...++..+.. ..+ +.+||+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 4678888999999999999998765 48999998876544 2333333333332 134 5899999
Q ss_pred eccCCCHHHHHHHhcC-CCcHHHHHHHHHHHHHHHHHHHhCC---CcccccCCCceeecCCCCeeeeccccchhccC-cc
Q 005007 416 YVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN---TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 490 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIL~gL~yLHs~g---IVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~ 490 (720)
||.+|+|.++|..... .++|....+|+.++++||+|||+.. |||||||+.|||||++.+.||+|||+|+.... ..
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999987655 8999999999999999999999853 99999999999999999999999999976654 33
Q ss_pred ccccc-cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC--cH----HHHHHHhcc------
Q 005007 491 YELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--GP----QAMFKVLNR------ 557 (720)
Q Consensus 491 ~~~t~-~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~--~~----~~i~ki~~~------ 557 (720)
...+. .||.+|+|||++.. ...+.++|||||||+|.||++|+.+..... .. +.....+..
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~-------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYAST-------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred ceeeecCCCCccCChhhhcc-------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 33333 89999999999873 468889999999999999999998876432 11 111111111
Q ss_pred -CCCCC-ccCC--HH---HHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 558 -TPPIP-EMLS--SE---GKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 558 -~~~iP-~~ls--~e---l~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+.+. .... .+ +..+..+|++.+|++||++.|+++
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11111 1222 23 446777999999999999999754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=320.90 Aligned_cols=232 Identities=27% Similarity=0.497 Sum_probs=193.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCC------hhHHHHHHHHhh-----------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDD------PKSAECIKQLEQ-----------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~------~~~~~~ik~L~~-----------~~~~ 409 (720)
...+.+..+.||+|+||+||+|+.. .+...||||.++..... .++++.+..|++ .++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456678899999999999999743 24467999999865443 233344444443 3678
Q ss_pred EEEEEEeccCCCHHHHHHHhc---------CC----CcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCee
Q 005007 410 LYIYLEYVHPGSINRYVREHC---------RD----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~---------~~----Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VK 476 (720)
+|||+|||..|||.++|+-+. .. |+..+...|+.||+.||+||-++.+|||||-..|+||.++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 999999999999999997432 12 88899999999999999999999999999999999999999999
Q ss_pred eeccccchhccCcccccccc---CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHH
Q 005007 477 LADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552 (720)
Q Consensus 477 L~DFGlA~~~~~~~~~~t~~---GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ 552 (720)
|+||||++..-..++..... --..||+||.|. ..+|+.++||||+||||||+++ |+.||.+..+.+.+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 99999999775544433211 135799999998 3679999999999999999998 999999999999999
Q ss_pred HHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 005007 553 KVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590 (720)
Q Consensus 553 ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~EL 590 (720)
.+..+ ...-|+.++.++.+||..||+.+|++||++.||
T Consensus 717 ~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 717 CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 98765 467789999999999999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=268.28 Aligned_cols=223 Identities=37% Similarity=0.673 Sum_probs=180.8
Q ss_pred CCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh--------------cCCEEEEEEEeccCCCHHHHHHH
Q 005007 366 TFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ--------------VDDHLYIYLEYVHPGSINRYVRE 428 (720)
Q Consensus 366 ~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~--------------~~~~lyLVmEy~~gGsL~~~L~~ 428 (720)
+||.||+|.+..+|+.||+|++....... ....+++.+.. .....+++|||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999999999999999987543321 11222222211 24678999999999999999976
Q ss_pred hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChHHHH
Q 005007 429 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 508 (720)
Q Consensus 429 ~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~ 508 (720)
. ..+++..++.++.+|+.+|.|||+.+|+|+||+|.||+++.++.++|+|||++.............++..|++||.+.
T Consensus 81 ~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 81 R-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred c-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 4 348999999999999999999999999999999999999999999999999998776554445667899999999986
Q ss_pred HhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh-ccCCCCCcc---CCHHHHHHHHHhhhcCCCCC
Q 005007 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPEM---LSSEGKDFLLRCFLRNPVER 584 (720)
Q Consensus 509 g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~-~~~~~iP~~---ls~el~dLI~~cL~~dP~kR 584 (720)
+ ..++.++|||+||+++|+|++|..||........+...+ ......... ++.++.++|.+||..+|++|
T Consensus 160 ~-------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 160 G-------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred c-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 2 456779999999999999999999998744444444433 333333322 88999999999999999999
Q ss_pred CCHHHHHcCccc
Q 005007 585 PSAVELLEHPFI 596 (720)
Q Consensus 585 PTa~ELL~Hpff 596 (720)
|++.++++|+||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.98 Aligned_cols=242 Identities=27% Similarity=0.479 Sum_probs=194.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------------HHHHHHHHhh------------cCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------------SAECIKQLEQ------------VDD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------------~~~~ik~L~~------------~~~ 408 (720)
.++|-++.+||+|||+.||+|.|....+.||||+-.+..+-.. +.++.+.|.+ ..+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3578899999999999999999999999999998765443211 1122222222 246
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC--CCcccccCCCceeec---CCCCeeeeccccc
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVD---ASGVVKLADFGMA 483 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~--gIVHRDIKP~NILLd---~~g~VKL~DFGlA 483 (720)
.+|-|+|||+|.+|..||+.+ +.++|.+++.|+.||+.||.||.+. .|||-||||.||||- ..|.+||+||||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 689999999999999999876 7799999999999999999999976 699999999999994 4579999999999
Q ss_pred hhccCcccc--------ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHH--
Q 005007 484 KHLTGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-- 553 (720)
Q Consensus 484 ~~~~~~~~~--------~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~k-- 553 (720)
+.+.+..+. ....||.||++||.+.- ....++++.++||||+|||+|..|+|+-||........+..
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvV---gkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVV---GKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeec---CCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 998765443 23569999999998863 22257899999999999999999999999986543332221
Q ss_pred -Hhc-cCCCCC--ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 554 -VLN-RTPPIP--EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 554 -i~~-~~~~iP--~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
|++ ....+| ..++.++++||++||+.--++|....+|-.||||..
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 222 223333 468999999999999999999999999999999853
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=310.92 Aligned_cols=226 Identities=30% Similarity=0.546 Sum_probs=181.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC------hhHHHHHHHHhh---------c--------CCEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQLEQ---------V--------DDHL 410 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~------~~~~~~ik~L~~---------~--------~~~l 410 (720)
.-|...+.||+|+||.||+++++++|+.||||.++..... ..++++++.|.. . .+.-
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 5788899999999999999999999999999988754321 123344444432 1 2335
Q ss_pred EEEEEeccCCCHHHHHHH--hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC--CC--Ceeeeccccch
Q 005007 411 YIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SG--VVKLADFGMAK 484 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~--~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~--~g--~VKL~DFGlA~ 484 (720)
.+|||||.||||+.+|++ ++..|+|.++..++..+..||.|||++|||||||||.||++-. +| .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 799999999999999974 3457999999999999999999999999999999999999843 23 58999999999
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH----HHHHHhcc---
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNR--- 557 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~----~i~ki~~~--- 557 (720)
.+.++....++.||+.|++||++.. ..+|+..+|.|||||++|+++||..||....+.. .+..++.+
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999998899999999999999873 3678999999999999999999999997654442 34433321
Q ss_pred ------------------CCCCCccCCHHHH----HHHHHhhhcCCCCCC
Q 005007 558 ------------------TPPIPEMLSSEGK----DFLLRCFLRNPVERP 585 (720)
Q Consensus 558 ------------------~~~iP~~ls~el~----dLI~~cL~~dP~kRP 585 (720)
..++|..++..+. ..|..+|..++++|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1233445555444 567788999999998
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=301.92 Aligned_cols=236 Identities=27% Similarity=0.459 Sum_probs=194.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCC-Cc--EEEEEEeccCCCCh------hHHHHHHHHhh----------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRET-GA--SCAIKEVDIIPDDP------KSAECIKQLEQ----------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~t-g~--~VAVK~l~~~~~~~------~~~~~ik~L~~----------~~~~lyLV 413 (720)
.++.+++++||+|.||+|++|.|+.. |+ .||||.++...... .++..+..|++ .+..+.||
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV 188 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMV 188 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHH
Confidence 35678889999999999999988763 33 48999987654332 22222222322 23556789
Q ss_pred EEeccCCCHHHHHHH-hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 414 LEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||++++|+|.+.|++ ....|-...+..|+.||+.||.||..+++|||||-..||||.....|||+||||.+.+......
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999999987 4567889999999999999999999999999999999999999999999999999988765544
Q ss_pred ccccC----CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCC
Q 005007 493 LSLKG----SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566 (720)
Q Consensus 493 ~t~~G----Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls 566 (720)
..+.+ -..|+|||.|+ ...++.++|||++||+||||++ |.-||.+.....++.+|-. ...+-|+.++
T Consensus 269 Yvm~p~rkvPfAWCaPEsLr-------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs 341 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLR-------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS 341 (1039)
T ss_pred eEecCCCcCcccccCHhHhc-------cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence 33322 34799999997 4678999999999999999998 9999999999988888863 3567789999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
+++.++++.||..+|.+|||+..|.+.-+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 99999999999999999999999865433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-33 Score=283.86 Aligned_cols=238 Identities=28% Similarity=0.453 Sum_probs=183.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHh---h---------c-------CCEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLE---Q---------V-------DDHLY 411 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~---~---------~-------~~~ly 411 (720)
+.+-.+-||-|+||+||.+.|..+|+.||+|++..... ..+....++.|- + . -..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34455789999999999999999999999997642211 111112222211 1 0 12468
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
+|.|+|. .+|.++|..- ..++.+.++-+++||++||+|||+.+|+||||||.|+|++.+..+||||||+++......
T Consensus 134 V~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8899996 8888888654 679999999999999999999999999999999999999999999999999998654332
Q ss_pred -ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh--------------
Q 005007 491 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-------------- 555 (720)
Q Consensus 491 -~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~-------------- 555 (720)
.+...+.|.+|+|||++.| ...|+.++||||+|||+.|||..+..|...+..+.+..|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMG------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMG------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hhhHHHHHHHHhccHHHhhc------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 2223456899999999997 4568889999999999999999999997766555544432
Q ss_pred ---------ccCCCCCc-----------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 556 ---------NRTPPIPE-----------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 556 ---------~~~~~iP~-----------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+...-|. .-..+..+++..+|..||++|++.++.+.|++.....
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11122221 2345788999999999999999999999999986544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=271.76 Aligned_cols=237 Identities=24% Similarity=0.438 Sum_probs=189.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhc-----------------CCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV-----------------DDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~-----------------~~~lyLVm 414 (720)
..++|++.+++|+|-|+.||.|.+..+.+.++||+++.... .+..++++.|+.. .....||+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 35689999999999999999999999999999999975432 2334444444432 23457889
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~~~~~~~~ 493 (720)
||+++.+...+. ..|+..+|+.++.|||.||.|||++||+|||+||.|++||.. -.++|+|+|+|..+.......
T Consensus 115 E~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 115 EYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 999988876655 448899999999999999999999999999999999999864 579999999999887766666
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCC-CCCCcHHHHHHHhc------------c-CC
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLN------------R-TP 559 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF-~~~~~~~~i~ki~~------------~-~~ 559 (720)
..+.+.+|--||++.. ...|+..-|+|||||+|..|+..+-|| .+.++.+.+.+|.. + ..
T Consensus 191 VRVASRyfKGPELLVd------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred eeeehhhcCCchheee------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 6678999999999974 345778999999999999999988776 45555555444421 0 00
Q ss_pred CCC------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 560 PIP------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 560 ~iP------------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.++ .-.++++.|||.++|..|-.+|+|+.|++.||||...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 010 1146899999999999999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=298.71 Aligned_cols=242 Identities=33% Similarity=0.568 Sum_probs=200.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------------hHHHHHHHHhh--cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------------KSAECIKQLEQ--VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------------~~~~~ik~L~~--~~~~lyLVmE 415 (720)
.+.+|.++..+|.|+||.||+|+|+.+++..|||+|++...+. +..+++.++.. .++.++|+||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3568999999999999999999999999999999998654321 11122222222 2577999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-cccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t 494 (720)
||.||+|.+.-.- .+.++|.++..+.++.++||+|||++|=+|||||..|||+++.|.|||+|||.+-.+.. -.....
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 9999999987654 47899999999999999999999999999999999999999999999999999876643 334567
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC-----CccCCHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-----PEMLSSEG 569 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i-----P~~ls~el 569 (720)
+.||++|||||+..-.. ...|...+|||++|++..||-.-.+|.-+.-....++.+-+..++- +..+++.+
T Consensus 172 fiGtpywmapEvaaver----kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVER----KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred ccCCccccchhHHHHHh----cccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 89999999999976322 3458889999999999999999999987777767666655443333 34688999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
-+|++.+|.++|++|||++.+|+|+|+..
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeecc
Confidence 99999999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=277.83 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=186.4
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----Chh---HHHHHHHHhh-----------------c
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPK---SAECIKQLEQ-----------------V 406 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~---~~~~ik~L~~-----------------~ 406 (720)
....+|..++.+|.|.- .|..|.|..+++.||+|++-.... .+. +..+...+.+ .
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34569999999999999 888999999999999997743321 111 1222222221 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
...+|+|||||. .+|...+.. .++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 345799999997 889888863 4888999999999999999999999999999999999999999999999999876
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--------
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------- 558 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-------- 558 (720)
...-....++.|.+|.|||++.+. .|...+||||+||++.||++|+..|.+.+..+...++....
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred CcccccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 554455668899999999999862 37789999999999999999999998766655555443100
Q ss_pred -------------------C----CCCcc-----------CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 559 -------------------P----PIPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 559 -------------------~----~iP~~-----------ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
. .+|+. -...++|++.+||..||++|++++++|+|||++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 01111 135678999999999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=302.55 Aligned_cols=234 Identities=26% Similarity=0.473 Sum_probs=196.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChh------HHHHHHHHhh-----------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPK------SAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~------~~~~ik~L~~-----------~~~~lyL 412 (720)
.+...+.++||.|.||.||+|+.+..|+ .||||.++..-.+.. ++-++-++.+ ....+.|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456889999999999999999988774 599999985433222 2223333332 1345789
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|.|||++|+|+.+|+++.+.|+..++.-+++.|+.||+||-++++|||||-..||||+.+..+|++||||++.+.+..
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 999999999999999998999999999999999999999999999999999999999999999999999999775543
Q ss_pred ccccccC--CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 491 YELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 491 ~~~t~~G--Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
...+..| -..|.|||.|. ..+++.++||||+|+||||.+. |..||.+..+.+.+..|..+ ..+-|..++
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa-------~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred cccccCCccceeecChhHhh-------hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCc
Confidence 1222223 35899999997 4679999999999999999776 99999999999998888754 566678899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+..|+..||++|-.+||.+.||+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=284.47 Aligned_cols=118 Identities=22% Similarity=0.423 Sum_probs=95.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhh---------------------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQ--------------------- 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~--------------------- 405 (720)
....+|.+.++||.|-|++||+|+|..+.+.||+|+++-.... ..++.+++.+..
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 3447999999999999999999999999999999999743321 122333333222
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHH-hcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceee
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLV 469 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILL 469 (720)
...++|||+|++ |-.|..+|+. .++.++...|+.|++|||.||.|||. .||||.||||+||||
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 145799999999 6778888764 46789999999999999999999996 599999999999998
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=281.88 Aligned_cols=235 Identities=28% Similarity=0.396 Sum_probs=187.8
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhh--------------cCCEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~--------------~~~~lyL 412 (720)
+..++...++++||+|-||.|.+|.-. .+..||||.++....... ...+++.|.+ .++.++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 445567889999999999999999854 479999999986543322 2233344433 2677899
Q ss_pred EEEeccCCCHHHHHHHhcCC-CcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 413 YLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~-Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||||++|+|.++|..+... +.......|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++.+....+
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999999876333 34455667999999999999999999999999999999999999999999997654433
Q ss_pred ccc---ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc--CCCCCCCCCcHHHHHHHhc--------cC
Q 005007 492 ELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSEFEGPQAMFKVLN--------RT 558 (720)
Q Consensus 492 ~~t---~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT--Gk~PF~~~~~~~~i~ki~~--------~~ 558 (720)
... .+--..|||+|.|.- .+++.++|||+||++|||+++ ...||....+++.+.+... ..
T Consensus 693 y~vqgr~vlpiRwmawEsill-------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHh-------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence 321 223568999999873 578999999999999999865 7889998887777666532 13
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 559 ~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+..|..++.++.++|.+||..+-++||+++++-.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 3457789999999999999999999999999854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=288.34 Aligned_cols=230 Identities=27% Similarity=0.522 Sum_probs=191.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCC--Cc--EEEEEEeccCCCChhHHH------HHHHHhh----------cCCEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRET--GA--SCAIKEVDIIPDDPKSAE------CIKQLEQ----------VDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~t--g~--~VAVK~l~~~~~~~~~~~------~ik~L~~----------~~~~lyLVm 414 (720)
...+.++||+|-||.||+|....- |+ -||||..+......+... +++.+.+ .+..++|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 345567999999999999975432 33 488998775432222111 1222222 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+++.|.|..||+.+...|+......|+.||..||.|||+...|||||-..|||+....-|||+|||+++.+.+..+...
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999999888776665
Q ss_pred ccC--CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHH
Q 005007 495 LKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 570 (720)
Q Consensus 495 ~~G--Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~ 570 (720)
..| -.-|||||-+. -..++.++|||-|||+|||+|. |.-||.+..+.+.+..+.+ ...+.|+.|++.+.
T Consensus 550 S~~kLPIKWmaPESIN-------fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESIN-------FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred cccccceeecCccccc-------hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 555 34699999986 3578999999999999999887 9999999888888777764 46789999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHH
Q 005007 571 DFLLRCFLRNPVERPSAVELL 591 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL 591 (720)
.|+.+||+.+|.+||++.||.
T Consensus 623 slmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHhccCcccCCcHHHHH
Confidence 999999999999999987653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=313.98 Aligned_cols=224 Identities=21% Similarity=0.368 Sum_probs=168.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhh-----------cCCEEEEEEEeccCCCH
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQ-----------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~-----------~~~~lyLVmEy~~gGsL 422 (720)
.|...++||+|+||+||+|+++.++..||||+++..... ..+++.+..+.+ .++..|+||||+++|+|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 355667899999999999999999999999988654322 222333433332 24567999999999999
Q ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH---hCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCC
Q 005007 423 NRYVREHCRDITESIVRNFTRHILNGLAYLH---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499 (720)
Q Consensus 423 ~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH---s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp 499 (720)
.++++. +++..+..|+.||++||+||| +.+|+||||||+|||++.++..++. ||....... .....||+
T Consensus 771 ~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~ 842 (968)
T PLN00113 771 SEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISS 842 (968)
T ss_pred HHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccc
Confidence 999953 889999999999999999999 6799999999999999998888876 666543322 12346899
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHH-hcc-------CCCC------
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKV-LNR-------TPPI------ 561 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki-~~~-------~~~i------ 561 (720)
.|||||++.+ ..++.++|||||||++|||++|+.||..... ....... ... .+.+
T Consensus 843 ~y~aPE~~~~-------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 843 AYVAPETRET-------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred cccCcccccC-------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 9999998762 4588899999999999999999999853211 1111110 000 0111
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11122357789999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=254.86 Aligned_cols=205 Identities=25% Similarity=0.453 Sum_probs=166.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh------------------cCCEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------------VDDHLY 411 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~------------------~~~~ly 411 (720)
+...+....+..||+|+||+|-+.++..+|...|+|.+..........+.+..+.- .+..++
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33445667788999999999999999999999999999866555555555555442 256789
Q ss_pred EEEEeccCCCHHHHHH---HhcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 412 IYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~---~~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
|.||.|. .+|..+-+ ++++.++|..+-+|+.-++.||+|||++ .|||||+||.||||+.+|+|||||||++-.+.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999997 78877764 3467899999999999999999999986 89999999999999999999999999998776
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC-CcHHHHHHHhccC
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRT 558 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~-~~~~~i~ki~~~~ 558 (720)
+.-....-.|...|||||.+..... ...|+.++||||||+++.||.+++.||... ...+.+.+++...
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n---~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELN---QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccC---cccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 5443333568899999999975432 336999999999999999999999999764 4445666666543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=278.83 Aligned_cols=238 Identities=25% Similarity=0.454 Sum_probs=193.3
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh-----------cCCEEEE
Q 005007 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~-----------~~~~lyL 412 (720)
.++..+.+..+-.+||-|.||.||.|++++-.-.||||.++.+....+ +..+++.+.+ .+-.+||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 344455667778899999999999999999999999998876543322 2223333322 2566999
Q ss_pred EEEeccCCCHHHHHHHhcC-CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 413 YLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|.|||..|.|.+||++..+ .++.-.+.+++.||..||+||..+++|||||-..|+|+.++..|||+||||++.+.+..+
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999999987543 356667778899999999999999999999999999999999999999999999887655
Q ss_pred ccc--ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCH
Q 005007 492 ELS--LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSS 567 (720)
Q Consensus 492 ~~t--~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~ 567 (720)
..- ..--.-|.|||-|. ...++.++|||+|||+|||+.| |..||.+.+..+.+..+.+ ....-|+.|++
T Consensus 421 TAHAGAKFPIKWTAPEsLA-------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLA-------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP 493 (1157)
T ss_pred ecccCccCcccccCccccc-------ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence 432 22345799999886 2468889999999999999988 9999999877666554443 34567999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+.+||+.||+++|.+||++.|+-+
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHH
Confidence 9999999999999999999999843
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=289.18 Aligned_cols=237 Identities=27% Similarity=0.476 Sum_probs=187.2
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEEC---C----CCcEEEEEEeccCCCChhHHH---HHHHHhh-------------
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR---E----TGASCAIKEVDIIPDDPKSAE---CIKQLEQ------------- 405 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~---~----tg~~VAVK~l~~~~~~~~~~~---~ik~L~~------------- 405 (720)
.+...++..+.+.||+|.||.|++|... . ....||||.++.......... +++.+..
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444455577889999999999999633 1 145699999886655422222 2222211
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCcee
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NIL 468 (720)
.++.+++|+||+..|+|..+|+... ..|+..++..++.||+.||+||++.++|||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 2467999999999999999998764 24899999999999999999999999999999999999
Q ss_pred ecCCCCeeeeccccchhccCccccc--cccCCC--CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCC
Q 005007 469 VDASGVVKLADFGMAKHLTGLSYEL--SLKGSP--NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 543 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~~~~~~~~--t~~GTp--~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~ 543 (720)
|..+..+||+|||+|+......... .-.|+. .|||||.+. ...|+.++||||+||+||||++ |..||.
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-------~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-------DRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-------cCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999665443332 122333 399999997 3678999999999999999999 999999
Q ss_pred CCC-cHHHHHHHh-ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 544 EFE-GPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 544 ~~~-~~~~i~ki~-~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.. ..+.+..+. +.....|..+++++.++++.||..+|++||++.|+.+
T Consensus 524 ~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 524 GIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 866 334433333 3356889999999999999999999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.14 Aligned_cols=239 Identities=27% Similarity=0.473 Sum_probs=182.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCCCChhHHHHHHHHhh---------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQ---------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~---tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------~~~~lyLV 413 (720)
..+.|...++||+|.|++||+|.+.. .++.||+|.+.....-.....++..|.. .++.+.+|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 44679999999999999999999887 7889999988766544444444444432 47889999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchhcc-----
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLT----- 487 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~----- 487 (720)
|||++.-+..+++.. ++..+++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|....
T Consensus 114 lp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 999998888887744 778999999999999999999999999999999999975 4788999999996210
Q ss_pred ------------C-----------------cc-----------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccc
Q 005007 488 ------------G-----------------LS-----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 527 (720)
Q Consensus 488 ------------~-----------------~~-----------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWS 527 (720)
. .. ......||++|+|||++... +.-+.++||||
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~------~~QttaiDiws 263 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC------PRQTTAIDIWS 263 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc------cCcCCccceee
Confidence 0 00 00124499999999999863 45677999999
Q ss_pred hhhhHHHHhcCCCCCCCC-CcHHHHHH---Hhc-----------cC------C---CC----------------------
Q 005007 528 LGCTVIEMLTGKPPWSEF-EGPQAMFK---VLN-----------RT------P---PI---------------------- 561 (720)
Q Consensus 528 LG~vLyELLTGk~PF~~~-~~~~~i~k---i~~-----------~~------~---~i---------------------- 561 (720)
.|||+.-+++++.||-.. ++...+.. |++ +. . .+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 999999999999998421 11111111 110 00 0 00
Q ss_pred ------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 562 ------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 562 ------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
-+..+..+.||+.+||..||.+|+|++++|+||||....
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 012345788999999999999999999999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=281.41 Aligned_cols=232 Identities=29% Similarity=0.472 Sum_probs=188.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCCCChhHHHHHHHHhh----------------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQ----------------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~----~VAVK~l~~~~~~~~~~~~ik~L~~----------------~~~~lyLV 413 (720)
...+++++||.|+||+||+|.+.-.|+ +||||++..........+++.+... ....+.||
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlv 775 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLV 775 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHH
Confidence 356778999999999999998865554 5888887654443333333322111 12346789
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
++|+++|.|.++++.+...+.-.....|..||++||.|||++++|||||-..||||..-..|||.|||+++.+.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 99999999999999998999999999999999999999999999999999999999999999999999999887654443
Q ss_pred cccC---CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHh-ccCCCCCccCCHH
Q 005007 494 SLKG---SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSE 568 (720)
Q Consensus 494 t~~G---Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~-~~~~~iP~~ls~e 568 (720)
...| -+-|||-|.+. ...|+.++||||+||++|||+| |.-||.+....++-..+. +.....|..++-+
T Consensus 856 ~~~~gK~pikwmale~i~-------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIR-------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTID 928 (1177)
T ss_pred cccccccCcHHHHHHHhh-------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHH
Confidence 3322 45688888876 4689999999999999999999 999999877655444332 3456778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+..+|.+||..|+..||+++++..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 999999999999999999998864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=286.23 Aligned_cols=229 Identities=29% Similarity=0.449 Sum_probs=170.9
Q ss_pred eeEEeecCCe-EEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh---------------cCCEEEEEEEeccCCCH
Q 005007 359 GKLIGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------VDDHLYIYLEYVHPGSI 422 (720)
Q Consensus 359 ~k~LG~G~fG-~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------~~~~lyLVmEy~~gGsL 422 (720)
.+++|.|+-| .||+|... |+.||||.+-.... .-..+++..|.+ .++.+||.+|.|. -+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~-~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF-DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH-HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 3578999887 57999764 88999996642211 112233333332 3567899999997 799
Q ss_pred HHHHHHhcCC---CcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---C--CCeeeeccccchhccCcc----
Q 005007 423 NRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---S--GVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 423 ~~~L~~~~~~---Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~--g~VKL~DFGlA~~~~~~~---- 490 (720)
.+++...... ......+.++.|++.||.+||+.+||||||||.||||+. + ..++|+|||+++.+..+.
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 9999763111 111456788999999999999999999999999999975 3 479999999999886543
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHHHhccCCCCC---ccCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPIP---EMLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~ki~~~~~~iP---~~ls 566 (720)
...+..||-+|+|||++.... -..++||||||||+|+.++| ..||.+.- +.-.+|+.+...+- ....
T Consensus 670 r~s~~sGt~GW~APE~L~~~~-------~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDR-------KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred cccCCCCcccccCHHHHhccc-------cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCch
Confidence 234567999999999998532 24489999999999999985 99997632 23334554443321 1112
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+++|||.+||..+|..||+|.++|.||||.+..
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 2899999999999999999999999999997543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=295.46 Aligned_cols=182 Identities=20% Similarity=0.268 Sum_probs=138.4
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC----------------
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---------------- 471 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---------------- 471 (720)
..++++|||+ +++|.++|......+++..++.|++||++||.|||++|||||||||+||||+.
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4678889988 57999999765567999999999999999999999999999999999999954
Q ss_pred ---CCCeeeeccccchhccCcc-----------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhh
Q 005007 472 ---SGVVKLADFGMAKHLTGLS-----------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 531 (720)
Q Consensus 472 ---~g~VKL~DFGlA~~~~~~~-----------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~v 531 (720)
++.+||+|||+++...... .....+||++|||||++.+ ..|+.++|||||||+
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~sDVwSlGvi 204 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-------SSSNCASDVYRLGVL 204 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-------CCCCchhhhhhHHHH
Confidence 4456677777765421100 0112468999999999873 457889999999999
Q ss_pred HHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 532 VIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 532 LyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
||||++|.+|+.... ..+..+.... +........+..+++.+||..+|.+||++.|+|+||||...
T Consensus 205 L~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 205 LFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 999999999876422 1222221111 11111124567799999999999999999999999999753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=267.09 Aligned_cols=231 Identities=23% Similarity=0.336 Sum_probs=173.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-------------ChhHHHHHHHHhh------cCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-------------DPKSAECIKQLEQ------VDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-------------~~~~~~~ik~L~~------~~~~lyLVmE 415 (720)
..++.++||+|.||.||+|+.. ++.||||++..... ..+...+++++-. ..-.++||+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4577889999999999999765 69999998853211 0111122222221 1236899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC---------CCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---------NTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~---------gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
|.+.|+|.+||+.+ .+++....+++.-|++||.|||+. .|+|||||..||||..|+...|+|||||..+
T Consensus 289 fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999999774 699999999999999999999962 6999999999999999999999999999887
Q ss_pred cCc---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCC------------CCCCC----CCc
Q 005007 487 TGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK------------PPWSE----FEG 547 (720)
Q Consensus 487 ~~~---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk------------~PF~~----~~~ 547 (720)
... ......+||..|||||+|.|...... ...=.+.||||+|.|||||++.. .||.. ...
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 532 23334779999999999998765442 23335799999999999998753 23331 111
Q ss_pred HHHHHHH---hccCCCCCccC-----CHHHHHHHHHhhhcCCCCCCCHHHH
Q 005007 548 PQAMFKV---LNRTPPIPEML-----SSEGKDFLLRCFLRNPVERPSAVEL 590 (720)
Q Consensus 548 ~~~i~ki---~~~~~~iP~~l-----s~el~dLI~~cL~~dP~kRPTa~EL 590 (720)
.+.+... .+..+.+|+.+ -.-+++.|.-||+.|++-|.|+.=+
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2223322 24567777654 3567899999999999999998643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=227.43 Aligned_cols=196 Identities=38% Similarity=0.657 Sum_probs=163.0
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hhHHHHHHHHhh--------------cCCEEEEEEEeccCCCHHH
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQ--------------VDDHLYIYLEYVHPGSINR 424 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~~~~~ik~L~~--------------~~~~lyLVmEy~~gGsL~~ 424 (720)
||+|.+|.||+|.+..+++.++||++...... ....+++..+.. .....+++|||+.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998865442 222223332222 1357899999999999999
Q ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchhccCcc-ccccccCCCCCC
Q 005007 425 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWM 502 (720)
Q Consensus 425 ~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~~~-~~~t~~GTp~Ym 502 (720)
++......+++..++.++.+++++|.|||++|++|+||+|.||+++. ++.++|+|||.+....... ......+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 99764346899999999999999999999999999999999999999 8999999999997664432 123355788999
Q ss_pred ChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCC
Q 005007 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPV 582 (720)
Q Consensus 503 APEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~ 582 (720)
+||.+... ..++.+.|+|+||+++|+| ..+.++|..||..+|.
T Consensus 161 ~pe~~~~~------~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~ 203 (215)
T cd00180 161 APEVLLGK------GYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPE 203 (215)
T ss_pred ChhHhccc------CCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcc
Confidence 99998631 2567899999999999999 6789999999999999
Q ss_pred CCCCHHHHHcCc
Q 005007 583 ERPSAVELLEHP 594 (720)
Q Consensus 583 kRPTa~ELL~Hp 594 (720)
+||++.++++|+
T Consensus 204 ~R~~~~~l~~~~ 215 (215)
T cd00180 204 KRPSAKEILEHL 215 (215)
T ss_pred cCcCHHHHhhCC
Confidence 999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=236.05 Aligned_cols=160 Identities=29% Similarity=0.331 Sum_probs=130.7
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp 499 (720)
|+|.+++.++...+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 7899999876677999999999999999999999998 999999999999999 9998765442 236899
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhccCCC-------CCccCCH--HH
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP-------IPEMLSS--EG 569 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~~~~-------iP~~ls~--el 569 (720)
.|||||++.+ ..++.++|||||||++|||++|+.||...... ..+..+...... .+..++. ++
T Consensus 69 ~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 69 YFMAPEVIQG-------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred cccChHHhcC-------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 9999999973 45788999999999999999999999765432 223333322211 1223344 69
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+++|.+||..||++||++.|+++|+|+..
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=257.58 Aligned_cols=235 Identities=25% Similarity=0.408 Sum_probs=178.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHH-----------Hhh------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQ-----------LEQ------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~-----------L~~------~~~~lyLV 413 (720)
..+.++.+.||+|.||.||+|.++ |+.||||++.-.... -++.++.+. +.. .-..++||
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 457899999999999999999998 999999998643211 122222221 111 12358999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~--------gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.+|.+.|+|+|||.. ..++.+...+++.-++.||.+||-. .|.|||||..||||..+|.+.|+|+|||..
T Consensus 288 TdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred eecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999999976 4699999999999999999999942 599999999999999999999999999976
Q ss_pred ccCcc-----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC----------CCCCCCC----C
Q 005007 486 LTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEF----E 546 (720)
Q Consensus 486 ~~~~~-----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG----------k~PF~~~----~ 546 (720)
..... ..+..+||..|||||+|....+.+- ..--..+||||||.||||++.. ++||.+. .
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~-Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKH-FESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhh-hhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 64432 2345689999999999975443221 1112369999999999999752 5788653 3
Q ss_pred cHHHHHHHh---ccCCCCCccCC-----HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 547 GPQAMFKVL---NRTPPIPEMLS-----SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 547 ~~~~i~ki~---~~~~~iP~~ls-----~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..+.+.+++ +..+.+|..+. ..+..+|+.||..||.-|.|+-.|.+
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 445555553 44566676553 24567899999999999999887754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=227.08 Aligned_cols=199 Identities=35% Similarity=0.569 Sum_probs=157.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hhHHHHHHHHhh--------------cCCEEEEEEEecc
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~~~~~ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
|.+++.||.|+||+||+|.+..+++.+|||.+...... .....++..+.. ..+..++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999999999999998754322 111112222211 2367899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--cccccc
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLK 496 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~t~~ 496 (720)
+++|.+++......+++..+..++.+++.+|.|||+++++|+||++.||+++.++.++|+|||++....... ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 999999997653338999999999999999999999999999999999999999999999999998765542 334556
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC-CCcH-HHHHHHhccCCC
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGP-QAMFKVLNRTPP 560 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~-~~~~-~~i~ki~~~~~~ 560 (720)
++..|++||.+. +...++.++|||+||+++|||++|+.||.. .+.. .....+..+.+.
T Consensus 161 ~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 161 GTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred ccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 888999999984 134566799999999999999999999977 4444 444444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=241.48 Aligned_cols=241 Identities=22% Similarity=0.362 Sum_probs=185.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----------------ChhHHHHHHHHhhcCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----------------DPKSAECIKQLEQVDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----------------~~~~~~~ik~L~~~~~~lyLVm 414 (720)
..+.|.+.+.||+|.||++.+|.++.+...+++|.+....- +...+.......+.-+.++++|
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 34689999999999999999999999999999997753221 1122222233334567889999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec--CCCCeeeeccccchhccCcccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd--~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||++.|+|..-+.. ..+.|...+.++.|++.||+|||++++||||||.+||||- +...|||||||+.+..... .
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V 177 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--V 177 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--e
Confidence 99999999988865 4589999999999999999999999999999999999993 3348999999998654221 1
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHHHhc-cCCCCCc---c
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLN-RTPPIPE---M 564 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~ki~~-~~~~iP~---~ 564 (720)
....-+..|.+||+.... ..+.....+..|||.||+++|.+|||++||.... ......+..+ ..+..|. .
T Consensus 178 ~~~~~~~~y~~pe~~~~~--~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTV--VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred hhhhhhcccCCcHHHhhc--cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 122346679999998754 3445677889999999999999999999997321 1122333332 3445554 4
Q ss_pred CCHHHHHHHHHhhhcCCCCC---CCHHHHHcCccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRN 598 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kR---PTa~ELL~Hpff~~ 598 (720)
+++.+..+.++-|..++++| .++.......|.+.
T Consensus 256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 78999999999999999999 77777777777753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=257.50 Aligned_cols=183 Identities=25% Similarity=0.414 Sum_probs=153.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-------------CChhHHHHHHHHh--------------hc
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-------------DDPKSAECIKQLE--------------QV 406 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-------------~~~~~~~~ik~L~--------------~~ 406 (720)
.+|..++.||+|+||.|++|.+++....|+||.|.... .-+.++.++..|. +.
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46999999999999999999999999999999775321 1223344433333 34
Q ss_pred CCEEEEEEEecc-CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 407 DDHLYIYLEYVH-PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 407 ~~~lyLVmEy~~-gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
++++||+||--. |.+|+++|.-+ ..++|.+++.|++|++.|+++||++||||||||-+|+.++.+|-+||+|||.+..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 788999998753 56899999654 7899999999999999999999999999999999999999999999999999876
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 544 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~ 544 (720)
...+ ....++||..|.|||++.| ..+.+..-|||+||++||-++...-||.+
T Consensus 720 ~ksg-pfd~f~gtv~~aapevl~g------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSG-PFDVFVGTVDYAAPEVLGG------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCC-CcceeeeeccccchhhhCC------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 5543 3457889999999999975 56677889999999999999999999865
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=238.88 Aligned_cols=232 Identities=22% Similarity=0.351 Sum_probs=183.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCCCChhHHHHHHHHhh--------------------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQ-------------------- 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg-----~~VAVK~l~~~~~~~~~~~~ik~L~~-------------------- 405 (720)
..+.++++..++-+|.||.||.|.+++.. +.|-+|.++..... ++....|.+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~---iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ---IQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH---HHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34567899999999999999999776532 34556655533222 222222211
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHh-------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREH-------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~-------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
....-++++.++.-|+|..+|..- ...++..++..++.||+.||+|||.+||||.||...|++||+.-.|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 123456778899889999999721 234777788899999999999999999999999999999999999999
Q ss_pred eccccchhccCcccccc---ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHH
Q 005007 478 ADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553 (720)
Q Consensus 478 ~DFGlA~~~~~~~~~~t---~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~k 553 (720)
+|=.+++.+-+.+++.- ...-..||++|.+. +..|+.++|||||||+||||+| |+.||.+.+..+....
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-------n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-------NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHh-------hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 99999998765554321 11245699999998 4678999999999999999999 9999999888777666
Q ss_pred Hhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 554 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 554 i~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.+ ....|-++++++..++..||..+|++||+++|+..
T Consensus 511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 6543 56778999999999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=263.77 Aligned_cols=237 Identities=28% Similarity=0.483 Sum_probs=181.8
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC--CC---------------------ChhHHHHHHHHhhcCCEEEEE
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII--PD---------------------DPKSAECIKQLEQVDDHLYIY 413 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~--~~---------------------~~~~~~~ik~L~~~~~~lyLV 413 (720)
....++|.|+||.|+.+......+.++.|+.... .. ++...+.+..+.+.. ..+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-GILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-cchhh
Confidence 5668999999999999988877777777765421 11 111122222222222 23344
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc----
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 489 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---- 489 (720)
||||++ ||+.++... +.+...++..++.||+.||+|||+.||.|||||++|||+..+|.+||+|||.+..+...
T Consensus 400 mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999998 999999764 57999999999999999999999999999999999999999999999999999766432
Q ss_pred -cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH---------HHhccCC
Q 005007 490 -SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---------KVLNRTP 559 (720)
Q Consensus 490 -~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~---------ki~~~~~ 559 (720)
.....++|+..|+|||++.+ ..+....+||||.|++++.|++|+.||......+..+ ++..+..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTG------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred hhhhcCcccCCcCcCcccccc------cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 23456789999999999975 3455678999999999999999999997543332221 1111222
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 560 ~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
.+-..++.+.+.+|.+||+.||.+|+|+++||+.+||+.....
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 3334578889999999999999999999999999999976644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=210.16 Aligned_cols=238 Identities=33% Similarity=0.539 Sum_probs=182.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-----HHHHHHHHhh---------------cCCEEEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----SAECIKQLEQ---------------VDDHLYIYLE 415 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-----~~~~ik~L~~---------------~~~~lyLVmE 415 (720)
|.+.+.||.|+||.||++.+. ..+|+|.+........ ....+..+.. .....++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999987 7899998875443321 1111111111 1334699999
Q ss_pred eccCCCHHHHHHHhc--CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCcc--
Q 005007 416 YVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 416 y~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~-- 490 (720)
|+.+++|.+++.... ..+.+..+..++.||+.+|.|+|+.+++||||||+|||++..+ .++++|||+++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776543 2699999999999999999999999999999999999999988 79999999998655433
Q ss_pred -----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---H-HHHHHHhccCCC-
Q 005007 491 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---P-QAMFKVLNRTPP- 560 (720)
Q Consensus 491 -----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~-~~i~ki~~~~~~- 560 (720)
......||..|++||.+.+.. ...+....|+|++|++++++++|..||..... . .....+......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred ccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 235678999999999987410 14677899999999999999999999877653 2 333333333222
Q ss_pred CCccC--------CHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 561 IPEML--------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 561 iP~~l--------s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..... ...+.+++..++..+|..|.+..+...+.|.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 22111 15789999999999999999999999886665433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=225.85 Aligned_cols=231 Identities=25% Similarity=0.312 Sum_probs=177.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCC-cEEEEEEeccCCC-----ChhHHHHHHHHh----------------hcCCEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPD-----DPKSAECIKQLE----------------QVDDHLYI 412 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg-~~VAVK~l~~~~~-----~~~~~~~ik~L~----------------~~~~~lyL 412 (720)
+|++++.||+|+||.||+|.+..++ ..+|+|....... ...+..++..+. ..++.-||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998775 6788887654321 223344445554 13456799
Q ss_pred EEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-----CCeeeeccccch--
Q 005007 413 YLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-----GVVKLADFGMAK-- 484 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-----g~VKL~DFGlA~-- 484 (720)
||+.+ |.+|.++..... +.++..++..++.|++.+|++||+.|+|||||||+|+++... -.+.|+|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99999 799999886654 789999999999999999999999999999999999999755 369999999998
Q ss_pred hccCcc--------c-cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh
Q 005007 485 HLTGLS--------Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 555 (720)
Q Consensus 485 ~~~~~~--------~-~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~ 555 (720)
.+.... . ...+.||..|+++.+..+ ...+.+.|+||++.++.||+.|..||..........++.
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCC-------CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 432211 1 224569999999998874 456779999999999999999999998766443333332
Q ss_pred c---cCCC--CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 556 N---RTPP--IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 556 ~---~~~~--iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
. .... .....+.++.+++..+-..+..++|....+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1 1111 233456778888888888899999988877653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-25 Score=250.42 Aligned_cols=226 Identities=26% Similarity=0.446 Sum_probs=189.5
Q ss_pred EEeecCCeEEEEEE---ECCCCcEEEEEEeccCCCCh-------hHHHHHHHH------------hhcCCEEEEEEEecc
Q 005007 361 LIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDP-------KSAECIKQL------------EQVDDHLYIYLEYVH 418 (720)
Q Consensus 361 ~LG~G~fG~VYla~---d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L------------~~~~~~lyLVmEy~~ 418 (720)
.+|.|+||.|+++. -.+.|..+|+|+++...... .+..++... .+.+..+|++++|+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999874 34567889999876432111 111111111 134677899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GT 498 (720)
||+|...+.+. ..+.+..++.+...++-+++++|+.+|+|||+|++||+++.+|++|+.|||+.+........ |||
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence 99999998765 77999999999999999999999999999999999999999999999999999987654433 999
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 578 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~ 578 (720)
..|||||++.+ ...++|+||+|++++||++|..||.. +.+..|+...+.+|..++.++++++..++.
T Consensus 157 ~eymApEI~~g---------h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 157 YEYRAPEIING---------HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred hhhhhhHhhhc---------cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHh
Confidence 99999999973 45689999999999999999999988 777888888999999999999999999999
Q ss_pred cCCCCCCC-----HHHHHcCcccccccccC
Q 005007 579 RNPVERPS-----AVELLEHPFIRNANYQN 603 (720)
Q Consensus 579 ~dP~kRPT-----a~ELL~Hpff~~~~~~~ 603 (720)
++|..|.- +.|+++|+||+...+..
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 99999964 57999999999887763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=246.02 Aligned_cols=223 Identities=27% Similarity=0.469 Sum_probs=176.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhcCCEEEEEEEeccCCCHHHHHHHhc
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHC 430 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~~~~lyLVmEy~~gGsL~~~L~~~~ 430 (720)
+...+|..+|+|-.|+||-||+++++.+.+.+|+|+=+ ... +++.+...-++.+.| ||-..+++..
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l------ilRnilt~a~npfvv------gDc~tllk~~- 145 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL------ILRNILTFAGNPFVV------GDCATLLKNI- 145 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccc-cch------hhhccccccCCccee------chhhhhcccC-
Confidence 34568999999999999999999999999999995322 111 111122223344444 6666666443
Q ss_pred CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC----------------cccccc
Q 005007 431 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG----------------LSYELS 494 (720)
Q Consensus 431 ~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~----------------~~~~~t 494 (720)
+.++... +.+++|||..||+|||+||+|+||+.-|++||.|||+.+.... .-....
T Consensus 146 g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKq 217 (1205)
T KOG0606|consen 146 GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQ 217 (1205)
T ss_pred CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcc
Confidence 4455433 7799999999999999999999999999999999999875321 011234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc---cCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE---MLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~---~ls~el~d 571 (720)
++|||.|+||||+.. ..|+..+|+|++|+|+||.+.|+.||.+...++++..++.....+|+ .+.+|+++
T Consensus 218 vcgTPeyiaPeVilr-------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~d 290 (1205)
T KOG0606|consen 218 VCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQD 290 (1205)
T ss_pred ccCCccccChhhhhh-------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHH
Confidence 789999999999984 45888999999999999999999999998888888888877666664 47899999
Q ss_pred HHHHhhhcCCCCC---CCHHHHHcCccccccccc
Q 005007 572 FLLRCFLRNPVER---PSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 572 LI~~cL~~dP~kR---PTa~ELL~Hpff~~~~~~ 602 (720)
+|.++|+.+|..| ..+-++.+|.||+...|.
T Consensus 291 li~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 291 LIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 9999999999999 467899999999988776
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=202.24 Aligned_cols=231 Identities=23% Similarity=0.350 Sum_probs=183.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH---HHHHHh------------hcCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLE------------QVDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~---~ik~L~------------~~~~~lyLVm 414 (720)
.....+|++++.||.|+||.+|+|....+|..||||+-.....++.... +...|. ..+++-.+||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3456799999999999999999999999999999997766555554332 233332 2456678999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCcc-
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~- 490 (720)
|++ |-+|++++.--.+.++..++.-++.|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||+|+.+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 999 79999998655578999999999999999999999999999999999999853 3579999999999875432
Q ss_pred -------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhccCCC
Q 005007 491 -------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRTPP 560 (720)
Q Consensus 491 -------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~~~~ 560 (720)
......||..|.+--...+..+ +.+-|+-|+|.||.++.-|..||.+... .+.+.+|......
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eq-------SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQ-------SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhh-------hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 2234679999999887776443 4578999999999999999999987644 3445556555444
Q ss_pred CC-----ccCCHHHHHHHHHhhhcCCCCCCCHH
Q 005007 561 IP-----EMLSSEGKDFLLRCFLRNPVERPSAV 588 (720)
Q Consensus 561 iP-----~~ls~el~dLI~~cL~~dP~kRPTa~ 588 (720)
.| ..++.|+.-.|..|-..--++-|...
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 44 45788999999999888777777654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=212.10 Aligned_cols=229 Identities=23% Similarity=0.337 Sum_probs=178.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHH---HHHHhh------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~---ik~L~~------------~~~~lyLVmEy 416 (720)
..-.|++|++||+|.||++++|.+.-+++.||||.-....+.+....+ .+.|.. ...+-.||||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 345899999999999999999999999999999976655555544443 344332 22344689999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-----CCeeeeccccchhccCcc-
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-----GVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-----g~VKL~DFGlA~~~~~~~- 490 (720)
+ |-+|+|+..=-++.|+.+++..++.|++.-|+|+|++.+|.|||||+|+||... ..|.|+|||+|+.+.+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9 789999997666789999999999999999999999999999999999999643 479999999999886543
Q ss_pred -------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---CcHHHHHHHhccCCC
Q 005007 491 -------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---EGPQAMFKVLNRTPP 560 (720)
Q Consensus 491 -------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---~~~~~i~ki~~~~~~ 560 (720)
...+..||..||+--...|. .-+.+-|+-|||.|+.+.|-|.+||.+. ...+.+.+|-...-.
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGr-------EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGR-------EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred cccCccccccccccceeeeEeeccccc-------hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 23467799999998877753 3466899999999999999999999875 344555665433222
Q ss_pred CC-----ccCCHHHHHHHHHhhhcCCCCCCCHH
Q 005007 561 IP-----EMLSSEGKDFLLRCFLRNPVERPSAV 588 (720)
Q Consensus 561 iP-----~~ls~el~dLI~~cL~~dP~kRPTa~ 588 (720)
.| +.++.++...|+..-..+-.+-|..+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 22 45677777777776666666666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=222.65 Aligned_cols=173 Identities=17% Similarity=0.206 Sum_probs=122.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCCC----C------hhHHHHHHHHhh--------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPD----D------PKSAECIKQLEQ--------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~-tg~~VAVK~l~~~~~----~------~~~~~~ik~L~~--------~~~~lyL 412 (720)
...+|++++.||+|+||+||+|+++. +++.||||++..... . ..+.++++.+.. ..+..||
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L 95 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL 95 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence 34689999999999999999999886 678889998753211 1 122223333322 1245799
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCccccc-CCCceeecCCCCeeeeccccchhccCcc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDI-KP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
|||||+|++|.. +.. .. ...|+.||++||.|||++||+|||| ||+|||++.++.+||+|||+|+.+....
T Consensus 96 VmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 96 VRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred EEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 999999999973 211 11 1468899999999999999999999 9999999999999999999998654322
Q ss_pred --------ccccccCCCCCCChHHHHHhhhcCCCCCCCcccccc-chhhhHH
Q 005007 491 --------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW-SLGCTVI 533 (720)
Q Consensus 491 --------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVW-SLG~vLy 533 (720)
.....++++.|+|||++...... .....+...|-| .-|=+.|
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~-~~~~~~~~~dgW~~TGDlg~ 218 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTPRERK-ILARKSLPSRIWLATGKKVY 218 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCChhhhc-cccccccccCcEEeCCCEEE
Confidence 11356689999999998643221 223334456767 4443333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=206.41 Aligned_cols=224 Identities=23% Similarity=0.318 Sum_probs=145.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHh-----------------h----------
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLE-----------------Q---------- 405 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~-----------------~---------- 405 (720)
..+.+++.||.|+|++||.+.+.+||+.+|||++....+... ..+.++.-. .
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 357889999999999999999999999999998865542221 111111100 0
Q ss_pred ------------cCC------EEEEEEEeccCCCHHHHHHH---hcCC---CcHHHHHHHHHHHHHHHHHHHhCCCcccc
Q 005007 406 ------------VDD------HLYIYLEYVHPGSINRYVRE---HCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRD 461 (720)
Q Consensus 406 ------------~~~------~lyLVmEy~~gGsL~~~L~~---~~~~---Lse~~i~~i~~QIL~gL~yLHs~gIVHRD 461 (720)
.+. +.+++|+-+. ++|.+++.- .... +....-..+..|+++.+++||..||+|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 011 2367788885 888888642 2111 11222235568999999999999999999
Q ss_pred cCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhh-cCCCCCCCccccccchhhhHHHHhcCCC
Q 005007 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ-KDGNPKLALAVDIWSLGCTVIEMLTGKP 540 (720)
Q Consensus 462 IKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~-~~g~~~~s~asDVWSLG~vLyELLTGk~ 540 (720)
|||+|+|++.+|.++|+||+........... ...+..|.+||+...... ......++.+.|.|+||+++|.|.+|..
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999999887654332221 345678999998765311 0023457889999999999999999999
Q ss_pred CCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCC
Q 005007 541 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER 584 (720)
Q Consensus 541 PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kR 584 (720)
||............+.. .. .+++.+++||..+|+.||++|
T Consensus 249 Pf~~~~~~~~~~~~f~~---C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEWDFSR---CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGGGGTT---SS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccccchh---cC-CcCHHHHHHHHHHccCCcccC
Confidence 99854332221111111 12 578899999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=189.06 Aligned_cols=125 Identities=19% Similarity=0.218 Sum_probs=97.8
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------------------------------hHHHHHHHHhhcC
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------------------------------KSAECIKQLEQVD 407 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------------------------------~~~~~ik~L~~~~ 407 (720)
.+.||+|+||.||+|.+. +|+.||||+++...... .+.+.+..+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999986432100 0223333343211
Q ss_pred ---------CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHH-HhCCCcccccCCCceeecCCCCeee
Q 005007 408 ---------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 408 ---------~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yL-Hs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
...+|||||++|++|...+... ..+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.++|
T Consensus 81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCCcEEEecCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 1238999999988776554333 5799999999999999999999 799999999999999998 588999
Q ss_pred eccccchhc
Q 005007 478 ADFGMAKHL 486 (720)
Q Consensus 478 ~DFGlA~~~ 486 (720)
+|||+|...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=183.90 Aligned_cols=127 Identities=17% Similarity=0.197 Sum_probs=97.3
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------------------------------hHHHHHHHHhhcC
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------------------------------KSAECIKQLEQVD 407 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------------------------------~~~~~ik~L~~~~ 407 (720)
.+.||+|+||+||+|.+. +|+.||||+++...... .+.+.+..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999987542110 0111222222211
Q ss_pred ---------CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeee
Q 005007 408 ---------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 408 ---------~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL 477 (720)
...||||||++|+++...+... ..+++..+..++.||+.+|.+||. +||+||||||+|||++ ++.++|
T Consensus 81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCCceEEEecCCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 1238999999988654432222 568889999999999999999999 9999999999999998 899999
Q ss_pred eccccchhccC
Q 005007 478 ADFGMAKHLTG 488 (720)
Q Consensus 478 ~DFGlA~~~~~ 488 (720)
+|||+++....
T Consensus 159 iDFG~a~~~~~ 169 (190)
T cd05145 159 IDVSQAVELDH 169 (190)
T ss_pred EEcccceecCC
Confidence 99999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.1e-20 Score=196.07 Aligned_cols=187 Identities=22% Similarity=0.360 Sum_probs=139.6
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee--cCCC--Ceeeecccc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASG--VVKLADFGM 482 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL--d~~g--~VKL~DFGl 482 (720)
...+|+||.-++ -+|..++.. ...+....+-++.|+|+|+.|||.+||.|||+|.+|||| |+|+ .+.|+|||.
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 346899998886 789999865 357888889999999999999999999999999999998 3444 688999998
Q ss_pred chhccC-------ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH--HHHH
Q 005007 483 AKHLTG-------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--AMFK 553 (720)
Q Consensus 483 A~~~~~-------~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~--~i~k 553 (720)
+-.... ....+...|.-.-||||+....-...- ...-.++|.|+.|.+.||+++..-||......- ....
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a-vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA-VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCce-eeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 743221 223345567888999999874321111 112247999999999999999999997632211 1111
Q ss_pred HhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCH---HHHHcCcccc
Q 005007 554 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSA---VELLEHPFIR 597 (720)
Q Consensus 554 i~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa---~ELL~Hpff~ 597 (720)
.....+.+|+.+++.+++++..+|+.||.+|++. ..+|+.-.|.
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 2235677899999999999999999999999874 4556544443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=219.14 Aligned_cols=231 Identities=22% Similarity=0.313 Sum_probs=163.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC------hhHHHHHHH-H------------hhcCCEEEEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQ-L------------EQVDDHLYIYLE 415 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~------~~~~~~ik~-L------------~~~~~~lyLVmE 415 (720)
+|...+.||++.|=+|.+|++.+ |. |+||++-..... ....+.++. + ...++.-|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 78888999999999999998875 44 889977543321 112222221 1 112445688888
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc--C-c--c
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--G-L--S 490 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~--~-~--~ 490 (720)
|+. .+|+|.|..+ .-+.+-+-+.|+.||+.||.-||..||+|+|||.+||||+.-+-+.|+||..-+..- . . .
T Consensus 102 yvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 886 7899988654 457777888899999999999999999999999999999999999999998765321 1 1 1
Q ss_pred cc---ccccCCCCCCChHHHHHhh----hcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhccCCCCC
Q 005007 491 YE---LSLKGSPNWMAPEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIP 562 (720)
Q Consensus 491 ~~---~t~~GTp~YmAPEvl~g~~----~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~~~~iP 562 (720)
+. .+-..-.+|+|||.+.... ........+++-||||+||+++||++ |+++|.- ..+++...+....+
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCH
Confidence 10 1111234699999997532 11122337889999999999999988 7999852 22222222211111
Q ss_pred c-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 563 E-----MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 563 ~-----~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+ .-+..++.||..|++.||.+|.+|++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 123478999999999999999999999985
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-20 Score=207.67 Aligned_cols=173 Identities=25% Similarity=0.447 Sum_probs=135.0
Q ss_pred EEEEEEEeccCCCHHHHHHHh--cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 409 HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
++||.|++|...+|.++|... ....+....+.|+.||+.|++| +|.+|||+||.||+...++.+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 478999999999999999643 3346777889999999999999 99999999999999999999999999998776
Q ss_pred cCcc-------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhccC
Q 005007 487 TGLS-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT 558 (720)
Q Consensus 487 ~~~~-------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~~ 558 (720)
.... .....+||.+||+||.|.+ ..|+.++|||+||+||+||++ -...|.. ...+..+ +.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-------~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~--r~ 474 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-------QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDI--RD 474 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-------hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh--hc
Confidence 5544 4456779999999999985 568899999999999999998 3322221 1111212 22
Q ss_pred CCCCc-cC--CHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 559 PPIPE-ML--SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 559 ~~iP~-~l--s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
..+|+ .+ -++-.+|+.+||...|.+||++.+.--|.|.
T Consensus 475 g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 475 GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 23331 11 2345689999999999999988877767664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-19 Score=181.08 Aligned_cols=155 Identities=12% Similarity=0.121 Sum_probs=111.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--------------HHHHHHHHhhc-----------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--------------SAECIKQLEQV----------- 406 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--------------~~~~ik~L~~~----------- 406 (720)
...+|++.++||.|+||.||++.+ ++..+|||++........ +++.+..+.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357999999999999999999755 477899999863321111 11122222220
Q ss_pred --------CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 407 --------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 407 --------~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
.+..+|||||++|.+|.++.. +++ ..+.+|+.+|..||++||+||||||+|||++.+| ++|+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 235789999999999988732 333 3456999999999999999999999999999999 9999
Q ss_pred ccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHh
Q 005007 479 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 536 (720)
Q Consensus 479 DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELL 536 (720)
|||............ .++.. ..|..++|+|+||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~d-----------~~vle-------r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAKD-----------RIDLE-------RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhHH-----------HHHHH-------hHhcccccccceeEeehHHH
Confidence 999887553221110 02221 23456899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=176.17 Aligned_cols=172 Identities=17% Similarity=0.160 Sum_probs=126.3
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---------hhHHHHHHHHhhc--------CCEEEEEEEeccCC
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---------PKSAECIKQLEQV--------DDHLYIYLEYVHPG 420 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---------~~~~~~ik~L~~~--------~~~lyLVmEy~~gG 420 (720)
+...|++|+||+||++.. .+..++.+.+.....- ..++++++.|... -+..|++|||+.|.
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 567899999999998765 5788888877655431 2334444444321 13459999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCccccc-CCCceeecCCCCeeeeccccchhccCcccc-------
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHLTGLSYE------- 492 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDI-KP~NILLd~~g~VKL~DFGlA~~~~~~~~~------- 492 (720)
+|...+.. . ...++.|++++|++||++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 84 ~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~r 155 (218)
T PRK12274 84 AMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARE 155 (218)
T ss_pred cHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHH
Confidence 98755421 1 1357889999999999999999999 799999999999999999999855432210
Q ss_pred -------ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC
Q 005007 493 -------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 544 (720)
Q Consensus 493 -------~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~ 544 (720)
.-..+++.|+.|+...-... .--.+.++++.|+-+|.++|+..++..
T Consensus 156 Dl~~llk~~~~y~~~~l~~~~~~~l~~-----~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 156 DLRHLLKHKRMYCPAALTPVERRVLKR-----TSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHhcCCCCCCHHHHhhhcc-----chhHHHHHHHhcchHHHHHhccCCccc
Confidence 11236899999997653211 111467899999999999999888654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=206.86 Aligned_cols=182 Identities=24% Similarity=0.297 Sum_probs=145.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC------------C-hhHHHH---HHHHhhcCCEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------------D-PKSAEC---IKQLEQVDDHLYIY 413 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~------------~-~~~~~~---ik~L~~~~~~lyLV 413 (720)
......|.|-+.||+|+||+||+|.... |+.||||+-+.... . ...... +..+....+.-+||
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3455689999999999999999999887 99999995432110 0 111111 11222346677899
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-------CCCeeeeccccchhc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------SGVVKLADFGMAKHL 486 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-------~g~VKL~DFGlA~~~ 486 (720)
+||.+.|+|.+++. ..+.++|..+..|..|||..|+.||..+|||+||||+|+||.. .--++|+|||-+..+
T Consensus 773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99999999999997 4578999999999999999999999999999999999999942 235999999998654
Q ss_pred ---cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCC
Q 005007 487 ---TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540 (720)
Q Consensus 487 ---~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~ 540 (720)
.+.......++|-.+-.+|+..| ..+++.+|.|.|+.++|-||.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~g-------rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREG-------RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcC-------CCCchhhhhHHHHHHHHHHHHHHH
Confidence 34444556778999999999873 678999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-18 Score=177.19 Aligned_cols=133 Identities=18% Similarity=0.170 Sum_probs=103.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEE-ECCCCcEEEEEEeccCCCC-----------------------------hhHHHHHHH
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDD-----------------------------PKSAECIKQ 402 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~-d~~tg~~VAVK~l~~~~~~-----------------------------~~~~~~ik~ 402 (720)
+.-|++.+.||+|+||.||+|. +..+|+.||||+++..... ..+...++.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3468999999999999999999 7778999999988743210 012223333
Q ss_pred Hhhc---------CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC-CcccccCCCceeecCC
Q 005007 403 LEQV---------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLVDAS 472 (720)
Q Consensus 403 L~~~---------~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g-IVHRDIKP~NILLd~~ 472 (720)
+... ....+|||||+.|++|..++... ..+.+..+..++.||+.+|.+||++| |+||||||+|||++ +
T Consensus 107 L~~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 107 LYEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred HHhcCCCCCeeeEecCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3320 12358999999998887665332 45677778899999999999999999 99999999999998 8
Q ss_pred CCeeeeccccchhcc
Q 005007 473 GVVKLADFGMAKHLT 487 (720)
Q Consensus 473 g~VKL~DFGlA~~~~ 487 (720)
+.++|+|||++....
T Consensus 185 ~~i~LiDFg~a~~~~ 199 (237)
T smart00090 185 GKVVIIDVSQSVELD 199 (237)
T ss_pred CCEEEEEChhhhccC
Confidence 899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=165.25 Aligned_cols=126 Identities=20% Similarity=0.213 Sum_probs=97.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---------------------------hhHHHHHHHHhhc-
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---------------------------PKSAECIKQLEQV- 406 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---------------------------~~~~~~ik~L~~~- 406 (720)
.|.+++.||+|+||.||+|.+. +|+.||||++...... ..+...+..+...
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 7999999987542210 0111122222221
Q ss_pred --------CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 407 --------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 407 --------~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
....++||||++|++|..++. ......++.+|+.+|.++|+.||+||||||+||||+.++.++|+
T Consensus 95 i~v~~~~~~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~li 167 (198)
T cd05144 95 FPVPKPIDWNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYII 167 (198)
T ss_pred CCCCceeecCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEE
Confidence 245689999999999876542 13456888999999999999999999999999999999999999
Q ss_pred ccccchhccC
Q 005007 479 DFGMAKHLTG 488 (720)
Q Consensus 479 DFGlA~~~~~ 488 (720)
|||++.....
T Consensus 168 Dfg~~~~~~~ 177 (198)
T cd05144 168 DWPQMVSTDH 177 (198)
T ss_pred ECCccccCCC
Confidence 9999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=155.43 Aligned_cols=125 Identities=22% Similarity=0.301 Sum_probs=90.5
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-----------------------------HHHHHHHHhhc---
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----------------------------SAECIKQLEQV--- 406 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-----------------------------~~~~ik~L~~~--- 406 (720)
++.||+|+||+||+|.+. +|+.||||++........ +.+.+..+...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 899999998764321110 01111111111
Q ss_pred ------CCEEEEEEEeccCCCHHH-HHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeee
Q 005007 407 ------DDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 407 ------~~~lyLVmEy~~gGsL~~-~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
-...++||||++|+.+.. .+... . . ...++.++.+++.+|.++|. +||+||||||+|||++ ++.++|+
T Consensus 81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~-~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDV-R-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CCceEecCCCEEEEEEeCCCCccChhhhhh-h-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 124589999999854332 12211 1 1 16778999999999999999 9999999999999999 8999999
Q ss_pred ccccchhccC
Q 005007 479 DFGMAKHLTG 488 (720)
Q Consensus 479 DFGlA~~~~~ 488 (720)
|||++.....
T Consensus 157 Dfg~a~~~~~ 166 (187)
T cd05119 157 DVPQAVEIDH 166 (187)
T ss_pred ECcccccccC
Confidence 9999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-17 Score=194.37 Aligned_cols=239 Identities=30% Similarity=0.441 Sum_probs=184.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCCCChhHHHH-------HHHHh------------hcCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAEC-------IKQLE------------QVDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~-tg~~VAVK~l~~~~~~~~~~~~-------ik~L~------------~~~~~lyLV 413 (720)
..|.+.+.||+|+|+.|-++.+.. ....+|+|.+..........+. .+.+. ...+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 477888889999999999988754 3455778866544311111111 11111 124567899
Q ss_pred EEeccCCCHHHHH-HHhcCCCcHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCceeecCCC-CeeeeccccchhccC-c
Q 005007 414 LEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTG-L 489 (720)
Q Consensus 414 mEy~~gGsL~~~L-~~~~~~Lse~~i~~i~~QIL~gL~yLH-s~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~-~ 489 (720)
+||..|+++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|..+.. .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999999999 554447888999999999999999999 99999999999999999999 999999999987655 2
Q ss_pred c---ccccccC-CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHH-HHHhcc----CCC
Q 005007 490 S---YELSLKG-SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR----TPP 560 (720)
Q Consensus 490 ~---~~~t~~G-Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i-~ki~~~----~~~ 560 (720)
+ .....+| ++.|+|||...+. .+.....|+||+|+++.-|++|..||......... ...... ...
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred CcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 2 2234678 9999999998752 34567899999999999999999999764433322 111211 123
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 561 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 561 iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
....++....+++.++|..+|..|.+.+++..++|+..
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 34668899999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=153.34 Aligned_cols=118 Identities=25% Similarity=0.411 Sum_probs=92.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Ch------------hHHHHHHHHhh-----------cCCEEEEEEE
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DP------------KSAECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~------------~~~~~ik~L~~-----------~~~~lyLVmE 415 (720)
+.||+|++|.||+|.+ +|..|+||+...... .. .+.+.+..+.. ..+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 678899997653221 11 11122222221 2345689999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
|++|++|.+++.... . ....++.+|+.+|.+||+.|++||||+|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986531 2 7889999999999999999999999999999998 88999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.2e-16 Score=160.61 Aligned_cols=225 Identities=20% Similarity=0.310 Sum_probs=167.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH----------------HHHHHh--hcCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE----------------CIKQLE--QVDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~----------------~ik~L~--~~~~~lyLVmEy 416 (720)
+..+..+|.+.-.|..|+|++. |..+++|++....-..+..+ ++-.+. +...++.+|..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 4556678889999999999887 55666776654322111111 111111 124578999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCCeee--eccccchhccCccc
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKL--ADFGMAKHLTGLSY 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~VKL--~DFGlA~~~~~~~~ 491 (720)
|+.|+|+.+|++.. -.++..++.+++.+|++|+.|||+.. |.---|....++||++-+.+| +|--++..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 99999999998653 24678899999999999999999863 334468889999999877665 44332221
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh--ccCCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~--~~~~~iP~~ls~el 569 (720)
.......|.||+||.+.... ....-.++|+|||+++||||.|...||.+....+.-.++. +-...+|..++..+
T Consensus 343 e~gr~y~pawmspealqrkp----ed~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKP----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred ccccccCcccCCHHHHhcCc----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 12233578899999997421 1123458999999999999999999999999888877764 44678899999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHH
Q 005007 570 KDFLLRCFLRNPVERPSAVELL 591 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL 591 (720)
..||.-|+..||.+||.+..++
T Consensus 419 ~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999987764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=151.14 Aligned_cols=114 Identities=25% Similarity=0.392 Sum_probs=88.1
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Ch------------hHHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DP------------KSAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~------------~~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
+||+|+||+||+|.. +|..|+||....... .. .+.+.+..+.. .++..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 578899997543221 11 12222333332 13446899999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
++|++|.+++.... . .++.||+.+|.+||+.|++|+||||+|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999885431 1 7899999999999999999999999999998 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=169.84 Aligned_cols=186 Identities=26% Similarity=0.422 Sum_probs=144.0
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCC-cccccCCCceeecCCCCeeeeccccchh
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-IHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gI-VHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
...+++|.+||..|+|.+.+......+++.....++++|+.||.|||.-.| .|+.++..|+++|....+||.|||+...
T Consensus 19 ~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~ 98 (484)
T KOG1023|consen 19 GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSL 98 (484)
T ss_pred CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhccc
Confidence 477899999999999999998877789999999999999999999998766 8999999999999999999999999876
Q ss_pred ccCc---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC----CcHHHHHHHhc-c
Q 005007 486 LTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF----EGPQAMFKVLN-R 557 (720)
Q Consensus 486 ~~~~---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~----~~~~~i~ki~~-~ 557 (720)
.... .......-..-|.|||++.+..........+.+.||||+|+++||+++.+.||... ...+.+..+.+ .
T Consensus 99 ~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~ 178 (484)
T KOG1023|consen 99 LEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGG 178 (484)
T ss_pred ccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcC
Confidence 5421 11111123446999999986432221123577899999999999999999999752 22345555554 2
Q ss_pred CC-CCCc-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 558 TP-PIPE-----MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 558 ~~-~iP~-----~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.. ..|. .+.+++..+++.||..+|.+||+++++-.
T Consensus 179 ~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 179 SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 21 1221 34567899999999999999999998843
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-15 Score=153.09 Aligned_cols=120 Identities=18% Similarity=0.247 Sum_probs=86.0
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----ChhHHHHHHHHhh----------------cC---CEEE-E
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPKSAECIKQLEQ----------------VD---DHLY-I 412 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~~~~~~ik~L~~----------------~~---~~ly-L 412 (720)
-.++||+|+||.||. +..++.. +||++..... ...++..++.+.. .+ +.++ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 347899999999995 7777666 5998865321 1223333444421 01 2334 7
Q ss_pred EEEe--ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHH-HHHHhCCCcccccCCCceeecCC----CCeeeeccccch
Q 005007 413 YLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGL-AYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMAK 484 (720)
Q Consensus 413 VmEy--~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL-~yLHs~gIVHRDIKP~NILLd~~----g~VKL~DFGlA~ 484 (720)
|||| +.+|+|.+++.+ ..+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+.
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 8999 557999999965 346666 36688888888 99999999999999999999743 379999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.9e-15 Score=167.92 Aligned_cols=122 Identities=22% Similarity=0.291 Sum_probs=89.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEecc-CCCCh------------hHHHHHHHHhh-----------cCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDP------------KSAECIKQLEQ-----------VDD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~-~~~~~------------~~~~~ik~L~~-----------~~~ 408 (720)
...|...++||+|+||+||+|.+.. ..+++|+... ..... .+.+.+..+.. .+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3455778999999999999998753 3444443211 11110 11122222221 134
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
..++||||++|++|.+++. ....++.||+++|.|||++||+||||||+|||+ .++.++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 5789999999999999885 346789999999999999999999999999999 6789999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.2e-15 Score=172.00 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=196.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHH----HHH---------HHh--hcCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAE----CIK---------QLE--QVDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~----~ik---------~L~--~~~~~lyLV 413 (720)
...+.+.+-+-+|.++.++.+.-..+|...++|+....... ...+. ... ... -....++||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45677888999999999999988888877777755432211 11110 000 000 134568999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc------
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT------ 487 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~------ 487 (720)
|+|+.|++|...|+.. +..+++-++.++..+.++++|||...++|||++|.|+|+..+|..++.|||......
T Consensus 883 ~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999999775 568888899999999999999999999999999999999999999999998432110
Q ss_pred C--------------------------ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCC
Q 005007 488 G--------------------------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 541 (720)
Q Consensus 488 ~--------------------------~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~P 541 (720)
+ ........||+.|.+||.+.+. ..+..+|+|++|++++|.++|.+|
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-------~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-------RHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-------cCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 0112346689999999999863 345689999999999999999999
Q ss_pred CCCCCcHHHHHHHhccCCCCC---ccCCHHHHHHHHHhhhcCCCCCCCHH---HHHcCcccccccccCCCCc
Q 005007 542 WSEFEGPQAMFKVLNRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAV---ELLEHPFIRNANYQNLSVP 607 (720)
Q Consensus 542 F~~~~~~~~i~ki~~~~~~iP---~~ls~el~dLI~~cL~~dP~kRPTa~---ELL~Hpff~~~~~~~l~~~ 607 (720)
|........+.++.++...+| ...+.++++++.++|..++.+|..+. ++-.|+||+...|.++...
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccc
Confidence 999888888888888766655 56899999999999999999998887 9999999999998877543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=142.36 Aligned_cols=119 Identities=18% Similarity=0.274 Sum_probs=87.0
Q ss_pred eeEEe-ecCCeEEEEEEECCCCcEEEEEEeccC-------CC-----------ChhHHHHHHHHhhc-------------
Q 005007 359 GKLIG-RGTFGSVYIGTNRETGASCAIKEVDII-------PD-----------DPKSAECIKQLEQV------------- 406 (720)
Q Consensus 359 ~k~LG-~G~fG~VYla~d~~tg~~VAVK~l~~~-------~~-----------~~~~~~~ik~L~~~------------- 406 (720)
+..|| .|+.|+||.++.. +..++||.++.. .. ...+.+.+..|...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45677 7888888888764 788999977421 10 01133334444321
Q ss_pred -CC---EEEEEEEeccC-CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccc
Q 005007 407 -DD---HLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 481 (720)
Q Consensus 407 -~~---~lyLVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFG 481 (720)
.. ..+|||||++| .+|.+++.+ ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 11 22599999997 689998864 3455543 5789999999999999999999999999999999999999
Q ss_pred cchh
Q 005007 482 MAKH 485 (720)
Q Consensus 482 lA~~ 485 (720)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-14 Score=161.69 Aligned_cols=244 Identities=22% Similarity=0.254 Sum_probs=182.4
Q ss_pred CCCCCCeEEeeEEee--cCCeEEEEEEE--CCCCcEEEEEEeccCCCC-------hhHHH----------HHH--HHhhc
Q 005007 350 SPKKSQWQKGKLIGR--GTFGSVYIGTN--RETGASCAIKEVDIIPDD-------PKSAE----------CIK--QLEQV 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~--G~fG~VYla~d--~~tg~~VAVK~l~~~~~~-------~~~~~----------~ik--~L~~~ 406 (720)
......+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.-... ..+.. .++ ...+.
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 444567788899999 99999999988 899999999963221110 00000 011 11123
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHH----HHHHHHhCCCcccccCCCceeecCC-CCeeeeccc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----GLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFG 481 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~----gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFG 481 (720)
.+.+||-+|+|. .+|..+....+..+++..++.++.+.++ ||.++|..+|+|-|+||+||++..+ ...+++|||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 577899999995 8899998877777999999999999999 9999999999999999999999999 899999999
Q ss_pred cchhccCcccccc------ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC--CcHHHHHH
Q 005007 482 MAKHLTGLSYELS------LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--EGPQAMFK 553 (720)
Q Consensus 482 lA~~~~~~~~~~t------~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~--~~~~~i~k 553 (720)
+...+........ ..|...|++||++.+ -++...|||+||.++.+-.+|....... +....+..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--------LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc--------ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 9988766543222 247778999999974 4677899999999999998876654322 22111111
Q ss_pred HhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 554 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 554 i~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
.. ...++-+..+.++...+..|++.++..|++++.++.|++++......
T Consensus 341 ~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~ 389 (524)
T KOG0601|consen 341 GY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVH 389 (524)
T ss_pred cc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhc
Confidence 11 11122234566777799999999999999999999999998654433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=125.28 Aligned_cols=118 Identities=19% Similarity=0.313 Sum_probs=92.4
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC---ChhHHHHHHHHhhc-------------CCEEEEEEEeccCCC
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQV-------------DDHLYIYLEYVHPGS 421 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~---~~~~~~~ik~L~~~-------------~~~lyLVmEy~~gGs 421 (720)
+.+.||+|.++.||++.+.. ..++||.+..... ...+...+..+.+. .+..+++|||+.|+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 45789999999999999753 7899998865432 23334444444431 235899999999887
Q ss_pred HHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC---CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 422 INRYVREHCRDITESIVRNFTRHILNGLAYLHST---NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 422 L~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~---gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
+..+ +......++.+++++|.+||.. +++|+|||++|||++..+.++|+|||++..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7544 4456677889999999999985 799999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.3e-12 Score=145.08 Aligned_cols=76 Identities=14% Similarity=0.232 Sum_probs=60.3
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHH-HHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN-GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~-gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|||||++|++|.+++......+ ....++.+++. .+..+|..|++|+|+||.||+++.+|.++|+|||++..+..
T Consensus 233 ~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 233 RVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 479999999999998875322222 23455566665 47888999999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-12 Score=147.07 Aligned_cols=126 Identities=16% Similarity=0.209 Sum_probs=89.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC---------------------------Chh-HHH--------
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---------------------------DPK-SAE-------- 398 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~---------------------------~~~-~~~-------- 398 (720)
.|.. +.||+|++|.||+|+.+.+|+.||||+++.... +.. ..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 5666 789999999999999998899999998863210 000 000
Q ss_pred ---------HHHHHhh---cC-------------CEEEEEEEeccCCCHHHHH--HHhcC---CCcHHHHHHHHHHHHHH
Q 005007 399 ---------CIKQLEQ---VD-------------DHLYIYLEYVHPGSINRYV--REHCR---DITESIVRNFTRHILNG 448 (720)
Q Consensus 399 ---------~ik~L~~---~~-------------~~lyLVmEy~~gGsL~~~L--~~~~~---~Lse~~i~~i~~QIL~g 448 (720)
.+..+.+ .. ...+|||||+.|+.|.++. ...+. .+.+..+..++.||+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 0011110 11 2235999999999998753 22211 366666777777765
Q ss_pred HHHHHhCCCcccccCCCceeecCCC----CeeeeccccchhccC
Q 005007 449 LAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHLTG 488 (720)
Q Consensus 449 L~yLHs~gIVHRDIKP~NILLd~~g----~VKL~DFGlA~~~~~ 488 (720)
..|++|+|+||.|||++.+| .++++|||++..+..
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 48999999999999999888 999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.7e-11 Score=116.73 Aligned_cols=115 Identities=17% Similarity=0.125 Sum_probs=85.2
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHhh----------cCCEEEEEEEeccCCCHHH
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQ----------VDDHLYIYLEYVHPGSINR 424 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~~----------~~~~lyLVmEy~~gGsL~~ 424 (720)
.+.|+.|.++.||++... +..|+||....... ...+...+..+.+ .....++||||++|.++..
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 367899999999999865 78899998754321 2233444444432 1233589999999988754
Q ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCC-----cccccCCCceeecCCCCeeeeccccchh
Q 005007 425 YVREHCRDITESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 425 ~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gI-----VHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
. ......++.+|+++|..||..++ +|+|+++.|||++ ++.++|+|||.+..
T Consensus 81 ~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 3 01123457899999999999985 9999999999998 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.8e-12 Score=141.73 Aligned_cols=235 Identities=25% Similarity=0.210 Sum_probs=168.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCCC----Ch---hHHHHHHHHhh------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPD----DP---KSAECIKQLEQ------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~-~tg~~VAVK~l~~~~~----~~---~~~~~ik~L~~------------~~~~l 410 (720)
....+|..+..||.|.|+.|+.+.-+ .++..|++|++..... +. .++.....+.. ...+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34457899999999999999998755 6888999998754321 11 11111111110 13457
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhccCc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGL 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~~~~ 489 (720)
||=.|||+++++...+.- ...+.+...+.++.|++.++.++|++.++|+|+||.||++..+ +..++.|||.+..+.-
T Consensus 342 ~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred cCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 888999999998777633 2568999999999999999999999999999999999999775 8899999999875321
Q ss_pred cccccccCCCCCC-ChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHH
Q 005007 490 SYELSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 568 (720)
Q Consensus 490 ~~~~t~~GTp~Ym-APEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~e 568 (720)
......++-+++ ..|++.. +..+..++|+++||..++|.++|...=... .....+..+..........+
T Consensus 420 -~~~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 420 -SSGVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred -ecccccccccccccchhhcc------ccccccccccccccccccccccCcccCccc---ccceeeecccccCCCchHHh
Confidence 112233344455 3565542 456778999999999999999987532221 12223333333333333488
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
+..+.+.++..+++.|+.+.++..|.-|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999999998886653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=9e-11 Score=118.80 Aligned_cols=126 Identities=18% Similarity=0.279 Sum_probs=88.5
Q ss_pred eeEEeecCCeEEEEEEECC------CCcEEEEEEeccCC-----------CCh--------------------hHHHHHH
Q 005007 359 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIP-----------DDP--------------------KSAECIK 401 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~------tg~~VAVK~l~~~~-----------~~~--------------------~~~~~ik 401 (720)
...||.|--+.||.|.... .+..+|||+.+... .+. ++.+.+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 35789999765211 010 0111122
Q ss_pred HHhhc---------CCEEEEEEEeccCCCHHH-HHHHhcCCCcHHHHHHHHHHHHHHHHHH-HhCCCcccccCCCceeec
Q 005007 402 QLEQV---------DDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVD 470 (720)
Q Consensus 402 ~L~~~---------~~~lyLVmEy~~gGsL~~-~L~~~~~~Lse~~i~~i~~QIL~gL~yL-Hs~gIVHRDIKP~NILLd 470 (720)
.+.+. -..-+|||||+.++.+.. .+++ ..+++..+..++.|++.+|..| |+.||||+||++.|||++
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~ 159 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH 159 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE
Confidence 22221 234689999997654432 2332 2456667788899999999999 899999999999999996
Q ss_pred CCCCeeeeccccchhcc
Q 005007 471 ASGVVKLADFGMAKHLT 487 (720)
Q Consensus 471 ~~g~VKL~DFGlA~~~~ 487 (720)
++.+.|+|||.+....
T Consensus 160 -~~~v~iIDF~qav~~~ 175 (197)
T cd05146 160 -DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -CCcEEEEECCCceeCC
Confidence 5789999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.4e-11 Score=134.87 Aligned_cols=195 Identities=23% Similarity=0.317 Sum_probs=140.1
Q ss_pred HHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCccc------cc----cccCCCCCCChHHHHHhh
Q 005007 443 RHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY------EL----SLKGSPNWMAPEVIKAVM 511 (720)
Q Consensus 443 ~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~------~~----t~~GTp~YmAPEvl~g~~ 511 (720)
.+.+.||.|+|.. ++||+.|.|++|.++..|.+||+.|+++....+... .. ...-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-- 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-- 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence 3455899999965 999999999999999999999999999876544111 11 1223567999999974
Q ss_pred hcCCCCCCCccccccchhhhHHHHh-cCCCCCCCCCcHHHHHHHhc----cCCCCCccCCHHHHHHHHHhhhcCCCCCCC
Q 005007 512 QKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLN----RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 586 (720)
Q Consensus 512 ~~~g~~~~s~asDVWSLG~vLyELL-TGk~PF~~~~~~~~i~ki~~----~~~~iP~~ls~el~dLI~~cL~~dP~kRPT 586 (720)
...+.++|+|||||++|.+. .|+.-+.............+ ........++.++++-|.++|..+...||+
T Consensus 184 -----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 184 -----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred -----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 45678999999999999999 67776665433322222111 123345678999999999999999999999
Q ss_pred HHHHHcCcccccccccCCCCcccccccccCCCCchhHHHHHHhhhcCCCCCcchhhccCCCCC
Q 005007 587 AVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPC 649 (720)
Q Consensus 587 a~ELL~Hpff~~~~~~~l~~~~~~~~~~~l~~~~~~~~e~~~~k~~~lp~~p~~~~r~rk~~~ 649 (720)
+.+++..+||.+.....+........ +...+..+-......-+|..|...+.++-+|+
T Consensus 259 ~~~l~~~~ff~D~~~~aLrfLD~l~~-----kdn~qKs~Flk~Ls~~ip~fp~rv~~~kiLP~ 316 (700)
T KOG2137|consen 259 LDLLLSIPFFSDPGLKALRFLDDLPQ-----KDNSQKSSFLKGLSKLIPTFPARVLFQKILPT 316 (700)
T ss_pred hhhhhcccccCCchhhhhhhcccccc-----cCcHHHHHHHHHHHHhhccCCHHHHHHhhhhH
Confidence 99999999999877665544332222 23333444444455667778877777766654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-09 Score=115.93 Aligned_cols=178 Identities=21% Similarity=0.360 Sum_probs=124.5
Q ss_pred CEEEEEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhC--CCcccccCCCceeecCCCCeeeecccc
Q 005007 408 DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDASGVVKLADFGM 482 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~--gIVHRDIKP~NILLd~~g~VKL~DFGl 482 (720)
-...++.|||.-|+|..+|++. ...+.....++|+.||+.||.|||+. -|+|+.+..+-|++..+|-|||.--..
T Consensus 145 ~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap 224 (458)
T KOG1266|consen 145 PRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAP 224 (458)
T ss_pred cceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCc
Confidence 3467888999999999999753 35688899999999999999999986 699999999999999999888853211
Q ss_pred chh-----ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHH
Q 005007 483 AKH-----LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFK 553 (720)
Q Consensus 483 A~~-----~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~k 553 (720)
... .........-.|-++|.+||.=. .....-++|||++|.+..||..|..--.+.+ ..+.+..
T Consensus 225 ~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-------~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~ 297 (458)
T KOG1266|consen 225 DSTHPSVNSTREAEKSVNTSLPGFSAPESGT-------TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN 297 (458)
T ss_pred cccchhhhhhhHhhhhccccCCccccCCcCc-------ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh
Confidence 100 00000111123678899998532 2345568999999999999988765322211 1112221
Q ss_pred HhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 554 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 554 i~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
.+.. +. ..--+++|.+||+-.|..||++.++|.||..-+
T Consensus 298 ~i~~---le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 298 VIIG---LE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred heee---cc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 1111 00 111257899999999999999999999998744
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.9e-09 Score=104.01 Aligned_cols=115 Identities=20% Similarity=0.352 Sum_probs=81.2
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEe-ccCCCChhH------------HHHHHHHhh-----------cCCEEEEEEE
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKS------------AECIKQLEQ-----------VDDHLYIYLE 415 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l-~~~~~~~~~------------~~~ik~L~~-----------~~~~lyLVmE 415 (720)
..+++|+-+.||.+... |..+.+|+= ...-.++.. ..++..+.. ..+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46889999999999664 555667732 111122222 222222222 2455679999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
|++|-.|.++|... . ..+++.+-.-+.-||..||||+||.++||++..+ .+.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99998899888664 1 4556666677788999999999999999999655 499999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.5e-09 Score=104.66 Aligned_cols=126 Identities=24% Similarity=0.349 Sum_probs=90.3
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccC-CCChh------------HHHHHHHHhhc-----------CCEEEEE
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-PDDPK------------SAECIKQLEQV-----------DDHLYIY 413 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~-~~~~~------------~~~~ik~L~~~-----------~~~lyLV 413 (720)
.+.+|-+|+-+.|+++.+. |+.+.||+=-.. -.++. +.+.+..+... ...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678899999999999764 888889843211 11111 12222222221 2345789
Q ss_pred EEeccC-CCHHHHHHHhcCCCcHHHH-HHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---Ceeeeccccchh
Q 005007 414 LEYVHP-GSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKH 485 (720)
Q Consensus 414 mEy~~g-GsL~~~L~~~~~~Lse~~i-~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~~ 485 (720)
|||++| ..+.+++......-.++.. ..++++|-+.|.-||.++|||+||..+||||..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999986 3788998776544444444 78999999999999999999999999999997665 358999999853
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.9e-08 Score=114.01 Aligned_cols=118 Identities=25% Similarity=0.429 Sum_probs=90.4
Q ss_pred cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH-s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++.+|||+|-+. -|..++++. ....+...+.||+.||.||| +.+++|++|.-.-|+|+..|.+||++|.++.
T Consensus 80 ~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 80 EEGTLYLVTERVR--PLETVLKEL----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred ccCceEEEeeccc--cHHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 4678999999995 677778663 47778888999999999997 6789999999999999999999999999886
Q ss_pred hccCccccc-cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC
Q 005007 485 HLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 538 (720)
Q Consensus 485 ~~~~~~~~~-t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG 538 (720)
...+..... ...---.|..|+.+.. -....|.|-|||+++|++.|
T Consensus 154 ~~~~~~~~~~~~~~~~s~~~P~~~~~---------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 154 KASGFNAPAKSLYLIESFDDPEEIDP---------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccccCCcccccchhhhcccChhhcCc---------cccchhhhhHHHHHHHHhCc
Confidence 654433211 1111123666665431 11457999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-08 Score=101.63 Aligned_cols=123 Identities=19% Similarity=0.262 Sum_probs=87.0
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC------ChhHHHHHHHHhhc------------C----CEEEEEEEec
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------DPKSAECIKQLEQV------------D----DHLYIYLEYV 417 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~------~~~~~~~ik~L~~~------------~----~~lyLVmEy~ 417 (720)
+.||.|.++.||++.... |+.+++|....... ...+.+.++.+... + +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998643 68899998764321 12333344444320 1 2568999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS------------------------------------------- 454 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs------------------------------------------- 454 (720)
+|.+|.+.+.. ..+++.....++.+|+++|.+||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99887665421 345666666667777777777763
Q ss_pred -------------CCCcccccCCCceeecC--CCCeeeeccccchh
Q 005007 455 -------------TNTIHRDIKGANLLVDA--SGVVKLADFGMAKH 485 (720)
Q Consensus 455 -------------~gIVHRDIKP~NILLd~--~g~VKL~DFGlA~~ 485 (720)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24589999999999988 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.5e-07 Score=101.65 Aligned_cols=227 Identities=18% Similarity=0.247 Sum_probs=149.0
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHH--------------------hh--cCCEEEEEE
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL--------------------EQ--VDDHLYIYL 414 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L--------------------~~--~~~~lyLVm 414 (720)
..++-||+|+-+.+|-.-.. +.. +.|+.....-.. ..+.+.+| .- ....+-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~-~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAA-QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh--hch-hheeecCCCchH-HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35678999999999975322 222 345543222111 11111111 11 122367888
Q ss_pred EeccCCC-HHHHH-----HHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 415 EYVHPGS-INRYV-----REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 415 Ey~~gGs-L~~~L-----~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
..+.|.. +.+++ ++.+....+..+.+..+.|+.+..-||+.|.+-+|+.++|||+.+++.|.|.|=..-....+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccC
Confidence 8888653 33333 23345688899999999999999999999999999999999999999999998554433344
Q ss_pred ccccccccCCCCCCChHHHH-HhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCc-------HH-HHHHH-h--
Q 005007 489 LSYELSLKGSPNWMAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEG-------PQ-AMFKV-L-- 555 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~-g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~-------~~-~i~ki-~-- 555 (720)
+......+|...|.+||.-. +... ...-+...|.|.||++|++||.| +.||.+... .+ .|..- .
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~---g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFV---GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred CceEecccCccccCCHHHhcccccc---ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 44445567999999999854 2111 12345678999999999999886 999976321 11 11110 0
Q ss_pred ---ccCC------CCC-ccCCHHHHHHHHHhhhc--CCCCCCCHHHH
Q 005007 556 ---NRTP------PIP-EMLSSEGKDFLLRCFLR--NPVERPSAVEL 590 (720)
Q Consensus 556 ---~~~~------~iP-~~ls~el~dLI~~cL~~--dP~kRPTa~EL 590 (720)
.+.. .+| +.++++++.|..+|+.. ++.-|||++..
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 1111 122 45789999999999985 35689998743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-07 Score=99.58 Aligned_cols=77 Identities=17% Similarity=0.242 Sum_probs=65.3
Q ss_pred EEEEEEEeccCC-CHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-------CCCeeeec
Q 005007 409 HLYIYLEYVHPG-SINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------SGVVKLAD 479 (720)
Q Consensus 409 ~lyLVmEy~~gG-sL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-------~g~VKL~D 479 (720)
.-+||||++++. +|.+++.+. .....+.....++.+|+..+.-||++||+|+|+++.||||+. ++.+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 478999999976 799998542 234567778899999999999999999999999999999975 46899999
Q ss_pred cccchh
Q 005007 480 FGMAKH 485 (720)
Q Consensus 480 FGlA~~ 485 (720)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.9e-08 Score=98.32 Aligned_cols=74 Identities=27% Similarity=0.414 Sum_probs=52.6
Q ss_pred EEEEEEecc--CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHH-HHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 410 LYIYLEYVH--PGSINRYVREHCRDITESIVRNFTRHILNGLAY-LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~--gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~y-LHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
-+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.+...
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred CEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 379999998 6666554322 23366778888899986555 579999999999999999776 8999999988654
Q ss_pred c
Q 005007 487 T 487 (720)
Q Consensus 487 ~ 487 (720)
.
T Consensus 157 ~ 157 (188)
T PF01163_consen 157 S 157 (188)
T ss_dssp T
T ss_pred C
Confidence 3
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.3e-07 Score=99.49 Aligned_cols=123 Identities=20% Similarity=0.252 Sum_probs=89.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC---------------------------ChhHHHHHHHHhhc--
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---------------------------DPKSAECIKQLEQV-- 406 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~---------------------------~~~~~~~ik~L~~~-- 406 (720)
+.++..||.|--+.||.|.+. .|..+|||.-+.... ..++.+.+..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 568899999999999999977 589999995432110 01122223333322
Q ss_pred -------CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeec
Q 005007 407 -------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 479 (720)
Q Consensus 407 -------~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~D 479 (720)
.+...+||||++|-.|...- ++.+.+..++..|++-+.-+-..||||+|+..-|||++++|.+.++|
T Consensus 172 ~VP~P~~~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 172 KVPKPIAWNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred CCCCccccccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEe
Confidence 45679999999987665432 24555666777777777767789999999999999999999999999
Q ss_pred cccchh
Q 005007 480 FGMAKH 485 (720)
Q Consensus 480 FGlA~~ 485 (720)
|--+..
T Consensus 246 wPQ~v~ 251 (304)
T COG0478 246 WPQAVP 251 (304)
T ss_pred Cccccc
Confidence 976543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.3e-06 Score=96.28 Aligned_cols=197 Identities=16% Similarity=0.172 Sum_probs=140.2
Q ss_pred CeEEEEEEECCCCcEEEEEEeccCC-----CChhHHHHHHHHhh---------------cCCEEEEEEEeccC-CCHHHH
Q 005007 367 FGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQ---------------VDDHLYIYLEYVHP-GSINRY 425 (720)
Q Consensus 367 fG~VYla~d~~tg~~VAVK~l~~~~-----~~~~~~~~ik~L~~---------------~~~~lyLVmEy~~g-GsL~~~ 425 (720)
-.+.|+|....+|..|.+|.++... ......+..+++.. .+..+++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3588999999999999999984332 22334455554432 24568999999986 456655
Q ss_pred HHH--------------hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 426 VRE--------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 426 L~~--------------~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
--. .+..++|..+|.|+.||..||.++|+.|+.-+-|.+.+||++.+.+|+|...|+...+....
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~- 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP- 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence 311 12458899999999999999999999999999999999999988899998888876554322
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCC-CCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~P-F~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
+ |.+.+. .+-|.=.||.+++.|.||..- |......+.... .+-..++.+++
T Consensus 448 -----~-------~~le~~----------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~------~I~~~yS~D~r 499 (655)
T KOG3741|consen 448 -----T-------EPLESQ----------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT------RITTTYSTDLR 499 (655)
T ss_pred -----C-------cchhHH----------hhhhHHHHHHHHHHHhhcccccccccchHHHHHH------HhhhhhhHHHH
Confidence 0 122211 146888999999999999642 111111111011 22345788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcC
Q 005007 571 DFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++|..+...++++ -++.++|.+
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHH
Confidence 9999999999987 678888765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.4e-07 Score=94.10 Aligned_cols=76 Identities=21% Similarity=0.325 Sum_probs=66.7
Q ss_pred EEEEEEEeccCC-CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---Ceeeeccccch
Q 005007 409 HLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAK 484 (720)
Q Consensus 409 ~lyLVmEy~~gG-sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~ 484 (720)
.-+||+|+++|. +|.+++.... .++......++.+|+..+.-||++||+|+|+++.||||+.++ .+.|+||+.++
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 458999999974 7999997642 377778889999999999999999999999999999999887 89999999876
Q ss_pred h
Q 005007 485 H 485 (720)
Q Consensus 485 ~ 485 (720)
.
T Consensus 170 ~ 170 (206)
T PF06293_consen 170 F 170 (206)
T ss_pred e
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.2e-07 Score=101.57 Aligned_cols=121 Identities=22% Similarity=0.314 Sum_probs=82.4
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----------------------C---hhHHHHHHHHhh---------
Q 005007 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----------------------D---PKSAECIKQLEQ--------- 405 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----------------------~---~~~~~~ik~L~~--------- 405 (720)
.-|+.++-|.||+|+.+. |+.||||+.+..-. . -...+++.++.+
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999875 99999997642110 0 001111111110
Q ss_pred ---------------------------cCCEEEEEEEeccCCCHHHHHHHhcCCCc-----HHHHHHHHHHHHHHHHHHH
Q 005007 406 ---------------------------VDDHLYIYLEYVHPGSINRYVREHCRDIT-----ESIVRNFTRHILNGLAYLH 453 (720)
Q Consensus 406 ---------------------------~~~~lyLVmEy~~gGsL~~~L~~~~~~Ls-----e~~i~~i~~QIL~gL~yLH 453 (720)
....-.|+|||++|..+.++..-....++ +..+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 12345799999999999888532223344 333444444443
Q ss_pred hCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 454 s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
..|++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 38999999999999999999999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.1e-05 Score=81.19 Aligned_cols=121 Identities=17% Similarity=0.226 Sum_probs=79.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----------hhHHHHHHHHhh----------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----------PKSAECIKQLEQ---------------- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----------~~~~~~ik~L~~---------------- 405 (720)
..+|...+++-......|.+-. -+|+.+.+|+....... ......+..+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4577777777777666666553 34788889966532111 011111111111
Q ss_pred ------cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeec
Q 005007 406 ------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 479 (720)
Q Consensus 406 ------~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~D 479 (720)
.-...+|||||++|..|.++.. +++ .+...|.++|.-||+.|++|+|+.|.|++++.+ .++++|
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence 0123468999999988876542 333 244567788999999999999999999999754 599999
Q ss_pred cccchh
Q 005007 480 FGMAKH 485 (720)
Q Consensus 480 FGlA~~ 485 (720)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.7e-05 Score=78.99 Aligned_cols=122 Identities=16% Similarity=0.223 Sum_probs=87.4
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEecc-C-------CCChh---HHHHHHHHhhc-----------------CCEEEEE
Q 005007 362 IGRGTFGSVYIGTNRETGASCAIKEVDI-I-------PDDPK---SAECIKQLEQV-----------------DDHLYIY 413 (720)
Q Consensus 362 LG~G~fG~VYla~d~~tg~~VAVK~l~~-~-------~~~~~---~~~~ik~L~~~-----------------~~~lyLV 413 (720)
-|+||.+-|+..... |+.+-||.-.. . ...+. +...+..|.+. ...-+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 367888889887543 44688885541 0 11222 33344444431 2236899
Q ss_pred EEeccC-CCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC--eeeeccccchh
Q 005007 414 LEYVHP-GSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKH 485 (720)
Q Consensus 414 mEy~~g-GsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~--VKL~DFGlA~~ 485 (720)
+|-+.| -+|.+++.+.. ...++..-..++.+|+..|.-||+.|+.|+|+-+.|||++.+|. |+++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 57888886531 24577777899999999999999999999999999999987777 99999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.1e-07 Score=103.41 Aligned_cols=230 Identities=22% Similarity=0.193 Sum_probs=154.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh------------cCCEEEEEEEeccCC-
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------VDDHLYIYLEYVHPG- 420 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~------------~~~~lyLVmEy~~gG- 420 (720)
..|....-+++|+++++|+.+...+...+ .|.+.........++.+.++.. .++...++|+|+.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34566677899999999999887766666 7777654333333344433332 245677888888776
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 500 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~ 500 (720)
+-...+......+.+-++..+.+.-+++|+|+|+.-=+||| |||.. ++.+|+.||+....+.......+..+|+.
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~ 395 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPE 395 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccccCCCCCC
Confidence 22111111112355556677778888999999998778999 88884 47899999999988776666678889999
Q ss_pred CCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc-----cCCHHH-HHHHH
Q 005007 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-----MLSSEG-KDFLL 574 (720)
Q Consensus 501 YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~-----~ls~el-~dLI~ 574 (720)
|+|||++.+ ..+....|+|++|+--.+|.-|.+|-... ......+ ...+..+. .++.-. .++..
T Consensus 396 ~~~pev~~~-------~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~-g~~p~s~~L~~~~aw~~~~~~~~~~ 465 (829)
T KOG0576|consen 396 PLAPEVIQE-------NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMI-GNGPNSPMLTDKSAWSPVFHRDFPA 465 (829)
T ss_pred CCCchhhcc-------cccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCC-CCCCCccccchhhhcCcccccCCcc
Confidence 999999874 45667899999999888888888775431 0111100 00010110 111111 24778
Q ss_pred HhhhcCCCCCCCHHHHHcCcccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.|+...|..|+....++.|.+|...
T Consensus 466 ~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 466 PCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cccCCCCCCCcchhhHHHHHHhccC
Confidence 8899899999999998888877543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1e-05 Score=93.12 Aligned_cols=78 Identities=22% Similarity=0.209 Sum_probs=54.6
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC----CCCeeeeccccch
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----SGVVKLADFGMAK 484 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~----~g~VKL~DFGlA~ 484 (720)
...|+||||+|.-+.++-.-....++...+...+.++..-+-+ ..|++|+|=.|.|||+.. ++.+.|.|||+..
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 4589999999987766543222446666555444443322222 468999999999999984 6789999999987
Q ss_pred hccC
Q 005007 485 HLTG 488 (720)
Q Consensus 485 ~~~~ 488 (720)
.+..
T Consensus 354 ~is~ 357 (538)
T KOG1235|consen 354 VISH 357 (538)
T ss_pred cccH
Confidence 6543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2e-05 Score=82.48 Aligned_cols=125 Identities=15% Similarity=0.199 Sum_probs=83.0
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-----------------------------HHHHHHHhhc---
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------------------AECIKQLEQV--- 406 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-----------------------------~~~ik~L~~~--- 406 (720)
...|..|--+.||+|.. .++..||||+.+.....-+. ...+..+.+.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777788889999975 46899999987643211100 0111111111
Q ss_pred ------CCEEEEEEEeccCCC-HHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeee
Q 005007 407 ------DDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 407 ------~~~lyLVmEy~~gGs-L~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
-.+-.|||||+.... -.-.|++ -.+...++..+..++++.|.-|-. .++||+||..-|||+. ++.+.||
T Consensus 132 vP~Pi~~~~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 132 VPEPIAFRNNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred CCCceeecCCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 123479999995331 0111111 123344678888999999988866 8999999999999998 8899999
Q ss_pred ccccchhcc
Q 005007 479 DFGMAKHLT 487 (720)
Q Consensus 479 DFGlA~~~~ 487 (720)
|||-|....
T Consensus 209 D~~QaV~~~ 217 (268)
T COG1718 209 DVSQAVTID 217 (268)
T ss_pred ECccccccC
Confidence 999886544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.99 E-value=4e-05 Score=76.59 Aligned_cols=125 Identities=19% Similarity=0.270 Sum_probs=69.7
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccC---CCChhHHHHHHHHhh----------------cCCEEEEEEEeccC
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDII---PDDPKSAECIKQLEQ----------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~---~~~~~~~~~ik~L~~----------------~~~~lyLVmEy~~g 419 (720)
++.|+.|..+.||++.... ..+++|..... .....+...+..+.. .....+++|+|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4789999999999998765 48889987543 111122233333332 13357899999999
Q ss_pred CCHHH----------------HHH---Hhc---CCCcHHH---------HHHH------------HHHHHH-HHHHHH--
Q 005007 420 GSINR----------------YVR---EHC---RDITESI---------VRNF------------TRHILN-GLAYLH-- 453 (720)
Q Consensus 420 GsL~~----------------~L~---~~~---~~Lse~~---------i~~i------------~~QIL~-gL~yLH-- 453 (720)
..+.. .+. ... ..+.... .... ...+.+ .+..++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 111 100 0000000 0000 111222 333333
Q ss_pred -----hCCCcccccCCCceeec-CCCCeeeeccccchh
Q 005007 454 -----STNTIHRDIKGANLLVD-ASGVVKLADFGMAKH 485 (720)
Q Consensus 454 -----s~gIVHRDIKP~NILLd-~~g~VKL~DFGlA~~ 485 (720)
...++|+|+.+.|||++ .++.|.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 24689999999999999 667778999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00021 Score=73.99 Aligned_cols=28 Identities=25% Similarity=0.389 Sum_probs=25.3
Q ss_pred CCcccccCCCceeecCCCCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 468999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00011 Score=73.41 Aligned_cols=122 Identities=19% Similarity=0.195 Sum_probs=81.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHH---HHhhc--------CCEEEEEEEeccCCCHH
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---QLEQV--------DDHLYIYLEYVHPGSIN 423 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik---~L~~~--------~~~lyLVmEy~~gGsL~ 423 (720)
.-+..+.||+|++|.||+|.++ |..+|+|+-...........+.+ .+.-. -+..++.|||++|-.|.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~ 100 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchh
Confidence 4456789999999999999886 77999997765544333333333 33221 12345669999988887
Q ss_pred HHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccC-CCceeecCCCCeeeeccccchhc
Q 005007 424 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK-GANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 424 ~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIK-P~NILLd~~g~VKL~DFGlA~~~ 486 (720)
+..... + ++-+..+++.-.-|-..||-|..|. |..++|-.++.+.|+||.-|+..
T Consensus 101 ~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 765421 1 2333455566555667899999986 44444445569999999998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00012 Score=89.21 Aligned_cols=171 Identities=28% Similarity=0.365 Sum_probs=122.7
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCC---ceeecCCCCeeee--ccccchhccC
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA---NLLVDASGVVKLA--DFGMAKHLTG 488 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~---NILLd~~g~VKL~--DFGlA~~~~~ 488 (720)
.|||.+-++...+... +.++..+++.+..++++||.|+|+....|.-+... +-.++.++.+.+. ||+..+.+..
T Consensus 265 ~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred HhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 3566666777777543 67889999999999999999999997666665555 4455667778887 9999988777
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHH
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 568 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~e 568 (720)
........-...|.++|..... ....+...|+|.+|..+..+..|..+-... .....++ +.....+
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~-----~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l------~~~~~~~ 409 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKEN-----TAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL------DVLSTSE 409 (1351)
T ss_pred cccchhhcCccccccccccccc-----cchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh------ccccchh
Confidence 6665555566678888876521 223344579999999999999876542211 1111111 1112226
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
..+++.+|+..+.++|+.+.++|.|+|.+..
T Consensus 410 ~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 410 LLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 7899999999999999999999999998643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00069 Score=69.88 Aligned_cols=29 Identities=24% Similarity=0.287 Sum_probs=26.2
Q ss_pred CCcccccCCCceeecCCCCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999988888999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=1.6e-05 Score=98.16 Aligned_cols=183 Identities=18% Similarity=0.115 Sum_probs=132.0
Q ss_pred CEEEEEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhC-----CCcccccCCCceeecCCCCeeeec
Q 005007 408 DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-----NTIHRDIKGANLLVDASGVVKLAD 479 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~-----gIVHRDIKP~NILLd~~g~VKL~D 479 (720)
...|++++|+.+|.++..|.+. ...+.+.-+.....+.+.+..-+|.. -.+|+++|+-|.+|..+..||+++
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 3457889999999999998653 23456666666667767788888854 368999999999999999999999
Q ss_pred cccchh-ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-c
Q 005007 480 FGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-R 557 (720)
Q Consensus 480 FGlA~~-~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~ 557 (720)
+|+.+. ...........+++.|+.+++.... .++.++|+|..|+.+|++..|..+|........-..+.+ .
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-------k~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~t 1456 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-------KFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHT 1456 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHHHHHH-------hhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccc
Confidence 999993 3333344456788999999998753 355579999999999999999888754222221111211 2
Q ss_pred CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 558 ~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
...++...+.++-.....+|-+.-..||.-...+.-+.|.
T Consensus 1457 f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1457 FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 3344555566666666667777778888888888776663
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00015 Score=78.47 Aligned_cols=123 Identities=16% Similarity=0.203 Sum_probs=85.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC---------------------------ChhHHHHHHHHhh--
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---------------------------DPKSAECIKQLEQ-- 405 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~---------------------------~~~~~~~ik~L~~-- 405 (720)
-|.+|..||-|--+-||++.+. .|...++|.-.+... ..++...++.|.+
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4568899999999999999875 488999994432110 0112222333433
Q ss_pred -------cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 406 -------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 406 -------~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
..++.++|||++.|-.|...-+ ...+..+...|..-+.-|-.+|+||+|+.--||+|++++.++++
T Consensus 172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 172 FPVPKPIDHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred CCCCCcccccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence 1356799999999887765431 11223344455555667788999999999999999999999999
Q ss_pred ccccchh
Q 005007 479 DFGMAKH 485 (720)
Q Consensus 479 DFGlA~~ 485 (720)
||--...
T Consensus 245 DFPQmvS 251 (465)
T KOG2268|consen 245 DFPQMVS 251 (465)
T ss_pred echHhhc
Confidence 9976543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0029 Score=67.95 Aligned_cols=127 Identities=20% Similarity=0.206 Sum_probs=73.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh-------------------cCCEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ-------------------VDDHLYIY 413 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~-------------------~~~~lyLV 413 (720)
....+.|+.|....||++.. .+| .+++|+........ ...+.+..|.. .++..+++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 34466778888889999864 334 57788765432111 12233333432 13557899
Q ss_pred EEeccCCCHH-----------HHH---HHhcCCCcH--------H---H--HH----------HHHHHHHHHHHHHHh--
Q 005007 414 LEYVHPGSIN-----------RYV---REHCRDITE--------S---I--VR----------NFTRHILNGLAYLHS-- 454 (720)
Q Consensus 414 mEy~~gGsL~-----------~~L---~~~~~~Lse--------~---~--i~----------~i~~QIL~gL~yLHs-- 454 (720)
|||++|..+. ..+ +.....+.. . . .. .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999985431 111 111011100 0 0 00 011123345555542
Q ss_pred -----CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 -----TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 -----~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988878999999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0066 Score=65.25 Aligned_cols=30 Identities=27% Similarity=0.387 Sum_probs=26.1
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++||+|+++.|||++.+..+-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866666899999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0026 Score=65.56 Aligned_cols=31 Identities=29% Similarity=0.389 Sum_probs=26.0
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.+++|+|+.+.|||++.++...|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998766667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0065 Score=62.10 Aligned_cols=29 Identities=24% Similarity=0.403 Sum_probs=26.0
Q ss_pred CCcccccCCCceeecC-CCCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDA-SGVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~-~g~VKL~DFGlA~ 484 (720)
+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6899999999999997 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0064 Score=64.48 Aligned_cols=125 Identities=16% Similarity=0.205 Sum_probs=72.4
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChhHHHHHHHHhh-------------------cCCEEEEEEEe
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQ-------------------VDDHLYIYLEY 416 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~~~~~ik~L~~-------------------~~~~lyLVmEy 416 (720)
..+.|..|....+|+... .+..+++|+..... ....+.+.+..+.+ .++..++||||
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 356778888889999864 24568889876411 11123334444432 13346899999
Q ss_pred ccCCCHHH-----------HH---HHhcCCCcH--------HHHH------------HHHHHHHHHHHHHHh-------C
Q 005007 417 VHPGSINR-----------YV---REHCRDITE--------SIVR------------NFTRHILNGLAYLHS-------T 455 (720)
Q Consensus 417 ~~gGsL~~-----------~L---~~~~~~Lse--------~~i~------------~i~~QIL~gL~yLHs-------~ 455 (720)
++|..+.. .+ +.....+.. .... .....+..++.++.. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99866421 11 110000100 0000 011122334445443 4
Q ss_pred CCcccccCCCceeecCCCCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999988778999998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0051 Score=67.89 Aligned_cols=125 Identities=20% Similarity=0.290 Sum_probs=86.2
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----------------------CCh---------hHHHHHHHHhh
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----------------------DDP---------KSAECIKQLEQ 405 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----------------------~~~---------~~~~~ik~L~~ 405 (720)
.+..+|..|--+.||.|.. .+|..+|||+.+... ..+ ++.+.++.+..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3456788899999999874 568899999775210 011 11222233332
Q ss_pred c---------CCEEEEEEEeccCCCH--HHHHHHhcCCCcHHHHHHHHHHHHHHHHHH-HhCCCcccccCCCceeecCCC
Q 005007 406 V---------DDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASG 473 (720)
Q Consensus 406 ~---------~~~lyLVmEy~~gGsL--~~~L~~~~~~Lse~~i~~i~~QIL~gL~yL-Hs~gIVHRDIKP~NILLd~~g 473 (720)
. -....|||+|+. ++= .-.|++ ..++...+..+-.|++.-|.-| |..++||.||.--|+|+ .+|
T Consensus 226 aGIP~PePIlLk~hVLVM~FlG-rdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 226 AGIPCPEPILLKNHVLVMEFLG-RDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred cCCCCCCceeeecceEeeeecc-CCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence 1 134579999995 331 122222 4577888888888888888887 56799999999999999 778
Q ss_pred Ceeeeccccchhc
Q 005007 474 VVKLADFGMAKHL 486 (720)
Q Consensus 474 ~VKL~DFGlA~~~ 486 (720)
.+.|+|-+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 9999999877543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.011 Score=72.32 Aligned_cols=30 Identities=20% Similarity=0.434 Sum_probs=24.8
Q ss_pred CCcccccCCCceeecCC--CCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDAS--GVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~--g~VKL~DFGlA~~ 485 (720)
.+||+|+++.|||++.+ ..+-|+||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 49999999999999853 3468999999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.045 Score=56.18 Aligned_cols=40 Identities=30% Similarity=0.344 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccc
Q 005007 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 439 ~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
..-+.+|++-|..+|..||+-+|+|+.|.. .=||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 344678888899999999999999999986 2579999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.012 Score=61.36 Aligned_cols=29 Identities=34% Similarity=0.599 Sum_probs=25.5
Q ss_pred CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.++|+|+.+.|||+++++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 579999999999998877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.026 Score=63.54 Aligned_cols=29 Identities=21% Similarity=0.300 Sum_probs=24.8
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
..++|+|+.+.|||+..+ .++|+||.++.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 468999999999999665 69999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.0054 Score=61.92 Aligned_cols=74 Identities=20% Similarity=0.190 Sum_probs=59.5
Q ss_pred EEEEEeccCCCHHHH---HHHhcCCCcHHHHHHHHHHHHHHHHHHHh---CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 411 YIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS---TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 411 yLVmEy~~gGsL~~~---L~~~~~~Lse~~i~~i~~QIL~gL~yLHs---~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
++|.||+..+++... +.+ ...-++....+|+.+|++.+++|+. ..+.-.|++++|+-|+++|++|++|...+.
T Consensus 32 ~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 567799987766421 111 2346889999999999999999987 457889999999999999999999998764
Q ss_pred h
Q 005007 485 H 485 (720)
Q Consensus 485 ~ 485 (720)
.
T Consensus 111 ~ 111 (188)
T PF12260_consen 111 V 111 (188)
T ss_pred h
Confidence 3
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.028 Score=60.51 Aligned_cols=65 Identities=11% Similarity=0.057 Sum_probs=41.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC---CCChhHHHHHHHHhhc-----------------CCEEEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII---PDDPKSAECIKQLEQV-----------------DDHLYIYLE 415 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~---~~~~~~~~~ik~L~~~-----------------~~~lyLVmE 415 (720)
-...+.||.|..+.||...... + .+.+|..+.. .....+.+.++.+.+. .+.-+||||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3455789999999999986432 3 4667775542 1223344455554331 245799999
Q ss_pred eccCCCH
Q 005007 416 YVHPGSI 422 (720)
Q Consensus 416 y~~gGsL 422 (720)
+++|+.+
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.042 Score=58.61 Aligned_cols=29 Identities=28% Similarity=0.366 Sum_probs=25.9
Q ss_pred CCcccccCCCceeecCC----CCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDAS----GVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~----g~VKL~DFGlA~ 484 (720)
.++|+|+.+.|||++.+ +.++|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 57999999999999875 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.16 Score=51.87 Aligned_cols=115 Identities=23% Similarity=0.330 Sum_probs=70.3
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCC------------------CChhHHHHH---HHHh-h-----------
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP------------------DDPKSAECI---KQLE-Q----------- 405 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~------------------~~~~~~~~i---k~L~-~----------- 405 (720)
...||+|+.=.||.- .. .....||++.... ......+++ ..+. .
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999999873 33 3345588776544 011112222 2222 1
Q ss_pred -----cCCEEEEEEEeccCC------CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC--
Q 005007 406 -----VDDHLYIYLEYVHPG------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-- 472 (720)
Q Consensus 406 -----~~~~lyLVmEy~~gG------sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-- 472 (720)
.+.-+-+|+|.+... +|.+++.+ +.+++ .+. ..|-+-.+||-+++|+.+||+|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 122346788877643 48888854 34655 333 334455678889999999999999999533
Q ss_pred C--Ceeeec-ccc
Q 005007 473 G--VVKLAD-FGM 482 (720)
Q Consensus 473 g--~VKL~D-FGl 482 (720)
+ .+.|+| ||-
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 2 577887 454
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.063 Score=59.66 Aligned_cols=29 Identities=21% Similarity=0.340 Sum_probs=24.4
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
..++|+|+.+.|||+++++ ++++||.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 4689999999999997654 8899998763
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.11 Score=55.91 Aligned_cols=30 Identities=17% Similarity=0.201 Sum_probs=27.5
Q ss_pred CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.13 Score=56.70 Aligned_cols=42 Identities=29% Similarity=0.340 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHh-------CC---CcccccCCCceeecCCCC-eeeeccccch
Q 005007 443 RHILNGLAYLHS-------TN---TIHRDIKGANLLVDASGV-VKLADFGMAK 484 (720)
Q Consensus 443 ~QIL~gL~yLHs-------~g---IVHRDIKP~NILLd~~g~-VKL~DFGlA~ 484 (720)
.++...++.+.+ .+ |||+|+.+.|||++.+.. +.++|||-+.
T Consensus 175 a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 175 AALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 344555555553 23 999999999999998874 9999999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.058 Score=59.80 Aligned_cols=73 Identities=22% Similarity=0.239 Sum_probs=54.3
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
.+.|++|++- |+.|.-+ .....+++..|+++.+..|.-+..+ ..=|||+...||||+ +|+|.|+||-+++.-
T Consensus 299 ~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred eEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 3467777775 4555322 2345677888888887766666544 577999999999998 999999999999854
Q ss_pred c
Q 005007 487 T 487 (720)
Q Consensus 487 ~ 487 (720)
.
T Consensus 372 ~ 372 (488)
T COG5072 372 Y 372 (488)
T ss_pred c
Confidence 3
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.28 Score=53.67 Aligned_cols=28 Identities=25% Similarity=0.495 Sum_probs=24.5
Q ss_pred CcccccCCCceeecC-CCCeeeeccccch
Q 005007 457 TIHRDIKGANLLVDA-SGVVKLADFGMAK 484 (720)
Q Consensus 457 IVHRDIKP~NILLd~-~g~VKL~DFGlA~ 484 (720)
.+|.|+.+.|||+++ ++.++|+||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 589999999999975 5789999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.073 Score=56.86 Aligned_cols=30 Identities=27% Similarity=0.416 Sum_probs=25.3
Q ss_pred CCcccccCCCceeecCCCC-eeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDASGV-VKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~-VKL~DFGlA~~ 485 (720)
.++|+|+++.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4799999999999987555 57999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.45 Score=59.79 Aligned_cols=31 Identities=45% Similarity=0.670 Sum_probs=26.2
Q ss_pred CCCcccccCCCceeecCCC--Cee-eeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASG--VVK-LADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g--~VK-L~DFGlA~~ 485 (720)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999998775 555 999998753
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.19 Score=56.60 Aligned_cols=60 Identities=23% Similarity=0.337 Sum_probs=43.8
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHH-HhCCCcccccCCCceeecC
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDA 471 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yL-Hs~gIVHRDIKP~NILLd~ 471 (720)
..||=+|+.|.++..+++.. ..+|...++++.-...||.-+ --.+.+|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 46677899999999999653 356666666666555554443 3468999999999999943
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.37 Score=52.80 Aligned_cols=31 Identities=23% Similarity=0.351 Sum_probs=28.1
Q ss_pred CCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
.++|+|+.+.||+|+.++.+-|+||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 5799999999999999999999999998654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.62 Score=52.78 Aligned_cols=28 Identities=18% Similarity=0.367 Sum_probs=23.9
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccc
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
.-.+|+||.+.|||++.++ ++++|..++
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 3689999999999998765 899997765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.14 E-value=0.3 Score=55.04 Aligned_cols=29 Identities=24% Similarity=0.320 Sum_probs=24.7
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.-.+|+||.+.|||++++ .+|++|..+|.
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence 468999999999999775 59999988774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.98 E-value=0.14 Score=54.48 Aligned_cols=29 Identities=24% Similarity=0.332 Sum_probs=25.5
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999998763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.90 E-value=1.8 Score=47.14 Aligned_cols=28 Identities=21% Similarity=0.253 Sum_probs=23.9
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999874
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.25 E-value=0.47 Score=47.86 Aligned_cols=31 Identities=23% Similarity=0.304 Sum_probs=26.0
Q ss_pred CCCcccccCCCceeecCCC-----Ceeeeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASG-----VVKLADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g-----~VKL~DFGlA~~ 485 (720)
..++|+|+.+.||++..++ .+.|+||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4689999999999997543 699999998753
|
subfamily of choline kinases |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=89.21 E-value=0.43 Score=50.95 Aligned_cols=47 Identities=23% Similarity=0.306 Sum_probs=35.0
Q ss_pred HHHHHHHHHHHHHHHhC--CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 439 RNFTRHILNGLAYLHST--NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 439 ~~i~~QIL~gL~yLHs~--gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
...+..+-.++.-.+.. -++|.|+.++|+|+++.|.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444455555555433 588999999999999989999999987753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.97 E-value=0.26 Score=50.06 Aligned_cols=29 Identities=34% Similarity=0.602 Sum_probs=25.2
Q ss_pred CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
-.+|+|+.|.||+++++| ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 358999999999998777 99999998854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.62 E-value=5.1 Score=45.09 Aligned_cols=29 Identities=24% Similarity=0.175 Sum_probs=23.5
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
...+|.|+-+.|||++. +.+.|+||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35689999999999854 569999997663
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=88.61 E-value=0.48 Score=47.91 Aligned_cols=30 Identities=37% Similarity=0.537 Sum_probs=21.1
Q ss_pred CCcccccCCCceee-cCCCCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLV-DASGVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILL-d~~g~VKL~DFGlA~~ 485 (720)
-++|.||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 57899999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=88.56 E-value=0.37 Score=53.06 Aligned_cols=29 Identities=21% Similarity=0.497 Sum_probs=25.5
Q ss_pred CCcccccCCCceeecC-CCCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDA-SGVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~-~g~VKL~DFGlA~ 484 (720)
.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5799999999999976 4789999998874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=88.22 E-value=2.2 Score=46.14 Aligned_cols=63 Identities=22% Similarity=0.273 Sum_probs=35.3
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh--------------cCCEEEEEEEeccC
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ--------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~--------------~~~~lyLVmEy~~g 419 (720)
.+..+.|+-|....+|+.. .+++.+.||.-..... ...+.+-++.|.+ .++.-||||||++.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4566788999999999987 5688899997763222 2334455555533 13445899999987
Q ss_pred C
Q 005007 420 G 420 (720)
Q Consensus 420 G 420 (720)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 720 | ||||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-42 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-37 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-36 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-36 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-36 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-35 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-35 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-35 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-35 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-34 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-33 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-33 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-33 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-33 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-33 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-33 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-33 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-33 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-33 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-33 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-32 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-32 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-30 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-29 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-29 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-28 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-28 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-28 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-28 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-28 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-28 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-27 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-27 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-26 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-26 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-26 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-26 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-24 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-23 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-23 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-23 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-23 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-23 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-23 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-23 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-23 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-23 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-23 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-23 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-23 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-23 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-23 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-23 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-23 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-23 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-23 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-23 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-23 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-23 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-23 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-23 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-23 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-23 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-22 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-21 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-20 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-19 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-18 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-18 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-16 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-16 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-16 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-15 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-15 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-15 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-15 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-15 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-08 |
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-121
Identities = 94/292 (32%), Positives = 146/292 (50%), Gaps = 38/292 (13%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
+ + + ++G+GT+G VY G + AIKE+ + + + L
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLH 67
Query: 405 Q---------------------VDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNF 441
+ + + I++E V GS++ +R + E + +
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 442 TRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGL-SYELSLKGSP 499
T+ IL GL YLH +HRDIKG N+L++ SGV+K++DFG +K L G+ + G+
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV--LN 556
+MAPE+I G A DIWSLGCT+IEM TGKPP+ E P AMFKV
Sbjct: 188 QYMAPEIID--KGPRG---YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242
Query: 557 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 608
P IPE +S+E K F+L+CF +P +R A +LL F++ ++ + + P
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-112
Identities = 75/329 (22%), Positives = 126/329 (38%), Gaps = 32/329 (9%)
Query: 303 PQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLI 362
+ L ++ + +A L P +T + P + +
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREEVHWMTHQPRV 66
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQVDDHLY 411
GRG+FG V+ +++TG CA+K+V + + L + +
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVN 126
Query: 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471
I++E + GS+ + ++ + E + L GL YLH+ +H D+K N+L+ +
Sbjct: 127 IFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185
Query: 472 SGV-VKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 524
G L DFG A L + G+ MAPEV+ K + K VD
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM---GKPCDAK----VD 238
Query: 525 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDFLLRCFLRNP 581
IWS C ++ ML G PW+++ K+ + PP IP + + + P
Sbjct: 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEP 298
Query: 582 VERPSAVELLEHPFIRNANYQNLSVPMRV 610
V R SA+EL L P +
Sbjct: 299 VHRASAMELRRKVGKALQEVGGLKSPWKG 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-101
Identities = 67/301 (22%), Positives = 127/301 (42%), Gaps = 47/301 (15%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
+ + + S + IGRG+F +VY G + ET A E+
Sbjct: 4 RNQQQDDIEELETKAVGM---SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 389 IIPDDPKSAECIKQLEQV-------------------------DDHLYIYLEYVHPGSIN 423
D + ++ ++ + + E + G++
Sbjct: 61 ---DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 424 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNT--IHRDIKGANLLVDA-SGVVKLADF 480
Y++ + ++R++ R IL GL +LH+ IHRD+K N+ + +G VK+ D
Sbjct: 118 TYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 481 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540
G+A S+ ++ G+P +MAPE+ + K +VD+++ G ++EM T +
Sbjct: 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEY 227
Query: 541 PWSEFEGPQAMFK-VLNRTPP--IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
P+SE + +++ V + P ++ E K+ + C +N ER S +LL H F +
Sbjct: 228 PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
Query: 598 N 598
Sbjct: 288 E 288
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-87
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 52/293 (17%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV- 406
S +++ + + IG G FGSV+ R G AIK + +
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 407 ------------------DDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHI 445
DDH+ I EY + GS+ + E+ R E+ +++ +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 486
GL Y+HS + +H DIK +N+ + + + K+ D G +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 546
+ +G ++A EV++ PK DI++L TV+ +P +
Sbjct: 185 SSPQ---VEEGDSRFLANEVLQ--ENYTHLPK----ADIFALALTVVCAAGAEPLPRNGD 235
Query: 547 GPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+ + R P IP++LS E + L +P RPSA+ L++H + +A
Sbjct: 236 QWHEIRQ--GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-85
Identities = 74/309 (23%), Positives = 121/309 (39%), Gaps = 33/309 (10%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
L + N L P +S + + P S + +Q+ +G G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 370 VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV---------------------DD 408
V+ ++E G A+K PK + ++L +V
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468
LY+ E S+ ++ + E+ V + R L LA+LHS +H D+K AN+
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 469 VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 528
+ G KL DFG+ L +G P +MAPE++ Q D++SL
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL----QGSYGTA----ADVFSL 241
Query: 529 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 588
G T++E+ EG Q + + P LSSE + L+ +P R +A
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQ-GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAE 300
Query: 589 ELLEHPFIR 597
LL P +R
Sbjct: 301 ALLALPVLR 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 3e-85
Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--------- 402
K + K IG G V+ N E AIK V++ D ++ + +
Sbjct: 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 403 -----------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
E D ++Y+ +E + +N ++++ + I +++ +++L +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEAVHT 123
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIK 508
+H +H D+K AN L+ G++KL DFG+A + T + S G+ N+M PE IK
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 509 ----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--TPPI 561
+ K++ D+WSLGC + M GK P+ + + +++
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
P++ + +D L C R+P +R S ELL HP+++
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-84
Identities = 71/331 (21%), Positives = 128/331 (38%), Gaps = 36/331 (10%)
Query: 298 RHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQ 357
H A + P S K +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFE--RQHMDSPDLGTDDDDKASSSANECISVKGRIYS 59
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--------------- 402
K IG G V+ N E AIK V++ D ++ + +
Sbjct: 60 ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 403 -----LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
E D ++Y+ +E + +N ++++ I +++ +++L + +H
Sbjct: 119 IRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIK----AV 510
+H D+K AN L+ G++KL DFG+A + T + S G+ N+M PE IK +
Sbjct: 177 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--TPPIPEMLSS 567
K++ D+WSLGC + M GK P+ + + +++ P++
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ +D L C R+P +R S ELL HP+++
Sbjct: 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 3e-84
Identities = 69/285 (24%), Positives = 127/285 (44%), Gaps = 34/285 (11%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ- 402
+ S S K + K IG G V+ N E AIK V++ D ++ + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 403 -------------------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 443
E D ++Y+ +E + +N ++++ + I +++ +
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWK 134
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPN 500
++L + +H +H D+K AN L+ G++KL DFG+A + T + S G+ N
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 501 WMAPEVIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVL 555
+M PE IK + K++ D+WSLGC + M GK P+ + + ++
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 556 NR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ P++ + +D L C R+P +R S ELL HP+++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 8e-77
Identities = 75/300 (25%), Positives = 120/300 (40%), Gaps = 38/300 (12%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
V + + ++ K IGRG F VY G A+K+V
Sbjct: 7 GMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66
Query: 389 IIPDDPKSAECIKQLEQ---------------------VDDHLYIYLEYVHPGSINRYVR 427
I D A+ + D+ L I LE G ++R ++
Sbjct: 67 I--FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 428 EHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484
+ I E V + + + L ++HS +HRDIK AN+ + A+GVVKL D G+ +
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 485 HLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW- 542
+ + SL G+P +M+PE I + N K DIWSLGC + EM + P+
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFK----SDIWSLGCLLYEMAALQSPFY 237
Query: 543 -SEFEGPQAMFKVLN-RTPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+ K+ PP+P + S E + + C +P +RP + + +A
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 8e-75
Identities = 92/270 (34%), Positives = 132/270 (48%), Gaps = 28/270 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ---- 405
W+ +G G FG VY N+ETGA A K ++ ++ E I+ L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE-IEILATCDHP 76
Query: 406 ----------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
D L+I +E+ G+++ + E R +TE ++ R +L L +LHS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKD 514
IHRD+K N+L+ G ++LADFG++ L S G+P WMAPEV+ KD
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 515 G--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEG 569
+ K DIWSLG T+IEM +PP E + + K+ PP P S E
Sbjct: 197 TPYDYK----ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252
Query: 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
+DFL +NP RPSA +LLEHPF+ +
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 8e-73
Identities = 86/320 (26%), Positives = 136/320 (42%), Gaps = 38/320 (11%)
Query: 310 LESNNHLNAHPLPLP-------PGALSPPKSSVTSAVM--PHIMEKPSASPKKSQWQKGK 360
+ +H + H +P GA+ P + + + P + E + + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------------- 404
IG G+FG+VY + AIK++ E
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 405 ---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
+ ++ +EY GS + + H + + E + T L GLAYLHS N IHRD
Sbjct: 121 GCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K N+L+ G+VKL DFG A + + S G+P WMAPEVI A+ + + K
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGK--- 233
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLR 579
VD+WSLG T IE+ KPP A++ + P S ++F+ C +
Sbjct: 234 -VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 580 NPVERPSAVELLEHPFIRNA 599
P +RP++ LL+H F+
Sbjct: 293 IPQDRPTSEVLLKHRFVLRE 312
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 3e-72
Identities = 84/275 (30%), Positives = 133/275 (48%), Gaps = 32/275 (11%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---------SAEC---- 399
++ +L+G GT+G VY G + +TG AIK +D+ D+ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 400 ---------IKQLEQVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGL 449
K +DD L++ +E+ GS+ ++ + E + R IL GL
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIK 508
++LH IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 509 AVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEM 564
D + K D+WSLG T IEM G PP + +A+F + P +
Sbjct: 203 CDENPDATYDFK----SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
S + + F+ C ++N +RP+ +L++HPFIR+
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-71
Identities = 91/267 (34%), Positives = 135/267 (50%), Gaps = 29/267 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC--IKQLEQ----- 405
K ++ + + IG+G G+VY + TG AI+++++ K I + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 406 ---------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
V D L++ +EY+ GS+ V E C + E + R L L +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDG 515
IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT---RKAY 193
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDF 572
PK VDIWSLG IEM+ G+PP+ +A++ + P PE LS+ +DF
Sbjct: 194 GPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599
L RC + +R SA ELL+H F++ A
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-71
Identities = 93/262 (35%), Positives = 145/262 (55%), Gaps = 25/262 (9%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------- 405
+ + +G G++GSVY ++ETG AIK+V + D + + I ++Q
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 406 ----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
+ L+I +EY GS++ +R + +TE + + L GL YLH IHRD
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 520
IK N+L++ G KLADFG+A LT ++ ++ G+P WMAPEVI+ + N
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGYNCV-- 205
Query: 521 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLRCF 577
DIWSLG T IEM GKPP+++ +A+F + PP PE+ S DF+ +C
Sbjct: 206 --ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263
Query: 578 LRNPVERPSAVELLEHPFIRNA 599
+++P +R +A +LL+HPF+R+A
Sbjct: 264 VKSPEQRATATQLLQHPFVRSA 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-70
Identities = 87/310 (28%), Positives = 140/310 (45%), Gaps = 34/310 (10%)
Query: 313 NNHLNAHPLPLPPGALSPPKSSVTSA-VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
++H ++ + L L VT + + IG G+ G V
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQ--------------VDDHLYIY 413
+ + +G A+K +D+ + E + + V + L++
Sbjct: 63 LAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 473
+E++ G++ V + + E + +L LAYLH+ IHRDIK ++L+ G
Sbjct: 121 MEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178
Query: 474 VVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 532
VKL+DFG ++ + SL G+P WMAPEVI + + VDIWSLG V
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYATE----VDIWSLGIMV 231
Query: 533 IEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLRCFLRNPVERPSAVE 589
IEM+ G+PP+ QAM ++ + PP +S +DFL R +R+P ER +A E
Sbjct: 232 IEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
Query: 590 LLEHPFIRNA 599
LL+HPF+
Sbjct: 292 LLDHPFLLQT 301
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-70
Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 48/301 (15%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
M S + ++ ++IG G V AIK +++ E
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL 60
Query: 400 IKQLE-----------------QVDDHLYIYLEYVHPGSINRYVREHCRD-------ITE 435
+K+++ V D L++ ++ + GS+ ++ + E
Sbjct: 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 436 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495
S + R +L GL YLH IHRD+K N+L+ G V++ADFG++ L
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 496 K------GSPNWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548
K G+P WMAPEV++ Q G + K DIWS G T IE+ TG P+ ++
Sbjct: 181 KVRKTFVGTPCWMAPEVME---QVRGYDFK----ADIWSFGITAIELATGAAPYHKYPPM 233
Query: 549 QAMFKVLNRTPP----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ + L PP + + + + C ++P +RP+A ELL H F +
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
Query: 599 A 599
A
Sbjct: 294 A 294
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-70
Identities = 98/273 (35%), Positives = 138/273 (50%), Gaps = 29/273 (10%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ- 402
M+ A P++ + K + IG+G+FG V+ G + T AIK +D+ + + + ++
Sbjct: 13 MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI 71
Query: 403 --LEQ--------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 446
L Q D L+I +EY+ GS + + E+ + R IL
Sbjct: 72 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREIL 129
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPE 505
GL YLHS IHRDIK AN+L+ G VKLADFG+A LT + G+P WMAPE
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEM 564
VIK Q + K DIWSLG T IE+ G+PP SE + +F + PP +
Sbjct: 190 VIK---QSAYDSK----ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN 242
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
S K+F+ C + P RP+A ELL+H FI
Sbjct: 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-68
Identities = 71/315 (22%), Positives = 133/315 (42%), Gaps = 29/315 (9%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLE--- 404
++ + + IG G+FG + + E G IKE++I K + ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 405 --------QVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHST 455
+ + LYI ++Y G + + + E + ++ I L ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKD 514
+HRDIK N+ + G V+L DFG+A+ L + + G+P +++PE+ + K
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE---NKP 201
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 573
N K DIW+LGC + E+ T K + + K+++ PP+ S + + +
Sbjct: 202 YNNK----SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257
Query: 574 LRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTES 633
+ F RNP +RPS +LE FI + P + L S + K +
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAK-RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316
Query: 634 LPDSPETRVRNRKLP 648
+ + + +K+
Sbjct: 317 SGQNSISVMPAQKIT 331
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-65
Identities = 58/271 (21%), Positives = 109/271 (40%), Gaps = 40/271 (14%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--------------------II------ 390
++ +LIG G FG V+ +R G + IK V I+
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 391 --PDDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILN 447
D L+I +E+ G++ +++ + + + + + I
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 507
G+ Y+HS I+RD+K +N+ + + VK+ DFG+ L KG+ +M+PE I
Sbjct: 134 GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI 193
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS 567
+D + VD+++LG + E+L FE + + R I ++
Sbjct: 194 S---SQDYGKE----VDLYALGLILAELLHVCDT--AFETSKFFTDL--RDGIISDIFDK 242
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ K L + + P +RP+ E+L +
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-64
Identities = 75/290 (25%), Positives = 133/290 (45%), Gaps = 31/290 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE--------- 404
+ +GRG +G V + +G A+K + + + + L+
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 405 ---------QVDDHLYIYLEYVHPGS---INRYVREHCRDITESIVRNFTRHILNGLAYL 452
+ ++I +E + S + V + + I E I+ I+ L +L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 453 HST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
HS + IHRD+K +N+L++A G VK+ DFG++ +L + G +MAPE I +
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI--PEMLSSE 568
+ G + DIWSLG T+IE+ + P+ + P Q + +V+ P + S+E
Sbjct: 186 NQKGYSVKS---DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGD 618
DF +C +N ERP+ EL++HPF +++ + F ++ LGD
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQHPFFT--LHESKGTDVASFVKLILGD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 8e-63
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 46/289 (15%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--- 396
MP E ++ IG G++G + G KE+D
Sbjct: 1 MPSRAED---------YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 397 ----AECIKQL-------------EQVDDHLYIYLEYVHPGSINRYVREHCRD---ITES 436
+++L ++ + LYI +EY G + + + ++ + E
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 437 IVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS 490
V + L H + +HRD+K AN+ +D VKL DFG+A+ L S
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 550
+ + G+P +M+PE + + N K DIWSLGC + E+ PP++ F +
Sbjct: 172 FAKTFVGTPYYMSPEQMN---RMSYNEK----SDIWSLGCLLYELCALMPPFTAFSQKEL 224
Query: 551 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
K+ + IP S E + + R RPS E+LE+P I
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-61
Identities = 73/289 (25%), Positives = 126/289 (43%), Gaps = 45/289 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
IGRG +GSV ++ +G A+K + D+ + + + L+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 405 -QVDDHLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHST-NTI 458
+ +I +E + S +++ + I E I+ T + L +L I
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAVMQK 513
HRDIK +N+L+D SG +KL DFG++ L S+ G +MAPE I +
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERIDPSASR 203
Query: 514 DG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI-----PEMLS 566
G + + D+WSLG T+ E+ TG+ P+ ++ + +V+ PP S
Sbjct: 204 QGYDVR----SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 615
+F+ C ++ +RP ELL+HPFI + + V V ++
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-61
Identities = 61/369 (16%), Positives = 118/369 (31%), Gaps = 84/369 (22%)
Query: 348 SASPKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--- 402
S P+ ++ +IG+G +V + + TG ++ +++ + ++
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELH 78
Query: 403 -LEQ--------------VDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHIL 446
+ D+ L++ ++ GS + H D + E + + +L
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSLKGS 498
L Y+H +HR +K +++L+ G V L+ + +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 499 PNWMAPEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 556
W++PEV++ Q + K DI+S+G T E+ G P+ + Q + + LN
Sbjct: 199 LPWLSPEVLQ---QNLQGYDAK----SDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 557 RTPP----------------------------------------------IPEMLSSEGK 570
T P S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 571 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 630
F+ +C RNP RPSA LL H F + + + + +
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSG 371
Query: 631 TESLPDSPE 639
L + E
Sbjct: 372 IFGLVTNLE 380
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-61
Identities = 61/310 (19%), Positives = 117/310 (37%), Gaps = 46/310 (14%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDH--- 409
K + ++G G G++ A+K + E ++ L + D+H
Sbjct: 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADRE-VQLLRESDEHPNV 80
Query: 410 ------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
YI +E ++ YV + + +GLA+LHS N
Sbjct: 81 IRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139
Query: 458 IHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELS----LKGSPNWMAPEVIK 508
+HRD+K N+L+ ++DFG+ K L + S + G+ W+APE++
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEM 564
+D VDI+S GC +++ G P+ + QA + +
Sbjct: 200 ----EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 624
++ + + +P +RPSA +L+HPF + ++ D++
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE-----------KQLQFFQDVSDRI 304
Query: 625 ERATRKTESL 634
E+ + +
Sbjct: 305 EKESLDGPIV 314
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-60
Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 28/273 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------------- 404
+G GT G V+ R+TG A+K++ + ++ + L+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 405 -QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDI 462
+ ++I +E + + R I E I+ T I+ L YL IHRD+
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEKHGVIHRDV 151
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
K +N+L+D G +KL DFG++ L + G +MAPE I P +
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP--PDPTKPDYDIR 209
Query: 523 VDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI---PEMLSSEGKDFLLRCFL 578
D+WSLG +++E+ TG+ P+ + + + KVL PP+ S + + F+ C
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLT 269
Query: 579 RNPVERPSAVELLEHPFIRNANYQNLSVPMRVF 611
++ +RP +LLEH FI+ Y+ L V + +
Sbjct: 270 KDHRKRPKYNKLLEHSFIK--RYETLEVDVASW 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 62/296 (20%), Positives = 104/296 (35%), Gaps = 57/296 (19%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-------------- 398
S +++ ++G+G FG V N AIK++ + +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 399 --------------CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 444
+ L+I +EY G++ + + R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-------- 496
IL L+Y+HS IHRD+K N+ +D S VK+ DFG+AK++ L L
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 497 -------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ 549
G+ ++A EV+ N K +D++SLG EM+ E
Sbjct: 185 DNLTSAIGTAMYVATEVLDG--TGHYNEK----IDMYSLGIIFFEMIYPFSTGME---RV 235
Query: 550 AMFKVLNR-----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
+ K L P + K + +P +RP A LL ++ +
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 196 bits (502), Expect = 7e-58
Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 41/279 (14%)
Query: 348 SASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIK 401
+ + ++ G L+G+G+F VY + TG AIK +I + ++
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQ 59
Query: 402 ---------------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 443
+L +++Y+ LE H G +NRY++ + +E+ R+F
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWM 502
I+ G+ YLHS +HRD+ +NLL+ + +K+ADFG+A L + L G+PN++
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTP 559
+PE+ + + D+WSLGC +L G+PP F+ + KV+
Sbjct: 180 SPEIA---TRSAHGLE----SDVWSLGCMFYTLLIGRPP---FDTDTVKNTLNKVVLADY 229
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+P LS E KD + + RNP +R S +L+HPF+
Sbjct: 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-58
Identities = 62/303 (20%), Positives = 119/303 (39%), Gaps = 57/303 (18%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLE----- 404
+ + +GRG FG V+ N+ + AIK + + P+ + + + +LE
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEHPGIV 66
Query: 405 ------------------QVDDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNFTRH 444
+LYI ++ ++ ++ C + S+ +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------GLSY 491
I + +LHS +HRD+K +N+ VVK+ DFG+ + +
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 551
G+ +M+PE I + K VDI+SLG + E+L P ++ E + +
Sbjct: 187 HTGQVGTKLYMSPEQIH---GNSYSHK----VDIFSLGLILFELLY--PFSTQMERVRTL 237
Query: 552 FKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRV 610
V N + PP+ + +P+ERP A+ ++E+ + ++ +R
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG-KTVLRQ 296
Query: 611 FSR 613
SR
Sbjct: 297 RSR 299
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-55
Identities = 74/298 (24%), Positives = 130/298 (43%), Gaps = 50/298 (16%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKS 396
P ++ P + ++ +G+ +G+G F + ++ +T A K I+P P
Sbjct: 5 PEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQ 58
Query: 397 AECIK---------------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIV 438
E + +D +++ LE S+ + +TE
Sbjct: 59 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEA 117
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 496
R + R I+ G YLH IHRD+K NL ++ VK+ DFG+A T + Y+ K
Sbjct: 118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKV 174
Query: 497 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF 552
G+PN++APEV+ +K + + VD+WS+GC + +L GKPP FE + +
Sbjct: 175 LCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPP---FETSCLKETY 224
Query: 553 -KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMR 609
++ IP+ ++ + + +P RP+ ELL F + Y +P+
Sbjct: 225 LRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPIT 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-55
Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 56/304 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSA----ECIKQL--- 403
W ++G+G +V+ G +++TG AIK + E +K+L
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 404 ----------EQVDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAY 451
E H + +E+ GS+ + E + ES R ++ G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 452 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 507
L +HR+IK N++ D V KL DFG A+ L +SL G+ ++ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 508 K-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPP-- 560
+ AV++KD K VD+WS+G T TG P+ FEGP+ M+K++ P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 561 -----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP-FI 596
+ L L + + + I
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 597 RNAN 600
+
Sbjct: 308 LHRG 311
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-55
Identities = 81/345 (23%), Positives = 144/345 (41%), Gaps = 52/345 (15%)
Query: 320 PLPLPPGA-----LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
P P PG ++ P + + I E + ++ +G+ +G+G F + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 375 NRETGASCAIKEVDIIP----DDPKSAECIK---------------QLEQV---DDHLYI 412
+ +T A K I+P P E + +D +++
Sbjct: 62 DADTKEVFAGK---IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118
Query: 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 472
LE S+ + +TE R + R I+ G YLH IHRD+K NL ++
Sbjct: 119 VLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177
Query: 473 GVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 528
VK+ DFG+A T + Y+ K G+PN++APEV+ +K + + VD+WS+
Sbjct: 178 LEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFE----VDVWSI 227
Query: 529 GCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP 585
GC + +L GKPP FE + + ++ IP+ ++ + + +P RP
Sbjct: 228 GCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 284
Query: 586 SAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 630
+ ELL F + Y +P+ + + ++ + RK
Sbjct: 285 TINELLNDEFF-TSGYIPARLPITCLTIPPRFSIAPSSLDPSNRK 328
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-54
Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 49/307 (15%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDH--- 409
K+ K++G G+ G+V G A+K + I D E IK L + DDH
Sbjct: 14 KNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALME-IKLLTESDDHPNV 71
Query: 410 ------------LYIYLEYVHPGSINRYV------REHCRDITESIVRNFTRHILNGLAY 451
LYI LE ++ V E+ + E + R I +G+A+
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 452 LHSTNTIHRDIKGANLLVDASGV-------------VKLADFGMAKHLTG--LSYELSLK 496
LHS IHRD+K N+LV S + ++DFG+ K L S+ +L
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 497 ---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP-WSEFEGPQAM 551
G+ W APE+++ +L ++DI+S+GC +L+ GK P ++ +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 552 FK----VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 607
+ + L +E D + + +P++RP+A+++L HP + + L
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS-KKLEFL 309
Query: 608 MRVFSRI 614
++V R+
Sbjct: 310 LKVSDRL 316
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 8e-54
Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 49/279 (17%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV 406
KK QW + G+ +G+G FG+VY+ +++ A+K ++ E Q+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK---VL--FKAQLEKAGVEHQL 56
Query: 407 ------------------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
+Y+ LEY G++ R +++ + E +
Sbjct: 57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYI 115
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 502
+ N L+Y HS IHRDIK NLL+ ++G +K+ADFG + H S L G+ +++
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYL 174
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMF-KVLNRTP 559
PE+I+ + + K VD+WSLG E L GKPP FE Q + ++
Sbjct: 175 PPEMIE---GRMHDEK----VDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEF 224
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
P+ ++ +D + R NP +RP E+LEHP+I
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-53
Identities = 76/327 (23%), Positives = 144/327 (44%), Gaps = 71/327 (21%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE------- 404
K ++K +G G G V+ +++ +G A K + + + I++L+
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 405 ----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
D + I +E++ GS+++ +++ R I E I+ + ++ GL YL
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 149
Query: 455 T-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
+HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ----- 203
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPW------------------------------- 542
++ DIWS+G +++EM G+ P
Sbjct: 204 --GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 543 -------SEFEGPQAMFKVL----NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVE 589
+ P A+F++L N PP + S E +DF+ +C ++NP ER +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 590 LLEHPFIRNANYQNLSVPMRVFSRINL 616
L+ H FI+ ++ + + + S I L
Sbjct: 322 LMVHAFIKRSDAEEVDFAGWLCSTIGL 348
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-51
Identities = 63/296 (21%), Positives = 109/296 (36%), Gaps = 55/296 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAE------------ 398
W ++G+G +V+ G +++TG AIK +
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 399 CIKQLEQV-----DDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAY 451
I +L + H + +E+ GS+ + E + ES R ++ G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 452 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 507
L +HR+IK N++ D V KL DFG A+ L +SL G+ ++ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 508 K-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPP-- 560
+ AV++KD K VD+WS+G T TG P+ FEGP+ M+K++ P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 561 -----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ L L + + +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 44/288 (15%)
Query: 349 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
A K ++ G+ +G+G FG+VY+ ++ A+K + + QL
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQL 61
Query: 404 E---------------------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
+Y+ LE+ G + + +++H R E F
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFM 120
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 502
+ + L Y H IHRDIK NLL+ G +K+ADFG + H ++ G+ +++
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMCGTLDYL 179
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMF-KVLNRTP 559
PE+I+ K + K VD+W G E L G PP F+ +++N
Sbjct: 180 PPEMIE---GKTHDEK----VDLWCAGVLCYEFLVGMPP---FDSPSHTETHRRIVNVDL 229
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 607
P LS KD + + +P +R ++EHP+++ AN + + P
Sbjct: 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK-ANSRRVLPP 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 50/283 (17%), Positives = 89/283 (31%), Gaps = 50/283 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK------------- 401
+ + +G G F V + G A+K + + E +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNI 88
Query: 402 --------QLEQVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGL 449
+ ++ L + G+ I R + +TE + I GL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGL 147
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----------GLSYELSLKGSP 499
+H+ HRD+K N+L+ G L D G L + + +
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-- 557
++ APE+ + + D+WSLGC + M+ G+ P ++ +
Sbjct: 208 SYRAPELFSVQSHCVIDER----TDVWSLGCVLYAMMFGEGP---YDMVFQKGDSVALAV 260
Query: 558 ----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ P SS L +P +RP LL
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 9e-49
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 57/292 (19%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD------------------IIPDDPKS 396
Q+ IG+G++G V + N A+K + P
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 397 AECIKQLEQV--------------------------DDHLYIYLEYVHPGSINRYVREHC 430
+ +EQV +DHLY+ E V+ G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLK 132
Query: 431 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490
++E R + + ++ G+ YLH IHRDIK +NLLV G +K+ADFG++ G
Sbjct: 133 P-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 491 YELSLK-GSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548
LS G+P +MAPE + + G A+D+W++G T+ + G+ P+ + E
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCPFMD-ERI 245
Query: 549 QAMF-KVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ K+ ++ P+ ++ + KD + R +NP R E+ HP++
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-48
Identities = 66/343 (19%), Positives = 133/343 (38%), Gaps = 72/343 (20%)
Query: 324 PPGALSPPKSSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASC 382
P G++ S+ ++ + ++ + K + ++ + + +G F + + +
Sbjct: 2 PLGSMKDILSNYSNLI--YLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFY 57
Query: 383 AIKEVD---------IIPDDPKSAECIKQLEQV------------------------DDH 409
A+K+ + + + + D
Sbjct: 58 ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE 117
Query: 410 LYIYLEYVHPGSINRYVREHCR-------DITESIVRNFTRHILNGLAYLHSTNTI-HRD 461
+YI EY+ SI ++ I +++ + +LN +Y+H+ I HRD
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
+K +N+L+D +G VKL+DFG ++++ + +G+ +M PE +G
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFMPPEFFSNESSYNG-----A 231
Query: 522 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEM---------------- 564
VDIWSLG + M P+S +F + + P
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291
Query: 565 ---LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604
LS+E DFL +NP ER ++ + L+H ++ + N ++L
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-48
Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 42/317 (13%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
+ S++H + H L P + A + P +SQ+Q G L+G G FGS
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHA--TKLAPGKEKEPLESQYQVGPLLGSGGFGS 58
Query: 370 VYIGTNRETGASCAIK-----EVDIIPDDPKSAEC----------------IKQLEQV-- 406
VY G AIK + + P + +L
Sbjct: 59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118
Query: 407 -DDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
D + LE P + ++ E + E + R+F +L + + H+ +HRDIK
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 177
Query: 465 ANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 523
N+L+D G +KL DFG L Y G+ + PE I+ + +
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR------YHRYHGRSA 230
Query: 524 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE 583
+WSLG + +M+ G P FE + +++ + +SSE + + C P +
Sbjct: 231 AVWSLGILLYDMVCGDIP---FEHDE---EIIRGQVFFRQRVSSECQHLIRWCLALRPSD 284
Query: 584 RPSAVELLEHPFIRNAN 600
RP+ E+ HP++++
Sbjct: 285 RPTFEEIQNHPWMQDVL 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-47
Identities = 40/338 (11%), Positives = 87/338 (25%), Gaps = 67/338 (19%)
Query: 320 PLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
S S V++++ + + +G ++G+ + T++
Sbjct: 36 VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ 95
Query: 377 ETGASCAIKEVDI---------------------------------------------IP 391
ETG S + P
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 392 DDPKSAECIKQLEQVDDHLYIYLEYVHPGS-------INRYVREHCRDITESIVRNFTRH 444
K + +L + + + H + + T
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQ 214
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 504
++ LA LH +H ++ ++++D G V L F S + P
Sbjct: 215 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV---VSSVSRGFEPP 271
Query: 505 EVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP 560
E+ +D + + D W+LG + + P ++ +
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN 331
Query: 561 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
IP+ + L +R ++ +E P
Sbjct: 332 IPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 6e-47
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 36/275 (13%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIK----- 401
A P W + +G G +G V + NR T + A+K I+ E IK
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICI 58
Query: 402 ----------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+ + Y++LEY G + + + E + F ++ G
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 505
+ YLH HRDIK NLL+D +K++DFG+A + E L G+ ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIP-- 562
++K A VD+WS G + ML G+ PW + + + +
Sbjct: 178 LLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ + S L + + NP R + ++ + +
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----- 401
P ++ K IG+G F V + + TG AIK +D +P S + +
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI 67
Query: 402 ----------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+L +V + LY+ +EY G + Y+ H R + E R+ R I++
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 126
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 505
+ Y H +HRD+K NLL+DA +K+ADFG + T L G+P + APE
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPE 183
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIP 562
+ + G VD+WSLG + +++G P F+G + + +VL IP
Sbjct: 184 LFQ------GKKYDGPEVDVWSLGVILYTLVSGSLP---FDGQNLKELRERVLRGKYRIP 234
Query: 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+S++ ++ L R + NP++R + ++++ +I
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 60/308 (19%), Positives = 111/308 (36%), Gaps = 54/308 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQVDDH-- 409
+ + +++ G F VY + +G A+K + ++ K+ + ++++ H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 410 --------------------LYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILN 447
++ L + G + ++ E ++ V
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 448 GLAYLHSTNT--IHRDIKGANLLVDASGVVKLADFGMAKHLT-------------GLSYE 492
+ ++H IHRD+K NLL+ G +KL DFG A ++ + E
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 552
++ +P + PE+I K DIW+LGC + + + P FE A
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEK----QDIWALGCILYLLCFRQHP---FED-GAKL 259
Query: 553 KVLNRTPPIPEML--SSEGKDFLLRCFLRNPVERPSAVELLEHPF-IRNANYQNLSVPMR 609
+++N IP + + NP ER S E++ I A N P+
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
Query: 610 VFSRINLG 617
N G
Sbjct: 320 ELLEQNGG 327
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-46
Identities = 58/284 (20%), Positives = 105/284 (36%), Gaps = 38/284 (13%)
Query: 346 KPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAE--- 398
+ + P ++ W+ + +G G FG V +++TG AIK+ + P + +
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI 63
Query: 399 ---------CIKQLEQV---------DDHLYIYLEYVHPGSINRYV--REHCRDITESIV 438
+ +V +D + +EY G + +Y+ E+C + E +
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSL 495
R I + L YLH IHRD+K N+++ + K+ D G AK L
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 555
G+ ++APE++ QK VD WS G E +TG P+ P +
Sbjct: 184 VGTLQYLAPELL---EQKKYTVT----VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
Query: 556 -NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
++ + L P + +++
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 73/313 (23%), Positives = 136/313 (43%), Gaps = 47/313 (15%)
Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASC 382
G + P+ S + P KK ++ GK++G G+F +V + T
Sbjct: 2 DGTAAEPRPGAGS---LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREY 58
Query: 383 AIKEVD---IIPDDPKSAECIKQ----LEQVD--------------DHLYIYLEYVHPGS 421
AIK ++ II + + + + ++D + LY L Y G
Sbjct: 59 AIKILEKRHIIKE--NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 422 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 481
+ +Y+R E+ R +T I++ L YLH IHRD+K N+L++ +++ DFG
Sbjct: 117 LLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 482 MAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 538
AK L+ S + S G+ +++PE++ + K + D+W+LGC + +++ G
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYVSPELL----TEKSACK---SSDLWALGCIIYQLVAG 228
Query: 539 KPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP------SAVELL 591
PP+ +F K++ PE + +D + + + + +R L
Sbjct: 229 LPPFRA-GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 592 EHPFIRNANYQNL 604
HPF + ++NL
Sbjct: 288 AHPFFESVTWENL 300
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-46
Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIK---------EVDIIPDDPKSAE----------- 398
K +G G G V + R+T AI+ D + E
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 399 -CIKQLEQV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
CI +++ + YI LE + G + V + R + E+ + + +L + YLH
Sbjct: 200 PCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHEN 258
Query: 456 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 512
IHRD+K N+L+ + ++K+ DFG +K L S +L G+P ++APEV+ +V
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNR----TPPIPEMLSS 567
N VD WSLG + L+G PP+SE ++ ++ + P + +S
Sbjct: 319 AGYNRA----VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603
+ D + + + +P R + E L HP++++ + +
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 71/297 (23%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAECIK----------- 401
++ G L+G G++G V + ET A+K + + P +K
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 402 ----QLEQV-----DDHLYIYLEYVHPGSIN--RYVREHCRDITESIVRNFTRHILNGLA 450
QL V +Y+ +EY G V E R + +++GL
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-R-FPVCQAHGYFCQLIDGLE 123
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVI 507
YLHS +H+DIK NLL+ G +K++ G+A+ L + + + + GSP + PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEM 564
+ G VDIWS G T+ + TG P FEG +F + + IP
Sbjct: 184 NGLDTFSG-----FKVDIWSAGVTLYNITTGLYP---FEGDNIYKLFENIGKGSYAIPGD 235
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSH 621
D L P +R S ++ +H + R + P+ + + D+
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR-KKHPPAEAPVPIPPSPDTKDRWR 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 72/299 (24%), Positives = 115/299 (38%), Gaps = 49/299 (16%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
PP T P ++ +++++ G L+G+G FG+V+ G AIK +
Sbjct: 9 GPPAPPGTPTPPPGGKDR---EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP 65
Query: 389 -----IIPDDPKSAEC------------------IKQLEQV---DDHLYIYLEYVHPGS- 421
S C + +L + + LE P
Sbjct: 66 RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD 125
Query: 422 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADF 480
+ Y+ E + E R F ++ + + HS +HRDIK N+L+D G KL DF
Sbjct: 126 LFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184
Query: 481 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI--EMLTG 538
G L Y G+ + PE I + AL +WSLG ++ +M+ G
Sbjct: 185 GSGALLHDEPYTDFD-GTRVYSPPEWIS------RHQYHALPATVWSLG--ILLYDMVCG 235
Query: 539 KPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
P FE Q ++L P +S + + RC P RPS E+L P+++
Sbjct: 236 DIP---FERDQ---EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 38/276 (13%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIK----- 401
A P W + +G G +G V + NR T + A+K I+ E IK
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICI 58
Query: 402 ----------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+ + Y++LEY G + + + E + F ++ G
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 505
+ YLH HRDIK NLL+D +K++DFG+A + E L G+ ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR---TPPI 561
++K A VD+WS G + ML G+ PW + + P
Sbjct: 178 LLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
++ S L + + NP R + ++ + +
Sbjct: 232 KKI-DSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 79/328 (24%), Positives = 137/328 (41%), Gaps = 44/328 (13%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK---------EVDIIPDDPKS 396
S PK + ++ K +G G G V + R+T AIK D +
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 397 AE------------CIKQLEQV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
E CI +++ + YI LE + G + V + R + E+ + +
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYF 120
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGSP 499
+L + YLH IHRD+K N+L+ + ++K+ DFG +K L S +L G+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPPWSEFEGPQAMFK---- 553
++APEV+ +V N VD WSLG VI L+G PP+SE ++
Sbjct: 181 TYLAPEVLVSVGTAGYNRA----VDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 554 -VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN-YQNLSVPMRVF 611
N P + +S + D + + + +P R + E L HP++++ + + +
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294
Query: 612 SRINLGDKSHDQVERATRKTESLPDSPE 639
+ + Q +RK ++
Sbjct: 295 NESTALPQVLAQP-STSRKRPREGEAEG 321
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 32/270 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ----LEQVD----- 407
+ IG+G+FG V I +T A+K ++ + + + ++ ++
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVFKELQIMQGLEHPFLV 78
Query: 408 ---------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ +++ ++ + G + RY + E V+ F ++ L YL + I
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
HRD+K N+L+D G V + DF +A L + ++ G+ +MAPE+
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF----SSRKGAG 193
Query: 519 LALAVDIWSLGCTVIEMLTGKPPW--SEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLR 575
+ AVD WSLG T E+L G+ P+ + + P S E L +
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 576 CFLRNPVER-PSAVELLEHPFIRNANYQNL 604
NP +R ++ P++ + N+ +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 90/327 (27%), Positives = 129/327 (39%), Gaps = 86/327 (26%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
S T + MEK ++ L+G G++G V N++TG AIK+
Sbjct: 9 SSGVDLGTENLYFQSMEK---------YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 389 IIPDD---PKSA------------ECIKQLEQV---DDHLYIYLEYVHPGSINRYVREHC 430
DD K A E + L +V Y+ E+V +I +
Sbjct: 60 ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFP 118
Query: 431 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490
+ +V+ + I+NG+ + HS N IHRDIK N+LV SGVVKL DFG A+ L
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL---- 174
Query: 491 YELSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 539
+P W APE++ G+ K AVD+W++GC V EM G+
Sbjct: 175 ------AAPGEVYDDEVATRWYRAPELLV------GDVKYGKAVDVWAIGCLVTEMFMGE 222
Query: 540 PPW---SEFEGPQAMFKVL-------------------NRTPPIPEM---------LSSE 568
P + S+ + + L R P I E LS
Sbjct: 223 PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV 282
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPF 595
D +C +P +RP ELL H F
Sbjct: 283 VIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 56/272 (20%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQ------ 405
++ + K IG+G FG V+ G + + AIK + + + ++ E ++ ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 406 -------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
+ + + +E+V G + + + I S+ I G+ Y+
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 453 HSTNT--IHRDIKGANLLVDASG-----VVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 505
+ N +HRD++ N+ + + K+ADFG+++ L G+ WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMAPE 196
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----NRTPPI 561
I A ++ K D +S + +LTG+ P+ E+ + F + P I
Sbjct: 197 TIGA-EEESYTEK----ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
PE ++ + C+ +P +RP +++
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 44/280 (15%)
Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIK 401
K K + G +G GTFG V IG ++ TG A+K I+ IK
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIK 59
Query: 402 ---------------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 443
+L QV ++ +EYV G + Y+ +H R + E R +
Sbjct: 60 REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQ 118
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPN 500
IL+ + Y H +HRD+K N+L+DA K+ADFG++ ++ + L+ GSPN
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 175
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNR 557
+ APEVI G VDIWS G + +L G P F+ +F K+
Sbjct: 176 YAAPEVIS------GRLYAGPEVDIWSCGVILYALLCGTLP---FDDEHVPTLFKKIRGG 226
Query: 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
IPE L+ L+ +P++R + ++ EH + +
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 75/314 (23%), Positives = 119/314 (37%), Gaps = 88/314 (28%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA-- 397
+MEK ++K IG G++G V+ NR+TG AIK+ DD K A
Sbjct: 1 MMEK---------YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR 51
Query: 398 ----------ECIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 444
+ L +V L++ EY ++ + + R + E +V++ T
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 500
L + + H N IHRD+K N+L+ V+KL DFG A+ L P+
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL----------TGPSDYYD 160
Query: 501 ------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------- 540
W +PE++ G+ + VD+W++GC E+L+G P
Sbjct: 161 DEVATRWYRSPELLV------GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
Query: 541 -------P----WSEFEGPQAMFKVLNRTPPIPE--------MLSSEGKDFLLRCFLRNP 581
F Q F + P +S L C +P
Sbjct: 215 IRKTLGDLIPRHQQVFSTNQY-FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP 273
Query: 582 VERPSAVELLEHPF 595
ER + +LL HP+
Sbjct: 274 TERLTCEQLLHHPY 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 49/270 (18%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC------IKQLEQVD----- 407
++IG G FG VY G A+K PD+ S K +
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 408 ---------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT- 457
+L + +E+ G +NR + + I I+ N+ I G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 458 --IHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 507
IHRD+K +N+L+ ++K+ DFG+A+ + ++S G+ WMAPEVI
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPEVI 186
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPE 563
+ + D+WS G V+ E+LTG+ P+ +G + V PIP
Sbjct: 187 R---ASMFSKG----SDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ C+ +P RPS +L+
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 75/314 (23%), Positives = 115/314 (36%), Gaps = 82/314 (26%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIK-------------- 401
IG+G++G V + +T A AIK ++ I +PK E IK
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 402 -QLEQV---DDHLYIYLEYVHPGSI----------------------------------- 422
+L +V + ++ + +E H G +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 423 ----NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVK 476
+ + E ++ N R I + L YLH+ HRDIK N L + S +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 477 LADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 531
L DFG++K L+ G+P ++APEV+ + G D WS G
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP-----KCDAWSAGVL 265
Query: 532 VIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVER 584
+ +L G P + +VLN P LS +D L RN ER
Sbjct: 266 LHLLLMGAVPFPGVND--ADTISQVLNKKLCFENPNYNV-LSPLARDLLSNLLNRNVDER 322
Query: 585 PSAVELLEHPFIRN 598
A+ L+HP+I
Sbjct: 323 FDAMRALQHPWISQ 336
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 44/214 (20%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 405 QVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
+LYI ++ ++ ++ R D + + I + +LHS +HRD+
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-------------GSPNWMAPEVIKA 509
K +N+ VVK+ DFG+ + E ++ G+ +M+PE I
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH- 249
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEM 564
+ + K VDI+SLG + E+L E +++ + P +
Sbjct: 250 --GNNYSHK----VDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFPLLFTQ 297
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ + +P ERP A +++E+ N
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 14/70 (20%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVD- 407
AS + ++ + +GRG FG V+ N+ + AIK + + + + +++++ +
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60
Query: 408 -DHLYIYLEY 416
+H I +
Sbjct: 61 LEHPGIVRYF 70
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIK--------- 401
+ + +G G+FG V + T+ +T A+K I ++
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66
Query: 402 ------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
+L V + + +EY G + Y+ E R +TE R F + I+ + Y
Sbjct: 67 RHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKR-MTEDEGRRFFQQIICAIEYC 124
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKA 509
H +HRD+K NLL+D + VK+ADFG++ +T ++ LK GSPN+ APEVI
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVIN- 180
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLS 566
G VD+WS G + ML G+ P F+ +F KV + +P+ LS
Sbjct: 181 -----GKLYAGPEVDVWSCGIVLYVMLVGRLP---FDDEFIPNLFKKVNSCVYVMPDFLS 232
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 624
+ + R + +P++R + E+ P+ N N + PM + ++
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWF-NVNLPDYLRPMEEVQGSYADSRIVSKL 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 46/277 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----------QVD 407
+++GRG V ++ T A+K +D+ SAE +++L +V
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 408 DH---------------LYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLA 450
H ++ + + G + + + ++E R R +L +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 138
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 510
LH N +HRD+K N+L+D +KL DFG + L + G+P+++APE+I+
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 511 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 561
M + VD+WS G VI +L G PP W + M +++ +P
Sbjct: 199 MNDNHPG-YGKEVDMWSTG--VIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEW 253
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ S KD + R + P +R +A E L HPF +
Sbjct: 254 DD-YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 47/354 (13%), Positives = 93/354 (26%), Gaps = 69/354 (19%)
Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIG 363
++LL+ L + + +VT+ V P S + + + + +
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71
Query: 364 RGTFGSVYIGTNRETGASCAIKEVD----------------------------------- 388
G V++ + E A+K
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 389 --IIPDDPKSAECIKQLEQVDD--------HLYIYLEYVH-----PGSINRYVREHCRDI 433
++P D + + Q+ + + + S +V D
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 434 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493
+ T ++ A L S +H NL + G + L D +
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMF 552
P AP A++ W LG ++ + P+ G + +
Sbjct: 252 ---SVPVTYAPR----EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 553 KVLNRTPPIPEML--------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
K + P + L K + R + R +E +E P
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 33/261 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD------- 407
G+ IG G+FG+VY G A+K +++ P+ + K L +
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 408 ------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
L I ++ S+ ++ + + R G+ YLH+ + IHRD
Sbjct: 86 MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 462 IKGANLLVDASGVVKLADFGMA--KHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPK 518
+K N+ + VK+ DFG+A K S++ L GS WMAPEVI+ + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPIPEMLSSEGKDF 572
D+++ G + E++TG+ P+S + +++ R + K
Sbjct: 206 ----SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 573 LLRCFLRNPVERPSAVELLEH 593
+ C + ERPS +L
Sbjct: 262 MAECLKKKRDERPSFPRILAE 282
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 32/261 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVD------ 407
+ + +++GRG FG V R AIK+++ + ++QL +V+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK 65
Query: 408 ------DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNT-- 457
+ + + +EY GS+ + E T + ++ G+AYLHS
Sbjct: 66 LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 458 -IHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
IHRD+K NLL+ A G V+K+ DFG A + + KGS WMAPEV + +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFE---GSNY 180
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVL-NRTPPIPEMLSSEGKDF 572
+ K D++S G + E++T + P+ E GP + M+ V PP+ + L +
Sbjct: 181 SEK----CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 573 LLRCFLRNPVERPSAVELLEH 593
+ RC+ ++P +RPS E+++
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKI 257
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 36/277 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK--------------- 401
K+IGRG F V + ++TG A+K + D++ C +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFREERDVLVNGDRRWIT 124
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
QL Q +++LY+ +EY G + + + I + R + I+ + +H +
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
HRDIK N+L+D G ++LADFG L G L G+P++++PE+++AV G
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGK 570
D W+LG EM G+ P+ + + K+++ P + E + E +
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
Query: 571 DFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 604
D ++ L P R A + HPF ++ L
Sbjct: 304 D-FIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 70/275 (25%), Positives = 116/275 (42%), Gaps = 50/275 (18%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------- 405
+ +G G FG V++ R +G IK I D +S ++Q+E
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIK---TINKD-RSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 406 ------VDDHLYIYL--EYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYLHS 454
+D+ +Y+ E G + R V R ++E V + ++N LAY HS
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 455 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
+ +H+D+K N+L +K+ DFG+A+ + + G+ +MAPEV K
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--- 199
Query: 512 QKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN---RTPPIPEM 564
+D K DIWS G V+ +LTG P + + K
Sbjct: 200 -RDVTFK----CDIWSAG--VVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVECRP 250
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
L+ + D L + ++P RPSA ++L H + + A
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 46/266 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------- 405
+ IG G+FG+V+ G+ A+K I+ + AE + + +
Sbjct: 42 KEKIGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 406 --------VDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHST 455
+L I EY+ GS+ R + + + E + + G+ YLH+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 456 NT--IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYELSLKGSPNWMAPEVIKAVM 511
N +HR++K NLLVD VK+ DFG++ K T LS + S G+P WMAPEV++
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLR--- 212
Query: 512 QKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSS 567
+ N K D++S G VI E+ T + PW Q + V + IP L+
Sbjct: 213 DEPSNEK----SDVYSFG--VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEH 593
+ + C+ P +RPS +++
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 68/327 (20%), Positives = 122/327 (37%), Gaps = 47/327 (14%)
Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
P + +Q+ K +G G +G V + ++ T
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 382 CAIKEVDIIPDDPKSAECIKQ----LEQVD--------------DHLYIYLEYVHPGSIN 423
AIK + S + + L+ +D + Y+ +E G +
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 424 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADF 480
+ + E + +L+G+ YLH N +HRD+K NLL+ + ++K+ DF
Sbjct: 125 DEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 481 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540
G++ G+ ++APEV++ K + K D+WS+G + +L G P
Sbjct: 184 GLSAVFENQKKMKERLGTAYYIAPEVLR----KKYDEK----CDVWSIGVILFILLAGYP 235
Query: 541 PWSEFEGP--QAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P F G Q + KV +P +S KD + + + R SA + LE
Sbjct: 236 P---FGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGAKDLIKQMLQFDSQRRISAQQALE 291
Query: 593 HPFIRN---ANYQNLSVPMR--VFSRI 614
HP+I+ + +P +
Sbjct: 292 HPWIKEMCSKKESGIELPSLANAIENM 318
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 341 PHIMEKPSASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
+ P P ++ K IG G FG + ++ T A+K I
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAID 60
Query: 398 ECIK---------------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVR 439
E ++ + ++V HL I +EY G + + R +E R
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEAR 119
Query: 440 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYELSLKG 497
F + +L+G++Y HS HRD+K N L+D S +K+ DFG +K S S G
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--AMFK-- 553
+P ++APEV+ D+WS G T+ ML G P FE P+ ++
Sbjct: 180 TPAYIAPEVLL------RQEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPRDYRKT 230
Query: 554 ---VLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+L+ IP+ +S E + R F+ +P R S E+ H +
Sbjct: 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 43/275 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK--------------- 401
KL+G+GTFG V + + TG A+K + II D
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLT 68
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
L+ Q D L +EY + G + ++ R TE R + I++ L YLHS + +
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDG 515
+RDIK NL++D G +K+ DFG+ K G+S ++K G+P ++APEV+ + +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL----EDND 181
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 574
+ AVD W LG + EM+ G+ P+ + + +F +L P LS E K L
Sbjct: 182 YGR---AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 575 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
++P +R A E++EH F + N+Q++
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 77/377 (20%), Positives = 140/377 (37%), Gaps = 62/377 (16%)
Query: 261 SPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHP 320
S N ++ + R N R R+ + Q++ L E+ +A P
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLN-REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 321 LPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA 380
+ + +A ++ +IGRG V +R TG
Sbjct: 67 KGTENLYFQSMGPE------DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120
Query: 381 SCAIKEVDIIPDDPKSAECIKQLEQV-------------------------DDHLYIYLE 415
A+K +++ + + + E +++ +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 416 YVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468
+ G +E R+ R +L +++LH+ N +HRD+K N+L
Sbjct: 181 LMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 469 VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 528
+D + ++L+DFG + HL L G+P ++APE++K M + VD+W+
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG-YGKEVDLWAC 291
Query: 529 GCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLR 579
G VI +L G PP W + M ++ +P + SS KD + R
Sbjct: 292 G--VILFTLLAGSPPFWHRRQ--ILMLRMIMEGQYQFSSPEWDD-RSSTVKDLISRLLQV 346
Query: 580 NPVERPSAVELLEHPFI 596
+P R +A + L+HPF
Sbjct: 347 DPEARLTAEQALQHPFF 363
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 60/263 (22%), Positives = 104/263 (39%), Gaps = 32/263 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD------- 407
G+LIG+G FG VY G AI+ +DI D+ + K+ Q
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 408 -------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
HL I ++ VR+ + + R + I+ G+ YLH+ +H+
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKD 514
D+K N+ D +G V + DFG+ L G +APE+I+ +
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 515 GNPKLAL--AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 570
KL D+++LG E+ + P+ ++++ + + E
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS 273
Query: 571 DFLLRCFLRNPVERPSAVELLEH 593
D LL C+ ERP+ +L++
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDM 296
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 50/285 (17%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE------------- 404
K +GRG F V ++ TG A K + + +C ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 405 ---------QVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+ + + LEY G I + + E ++E+ V + IL G+ YLH
Sbjct: 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 455 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 511
N +H D+K N+L+ G +K+ DFGM++ + + G+P ++APE++
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN--- 206
Query: 512 QKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIP 562
+P + A D+W++G +I +LT P E Q + +
Sbjct: 207 ---YDP-ITTATDMWNIG--IIAYMLLTHTSPFVGEDN--QETYLNISQVNVDYSEETFS 258
Query: 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 607
+S DF+ ++NP +RP+A L H +++ +++NL P
Sbjct: 259 S-VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 39/262 (14%), Positives = 91/262 (34%), Gaps = 39/262 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---------------- 402
+ G ++ G + G +K + + + + +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 403 ----LEQVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNT 457
H + ++ GS+ + E + +S F + G+A+LH+
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 458 --IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
+ ++++D +++ + +P W+APE ++ +D
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQK-KPEDT 187
Query: 516 NPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKD 571
N + + D+WS V+ E++T + P+++ + KV P IP +S
Sbjct: 188 NRR---SADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 572 FLLRCFLRNPVERPSAVELLEH 593
+ C +P +RP ++
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPI 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 61/333 (18%), Positives = 119/333 (35%), Gaps = 49/333 (14%)
Query: 341 PHIMEKPSASPKKSQ----WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDD 393
P +E + + + + +G G FG V+ ++E +K + ++ D
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 394 PKSAEC------------------IKQLEQV---DDHLYIYLEYVHPGS-INRYVREHCR 431
I ++ + + +E G + ++ H R
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126
Query: 432 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491
+ E + R +++ + YL + IHRDIK N+++ +KL DFG A +L
Sbjct: 127 -LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 492 ELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548
G+ + APEV+ GNP +++WSLG T+ ++ + P+ E E
Sbjct: 186 ---FYTFCGTIEYCAPEVLM------GNPYRGPELEMWSLGVTLYTLVFEENPFCELE-- 234
Query: 549 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 608
+ + P ++S E + P R + +L+ P++
Sbjct: 235 ----ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV-TQPVNLADYTW 289
Query: 609 RVFSRINLGDKSHDQVERATRKTESLPDSPETR 641
R+N + SL D + +
Sbjct: 290 EEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQ 322
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-42
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 47/288 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQ----LEQVD--- 407
+++G+G+FG V + ++ TG CA+K +I E + + L+Q+D
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 408 -----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ Y+ E G + + R +E R +L+G+ Y+H
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNK 146
Query: 457 TIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
+HRD+K NLL+ +++ DFG++ H G+ ++APEV+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH----G 202
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLS 566
+ K D+WS G + +L+G PP E + KV P + +S
Sbjct: 203 TYDEK----CDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKK-VS 255
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 614
KD + + P R SA + L+H +I+ + +SV +
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-41
Identities = 58/280 (20%), Positives = 114/280 (40%), Gaps = 46/280 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-------------- 404
++G+G+FG V +R T A+K +I + +
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 405 -------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+ YI E G + + + R +E + + +G+ Y+H N
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 458 IHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
+HRD+K N+L+ + +K+ DFG++ + G+ ++APEV++
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR----GT 198
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSS 567
+ K D+WS G + +L+G PP + + E + +V P +S
Sbjct: 199 YDEK----CDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT-ISD 251
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 607
+ KD + + +P R +A + LEHP+I+ + + ++
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 51/281 (18%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQ----LEQVD--- 407
+++G+G +G V+ T TG A+K + +I + K K LE+V
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 408 -----------DHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYL 452
LY+ LEY+ G + R E + I L +L
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHL 137
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKA 509
H I+RD+K N++++ G VKL DFG+ K + G+ +MAPE++
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEIL-- 193
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSE 568
+ G+ + AVD WSLG + +MLTG PP++ E + K+L +P L+ E
Sbjct: 194 --MRSGHNR---AVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLPPYLTQE 247
Query: 569 GKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
+D L + RN R A E+ HPF R+ N++ L
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 47/271 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----AECIKQLE--------- 404
G+++G+G FG T+RETG +KE+ ++ + + ++ LE
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 405 --QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 462
D L EY+ G++ ++ S +F + I +G+AYLHS N IHRD+
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 463 KGANLLVDASGVVKLADFGMAKHLTGLSYE---------------LSLKGSPNWMAPEVI 507
N LV + V +ADFG+A+ + + ++ G+P WMAPE+I
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 508 KAVMQKDGNP---KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NRTPPI 561
G K VD++S G + E++ ++ F +
Sbjct: 195 N------GRSYDEK----VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P +RC +P +RPS V+L
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-41
Identities = 88/420 (20%), Positives = 156/420 (37%), Gaps = 73/420 (17%)
Query: 341 PHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK 395
P ++ K + G +G GTFG V +G + TG A+K I+
Sbjct: 2 PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLD 58
Query: 396 SAECIK---------------QLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESI 437
I+ +L QV +++ +EYV G + Y+ ++ R + E
Sbjct: 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKE 117
Query: 438 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK- 496
R + IL+G+ Y H +HRD+K N+L+DA K+ADFG++ ++ + L+
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRT 174
Query: 497 --GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF 552
GSPN+ APEVI G VDIWS G + +L G P F+ +F
Sbjct: 175 SCGSPNYAAPEVIS------GRLYAGPEVDIWSSGVILYALLCGTLP---FDDDHVPTLF 225
Query: 553 -KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN--ANYQNLSVPMR 609
K+ + P+ L+ L +P++R + ++ EH + + Y P
Sbjct: 226 KKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSY 285
Query: 610 VFSRIN---------LGDKSHDQVERATRKTESLPDSPETR-----VRNRKLPCNSEVCP 655
+ I+ + S ++V P + NR++ ++
Sbjct: 286 SSTMIDDEALKEVCEKFECSEEEVLSCLYNRN--HQDPLAVAYHLIIDNRRIMNEAK--- 340
Query: 656 QCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCAPLRSQGQ 715
+ A+ H++ F + ++ + QG
Sbjct: 341 -------DFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGV 393
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 52/285 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ----LEQVDDH--- 409
++IGRG++ V + ++T A+K V + D+ + ++ EQ +H
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDWVQTEKHVFEQASNHPFL 72
Query: 410 ------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
I+RD+K N+L+D+ G +KL D+GM K GL + G+PN++APE++ + +
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL----RGE 185
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--------MF-KVLNRTPPIPEML 565
+VD W+LG + EM+ G+ P+ +F +L + IP L
Sbjct: 186 DYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
Query: 566 SSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 604
S + L ++P ER ++ HPF RN ++ +
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-41
Identities = 39/334 (11%), Positives = 94/334 (28%), Gaps = 64/334 (19%)
Query: 322 PLPPGALSPPKSSVTSAVMP---HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRET 378
S S V++++ + + +G ++G+ + T++ET
Sbjct: 43 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 102
Query: 379 GASCAIKEVDIIPDDPKS--------AECIKQLEQV------------------------ 406
G S + P + ++ L +
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 407 ---------DDHLYIYLEYV-----------HPGSINRYVREHCRDITESIVRNFTRHIL 446
+ +++ + + + H + + T ++
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVI 221
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAP 504
LA LH +H ++ ++++D G V L F + +S P A
Sbjct: 222 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAE 281
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM 564
++ + + A D W+LG + + P ++ + IP+
Sbjct: 282 RMLP--FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP 339
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ + L +R ++ +E P
Sbjct: 340 V----RALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 83/348 (23%), Positives = 139/348 (39%), Gaps = 92/348 (26%)
Query: 318 AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTN 375
AH G L P M +A S ++++ +G GT+G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQG------PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAID 55
Query: 376 RETGASCAIKEVDIIPDD---PKSA------------ECIKQLEQV---DDHLYIYLEYV 417
T + AIK + + ++ P +A I +L+ V + L++ EY
Sbjct: 56 TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115
Query: 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----- 472
+ +Y+ + D++ ++++F ++NG+ + HS +HRD+K NLL+ S
Sbjct: 116 E-NDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASET 173
Query: 473 GVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDGNPKLAL 521
V+K+ DFG+A+ G P W PE++ G+ +
Sbjct: 174 PVLKIGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILL------GSRHYST 217
Query: 522 AVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP------------------- 559
+VDIWS+ C EML P + SE + +F+VL P
Sbjct: 218 SVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDTTWPGVTALPDWKQSFP 276
Query: 560 ---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ +L EG D L +PV+R SA LEHP+ +
Sbjct: 277 KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 7e-41
Identities = 67/342 (19%), Positives = 122/342 (35%), Gaps = 67/342 (19%)
Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
+ A+ P + + + K + +G G +G V + + +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 382 CAIK-----EVDIIPDDPKSAECIKQLEQV------------------------DDHLYI 412
AIK + D + K E++ + Y+
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 413 YLEYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465
E+ G + +++ E N + IL+G+ YLH N +HRDIK
Sbjct: 124 VTEFYEGGELFEQIINRHKF--------DECDAANIMKQILSGICYLHKHNIVHRDIKPE 175
Query: 466 NLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 522
N+L+ ++ +K+ DFG++ + G+ ++APEV+K K N K
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEK---- 227
Query: 523 VDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLNRTPPIPE----MLSSEGKDFLLRC 576
D+WS G + +L G PP + + Q + KV +S E K+ +
Sbjct: 228 CDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285
Query: 577 FLRNPVERPSAVELLEHPFIR----NANYQNLSVPMRVFSRI 614
+ +R +A E L +I+ N N + S +
Sbjct: 286 LTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-41
Identities = 77/342 (22%), Positives = 144/342 (42%), Gaps = 59/342 (17%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKG-------KLI 362
+ +H + H +P + ++ S + + K+ G ++I
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 363 GRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ----LEQVDDH------ 409
GRG++ V + ++T A++ V + D+ + ++ EQ +H
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE--DIDWVQTEKHVFEQASNHPFLVGL 118
Query: 410 ---------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
L+ +EYV+ G + +++ R + E R ++ I L YLH I+R
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNP 517
D+K N+L+D+ G +KL D+GM K GL + G+PN++APE++ + +
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL----RGEDYG 231
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--------MF-KVLNRTPPIPEMLSSE 568
+VD W+LG + EM+ G+ P+ +F +L + IP LS +
Sbjct: 232 F---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288
Query: 569 GKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 604
L ++P ER ++ HPF RN ++ +
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-41
Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 45/282 (15%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQ----LEQVDDH- 409
K++G G +G V++ + +TG A+K + I K+ E + LE +
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 410 --------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
L++ L+Y++ G + ++ TE V+ + I+ L +LH
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIKAVM 511
I+RDIK N+L+D++G V L DFG++K ++ E G+ +MAP++++
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVRG-- 234
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEMLSS 567
G+ K AVD WSLG + E+LTG P+ E + ++L PP P+ +S+
Sbjct: 235 GDSGHDK---AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 568 EGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
KD + R +++P +R A E+ EH F + N+ +L
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 40/272 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ----LE-------- 404
K++G+G+FG V++ ++T AIK + ++ DD EC L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLAWEHPFL 80
Query: 405 -------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
Q ++L+ +EY++ G + +++ C S + I+ GL +LHS
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
++RD+K N+L+D G +K+ADFGM K + + G+P+++APE++
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL----LGQ 193
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFL 573
+VD WS G + EML G+ P+ + + +F + P P L E KD L
Sbjct: 194 KYNH---SVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEKEAKDLL 249
Query: 574 LRCFLRNPVER-PSAVELLEHPFIRNANYQNL 604
++ F+R P +R ++ +HP R N++ L
Sbjct: 250 VKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 149 bits (380), Expect = 1e-40
Identities = 83/304 (27%), Positives = 131/304 (43%), Gaps = 78/304 (25%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------EC 399
+++K + IG GT+G+V+ NRET A+K V + DD P SA +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 400 IKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
I +L V D L + E+ + +Y D+ IV++F +L GL + HS N
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APE 505
+HRD+K NLL++ +G +KLA+FG+A+ G P W P+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEVVTLWYRPPD 171
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTP-- 559
V+ G + ++D+WS GC E+ P + + +F++L TP
Sbjct: 172 VLF------GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTE 224
Query: 560 -------------PIPE------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHP 594
P P L++ G+D L NPV+R SA E L+HP
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 595 FIRN 598
+ +
Sbjct: 285 YFSD 288
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-40
Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 49/282 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ----LEQVD----- 407
+++GRG FG V+ + TG A K+++ + + L +V
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMVEKKILAKVHSRFIV 248
Query: 408 ---------DHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
L + + ++ G I ++ E +T I++GL +LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQ 307
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 511
N I+RD+K N+L+D G V+++D G+A + + K G+P +MAPE++
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLL--- 362
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEMLSS 567
+ +VD ++LG T+ EM+ + P+ E + + +VL + P+ S
Sbjct: 363 ----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 568 EGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
KDF ++P +R S L HP R+ +++ L
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 74/304 (24%), Positives = 126/304 (41%), Gaps = 76/304 (25%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------EC 399
++ + IG GT+G VY N G + A+K++ + +D P +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 400 IKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
I +L V L + E++ + + + + ++F +LNG+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APE 505
+HRD+K NLL++ G +K+ADFG+A+ G P W AP+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEIVTLWYRAPD 170
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL------- 555
V+ G+ K + +DIWS+GC EM+ G P + SE + +F++L
Sbjct: 171 VLM------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 556 --------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P+P + L G D L + +P +R +A + LEH +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
Query: 597 RNAN 600
+ N
Sbjct: 285 KENN 288
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 72/356 (20%), Positives = 137/356 (38%), Gaps = 60/356 (16%)
Query: 344 MEKPSASPKKSQWQK-----------GKLIGRGTFGSVYIGTNRETGASCAIK------- 385
M+ Q + + IG G++ ++ T A+K
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 386 ----EVDIIPDDPKSAECIKQLEQVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESI 437
E++I+ + I + DD Y+Y+ E + G + ++ + ++ +E
Sbjct: 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSERE 117
Query: 438 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYEL 493
I + YLH+ +HRD+K +N+L +++ DFG AK L + L
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 494 SLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEF-EGP 548
+ N++APEV++ Q A DIWSLG V+ MLTG P + + P
Sbjct: 178 MTPCYTANFVAPEVLER--QGYD-----AACDIWSLG--VLLYTMLTGYTPFANGPDDTP 228
Query: 549 QAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602
+ + ++ + +S KD + + +P +R +A +L HP+I + + Q
Sbjct: 229 EEILARIGSGKFSLSGGYWNS-VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD-Q 286
Query: 603 NLSVPMRVFSRINLGDKSHDQVERATRKTESL-----PDSPETRVRNRKLPCNSEV 653
+ +L + A + +S S + R K ++ +
Sbjct: 287 LPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL 342
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 46/272 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAE-------------CIK 401
IGRG++G V I + T A K IP +D + I+
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAK---KIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 402 QLEQVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
E +D+ IYL E G + V ES + +L+ +AY H N H
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 460 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
RD+K N L +KL DFG+A + G+P +++P+V++
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE----GLYG 185
Query: 517 PKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLNRTPPIPE----MLSSE 568
P+ D WS G V+ +L G PP + + + K+ T PE +S +
Sbjct: 186 PE----CDEWSAG--VMMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLNVSPQ 237
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
+ + R ++P +R ++++ LEH +
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-40
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 36/274 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQ-LEQVD------- 407
+++G+G FG V R TG A K + A KQ LE+V+
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 408 -------DHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIH 459
D L + L ++ G + ++ + E+ + I GL LH ++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
RD+K N+L+D G ++++D G+A H+ G+ +MAPEV+K N +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-------NERY 362
Query: 520 ALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLR 575
+ D W+LGC + EM+ G+ P+ + + + V E S + + +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
Query: 576 CFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
++P ER SA E+ EHP + N++ L
Sbjct: 423 LLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 76/323 (23%), Positives = 137/323 (42%), Gaps = 85/323 (26%)
Query: 345 EKPSASPKKSQWQKGKL--------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--- 393
+S +++ + +G + +G GT+G VY + G A+K + + +D
Sbjct: 4 HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62
Query: 394 PKSA------------ECIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIV 438
P +A I L V + L + E++ + + + E+ + +S +
Sbjct: 63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQI 121
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498
+ + +L G+A+ H +HRD+K NLL+++ G +KLADFG+A+ G
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR----------AFGI 171
Query: 499 PN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SE 544
P W AP+V+ G+ K + +VDIWS+GC EM+TGKP + ++
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLM------GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225
Query: 545 FEGPQAMFKVL------------------NRTPPIPE---------MLSSEGKDFLLRCF 577
+ +F +L RT + E EG D L
Sbjct: 226 DDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNML 285
Query: 578 LRNPVERPSAVELLEHPFIRNAN 600
+P +R SA + + HP+ ++ +
Sbjct: 286 CFDPNKRISARDAMNHPYFKDLD 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 44/276 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ----LE-------- 404
++G+G+FG V + + T A+K + +I DD EC L
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFL 83
Query: 405 -------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
Q D LY +EYV+ G + ++ + E + I GL +L S
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
I+RD+K N+++D+ G +K+ADFGM K + ++ K G+P+++APE+I
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEII----AYQ 196
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFL 573
K +VD W+ G + EML G+ P+ E +F ++ P+ +S E
Sbjct: 197 PYGK---SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAIC 252
Query: 574 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
++P +R ++ EH F R +++ L
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 52/283 (18%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD----IIPDDPKSAECIKQ----LEQVD--- 407
G+ +G G F V + TG A K + S E I++ L ++
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 408 -----------DHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHS 454
+ + LE V G + + +E +TE F + IL+G+ YLHS
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHS 126
Query: 455 TNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 510
H D+K N+++ + +KL DFG+A + + ++ G+P ++APE++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN-- 184
Query: 511 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 561
P L L D+WS+G VI +L+G P E + Q +
Sbjct: 185 ----YEP-LGLEADMWSIG--VITYILLSGASPFLGETK--QETLTNISAVNYDFDEEYF 235
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604
S KDF+ R +++P R + + LEH +I+ +N+
Sbjct: 236 SN-TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 75/311 (24%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSA------------ECI 400
+ K +G GT+ +VY G ++ T A+KE+ + ++ P +A I
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 401 KQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
L + + L + EY+ + +Y+ + I V+ F +L GLAY H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APEV 506
+HRD+K NLL++ G +KLADFG+A+ K P W P++
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLWYRPPDI 171
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-------- 555
+ G+ + +D+W +GC EM TG+P + + E +F++L
Sbjct: 172 LL------GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225
Query: 556 ----------NRTPPIPE---------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
P L S+G D L + R SA + ++HPF
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285
Query: 597 RNANYQNLSVP 607
+ + +P
Sbjct: 286 LSLGERIHKLP 296
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 47/282 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD------- 407
+ +G+G F V ++ TG A K ++ + + +++ ++
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 408 -------DHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
Y+ + V G + V RE +E+ + + IL +AY HS +
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 459 HRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
HR++K NLL+ VKLADFG+A + G+P +++PEV+K
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK------K 181
Query: 516 NPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLS 566
+P + VDIW+ G VI +L G PP W E + ++ ++ +P ++
Sbjct: 182 DP-YSKPVDIWACG--VILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDT-VT 235
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 608
E K + NP +R +A + L+ P+I N ++
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 71/298 (23%), Positives = 120/298 (40%), Gaps = 60/298 (20%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIK---------------------EVDIIP--DDPK 395
G+ +G G F V + TG A K EV I+ P
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 396 SAECIKQLEQV---DDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLA 450
+ L +V + + LE V G + + +E +TE F + ILNG+
Sbjct: 76 ----VITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVY 128
Query: 451 YLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 506
YLHS H D+K N+++ +K+ DFG+A + + ++ G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----R 557
+ P L L D+WS+G VI +L+G P + + Q V
Sbjct: 189 VN------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANVSAVNYEFE 237
Query: 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 615
S+ KDF+ R +++P +R + + L+HP+I+ + Q +
Sbjct: 238 DEYFSN-TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME 294
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 76/279 (27%), Positives = 120/279 (43%), Gaps = 50/279 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIK-------------- 401
++IG+G F V NRETG A+K VD S E +K
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 402 -QLEQV---DDHLYIYLEYVHPGSI-NRYV-REHCRDI-TESIVRNFTRHILNGLAYLHS 454
+L + D LY+ E++ + V R + +E++ ++ R IL L Y H
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 455 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 510
N IHRD+K +L+ + S VKL FG+A L + G+P++MAPEV+K
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK-- 206
Query: 511 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 561
P VD+W G VI +L+G P + + +F ++
Sbjct: 207 ----REP-YGKPVDVWGCG--VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQW 256
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
+S KD + R + +P ER + E L HP+++ +
Sbjct: 257 SH-ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 45/277 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK--------------- 401
+++G+G+FG V + +ETG A+K + I+ DD EC
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFL 86
Query: 402 -QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
QL Q D L+ +E+V+ G + +++ R E+ R + I++ L +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
I+RD+K N+L+D G KLADFGM K G+ ++ G+P+++APE++ Q+
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL----QEM 199
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFL 573
AVD W++G + EML G P+ E +F +LN P L + L
Sbjct: 200 LYGP---AVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGIL 255
Query: 574 LRCFLRNPVER------PSAVELLEHPFIRNANYQNL 604
+NP R +L HPF + ++ L
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 66/272 (24%), Positives = 124/272 (45%), Gaps = 40/272 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQ----LEQV------ 406
+ +G G+FG V++ +R G A+K + ++ K E L V
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTNDERLMLSIVTHPFII 69
Query: 407 --------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+++ ++Y+ G + +R + + + + + L YLHS + I
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDII 128
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
+RD+K N+L+D +G +K+ DFG AK++ ++Y +L G+P+++APEV+ K
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVV----STKPYNK 182
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLRCF 577
++D WS G + EML G P+ + + K+LN P + + KD L R
Sbjct: 183 ---SIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 238
Query: 578 LRNPVER-----PSAVELLEHPFIRNANYQNL 604
R+ +R ++ HP+ + ++ L
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-40
Identities = 77/312 (24%), Positives = 124/312 (39%), Gaps = 68/312 (21%)
Query: 340 MPHIMEKPSAS----PKKSQWQKG----------KLIGRGTFGSVYIGTNRETGASCAIK 385
M H S+ + + +K +++G G G V +R TG CA+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 386 EVDIIPDDPKSAECIKQLEQVDDH-------------------LYIYLEYVHPGSI-NRY 425
++ D PK+ + + Q L I +E + G + +R
Sbjct: 61 ---LLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 426 VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGM 482
+ TE R I + +LHS N HRD+K NLL + V+KL DFG
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 483 AKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLT 537
AK T + +L+ +P ++APEV+ +K + D+WSLG VI +L
Sbjct: 178 AKETT----QNALQTPCYTPYYVAPEVLGP--EKYD-----KSCDMWSLG--VIMYILLC 224
Query: 538 GKPP-WSE--FEGPQAMFKVLNR------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 588
G PP +S M + + P E +S + K + +P ER +
Sbjct: 225 GFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDAKQLIRLLLKTDPTERLTIT 283
Query: 589 ELLEHPFIRNAN 600
+ + HP+I +
Sbjct: 284 QFMNHPWINQSM 295
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-40
Identities = 83/320 (25%), Positives = 140/320 (43%), Gaps = 53/320 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIK--------------- 401
K+IGRG FG V + ++ T A+K + ++I +
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR--SDSAFFWEERDIMAFANSPWVV 132
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
QL Q D +LY+ +EY+ G + + D+ E R +T ++ L +HS I
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
HRD+K N+L+D SG +KLADFG + G+ + G+P++++PEV+K+ + G+
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS---QGGD 247
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIP----EMLSSEGKD 571
D WS+G + EML G P+ + + K++N + +S E K+
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 572 FLLRCFLRNPVER---PSAVELLEHPFIRNANYQNLS--------VPMRVFSRINLGDKS 620
L+ FL + R E+ H F +N + + VP + S D S
Sbjct: 307 -LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP-DLSSD---IDTS 361
Query: 621 H-DQVERATRKTESLPDSPE 639
+ D +E + E+ P
Sbjct: 362 NFDDLEEDKGEEETFPIPKA 381
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 46/272 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---------------QL 403
+ +GRG FG V+ + + K + +K L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAK---FVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 404 EQV---DDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ + L + E++ I R + E + ++ + L +LHS N H
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHNIGH 125
Query: 460 RDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
DI+ N++ S +K+ +FG A+ L L +P + APEV + +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ------HDV 179
Query: 518 KLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSE 568
++ A D+WSLG + +L+G P +E Q + ++N E +S E
Sbjct: 180 -VSTATDMWSLG--TLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKE-ISIE 233
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
DF+ R ++ R +A E L+HP+++
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-40
Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 44/276 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK--------------- 401
KL+G+GTFG V + + TG A+K + I+ D
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNSRHPFLT 211
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NT 457
L+ Q D L +EY + G + ++ R +E R + I++ L YLHS N
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNV 270
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
++RD+K NL++D G +K+ DFG+ K G+ ++K G+P ++APEV++ D
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE---DND 325
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFL 573
AVD W LG + EM+ G+ P+ + + +F +L P L E K L
Sbjct: 326 YGR----AVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLL 380
Query: 574 LRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 604
++P +R A E+++H F +Q++
Sbjct: 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 86/347 (24%), Positives = 129/347 (37%), Gaps = 87/347 (25%)
Query: 312 SNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
S NA + L P + + ++ + K+IG G+FG V+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSA-------------------ECIKQLEQVDDHLYI 412
E+ AIK+ + D + D +++
Sbjct: 58 QAKLVESD-EVAIKK---VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 413 YL--EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 467
L EYV P ++ R R + + + +++ + +L LAY+HS HRDIK NL
Sbjct: 114 NLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNL 172
Query: 468 LVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQKDGNPK 518
L+D SGV+KL DFG AK L G PN + APE+I G
Sbjct: 173 LLDPPSGVLKLIDFGSAKILI--------AGEPNVSYICSRYYRAPELIF------GATN 218
Query: 519 LALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP---IPEM-------- 564
+DIWS GC + E++ G+P + S + + KVL TP I M
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPSREQIKTMNPNYMEHK 277
Query: 565 ----------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
+ D + R P R +A+E L HPF
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 76/356 (21%), Positives = 135/356 (37%), Gaps = 79/356 (22%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSA-------- 397
+ +++K +G G F +VY ++ T AIK++ + ++A
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 398 ----ECIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
I L ++ + +++ + ++++ +T S ++ + L GL
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 500
YLH +HRD+K NLL+D +GV+KLADFG+AK GSPN
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGSPNRAYTHQVVTR 176
Query: 501 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL- 555
W APE++ G + VD+W++GC + E+L P S+ + +F+ L
Sbjct: 177 WYRAPELLF------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
Query: 556 -------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELL 591
P IP + D + FL NP R +A + L
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
Query: 592 EHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKL 647
+ + N + + K A ++ ++ E +KL
Sbjct: 291 KMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKR--KRTEALEQGGLPKKL 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 84/325 (25%), Positives = 136/325 (41%), Gaps = 84/325 (25%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSA------------EC 399
SQ+++ + +G GT+ +VY G N+ TG A+KEV + ++ P +A E
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 400 IKQLEQV---DDHLYIYLEYVH---PGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 452
I +L V ++ L + E++ + +R V R + ++V+ F +L GLA+
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------WM 502
H +HRD+K NLL++ G +KL DFG+A+ G P W
Sbjct: 125 HENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPVNTFSSEVVTLWY 174
Query: 503 -APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRT 558
AP+V+ G+ + ++DIWS GC + EM+TGKP + ++ E + +F ++ T
Sbjct: 175 RAPDVLM------GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM-GT 227
Query: 559 P--------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPS 586
P E L DFL NP R S
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 587 AVELLEHPFIRNANYQNLSVPMRVF 611
A + L HP+ + R
Sbjct: 288 AKQALHHPWFAEYYHHASMGGSRSH 312
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 59/273 (21%), Positives = 115/273 (42%), Gaps = 46/273 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAE---------------CI 400
++G+G+FG V +R T A+K ++ D + +
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 401 KQLEQVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
++ + YI E G + + ++ +E + + +G+ Y+H N +H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 460 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
RD+K N+L+ + +K+ DFG++ + G+ ++APEV++ +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR----GTYD 200
Query: 517 PKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSS 567
K D+WS G VI +L+G PP + + E + +V P +S
Sbjct: 201 EK----CDVWSAG--VILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT-ISD 251
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
+ KD + + +P R +A + LEHP+I+ +
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-39
Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 43/275 (15%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK--------------- 401
K+IG+G+FG V + ++ A+K + I+ + I
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKNVKHPFL 101
Query: 402 -QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
L Q D LY L+Y++ G + +++ R E R + I + L YLHS N
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 514
++RD+K N+L+D+ G + L DFG+ K + + + G+P ++APEV+ K
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL----HKQ 214
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFL 573
+ VD W LG + EML G PP+ M+ +LN+ + +++ + L
Sbjct: 215 PYDR---TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPNITNSARHLL 270
Query: 574 LRCFLRNPVER----PSAVELLEHPFIRNANYQNL 604
++ +R +E+ H F N+ +L
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 48/293 (16%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-------------- 398
+ + +++G G F V++ R TG A+K I P +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK---CIKKSPAFRDSSLENEIAVLKKIK 64
Query: 399 --CIKQLEQV---DDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 451
I LE + H Y+ ++ V G + +R + R TE + +L+ + Y
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKY 121
Query: 452 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 508
LH +HRD+K NLL + + + + DFG++K + G+P ++APEV+
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVLA 180
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 561
+ AVD WS+G +L G PP + E E +F K+ +P
Sbjct: 181 -------QKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEFESPFW 231
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 614
+ +S KDF+ ++P ER + + L HP+I + + V +I
Sbjct: 232 DD-ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-39
Identities = 83/470 (17%), Positives = 164/470 (34%), Gaps = 49/470 (10%)
Query: 171 PTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF 230
T + + ++ I + + + + + + P
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 231 SSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSP 290
+ +W+ L ++ + + S S+
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 291 RKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSAS 350
+ L + + + + N A + + + K +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 351 PKKSQWQKG-----KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK- 401
+ + + ++G+G+FG V + + T A+K + +I DD EC
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV 390
Query: 402 ---------------QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 443
QL Q D LY +EYV+ G + ++ + E +
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAA 449
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPN 500
I GL +L S I+RD+K N+++D+ G +K+ADFGM K + ++ K G+P+
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPD 507
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTP 559
++APE+I K +VD W+ G + EML G+ P+ E +F ++
Sbjct: 508 YIAPEII----AYQPYGK---SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV 559
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
P+ +S E ++P +R ++ EH F R +++ L
Sbjct: 560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 59/309 (19%), Positives = 125/309 (40%), Gaps = 53/309 (17%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA--------------ECIKQL 403
K K +G G+F ++++ + A+K II ++ I +L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 404 EQV---DDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+V H ++ +E ++ G + R ++ +E+ R +++ ++++H +H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 460 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAVMQKDG 515
RD+K NLL + + +K+ DFG A+ + L + ++ APE++ ++G
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN----QNG 185
Query: 516 NPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEG-----PQAMFK-----VLNRTPPIP 562
+ + D+WSLG VI ML+G+ P S + K +
Sbjct: 186 YDE---SCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240
Query: 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHD 622
+ +S E KD + +P +R L + ++++ + + ++ S
Sbjct: 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS----QLSSNPLMTPDILGSSGA 296
Query: 623 QVERATRKT 631
V + T
Sbjct: 297 AVHTCVKAT 305
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-39
Identities = 80/308 (25%), Positives = 119/308 (38%), Gaps = 82/308 (26%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA------------- 397
P++ + K+IG G+FG VY ++G AIK+ + D +
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNRELQIMRKLDHC 107
Query: 398 ------ECIKQLEQVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFTRHIL 446
+ D +Y+ L +YV P ++ R R + R + V+ + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPN----- 500
LAY+HS HRDIK NLL+D + V+KL DFG AK L +G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--------RGEPNVSYIC 218
Query: 501 --WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKV 554
+ APE+I G ++D+WS GC + E+L G+P + S + + KV
Sbjct: 219 SRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 555 LNRTPP---IPEM------------------------LSSEGKDFLLRCFLRNPVERPSA 587
L TP I EM E R P R +
Sbjct: 273 LG-TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331
Query: 588 VELLEHPF 595
+E H F
Sbjct: 332 LEACAHSF 339
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 40/272 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ----LEQVD----- 407
K +G G+FG V + ++E+G A+K + ++ K E L+ V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLNEKRILQAVNFPFLV 104
Query: 408 ---------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+LY+ +EYV G + ++R +E R + I+ YLHS + I
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
+RD+K NLL+D G +++ DFG AK + G ++ +L G+P +APE+I G K
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEII----LSKGYNK 217
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLRCF 577
AVD W+LG + EM G PP+ + P ++ K+++ P SS+ KD L
Sbjct: 218 ---AVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 578 LRNPVER-----PSAVELLEHPFIRNANYQNL 604
+ +R ++ H + ++ +
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-39
Identities = 80/322 (24%), Positives = 123/322 (38%), Gaps = 54/322 (16%)
Query: 317 NAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVY 371
LP PP PP P K KK+ +++G G G V
Sbjct: 24 PTPALPHPPAQPPPPPPQQ----FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDH-------------------LYI 412
N+ T A+K ++ D PK+ ++ + L I
Sbjct: 80 QIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 413 YLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-- 469
+E + G + +R + TE + I + YLHS N HRD+K NLL
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196
Query: 470 -DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 528
+ ++KL DFG AK T + + +P ++APEV+ +K + D+WSL
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYD-----KSCDMWSL 249
Query: 529 GCTVIE--MLTGKPP-WSE--FEGPQAMF-KVLNRTP--PIPE--MLSSEGKDFLLRCFL 578
G VI +L G PP +S M ++ P PE +S E K +
Sbjct: 250 G--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307
Query: 579 RNPVERPSAVELLEHPFIRNAN 600
P +R + E + HP+I +
Sbjct: 308 TEPTQRMTITEFMNHPWIMQST 329
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 38/277 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIK--------------- 401
K+IGRG FG V + + A+K + +++ C +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFREERDVLVNGDSKWIT 137
Query: 402 QLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
L Q D++LY+ ++Y G + + + + E + R + ++ + +H + +
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A + G
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA--MEGGK 255
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRT-----PPIPEMLSSEGK 570
+ D WSLG + EML G+ P+ E + K++N P +S K
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 571 DFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 604
D L+R + + R + +HPF ++ N+
Sbjct: 315 D-LIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 76/326 (23%), Positives = 137/326 (42%), Gaps = 57/326 (17%)
Query: 314 NHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPK-----------KSQWQKGKLI 362
+H + H + G + S++S S P ++ +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 363 GRGTFGSVYIGTNRETGASCAIK-------------EVDIIPDDPKSAECIKQLEQV--- 406
GRG VY + T A+K E+ ++ S I +L+++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLR--LSHPNIIKLKEIFET 119
Query: 407 DDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464
+ + LE V G + +R V + + +E + + IL +AYLH +HRD+K
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVHRDLKP 176
Query: 465 ANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 521
NLL +K+ADFG++K + ++ G+P + APE+++
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR----GCAYGP--- 229
Query: 522 AVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDF 572
VD+WS+G +I +L G P + E G Q MF ++LN +P E +S KD
Sbjct: 230 EVDMWSVG--IITYILLCGFEPFYDE-RGDQFMFRRILNCEYYFISPWWDE-VSLNAKDL 285
Query: 573 LLRCFLRNPVERPSAVELLEHPFIRN 598
+ + + +P +R + + L+HP++
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 53/281 (18%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV---DIIPDDPKSAEC-------------- 399
K++G+G+FG V++ + + A+K + + D
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTKMERDILVEVNHPF 87
Query: 400 IKQLE---QVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYL 452
I +L Q + LY+ L+++ G +++ V TE V+ + + L +L
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALALDHL 142
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKA 509
HS I+RD+K N+L+D G +KL DFG++K + +E G+ +MAPEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVV-- 198
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSE 568
+ G+ + + D WS G + EMLTG P+ + + +L +P+ LS E
Sbjct: 199 --NRRGHTQ---SADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQFLSPE 252
Query: 569 GKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
+ L F RNP R E+ H F ++ L
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 66/307 (21%), Positives = 122/307 (39%), Gaps = 47/307 (15%)
Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK 385
G + +++ + + +G+G F V ++ TG A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 386 EVDIIPDDPKSAECIKQ----LEQVD--------------DHLYIYLEYVHPGSI-NRYV 426
++ + + +++ ++ Y+ + V G + V
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 427 -REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGM 482
RE +E+ + + IL +AY HS +HR++K NLL+ VKLADFG+
Sbjct: 121 AREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 483 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKP 540
A + G+P +++PEV+K + + VDIW+ G VI +L G P
Sbjct: 178 AIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKP----VDIWACG--VILYILLVGYP 228
Query: 541 P-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P W E + ++ ++ +P ++ E K + NP +R +A + L+
Sbjct: 229 PFWDEDQ--HRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 594 PFIRNAN 600
P+I N
Sbjct: 286 PWICNRE 292
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 73/319 (22%), Positives = 121/319 (37%), Gaps = 85/319 (26%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSA--- 397
P S S+++ IG G +G+VY + +G A+K V + P S
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 398 -ECIKQLEQVDDHLYI--YLEYVHPGSINRY-----VREHC-------------RDITES 436
+++L + +H + ++ +R V EH +
Sbjct: 62 VALLRRL-EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496
+++ R L GL +LH+ +HRD+K N+LV + G VKLADFG+A+ +
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR----------IY 170
Query: 497 GSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEMLTGKPPW---S 543
+ P V+ +A P++ L VD+WS+GC EM KP + S
Sbjct: 171 SYQMALTPVVVTLWYRA-------PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223
Query: 544 EFEGPQAMFKVL-------------------NRTPPIP-----EMLSSEGKDFLLRCFLR 579
E + +F ++ P P + G LL
Sbjct: 224 EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283
Query: 580 NPVERPSAVELLEHPFIRN 598
NP +R SA L+H ++
Sbjct: 284 NPHKRISAFRALQHSYLHK 302
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 52/294 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD----IIPDDPKSAECIKQ----LEQVD--- 407
G+ +G G F V + TG A K + S E I++ L QV
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 408 -----------DHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHS 454
+ + LE V G + + +E ++E +F + IL+G+ YLH+
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT 133
Query: 455 TNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 510
H D+K N+++ +KL DFG+A + ++ G+P ++APE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-- 191
Query: 511 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 561
P L L D+WS+G VI +L+G P + + Q + +
Sbjct: 192 ----YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITSVSYDFDEEFF 242
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 615
S KDF+ + ++ +R + E L HP+I + Q V +
Sbjct: 243 SH-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 78/383 (20%), Positives = 148/383 (38%), Gaps = 55/383 (14%)
Query: 269 SADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL 328
D + S + R + + + E + + + P
Sbjct: 11 GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
+P + + K A K +++G G FG V+ TG A K
Sbjct: 71 APFDHRI-------VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK--- 120
Query: 389 IIP-DDPKSAECIKQ----LEQVD--------------DHLYIYLEYVHPGSI-NRYVRE 428
II K E +K + Q+D + + + +EYV G + +R + E
Sbjct: 121 IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE 180
Query: 429 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHL 486
+TE F + I G+ ++H +H D+K N+L + +K+ DFG+A+
Sbjct: 181 SYN-LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 487 TGLSYELSLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-W 542
+L + G+P ++APEV+ + ++ D+WS+G VI +L+G P
Sbjct: 240 KP-REKLKVNFGTPEFLAPEVVN------YDF-VSFPTDMWSVG--VIAYMLLSGLSPFL 289
Query: 543 SEFEGPQAMFKVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ + + + +L + +S E K+F+ + ++ R SA E L+HP++
Sbjct: 290 GDND-AETLNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
Query: 598 NAN-YQNLSVPMRVFSRINLGDK 619
+ + LS + + D
Sbjct: 348 DHKLHSRLSAQKKKNRGSDAQDF 370
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 61/355 (17%), Positives = 106/355 (29%), Gaps = 84/355 (23%)
Query: 320 PLPLPPGALSPPKSSVTSAVMPHIMEK--------PSASPKKSQWQK------------- 358
P G + P V + ++ K S+ P +WQ
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQL 62
Query: 359 -------GKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQV 406
L+G G F VY T + +K P +P QL +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMER 120
Query: 407 ------------------DDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRH 444
+ + E G+ IN Y + + + +V +F
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLV-----------DASGVVKLADFGMAKHLTGLSYEL 493
+L + +H IH DIK N ++ D S + L D G + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 494 SLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 550
+ + E++ K N + +D + + TV ML G + EG +
Sbjct: 241 IFTAKCETSGFQCVEMLS---NKPWNYQ----IDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 551 MFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN--ANYQN 603
+ L R P +M +F +++LL + +Y N
Sbjct: 294 KPEGLFRRLPHLDMW----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-38
Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 56/294 (19%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ- 402
M + + ++Q + +G+G F V G A ++ + + +++
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 403 ---LEQVD--------------DHLYIYLEYVHPGSINRYVREHCRDI------TESIVR 439
+ H Y+ + V G E DI +E+
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSEADAS 113
Query: 440 NFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELS-L 495
+ + IL + + H +HR++K NLL+ VKLADFG+A + G
Sbjct: 114 HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF 552
G+P +++PEV++ + VD+W+ G VI +L G PP W E + ++
Sbjct: 174 AGTPGYLSPEVLR---KDPYGKP----VDLWACG--VILYILLVGYPPFWDEDQ--HRLY 222
Query: 553 -KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
++ +P ++ E KD + + NP +R +A E L+HP+I + +
Sbjct: 223 QQIKAGAYDFPSPEWDT-VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 66/275 (24%), Positives = 122/275 (44%), Gaps = 38/275 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDD--------------PKSAEC--I 400
++IGRG FG VY +TG A+K +D I + +C I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 401 KQLE---QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+ D L L+ ++ G ++ ++ +E+ +R + I+ GL ++H+
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
++RD+K AN+L+D G V+++D G+A + + G+ +MAPEV+ +
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL---QKGVAYD 369
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFLL 574
+ D +SLGC + ++L G P+ + + + L +P+ S E + L
Sbjct: 370 S---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 575 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
R+ R A E+ E PF R+ ++Q +
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 66/310 (21%), Positives = 110/310 (35%), Gaps = 64/310 (20%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-----------------CI 400
+ ++G G V N T A+K II P +
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 401 KQLEQV---DDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+L + +D Y+ E + GSI + + E + + + L +LH+
Sbjct: 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKG 131
Query: 457 TIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK--------GSPNWMAPE 505
HRD+K N+L + VK+ DF + + + GS +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMFKVLNRTPPIP 562
V++A + D+WSLG VI +L+G PP +
Sbjct: 192 VVEA--FSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 563 EML------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN-ANYQN 603
+ S KD + + +R+ +R SA ++L+HP+++ A
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
Query: 604 LSVPMRVFSR 613
L PM V R
Sbjct: 308 LPTPM-VLQR 316
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 47/271 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIK---------------EVDIIP--DDPKSAECIK 401
+ +G G FG V+ + TG K E+ I+ PK +
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK----LI 111
Query: 402 QLEQV---DDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
L + + LE++ G + +R E + ++E+ V N+ R GL ++H +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSI 170
Query: 458 IHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
+H DIK N++ + VK+ DFG+A L + + APE++
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD------R 224
Query: 516 NPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMFKVLN-----RTPPIPEMLSS 567
P + D+W++G V+ +L+G P E + + + V +S
Sbjct: 225 EP-VGFYTDMWAIG--VLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSS-VSP 279
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
E KDF+ + P +R + + LEHP+++
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD----IIPDDPKSAECIKQ----LEQVD--- 407
G+ +G G F V + TG A K + E I++ L QV
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 408 -----------DHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHS 454
+ + LE V G + + +E ++E +F + IL+G+ YLH+
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT 133
Query: 455 TNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 510
H D+K N+++ +KL DFG+A + ++ G+P ++APE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-- 191
Query: 511 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 561
P L L D+WS+G VI +L+G P + + Q +
Sbjct: 192 ----YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITAVSYDFDEEFF 242
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 615
+ S KDF+ + ++ +R + E L HP+I + Q V +
Sbjct: 243 SQ-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLE 295
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 76/320 (23%), Positives = 121/320 (37%), Gaps = 83/320 (25%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDD---PKSA-- 397
MEK Q++ IG G +G V+ + + G A+K V + + P S
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 398 --ECIKQLEQVDDHLYI--YLEYVHPGSINRY-----VREHC-------------RDITE 435
++ L + +H + + +R V EH +
Sbjct: 61 EVAVLRHL-ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 436 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495
+++ +L GL +LHS +HRD+K N+LV +SG +KLADFG+A+ +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----------I 169
Query: 496 KGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEMLTGKP----- 540
+ V+ +A P++ L VD+WS+GC EM KP
Sbjct: 170 YSFQMALTSVVVTLWYRA-------PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222
Query: 541 ---------------P----WSEFEG-PQAMFKVLNRTP--PIPEMLSSEGKDFLLRCFL 578
P W P+ F + P + GKD LL+C
Sbjct: 223 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282
Query: 579 RNPVERPSAVELLEHPFIRN 598
NP +R SA L HP+ ++
Sbjct: 283 FNPAKRISAYSALSHPYFQD 302
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 79/314 (25%), Positives = 122/314 (38%), Gaps = 91/314 (28%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQVDDH 409
++Q ++ G+GTFG+V +G + TG S AIK+ + DP+ + ++ L + H
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIMQDLAVL-HH 78
Query: 410 ----------------------LYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRH 444
L + +EYV P +++R R + R +++ F
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 445 ILNGLAYLH--STNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPN- 500
++ + LH S N HRDIK N+LV+ A G +KL DFG AK L+ PN
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--------PSEPNV 189
Query: 501 ------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------- 540
+ APE+I GN AVDIWS+GC EM+ G+P
Sbjct: 190 AYICSRYYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243
Query: 541 ------------------PWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNP 581
++ + + + + E D L P
Sbjct: 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303
Query: 582 VERPSAVELLEHPF 595
ER E L HP+
Sbjct: 304 EERMKPYEALCHPY 317
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 71/299 (23%), Positives = 108/299 (36%), Gaps = 75/299 (25%)
Query: 341 PHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 395
PH+ K KK+ +++G G G V N+ T A+K ++ D PK
Sbjct: 2 PHV--KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPK 56
Query: 396 SAECIKQLEQVDDH-----LYIYLEYVHPGSINRY-VREHCR------DITESIVRNFT- 442
+ ++ + + E ++ G V E I + + FT
Sbjct: 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116
Query: 443 -------RHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYE 492
+ I + YLHS N HRD+K NLL + ++KL DFG AK TG Y+
Sbjct: 117 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYD 176
Query: 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE--FEG 547
S D+WSLG VI +L G PP +S
Sbjct: 177 KS----------------------------CDMWSLG--VIMYILLCGYPPFYSNHGLAI 206
Query: 548 PQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
M ++ P E +S E K + P +R + E + HP+I +
Sbjct: 207 SPGMKTRIRMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 73/376 (19%), Positives = 131/376 (34%), Gaps = 66/376 (17%)
Query: 265 RNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLP 324
N + P+ P + R + K + +N++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAI 384
P + V + + +G G FG V+ T R TG + A
Sbjct: 145 PQPVEIKHDHV-----------------LDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 385 K---------------EVDIIP--DDPKSAECIKQLEQV---DDHLYIYLEYVHPGSI-N 423
K E+ + P + L D+ + + E++ G +
Sbjct: 188 KFVMTPHESDKETVRKEIQTMSVLRHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 424 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFG 481
+ EH + ++E + R + GL ++H N +H D+K N++ S +KL DFG
Sbjct: 244 KVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 482 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGK 539
+ HL G+ + APEV + + D+WS+G V+ +L+G
Sbjct: 303 LTAHLDPKQSVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVG--VLSYILLSGL 353
Query: 540 PP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P E + V + +S +GKDF+ + L +P R + + LE
Sbjct: 354 SPFGGEND--DETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLLLADPNTRMTIHQALE 410
Query: 593 HPFIRNANYQNLSVPM 608
HP++ N +
Sbjct: 411 HPWLTPGNAPGRDSQI 426
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 69/272 (25%), Positives = 111/272 (40%), Gaps = 42/272 (15%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIK--EVDIIPDDPKS----AECIK 401
K+++++K K++G G FG+VY G + AIK P K A +
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 402 QLEQVDDH--------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 447
+ D+ + + + + G + YVREH +I + N+ I
Sbjct: 73 SV----DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAP 504
G+ YL +HRD+ N+LV VK+ DFG+AK L E +G P WMA
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPI 561
E I D+WS G TV E++T G P+ + + R P
Sbjct: 189 ESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P + + + + +C++ + RP EL+
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 67/315 (21%), Positives = 122/315 (38%), Gaps = 84/315 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA------------E 398
S+++K IG+GTFG V+ +R+TG A+K+V + + P +A E
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 399 CIKQLEQV-----------DDHLYIYLEYV-HPGSINRYVREHCRDITESIVRNFTRHIL 446
+ L ++ +Y+ ++ H + + T S ++ + +L
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 506
NGL Y+H +HRD+K AN+L+ GV+KLADFG+A+ + L+ PN V
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQPNRYTNRV 189
Query: 507 I----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF 552
+ + P+L L +D+W GC + EM T P +E +
Sbjct: 190 VTLWYRP-------PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 553 KVL------------------NRTPPIPE-----------MLSSEGKDFLLRCFLRNPVE 583
++ + + D + + + +P +
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 584 RPSAVELLEHPFIRN 598
R + + L H F +
Sbjct: 303 RIDSDDALNHDFFWS 317
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 66/333 (19%), Positives = 112/333 (33%), Gaps = 106/333 (31%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV-------------------------- 387
++ GK +G G+FG V + E+G A+K+V
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 388 DII----------------------PDDPKSAECIKQLEQVDDHLYIYL--EYVHPGSIN 423
D ++ + + + Y+ + EYV P +++
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 424 RYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLAD 479
+ ++ R I +++ + + + ++HS HRDIK NLLV++ +KL D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 480 FGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCT 531
FG AK L P+ + APE++ G + ++D+WS+GC
Sbjct: 186 FGSAKKLI--------PSEPSVAYICSRFYRAPELML------GATEYTPSIDLWSIGCV 231
Query: 532 VIEMLTGKP--------------------PWSE---FEGPQAMFKVLNRTPPIP------ 562
E++ GKP P E P
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291
Query: 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
E S D L + P R + E + HPF
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 58/290 (20%), Positives = 107/290 (36%), Gaps = 59/290 (20%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIK------------EVDIIPDDPKSAECIKQL- 403
Q K IG+G +G V++G R G A+K E +I E I
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 404 ------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
LY+ +Y GS+ Y++ + + ++GL +LH+
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 458 --------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAP 504
HRD+K N+LV +G +AD G+A + E+ + G+ +M P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFEGPQAMFKV 554
EV+ + ++ + D++S G + E+ + P+ + ++
Sbjct: 216 EVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 555 L-------NRTPPIPEMLSSEGKDFLL-----RCFLRNPVERPSAVELLE 592
+ P P SS+ + C+ NP R +A+ + +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 63/290 (21%), Positives = 111/290 (38%), Gaps = 59/290 (20%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIK------------EVDIIPDDPKSAECIKQL- 403
+ +G+G +G V+ G+ + G + A+K E ++ E I
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 404 ------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
L++ Y GS+ Y++ D + I +GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL--RIVLSIASGLAHLHIEIF 126
Query: 458 --------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAP 504
HRD+K N+LV +G +AD G+A + + +L + G+ +MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFEGPQAMFKV 554
EV+ +Q D VDIW+ G + E+ KPP+ + F+
Sbjct: 187 EVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 555 L-------NRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 592
+ + P IP S+ + C+ +NP R +A+ + +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 68/261 (26%), Positives = 101/261 (38%), Gaps = 39/261 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKS----AECIKQLEQVDDH--- 409
G+ IGRG FG V+ G R A+K + PD A +KQ H
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY----SHPNI 174
Query: 410 ------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+YI +E V G ++R + + G+ YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKD 514
IHRD+ N LV V+K++DFGM++ Y S L+ P W APE +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-----NY 289
Query: 515 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 571
G + + D+WS G + E + G P+ Q V R P PE+
Sbjct: 290 G--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVFR 346
Query: 572 FLLRCFLRNPVERPSAVELLE 592
+ +C+ P +RPS + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 40/262 (15%)
Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEV--DIIPDDPKS----AECIKQLEQVDDH 409
+++G G FG VY G ++ + A+K D D+ + A +K L DH
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL----DH 72
Query: 410 --------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
+I +E G + Y+ + + + ++ I +AYL S
Sbjct: 73 PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQK 513
N +HRDI N+LV + VKL DFG+++++ Y + P WM+PE I
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI-----N 187
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 570
+ A D+W + E+L+ GK P+ E + + R P P++
Sbjct: 188 FR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLY 244
Query: 571 DFLLRCFLRNPVERPSAVELLE 592
+ RC+ +P +RP EL+
Sbjct: 245 TLMTRCWDYDPSDRPRFTELVC 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-32
Identities = 71/345 (20%), Positives = 128/345 (37%), Gaps = 37/345 (10%)
Query: 287 LRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEK 346
L + F +R + + + + + + ++S
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379
Query: 347 PSASPK---KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAE-- 398
PS + + + G+ IG G FG V+ G + AIK D +
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL 439
Query: 399 ------------CIKQLEQV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 444
I +L V ++ ++I +E G + +++ + + + +
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWM 502
+ LAYL S +HRDI N+LV ++ VKL DFG+++++ +Y + KG P WM
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 559
APE I + A D+W G + E+L G P+ + + ++ N R P
Sbjct: 560 APESI-----NFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQ 602
P + +C+ +P RP EL + Q
Sbjct: 613 M-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 66/264 (25%), Positives = 107/264 (40%), Gaps = 44/264 (16%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKS------AECIKQLEQVD 407
G+ IG G FG V+ G N + AIK D A ++Q
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVREKFLQEALTMRQF---- 73
Query: 408 DH--------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
DH ++I +E G + +++ + + + + + LAYL
Sbjct: 74 DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKAVM 511
S +HRDI N+LV ++ VKL DFG+++++ +Y + KG P WMAPE I
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---- 189
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSE 568
+ A D+W G + E+L G P+ + + ++ N R P P
Sbjct: 190 -NFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCPPT 245
Query: 569 GKDFLLRCFLRNPVERPSAVELLE 592
+ +C+ +P RP EL
Sbjct: 246 LYSLMTKCWAYDPSRRPRFTELKA 269
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 75/321 (23%), Positives = 127/321 (39%), Gaps = 46/321 (14%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIK--EVDIIPDDPKS----AECIK 401
K+++++K K++G G FG+VY G + AIK P K A +
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 402 QLEQVDDH--------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 447
+ D+ + + + + G + YVREH +I + N+ I
Sbjct: 73 SV----DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAP 504
G+ YL +HRD+ N+LV VK+ DFG+AK L E +G P WMA
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPI 561
E I D+WS G TV E++T G P+ + + R P
Sbjct: 189 ESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRN-ANYQNLSVPMRVFSRINLGD 618
P + + + +++C++ + RP EL+ R+ Y + R+ + D
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP-SPTD 299
Query: 619 KSHDQVERATRKTESLPDSPE 639
+ + + + D+ E
Sbjct: 300 SNFYRALMDEEDMDDVVDADE 320
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 67/305 (21%), Positives = 108/305 (35%), Gaps = 81/305 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA--ECIKQLEQVDDHLY 411
+Q + +GRG + V+ N +K + P K E IK LE +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIKRE-IKILENLRGGPN 92
Query: 412 IY--LEYVHPGSINR--YVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTI 458
I + V V EH + +T+ +R + IL L Y HS +
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 152
Query: 459 HRDIKGANLLVDAS-GVVKLADFGMA------KHLTGLSYELSLKGSPNWM-APEVIKAV 510
HRD+K N+++D ++L D+G+A + S + PE++
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASR-----YFKGPELLVDY 205
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QAMFKVL--------- 555
D ++D+WSLGC + M+ K P+ F G + KVL
Sbjct: 206 QMYD------YSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAKVLGTEDLYDYI 257
Query: 556 ---------------NRTPPIP----------EMLSSEGKDFLLRCFLRNPVERPSAVEL 590
R ++S E DFL + + R +A E
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317
Query: 591 LEHPF 595
+EHP+
Sbjct: 318 MEHPY 322
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 65/274 (23%), Positives = 108/274 (39%), Gaps = 45/274 (16%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-NRETGAS--CAIK---EVDIIPDDPKS-----AECI 400
+ + + +G G+FG V G + +G + A+K + + +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 401 KQLEQVDDH--------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 446
L DH + + E GS+ +R+H + + +
Sbjct: 76 HSL----DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWM 502
G+ YL S IHRD+ NLL+ +VK+ DFG+ + L Y + P W
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RT 558
APE +K + A D W G T+ EM T G+ PW G Q + K+ R
Sbjct: 192 APESLK-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
P PE + + +++C+ P +RP+ V L +
Sbjct: 245 PR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 60/305 (19%), Positives = 103/305 (33%), Gaps = 65/305 (21%)
Query: 348 SASPKKSQW------QKGKLIGRGTFGSVYIGTNRETGASCAIK------------EVDI 389
S P Q + IG+G FG V+ G R G A+K E +I
Sbjct: 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEI 87
Query: 390 IPDDPKSAECI-------KQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
E I + L++ +Y GS+ Y+ + + I
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 145
Query: 443 RHILNGLAYLHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494
+GLA+LH HRD+K N+LV +G +AD G+A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 495 LK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------K 539
+ G+ +MAPEV+ + DI+++G E+ +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 540 PPWSEFEGPQAMFKVL-------NRTPPIPEMLSSEGKDFLL-----RCFLRNPVERPSA 587
P+ + + + P IP S ++ C+ N R +A
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 588 VELLE 592
+ + +
Sbjct: 325 LRIKK 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 70/303 (23%), Positives = 124/303 (40%), Gaps = 76/303 (25%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------ECIKQLE 404
L+G G +G V T++ TG AIK+++ D P A E I +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIF 75
Query: 405 QV--------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ + +YI E + ++R + + +++ ++ F L + LH +N
Sbjct: 76 NIQRPDSFENFNEVYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-----------APE 505
IHRD+K +NLL++++ +K+ DFG+A+ + + + S APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF 545
V+ + A+D+WS GC + E+ +P P S+
Sbjct: 193 VMLTSAKYSR------AMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 546 -------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ K L P P +M + +G D L R + +P +R +A E LEH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 594 PFI 596
P++
Sbjct: 307 PYL 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 34/268 (12%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAE--------- 398
K+++ +K K++G G FG+V+ G IK ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 399 -----CIKQLEQV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
I +L + L + +Y+ GS+ +VR+H + ++ N+ I G+ Y
Sbjct: 71 SLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAPEVIK 508
L +HR++ N+L+ + V++ADFG+A L +L + P WMA E I
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI- 189
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEML 565
G K D+WS G TV E++T G P++ + + R P++
Sbjct: 190 ----HFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-PQIC 242
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ + +++C++ + RP+ EL
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANE 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 66/258 (25%), Positives = 109/258 (42%), Gaps = 37/258 (14%)
Query: 359 GKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAE---------------CIKQ 402
K +G G FG V +G + A+K +I + S + + +
Sbjct: 13 LKELGSGQFGVVKLGKWKGQY--DVAVK---MIKEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 403 LEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
V + +YI EY+ G + Y+R H + + S + + G+A+L S IH
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNP 517
RD+ N LVD VK++DFGM +++ Y S+ P W APEV
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF-----HYF-- 180
Query: 518 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 574
K + D+W+ G + E+ + GK P+ + + + KV R P + S +
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQIMY 239
Query: 575 RCFLRNPVERPSAVELLE 592
C+ P +RP+ +LL
Sbjct: 240 SCWHELPEKRPTFQQLLS 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 67/285 (23%), Positives = 123/285 (43%), Gaps = 38/285 (13%)
Query: 349 ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDD-PKSA 397
SP +W +G G +G VY G ++ + A+K E + ++ K A
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 398 ECIKQLE-----------QVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHI 445
+K+++ + YI E++ G++ Y+RE R ++ ++ I
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 446 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMA 503
+ + YL N IHRD+ N LV + +VK+ADFG+++ +TG +Y P W A
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPP 560
PE + K ++ D+W+ G + E+ T G P+ + Q + R
Sbjct: 181 PESL-----AYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 561 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQN 603
PE + + + C+ NP +RPS E+ + + ++ +
Sbjct: 234 -PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 40/283 (14%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
+ + + K W + +G+G FG V++GT T AIK + P
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKP 218
Query: 392 DDPKSAECIK--------------QLEQV--DDHLYIYLEYVHPGSINRYVREHCRD-IT 434
++ QL V ++ +YI EY+ GS+ +++ +
Sbjct: 219 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR 278
Query: 435 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494
+ + I +G+AY+ N +HRD++ AN+LV + V K+ADFG+A+ + Y
Sbjct: 279 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 495 LKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 551
P W APE + + D+WS G + E+ T G+ P+ + +
Sbjct: 339 QGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 552 FKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+V R P P D + +C+ + P ERP+ L
Sbjct: 392 DQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 63/307 (20%), Positives = 108/307 (35%), Gaps = 67/307 (21%)
Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT----NRETGASCAIKE--VD 388
I+ + + + + + +G G FG V + TG A+K +
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61
Query: 389 IIPDDPKS----AECIKQL-------------EQVDDHLYIYLEYVHPGSINRYVREHCR 431
+ E ++ L E + + + +E++ GS+ Y+ ++
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 432 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490
I + I G+ YL S +HRD+ N+LV++ VK+ DFG+ K +
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 491 -YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 546
Y + SP W APE + K +A D+WS G T+ E+LT S
Sbjct: 182 YYTVKDDRDSPVFWYAPECL-----MQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 547 GPQAMFKVLNRTPPIPEMLSSEGKDFL--------------------LRCFLRNPVERPS 586
M P +M + + L +C+ P R S
Sbjct: 235 LFLKMIG-----PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289
Query: 587 AVELLEH 593
L+E
Sbjct: 290 FQNLIEG 296
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 61/267 (22%), Positives = 103/267 (38%), Gaps = 39/267 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIK--------------EVDIIP--DDPKSAECIKQ 402
+ IG G FG V++G AIK E +++ PK + Q
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFIEEAEVMMKLSHPK----LVQ 67
Query: 403 LEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
L V + + E++ G ++ Y+R + + G+AYL IH
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNP 517
RD+ N LV + V+K++DFGM + + Y S P W +PEV
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-----SFS-- 180
Query: 518 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLL 574
+ + D+WS G + E+ + GK P+ + + + R P + S+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMN 239
Query: 575 RCFLRNPVERPSAVELLEH--PFIRNA 599
C+ P +RP+ LL +
Sbjct: 240 HCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-31
Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 42/298 (14%)
Query: 341 PHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 393
P + KP +K W + K +G G FG V++ T + A+K + P
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKT--MKPGS 224
Query: 394 PKSAE--------------CIKQLEQV--DDHLYIYLEYVHPGSINRYVREH-CRDITES 436
+ +L V + +YI E++ GS+ +++
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 284
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496
+ +F+ I G+A++ N IHRD++ AN+LV AS V K+ADFG+A+ + Y
Sbjct: 285 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 497 GS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553
P W APE I G + D+WS G ++E++T G+ P+ P+ +
Sbjct: 345 AKFPIKWTAPEAI-----NFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397
Query: 554 VLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQNLSVP 607
+ R P PE E + ++RC+ P ERP+ + F Q +P
Sbjct: 398 LERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 51/295 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEV-DIIPDDPKS----AECIKQ 402
++ + +G+G FGSV + TGA A+K++ PD + + +K
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 403 L-------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
L L + +EY+ G + +++ H + S + ++ I G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-NWMAPE 505
YL S +HRD+ N+LV++ VK+ADFG+AK L Y + G SP W APE
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEM 564
+ D + D+WS G + E+ T S M P + +
Sbjct: 201 SL-----SDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 565 LSS--EGK-------------DFLLRCFLRNPVERPSAVELLEH--PFIRNANYQ 602
L EG+ + + C+ +P +RPS L +
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 37/266 (13%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGAS---CAIKEV--DIIPDDPKS----AECIKQLE--- 404
++IG+G FG VY G + + CAIK + ++ ++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 405 ---------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
+ ++ L Y+ G + +++R R+ T + +F + G+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAV 510
+HRD+ N ++D S VK+ADFG+A+ + Y + W A E +
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL--- 200
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSS 567
+ + D+WS G + E+LT G PP+ + + R P PE
Sbjct: 201 --QTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPD 255
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEH 593
+ +C+ +P RP+ L+
Sbjct: 256 SLYQVMQQCWEADPAVRPTFRVLVGE 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 67/292 (22%), Positives = 112/292 (38%), Gaps = 50/292 (17%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
PH E+P + + K+IG G G V G R G AIK +
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 389 IIPDDPKSAE--------------CIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCR 431
+ + + I +LE V I EY+ GS++ ++R H
Sbjct: 87 AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 432 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491
T + R + G+ YL +HRD+ N+LVD++ V K++DFG+++ L
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 492 E--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 542
+ ++ W APE I + A D+WS G + E+L G+ P+
Sbjct: 207 AAYTTTGGKIPIR----WTAPEAI-----AFR--TFSSASDVWSFGVVMWEVLAYGERPY 255
Query: 543 SEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ V R P P +L C+ ++ +RP +++
Sbjct: 256 WNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 69/299 (23%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------E 398
+ +G G +GSV ++ +G AIK++ A E
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 399 CIKQLEQV---------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
+ L V Y+ + ++ + + + +E ++ +L GL
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQMLKGL 139
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEVIK 508
Y+HS +HRD+K NL V+ +K+ DFG+A+ E++ W APEVI
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVIL 196
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF--- 545
+ M + VDIWS+GC + EMLTGK P +EF
Sbjct: 197 SWMHYNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250
Query: 546 ---EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ ++ + L +TP ++ S + D L + + +R +A + L HPF
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/291 (23%), Positives = 110/291 (37%), Gaps = 47/291 (16%)
Query: 344 MEKPS-ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIK---------- 385
PS A W K +G G FG V G R AIK
Sbjct: 6 KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSED 64
Query: 386 ----EVDIIP--DDPKSAECIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITES 436
E ++ K + QL V ++I EY+ G + Y+RE
Sbjct: 65 EFIEEAKVMMNLSHEK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ 120
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 496
+ + + + YL S +HRD+ N LV+ GVVK++DFG+++++ Y S+
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 497 GS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553
P W PEV+ K + DIW+ G + E+ + GK P+ F +
Sbjct: 181 SKFPVRWSPPEVL-----MYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 554 VLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNAN 600
+ R P + S + + C+ ERP+ LL + + +
Sbjct: 234 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 59/265 (22%), Positives = 107/265 (40%), Gaps = 43/265 (16%)
Query: 358 KGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKS-------AECIKQLEQVDD 408
+ K +G G FG+V G ++ + A+K + +DP A ++QL D
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL----D 76
Query: 409 H--------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+ + +E G +N+Y++++ R + + + + G+ YL
Sbjct: 77 NPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE 135
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAV 510
+N +HRD+ N+L+ K++DFG++K L Y+ G P W APE I
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--- 192
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSS 567
K + D+WS G + E + G+ P+ +G + + R P
Sbjct: 193 --NYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPR 247
Query: 568 EGKDFLLRCFLRNPVERPSAVELLE 592
E D + C+ + RP +
Sbjct: 248 EMYDLMNLCWTYDVENRPGFAAVEL 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 68/409 (16%), Positives = 133/409 (32%), Gaps = 113/409 (27%)
Query: 345 EKPSASPKKSQWQKGKL---IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAEC 399
K S+ ++ + +GRGT+G VY ++ A+K+++ SA
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR 67
Query: 400 ------------IKQLEQV-----DDHLYIYLEYV----------HPGSINRYVREHCRD 432
+ L++V D +++ +Y H S
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ--- 124
Query: 433 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMAKHLTG 488
+ +V++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD G A+
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---- 180
Query: 489 LSYELSLKGSPNWM---------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 539
+ LK + APE++ G A+DIW++GC E+LT +
Sbjct: 181 -LFNSPLKPLADLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSE 233
Query: 540 P-----------------------------------------PWSEFEGPQAMFKVLNRT 558
P P
Sbjct: 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 293
Query: 559 PPIPEM------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA------NYQNLSV 606
I M S+ L + +P++R ++ + ++ P+ + +
Sbjct: 294 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQI 353
Query: 607 PMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCP 655
P + + ++ ++ + + T + +++ P
Sbjct: 354 PYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPP 402
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 60/265 (22%), Positives = 101/265 (38%), Gaps = 45/265 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKS-------AECIKQLE--- 404
+L+GRG G VY + A+K ++ DP A +L+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALK---LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 405 --------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
++D LY+ + ++ + +R + R I + L H+
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAG 154
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKD 514
HRD+K N+LV A L DFG+A L+ + G+ +MAPE +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE------RFS 208
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLNRTPPIPEM----LSSE 568
+ DI++L C + E LTG PP ++G M +N+ P P +
Sbjct: 209 ESHATY-RADIYALTCVLYECLTGSPP---YQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 569 GKDFLLRCFLRNPVER-PSAVELLE 592
+ R +NP +R + +L
Sbjct: 265 FDAVIARGMAKNPEDRYVTCGDLSA 289
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 68/300 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------E 398
++Q +G G +GSV + +TG A+K++ A E
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 399 CIKQLEQV---------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
+ L V + +Y+ + +N V+ C+ +T+ V+ IL GL
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGL 145
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEVIK 508
Y+HS + IHRD+K +NL V+ +K+ DFG+A+H E++ + W APE++
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIML 202
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF--- 545
M + VDIWS+GC + E+LTG+ P +E
Sbjct: 203 NWMHYNQ------TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 546 ---EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
E + + L + P + + + D L + + + +R +A + L H +
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 41/260 (15%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKE--VDIIPDDPKS----AECIKQLEQVDDH---- 409
+G G FGSV G R+ AIK D + A+ + QL D+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL----DNPYIV 73
Query: 410 ----------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
L + +E G +++++ +I S V + G+ YL N +H
Sbjct: 74 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQKDG 515
RD+ N+L+ K++DFG++K L Y G P W APE I
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-----NFR 188
Query: 516 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDF 572
K + D+WS G T+ E L+ G+ P+ + +GP+ M + R P E
Sbjct: 189 --KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYAL 245
Query: 573 LLRCFLRNPVERPSAVELLE 592
+ C++ +RP + + +
Sbjct: 246 MSDCWIYKWEDRPDFLTVEQ 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 75/366 (20%), Positives = 131/366 (35%), Gaps = 48/366 (13%)
Query: 258 SPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLN 317
SP+ P + + H + SP + K+ N +
Sbjct: 2 SPIDPMGHHHHH--HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59
Query: 318 -AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
A+ + + AL+P V+ ++IGRG FG VY GT
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGP--------SSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 377 ETGAS---CAIKEVDIIPDDP------KSAECIKQLE------------QVDDHLYIYLE 415
+ CA+K ++ I D +K + + + L
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171
Query: 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 475
Y+ G + ++R + T + F + G+ +L S +HRD+ N ++D V
Sbjct: 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231
Query: 476 KLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGC 530
K+ADFG+A+ + ++ + WMA E + + K D+WS G
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-----QTQ--KFTTKSDVWSFGV 284
Query: 531 TVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA 587
+ E++T G PP+ + +L R PE + +L+C+ RPS
Sbjct: 285 LLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSF 343
Query: 588 VELLEH 593
EL+
Sbjct: 344 SELVSR 349
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 88/315 (27%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV-------------------------- 387
S++ K +G G G V+ + + AIK++
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 388 ----DII-PDDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
+I+ P + + + L +++ +YI EY+ + + + E R F
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNS-VYIVQEYM-ETDLANVLE--QGPLLEEHARLFM 126
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNW 501
+L GL Y+HS N +HRD+K ANL ++ V+K+ DFG+A+ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------PHYSHKGH 180
Query: 502 M----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 540
+ +P ++ + A+D+W+ GC EMLTGK
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 541 ---------PWSEF-----EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNP 581
E + P P ++L S E DFL + +P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 582 VERPSAVELLEHPFI 596
++R +A E L HP++
Sbjct: 295 MDRLTAEEALSHPYM 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 59/307 (19%), Positives = 109/307 (35%), Gaps = 80/307 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------E 398
++ IG G +G V + AIK++ + E
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHE 85
Query: 399 CIKQLEQV--------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
I + + +YI + + + + ++ + ++ + F IL GL
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLYQILRGLK 142
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-------- 502
Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ ++
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD------PDHDHTGFLTEYVATRW 196
Query: 503 --APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP-------------------- 540
APE++ ++DIWS+GC + EML+ +P
Sbjct: 197 YRAPEIMLNSKGYTK------SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250
Query: 541 PWSEF------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVE 589
P E + L +P + S+ D L + NP +R +
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 590 LLEHPFI 596
L HP++
Sbjct: 311 ALAHPYL 317
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 52/286 (18%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKS-----AECIKQ 402
++ + + +G+G FGSV + TG A+K++ ++ E +K
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 403 L-------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
L +L + +EY+ GS+ Y+++H I + +T I G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKG-SP-NWMAPE 505
YL + IHRD+ N+LV+ VK+ DFG+ K L +++ G SP W APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----------------GKPPWSEFEGPQ 549
+ + K ++A D+WS G + E+ T G +
Sbjct: 188 SL-----TES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 550 AMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ + N R P P+ E + C+ N +RPS +L
Sbjct: 241 LIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/264 (24%), Positives = 115/264 (43%), Gaps = 41/264 (15%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKS-------AECIKQLE------ 404
+G G +VY+ + AIK + I + ++ QL
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ DD Y+ +EY+ +++ Y+ H ++ NFT IL+G+ + H +H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
RDIK N+L+D++ +K+ DFG+AK L T L+ + G+ + +PE Q G
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE------QAKGEA 188
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIP-----EMLSSEG 569
DI+S+G + EML G+PP F G A+ K + + P + +
Sbjct: 189 TDE-CTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244
Query: 570 KDFLLRCFLRNPVERP-SAVELLE 592
+ +LR ++ R + E+ +
Sbjct: 245 SNVILRATEKDKANRYKTIQEMKD 268
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 63/311 (20%), Positives = 118/311 (37%), Gaps = 81/311 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-----ECIKQLEQVD- 407
++Q K IG G G V + + AIK++ + A E + ++ V+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNH 83
Query: 408 -------------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+YI +E + ++ + ++ ++ + +L G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ---MELDHERMSYLLYQMLCG 139
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVI 507
+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ + APEVI
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI 198
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF-- 545
VDIWS+GC + EM+ G P EF
Sbjct: 199 -------LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 546 ---EGPQAMFKVLNRTPPIP-----------------EMLSSEGKDFLLRCFLRNPVERP 585
+ + + ++ +S+ +D L + + + +R
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 586 SAVELLEHPFI 596
S E L+HP+I
Sbjct: 312 SVDEALQHPYI 322
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 66/329 (20%), Positives = 118/329 (35%), Gaps = 101/329 (30%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-----ECIKQLEQVDDH----- 409
K +G+G +G V+ +R TG A+K++ + A E I L ++ H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE-IMILTELSGHENIVN 73
Query: 410 ------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+Y+ +Y+ ++ +R + + ++ + YLHS
Sbjct: 74 LLNVLRADNDRDVYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM--------------- 502
+HRD+K +N+L++A VK+ADFG+++ + +
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 503 -------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------- 540
APE++ + +D+WSLGC + E+L GKP
Sbjct: 191 VATRWYRAPEILLGSTKYTK------GIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 541 -----PWSEF------EGPQAMFKVLNRTPPIPEM---------------------LSSE 568
P +E + M + L I + + E
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPFIR 597
D L + NP +R SA + L+HPF+
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 65/289 (22%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--- 396
SP +W +G G +G VY G ++ + A+K + D +
Sbjct: 206 YGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEF 263
Query: 397 ---AECIKQLEQ-----------VDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNF 441
A +K+++ + YI E++ G++ Y+RE R ++ ++
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 442 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-PN 500
I + + YL N IHR++ N LV + +VK+ADFG+++ +TG +Y P
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383
Query: 501 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-- 556
W APE + K ++ D+W+ G + E+ T G P+ + Q +
Sbjct: 384 KWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436
Query: 557 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQN 603
R PE + + + C+ NP +RPS E+ + + ++ +
Sbjct: 437 RMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 75/356 (21%), Positives = 124/356 (34%), Gaps = 48/356 (13%)
Query: 273 SPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPK 332
L SS SN P +L + + N+ P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307
Query: 333 SSVTSAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASC--A 383
+ ++V P K + +G G FGSV G R A
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367
Query: 384 IKE--VDIIPDDPKS----AECIKQLEQVDDH--------------LYIYLEYVHPGSIN 423
IK D + A+ + QL D+ L + +E G ++
Sbjct: 368 IKVLKQGTEKADTEEMMREAQIMHQL----DNPYIVRLIGVCQAEALMLVMEMAGGGPLH 423
Query: 424 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483
+++ +I S V + G+ YL N +HR++ N+L+ K++DFG++
Sbjct: 424 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 484 KHLTGLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 538
K L Y G P W APE I K + D+WS G T+ E L+ G
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECIN-------FRKFSSRSDVWSYGVTMWEALSYG 536
Query: 539 KPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ P+ + +GP+ M + R P E + C++ +RP + + +
Sbjct: 537 QKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 37/264 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEV--DIIPDDPKS----AECIKQLE----- 404
++IGRG FG VY GT + CA+K + + +K
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 405 -------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+ + + L Y+ G + ++R + T + F + G+ YL S
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQ 512
+HRD+ N ++D VK+ADFG+A+ + Y + WMA E +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL----- 204
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEG 569
+ K D+WS G + E++T G PP+ + +L R PE
Sbjct: 205 QTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPL 261
Query: 570 KDFLLRCFLRNPVERPSAVELLEH 593
+ +L+C+ RPS EL+
Sbjct: 262 YEVMLKCWHPKAEMRPSFSELVSR 285
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 70/303 (23%), Positives = 123/303 (40%), Gaps = 52/303 (17%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
V PH E P+ + + K++G G FG V G + S AIK +
Sbjct: 23 VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAE--------------CIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCR 431
+ + + + I +LE V + I EY+ GS++ ++R+H
Sbjct: 83 VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 432 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491
T + R I +G+ YL +HRD+ N+L++++ V K++DFG+ + L
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202
Query: 492 E--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 542
+ ++ W +PE I K A D+WS G + E+++ G+ P+
Sbjct: 203 AAYTTRGGKIPIR----WTSPEAI-----AYR--KFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 543 SEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 598
E + V R PP P + +L C+ ++ RP +++ IRN
Sbjct: 252 WEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
Query: 599 ANY 601
Sbjct: 311 PGS 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 67/316 (21%), Positives = 110/316 (34%), Gaps = 72/316 (22%)
Query: 344 MEKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------------EVDI 389
ME ++ P + +LIGRG +G+VY G+ E A+K E +I
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQNFINEKNI 58
Query: 390 IPDDPKS---------AECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 440
P + + +EY GS+ +Y+ H D S
Sbjct: 59 Y-RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC--R 115
Query: 441 FTRHILNGLAYLHSTNT---------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491
+ GLAYLH+ HRD+ N+LV G ++DFG++ LTG
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 492 EL---------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG---- 538
S G+ +MAPEV++ + VD+++LG E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 539 ---------KPPWSEFEGPQAMFKVL-------NRTPPIPEMLSSEG------KDFLLRC 576
+ + G F+ + + P PE K+ + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 577 FLRNPVERPSAVELLE 592
+ ++ R +A E
Sbjct: 296 WDQDAEARLTAQXAEE 311
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 65/297 (21%), Positives = 120/297 (40%), Gaps = 59/297 (19%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEV 387
+ P+ + K + K+IG G FG VY G + + AIK +
Sbjct: 22 FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL 81
Query: 388 DIIPDDPKS------AECIKQLEQVDDH---------------LYIYLEYVHPGSINRYV 426
+ + A + Q H + I EY+ G++++++
Sbjct: 82 KAGYTEKQRVDFLGEAGIMGQF----SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
Query: 427 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486
RE + + + R I G+ YL + N +HRD+ N+LV+++ V K++DFG+++ L
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 487 TGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 537
+ ++ W APE I K A D+WS G + E++T
Sbjct: 198 EDDPEATYTTSGGKIPIR----WTAPEAI-----SYR--KFTSASDVWSFGIVMWEVMTY 246
Query: 538 GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
G+ P+ E + M + + R P P S +++C+ + RP +++
Sbjct: 247 GERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 33/268 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDD-PKSAECIKQLEQ--------- 405
+ +G G FG V++G A+K + + PD A +KQL+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 406 -VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+ +YI EY+ GS+ +++ +T + + + I G+A++ N IHRD++
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLAL 521
AN+LV + K+ADFG+A+ + Y P W APE I G +
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-----NYG--TFTI 189
Query: 522 AVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFL 578
D+WS G + E++T G+ P+ P+ + + R P+ E + C+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWK 248
Query: 579 RNPVERPSAVELLEH--PFIRN--ANYQ 602
P +RP+ L F YQ
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFTATEGQYQ 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 59/297 (19%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK 395
SA + + + +G+G FGSV + TG A+K++ ++
Sbjct: 27 GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 86
Query: 396 S-----AECIKQL-------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESI 437
E +K L +L + +EY+ GS+ Y+++H I
Sbjct: 87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146
Query: 438 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSL 495
+ +T I G+ YL + IHRD+ N+LV+ VK+ DFG+ K L Y++
Sbjct: 147 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 496 KG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT---------------- 537
G SP W APE + + K ++A D+WS G + E+ T
Sbjct: 207 PGESPIFWYAPESL-----TES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 538 GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
G + + + N R P P+ E + C+ N +RPS +L
Sbjct: 260 GNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 53/296 (17%), Positives = 107/296 (36%), Gaps = 65/296 (21%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC---IKQLEQV---- 406
Q ++ RG FG V+ A+K D +S + + L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFP--IQDKQSWQNEYEVYSLPGMKHEN 79
Query: 407 --------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
D L++ + GS++ +++ + ++ + + + + GLAYL
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYL 137
Query: 453 HSTNT----------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSP 499
H HRDIK N+L+ + +ADFG+A G+
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS----EFEGP------- 548
+MAPEV++ + + L +D++++G + E+ + E+ P
Sbjct: 198 RYMAPEVLEGAI--NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 549 ----QAMFKVL---NRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 592
+ M +V+ + P + + + + C+ + R SA + E
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 33/256 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK--------------QLE 404
+G+G FG V++GT T AIK + P ++ QL
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 405 QV--DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRD 461
V ++ +YI EY+ GS+ +++ + + + I +G+AY+ N +HRD
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKL 519
++ AN+LV + V K+ADFG+A+ + Y P W APE +
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-------YGRF 441
Query: 520 ALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRC 576
+ D+WS G + E+ T G+ P+ + + +V R P P D + +C
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQC 500
Query: 577 FLRNPVERPSAVELLE 592
+ + P ERP+ L
Sbjct: 501 WRKEPEERPTFEYLQA 516
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 68/293 (23%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC----IKQLEQVD-------- 407
+ +G G +G+V + TGA AIK++ A+ ++ L+ +
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 408 ------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
Y+ + ++ + + ++ + E ++ +L GL Y+H+
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKD 514
IHRD+K NL V+ +K+ DFG+A+ E++ W APEVI M+
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWMRYT 204
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF------EGP 548
VDIWS+GC + EM+TGK P +EF +
Sbjct: 205 Q------TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 549 QAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
+ K L +L S + L + + + +R +A E L HP+
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 335 VTSAVMPHIMEKPSASPK---KSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAI 384
T + P +ME A+ +S W + + IG+G FG V +G R G A+
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAV 221
Query: 385 KEV--DIIPDD-PKSAECIKQLE------------QVDDHLYIYLEYVHPGSINRYVREH 429
K + D A + QL + LYI EY+ GS+ Y+R
Sbjct: 222 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281
Query: 430 CR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488
R + + F+ + + YL N +HRD+ N+LV V K++DFG+ K +
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341
Query: 489 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545
L +K W APE + ++ K + D+WS G + E+ + G+ P+
Sbjct: 342 TQDTGKLPVK----WTAPEAL-----REK--KFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
Query: 546 EGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ +V + P+ D + C+ + RP+ ++L E
Sbjct: 391 PLKDVVPRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 23/194 (11%)
Query: 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 470
YI +EYV ++ V +T L + H IHRD+K AN+++
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 471 ASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 526
A+ VK+ DFG+A+ + + ++ G+ +++PE Q G+ A D++
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------QARGDSVDA-RSDVY 203
Query: 527 SLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIP----EMLSSEGKDFLLRCFLR 579
SLGC + E+LTG+PP F G + ++ + P P E LS++ +L+ +
Sbjct: 204 SLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260
Query: 580 NPVERP-SAVELLE 592
NP R +A E+
Sbjct: 261 NPENRYQTAAEMRA 274
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/281 (18%), Positives = 100/281 (35%), Gaps = 58/281 (20%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKS-----AEC 399
+ + +G+GTF ++ G RE G +K +D + A
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 400 IKQLEQVDDH---------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 444
+ +L H + E+V GS++ Y++++ I +
Sbjct: 66 MSKL----SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 445 ILNGLAYLHSTNTIHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSLK 496
+ + +L IH ++ N+L+ +KL+D G++ + +
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL---Q 178
Query: 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 555
W+ PE I ++ L LA D WS G T+ E+ + G P S + + +
Sbjct: 179 ERIPWVPPECI-----ENPK-NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 556 NR----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+R P E+ + + C P RPS ++
Sbjct: 233 DRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIR 268
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 64/349 (18%), Positives = 111/349 (31%), Gaps = 109/349 (31%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------E 398
+++ LIG G++G V ++ AIK++ + +D +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 399 CIKQLEQV--------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
+ ++ + D LY+ LE + R +TE ++ ++L G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVK 170
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 510
Y+HS +HRD+K AN LV+ VK+ DFG+A+ + S +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 511 MQKDGN---------------PKLAL-------AVDIWSLGCTVIEM------------- 535
P+L L A+D+WS+GC E+
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
Query: 536 ---------------------------------------LTGKPP---WSEFEGPQA--M 551
+ G P E A
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350
Query: 552 FKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 595
++ + E S++ L R + NP +R + E L HPF
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 42/276 (15%)
Query: 346 KPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDD-PK 395
+S W + + IG+G FG V +G R A+K + D
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLA 63
Query: 396 SAECIKQLE------------QVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFT 442
A + QL + LYI EY+ GS+ Y+R R + + F+
Sbjct: 64 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-N 500
+ + YL N +HRD+ N+LV V K++DFG+ K G P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK 179
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--R 557
W APE + ++ K + D+WS G + E+ + G+ P+ + +V +
Sbjct: 180 WTAPEAL-----REK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 232
Query: 558 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P+ + + C+ + RPS ++L E
Sbjct: 233 MDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 78/369 (21%), Positives = 124/369 (33%), Gaps = 68/369 (18%)
Query: 293 VYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSS-VTSAVMPHIMEKPSASP 351
Y H + E L L P LS ++S + + P+ S
Sbjct: 3 YYHHHHHHDYDIPTTENL-YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61
Query: 352 KKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEV--DIIPDDPKS- 396
+ +G G FG VY G N + A+K + D
Sbjct: 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 121
Query: 397 ---AECIKQLEQVDDH---------------LYIYLEYVHPGSINRYVREHCRD------ 432
A I + +H +I LE + G + ++RE
Sbjct: 122 LMEALIISKF----NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 433 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 489
+ + + R I G YL + IHRDI N L+ G V K+ DFGMA+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 490 SYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 543
Y KG WM PE +G D WS G + E+ + G P+
Sbjct: 238 GYY--RKGGCAMLPVKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 544 EFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNA 599
+ + V R P P+ + +C+ P +RP+ +LE ++
Sbjct: 289 SKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
Query: 600 NYQNLSVPM 608
+ N ++P+
Sbjct: 348 DVINTALPI 356
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 61/317 (19%), Positives = 101/317 (31%), Gaps = 92/317 (29%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-------------I 400
S + + I G++G+V G + G AIK V D ++ I
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 401 KQLEQVD-------------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 441
+ L LY+ E + + + + + I+ ++ F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 442 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 501
HIL GL LH +HRD+ N+L+ + + + DF +A+ T +
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT----------ADAN 189
Query: 502 M----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 540
APE++ VD+WS GC + EM K
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 541 ---------PWSEF----EGPQA---MFKVLNRTPPIP--EML---SSEGKDFLLRCFLR 579
P E P A + L+ P ++ D + +
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 580 NPVERPSAVELLEHPFI 596
NP R S + L HP+
Sbjct: 304 NPQRRISTEQALRHPYF 320
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 72/289 (24%), Positives = 111/289 (38%), Gaps = 62/289 (21%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIG----TNRETGASCAIKEV--DIIPDDPKS----AECIK 401
K +K + +G G FG V + TN TG A+K + D P + ++
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR 88
Query: 402 QL-------------EQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
L + L + +EYV GS+ Y+ H I + + F + I G
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEG 146
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-NWMAP 504
+AYLH+ + IHRD+ N+L+D +VK+ DFG+AK + Y + G SP W AP
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPE 563
E + K+ K A D+WS G T+ E+LT S + +
Sbjct: 207 ECL-----KEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGIAQGQ 254
Query: 564 MLSSEGKDFL--------------------LRCFLRNPVERPSAVELLE 592
M + L C+ RP+ L+
Sbjct: 255 MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 68/317 (21%), Positives = 107/317 (33%), Gaps = 58/317 (18%)
Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT---- 374
G+ P S + HI+E P +G G FG V++
Sbjct: 6 GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65
Query: 375 -NRETGASCAIKEVDIIPDDPKS-----AECIKQLE-----------QVDDHLYIYLEYV 417
+ A+K + + + AE + L+ L + EY+
Sbjct: 66 LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125
Query: 418 HPGSINRYVREHCRDITESIVRN--------------FTRHILNGLAYLHSTNTIHRDIK 463
G +NR++R H D + G+ YL + +HRD+
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185
Query: 464 GANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPK 518
N LV VVK+ DFGM++ + Y G WM PE I K
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESI-----LYR--K 236
Query: 519 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRC 576
D+WS G + E+ T GK PW + +A+ + P E + C
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGC 296
Query: 577 FLRNPVERPSAVELLEH 593
+ R P +R S ++
Sbjct: 297 WQREPQQRHSIKDVHAR 313
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 67/321 (20%), Positives = 119/321 (37%), Gaps = 56/321 (17%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
+ S++H + H L P ++ + V+ + GK++G G FGS
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDR-----------NLLILGKILGEGEFGS 49
Query: 370 VYIGT---NRETGASCAIKEV--DIIPDDPKS-----AECIKQLE--------------- 404
V G T A+K + D A C+K
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 405 -QVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTI 458
Q + L ++ G ++ Y+ + I + F I G+ YL + N +
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL 169
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAPEVIKAVMQKDG 515
HRD+ N ++ V +ADFG++K + Y + + P W+A E + D
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-----ADR 224
Query: 516 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDF 572
D+W+ G T+ E+ T G P+ + + +L+ R PE E +
Sbjct: 225 --VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ-PEDCLDELYEI 281
Query: 573 LLRCFLRNPVERPSAVELLEH 593
+ C+ +P++RP+ L
Sbjct: 282 MYSCWRTDPLDRPTFSVLRLQ 302
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 63/319 (19%), Positives = 115/319 (36%), Gaps = 97/319 (30%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------E 398
++Q K IG G G V + + AIK++ + A +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 399 CIKQLEQV---------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449
I L V +Y+ +E + ++ + ++ ++ + +L G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQMLCGI 177
Query: 450 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM------- 502
+LHS IHRD+K +N++V + +K+ DFG+A+ G+ M
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----------GTSFMMTPYVVTR 227
Query: 503 ---APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------------- 540
APEVI VDIWS+GC + EM+ K
Sbjct: 228 YYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280
Query: 541 -PWSEF-----EGPQAMFKVLNRTPPIP-----------------EMLSSEGKDFLLRCF 577
P EF + + + + ++ +S+ +D L +
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 578 LRNPVERPSAVELLEHPFI 596
+ +P +R S + L+HP+I
Sbjct: 341 VIDPAKRISVDDALQHPYI 359
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 67/295 (22%), Positives = 108/295 (36%), Gaps = 59/295 (20%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEV--DIIPDDPKS----AECIKQLEQVD 407
+ +G G FG VY G N + A+K + D A I +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF---- 90
Query: 408 DH---------------LYIYLEYVHPGSINRYVREHCRD------ITESIVRNFTRHIL 446
+H +I +E + G + ++RE + + + R I
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGSPN--- 500
G YL + IHRDI N L+ G V K+ DFGMA+ + SY KG
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY--RKGGCAMLP 208
Query: 501 --WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-- 555
WM PE +G D WS G + E+ + G P+ + + V
Sbjct: 209 VKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 556 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQNLSVPM 608
R P P+ + +C+ P +RP+ +LE ++ + N ++P+
Sbjct: 262 GRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 44/272 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEV--DIIPDDPKS-----AECIKQLE---- 404
G+++G+G FGSV ++ S A+K + DII A C+K+ +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 405 -------------QVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHIL 446
+ L ++ G ++ ++ ++ + F I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMA 503
G+ YL S N IHRD+ N ++ V +ADFG+++ + Y S P W+A
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI 561
E + D + D+W+ G T+ E++T G+ P++ E + ++
Sbjct: 208 LESL-----ADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P E D + +C+ +P +RPS L
Sbjct: 261 PPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 69/344 (20%), Positives = 117/344 (34%), Gaps = 113/344 (32%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------ECIKQLE 404
LIGRG++G VY+ ++ T + AIK+V+ + +D + I +L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 405 QV--------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ D LYI LE + + + +TE ++ ++L G ++H +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG 149
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTGLSYELSLKGSPNWM- 502
IHRD+K AN L++ VK+ DFG+A K +
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209
Query: 503 ---------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE--------F 545
APE+I ++DIWS GC E+L F
Sbjct: 210 SHVVTRWYRAPELILLQENYTK------SIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 546 EGPQAMFKV----------------LNR------TPPIPEMLS---------------SE 568
G LN TP ++ + +
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323
Query: 569 GKDF-------------LLRCFLR-NPVERPSAVELLEHPFIRN 598
+ LL L+ NP +R + + L+HP++++
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 43/183 (23%), Positives = 72/183 (39%), Gaps = 22/183 (12%)
Query: 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 470
YI +EYV S+ R + + + + IL L+YLHS ++ D+K N+++
Sbjct: 160 YIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216
Query: 471 ASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 530
+KL D G + L G+P + APE P +A DI+++G
Sbjct: 217 EEQ-LKLIDLGAVSRINSFG---YLYGTPGFQAPE------IVRTGP--TVATDIYTVGR 264
Query: 531 TVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP-SAVE 589
T+ + P G L P+ + L R +P +R +A E
Sbjct: 265 TLAALTLDLPT---RNGRYV--DGLPEDDPVLK-TYDSYGRLLRRAIDPDPRQRFTTAEE 318
Query: 590 LLE 592
+
Sbjct: 319 MSA 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/347 (18%), Positives = 115/347 (33%), Gaps = 117/347 (33%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--------------EVDII----------PDDPK 395
+ +G G F +V++ + A+K E+ ++ D
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 396 SAECIKQLEQ------VDDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRHIL 446
+ +K L+ H+ + E N + R I V+ ++ +L
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE---VLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 447 NGLAYLHS-TNTIHRDIKGANLLVDAS------GVVKLADFGMAKHLTG-LSYELSLKGS 498
GL Y+H IH DIK N+L++ +K+AD G A + + +
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ---T 198
Query: 499 PNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKPPWSEFEG------- 547
+ +PEV+ L DIWS C + E++TG FE
Sbjct: 199 REYRSPEVL-----------LGAPWGCGADIWSTACLIFELITGDFL---FEPDEGHSYT 244
Query: 548 ----------------PQAMFKVLNRT------------------PPIPEMLSSEGK--- 570
P + + T P+ ++L+ + K
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 571 -------DFLLRCFLRNPVERPSAVELLEHPFIRNA-NYQNLSVPMR 609
DFL +P +R A L+ HP++++ + + VP R
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 351
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/275 (22%), Positives = 102/275 (37%), Gaps = 51/275 (18%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEV--DIIPDDPKS----AECIKQLEQVD 407
+ +G+G+FG VY G E AIK V + A +K+
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF---- 85
Query: 408 DH---------------LYIYLEYVHPGSINRYVREHCRDITESIVRN---------FTR 443
+ + +E + G + Y+R + + V
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 500
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y P
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 501 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T 558
WM+PE + KDG D+WS G + E+ T + P+ Q + V+
Sbjct: 206 WMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P+ + + C+ NP RPS +E++
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 68/330 (20%), Positives = 111/330 (33%), Gaps = 111/330 (33%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--------------EVDII-------PDDPKSAE 398
K+IG+G+FG V + + A+K E+ I+ D+ +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN-- 160
Query: 399 CIKQLEQVD--DHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLH 453
I LE +H+ + E + S+N Y + + + +VR F IL L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 454 STNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 510
IH D+K N+L+ +K+ DFG + + + + S + APEVI
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SRFYRAPEVI--- 271
Query: 511 MQKDGNPKLAL----AVDIWSLGCTVIEMLTG---------------------KPPWS-- 543
L +D+WSLGC + E+LTG P
Sbjct: 272 --------LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 544 --------EFEGPQAMFKVLNRTPPIPEMLSSEGK------------------------- 570
T ++ + G+
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 571 ---DFLLRCFLRNPVERPSAVELLEHPFIR 597
DFL +C +P R + + L HP++R
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 64/308 (20%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKE 386
+ H P S+W + GK +GRG FG V T + A+K
Sbjct: 8 LDEHCERLP---YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 387 VDIIPDDP------KSAECIKQLE-------------QVDDHLYIYLEYVHPGSINRYVR 427
+ + + + + L + +E+ G+++ Y+R
Sbjct: 65 LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
Query: 428 EHCRDITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 472
+ V ++ + G+ +L S IHRD+ N+L+
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 473 GVVKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLG 529
VVK+ DFG+A+ + Y P WMAPE I D + D+WS G
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDR--VYTIQSDVWSFG 237
Query: 530 CTVIEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERP 585
+ E+ + G P+ + + + L R P+ + E +L C+ P +RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRP 296
Query: 586 SAVELLEH 593
+ EL+EH
Sbjct: 297 TFSELVEH 304
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 73/315 (23%), Positives = 118/315 (37%), Gaps = 64/315 (20%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEV--DIIPDDP 394
P+ +W GK +G G FG V + + + A+K + D D
Sbjct: 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84
Query: 395 KS----AECIKQLEQ------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIV 438
E +K + + D LY+ +EY G++ Y+R E
Sbjct: 85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 439 RN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483
T + G+ YL S IHRD+ N+LV + V+K+ADFG+A
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 484 KHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 539
+ + Y+ + G P WMAPE + D D+WS G + E+ T G
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMWEIFTLGG 257
Query: 540 PPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH----- 593
P+ + + P ++E + C+ P +RP+ +L+E
Sbjct: 258 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
Query: 594 PFIRNANYQNLSVPM 608
N Y +LS P+
Sbjct: 318 TLTTNEEYLDLSQPL 332
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 61/301 (20%), Positives = 112/301 (37%), Gaps = 62/301 (20%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEV--DIIPD 392
P+ P +W GK +G G FG V T + + A+K +
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 393 DPKS----AECIKQLEQ------------VDDHLYIYLEYVHPGSINRYVREHCRDITES 436
+ ++ + + L + + EY G + ++R S
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 437 IVRN-----------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 479
F+ + G+A+L S N IHRD+ N+L+ + K+ D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 480 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 536
FG+A+ + +Y + P WMAPE I + D+WS G + E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNC--VYTFESDVWSYGIFLWELF 241
Query: 537 T-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ G P+ +K++ R PE +E D + C+ +P++RP+ ++++
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 593 H 593
Sbjct: 301 L 301
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 70/343 (20%), Positives = 108/343 (31%), Gaps = 130/343 (37%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--------------EVDII----PDDPKSAECIK 401
+ +G GTFG V + + + A+K E DI+ DD + +K
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 402 QLEQVD--DHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNGLAYLHSTN 456
+ DH+ + E + + Y + + ++ + IL L YL +
Sbjct: 101 YHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS 157
Query: 457 TIHRDIKGAN-LLVDASGV------------------------VKLADFGMA-----KHL 486
H D+K N LL D +KL DFG A H
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217
Query: 487 TGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGK 539
+ ++ Y APEVI L L + D+WS GC + E+ TG
Sbjct: 218 SIINTRQYR----------APEVI-----------LNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 540 P---------------------------------------------PWSEFEGPQAMFKV 554
W E K
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 555 LNRTPPIPEMLSSEG-KDFLLRCFLRNPVERPSAVELLEHPFI 596
+ + P+ +++ E DFL +P RPS ELL+H F+
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 65/283 (22%), Positives = 108/283 (38%), Gaps = 64/283 (22%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKS-----AECIKQLEQVDD 408
+ +G G FG V++ + A+K + + AE + L
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL----Q 75
Query: 409 H---------------LYIYLEYVHPGSINRYVREHCRDITESIVRN------------- 440
H L + EY+ G +N+++R H D +
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 441 --FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY------- 491
I +G+ YL S + +HRD+ N LV A+ +VK+ DFGM++ + Y
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 550
L ++ WM PE I K D+WS G + E+ T GK PW + +
Sbjct: 196 MLPIR----WMPPESI-----MYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 551 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ + R P + E D +L C+ R P +R + E+ +
Sbjct: 245 IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 69/342 (20%), Positives = 107/342 (31%), Gaps = 132/342 (38%)
Query: 360 KLIGRGTFGSVYIGTNRETGA-SCAIK--------------EVDII-------PDDPKSA 397
+G G FG V + + G A+K E+ ++ P+
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR- 78
Query: 398 ECIKQLEQVD--DHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNGLAYL 452
C++ LE + H+ I E + ++ Y ++E+ +R I + +L
Sbjct: 79 -CVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 453 HSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----KHLTG 488
HS H D+K N L V + +K+ DFG A H T
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 489 LS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKP- 540
+S Y APEVI LAL D+WS+GC +IE G
Sbjct: 195 VSTRHYR----------APEVI-----------LALGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 541 ---------------------------------------PWSEFEGPQAMFKVLNRTPPI 561
W E A V P+
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE--HSSAGRYVSRACKPL 291
Query: 562 PEMLSSEGK------DFLLRCFLRNPVERPSAVELLEHPFIR 597
E + S+ D + + +P +R + E L+HPF
Sbjct: 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 77/358 (21%), Positives = 131/358 (36%), Gaps = 63/358 (17%)
Query: 288 RSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKP 347
+ P V+ + L + ES++ +N+ PL ++ T +
Sbjct: 12 QDPPAVHKLTKRIPLRRQVTVSAESSSSMNS-NTPLVRITTRLSSTADTPMLAG---VSE 67
Query: 348 SASPKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEV--DIIP 391
P+ +W GK +G G FG V + + + A+K + D
Sbjct: 68 YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 392 DDPKS----AECIKQLEQ------------VDDHLYIYLEYVHPGSINRYVREHCRDITE 435
D E +K + + D LY+ +EY G++ Y+R E
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 436 SIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 480
T + G+ YL S IHRD+ N+LV + V+K+ADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 481 GMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 537
G+A+ + Y+ + G P WMAPE + D D+WS G + E+ T
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMWEIFT 300
Query: 538 -GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
G P+ + + P ++E + C+ P +RP+ +L+E
Sbjct: 301 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 65/292 (22%), Positives = 105/292 (35%), Gaps = 53/292 (18%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS--CAIKEV-DIIPDDPKS-----AECIKQLEQ----- 405
+IG G FG V ++ G AIK + + D E + +L
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 406 -------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN---------------FTR 443
+LY+ +EY G++ ++R+ T+ F
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 444 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NW 501
+ G+ YL IHRD+ N+LV + V K+ADFG+++ Y G P W
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 207
Query: 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL--NRT 558
MA E + D+WS G + E+++ G P+ + K+ R
Sbjct: 208 MAIESL-----NYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260
Query: 559 PPIPEMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQNLSVP 607
P E D + +C+ P ERPS + L Y N ++
Sbjct: 261 EK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 311
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 58/282 (20%), Positives = 97/282 (34%), Gaps = 59/282 (20%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIK----------------EVDIIP--DDPK 395
+ +G FG VY G E + AIK E + P
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 396 SAECIKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 440
+ L V D L + Y G ++ ++ +
Sbjct: 74 ----VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 441 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 496
I G+ YL S + +H+D+ N+LV VK++D G+ + + Y+L
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 497 GS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553
P WMAPE I G K ++ DIWS G + E+ + G P+ + +
Sbjct: 190 SLLPIRWMAPEAI-----MYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 554 VLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ N P P+ + ++ C+ P RP ++
Sbjct: 243 IRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 62/304 (20%), Positives = 105/304 (34%), Gaps = 72/304 (23%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
P+ P +W Q GK +G G FG V T + A+K ++
Sbjct: 32 PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTA 88
Query: 395 KSAEC------IKQLEQVDDH---------------LYIYLEYVHPGSINRYVREHCRDI 433
+ E +K + + H + + EY G + ++R R +
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 434 TESIVRNFTRHILN-------------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 480
+ G+A+L S N IHRD+ N+L+ V K+ DF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 481 GMAKHLTGLSY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 533
G+A+ + S L +K WMAPE I D + D+WS G +
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVK----WMAPESI-----FDC--VYTVQSDVWSYGILLW 257
Query: 534 EMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVE 589
E+ + G P+ +K++ + P + C+ P RP+ +
Sbjct: 258 EIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQQ 316
Query: 590 LLEH 593
+
Sbjct: 317 ICSF 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 61/296 (20%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDP-- 394
P+ +W GK +G G FG V + A+K + +
Sbjct: 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 118
Query: 395 ----KSAECIKQLEQ------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIV 438
E +K + + D LY+ +EY G++ Y++ E
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 439 RN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483
+ G+ YL S IHRD+ N+LV V+K+ADFG+A
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 484 KHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 539
+ + Y+ + G P WMAPE + D D+WS G + E+ T G
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDR--IYTHQSDVWSFGVLLWEIFTLGG 291
Query: 540 PPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P+ + + +R P ++E + C+ P +RP+ +L+E
Sbjct: 292 SPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 66/301 (21%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEV--DIIPDDPKS 396
+ +W GK +G G FG V T R + A+K + + P + +
Sbjct: 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 397 ----AECIKQLE-----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN- 440
+KQ+ D L + +EY GS+ ++RE + +
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 441 ----------------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478
F I G+ YL +HRD+ N+LV +K++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 479 DFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 535
DFG+++ + SY +G P WMA E + D D+WS G + E+
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-----FDH--IYTTQSDVWSFGVLLWEI 245
Query: 536 LT-GKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+T G P+ + + +R P+ S E +L+C+ + P +RP ++ +
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 593 H 593
Sbjct: 305 D 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 61/303 (20%), Positives = 108/303 (35%), Gaps = 65/303 (21%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEV--DIIPDDPKS----AECIKQLEQ-- 405
GK++G G FG V T A+K + + ++ + + QL
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 406 ----------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------------- 439
+ +Y+ EY G + Y+R +E +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 440 ------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493
F + G+ +L + +HRD+ N+LV VVK+ DFG+A+ + S +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 494 SLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 549
+ WMAPE + +G + D+WS G + E+ + G P+
Sbjct: 230 VRGNARLPVKWMAPESL-----FEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 550 AMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH-----PFIRNANY 601
+K++ + P + E + C+ + +RPS L A Y
Sbjct: 283 NFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMY 341
Query: 602 QNL 604
QN+
Sbjct: 342 QNV 344
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 63/341 (18%), Positives = 106/341 (31%), Gaps = 128/341 (37%)
Query: 360 KLIGRGTFGSVYIGTNRETG-ASCAIK--------------EVDII-------PDDPKSA 397
+G GTFG V + G + A+K E++++ ++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL- 83
Query: 398 ECIKQLEQVD--DHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNGLAYL 452
C+ + + H+ I E + N + ++E+ + VR+ + + L +L
Sbjct: 84 -CVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 453 HSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----KHLTG 488
H H D+K N L V++ +++ADFG A H T
Sbjct: 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTI 199
Query: 489 LS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKPP 541
++ Y PEVI L L D+WS+GC + E G
Sbjct: 200 VATRHYR----------PPEVI-----------LELGWAQPCDVWSIGCILFEYYRGFTL 238
Query: 542 W---SEFE---------G--PQAMFK------------------------VLNRTPPIPE 563
+ E G P M V P+
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298
Query: 564 MLSSEGK------DFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ + D + R +P +R + E L HPF
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 56/289 (19%), Positives = 103/289 (35%), Gaps = 65/289 (22%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP------KSAECIKQLE--- 404
+ IG G FG V+ E A+K + + A + + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 405 --------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN---------------- 440
V + + EY+ G +N ++R S+ +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 441 -------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 491
R + G+AYL +HRD+ N LV + VVK+ADFG+++++ Y
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 492 -----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545
+ ++ WM PE I + D+W+ G + E+ + G P+
Sbjct: 232 ADGNDAIPIR----WMPPESI-----FYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 546 EGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ ++ V + PE E + + C+ + P +RPS +
Sbjct: 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 63/336 (18%), Positives = 104/336 (30%), Gaps = 116/336 (34%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--------------EVDII-------PDDPKSAE 398
LIG+G+FG V +R AIK EV ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY-- 117
Query: 399 CIKQLEQVD--DHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLH 453
+ +HL + E + S N Y + R ++ ++ R F + + L +L
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 454 ST--NTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 509
+ + IH D+K N+L+ +K+ DFG + L Y S + +PEV+
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPEVL-- 230
Query: 510 VMQKDGNPKLAL----AVDIWSLGCTV---------------------IEMLTGKPP--- 541
L + A+D+WSLGC + I + G PP
Sbjct: 231 ---------LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 542 ------------------WSEFEGPQ-------------AMFKVLNRTPPIPEMLSSEGK 570
W+ + + P G
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 571 ---------DFLLRCFLRNPVERPSAVELLEHPFIR 597
D +LR +P R L+H F +
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 15/185 (8%)
Query: 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 475
+ +T + ++ + G+ +L S IHRD+ N+L+ VV
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232
Query: 476 KLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 532
K+ DFG+A+ + + + WMAPE I + + D+WS G +
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLL 285
Query: 533 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 588
E+ + G P+ + + + L R P+ + E +L C+ P +RP+
Sbjct: 286 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFS 344
Query: 589 ELLEH 593
EL+EH
Sbjct: 345 ELVEH 349
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 25/255 (9%), Positives = 52/255 (20%), Gaps = 66/255 (25%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ--------------- 405
G + + A+ VD P + +++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 406 ------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ E++ GS+ + + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
+ + V G V LA
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDANPQD----------------------------- 183
Query: 520 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD-------F 572
DI +G ++ +L + P E + T P + +D
Sbjct: 184 ----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 573 LLRCFLRNPVERPSA 587
R + R ++
Sbjct: 240 AARSVQGDGGIRSAS 254
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 68/222 (30%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQLEQV------ 406
LIG G FG VY G R+ GA A+K P+S E I+ L
Sbjct: 46 LIGHGVFGKVYKGVLRD-GAKVALKRRT-----PESSQGIEEFETE-IETLSFCRHPHLV 98
Query: 407 --------DDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN---------- 447
+ + IY +Y+ G+ ++ H + ++
Sbjct: 99 SLIGFCDERNEMILIY-KYMENGN----LKRHLYG------SDLPTMSMSWEQRLEICIG 147
Query: 448 ---GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSP 499
GL YLH+ IHRD+K N+L+D + V K+ DFG++K G + + +KG+
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLSTVVKGTL 205
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 541
++ PE +L D++S G + E+L +
Sbjct: 206 GYIDPEYFI-------KGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLE------- 404
+++ G+ IG G+FG +Y+GT+ G AIK + P ++ K ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
D+ + +E + P S+ R + V +++ + Y+HS N IH
Sbjct: 70 IRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 460 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSPNWMAPEVIK 508
RD+K N L+ +V + DFG+AK +L G+ + +
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188
Query: 509 AVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542
+ Q +D D+ SLG ++ G PW
Sbjct: 189 GIEQSRRD---------DLESLGYVLMYFNLGSLPW 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 40/218 (18%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLE------- 404
++ G+ IG G+FG ++ GTN AIK D P K L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN 70
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
Q H + ++ + P S+ + R + V + +L + +H + ++
Sbjct: 71 VYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 460 RDIKGANLLVDASG-----VVKLADFGMAK----HLTG--LSYE--LSLKGSPNWMAPEV 506
RDIK N L+ ++ + DFGM K +T + Y +L G+ +M+
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 189
Query: 507 IKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542
Q +D D+ +LG + L G PW
Sbjct: 190 HLGREQSRRD---------DLEALGHVFMYFLRGSLPW 218
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 71/293 (24%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQLE 404
+ G +G G FG VY G T + A+K++ D + E IK +
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAA-MVDITTEELKQQFDQE-IKVMA 85
Query: 405 QV--------------DDH-LYIYLEYVHPGSINRYVREHCRDITESIVRN-FTRH---- 444
+ D +Y Y+ GS + + + + + R
Sbjct: 86 KCQHENLVELLGFSSDGDDLCLVY-VYMPNGS----LLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 445 -ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGS 498
NG+ +LH + IHRDIK AN+L+D + K++DFG+A+ + + + G+
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMTSRIVGT 198
Query: 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF----KV 554
+MAPE ++ G ++ DI+S G ++E++TG P E PQ + ++
Sbjct: 199 TAYMAPEALR------G--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 555 LNRTPPIPEMLSSEGKDFL-----------LRCFLRNPVERPS---AVELLEH 593
+ I + + + D +C +RP +LL+
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 54/356 (15%), Positives = 104/356 (29%), Gaps = 118/356 (33%)
Query: 360 KLIGRGTFGSVY--------------IGTNRETGASCAIKEVDII-------PDDPKSAE 398
+ +G G F +V+ + + E A+ E+ ++ P+DP
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 399 CIKQLEQVD------DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAY 451
++ L+ H+ + E + + +++ + + + + V+ + +L GL Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 452 LHST-NTIHRDIKGANLLVDASGVVKLADF-------GMAKHLTGLSYELSLKGSPNWMA 503
LH+ IH DIK N+L+ + S + +
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 504 PEVIKAVMQKDGNPKLA---------------------------------LAVDIWSLGC 530
++ + K+A DIWS C
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTAC 281
Query: 531 TVIEMLTGKPPWSEFEG------------------------------------------- 547
E+ TG + G
Sbjct: 282 MAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341
Query: 548 -----PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
P +F+VL + ++ DFLL P +R +A E L HP++ +
Sbjct: 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 53/218 (24%), Positives = 80/218 (36%), Gaps = 40/218 (18%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLE------- 404
++ GK IG G FG + +G N T AIK P KQL
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ + LE + P S+ R + V +++ + Y+HS N I+
Sbjct: 70 VYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIY 128
Query: 460 RDIKGANLLVDASG-----VVKLADFGMAK----HLTGLSYE----LSLKGSPNWMAPEV 506
RD+K N L+ G V+ + DF +AK T SL G+ +M+
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINT 188
Query: 507 IKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542
Q +D D+ +LG + L G PW
Sbjct: 189 HLGKEQSRRD---------DLEALGHMFMYFLRGSLPW 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 54/333 (16%), Positives = 91/333 (27%), Gaps = 101/333 (30%)
Query: 316 LNAHPLPLPPGALSPPKSSVTSAVMP--HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIG 373
++ H L S P +++ +QW GK IG G FG +Y+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDME----GNQWVLGKKIGSGGFGLIYLA 56
Query: 374 TNRETGASCAIKEVDIIPDDPKS----AECIKQLEQVDD----------------HLYIY 413
A V + + + +++ + D Y
Sbjct: 57 FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116
Query: 414 LEYVHPGSINRY------------VREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 461
G R+ + +S V +L+ L Y+H +H D
Sbjct: 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176
Query: 462 IKGANLLVDA--SGVVKLADFGMAKH-----------------LTG----------LSYE 492
IK ANLL+ V LAD+G++ G
Sbjct: 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA 236
Query: 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 552
LS + D+ LG ++ L GK PW +
Sbjct: 237 LSRRS--------------------------DVEILGYCMLRWLCGKLPWEQNLKDPVAV 270
Query: 553 KVLNRTPPIPEMLSSEGKDFLLRCFLRN--PVE 583
+ +T + E+ +L+ E
Sbjct: 271 QTA-KTNLLDEL-----PQSVLKWAPSGSSCCE 297
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 57/218 (26%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIK----------------EVDIIPDDPKSAE------ 398
++GRG FG VY G G A+K EV++I S
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMI-----SMAVHRNLL 90
Query: 399 -----CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH-----ILNG 448
C+ + L +Y Y+ GS+ +RE + + R G
Sbjct: 91 RLRGFCMTP----TERLLVY-PYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARG 143
Query: 449 LAYLH---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMA 503
LAYLH IHRD+K AN+L+D + DFG+AK + ++ ++G+ +A
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 541
PE + G K + D++ G ++E++TG+
Sbjct: 204 PEYLST-----G--KSSEKTDVFGYGVMLLELITGQRA 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLE------- 404
+++ G+ IG G+FG +Y+GTN +T AIK ++ P ++ + L+
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPN 67
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
D+ + ++ + P S+ R ++ V ++N + ++HS + +H
Sbjct: 68 VRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 460 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSPNWMAPEVIK 508
RDIK N L+ + V + DFG+AK S +L G+ + +
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186
Query: 509 AVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542
+ Q +D D+ SLG ++ L G PW
Sbjct: 187 GIEQSRRD---------DLESLGYVLMYFLRGSLPW 213
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 37/240 (15%), Positives = 71/240 (29%), Gaps = 62/240 (25%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------ASCAIKEVDIIPDDPKSAECIKQLE 404
QW+ R G +Y T ++K + D + +
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDGRLFNEQNFFQ 97
Query: 405 QVDDHLYIYLEY-----------------VHPGSIN-----------RYVREHC--RDIT 434
+ L + VH + + ++
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 435 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKH----LTG 488
E V +L+ L +LH +H ++ N+ VD V LA +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 489 LSY----ELSLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 542
++Y +G +++ ++ K + D+ SLG +++ L G PW
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS---------DLQSLGYCMLKWLYGFLPW 268
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 44/241 (18%), Positives = 81/241 (33%), Gaps = 64/241 (26%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-------- 404
+ W+ G IG+G FG +Y+ + + S ++ +P L
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQR 89
Query: 405 -QVDDHLYIYLEY---------------VHPGSINRY--------------VREHC-RDI 433
+ + ++ +H + Y + E +
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 434 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAK----HLT 487
+ V + IL+ L Y+H +H DIK +NLL++ V L D+G+A
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 488 GLSYEL----SLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPP 541
+Y G+ + + + V + D+ LG +I+ LTG P
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG---------DLEILGYCMIQWLTGHLP 260
Query: 542 W 542
W
Sbjct: 261 W 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 1e-07
Identities = 39/227 (17%), Positives = 75/227 (33%), Gaps = 33/227 (14%)
Query: 392 DDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
+ K + + DD L+I LE+ G +R + ++ + LA
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAV 176
Query: 452 LHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLT----GLSYEL--------SLKGS 498
++ HRD+ N+L+ + + KL K T GL + G
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI 236
Query: 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF------ 552
+ + + + DG+ + DI+ L W E+ +
Sbjct: 237 VVFCDVSMDEDLFTGDGDYQF----DIYRLMKKENNN-----RWGEYHPYSNVLWLHYLT 287
Query: 553 -KVLNRTPPIPEMLSSEGKDFL--LRCFLRNPVERPSAVELLEHPFI 596
K+L + + + K ++ F R + SA +LL +
Sbjct: 288 DKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 7e-06
Identities = 49/383 (12%), Positives = 108/383 (28%), Gaps = 112/383 (29%)
Query: 331 PKSSVTSAVMPHIMEKPSASPKKSQ-----W---QKGKLIGRGTFGSV------------ 370
PKS ++ + HI+ A S W K + + + V
Sbjct: 42 PKSILSKEEIDHIIMSKDA---VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 371 ---YIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQ----LEQVDDHLYIYLE 415
+ T I++ D + +D + + + L ++ +
Sbjct: 99 KTEQRQPSMMT--RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV--- 153
Query: 416 YVH--PG---SINRYVREHCRDITESIVRNFTRHI--LNGLAYLHSTNTIHRDIKGANLL 468
+ G + + C + I LN L +S T+ ++ LL
Sbjct: 154 LIDGVLGSGKTW--VALDVCLS--YKVQCKMDFKIFWLN-LKNCNSPETVLEMLQ--KLL 206
Query: 469 VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV--DIW 526
+ + ++K + + E+ + + K + L V ++
Sbjct: 207 YQIDP----------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENCLLVLLNVQ 254
Query: 527 S--------LGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS-SEGKDFLLRCF 577
+ L C ++ + T ++F + L+ E K LL+
Sbjct: 255 NAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSLLLKYL 311
Query: 578 LRNPVERPSAV------------ELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVE 625
P + P V E + N++++ + D++
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV---------------NCDKLT 356
Query: 626 RATRKT-ESLPDSPETRVRNRKL 647
+ L + E R +L
Sbjct: 357 TIIESSLNVL-EPAEYRKMFDRL 378
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 58/436 (13%), Positives = 119/436 (27%), Gaps = 145/436 (33%)
Query: 238 EIQDWSTAEVPDLGRFVGC----TSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKV 293
+Q+ +L C T+ R D L +
Sbjct: 252 NVQNAKAWNAFNLS----CKILLTT------RFKQVTD--------------FLSAATTT 287
Query: 294 YFPLRHKSL---PQNSKELLESNNHLNAHPLPLPPGAL--SPPKSSVTSAVMPHIMEKPS 348
+ L H S+ P K LL +L+ P LP L +P + S+ + + +
Sbjct: 288 HISLDHHSMTLTPDEVKSLLL--KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAI--KEVDI------------IPDDP 394
+ + +I + + R+ ++ I I D
Sbjct: 346 NWKHVNCDKLTTII-ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 395 KS--AECIKQL---EQVDDHLY----IYLEY---------VHPGSINRYVREHCRDITES 436
+ K +Q + IYLE +H ++ Y D +
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 437 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELS 494
I ++ + + + H L + + +T + L
Sbjct: 465 IPPYLDQYFYSHIGH-------H-----------------LKNIEHPERMTLFRMVF-LD 499
Query: 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 554
+ ++ ++ D W+ +++ L + +
Sbjct: 500 F----RF-----LEQKIRHDSTA--------WNASGSILNTLQQLKFYKPY--------- 533
Query: 555 LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF---IRNANYQNLSVPMR-V 610
+ P E L + DFL + L+ + +R A L +
Sbjct: 534 ICDNDPKYERLVNAILDFLPKI----------EENLICSKYTDLLRIA----LMAEDEAI 579
Query: 611 FSRINLGDKSHDQVER 626
F +++H QV+R
Sbjct: 580 F------EEAHKQVQR 589
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.73 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.87 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.01 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=476.08 Aligned_cols=243 Identities=26% Similarity=0.530 Sum_probs=213.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|+++++||+|+||+||+|+++.+|+.||||+++... .. ....++++.+.. .++++||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999996321 11 112223333322 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---cc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---~~ 491 (720)
|||+||+|.++|++. +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+... ..
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999999775 67999999999999999999999999999999999999999999999999999876432 23
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
..+++||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+++.....+|+.+++++++
T Consensus 191 ~~~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~d 263 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263 (311)
T ss_dssp BCCCCSCGGGCCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHH
T ss_pred ccCcccCcccCCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHH
Confidence 457899999999999985 4588999999999999999999999999888889999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCHHH------HHcCcccccccccCC
Q 005007 572 FLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 604 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~E------LL~Hpff~~~~~~~l 604 (720)
||.+||++||++|||++| |++||||++.+|..+
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 999999999999999987 689999999887765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=459.51 Aligned_cols=237 Identities=27% Similarity=0.487 Sum_probs=192.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++...... +++++++.+.+ .++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999996432111 12222233221 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||| +|+|.++|.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.........+
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999 68999999765 6799999999999999999999999999999999999999999999999999998776666677
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.+||+.|||||++.+ ..+++.++|||||||++|||++|++||.+.+..+.+.++......+|..+++++++||.
T Consensus 171 ~~GT~~Y~APE~~~~------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 171 SCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----CTTSCHHHHSS------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred eeECcccCChhhhcC------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 899999999999963 34567899999999999999999999999888888888888899999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+||++||++|||++|+|+||||+.
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHccCChhHCcCHHHHHcCccccc
Confidence 999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-55 Score=471.67 Aligned_cols=239 Identities=34% Similarity=0.575 Sum_probs=206.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--h---hHHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--P---KSAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~---~~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
...|++++.||+|+||+||+|+++.+|+.||||+++..... . +++++++.+.+ .++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45799999999999999999999999999999999653322 1 23333333332 36789999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
|+||+|.+++.+ +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+... ....+.
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 999999999965 56999999999999999999999999999999999999999999999999999877543 445678
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dL 572 (720)
+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..+..... ..+..+++++++|
T Consensus 231 ~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 231 VGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp CSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred ccCcCcCCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 99999999999863 4689999999999999999999999999888888887776533 3345789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|.+||++||++|||++|+|+||||+...
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=471.37 Aligned_cols=240 Identities=26% Similarity=0.493 Sum_probs=201.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH-------HHHHHHhh-----------cCCEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-------ECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~-------~~ik~L~~-----------~~~~lyLVm 414 (720)
-++|++++.||+|+||+||+|+++.+|+.||||+++......... ++++.|.+ .++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999999999999999997654433221 22222221 367899999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cc
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~ 492 (720)
|||+||+|.++|... ...++|..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 999999999999754 3457999999999999999999999999999999999999999999999999998775432 33
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKD 571 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~d 571 (720)
.+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.+++... ++++..+++++++
T Consensus 183 ~~~~GT~~YmAPE~l~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 183 RACIGTPYYLSPEICEN-------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255 (350)
T ss_dssp HHHHSCCTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred cccCCCccccCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 46789999999999973 468899999999999999999999999988888888888654 4677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
||.+||++||++|||++|+|+||||+..
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=474.83 Aligned_cols=239 Identities=34% Similarity=0.574 Sum_probs=206.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
.+.|++++.||+|+||+||+|+++.+|+.||||+++...... +++.+++.+.+ .++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999999999999999997543322 22333333322 36789999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
|+||+|.+++.. +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+... ....++
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 999999999965 56999999999999999999999999999999999999999999999999999877543 445678
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dL 572 (720)
+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..+..... ..+..+++++++|
T Consensus 308 ~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 308 VGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp EECTTTCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred ccCcCcCCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 99999999999863 4689999999999999999999999999888888887776532 3456789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|.+||++||++|||++|||+||||+...
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=462.51 Aligned_cols=241 Identities=28% Similarity=0.485 Sum_probs=206.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCCC-------hhHHHHHHHHh-----------hcCCEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDD-------PKSAECIKQLE-----------QVDDHLYI 412 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~-----------~~~~~lyL 412 (720)
++|++++.||+|+||+||+|++. .+++.||||+++..... ..+++++..+. +.++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999874 47889999988632211 11111111111 23678999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~ 491 (720)
|||||+||+|.++|.+. +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.... ...
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 99999999999999775 6799999999999999999999999999999999999999999999999999986543 334
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
..+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.++......+|..+++++++
T Consensus 183 ~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 255 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 255 (304)
T ss_dssp CCSCCCCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccccccCcccCCHHHhcc-------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 557899999999999974 4688999999999999999999999999998899999999999999999999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 005007 572 FLLRCFLRNPVERPS-----AVELLEHPFIRNANYQ 602 (720)
Q Consensus 572 LI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~ 602 (720)
||.+||++||++||| ++|+|+||||+..++.
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 999999999999998 5899999999887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=461.50 Aligned_cols=240 Identities=28% Similarity=0.469 Sum_probs=204.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh-----------cCCEEEEEEEeccCCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----------VDDHLYIYLEYVHPGS 421 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~-----------~~~~lyLVmEy~~gGs 421 (720)
...|+++++||+|+||+||+|+++.+|+.||||+++......+++.++..+.+ .++.+|||||||+||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 45799999999999999999999999999999999876555455554444432 3678999999999999
Q ss_pred HHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCccc------ccc
Q 005007 422 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY------ELS 494 (720)
Q Consensus 422 L~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~~------~~t 494 (720)
|.++|++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .|||+|||+|+.+..... ...
T Consensus 137 L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~ 215 (336)
T 4g3f_A 137 LGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215 (336)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CC
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCc
Confidence 99999775 6799999999999999999999999999999999999999988 699999999987654321 234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~d 571 (720)
++||+.|||||++.+ ..|+.++||||||||||||++|++||.+....+.+.++..... .+|..+++++++
T Consensus 216 ~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 216 IPGTETHMAPEVVMG-------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp CCCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred cccCccccCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 689999999999973 4688999999999999999999999998777777777776654 467789999999
Q ss_pred HHHHhhhcCCCCCCCHHHH-------------HcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVEL-------------LEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~EL-------------L~Hpff~~~~ 600 (720)
||.+||++||.+|||+.|| |+|||+....
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999999999999999998 5689986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=442.99 Aligned_cols=233 Identities=28% Similarity=0.516 Sum_probs=193.6
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhhc------------------CCEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQV------------------DDHLYIY 413 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~~------------------~~~lyLV 413 (720)
|++.++||+|+||+||+|.++.++..||||++.......... +++..+... ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999999999999999999999999997543332221 222222221 2458999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecC-CCCeeeeccccchhccCcc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~~~ 490 (720)
||||+||+|.++|.+. +.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.|||+|||+|+.... .
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~ 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-S 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-T
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-C
Confidence 9999999999999775 67999999999999999999999998 999999999999974 79999999999986433 4
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cC--CCCCccCCH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEMLSS 567 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~--~~iP~~ls~ 567 (720)
...+.+||+.|||||++. ..|+.++||||||||||||+||++||.+......+.+.+. .. ..++..+++
T Consensus 186 ~~~~~~GTp~YmAPE~~~--------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccCCcccCccccCHHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 456789999999999875 2488999999999999999999999987666655555443 32 234567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
++++||.+||++||++|||++|+|+||||++
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=454.99 Aligned_cols=241 Identities=26% Similarity=0.411 Sum_probs=200.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-----------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-----------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-----------------~~ 407 (720)
..++|++++.||+|+||+||+|+++.+|+.||||+++....... ++++++.+.+ ..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 34689999999999999999999999999999999975544332 2222222221 12
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
+++|||||||. |+|.++|.+. +.+++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 57899999996 7899999764 689999999999999999999999999999999999999999999999999998764
Q ss_pred C-----ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC-
Q 005007 488 G-----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI- 561 (720)
Q Consensus 488 ~-----~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i- 561 (720)
. .....+++||++|||||++.+ ..+|+.++||||||||||||++|++||.+.+..+.+..|+......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLS------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cCccccccccccceeChHhcCHHHhcC------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 3 233456899999999999874 3567899999999999999999999999988877777665321110
Q ss_pred ------------------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 562 ------------------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 562 ------------------------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
...++++++|||.+||++||.+|||++|+|+||||+...
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 124689999999999999999999999999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=441.94 Aligned_cols=238 Identities=26% Similarity=0.425 Sum_probs=188.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCCChhHHHHHHHHhh---------------cCCEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------VDDHLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------~~~~lyLVm 414 (720)
.++|+++++||+|+||+||+|+++ .+++.||||++..........++++.+.. .++++||||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 468999999999999999999875 46789999988654433333333333332 257899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhccCc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGL---- 489 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~~~~---- 489 (720)
|||+||+|.+++. .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 100 E~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 100 PYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp ECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred eCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 9999999999983 49999999999999999999999999999999999999876 89999999999754321
Q ss_pred -------------------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC
Q 005007 490 -------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 544 (720)
Q Consensus 490 -------------------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~ 544 (720)
....+.+||++|||||++.+ ...|+.++||||+|||+|||++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK------CPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcC------CCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 11234679999999999974 35688999999999999999999999954
Q ss_pred C-CcHHHHHHHhc--------------------------------------c----------------CCCCCccCCHHH
Q 005007 545 F-EGPQAMFKVLN--------------------------------------R----------------TPPIPEMLSSEG 569 (720)
Q Consensus 545 ~-~~~~~i~ki~~--------------------------------------~----------------~~~iP~~ls~el 569 (720)
. +..+.+..|.. . .......+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 3 33333333211 0 001123578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+|||.+||++||++|+|++|+|+||||++.+
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=467.36 Aligned_cols=243 Identities=26% Similarity=0.449 Sum_probs=207.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChhH----HHHHHHHh--------------hcCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKS----AECIKQLE--------------QVDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~~----~~~ik~L~--------------~~~~~l 410 (720)
.++|+++++||+|+||+||+|+++.+|+.||||+++... ..... ..++..+. +.++++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999999999999999986321 11111 11122221 136789
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|||||||.||+|.++|.+. +.|+|..++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+...
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 9999999999999999875 67999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---CcHHHHHHHhccCCCCCccCCH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---EGPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---~~~~~i~ki~~~~~~iP~~ls~ 567 (720)
...+.+||+.|||||++.+ ...|+.++||||||||||||++|++||.+. +..+....+......+|..+++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp CCCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CCCCccCCcCccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 3457899999999999952 246889999999999999999999999753 2334556677788899999999
Q ss_pred HHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccccccC
Q 005007 568 EGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQN 603 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~~ 603 (720)
++++||.+||++||.+|++ ++||++||||+..+|..
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 9999999999999999998 79999999999887653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=425.89 Aligned_cols=237 Identities=24% Similarity=0.443 Sum_probs=176.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhhc-------------------------
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQV------------------------- 406 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~~------------------------- 406 (720)
+|++++.||+|+||+||+|+++.+|+.||||+++........ .+++..+...
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 699999999999999999999999999999999765432221 1222323221
Q ss_pred -CCEEEEEEEeccCCCHHHHHHHhcC--CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccc
Q 005007 407 -DDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 407 -~~~lyLVmEy~~gGsL~~~L~~~~~--~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
+.++|||||||+||+|.+++..... ...+..++.|+.||++||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 1247999999999999999976421 2345668999999999999999999999999999999999999999999999
Q ss_pred hhccCcc-------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HH
Q 005007 484 KHLTGLS-------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQ 549 (720)
Q Consensus 484 ~~~~~~~-------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~ 549 (720)
+.+.... ...+.+||+.|||||++.+ ..|+.++||||||||||||++ ||..... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-------NSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp --------------------------CCCTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcC-------CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 8764322 1234679999999999873 468899999999999999996 7764322 22
Q ss_pred HHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 550 AMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 550 ~i~ki~~~~-~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.+..+.... ++.+...++++++||++||++||++|||+.|+|+||||++.++
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 233333222 2222345678899999999999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=456.29 Aligned_cols=242 Identities=25% Similarity=0.435 Sum_probs=210.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
++|++++.||+|+||+||+|.++.+|+.||||++....... +++++++.+.+ .++.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 58999999999999999999999999999999986532111 12222333221 367899999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC--CCeeeeccccchhccCccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~--g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+||+|.++|.+..+.|+|.+++.|++||+.||+|||++||+||||||+||||+.+ |.+||+|||+|+.+.......+.
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~ 316 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence 9999999997666789999999999999999999999999999999999999854 89999999999988776666778
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGKD 571 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~d 571 (720)
+||++|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.++......++ ..+++++++
T Consensus 317 ~GT~~y~APEv~~~-------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 317 TGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp CSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred EECccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 99999999999973 4689999999999999999999999999988888888887765554 468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
||.+||++||.+|||+.|+|+||||+.....
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=419.91 Aligned_cols=237 Identities=25% Similarity=0.436 Sum_probs=191.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH----HHHHHhh-------------cCCEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE----CIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~----~ik~L~~-------------~~~~lyL 412 (720)
+...++++++++||+|+||+||+|++. ..||||+++.........+ ++..+.. .++.+||
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEE
Confidence 445678999999999999999999865 3599999986554443322 2222222 2566899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~--- 489 (720)
|||||+||+|.++|......+++..+..|+.||++||+|||+++||||||||+||||+.++++||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999999876678999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC------CCCCc
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------PPIPE 563 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------~~iP~ 563 (720)
......+||+.|||||++.+. ....|+.++||||||||||||+||+.||.+.+....+..++... ..++.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQ----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp -----CCCCTTSCCHHHHHCC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred eeecccccCCCccCHHHhhcc----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 233457899999999999741 12458999999999999999999999999877776666655432 23456
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+++++++||.+||+.||++|||+.||+++
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 789999999999999999999999988654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=417.90 Aligned_cols=239 Identities=26% Similarity=0.487 Sum_probs=196.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~l 410 (720)
..++|.+++.||+|+||+||+|++. .++..||||+++...... ...++++.+.. .++.+
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3568999999999999999999875 468899999997532211 11122222222 25679
Q ss_pred EEEEEeccCCCHHHHHHHhc------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 411 YIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
|||||||+||+|.++|++.. ..+++..+..|+.||++||.|||+++||||||||+||||+.++.+||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 99999999999999997642 469999999999999999999999999999999999999999999999
Q ss_pred ccccchhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHH
Q 005007 479 DFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554 (720)
Q Consensus 479 DFGlA~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki 554 (720)
|||+|+........ ....||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999876543322 23568999999999985 468999999999999999998 99999998888888887
Q ss_pred hcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 555 LNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 555 ~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
..+ .++.|..+++++.+||.+||+.||++|||+.||+ .|+++.
T Consensus 244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 754 4678899999999999999999999999999995 466543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=418.19 Aligned_cols=235 Identities=25% Similarity=0.441 Sum_probs=188.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~l 410 (720)
..++|.+.++||+|+||+||+|+++ .+++.||||+++...... ...+++..+.. .++.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3468999999999999999999865 468899999997432111 11122222222 24679
Q ss_pred EEEEEeccCCCHHHHHHHhc--------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCee
Q 005007 411 YIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 476 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~--------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VK 476 (720)
|||||||++|+|.++|+++. ..+++.++..|+.||++||.|||+++||||||||+||||+.++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 99999999999999997542 3589999999999999999999999999999999999999999999
Q ss_pred eeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHH
Q 005007 477 LADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 552 (720)
Q Consensus 477 L~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ 552 (720)
|+|||+++....... ....+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+....+.+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcC-------CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999987644322 234679999999999873 568999999999999999999 999999988888887
Q ss_pred HHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 553 KVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 553 ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+..+ .+++|..+++++++||.+||+.||++|||+.||+++
T Consensus 272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 77654 577889999999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=412.49 Aligned_cols=235 Identities=23% Similarity=0.371 Sum_probs=194.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChh---HHHHHHHHhh--------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPK---SAECIKQLEQ--------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~--------------~~~~ 409 (720)
...++++++.||+|+||+||+|... .+++.||||+++....... ..+++..+.. .++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3457899999999999999999863 4678999999975433221 1222222222 2467
Q ss_pred EEEEEEeccCCCHHHHHHHh---------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC
Q 005007 410 LYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 474 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~ 474 (720)
+|||||||++|+|.++|... ...+++..+..|+.||++||+|||+++||||||||+||||+.+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 89999999999999999653 235899999999999999999999999999999999999999999
Q ss_pred eeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHH
Q 005007 475 VKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 550 (720)
Q Consensus 475 VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~ 550 (720)
+||+|||+++...... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+....+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhC-------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999998764432 2334679999999999985 468999999999999999998 8999999888888
Q ss_pred HHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 551 MFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 551 i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+..+..+ ..+.|..+++++.+||.+||+.||++|||+.||+++
T Consensus 257 ~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8777654 457889999999999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=420.69 Aligned_cols=237 Identities=24% Similarity=0.448 Sum_probs=195.8
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeccCCCChh------HHHHHHHHhh-------------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPK------SAECIKQLEQ------------- 405 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~t-----g~~VAVK~l~~~~~~~~------~~~~ik~L~~------------- 405 (720)
+...++|++++.||+|+||+||+|.+..+ ++.||||.++....... +++++..+.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34467899999999999999999987654 46899999975443222 2222333322
Q ss_pred cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec
Q 005007 406 VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 470 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd 470 (720)
.++.+|||||||++|+|.++|++.. ..+++..+..|+.||++||+|||+++||||||||+||||+
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 1346899999999999999997532 3489999999999999999999999999999999999999
Q ss_pred CCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCC
Q 005007 471 ASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 546 (720)
Q Consensus 471 ~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~ 546 (720)
.++++||+|||+|+.+.... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-------CCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999998764432 2235678999999999985 468999999999999999998 999999877
Q ss_pred cHHHHHHHhc--cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 547 GPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 547 ~~~~i~ki~~--~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+.+.+++. ..+.+|+.+++++++||.+||+.||++|||+.||++|
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6555555443 3567889999999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=401.15 Aligned_cols=242 Identities=27% Similarity=0.477 Sum_probs=212.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------~~~~lyLV 413 (720)
...+|++++.||+|+||+||+|.+..+|+.||||++.......... ++++.+.. .++.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4468999999999999999999999999999999997544333221 22222222 25779999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.........
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 9999999999999775 679999999999999999999999999999999999999999999999999998877666667
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||++|+|||++.+ ....+.++|||||||++|||++|+.||.+.+..+...++......+|..+++++.+||
T Consensus 172 ~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQG------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp TTSSSGGGCCHHHHHT------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cccCCcceeCcccccC------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7889999999999974 3345689999999999999999999999988888888888888999999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+||..||.+|||++|+|+||||+...
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=407.60 Aligned_cols=243 Identities=28% Similarity=0.501 Sum_probs=204.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CCh-h---HHHHHHHHhh------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDP-K---SAECIKQLEQ------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~-~---~~~~ik~L~~------------~~~~ly 411 (720)
..++|+++++||+|+||+||+|+++.+|+.||||+++... ... . +.+++..+.. .++.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999999999999999986421 111 1 1122222211 256799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~ 490 (720)
||||||.||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++... ...
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence 999999999999999775 679999999999999999999999999999999999999999999999999998643 333
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|++||...+..+.+.+++.....+|..++++++
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 252 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEM-------LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDAT 252 (353)
T ss_dssp ------CCGGGCCHHHHHHH-------HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccccCCCcCeEChhhcCCC-------CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 44567899999999999852 46789999999999999999999999998889999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCH------HHHHcCccccccccc
Q 005007 571 DFLLRCFLRNPVERPSA------VELLEHPFIRNANYQ 602 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa------~ELL~Hpff~~~~~~ 602 (720)
+||++||++||.+||++ +|+++||||+...+.
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 99999999999999999 999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=399.78 Aligned_cols=242 Identities=31% Similarity=0.509 Sum_probs=209.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC----CCC-hhHHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDD-PKSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~----~~~-~~~~~~ik~L~~--------------~~~~lyLV 413 (720)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ... .....++..+.. .++.+|||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35899999999999999999999999999999998632 111 112222233322 25789999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~~ 492 (720)
|||++||+|..++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++... .....
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 9999999999999765 679999999999999999999999999999999999999999999999999998643 33344
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+......+|..+++++++|
T Consensus 163 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp CCCEECGGGCCGGGGSS-------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccChhhCChhhhcC-------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 56789999999999852 45788999999999999999999999988888888888888888999999999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 573 LLRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 573 I~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
|.+||++||.+|| +++|+++||||+...+.
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999999999999 99999999999877654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=399.40 Aligned_cols=244 Identities=26% Similarity=0.450 Sum_probs=209.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChh-HHHHHHHHhh---------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPK-SAECIKQLEQ---------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~-~~~~ik~L~~---------------~~~~ly 411 (720)
...+|+++++||+|+||+||+|+++.+|+.||||+++... .... ...+...+.. .++.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4568999999999999999999999999999999986421 1111 1122222221 246799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~ 490 (720)
|||||++||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++... ...
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 999999999999999765 679999999999999999999999999999999999999999999999999998643 233
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.+++.....+|..++.+++
T Consensus 177 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTT-------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccccccCCccccChhhhcC-------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4456789999999999863 457899999999999999999999999988888888999888899999999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHcCcccccccccC
Q 005007 571 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN 603 (720)
Q Consensus 571 dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~~ 603 (720)
+||.+||.+||.+|| +++||++||||+...|..
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 999999999999999 479999999999876643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=400.05 Aligned_cols=244 Identities=30% Similarity=0.559 Sum_probs=210.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC----CCChh----HHHHHHHH-h-----------hcCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDDPK----SAECIKQL-E-----------QVDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~----~~~~~----~~~~ik~L-~-----------~~~~~ly 411 (720)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. ..... +..++..+ . +.++.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 456999999999999999999999999999999998642 11111 11222222 1 1257899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~ 490 (720)
|||||++||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++... ...
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 999999999999999765 679999999999999999999999999999999999999999999999999998643 233
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.++......+|..++++++
T Consensus 174 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 246 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccCCCCCcccCChhhhcC-------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence 4557789999999999863 457899999999999999999999999988888888888888889999999999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHHcCcccccccccC
Q 005007 571 DFLLRCFLRNPVERPSAV-ELLEHPFIRNANYQN 603 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~-ELL~Hpff~~~~~~~ 603 (720)
+||.+||+.||.+||++. ||++||||+...+..
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~ 280 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 280 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred HHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence 999999999999999998 999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=404.71 Aligned_cols=243 Identities=27% Similarity=0.499 Sum_probs=205.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----h---hHHHHHHHHhh------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----P---KSAECIKQLEQ------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~---~~~~~ik~L~~------------~~~~ly 411 (720)
..++|+++++||+|+||+||+|+++.+++.||||+++..... . .+..++..+.. .++.+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 346899999999999999999999999999999998743211 1 12222222211 357799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc-cCcc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~-~~~~ 490 (720)
||||||.||+|..++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.. ....
T Consensus 130 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999999999999765 67999999999999999999999999999999999999999999999999999863 3344
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---------CcHHHHHHHhccCCCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---------EGPQAMFKVLNRTPPI 561 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---------~~~~~i~ki~~~~~~i 561 (720)
...+.+||+.|+|||++.+ ..|+.++|||||||+||||++|++||... ........+......+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~-------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 281 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred ccccccCCcccCCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence 5567889999999999973 46889999999999999999999999632 2233555667788899
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCH------HHHHcCccccccccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSA------VELLEHPFIRNANYQ 602 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa------~ELL~Hpff~~~~~~ 602 (720)
|..++.++++||++||++||.+|+++ +||++||||+..+|.
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 99999999999999999999999984 899999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=401.45 Aligned_cols=244 Identities=28% Similarity=0.486 Sum_probs=208.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHH---H-h--------------hcCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQ---L-E--------------QVDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~---L-~--------------~~~~~ly 411 (720)
..++|+++++||+|+||+||+|+++.+++.||||+++..... ......+.+ + . +.++.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 446899999999999999999999999999999998643211 111111111 1 1 1357899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~ 490 (720)
|||||+.||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++... ...
T Consensus 116 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 999999999999999765 679999999999999999999999999999999999999999999999999998743 333
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+.+++.....++..++.+++
T Consensus 195 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR 267 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHH
T ss_pred ccccccCCccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Confidence 4567889999999999863 458889999999999999999999999988888888899888889999999999
Q ss_pred HHHHHhhhcCCCCCCCH----HHHHcCcccccccccC
Q 005007 571 DFLLRCFLRNPVERPSA----VELLEHPFIRNANYQN 603 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa----~ELL~Hpff~~~~~~~ 603 (720)
+||.+||++||.+|+++ .|+++|+||+..+|..
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 99999999999999986 6999999999877654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=396.31 Aligned_cols=242 Identities=24% Similarity=0.424 Sum_probs=208.4
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh--------------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ--------------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~--------------~~~ 408 (720)
...++|++++.||+|+||+||+|.++.+|+.||||+++...... ....++..+.. .++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 34568999999999999999999999999999999997543221 12233333332 256
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC----Ceeeeccccch
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAK 484 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g----~VKL~DFGlA~ 484 (720)
.+||||||+.||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 799999999999999999664 6799999999999999999999999999999999999998877 79999999998
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC--
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP-- 562 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP-- 562 (720)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+......++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred EcCCCCccccCCCCccEECchHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 8766555567789999999999863 4578899999999999999999999999888888888887766665
Q ss_pred --ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 --~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 46899999999999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=389.81 Aligned_cols=240 Identities=25% Similarity=0.497 Sum_probs=208.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyLV 413 (720)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .. ....++...+.. .++.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 358999999999999999999999999999999986321 11 111122222221 25689999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... ...
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTY 161 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBC
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--ccc
Confidence 9999999999999765 6799999999999999999999999999999999999999999999999999987543 234
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+.+++.....+|..+++++++||
T Consensus 162 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 162 TLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234 (318)
T ss_dssp CCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cccCCccccCHhHhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 6789999999999863 457889999999999999999999999988888888899888899999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 574 LRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 574 ~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
.+||..||.+|+ +++|+++||||+...+.
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 999999999999 99999999999877654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=391.70 Aligned_cols=242 Identities=27% Similarity=0.503 Sum_probs=203.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hh-------HHHHHHHHhh------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PK-------SAECIKQLEQ------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~-------~~~~ik~L~~------------~~~~lyL 412 (720)
.++|++++.||+|+||+||+|+++.+++.||||+++..... .. +..++..+.. .++.+||
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999754321 11 1112222211 2567999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Cccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~~ 491 (720)
||||++||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++... ....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 99999999999999765 679999999999999999999999999999999999999999999999999998643 3334
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---------CcHHHHHHHhccCCCCC
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---------EGPQAMFKVLNRTPPIP 562 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---------~~~~~i~ki~~~~~~iP 562 (720)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+......+|
T Consensus 167 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 239 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239 (345)
T ss_dssp BCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred ccccCCCccccCccccCC-------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence 456789999999999863 45788999999999999999999999652 22334556667788899
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCH------HHHHcCccccccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSA------VELLEHPFIRNANYQ 602 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa------~ELL~Hpff~~~~~~ 602 (720)
..++.++++||.+||++||.+||++ +|+++||||+...|.
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 9999999999999999999999995 899999999877654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=403.24 Aligned_cols=253 Identities=25% Similarity=0.447 Sum_probs=208.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--------CChhHHHHHHHHhh-----------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--------DDPKSAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--------~~~~~~~~ik~L~~-----------~~~~lyL 412 (720)
..++|+++++||+|+||+||+|+++.+|+.||||+++... ....+..++..+.. .++.+||
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3568999999999999999999999999999999986311 11112222222221 3577999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~- 491 (720)
|||||+||+|.+++.+....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 9999999999999987656899999999999999999999999999999999999999999999999999987654332
Q ss_pred -cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCC---CccC
Q 005007 492 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPI---PEML 565 (720)
Q Consensus 492 -~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~i---P~~l 565 (720)
....+||+.|+|||++.+.....+...|+.++|||||||++|||++|+.||...+..+.+.+++.. ...+ +..+
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCC
Confidence 235689999999999986433333456889999999999999999999999988887777777642 2233 4679
Q ss_pred CHHHHHHHHHhhhcCCCCC---CCHHHHHcCcccccccccCCC
Q 005007 566 SSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNLS 605 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kR---PTa~ELL~Hpff~~~~~~~l~ 605 (720)
++++++||++||. +|.+| ++++|+++||||+...|..+.
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 9999999999999 99998 599999999999998887653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=392.48 Aligned_cols=240 Identities=29% Similarity=0.482 Sum_probs=209.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-----CChhHHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-----~~~~~~~~ik~L~~--------------~~~~lyLV 413 (720)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ......+++..+.. .++.+|||
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999999999999999985321 11112222333322 25679999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||++||+|.+++.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..... ..
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~ 196 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cc
Confidence 9999999999999775 67999999999999999999999999999999999999999999999999999876543 34
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+.++......+|..++.++++||
T Consensus 197 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 197 TLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp CCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred cccCCccccCHHHhcC-------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 5689999999999863 457889999999999999999999999988888888888888899999999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 005007 574 LRCFLRNPVERPS-----AVELLEHPFIRNANYQ 602 (720)
Q Consensus 574 ~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~ 602 (720)
.+||+.||.+||+ ++||++||||+...+.
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 9999999999998 9999999999876653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.47 Aligned_cols=241 Identities=27% Similarity=0.476 Sum_probs=196.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----------ChhHHHHHHHHhhc--------------C
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----------DPKSAECIKQLEQV--------------D 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----------~~~~~~~ik~L~~~--------------~ 407 (720)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+..+++.+... .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 45699999999999999999999999999999999874321 11233334444310 1
Q ss_pred C-----EEEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccc
Q 005007 408 D-----HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 481 (720)
Q Consensus 408 ~-----~lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFG 481 (720)
. .+++||||+. |+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 1 5799999997 69999997653 239999999999999999999999999999999999999999999999999
Q ss_pred cchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--
Q 005007 482 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-- 559 (720)
Q Consensus 482 lA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-- 559 (720)
+++............||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+.+.++.....
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT-------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccCCCcccCCccccccccCchHHcC-------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9987766555567789999999999974 4578899999999999999999999998887777766643210
Q ss_pred ---C----------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 ---P----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 ---~----------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
. +...+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0 1124789999999999999999999999999999998643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=405.54 Aligned_cols=251 Identities=24% Similarity=0.459 Sum_probs=208.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC-----CCC---hhHHHHHHHHh-----------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-----PDD---PKSAECIKQLE-----------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~-----~~~---~~~~~~ik~L~-----------~~~~~lyL 412 (720)
..++|+++++||+|+||+||+|+++.+++.||||+++.. ... ..+..++..+. +.++.+||
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 346899999999999999999999999999999998631 111 11222222222 13578999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~- 491 (720)
|||||.||+|.+++.+..+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999999987567899999999999999999999999999999999999999999999999999976654332
Q ss_pred -cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCc---cC
Q 005007 492 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE---ML 565 (720)
Q Consensus 492 -~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~---~l 565 (720)
....+||+.|||||++..... +...|+.++|||||||+||||++|++||.+.+..+.+.+++.. ...+|. .+
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~--~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEG--GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHT--SCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred ccccccCCcCeeChHHHhhccc--CCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 234689999999999974321 2356889999999999999999999999998888888887643 344444 48
Q ss_pred CHHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccccccCC
Q 005007 566 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~~~~l 604 (720)
++++++||++||..+|++ |++++|+++||||+..+|..+
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 999999999999988888 999999999999999887765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=388.33 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=207.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHHHhh--------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..++|++++.||+|+||+||+|.+..+++.||+|.+......... .+++..+.. ..+.+|+||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 356999999999999999999999999999999998754322111 122222221 25789999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC--CCCeeeeccccchhccCcccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~--~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 9999999999766567999999999999999999999999999999999999987 78999999999988766555566
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGK 570 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~ 570 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|..||......+.+..+......++ ..++.+++
T Consensus 163 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 163 LFTAPEYYAPEVHQH-------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp EESCGGGSCHHHHTT-------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred ccCChhhcCcHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 789999999999863 4578899999999999999999999999888888888887776665 36899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+||.+||..||.+|||+.|+|+||||+..
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=401.68 Aligned_cols=243 Identities=29% Similarity=0.484 Sum_probs=205.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CCh---hHHHHHHHHh--------------hcCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDP---KSAECIKQLE--------------QVDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~---~~~~~ik~L~--------------~~~~~lyL 412 (720)
..++|+++++||+|+||+||+|.++.+|+.||||+++... ... ....++..+. ..++.+||
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999999999999999986321 110 1111111111 13577999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccC-cc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~ 490 (720)
|||||+||+|.+++... ..+++..++.|+.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++.... ..
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999999999999765 679999999999999999999998 9999999999999999999999999999986433 33
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
.....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||...+....+..+......+|..++++++
T Consensus 305 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 377 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 377 (446)
T ss_dssp --CCSSSCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccccccCCccccCHhhcCC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence 4456789999999999973 468899999999999999999999999988888888888888899999999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 571 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 571 dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+||.+||+.||.+|| +++|+|+||||+...++
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 999999999999999 99999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=383.98 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=203.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCC---------ChhHHHHHHHHhh-----------cC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPD---------DPKSAECIKQLEQ-----------VD 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~---------~~~~~~~ik~L~~-----------~~ 407 (720)
...++|+++++||+|+||+||+|++. .+|+.||||+++.... ...+..+++.+.+ .+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34568999999999999999999985 6899999999875321 1112233333322 25
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
+.+||||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 6789999999999999999765 679999999999999999999999999999999999999999999999999997643
Q ss_pred C-ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCC
Q 005007 488 G-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS 566 (720)
Q Consensus 488 ~-~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls 566 (720)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+.++......+|..++
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMR-------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT 245 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred cCCccccccCCCcCccCHhhCcC-------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 2 233446789999999999863 45788999999999999999999999998888888888888888999999
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 567 SEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
.++++||.+||..||.+|| +++|+|+||||+...+.
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 9999999999999999999 89999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=423.98 Aligned_cols=245 Identities=26% Similarity=0.443 Sum_probs=212.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC-----CCChhHHHHHHHHhh---------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-----PDDPKSAECIKQLEQ---------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~-----~~~~~~~~~ik~L~~---------------~~~~ly 411 (720)
...+|+++++||+|+||+||+|+++.+++.||||+++.. ........+...+.. ..+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456899999999999999999999999999999998632 111122222222221 256799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc-Ccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLS 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~-~~~ 490 (720)
|||||++||+|.++|... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++... ...
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999999999999875 679999999999999999999999999999999999999999999999999998643 334
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
...+.+||+.|||||++. ...|+.++||||||||||||++|++||.+.+..+.+.+++.....+|..++++++
T Consensus 498 ~~~~~~GT~~Y~APE~l~-------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 570 (674)
T ss_dssp CBCCCCSCSSSCCHHHHT-------CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred ccccccCCCcccCHhhhc-------CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence 455788999999999986 3568999999999999999999999999999889999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHcCcccccccccCC
Q 005007 571 DFLLRCFLRNPVERPSA-----VELLEHPFIRNANYQNL 604 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa-----~ELL~Hpff~~~~~~~l 604 (720)
+||++||++||.+|+++ +||++||||+..+|..+
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 99999999999999997 99999999998876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=377.17 Aligned_cols=240 Identities=35% Similarity=0.601 Sum_probs=202.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--HHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--SAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...+|++++.||+|+||+||+|.+..+|+.||||++........ ..+++..+.. .++.+|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34689999999999999999999999999999999865433221 1222222222 3577999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+.||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9999999999976 369999999999999999999999999999999999999999999999999998765432 3345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CCCCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~~iP~~ls~el~d 571 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+... ....+..+++++++
T Consensus 176 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp CCSCGGGCCHHHHHC-------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred ccCCcCccChhhhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 679999999999973 46788999999999999999999999987776666655432 33457789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||+.||++|||+.|+|+||||+...
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999999999999998543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=386.64 Aligned_cols=242 Identities=28% Similarity=0.415 Sum_probs=188.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...++|++++.||+|+||+||+|+++.+++.||||++...... ....+++..+.. ..+.+|||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3457999999999999999999999999999999999754332 222233333332 2567999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC--eeeeccccchhccCccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~--VKL~DFGlA~~~~~~~~~~ 493 (720)
|+.||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||+++.........
T Consensus 97 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 97 YASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99999999999765 67999999999999999999999999999999999999987765 9999999998655444455
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc----HHHHHHHhccCCCCCc--cCCH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE--MLSS 567 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----~~~i~ki~~~~~~iP~--~ls~ 567 (720)
..+||+.|+|||++.+ ....+.++|||||||++|||++|+.||..... ...+..+......+|. .+++
T Consensus 176 ~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLR------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----CTTSCHHHHHC------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred CCcCCCCcCChhhhcC------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 6789999999999974 23334559999999999999999999986443 3444555555555554 5899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||+.||.+|||+.|+|+||||...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999999999654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=379.51 Aligned_cols=242 Identities=28% Similarity=0.502 Sum_probs=192.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh--------------cCCEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~--------------~~~~lyL 412 (720)
...++|++++.||+|+||+||+|++. +|+.||||++........ ..+++..+.. .++.+||
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34579999999999999999999985 599999999975443321 1222232322 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~ 491 (720)
||||+. |+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 97 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 999998 5888888776677999999999999999999999999999999999999999999999999999876432 23
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc---cCCC--------
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---RTPP-------- 560 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~---~~~~-------- 560 (720)
.....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+.. ....
T Consensus 176 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp --CCCCCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred ccCCcccCCcCCHHHhcC------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 344578999999999863 35688899999999999999999999987666555554432 1110
Q ss_pred -------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 561 -------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 561 -------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+...+++++++||.+||+.||++|||++|+|+||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1124678999999999999999999999999999998765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=400.61 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=187.8
Q ss_pred CCCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh----------------cCCEEEEEEE
Q 005007 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----------------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~-k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~----------------~~~~lyLVmE 415 (720)
..+|.+. ++||+|+||+||+|.++.+|+.||||+++.......+++.+..+.. .++.+|||||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 4578776 7999999999999999999999999999743222222222222211 0345899999
Q ss_pred eccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCccc
Q 005007 416 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~~ 491 (720)
||.||+|.++|.+.. ..+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+++.......
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~ 219 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence 999999999997642 35999999999999999999999999999999999999987 78999999999987765555
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH----HHHHHhccCCCCC----c
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIP----E 563 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~----~i~ki~~~~~~iP----~ 563 (720)
....+||+.|+|||++. ...|+.++|||||||+||||++|+.||....... ....+......++ .
T Consensus 220 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 220 LTTPCYTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp -------CTTCCGGGSC-------CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred cccCCCCCCccCHhhcC-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 56778999999999874 3568899999999999999999999997654321 3344444444443 4
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+++++++||++||+.||++|||+.|+|+||||...
T Consensus 293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 689999999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=389.30 Aligned_cols=235 Identities=24% Similarity=0.336 Sum_probs=175.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH-HHHHHhhc---------------C---CEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQV---------------D---DHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~-~ik~L~~~---------------~---~~lyLVm 414 (720)
++|.+.++||+|+||+||+|++ +|+.||||+++.........+ ++..+... + ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4799999999999999999987 489999999864321111111 11111110 1 2579999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~--------gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
|||+||+|.++|+. ..+++..+..|+.||+.||.|||++ +||||||||+||||+.++++||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999976 4699999999999999999999987 9999999999999999999999999999876
Q ss_pred cCccc-----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC--------------Cc
Q 005007 487 TGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--------------EG 547 (720)
Q Consensus 487 ~~~~~-----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~--------------~~ 547 (720)
..... ....+||+.|||||++.+..... ...|+.++||||||||||||+||++||... ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~-~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTT-CHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cCCCCceeeecccccccccccCHHHhccccccc-CCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 54322 22467999999999997421111 124678999999999999999998766321 11
Q ss_pred HHHHHHHh-cc--CCCCCccC-----CHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 548 PQAMFKVL-NR--TPPIPEML-----SSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 548 ~~~i~ki~-~~--~~~iP~~l-----s~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+.+.+.+ .. .+.+|... ...+.+||.+||+.||++|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 23333332 22 34455432 3578899999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=379.33 Aligned_cols=240 Identities=25% Similarity=0.445 Sum_probs=204.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh--------------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~--------------~~~~l 410 (720)
.++|++++.||+|+||+||+|.++.+|+.||||+++...... ...+++..+.. .++.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999999999999999987543211 11222333322 25679
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC----Ceeeeccccchhc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHL 486 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g----~VKL~DFGlA~~~ 486 (720)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999999654 6799999999999999999999999999999999999998887 8999999999877
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP---- 562 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP---- 562 (720)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+......++
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCCccccccCCcCcCCceeecC-------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 65555556789999999999863 4578899999999999999999999998887777777766655554
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++.++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 46899999999999999999999999999999997643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=371.15 Aligned_cols=239 Identities=29% Similarity=0.494 Sum_probs=192.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|++++.||+|+||+||+|.++.+|+.||||++......... .+++..+.. .++.+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5899999999999999999999999999999999765443322 222333322 2577899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+. |+|.+++....+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus 82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 997 5677777665678999999999999999999999999999999999999999999999999999876432 23345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCC-CCCCcHHHHHHHhcc---C------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNR---T------------ 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF-~~~~~~~~i~ki~~~---~------------ 558 (720)
..||+.|+|||++.+ ...++.++|||||||++|||++|..|| ...+..+.+..+... .
T Consensus 161 ~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccccCCcChHHHcC------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 678999999999863 345789999999999999999887774 555544554444321 0
Q ss_pred --------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 559 --------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 559 --------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
......+++++++||.+||+.||++|||++|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01123478999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=396.43 Aligned_cols=248 Identities=28% Similarity=0.466 Sum_probs=206.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC-----CCCh---hHHHHHHHHhh-----------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-----PDDP---KSAECIKQLEQ-----------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~-----~~~~---~~~~~ik~L~~-----------~~~~lyL 412 (720)
..++|+++++||+|+||+||+|+++.+++.||||+++.. .... .+..++..+.+ .++.+||
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 346899999999999999999999999999999998531 1111 22223332221 3578999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 147 V~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999999999975 469999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP--~~ls 566 (720)
...+.+||+.|+|||++.+.. +...|+.++|||||||+||||++|++||.+.+..+.+.+++.. ...+| ..++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTT---TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred cccCCcCCccccCHHHhhccC---CCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 234678999999999997421 1233788999999999999999999999998888888887753 23344 4689
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccccccCC
Q 005007 567 SEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~k--RPTa~ELL~Hpff~~~~~~~l 604 (720)
+++++||.+||+.+|.+ |++++||++||||+...|..+
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 99999999999988888 999999999999998776543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=387.18 Aligned_cols=239 Identities=24% Similarity=0.416 Sum_probs=204.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------cCCEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------~~~~lyLVm 414 (720)
.++|++++.||+|+||+||+|.++.+|+.||||++.......... +++..+.. .++.+|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 358999999999999999999999999999999997654333221 12222221 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---CeeeeccccchhccCccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~~~~~~~~ 491 (720)
||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.......
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 999999999999764 6799999999999999999999999999999999999998654 599999999987766555
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~ 567 (720)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+......++ ..+++
T Consensus 187 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKK-------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CCCSCSCTTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred cccCCCCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 566789999999999863 4578899999999999999999999998888788777777665554 35899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||+.||++|||+.|+|+||||...
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=391.20 Aligned_cols=238 Identities=25% Similarity=0.439 Sum_probs=185.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHh-h-------------cCCEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLE-Q-------------VDDHLY 411 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~-~-------------~~~~ly 411 (720)
.++|++++.||+|+||+||+|.++.+|+.||||++......... ...+..+. + ....+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 35899999999999999999999999999999998643322221 12222222 1 123689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC---
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--- 488 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~--- 488 (720)
||||||. |+|..++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 9999997 699999976 4699999999999999999999999999999999999999999999999999976532
Q ss_pred -------------------ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH
Q 005007 489 -------------------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ 549 (720)
Q Consensus 489 -------------------~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~ 549 (720)
.......+||++|+|||++.+ ...|+.++|||||||+||||++|++||.+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 112234679999999999863 3568899999999999999999999999887777
Q ss_pred HHHHHhccCCC-----------------------------------------------CCccCCHHHHHHHHHhhhcCCC
Q 005007 550 AMFKVLNRTPP-----------------------------------------------IPEMLSSEGKDFLLRCFLRNPV 582 (720)
Q Consensus 550 ~i~ki~~~~~~-----------------------------------------------iP~~ls~el~dLI~~cL~~dP~ 582 (720)
.+..++..... .+..+++++.+||.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 66665431100 1125789999999999999999
Q ss_pred CCCCHHHHHcCcccccc
Q 005007 583 ERPSAVELLEHPFIRNA 599 (720)
Q Consensus 583 kRPTa~ELL~Hpff~~~ 599 (720)
+|||++|+|+||||+..
T Consensus 319 ~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 319 KRISANDALKHPFVSIF 335 (388)
T ss_dssp GSCCHHHHTTSTTTTTT
T ss_pred cCCCHHHHhCCHHHHHh
Confidence 99999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=378.75 Aligned_cols=243 Identities=29% Similarity=0.521 Sum_probs=185.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
.++|++++.||+|+||+||+|.++.+|+.||||+++..... ....+++..+.. .++.+|||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35899999999999999999999999999999999754432 222333333332 2568999999
Q ss_pred eccCCCHHHHHHHhc-----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-
Q 005007 416 YVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 489 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~- 489 (720)
|+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 998 69999997642 35899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---C--------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---T-------- 558 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~-------- 558 (720)
.......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+... .
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ccCCCCcccccccCchHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 23345678999999999863 345788999999999999999999999988776666555321 0
Q ss_pred -----------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 559 -----------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 559 -----------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
...+..++.++++||.+||+.||++|||+.|+|+||||+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 01123578899999999999999999999999999999875543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=391.36 Aligned_cols=239 Identities=28% Similarity=0.463 Sum_probs=203.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC-----CCChhHHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-----PDDPKSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~-----~~~~~~~~~ik~L~~--------------~~~~lyLV 413 (720)
..+|++++.||+|+||+||+|.+..+|+.||||++... .......+++..+.. ..+.+|||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999998532 112223333333332 25678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+ +|+|.+++.+. +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 9999 68999999765 679999999999999999999999999999999999999999999999999998877766667
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+........++......+|..+++++++||
T Consensus 166 ~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 166 TSCGSPNYAAPEVING------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp CCTTSTTTSCGGGSCC------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred cccCCcCcCCHHHHcC------CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 7889999999999863 2334789999999999999999999998766555555555566778889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+||+.||.+|||++|+|+||||+..
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=370.79 Aligned_cols=238 Identities=26% Similarity=0.486 Sum_probs=192.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|++++.||+|+||+||+|.+ .+|+.||||++....... ...+++..+.. .++.+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5899999999999999999998 679999999997543221 22233333332 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+. ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 81 HLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp CCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 998 5999999776678999999999999999999999999999999999999999999999999999876432 22334
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CC------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TP------------ 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~------------ 559 (720)
..||+.|+|||++.+ ...++.++|||||||++|||++|+.||......+.+..+... ..
T Consensus 160 ~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccCchheeC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 578999999999863 345889999999999999999999999988776666655421 00
Q ss_pred --------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 560 --------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 560 --------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+...+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123478999999999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=362.54 Aligned_cols=241 Identities=24% Similarity=0.407 Sum_probs=204.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------~~~~lyLV 413 (720)
..++|++++.||+|+||+||+|.++.+|+.||||++.......... +++..+.. .++..|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4579999999999999999999999999999999997544332221 12222221 25678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC---eeeeccccchhccCcc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKHLTGLS 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~---VKL~DFGlA~~~~~~~ 490 (720)
|||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.......
T Consensus 84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999999998765 67999999999999999999999999999999999999987665 9999999998776655
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLS 566 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls 566 (720)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......+ ..++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKK-------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cccCCCCCcCCcCchhhcC-------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 5566789999999999863 4578899999999999999999999998888777777766655444 4689
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=390.56 Aligned_cols=247 Identities=23% Similarity=0.430 Sum_probs=208.4
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~ly 411 (720)
...++|++++.||+|+||+||+|.+..+++.||||++.... .. ....+++..+.. .++.+|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999986321 11 112223333332 256799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+||||+.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.......
T Consensus 92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 999999999999999764 6799999999999999999999999999999999999999999999999999988766666
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---CcHHHHHHHhccCCCCCccCCHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---EGPQAMFKVLNRTPPIPEMLSSE 568 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---~~~~~i~ki~~~~~~iP~~ls~e 568 (720)
....+||+.|+|||++.+. ....|+.++|||||||+||||++|+.||... ...+.+..+......+|..++.+
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSR----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCC----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred eeccCCCccccCCeeeccC----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence 6778999999999998531 1235788999999999999999999999743 33445556667778889999999
Q ss_pred HHHHHHHhhhcCCCCCCC-HHHHHcCccccccccc
Q 005007 569 GKDFLLRCFLRNPVERPS-AVELLEHPFIRNANYQ 602 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPT-a~ELL~Hpff~~~~~~ 602 (720)
+.+||.+||+.||.+||+ ++++++||||+...+.
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 999999999999999998 9999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=396.57 Aligned_cols=240 Identities=23% Similarity=0.413 Sum_probs=202.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhh--------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~--------------~~~~lyLV 413 (720)
..++|++++.||+|+||+||+|.++.+|+.||+|++......... .+++..+.. .++.+|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346899999999999999999999999999999999765432221 122222221 35789999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec---CCCCeeeeccccchhccCcc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd---~~g~VKL~DFGlA~~~~~~~ 490 (720)
||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++......
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999999765 6799999999999999999999999999999999999998 46789999999998765433
Q ss_pred -ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccC
Q 005007 491 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML 565 (720)
Q Consensus 491 -~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~l 565 (720)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++ ..+
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~-------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRK-------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ceeecccCCcccCCHHHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 3346789999999999863 4688899999999999999999999999888888888877665554 368
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=379.02 Aligned_cols=243 Identities=26% Similarity=0.498 Sum_probs=192.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh----HHHHHHHHhh--------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~--------------~~~~lyLV 413 (720)
..++|+++++||+|+||+||+|++..+++.||||+++....... ..+++..+.. .++.+|||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 34589999999999999999999999999999999975433221 1223333332 35789999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec-----CCCCeeeeccccchhccC
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-----ASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd-----~~g~VKL~DFGlA~~~~~ 488 (720)
|||+. |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+ ..+.+||+|||+++....
T Consensus 112 ~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 99998 5999999765 5799999999999999999999999999999999999994 455699999999987653
Q ss_pred c-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--C-----
Q 005007 489 L-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--P----- 560 (720)
Q Consensus 489 ~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--~----- 560 (720)
. .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||......+.+.++..... .
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp ----------CCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccCCCcCCccccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 2 23345578999999999863 34578999999999999999999999998887777766653210 0
Q ss_pred -----------C------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 561 -----------I------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 561 -----------i------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
+ +..+++++++||.+||+.||++|||++|+|+||||+...+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 0 11268999999999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=378.52 Aligned_cols=242 Identities=26% Similarity=0.419 Sum_probs=195.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---h---hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---P---KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~---~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
..++|++++.||+|+||+||+|++..+++.||||++...... . ++...++.+.. .++..||||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 456999999999999999999999999999999998654321 1 12222232221 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---cc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---~~ 491 (720)
|||+||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+... ..
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999999999654 56999999999999999999999999999999999999999999999999999865422 22
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhccCCC--CCccCCHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP--IPEMLSSE 568 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~~~~--iP~~ls~e 568 (720)
....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||...... ..+......... ....++++
T Consensus 164 ~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (323)
T ss_dssp BCSCCSCGGGSCHHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred cCCCccCcCccCcHHhcc------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHH
Confidence 345679999999999974 234577999999999999999999999865543 233333333222 23568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=381.02 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=188.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
..++|++.+.||+|+||+||+|.+..+++.||||+++....... +++.+..+.+ ..+.+||||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 44689999999999999999999999999999999875433222 2223333321 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCcccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++..........
T Consensus 131 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 131 TGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp CSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 999999999764 67999999999999999999999999999999999999975 88999999999987765555556
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH-HHHHHhccCCCC----CccCCHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTPPI----PEMLSSEG 569 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~-~i~ki~~~~~~i----P~~ls~el 569 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+......+ ...++.++
T Consensus 210 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 210 VCGTPGYCAPEILRG-------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ---CGGGSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred ccCCCCccCHHHhcC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence 789999999999863 457889999999999999999999998766655 444555544332 35689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
++||.+||+.||++|||+.|+|+||||.....
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 99999999999999999999999999986543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=384.14 Aligned_cols=245 Identities=22% Similarity=0.434 Sum_probs=195.5
Q ss_pred CCCCCeEEeeEEeec--CCeEEEEEEECCCCcEEEEEEeccCCCChhHHH----HHHHHhh--------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE----CIKQLEQ--------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G--~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~----~ik~L~~--------------~~~~l 410 (720)
....+|+++++||+| +||+||+|+++.+|+.||||+++.........+ ++..+.. .++.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 455799999999999 999999999999999999999976543332221 2222221 35779
Q ss_pred EEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 411 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
|||||||++|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999999764 356999999999999999999999999999999999999999999999999998654321
Q ss_pred --------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--
Q 005007 490 --------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-- 559 (720)
Q Consensus 490 --------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-- 559 (720)
......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+....+.+..++....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTT-----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred cccccccccccccccccccccCHHHHhcc-----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 122234789999999998631 14588899999999999999999999987666555544432211
Q ss_pred --------------------------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 560 --------------------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 560 --------------------------------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
.++..+++++++||.+||+.||++|||+.|+|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 234567899999999999999999999999999999
Q ss_pred ccccc
Q 005007 596 IRNAN 600 (720)
Q Consensus 596 f~~~~ 600 (720)
|+...
T Consensus 337 f~~~~ 341 (389)
T 3gni_B 337 FKQIK 341 (389)
T ss_dssp GGGC-
T ss_pred HHHHh
Confidence 98654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.02 Aligned_cols=238 Identities=25% Similarity=0.441 Sum_probs=205.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
.++|++.+.||+|+||+||+|.+..++..||+|++...... ....+++..+.. .++.+|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 35799999999999999999999999999999998653221 122223333332 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence 9999999999765 679999999999999999999999999999999999999 788999999999998776666666
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc----cCCHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE----MLSSEG 569 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~----~ls~el 569 (720)
...||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+......++. .+++++
T Consensus 167 ~~~~t~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEG--------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp CCCSCTTTCCHHHHTT--------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred ccCCCCCccChHHhcc--------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 7789999999999852 3788999999999999999999999998888888888887777765 689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+||.+||+.||++|||+.|+|+||||+..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=381.07 Aligned_cols=238 Identities=24% Similarity=0.393 Sum_probs=198.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhHHHHHHHHhh------------cCCEEEEEEEeccC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQ------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~~~~ik~L~~------------~~~~lyLVmEy~~g 419 (720)
.++|++++.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+..+.. .++.+|||||||.|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 4589999999999999999999999999999999976543 3344444544421 35679999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-C---CeeeeccccchhccCc-ccccc
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-G---VVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g---~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||+..+ + .+||+|||+++..... .....
T Consensus 101 g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 179 (342)
T 2qr7_A 101 GELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179 (342)
T ss_dssp CBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCC
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceec
Confidence 9999999764 679999999999999999999999999999999999998543 3 5999999999876543 33456
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC---CcHHHHHHHhccCCCCC----ccCCH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---EGPQAMFKVLNRTPPIP----EMLSS 567 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~---~~~~~i~ki~~~~~~iP----~~ls~ 567 (720)
.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||... ...+.+..+......++ ..+++
T Consensus 180 ~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 180 PCYTANFVAPEVLERQ-------GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp SSCCSSCCCHHHHHHH-------HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred cCCCccccCHHHhcCC-------CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 7899999999999752 3667999999999999999999999753 33455555655554443 56899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
++++||.+||..||++|||+.|+|+||||..
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 9999999999999999999999999999965
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=391.70 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=177.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhh-------------------cCC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ-------------------VDD 408 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~-------------------~~~ 408 (720)
..++|+++++||+|+||+||+|+++.+|+.||||++......... .++++.+.. ..+
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 346899999999999999999999999999999998654333221 122222222 124
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||+. |+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred eEEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 6899999985 8999999654 6799999999999999999999999999999999999999999999999999986542
Q ss_pred cc----------------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc---
Q 005007 489 LS----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--- 537 (720)
Q Consensus 489 ~~----------------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT--- 537 (720)
.. .....+||++|+|||++.. ...|+.++||||||||||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL------QENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhC------CCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 11 2345678999999998753 3568899999999999999999
Q ss_pred --------CCCCCCCCCc--------------------HHHH---HHHhccCC---------------------------
Q 005007 538 --------GKPPWSEFEG--------------------PQAM---FKVLNRTP--------------------------- 559 (720)
Q Consensus 538 --------Gk~PF~~~~~--------------------~~~i---~ki~~~~~--------------------------- 559 (720)
|+++|.+... ...+ ..+++...
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 7777765331 1111 11111100
Q ss_pred -CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 560 -PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 560 -~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
.....+++++.+||.+||+.||++|||++|+|+||||+......
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 01124589999999999999999999999999999999775443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=400.48 Aligned_cols=241 Identities=29% Similarity=0.487 Sum_probs=210.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyL 412 (720)
...+|++++.||+|+||+||+|.+..+|+.||||+++... .. ....+++..+.. ..+.+||
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999999999999999986321 11 112223333322 2567999
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 94 v~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 99999999999999754 67999999999999999999999999999999999999999999999999999887666666
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
.+.+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+......+.++.......|..+++++++|
T Consensus 173 ~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISG------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246 (476)
T ss_dssp CCCCSCSTTCCHHHHTT------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred cccCCCcCeEChhhccC------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence 67889999999999874 334578999999999999999999999998888888888888888899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||+.||.+|||+.|+++||||+..
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=381.42 Aligned_cols=240 Identities=27% Similarity=0.459 Sum_probs=196.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC---C---C-hhHHHHHHHHhh--------------cCCEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---D---D-PKSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~---~---~-~~~~~~ik~L~~--------------~~~~ly 411 (720)
.++|++++.||+|+||+||+|.++.+|+.||||+++... . . ....+++..+.. .++.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 458999999999999999999999999999999985321 1 1 111222222222 357899
Q ss_pred EEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC---eeeeccccchh
Q 005007 412 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKH 485 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~---VKL~DFGlA~~ 485 (720)
||||||+||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 235899999999999999999999999999999999999987654 99999999987
Q ss_pred ccCccc-cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC--
Q 005007 486 LTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP-- 562 (720)
Q Consensus 486 ~~~~~~-~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP-- 562 (720)
...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+. ..+.+..+......++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKR-------EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcC-------CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcc
Confidence 654332 345679999999999863 45788999999999999999999999874 3455555655555444
Q ss_pred --ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 --~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++++||.+||+.||++|||+.|+|+||||+...
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 46899999999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.50 Aligned_cols=240 Identities=30% Similarity=0.553 Sum_probs=191.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|++++.||+|+||+||+|.+..+|+.||||++.......... +++..+.. .++.+++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 58999999999999999999999999999999987654433221 12222222 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 99999999888654 67999999999999999999999999999999999999999999999999999876533 23345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+....
T Consensus 162 ~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 162 EVATRWYRSPELLVG------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----GGGCCHHHHHT------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred CcCCccccChHHHhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 679999999999974 3567889999999999999999999998877666554443210
Q ss_pred ---CCCC------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 ---PPIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 ---~~iP------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++ ..++.++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0111 24788999999999999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.44 Aligned_cols=238 Identities=26% Similarity=0.464 Sum_probs=193.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
.++|++.+.||+|+||+||+|.++.++..||||++....... ....+++.+.. ..+.+|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 358999999999999999999999999999999987543321 12223333332 2567899999
Q ss_pred eccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCc
Q 005007 416 YVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 416 y~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~ 489 (720)
|+++|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999998643 3679999999999999999999999999999999999999 45688999999999877665
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC---ccCC
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP---EMLS 566 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP---~~ls 566 (720)
.......||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+....+.......+ ..++
T Consensus 181 ~~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK--------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp ------CTTGGGCCHHHHT--------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred ccCcCcccccCcCChHHhc--------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 5556678999999999874 2478899999999999999999999998877776666655444333 3478
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.32 Aligned_cols=238 Identities=27% Similarity=0.427 Sum_probs=194.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHh-----h-----------cCCE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLE-----Q-----------VDDH 409 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~-----~-----------~~~~ 409 (720)
....++|+++++||+|+||+||+|++..+++.||||+++...... .+.++++.+. . ..+.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 445679999999999999999999999999999999986432111 1223333332 1 2567
Q ss_pred EEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-----------------
Q 005007 410 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----------------- 471 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~----------------- 471 (720)
+||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 89999999 899999997643 45999999999999999999999999999999999999975
Q ss_pred --------CCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCC
Q 005007 472 --------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 543 (720)
Q Consensus 472 --------~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~ 543 (720)
++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-------LGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-------CCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999976543 2345679999999999973 458899999999999999999999999
Q ss_pred CCCcHHHHHHHhccCCCCCc----------------------------------------------cCCHHHHHHHHHhh
Q 005007 544 EFEGPQAMFKVLNRTPPIPE----------------------------------------------MLSSEGKDFLLRCF 577 (720)
Q Consensus 544 ~~~~~~~i~ki~~~~~~iP~----------------------------------------------~ls~el~dLI~~cL 577 (720)
..+..+.+..+......+|. ..++++.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 87776666555433222221 12377889999999
Q ss_pred hcCCCCCCCHHHHHcCcccc
Q 005007 578 LRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 578 ~~dP~kRPTa~ELL~Hpff~ 597 (720)
+.||.+|||+.|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.57 Aligned_cols=240 Identities=24% Similarity=0.432 Sum_probs=205.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh--------------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~--------------~~~~l 410 (720)
.++|++++.||+|+||+||+|.+..+|+.||||+++...... ...+++..+.. .++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999999999999999987543211 11222222322 25678
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC----Ceeeeccccchhc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHL 486 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g----~VKL~DFGlA~~~ 486 (720)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999999764 6799999999999999999999999999999999999999888 7999999999877
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP---- 562 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP---- 562 (720)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+......++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CccccccccCCCCCccCcccccC-------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 66555556779999999999863 4578899999999999999999999998888777777776665554
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++++||.+||..||++|||+.|+|+||||+...
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 46899999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=374.93 Aligned_cols=239 Identities=27% Similarity=0.460 Sum_probs=194.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----------------------------hhHHHHHHHHh
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----------------------------PKSAECIKQLE 404 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----------------------------~~~~~~ik~L~ 404 (720)
.++|++++.||+|+||+||+|++..+++.||||++...... ....+++..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998643211 11122222222
Q ss_pred h----------------cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCcee
Q 005007 405 Q----------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468 (720)
Q Consensus 405 ~----------------~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NIL 468 (720)
. .++.+||||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 2 14678999999999999886533 57999999999999999999999999999999999999
Q ss_pred ecCCCCeeeeccccchhccCcc-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc
Q 005007 469 VDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 547 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~~~~~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~ 547 (720)
|+.++.+||+|||+++...... ......||+.|+|||++.+. ....++.++|||||||++|||++|+.||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET----RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT----CCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999998765432 23456799999999987531 111247789999999999999999999998777
Q ss_pred HHHHHHHhccCCCCC--ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 548 PQAMFKVLNRTPPIP--EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 548 ~~~i~ki~~~~~~iP--~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
......+......+| ..+++++++||.+||+.||++|||+.|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 666666666555544 46899999999999999999999999999999995
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=376.86 Aligned_cols=242 Identities=26% Similarity=0.458 Sum_probs=192.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC------hhHHHHHHHHhh-----------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQLEQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~------~~~~~~ik~L~~-----------~~~~lyLVmEy 416 (720)
++|++++.||+|+||+||+|.+..+++.||||++...... ..+.+.++.+.. .++.+||||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5899999999999999999999999999999998643321 123333333321 35678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
+. |+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 97 6999999877677999999999999999999999999999999999999999999999999999765432 223345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CC--C----------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TP--P---------- 560 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~--~---------- 560 (720)
.||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+... .. .
T Consensus 161 ~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 161 VVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --CGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cCcccccChhhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 78999999999863 356888999999999999999999999988776666555431 10 0
Q ss_pred ---------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 561 ---------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 561 ---------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
....+++++++||.+||+.||.+|||++|+|+||||......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 012468899999999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=376.36 Aligned_cols=234 Identities=27% Similarity=0.393 Sum_probs=188.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHH---Hhh---------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQ---LEQ---------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~---L~~---------------~~~~lyLV 413 (720)
.++|+++++||+|+||+||+|++..+|+.||||++......... .+.+.. +.. .++.+|||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 35899999999999999999999999999999988654333221 111111 111 25678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.........
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 9999 689999998877789999999999999999999999999999999999999999999999999998776555555
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--CCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~~iP~~ls~el~d 571 (720)
...||+.|+|||++.+ .++.++|||||||++|||++|..++... .....+.... ..++..+++++.+
T Consensus 215 ~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG--------SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp CCCCCGGGCCGGGGGT--------CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred ccCCCccccCHhHhcC--------CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHHHH
Confidence 6779999999998752 4788999999999999999997666542 2223333222 1234568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
||.+||+.||++|||++|+|+||||+.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.33 Aligned_cols=242 Identities=24% Similarity=0.427 Sum_probs=195.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----h---HHHHHHHHhh-------------------c
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----K---SAECIKQLEQ-------------------V 406 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~---~~~~ik~L~~-------------------~ 406 (720)
.++|++++.||+|+||+||+|+++.+|+.||||++....... . +.+.++.+.. .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999999999999999886543322 1 2223333221 0
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
++.+||||||+. |+|.+.+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 346899999998 5888888776678999999999999999999999999999999999999999999999999999865
Q ss_pred cC-----ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC
Q 005007 487 TG-----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 561 (720)
Q Consensus 487 ~~-----~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i 561 (720)
.. ........||+.|+|||++.+ ...++.++|||||||++|||++|++||.+......+..+......+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccccccCCcccccCccCchhhcC------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 42 122345678999999999863 3457889999999999999999999999887766666554321111
Q ss_pred Ccc--------------------------------CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 562 PEM--------------------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 562 P~~--------------------------------ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
+.. .++++++||.+||+.||++|||++|+|+||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 110 2678999999999999999999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=367.71 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=191.8
Q ss_pred CCCCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh---------------cCCEEEEE
Q 005007 352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ---------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~-k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~---------------~~~~lyLV 413 (720)
..++|++. ++||+|+||+||+|.+..+++.||||+++...... ...+++..+.+ .++.+|||
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45689995 78999999999999999999999999997543321 12223333322 25678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC---eeeeccccchhccCc-
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKHLTGL- 489 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~---VKL~DFGlA~~~~~~- 489 (720)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999999775 67999999999999999999999999999999999999988776 999999998765321
Q ss_pred -------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---------------
Q 005007 490 -------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--------------- 547 (720)
Q Consensus 490 -------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--------------- 547 (720)
......+||+.|+|||++.+.... ...++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEE--ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHH--HHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred ccccccccccccccCCcCccChHHhhccccc--ccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 112345699999999999742100 02366799999999999999999999976532
Q ss_pred HHHHHHHhccCCCCCc----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 548 PQAMFKVLNRTPPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 548 ~~~i~ki~~~~~~iP~----~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
......+......+|. .++.++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2344455556666663 58999999999999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=395.02 Aligned_cols=235 Identities=25% Similarity=0.380 Sum_probs=185.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------------CC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------------DD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------------~~ 408 (720)
.++|++++.||+|+||+||+|++..+|+.||||++......... .+++..+... .+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999999753222211 1222222211 14
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||+.+ +|.+.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 67999999985 5766664 3499999999999999999999999999999999999999999999999999988766
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------- 559 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--------- 559 (720)
.......+||++|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+++....
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp CCCC----CCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred CcccCCCcccccccCHHHHcC-------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 555667889999999999974 4588899999999999999999999998877766666543110
Q ss_pred -------------C---------CCcc-----------CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 560 -------------P---------IPEM-----------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 560 -------------~---------iP~~-----------ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
. +|.. .++++++||.+||+.||++|||++|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0 0110 1567999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=389.50 Aligned_cols=244 Identities=27% Similarity=0.443 Sum_probs=198.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhhc-----------------CCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQV-----------------DDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~~-----------------~~~lyLV 413 (720)
...+|+++++||+|+||+||+|++..+|+.||||++...... .+++++++.+.+. +..+++|
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 345799999999999999999999999999999998654332 2345555444321 1236799
Q ss_pred EEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-CCeeeeccccchhccCc
Q 005007 414 LEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGL 489 (720)
Q Consensus 414 mEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-g~VKL~DFGlA~~~~~~ 489 (720)
|||+. ++|.+++.. ....+++..++.|+.||++||.|||++||+||||||+||||+.+ +.+||+|||+++.+...
T Consensus 132 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred hhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 99998 467766643 34679999999999999999999999999999999999999965 57899999999877655
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc------------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------ 557 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------------ 557 (720)
......+||++|+|||++.+ ...|+.++||||||||||||++|++||.+.+..+.+.+++..
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred CCceeeeeCCCcCCHHHHcC------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 55567789999999999863 346889999999999999999999999988776666655431
Q ss_pred -----CCC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 558 -----TPP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 558 -----~~~------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
... ++..+++++++||.+||+.||.+|||+.|+|+||||+.....
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 111 234568999999999999999999999999999999876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=376.64 Aligned_cols=242 Identities=26% Similarity=0.526 Sum_probs=204.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--h-----------hHHHHHHHHh-h-----------cCC
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--P-----------KSAECIKQLE-Q-----------VDD 408 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~-----------~~~~~ik~L~-~-----------~~~ 408 (720)
.+|++.+.||+|+||.||+|.++.+|+.||||++...... . .+...+..+. . ..+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4799999999999999999999999999999998754321 1 1112222231 1 256
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||++|++|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 789999999999999999765 6799999999999999999999999999999999999999999999999999987766
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----cc
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EM 564 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ 564 (720)
.......+||+.|+|||++.+.... ....++.++|||||||++|||++|+.||........+..+......++ ..
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDE-THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCT-TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CcccccCCCCCCccChhhccccccc-cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 5555677899999999999764221 134588899999999999999999999998777777777766655443 46
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
++.++.+||.+||+.||++|||+.|+|+||||+
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 789999999999999999999999999999996
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=376.85 Aligned_cols=243 Identities=28% Similarity=0.525 Sum_probs=202.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccC---------CCChhHHHHHHHHhh------------cCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDII---------PDDPKSAECIKQLEQ------------VDD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~---------~~~~~~~~~ik~L~~------------~~~ 408 (720)
..+|+++++||+|+||+||+|++. .+|+.||||+++.. .....+.+++..+.. .++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 58999999988532 122345556666542 256
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 799999999999999999765 6799999999999999999999999999999999999999999999999999986543
Q ss_pred c--cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC----CcHHHHHHHhccCCCCC
Q 005007 489 L--SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF----EGPQAMFKVLNRTPPIP 562 (720)
Q Consensus 489 ~--~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~----~~~~~i~ki~~~~~~iP 562 (720)
. ......+||+.|+|||++.+ +...++.++|||||||+||||++|+.||... ........+......+|
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRG-----GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTT-----CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred CCCCcccCcccCcCccChhhhcC-----CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 2 22345679999999999863 1235778999999999999999999999743 22344455566777888
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
..++..+++||.+||..||.+|| +++|+++|+||+...+
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 99999999999999999999999 9999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=361.99 Aligned_cols=241 Identities=28% Similarity=0.510 Sum_probs=202.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----ChhHHHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPKSAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~~~~~~ik~L~~--------------~~~~lyL 412 (720)
..++|++++.||+|+||+||+|.+..++..||||++..... .....+++..+.. .++.+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34689999999999999999999999999999998853210 1111222222222 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~ 164 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR 164 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cc
Confidence 99999999999999775 67999999999999999999999999999999999999999999999999998654432 23
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......+|..+++++++|
T Consensus 165 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---CCCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred cccCCCCCccCHhHhcc-------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 45679999999999863 45778999999999999999999999988888888888888888999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
|.+||+.||.+|||+.|+|+||||+....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.95 Aligned_cols=249 Identities=24% Similarity=0.454 Sum_probs=207.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---h-----------hHHHHHHHHh-h-----------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---P-----------KSAECIKQLE-Q----------- 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~-----------~~~~~ik~L~-~----------- 405 (720)
..++|++++.||+|+||+||+|.++.+|+.||||+++..... . .+.+.++.+. .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457999999999999999999999999999999999754311 0 1122223332 1
Q ss_pred cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 406 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.++.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 246789999999999999999765 6799999999999999999999999999999999999999999999999999987
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC---
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 562 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP--- 562 (720)
...........||+.|+|||++.+.... ....++.++|||||||++|||++|+.||...........+......++
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred cCCCcccccccCCccccCHHHhcccccc-ccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 7655555667899999999999754322 235678899999999999999999999998877777777766554433
Q ss_pred -ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 563 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 563 -~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
..++.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 4689999999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=386.18 Aligned_cols=241 Identities=22% Similarity=0.377 Sum_probs=203.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
.++|++++.||+|+||+||+|.++.+|+.||+|++....... ...+++..+.. .++.+||||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 358999999999999999999999999999999987532111 11222222322 25679999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC--CCCeeeeccccchhccCcccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~--~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|.||+|.+++......+++..++.++.||+.||+|||++||+||||||+||||+. .+.+||+|||+++..........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 9999999999766567999999999999999999999999999999999999974 47899999999987765555556
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGK 570 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~ 570 (720)
.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......++ ..++++++
T Consensus 210 ~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 210 TTATAEFAAPEIVDR-------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp ECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred eccCCCccCchhccC-------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 689999999999863 4578899999999999999999999998887777777766544333 46899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||.+||+.||.+|||+.|+|+||||+...
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=382.11 Aligned_cols=241 Identities=27% Similarity=0.465 Sum_probs=198.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhh-------------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQ------------------------- 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~------------------------- 405 (720)
...+|++++.||+|+||+||+|++..+|+.||||++...... .++.++++.+.+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 456899999999999999999999999999999988654322 233333333221
Q ss_pred ------------------------cCCEEEEEEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCc
Q 005007 406 ------------------------VDDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTI 458 (720)
Q Consensus 406 ------------------------~~~~lyLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIV 458 (720)
.+..++|||||++ |+|.+++.. ....+++..++.|+.||+.||.|||++||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCc
Confidence 1234889999998 688877753 346799999999999999999999999999
Q ss_pred ccccCCCceeec-CCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc
Q 005007 459 HRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 537 (720)
Q Consensus 459 HRDIKP~NILLd-~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT 537 (720)
||||||+||||+ .++.+||+|||+++............||+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG------ATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC------CCCCCcchhhhhHHHHHHHHHh
Confidence 999999999997 689999999999988766666667789999999999863 3458899999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHhccC-----------------C------------CCCccCCHHHHHHHHHhhhcCCCCCCCHH
Q 005007 538 GKPPWSEFEGPQAMFKVLNRT-----------------P------------PIPEMLSSEGKDFLLRCFLRNPVERPSAV 588 (720)
Q Consensus 538 Gk~PF~~~~~~~~i~ki~~~~-----------------~------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ 588 (720)
|++||.+....+.+..++... . .++..+++++++||.+||+.||.+|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 999999887777666654310 0 13556889999999999999999999999
Q ss_pred HHHcCcccccc
Q 005007 589 ELLEHPFIRNA 599 (720)
Q Consensus 589 ELL~Hpff~~~ 599 (720)
|+|+||||+..
T Consensus 318 e~l~hp~f~~~ 328 (383)
T 3eb0_A 318 EAMAHPFFDHL 328 (383)
T ss_dssp HHHTSGGGHHH
T ss_pred HHhcCHHHHHH
Confidence 99999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=363.11 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=185.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH----Hhh--------------cCCEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQ--------------VDDHLYI 412 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~----L~~--------------~~~~lyL 412 (720)
...++|++++.||+|+||+||+|.+..+|+.||||+++.........+.+.. +.. .++.+|+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457999999999999999999999999999999999755333332222222 111 2567899
Q ss_pred EEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 413 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
||||++ |+|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999997 588887754 346799999999999999999999998 999999999999999999999999999987766
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHhc-cCCCC-CccC
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLN-RTPPI-PEML 565 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~~-~~~~i-P~~l 565 (720)
........||+.|+|||++.... ....++.++|||||||++|||++|+.||..... ...+..... ..... +..+
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPEL---NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp -------CCCCCCSCHHHHSCCT---TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred cccccccCCCccccChhhcChhh---cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 55555567999999999973211 134688899999999999999999999986433 333333333 33333 3468
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 99999999999999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=372.57 Aligned_cols=242 Identities=26% Similarity=0.492 Sum_probs=207.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHHHHHhh--------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~ik~L~~--------------~~~~ly 411 (720)
....+|++++.||+|+||+||+|.+..+++.||+|++..... .... ..++..+.. .++.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 345789999999999999999999999999999999864322 1111 112222221 256789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-c
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~ 490 (720)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus 118 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999999998765 67999999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+......+|..+++++.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSK-------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 269 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHT-------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred cccccCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHH
Confidence 3345679999999999973 457889999999999999999999999888777778888888888999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||.+||+.||++|||+.|+|+|+||....
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=359.52 Aligned_cols=241 Identities=30% Similarity=0.502 Sum_probs=196.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyL 412 (720)
..++|++++.||+|+||+||+|.+..+|+.||||++.... .. ....+++..+.. .++.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999999999999999986421 11 111222222222 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 99999999999999765 57999999999999999999999999999999999999999999999999999877665555
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
....||+.|+|||++.+ ....+.++|||||||++|||++|+.||...........+......+|..++.++.+|
T Consensus 168 ~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISG------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp ---------CCTGGGTT------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ecccCCccccCHHHHcC------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 56679999999999863 233468999999999999999999999988777777777778888899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||+.||.+|||+.|+|+||||+..
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=365.94 Aligned_cols=240 Identities=33% Similarity=0.608 Sum_probs=180.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyLV 413 (720)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .. ....+++..+.. ..+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 358999999999999999999999999999999986321 11 112222333222 25678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~ 492 (720)
|||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 9999999999999876678999999999999999999999999999999999999999999999999999866432 223
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.++......+|..++.++++|
T Consensus 170 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 170 YTLCGTPNYISPEIATR-------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred eeccCCCCcCCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence 35679999999999874 35678999999999999999999999887766666666666677888899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||+.||++|||++|+|+||||...
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=374.31 Aligned_cols=246 Identities=25% Similarity=0.436 Sum_probs=199.1
Q ss_pred CCCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh---------------cCCEEEE
Q 005007 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ---------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~-k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~---------------~~~~lyL 412 (720)
.++|.+. +.||+|+||+||+|.+..+|+.||||+++...... ...+++..+.. ..+.+|+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4578887 89999999999999999999999999987543222 11222222221 2567899
Q ss_pred EEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccC
Q 005007 413 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG 488 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~ 488 (720)
||||+.||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998543 356999999999999999999999999999999999999987 78999999999987765
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC----Ccc
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----PEM 564 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i----P~~ 564 (720)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+....... +..
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNY-------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp -------CCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred ccccccccCCcCccCCeeecC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 555556789999999999863 457889999999999999999999999888777777666544333 346
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccCCC
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLS 605 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~l~ 605 (720)
+++++++||.+||+.||.+|||++|+|+||||+...+..+.
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence 89999999999999999999999999999999988776553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=383.38 Aligned_cols=244 Identities=27% Similarity=0.448 Sum_probs=187.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------C-----C
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------D-----D 408 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------~-----~ 408 (720)
..++|+++++||+|+||+||+|+++.+|+.||||++......... .++++.+... . +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 456999999999999999999999999999999999754333221 1222222221 1 5
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||+. |+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 6899999996 6999999654 6799999999999999999999999999999999999999999999999999987643
Q ss_pred cc-----------------------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-------
Q 005007 489 LS-----------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG------- 538 (720)
Q Consensus 489 ~~-----------------------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG------- 538 (720)
.. .....+||++|+|||++.. ...|+.++||||||||||||++|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL------QENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhc------CCCCCcccccchHHHHHHHHHhcccccccc
Confidence 22 2356789999999999853 35688999999999999999984
Q ss_pred ----CCCCCCCCc-----------------HHHHHHH---hcc---------------------CCCC-------CccCC
Q 005007 539 ----KPPWSEFEG-----------------PQAMFKV---LNR---------------------TPPI-------PEMLS 566 (720)
Q Consensus 539 ----k~PF~~~~~-----------------~~~i~ki---~~~---------------------~~~i-------P~~ls 566 (720)
+++|.+... ...+..+ ++. .... ...++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 444433220 1111111 111 0011 13479
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
+++.+||.+||+.||++|||++|+|+||||+......
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999999999999999999999999999999765543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=374.10 Aligned_cols=244 Identities=25% Similarity=0.435 Sum_probs=194.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh--------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~--------------~~~~l 410 (720)
..++|++++.||+|+||+||+|.+..+|+.||||++...... ....+++..+.. .++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 356899999999999999999999999999999998743211 112233333322 24678
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~- 489 (720)
|+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999985 899999776677999999999999999999999999999999999999999999999999999876433
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--C---CC---
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--P---PI--- 561 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--~---~i--- 561 (720)
.......||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+....+.+.+++... + .+
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcccccccccCchHhhC------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 23345679999999999863 3457889999999999999999999999888777766665320 0 00
Q ss_pred --------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 562 --------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 562 --------------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
...+++++++||.+||+.||.+|||+.|+|+||||++....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 13467899999999999999999999999999999875443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=370.49 Aligned_cols=240 Identities=22% Similarity=0.373 Sum_probs=193.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
..++|+++++||+|+||+||+|++..+++.||||+++..... ..+..+++.+.. .....++|||
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 356899999999999999999999999999999998743211 123333444431 1456899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCcccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~~~~t 494 (720)
|+.+++|.+++. .+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..........
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 189 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccc
Confidence 999999999874 389999999999999999999999999999999999999777 899999999987766555566
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-cHHHHHHHhc-------------cCC-
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLN-------------RTP- 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-~~~~i~ki~~-------------~~~- 559 (720)
..||+.|+|||++.+ ...++.++|||||||++|||++|+.||.... ..+.+..+.. ...
T Consensus 190 ~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 190 RVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp CCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred ccccccccChhhhcC------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 789999999999863 3568889999999999999999999995432 2222222111 111
Q ss_pred -----------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 560 -----------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 560 -----------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
..+..+++++++||.+||+.||++|||++|+|+||||+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 112237999999999999999999999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=381.87 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=196.6
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEEeccC
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLEYVHP 419 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmEy~~g 419 (720)
|...++||+|+||+||+|.+..+|+.||||+++..... ....+++..+.. .++.+||||||++|
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 34478999999999999999999999999999754211 111222222322 25678999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee--cCCCCeeeeccccchhccCccccccccC
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKG 497 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL--d~~g~VKL~DFGlA~~~~~~~~~~t~~G 497 (720)
|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++............|
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 250 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence 99999997766679999999999999999999999999999999999999 5678999999999988766555556779
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHHHHH
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGKDFL 573 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~dLI 573 (720)
|+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+.+++.....++ ..+++++++||
T Consensus 251 t~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 251 TPEFLAPEVVNY-------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp SCTTCCHHHHTT-------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred CCcEeChhhccC-------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 999999999863 4678899999999999999999999999888888888877655444 45899999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+||+.||.+|||+.|+|+||||+...
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=359.74 Aligned_cols=242 Identities=25% Similarity=0.482 Sum_probs=206.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----C-ChhHHHHHHHHhh--------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----D-DPKSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~-~~~~~~~ik~L~~--------------~~~~ly 411 (720)
...++|++++.||+|+||+||+|.+..+++.||||++.... . .....+++..+.. .++.+|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 34568999999999999999999999999999999985321 1 1112222222222 256789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R 168 (284)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred EEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence 999999999999999775 57999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......+|..++.++++
T Consensus 169 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEG-------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241 (284)
T ss_dssp BCCCCSCGGGCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred cccccCCCCcCCHHHhcc-------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence 345679999999999863 4578899999999999999999999998888788888888888889999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
||.+||..||.+|||+.|+|+||||+....
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=391.15 Aligned_cols=241 Identities=24% Similarity=0.391 Sum_probs=203.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---------------hhHHHHHHHHhh----------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---------------PKSAECIKQLEQ---------- 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---------------~~~~~~ik~L~~---------- 405 (720)
...++|+++++||+|+||+||+|.++.+++.||||++...... ....+++..+..
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3457899999999999999999999999999999998754311 111222333322
Q ss_pred ----cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---Ceeee
Q 005007 406 ----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLA 478 (720)
Q Consensus 406 ----~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~ 478 (720)
.++.+|||||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 256789999999999999999765 6799999999999999999999999999999999999998776 69999
Q ss_pred ccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC
Q 005007 479 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 558 (720)
Q Consensus 479 DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~ 558 (720)
|||+++...........+||+.|+|||++. ..++.++|||||||++|+|++|++||.+....+.+..+....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc--------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 999998876665566778999999999985 247889999999999999999999999988888888888776
Q ss_pred CCCC----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 PPIP----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 ~~iP----~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++ ..+++++++||.+||+.||.+|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 6555 56899999999999999999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=356.28 Aligned_cols=235 Identities=26% Similarity=0.426 Sum_probs=190.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHHHHHH---Hhh---------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQ---LEQ---------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~~ik~---L~~---------------~~~~lyLV 413 (720)
.++|++++.||+|+||+||+|.+..+++.||||+++...... ...+.+++ +.. .++.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 358999999999999999999999999999999987543322 22222222 211 25778999
Q ss_pred EEeccCCCHHHHHHHhc---CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC------------------
Q 005007 414 LEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS------------------ 472 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~------------------ 472 (720)
|||++|++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999997642 569999999999999999999999999999999999999844
Q ss_pred -CCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHH
Q 005007 473 -GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 551 (720)
Q Consensus 473 -g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i 551 (720)
..+||+|||++...... ....||+.|+|||++.+ ...++.++|||||||++|||++|.+++.... ..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~ 237 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGD---QW 237 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HH
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcC------CCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HH
Confidence 47999999999876543 23459999999999863 3456789999999999999999998875432 23
Q ss_pred HHHh-ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 552 FKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 552 ~ki~-~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
..+. .....+|..+++++.+||.+||+.||++|||+.|+|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3333 34556788899999999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=402.49 Aligned_cols=244 Identities=26% Similarity=0.454 Sum_probs=205.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-----CChhHHHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-----~~~~~~~~ik~L~~--------------~~~~lyL 412 (720)
..++|+++++||+|+||+||+|+++.+|+.||||++.... .......++..+.. .++.+||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4568999999999999999999999999999999985321 11111222222222 3578999
Q ss_pred EEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 413 YLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||||++||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999999999997642 3499999999999999999999999999999999999999999999999999988766555
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHHHhccCCCCCccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~ki~~~~~~iP~~ls~ 567 (720)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.... .......+......+|..+++
T Consensus 342 ~~~~~GT~~Y~APEvl~~-------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~ 414 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414 (576)
T ss_dssp EECCCSCGGGCCHHHHTT-------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccccCCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence 566789999999999863 457889999999999999999999998653 234444555667778889999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 568 EGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
++++||.+||+.||.+|| +++|+++||||+...+.
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 999999999999999999 89999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=375.49 Aligned_cols=234 Identities=22% Similarity=0.403 Sum_probs=198.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------------hhHHHHHHHHhh-----------cCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQ-----------VDD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------------~~~~~~ik~L~~-----------~~~ 408 (720)
.++|++++.||+|+||+||+|.++.+++.||||+++..... ..++..++.+.. .++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35899999999999999999999999999999998754321 113333333321 356
Q ss_pred EEEEEEEeccCC-CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 409 HLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 409 ~lyLVmEy~~gG-sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
.+++||||+.+| +|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 789999999777 999999764 679999999999999999999999999999999999999999999999999998876
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCH
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS 567 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~ 567 (720)
........+||+.|+|||++.+ ...++.++|||||||++|||++|+.||..... ........|..+++
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMG------NPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSK 249 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTT------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCH
T ss_pred CCCceeccCCCccccChhhhcC------CCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCH
Confidence 6665667789999999999873 33458899999999999999999999976322 33445566778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||+.||++|||++|+|+||||+..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=385.57 Aligned_cols=240 Identities=25% Similarity=0.406 Sum_probs=194.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhh-----------------cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQ-----------------VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~-----------------~~~~ 409 (720)
....+|+++++||+|+||+||+|.+..+++.||||+++..... ..++++++.+.. ..+.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3456899999999999999999999999999999999743211 112333344432 2567
Q ss_pred EEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC--eeeeccccchhc
Q 005007 410 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~--VKL~DFGlA~~~ 486 (720)
+||||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++. +||+|||+++..
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 899999996 79999987643 45999999999999999999999999999999999999999987 999999999754
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC------
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------ 560 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~------ 560 (720)
.. .....+||+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..+.+..++.....
T Consensus 253 ~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 253 HQ--RVYTYIQSRFYRAPEVILG-------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TC--CCCSSCSCGGGCCHHHHHT-------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CC--cccccCCCCCccChHHHhC-------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 33 2345689999999999984 45789999999999999999999999988776665554321000
Q ss_pred -----------------------------------------------------CCccCCHHHHHHHHHhhhcCCCCCCCH
Q 005007 561 -----------------------------------------------------IPEMLSSEGKDFLLRCFLRNPVERPSA 587 (720)
Q Consensus 561 -----------------------------------------------------iP~~ls~el~dLI~~cL~~dP~kRPTa 587 (720)
++...++++++||.+||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 112247889999999999999999999
Q ss_pred HHHHcCccccccc
Q 005007 588 VELLEHPFIRNAN 600 (720)
Q Consensus 588 ~ELL~Hpff~~~~ 600 (720)
+|+|+||||+...
T Consensus 404 ~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 404 GQALRHPWLRRRL 416 (429)
T ss_dssp HHHHTSTTTC---
T ss_pred HHHhCChhhccCC
Confidence 9999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=364.93 Aligned_cols=237 Identities=34% Similarity=0.595 Sum_probs=199.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh--HHHHHHHHhh--------------cCCEEEEEEEecc
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--SAECIKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~--~~~~ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
.|...+.||+|+||+||+|.+..+|+.||||++........ ..+++..+.. ..+.+|+||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 58889999999999999999999999999999975443221 2223333322 2567899999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccccC
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKG 497 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~~G 497 (720)
|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......|
T Consensus 126 ~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 126 GGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp SCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 9999999864 46999999999999999999999999999999999999999999999999999876543 23345679
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHHHH
Q 005007 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDFLL 574 (720)
Q Consensus 498 Tp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dLI~ 574 (720)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+..... ..+..+++++++||.
T Consensus 204 t~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 204 TPYWMAPEVISR-------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred CccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 999999999863 4578899999999999999999999998777777666655432 233468999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||+.||++|||+.|+|+||||....
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHccCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999999997644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.76 Aligned_cols=242 Identities=26% Similarity=0.486 Sum_probs=206.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhH----HHHHHHHhh--------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKS----AECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~----~~~ik~L~~--------------~~~~ly 411 (720)
...++|++++.||+|+||+||+|.+..+++.||+|++...... ... ..++..+.. .++.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 3457899999999999999999999999999999998654221 111 112222221 256789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-c
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~ 490 (720)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999999998765 67999999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 570 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~ 570 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......+|..+++++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSK-------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 243 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTT-------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHH
T ss_pred ccccccCCCCcCCcchhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHH
Confidence 3345679999999999863 457889999999999999999999999888877888888888888999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||.+||+.||++|||++|+|+|+||....
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 999999999999999999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=388.84 Aligned_cols=241 Identities=24% Similarity=0.439 Sum_probs=205.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hhHHHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~~--------------~~~~lyL 412 (720)
..++|+++++||+|+||+||+|.++.+|+.||||++...... ....+++..+.. .++.+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999998643221 112223333332 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~ 489 (720)
|||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 104 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999999765 679999999999999999999999999999999999999 56789999999999887766
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccC
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML 565 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~l 565 (720)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+....+.+.++......++ ..+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG--------TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT--------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cccccCCCCccccCceeecC--------CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 55566789999999999863 478899999999999999999999999888888888877654433 468
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 999999999999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=383.50 Aligned_cols=240 Identities=13% Similarity=0.100 Sum_probs=187.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHh--hcC---------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLE--QVD--------------- 407 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~--~~~--------------- 407 (720)
..+|++++.||+|+||+||+|.+..+|+.||||++....... ++..+++.|. +..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346999999999999999999999999999999998654321 1111133333 110
Q ss_pred --------------------CEEEEEEEeccCCCHHHHHHHhcCCCcHHHH------HHHHHHHHHHHHHHHhCCCcccc
Q 005007 408 --------------------DHLYIYLEYVHPGSINRYVREHCRDITESIV------RNFTRHILNGLAYLHSTNTIHRD 461 (720)
Q Consensus 408 --------------------~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i------~~i~~QIL~gL~yLHs~gIVHRD 461 (720)
..+|||||||+ |+|.+++......+.+... ..++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 34799999998 8999999876555666655 67779999999999999999999
Q ss_pred cCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCC
Q 005007 462 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 541 (720)
Q Consensus 462 IKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~P 541 (720)
|||+||||+.+|.+||+|||+++..... .....||+.|+|||++.+ +...++.++|||||||+||||++|+.|
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNA-----STATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTC-----SEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccC-----CCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999866432 224557799999999952 124678999999999999999999999
Q ss_pred CCCCCcHH--HHHH-----HhccCCCC--CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 542 WSEFEGPQ--AMFK-----VLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 542 F~~~~~~~--~i~k-----i~~~~~~i--P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|....... .... .......+ +..+++++++||.+||+.||++|||+.|+|+||||+...
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 97653211 0000 01112222 247899999999999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=388.07 Aligned_cols=238 Identities=26% Similarity=0.447 Sum_probs=199.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
.++|++++.||+|+||+||+|+++.++..||||++..... .....+++..+.. ..+.+||||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3579999999999999999999999999999999875432 1222333333332 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC---CCeeeeccccchhccCccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~---g~VKL~DFGlA~~~~~~~~ 491 (720)
|||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.. +.+||+|||+++.......
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 999999999999765 679999999999999999999999999999999999999764 5599999999988776666
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~ 567 (720)
....+||+.|+|||++. ..|+.++|||||||++|+|++|++||.+....+.+.++......++ ..+++
T Consensus 195 ~~~~~gt~~y~aPE~l~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR--------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp BCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred ccccCCCcCeeCHHHHc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 66778999999999974 2478899999999999999999999999888888888877655543 35899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999999999999999764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=375.35 Aligned_cols=238 Identities=25% Similarity=0.437 Sum_probs=190.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------C------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------D------ 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------~------ 407 (720)
..++|++++.||+|+||+||+|.+..+|+.||||++......... .++++.+... +
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 356899999999999999999999999999999998654333221 1222222221 1
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
..+||||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3469999999 7999999976 569999999999999999999999999999999999999999999999999998754
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------- 559 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~-------- 559 (720)
.. ....+||++|+|||++.+ ...++.++|||||||++|||++|++||.+.+..+.+.+++....
T Consensus 180 ~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 180 SE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp SS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cc--cCcCcCCCCcCCHHHHhC------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 32 345679999999999974 24588899999999999999999999998777666655532110
Q ss_pred -----------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 -----------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 -----------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+...+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12245689999999999999999999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.12 Aligned_cols=244 Identities=37% Similarity=0.648 Sum_probs=200.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
....++|++++.||+|+||+||+|.+..+|+.||||++..........+++..+.. .++.+|+|||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34567899999999999999999999999999999999865554444444444443 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 999999999998666789999999999999999999999999999999999999999999999999997665432 2345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~iP~~ls~el~d 571 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+..+.... ...+..++.++.+
T Consensus 185 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 185 VIGTPFWMAPEVIQE-------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp CCSCGGGCCHHHHSS-------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cCCCCCccChhhcCC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 679999999999863 457889999999999999999999999877766665554432 2346678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||..||.+|||+.|+|+||||+...
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.59 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=192.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEE-CCCCcEEEEEEeccCCCC----hhHHHHHHHHhh-----------------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDD----PKSAECIKQLEQ-----------------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d-~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~-----------------~~~ 408 (720)
...++|++++.||+|+||+||+|.+ ..+++.||||+++..... ..+.+.++.+.. .++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 3457999999999999999999998 568899999998643211 112233333332 256
Q ss_pred EEEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC----------------
Q 005007 409 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---------------- 471 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---------------- 471 (720)
.+||||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 789999999 899999997653 36899999999999999999999999999999999999987
Q ss_pred ---CCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH
Q 005007 472 ---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548 (720)
Q Consensus 472 ---~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~ 548 (720)
++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-------LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999764432 345679999999999863 45788999999999999999999999887765
Q ss_pred HHHHHHhccCCCC--------------------------------------------CccCCHHHHHHHHHhhhcCCCCC
Q 005007 549 QAMFKVLNRTPPI--------------------------------------------PEMLSSEGKDFLLRCFLRNPVER 584 (720)
Q Consensus 549 ~~i~ki~~~~~~i--------------------------------------------P~~ls~el~dLI~~cL~~dP~kR 584 (720)
+.+..+......+ +...++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 5444432211111 12235778999999999999999
Q ss_pred CCHHHHHcCccccccc
Q 005007 585 PSAVELLEHPFIRNAN 600 (720)
Q Consensus 585 PTa~ELL~Hpff~~~~ 600 (720)
||+.|+|+||||+...
T Consensus 321 pt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 321 ITLREALKHPFFDLLK 336 (339)
T ss_dssp CCHHHHTTSGGGGGGG
T ss_pred cCHHHHhcCHHHHHHh
Confidence 9999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=396.84 Aligned_cols=244 Identities=26% Similarity=0.434 Sum_probs=204.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----C-ChhHHHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----D-DPKSAECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~-~~~~~~~ik~L~~--------------~~~~lyL 412 (720)
..++|+++++||+|+||+||+|+++.+|+.||||++.... . ......++..+.. .++.+||
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999999999999999985321 1 1111222222222 3567999
Q ss_pred EEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
||||++||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999999754 246999999999999999999999999999999999999999999999999999876544
Q ss_pred cc-cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHHHhccCCCCCcc
Q 005007 490 SY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPEM 564 (720)
Q Consensus 490 ~~-~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~ki~~~~~~iP~~ 564 (720)
.. ....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.... ..+....+......+|..
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~ 415 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTT
T ss_pred CcccccccCCccccChhhhcC-------CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcc
Confidence 32 345689999999999963 468899999999999999999999997642 345666677778888999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQ 602 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~ 602 (720)
++.++++||.+||++||.+||+ +++|++||||+...+.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 9999999999999999999996 5899999999986653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=375.86 Aligned_cols=237 Identities=22% Similarity=0.365 Sum_probs=186.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhh----------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQ---------------------- 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~---------------------- 405 (720)
...+|+++++||+|+||+||+|++..+++.||||+++..... ..++++++.+..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 357899999999999999999999999999999998743211 123334444431
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCC---------
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASG--------- 473 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g--------- 473 (720)
....+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 124689999999 56666666543 36799999999999999999999998 999999999999998775
Q ss_pred ----------------------------------------CeeeeccccchhccCccccccccCCCCCCChHHHHHhhhc
Q 005007 474 ----------------------------------------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513 (720)
Q Consensus 474 ----------------------------------------~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~ 513 (720)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~---- 267 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG---- 267 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT----
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC----
Confidence 8999999999766432 345579999999999974
Q ss_pred CCCCCCCccccccchhhhHHHHhcCCCCCCCCCc------HHHHHHH---hcc---------------------------
Q 005007 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG------PQAMFKV---LNR--------------------------- 557 (720)
Q Consensus 514 ~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~------~~~i~ki---~~~--------------------------- 557 (720)
..++.++|||||||+||||++|+.||..... ...+..+ ++.
T Consensus 268 ---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 268 ---SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp ---SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred ---CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 4578899999999999999999999975442 1222222 111
Q ss_pred ------------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 558 ------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 558 ------------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
...++...+.++++||.+||+.||++|||++|+|+||||+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 11123334577899999999999999999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.22 Aligned_cols=241 Identities=25% Similarity=0.438 Sum_probs=198.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--------hhHHHHHHHHhh--------------cCCEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------PKSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--------~~~~~~ik~L~~--------------~~~~ly 411 (720)
++|++++.||+|+||+||+|.+..+|+.||||+++..... ....+++..+.. .++.+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4799999999999999999999999999999998754321 111222222222 256789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC----Ceeeeccccchhcc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHLT 487 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g----~VKL~DFGlA~~~~ 487 (720)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999999765 6799999999999999999999999999999999999998877 89999999998765
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----c
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----E 563 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~ 563 (720)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+......++ .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp --------CCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCCcccccCCCcCccCcceecC-------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 5544456679999999999863 4578899999999999999999999998887777777766555444 4
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
.+++++.+||.+||..||.+|||+.|+|+||||+.....
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 678999999999999999999999999999999875433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=369.50 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=195.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhhc-------------------CC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQV-------------------DD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~~-------------------~~ 408 (720)
....+|+++++||+|+||+||+|++..+++.||||++........ ..++++.+... ..
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 345699999999999999999999999999999999975332221 11222222221 14
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|+||||+. |+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred eEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 6899999997 699999965 4699999999999999999999999999999999999999999999999999986643
Q ss_pred ccc----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC-----
Q 005007 489 LSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----- 559 (720)
Q Consensus 489 ~~~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~----- 559 (720)
... ....+||+.|+|||++.+ ...++.++|||||||++|||++|++||.+....+.+..+.....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHT------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred CCCccccccccccccCCCCCHHhcC------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 321 234579999999999874 34578899999999999999999999988776666555532100
Q ss_pred ---------------------C-----CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 560 ---------------------P-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 560 ---------------------~-----iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
. +...+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 113578999999999999999999999999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=387.89 Aligned_cols=240 Identities=23% Similarity=0.431 Sum_probs=201.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CChhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
.++|+++++||+|+||+||+|.++.+++.||||++.... ......+++..+.. ..+.+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 358999999999999999999999999999999985321 11122223333322 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec---CCCCeeeeccccchhccCccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd---~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.......
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 999999999999765 6799999999999999999999999999999999999995 456899999999988766655
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~ 567 (720)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+....+.+..+......++ ..+++
T Consensus 180 ~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp --CCTTGGGGCCGGGGGS--------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred cCCCcCCCCCCCHHHhCC--------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 567789999999999852 478899999999999999999999999888888888776654432 46899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999999999999999999999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=366.46 Aligned_cols=244 Identities=24% Similarity=0.402 Sum_probs=194.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh----------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ----------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~----------------~~~~lyL 412 (720)
...+|+++++||+|+||+||+|.+..+|+.||||+++...... ...+++..+.. ....+||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3568999999999999999999999999999999987432211 11222222222 1237899
Q ss_pred EEEeccCCCHHHHHHHhcC--CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee----cCCCCeeeeccccchhc
Q 005007 413 YLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHL 486 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~--~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL----d~~g~VKL~DFGlA~~~ 486 (720)
||||++|++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999976432 39999999999999999999999999999999999999 78888999999999887
Q ss_pred cCccccccccCCCCCCChHHHHHhhhc-CCCCCCCccccccchhhhHHHHhcCCCCCCCCC----cHHHHHHHhccCC--
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTP-- 559 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~-~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~----~~~~i~ki~~~~~-- 559 (720)
..........||+.|+|||++...... .....++.++|||||||++|||++|+.||.... ..+.+.+++...+
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 666655677899999999999753211 113568899999999999999999999997533 2445555554332
Q ss_pred -----------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 560 -----------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 560 -----------------------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
.++..++..+.+||.+||+.||++|||++|+|+||-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 122334578899999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=358.63 Aligned_cols=242 Identities=29% Similarity=0.502 Sum_probs=199.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCCCC-------hhHHHHHHHHhh-----------------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDD-------PKSAECIKQLEQ----------------- 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~-~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~----------------- 405 (720)
...++|++++.||+|+||+||+|.+. .+|+.||||+++..... ..+..+++.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34468999999999999999999995 67899999988643211 123444444431
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeecccc
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 482 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGl 482 (720)
.+..+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 1245799999998 69999997643 3499999999999999999999999999999999999999999999999999
Q ss_pred chhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----
Q 005007 483 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---- 558 (720)
Q Consensus 483 A~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---- 558 (720)
++............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+.+++...
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccCCCCccccccccceeCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 987665444556789999999999863 457889999999999999999999999887776666654210
Q ss_pred -----------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 -----------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 -----------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+...++.++++||.+||..||++|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 012345789999999999999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.04 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=191.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh-----------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ-----------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~-----------------~~~~l 410 (720)
..++|+++++||+|+||+||+|.+..+++.||||+++...... .+..+++.+.. .++.+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4579999999999999999999999999999999997432111 12223333321 24678
Q ss_pred EEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHH--hCCCcccccCCCceeec--CCCCeeeeccccchh
Q 005007 411 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLH--STNTIHRDIKGANLLVD--ASGVVKLADFGMAKH 485 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLH--s~gIVHRDIKP~NILLd--~~g~VKL~DFGlA~~ 485 (720)
||||||+. |+|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+++.
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999996 69999997653 56999999999999999999999 57999999999999994 478899999999987
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC---
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 562 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP--- 562 (720)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+.+++......|
T Consensus 211 ~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 211 LGQR--IYQYIQSRFYRSPEVLLG-------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccc--cccccCCccccChHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6432 345679999999999973 4588999999999999999999999998877776666543211000
Q ss_pred ---------------cc----------------------------------------------CCHHHHHHHHHhhhcCC
Q 005007 563 ---------------EM----------------------------------------------LSSEGKDFLLRCFLRNP 581 (720)
Q Consensus 563 ---------------~~----------------------------------------------ls~el~dLI~~cL~~dP 581 (720)
.. ..+++++||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 00 01478999999999999
Q ss_pred CCCCCHHHHHcCcccccc
Q 005007 582 VERPSAVELLEHPFIRNA 599 (720)
Q Consensus 582 ~kRPTa~ELL~Hpff~~~ 599 (720)
++|||++|+|+||||+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSCCHHHHTTSGGGCC-
T ss_pred hhCCCHHHHhcCcccccC
Confidence 999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=367.44 Aligned_cols=244 Identities=30% Similarity=0.470 Sum_probs=187.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-hhHHHHHHHHhhc---------------------CCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQV---------------------DDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-~~~~~~ik~L~~~---------------------~~~l 410 (720)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ....++++.+... ...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 35899999999999999999999999999999988654322 2333444333321 1137
Q ss_pred EEEEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHH--hCCCcccccCCCceeecC-CCCeeeeccccch
Q 005007 411 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLH--STNTIHRDIKGANLLVDA-SGVVKLADFGMAK 484 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLH--s~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~ 484 (720)
++||||+.+ +|...+.. ....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+++
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 899999985 55555442 3467899999999999999999999 999999999999999996 8999999999998
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC------
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 558 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------ 558 (720)
............||+.|+|||++.+ ...++.++|||||||++|||++|+.||........+..+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFG------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCCCCCcccccCCcceeCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 8776666667789999999999863 3458899999999999999999999999887776666554311
Q ss_pred --------------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 559 --------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 559 --------------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
...+...++++++||.+||+.||.+|||+.|+|+||||+......
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 111222568999999999999999999999999999998765443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=366.79 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=192.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-------------~~~~l 410 (720)
...++|++++.||+|+||+||+|.+. +++.||||++........ ++..+..+.. .++.+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34678999999999999999999984 689999999976544432 2233333432 24678
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|||||| .+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++......
T Consensus 85 ~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999995 578999999775 6799999999999999999999999999999999999996 6889999999998765432
Q ss_pred ---ccccccCCCCCCChHHHHHhhhcC----CCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhc--cCCC
Q 005007 491 ---YELSLKGSPNWMAPEVIKAVMQKD----GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLN--RTPP 560 (720)
Q Consensus 491 ---~~~t~~GTp~YmAPEvl~g~~~~~----g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~--~~~~ 560 (720)
.....+||+.|+|||++.+..... ....++.++|||||||++|||++|+.||...... ..+..++. ....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 223567999999999997521110 1246888999999999999999999999875443 44444443 3456
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 561 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 561 iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+|...+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 678889999999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=364.61 Aligned_cols=236 Identities=24% Similarity=0.419 Sum_probs=183.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH---HHHHHHhhc------------------------
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQV------------------------ 406 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~~------------------------ 406 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++......... ++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 47999999999999999999999999999999997544332211 222222211
Q ss_pred -----------------------------------------------CCEEEEEEEeccCCCHHHHHHHhc--CCCcHHH
Q 005007 407 -----------------------------------------------DDHLYIYLEYVHPGSINRYVREHC--RDITESI 437 (720)
Q Consensus 407 -----------------------------------------------~~~lyLVmEy~~gGsL~~~L~~~~--~~Lse~~ 437 (720)
+..+|+|||||+||+|.+++.... ....+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 113899999999999999997642 2345567
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-------------ccccccCCCCCCCh
Q 005007 438 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-------------YELSLKGSPNWMAP 504 (720)
Q Consensus 438 i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-------------~~~t~~GTp~YmAP 504 (720)
++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 89999999999999999999999999999999999999999999998765432 22345799999999
Q ss_pred HHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCC
Q 005007 505 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVE 583 (720)
Q Consensus 505 Evl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~~ls~el~dLI~~cL~~dP~k 583 (720)
|++.+ ..++.++|||||||++|||++|..|+.. ....+..+.... +..+...++++++||.+||+.||++
T Consensus 246 E~~~~-------~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 246 EQIHG-------NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp HHHHC-------CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred HHhcC-------CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 99973 4678999999999999999998776532 112222222221 1122446788999999999999999
Q ss_pred CCCHHHHHcCccccc
Q 005007 584 RPSAVELLEHPFIRN 598 (720)
Q Consensus 584 RPTa~ELL~Hpff~~ 598 (720)
|||+.|+|+||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=359.06 Aligned_cols=246 Identities=29% Similarity=0.563 Sum_probs=181.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH---Hhh--------------cCCEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQ--------------VDDHLYI 412 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~---L~~--------------~~~~lyL 412 (720)
....++|++++.||+|+||+||+|++..+++.||||++..........+..++ +.. .++.+|+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34567999999999999999999999999999999988643221111111111 111 2467899
Q ss_pred EEEeccCCCHHHHHHH-------hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 413 YLEYVHPGSINRYVRE-------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~-------~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999999974 235699999999999999999999999999999999999999999999999999976
Q ss_pred ccCcc------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC
Q 005007 486 LTGLS------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 559 (720)
Q Consensus 486 ~~~~~------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~ 559 (720)
..... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQV------RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHH------HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccc------cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 54321 22345799999999998752 2367899999999999999999999988776666555543322
Q ss_pred ----------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 560 ----------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 560 ----------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.....++.++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 223457899999999999999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=369.72 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=196.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC------CC-hhHHHHHHHHhh--------------cCCEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP------DD-PKSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~------~~-~~~~~~ik~L~~--------------~~~~ly 411 (720)
.++|++++.||+|+||+||+|.+..+++.||||++.... .. ....+++..+.. .++.+|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 458999999999999999999999999999999886321 11 111122222222 256789
Q ss_pred EEEEeccCCCHHHHHHHh---------------------------------------cCCCcHHHHHHHHHHHHHHHHHH
Q 005007 412 IYLEYVHPGSINRYVREH---------------------------------------CRDITESIVRNFTRHILNGLAYL 452 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~---------------------------------------~~~Lse~~i~~i~~QIL~gL~yL 452 (720)
||||||+||+|.+++... ...+++..++.|+.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421 11246888999999999999999
Q ss_pred HhCCCcccccCCCceeecCCC--CeeeeccccchhccCcc-----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccc
Q 005007 453 HSTNTIHRDIKGANLLVDASG--VVKLADFGMAKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 525 (720)
Q Consensus 453 Hs~gIVHRDIKP~NILLd~~g--~VKL~DFGlA~~~~~~~-----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDV 525 (720)
|++||+||||||+||||+.++ .+||+|||+++.+.... ......||+.|+|||++.+ ....++.++||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di 259 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT-----TNESYGPKCDA 259 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC-----SSSCCCTHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc-----CCCCCCcHHHH
Confidence 999999999999999998776 89999999998653321 2245679999999999863 12467889999
Q ss_pred cchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 526 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 526 WSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|||||++|||++|+.||......+.+..++.....++ ..+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999999888888888877655443 24799999999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=354.23 Aligned_cols=239 Identities=27% Similarity=0.494 Sum_probs=196.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhhc------------------C
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQV------------------D 407 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~~------------------~ 407 (720)
......|++.+.||+|+||+||+|.+..++..||+|++.......... +++..+... +
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344567999999999999999999999999999999987544333221 122222221 3
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeec-CCCCeeeeccccch
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGMAK 484 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd-~~g~VKL~DFGlA~ 484 (720)
..+|+||||+++|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 4589999999999999999765 67999999999999999999999999 99999999999997 78999999999997
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---CCC
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPI 561 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---~~i 561 (720)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........+...+... ..+
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred ccccc-ccccccCCcCcCCHHHHh--------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcccc
Confidence 54432 334567999999999875 247889999999999999999999998866655555444332 234
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+..+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 5667899999999999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=385.01 Aligned_cols=243 Identities=28% Similarity=0.468 Sum_probs=188.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-------------ChhHHHHHHHHhh----------cCCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-------------DPKSAECIKQLEQ----------VDDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-------------~~~~~~~ik~L~~----------~~~~ 409 (720)
.++|++++.||+|+||+||+|.++.+++.||||++..... ...++..++.+.+ ..+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 4689999999999999999999999999999999864210 1122333333322 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---Ceeeeccccchhc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~~~ 486 (720)
+||||||+++|+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred eEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 89999999999999988654 6799999999999999999999999999999999999997544 5999999999987
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH-HHHHHhccCCCCC---
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTPPIP--- 562 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~-~i~ki~~~~~~iP--- 562 (720)
.........+||+.|+|||++.+. +...++.++|||||||++|||++|++||....... ....+......++
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp C-----------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred CCCccccccCCCCCccCceeeecC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 666556678899999999997531 13457889999999999999999999998654432 3333344433332
Q ss_pred -ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 -~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++++||.+||+.||++|||++|+|+||||++..
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 45899999999999999999999999999999997644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.49 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=191.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCC-cEEEEEEeccCCCC----hhHHHHHHHHhh-----------------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDD----PKSAECIKQLEQ-----------------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg-~~VAVK~l~~~~~~----~~~~~~ik~L~~-----------------~~~ 408 (720)
...++|++++.||+|+||+||+|.+..++ +.||||+++..... ..+.+.++.+.. ..+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34579999999999999999999998877 68999998643211 112233333332 246
Q ss_pred EEEEEEEeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee------------------
Q 005007 409 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV------------------ 469 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL------------------ 469 (720)
.+||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 789999999 577777776543 569999999999999999999999999999999999999
Q ss_pred -cCCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH
Q 005007 470 -DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548 (720)
Q Consensus 470 -d~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~ 548 (720)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-------LGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999764432 345679999999999963 45788999999999999999999999987766
Q ss_pred HHHHHHhccCCCCCc--------------------------------------------cCCHHHHHHHHHhhhcCCCCC
Q 005007 549 QAMFKVLNRTPPIPE--------------------------------------------MLSSEGKDFLLRCFLRNPVER 584 (720)
Q Consensus 549 ~~i~ki~~~~~~iP~--------------------------------------------~ls~el~dLI~~cL~~dP~kR 584 (720)
+.+..+......+|. ..+.++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 555444322222221 124578899999999999999
Q ss_pred CCHHHHHcCccccccc
Q 005007 585 PSAVELLEHPFIRNAN 600 (720)
Q Consensus 585 PTa~ELL~Hpff~~~~ 600 (720)
||+.|+|+||||+...
T Consensus 326 pt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLT 341 (355)
T ss_dssp CCHHHHTTSGGGGGCC
T ss_pred cCHHHHhcChhhcCCC
Confidence 9999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.07 Aligned_cols=244 Identities=31% Similarity=0.500 Sum_probs=194.0
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------cCCEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------~~~~ly 411 (720)
....++|+++++||+|+||+||+|++..+|+.||||++.......... +++..+.. .++.+|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 344569999999999999999999999999999999987554433221 22222222 256789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-c
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~ 490 (720)
+||||+.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .
T Consensus 101 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999998888887543 67999999999999999999999999999999999999999999999999999865432 2
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC------------
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------ 558 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------------ 558 (720)
......||+.|+|||++.+ ...++.++|||||||++|||++|+.||......+.+..+....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVG------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----CCCCCTTCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCCCcCCccccCcccccC------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 3345679999999999863 3467889999999999999999999999887766655543210
Q ss_pred -------CCCC------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 -------PPIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 -------~~iP------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++ ..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0111 24689999999999999999999999999999997643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.37 Aligned_cols=242 Identities=22% Similarity=0.405 Sum_probs=193.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHH-HHHHHh---hc------------------C
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAE-CIKQLE---QV------------------D 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~-~ik~L~---~~------------------~ 407 (720)
...++|++++.||+|+||+||+|.+..+++.||||+++...... .... ..+++. .. .
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34579999999999999999999999999999999997643222 2111 122221 10 1
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
...||||||++|++|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 1349999999999999999765 679999999999999999999999999999999999999999999999999998664
Q ss_pred Ccc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC-
Q 005007 488 GLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP- 562 (720)
Q Consensus 488 ~~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP- 562 (720)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.......+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG-------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240 (311)
T ss_dssp --------------CCTTCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred ccccccccccccCcCcccCCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence 332 2234569999999999973 4678899999999999999999999998887777766665544332
Q ss_pred ---ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 ---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 ---~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++.+||.+||+.||++||++.++|.|+|++...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 45899999999999999999999999999999997544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=370.07 Aligned_cols=239 Identities=20% Similarity=0.360 Sum_probs=177.5
Q ss_pred CCeEEe---eEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh------------cCCEEEEEEEe
Q 005007 354 SQWQKG---KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~---k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~------------~~~~lyLVmEy 416 (720)
.+|++. +.||+|+||+||+|.++.+|+.||||++..... ...++..++.+.. .++.+||||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 356664 889999999999999999999999999864321 1122223333321 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---CeeeeccccchhccCc-ccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL-SYE 492 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~DFGlA~~~~~~-~~~ 492 (720)
++||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..... ...
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 88 LNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 9999999999765 6799999999999999999999999999999999999998766 8999999999865433 233
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-------HHHHHHHhccCCCCC---
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-------PQAMFKVLNRTPPIP--- 562 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-------~~~i~ki~~~~~~iP--- 562 (720)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+..+......++
T Consensus 167 ~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ-------NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred cccCCCcCccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 45678999999999863 4588999999999999999999999976432 345555665555554
Q ss_pred -ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 -~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 35899999999999999999999999999999998653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=367.71 Aligned_cols=246 Identities=27% Similarity=0.543 Sum_probs=196.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH---Hhh--------------cCCEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQ--------------VDDHLYI 412 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~---L~~--------------~~~~lyL 412 (720)
....++|++++.||+|+||+||+|.+..+++.||+|++.............++ +.. .++.+||
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 34456899999999999999999999999999999999765332222222222 221 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||||++|++|.+++... +.+++..++.|+.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...... .
T Consensus 109 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 186 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 186 (360)
T ss_dssp EECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C
T ss_pred EEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 99999999999999765 6799999999999999999999996 9999999999999999999999999999765432 2
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH-------------------
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF------------------- 552 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~------------------- 552 (720)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 187 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp ----CCCCTTCCHHHHTT-------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccCCCCCCCeECHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 345679999999999863 468899999999999999999999998655433211
Q ss_pred -----------------------HHhcc-CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccCC
Q 005007 553 -----------------------KVLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604 (720)
Q Consensus 553 -----------------------ki~~~-~~~iP-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~l 604 (720)
.+... ...++ ..++.++++||.+||+.||.+|||++|+|+||||+......+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence 11111 12222 347899999999999999999999999999999987665443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=378.51 Aligned_cols=244 Identities=29% Similarity=0.472 Sum_probs=196.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhHHHHHHHHhhc-----------------CCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQV-----------------DDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~~~~ik~L~~~-----------------~~~lyLV 413 (720)
...+|+++++||+|+||+||+|++..+++ ||||++..... ..++.++++.+.+. ...+|+|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 34589999999999999999999988766 88887754332 23345555444321 1237899
Q ss_pred EEeccCCCHHHHHH---HhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec-CCCCeeeeccccchhccCc
Q 005007 414 LEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 414 mEy~~gGsL~~~L~---~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd-~~g~VKL~DFGlA~~~~~~ 489 (720)
|||+.++ |...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.....
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9999865 444432 2346799999999999999999999999999999999999999 7999999999999887666
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-----------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----------- 558 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~----------- 558 (720)
.......||++|+|||++.+ ...|+.++|||||||++|||++|++||.+....+.+..++...
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CCCcccccCcCccCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 66667889999999999863 3468899999999999999999999999887776666554310
Q ss_pred ------CC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccC
Q 005007 559 ------PP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 603 (720)
Q Consensus 559 ------~~------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~~ 603 (720)
.. ++..+++++++||.+||+.||.+|||+.|+|+||||+......
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 01 2334789999999999999999999999999999998765443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=362.23 Aligned_cols=242 Identities=26% Similarity=0.483 Sum_probs=193.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhhc-------------------CC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQV-------------------DD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~~-------------------~~ 408 (720)
...++|++++.||+|+||+||+|.+..+|+.||||+++........ .+++..+... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4567999999999999999999999999999999999643322111 1222222211 25
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 6899999997 699999876 5699999999999999999999999999999999999999999999999999986542
Q ss_pred cc-----------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-
Q 005007 489 LS-----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN- 556 (720)
Q Consensus 489 ~~-----------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~- 556 (720)
.. ......||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+....+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHS------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCccccccchhhccccccccCCeeecc------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 21 1234578999999999863 35688999999999999999999999988776555444321
Q ss_pred --cC---------------------CC--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 557 --RT---------------------PP--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 557 --~~---------------------~~--------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.. .. .+..+++++++||.+||+.||++|||+.|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 10 00 11357899999999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=362.82 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=194.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-------------ChhHHHHHHHHhh----------cCCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-------------DPKSAECIKQLEQ----------VDDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-------------~~~~~~~ik~L~~----------~~~~ 409 (720)
.++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+.++.+.+ ..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3589999999999999999999999999999999864321 1122233333322 1345
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC---eeeeccccchhc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKHL 486 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~---VKL~DFGlA~~~ 486 (720)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 89999999999999999654 67999999999999999999999999999999999999987664 999999999876
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhccCCCC----
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI---- 561 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~~~~i---- 561 (720)
..........||+.|+|||++.+. +...++.++|||||||++|||++|+.||...... .....+......+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHT----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ccccccccccCCcCccCchhhccC----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 554444556799999999998642 1345788999999999999999999999765443 2233333333332
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+..+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 245799999999999999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.45 Aligned_cols=249 Identities=33% Similarity=0.610 Sum_probs=195.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-H---HHHHHHHh-h-----------c------C
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-S---AECIKQLE-Q-----------V------D 407 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~---~~~ik~L~-~-----------~------~ 407 (720)
....++|++++.||+|+||+||+|.+..+|+.||||++........ . ...+..+. + . .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 3456799999999999999999999999999999999875543322 2 22233331 1 0 4
Q ss_pred CEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 408 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
+.+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 5789999999999999999764 356999999999999999999999999999999999999999999999999999766
Q ss_pred cCc-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--CCCc
Q 005007 487 TGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPE 563 (720)
Q Consensus 487 ~~~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--~iP~ 563 (720)
... .......||+.|+|||++.+... ....++.++|||||||++|||++|+.||........+..+..... ..+.
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257 (326)
T ss_dssp -----------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred CcCccccccccCCccccChhhhccccc--cCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence 432 22345679999999999863211 124578899999999999999999999988777666666554332 2345
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 6899999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.98 Aligned_cols=235 Identities=26% Similarity=0.394 Sum_probs=181.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhhc--------------------CC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQV--------------------DD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~~--------------------~~ 408 (720)
.++|++++.||+|+||+||+|++..+++.||||++.......... +++..+... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999999999999999997543332211 222222211 13
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999997 57888885 3599999999999999999999999999999999999999999999999999987765
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC--------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-------- 560 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~-------- 560 (720)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.+++.....
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------CTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccCCceecCCccCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 444556789999999999873 45788999999999999999999999988777766666542111
Q ss_pred --------------C---------Cc-----------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 561 --------------I---------PE-----------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 561 --------------i---------P~-----------~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+ +. ..+.++++||.+||+.||.+|||++|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 00 11568999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=378.81 Aligned_cols=239 Identities=14% Similarity=0.174 Sum_probs=182.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHH---------------HHHhhc-----
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECI---------------KQLEQV----- 406 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~i---------------k~L~~~----- 406 (720)
..++|++++.||+|+||+||+|+++.+|+.||||++..... .... .+++ +.+...
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 35689999999999999999999999999999999864321 1111 1111 111000
Q ss_pred ----C------------C-----EEEEEEEeccCCCHHHHHHHhcCCCcH-------HHHHHHHHHHHHHHHHHHhCCCc
Q 005007 407 ----D------------D-----HLYIYLEYVHPGSINRYVREHCRDITE-------SIVRNFTRHILNGLAYLHSTNTI 458 (720)
Q Consensus 407 ----~------------~-----~lyLVmEy~~gGsL~~~L~~~~~~Lse-------~~i~~i~~QIL~gL~yLHs~gIV 458 (720)
+ + ..||||||+ +|+|.+++... +.+++ ..++.|+.||+.||+|||++||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 0 0 379999999 68999999764 33444 88889999999999999999999
Q ss_pred ccccCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChHHHHHh----hhcCCCCCCCccccccchhhhHHH
Q 005007 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV----MQKDGNPKLALAVDIWSLGCTVIE 534 (720)
Q Consensus 459 HRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~----~~~~g~~~~s~asDVWSLG~vLyE 534 (720)
||||||+||||+.+|.+||+|||+++.... .....+| +.|+|||++.+. ........++.++|||||||+|||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999999986433 3345678 999999999863 001111257889999999999999
Q ss_pred HhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 535 MLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 535 LLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|++|+.||........+..+. ..+..+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999997654433322222 2235688999999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=357.45 Aligned_cols=239 Identities=26% Similarity=0.433 Sum_probs=199.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
..++|++++.||+|+||+||+|.+..+|+.||||+++..... ....+++..+.. .++.+|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 346899999999999999999999999999999999754321 112222333322 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCcccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
|++|++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..... ..
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~ 164 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM 164 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence 99999999999765 679999999999999999999999999999999999999 78899999999999765432 23
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC----CccCCHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----PEMLSSE 568 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i----P~~ls~e 568 (720)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+.+..+......+ +..++++
T Consensus 165 ~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 165 STACGTPGYVAPEVLA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp HHHHSCCCBCCTTTBS-------SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred ccccCCCCccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 4456999999999875 2467899999999999999999999999887777777776654433 3568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+++||.+||..||.+|||++|+|+||||+..
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.66 Aligned_cols=247 Identities=35% Similarity=0.588 Sum_probs=199.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
..++|++++.||+|+||+||+|.+..+++.||+|++....... ....++..+.. .++.+|+|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999999999999999987543221 11222222222 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t 494 (720)
|+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999999999876678999999999999999999999999999999999999999999999999998654221 22234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~d 571 (720)
..||+.|+|||++..... ....++.++|||||||++|||++|+.||........+..+..... ..+..++.++.+
T Consensus 177 ~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETM--KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp --CCGGGCCHHHHHHHHT--TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccCChhhcCCeeeccccC--CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence 679999999999864321 134578899999999999999999999998887777766665433 235678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||..||.+|||+.|+|+||||+...
T Consensus 255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 255 FLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 99999999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=371.99 Aligned_cols=244 Identities=27% Similarity=0.488 Sum_probs=192.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-------------~~~~ly 411 (720)
...+|++++.||+|+||+||+|.+.. ++.||||++........ ++.++..+.. .++.+|
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34579999999999999999999875 99999999976543322 2233334432 246689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
|||| +.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus 133 lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9999 5579999999765 5799999999999999999999999999999999999995 6899999999998765432
Q ss_pred --ccccccCCCCCCChHHHHHhhhc----CCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHhcc--CCCC
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQK----DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNR--TPPI 561 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~----~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~~~--~~~i 561 (720)
.....+||+.|+|||++.+.... .....++.++||||||||||||++|+.||..... ...+..++.. ...+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 23456799999999999742110 0123688999999999999999999999987543 3455555543 3456
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|...+.++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 77789999999999999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.62 Aligned_cols=233 Identities=23% Similarity=0.355 Sum_probs=191.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH---HHHHHhh------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~---~ik~L~~------------~~~~lyLVmEy 416 (720)
..++|++++.||+|+||+||+|++..+|+.||||++........... .++.+.. .++..|+||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 35799999999999999999999999999999999876554443333 3333332 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCccc--
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 9 899999998666789999999999999999999999999999999999999 4889999999999987654322
Q ss_pred ------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhccCCC--
Q 005007 492 ------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRTPP-- 560 (720)
Q Consensus 492 ------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~~~~-- 560 (720)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+..+......
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccCChhhhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 245679999999999873 4578999999999999999999999986432 2333333322222
Q ss_pred ---CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 561 ---IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 561 ---iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++..+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 23568999999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.51 Aligned_cols=239 Identities=32% Similarity=0.558 Sum_probs=200.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-----HHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----SAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-----~~~~ik~L~~--------------~~~~lyLVm 414 (720)
..|++++.||+|+||+||+|.+..+|+.||||++........ ..+++..+.. .++.+||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 469999999999999999999999999999999976433221 1122222222 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence 9997 7888888766678999999999999999999999999999999999999999999999999999766432 35
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC--CCCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--~iP~~ls~el~dL 572 (720)
..||+.|+|||++.+. ....++.++|||||||++|||++|+.||........+..+..... ..+..+++++++|
T Consensus 210 ~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp CCSCGGGCCHHHHHTT----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred ccCCcceeCHhhhccc----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 6799999999998632 134578899999999999999999999998877777766665432 2345789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
|.+||+.||++|||++|+|+|+||....
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999999999997543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=350.12 Aligned_cols=240 Identities=27% Similarity=0.441 Sum_probs=199.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh----------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ----------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~----------------~~~~lyL 412 (720)
.++|++++.||+|+||+||+|.+..+|+.||||++.......... +++..+.. .++.+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999999999999999997654333221 12222221 2467899
Q ss_pred EEEeccCCCHHHHHHHhc---CCCcHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCCceeecCCCCeeeeccccch
Q 005007 413 YLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTN-----TIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIL~gL~yLHs~g-----IVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997542 34999999999999999999999999 9999999999999999999999999998
Q ss_pred hccCcc-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCC
Q 005007 485 HLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIP 562 (720)
Q Consensus 485 ~~~~~~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP 562 (720)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.... ..++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNR-------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHC-------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred eeccccccccccCCCccccChHHhcc-------CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 765432 2234579999999999873 457889999999999999999999999887776666666543 4678
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
..+++++.+||.+||+.||.+||++.|||+|+|+...
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 8899999999999999999999999999999999643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.47 Aligned_cols=239 Identities=39% Similarity=0.636 Sum_probs=201.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...|++++.||+|+||+||+|.+..+++.||||++......... .+++..+.. .++.+|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35799999999999999999999999999999999755432221 222222222 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999999964 579999999999999999999999999999999999999999999999999997765433 2345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI 573 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ....++..++.++.+||
T Consensus 179 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp CCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHH
T ss_pred cCCCcCccCHHHHhc-------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHH
Confidence 679999999999863 4578899999999999999999999998777666665544 34456778999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+||..||.+|||+.|+|+|+||....
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=352.50 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=194.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh---HHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
++|++++.||+|+||+||+|.+..+++.||||+++....... ..+++..+.. .++..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 579999999999999999999999999999999875432221 1122222222 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---cccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYEL 493 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---~~~~ 493 (720)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 9999999998654 56999999999999999999999999999999999999999999999999999765432 2234
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhccCCC--CCccCCHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP--IPEMLSSEGK 570 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~~~~--iP~~ls~el~ 570 (720)
...||+.|+|||++.+ ...++.++|||||||++|||++|+.||...... ..+..+...... ....++++++
T Consensus 166 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 166 KMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp CCCSCGGGCCGGGGTC------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred CCccccCccChHHHhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 5679999999999863 233577899999999999999999999875543 233333333222 2356899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+||.+||..||.+|||+.|+|+|+||+...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.10 Aligned_cols=234 Identities=20% Similarity=0.271 Sum_probs=190.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH---HHHHHHhh------------cCCEEEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQ------------VDDHLYIYLE 415 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~------------~~~~lyLVmE 415 (720)
...++|++++.||+|+||+||+|.+..+|+.||||++.......... ..++.+.. .+...|+|||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 34578999999999999999999999999999999987554433333 33333321 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC-----eeeeccccchhccCcc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-----VKLADFGMAKHLTGLS 490 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~-----VKL~DFGlA~~~~~~~ 490 (720)
|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 99999999876667999999999999999999999999999999999999987776 9999999998765432
Q ss_pred --------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC---cHHHHHHHhccC-
Q 005007 491 --------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRT- 558 (720)
Q Consensus 491 --------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~---~~~~i~ki~~~~- 558 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLG-------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcC-------CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 1345679999999999863 457899999999999999999999998743 333333333221
Q ss_pred -C---CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 559 -P---PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 559 -~---~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
. .+...+++++.+||.+||+.||.+||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1 123468999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.57 Aligned_cols=233 Identities=23% Similarity=0.359 Sum_probs=186.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH---HHHHHHHhh------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---AECIKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~------------~~~~lyLVmEy 416 (720)
..++|++++.||+|+||+||+|.+..+++.||||++......... .++++.+.. .++..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 356899999999999999999999999999999987654443333 333333332 35678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCccc--
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 9 899999998766789999999999999999999999999999999999999 7889999999999987654322
Q ss_pred ------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhccCCCC-
Q 005007 492 ------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRTPPI- 561 (720)
Q Consensus 492 ------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~~~~i- 561 (720)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+.......
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 166 HIPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCCCCCSCCCCSCGGGCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCCCCcccccCCCccccchHHhcC-------CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 235679999999999873 4578999999999999999999999976432 22333333222222
Q ss_pred ----CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 562 ----PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 562 ----P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2567899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.46 Aligned_cols=237 Identities=26% Similarity=0.466 Sum_probs=193.0
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-----------CChhHHHHHHHHh----h---------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----------DDPKSAECIKQLE----Q--------- 405 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-----------~~~~~~~~ik~L~----~--------- 405 (720)
....++|++++.||+|+||+||+|++..+++.||||+++... ....+...+..+. +
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999999999999999986432 1223445555552 1
Q ss_pred --cCCEEEEEEEe-ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec-CCCCeeeeccc
Q 005007 406 --VDDHLYIYLEY-VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFG 481 (720)
Q Consensus 406 --~~~~lyLVmEy-~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd-~~g~VKL~DFG 481 (720)
.++..++|||| +.+++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 24567999999 7899999999775 5799999999999999999999999999999999999999 88999999999
Q ss_pred cchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC
Q 005007 482 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 561 (720)
Q Consensus 482 lA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i 561 (720)
+++...... .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||... ..+......+
T Consensus 186 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~ 252 (312)
T 2iwi_A 186 SGALLHDEP-YTDFDGTRVYSPPEWISR------HQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHF 252 (312)
T ss_dssp SCEECCSSC-BCCCCSCTTTSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCC
T ss_pred hhhhcccCc-ccccCCcccccCceeeec------CCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCC
Confidence 998765433 345679999999999875 234456899999999999999999999753 2344556677
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+..++.++++||.+||+.||++|||++|+|+|+||+...
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 888999999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=360.68 Aligned_cols=237 Identities=28% Similarity=0.498 Sum_probs=199.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----------ChhHHHHHHHHhh-------------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----------DPKSAECIKQLEQ------------- 405 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----------~~~~~~~ik~L~~------------- 405 (720)
....++|+++++||+|+||+||+|.+..+++.||||+++.... ...+...++.+..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456799999999999999999999999999999999864321 1234555555542
Q ss_pred cCCEEEEEEEeccC-CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec-CCCCeeeeccccc
Q 005007 406 VDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMA 483 (720)
Q Consensus 406 ~~~~lyLVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd-~~g~VKL~DFGlA 483 (720)
.++.+++||||+.+ ++|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 24678999999986 8999999765 6799999999999999999999999999999999999999 7899999999999
Q ss_pred hhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc
Q 005007 484 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 563 (720)
Q Consensus 484 ~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~ 563 (720)
+..... ......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.... .+......++.
T Consensus 198 ~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~ 264 (320)
T 3a99_A 198 ALLKDT-VYTDFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 264 (320)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS
T ss_pred cccccc-cccCCCCCccCCChHHhcc------CCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccc
Confidence 876543 2345679999999999975 2345788999999999999999999997532 23445566778
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 8999999999999999999999999999999997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=373.74 Aligned_cols=242 Identities=23% Similarity=0.444 Sum_probs=176.9
Q ss_pred CCeEE-eeEEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCChhHHHHHHHHhh----------------cCCEEEEEE
Q 005007 354 SQWQK-GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQ----------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i-~k~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~~~~~~ik~L~~----------------~~~~lyLVm 414 (720)
+.|.+ +++||+|+||+||+|.++ .+++.||||+++.........+++..+.. .+..+||||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 35776 678999999999999966 57899999999765444444444443332 256789999
Q ss_pred EeccCCCHHHHHHHhc--------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee----cCCCCeeeecccc
Q 005007 415 EYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGM 482 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~--------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL----d~~g~VKL~DFGl 482 (720)
||+. |+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 9997 68888885321 249999999999999999999999999999999999999 6788999999999
Q ss_pred chhccCc----cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---------HH
Q 005007 483 AKHLTGL----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---------PQ 549 (720)
Q Consensus 483 A~~~~~~----~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---------~~ 549 (720)
++.+... ......+||++|+|||++.+ ...++.++||||||||||||++|++||..... .+
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp CC----------------CCCTTCCHHHHTT------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcC------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9876432 22345679999999999873 34588999999999999999999999975433 23
Q ss_pred HHHHHhc---cCCC--------C---------------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005007 550 AMFKVLN---RTPP--------I---------------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELL 591 (720)
Q Consensus 550 ~i~ki~~---~~~~--------i---------------------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL 591 (720)
.+..++. .... + ....++++.+||.+||+.||.+|||++|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 3333321 1100 0 011267899999999999999999999999
Q ss_pred cCccccccccc
Q 005007 592 EHPFIRNANYQ 602 (720)
Q Consensus 592 ~Hpff~~~~~~ 602 (720)
+||||......
T Consensus 333 ~hp~f~~~~~~ 343 (405)
T 3rgf_A 333 QDPYFLEDPLP 343 (405)
T ss_dssp TSGGGTSSSCC
T ss_pred cChhhccCCCC
Confidence 99999875543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=368.17 Aligned_cols=241 Identities=27% Similarity=0.414 Sum_probs=167.9
Q ss_pred CCCCeEEee-EEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHH-HHHhh---------------cCCEEEEEE
Q 005007 352 KKSQWQKGK-LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQ---------------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k-~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~i-k~L~~---------------~~~~lyLVm 414 (720)
..++|++.+ +||+|+||+||+|.++.+|+.||||++............. ..+.. .++.+||||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 456899955 6999999999999999999999999986432111111111 11111 023489999
Q ss_pred EeccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCcc
Q 005007 415 EYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~ 490 (720)
||++||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+++.....
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~- 184 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN- 184 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-
Confidence 9999999999997653 36999999999999999999999999999999999999976 456999999999765432
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHH----HHHhccCCCC----C
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM----FKVLNRTPPI----P 562 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i----~ki~~~~~~i----P 562 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+......+ .
T Consensus 185 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred ccccCCCCcCccChhhhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 2345678999999999863 45778999999999999999999999765443321 1222222222 2
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 46899999999999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.69 Aligned_cols=240 Identities=24% Similarity=0.394 Sum_probs=185.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------------hHHHHHHHHhh-------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------------KSAECIKQLEQ------------- 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------------~~~~~ik~L~~------------- 405 (720)
..++|++++.||+|+||+||+|.+.. |+.||||++....... ...+++..+..
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45799999999999999999999865 9999999886432211 11222222221
Q ss_pred ------cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeec
Q 005007 406 ------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 479 (720)
Q Consensus 406 ------~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~D 479 (720)
....+|+||||+. |+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 1236899999998 789888877666899999999999999999999999999999999999999999999999
Q ss_pred cccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-
Q 005007 480 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT- 558 (720)
Q Consensus 480 FGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~- 558 (720)
||+++............||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+.+..+....
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQ------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp TTC---------------CGGGCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cCcccccccccccceecccceecCcHHhcC------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999987665555556789999999999863 2457889999999999999999999999877666655543210
Q ss_pred -----------------------CC--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 559 -----------------------PP--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 559 -----------------------~~--------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.. .+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01 123468899999999999999999999999999999865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=370.36 Aligned_cols=237 Identities=25% Similarity=0.422 Sum_probs=176.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------------CC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------------DD 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------------~~ 408 (720)
.++|++++.||+|+||+||+|.+..+|+.||||++......... .+++..+... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46999999999999999999999999999999998654332211 1222222221 24
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 579999999 6999999865 5699999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-----------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------- 557 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~----------- 557 (720)
. .....||++|+|||++.+ ...++.++|||||||++|||++|++||.+.+..+.+..++..
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 185 E--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------CCCTTCCHHHHTT------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred c--CCCcCcCcCccChHHHcC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 2 345679999999999863 346888999999999999999999999987776665554321
Q ss_pred ------------CCCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 ------------TPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 ------------~~~iP--------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
....+ ..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 01111 24688999999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=356.15 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=199.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-----C-ChhHHHHHHHHhh----------------cCCEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----D-DPKSAECIKQLEQ----------------VDDHL 410 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-----~-~~~~~~~ik~L~~----------------~~~~l 410 (720)
.++|++++.||+|+||.||+|.+..+++.||||+++... . .....+++..+.. ..+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999986421 0 1111222222222 13468
Q ss_pred EEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 411 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
|+||||+.++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 77777653 356999999999999999999999999999999999999999999999999999865422
Q ss_pred ---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCC
Q 005007 490 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS 566 (720)
Q Consensus 490 ---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls 566 (720)
.......||+.|+|||++.+. ...++.++|||||||++|||++|+.||......+.+..+......++..++
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGL-----DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG 237 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCC-----SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred ccccccccCCCCCCCcChhhccCc-----ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence 223356699999999998631 233577999999999999999999999988877777888888888899999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+++.+||.+||..||.+|||+.|+|+|+||+...
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.46 Aligned_cols=241 Identities=27% Similarity=0.450 Sum_probs=188.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh------------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ------------------------ 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~------------------------ 405 (720)
..++|++++.||+|+||+||+|.+..+|+.||||++...... ....+++..+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 457999999999999999999999999999999998753211 011122222221
Q ss_pred ----cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec-CCCCeeeecc
Q 005007 406 ----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADF 480 (720)
Q Consensus 406 ----~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd-~~g~VKL~DF 480 (720)
..+.+|+||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 1256899999998 699999964 5699999999999999999999999999999999999997 5679999999
Q ss_pred ccchhccCc----cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc
Q 005007 481 GMAKHLTGL----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 556 (720)
Q Consensus 481 GlA~~~~~~----~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~ 556 (720)
|+++..... .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||......+.+..+..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHC------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccCCCcccccccccccccccccCcHHhcC------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999865432 12234567999999999873 24688899999999999999999999998877666665543
Q ss_pred cCCC------------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 557 RTPP------------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 557 ~~~~------------------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
..+. ++..++.++++||.+||+.||++|||++|+|+||||+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 3211 12357899999999999999999999999999999986554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.63 Aligned_cols=238 Identities=23% Similarity=0.431 Sum_probs=199.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh----hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~----~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|++++.||+|+||+||+|.+..+++.||||++....... ...+++..+.. ..+.+|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 58999999999999999999999999999999986432211 12223333332 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC---CCeeeeccccchhccCcccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~---g~VKL~DFGlA~~~~~~~~~ 492 (720)
|+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.........
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 99999999998765 579999999999999999999999999999999999999764 47999999999877655444
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSE 568 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~e 568 (720)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+......++ ..++++
T Consensus 181 ~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp SCHHHHHTTCCHHHHTT--------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred ccccCcccccChHHhcC--------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 55668999999999853 378899999999999999999999998877777777766544332 468999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+.+||.+||..||++|||+.|+|+||||+...
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.55 Aligned_cols=246 Identities=28% Similarity=0.485 Sum_probs=181.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHH----Hhh--------------cCCEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQ--------------VDDHLYIY 413 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~----L~~--------------~~~~lyLV 413 (720)
..++|++++.||+|+||+||+|.++.+|+.||||++..........+.+.. +.. .++.+|||
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 456899999999999999999999999999999999765433322222221 111 25678999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
|||+ ++.+..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.........
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 9999 5677777665567899999999999999999999995 9999999999999999999999999999876655545
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC-cHHHHHHHhccCC-CCC--ccCCHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLNRTP-PIP--EMLSSE 568 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~-~~~~i~ki~~~~~-~iP--~~ls~e 568 (720)
....||+.|+|||++.+... ....++.++|||||||++|||++|+.||.... ..+.+..+..... .++ ..++.+
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDP--TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259 (318)
T ss_dssp -----CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred cccCCCccccChhhcccccc--cccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence 56679999999999853111 12457889999999999999999999998743 4445555554432 333 357999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=349.09 Aligned_cols=238 Identities=25% Similarity=0.461 Sum_probs=190.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-H----HHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-S----AECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~----~~~ik~L~~--------------~~~~lyL 412 (720)
..++|++++.||+|+||+||+|.+..+++.||||++........ . .+++..+.. .++.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35689999999999999999999999999999999865433222 1 112222221 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
||||++|++|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999999765 679999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-----CCccC
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-----IPEML 565 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~-----iP~~l 565 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+........+.+..... ++..+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG-------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp -------CCSSCCHHHHHT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred ccCccccCccccCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 2234679999999999974 45788999999999999999999999988777766666554322 34568
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
++.+.++|.+||.+||.+||+..+.+.+.|..
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999999999555555555554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.69 Aligned_cols=236 Identities=25% Similarity=0.462 Sum_probs=192.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEE-----ECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-------------c
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-------------V 406 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~-----d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-------------~ 406 (720)
...++|++++.||+|+||+||+|. +..+++.||||+++....... +++.+..+.. .
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 345799999999999999999998 566779999999975433222 2223333311 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcC-------------------------------------------------------
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCR------------------------------------------------------- 431 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~------------------------------------------------------- 431 (720)
++.+++|||||.||+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3448999999999999999976422
Q ss_pred ----------CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc---ccccccCC
Q 005007 432 ----------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGS 498 (720)
Q Consensus 432 ----------~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---~~~t~~GT 498 (720)
.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 18999999999999999999999999999999999999999999999999998654322 22345678
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHHHHHH
Q 005007 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLR 575 (720)
Q Consensus 499 p~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el~dLI~~ 575 (720)
+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+.+...+. .....|..+++++.++|.+
T Consensus 259 ~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 259 LKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp GGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred ceeEChhhhcC-------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 99999999974 457899999999999999998 9999988765555544443 3556788899999999999
Q ss_pred hhhcCCCCCCCHHHHHcC
Q 005007 576 CFLRNPVERPSAVELLEH 593 (720)
Q Consensus 576 cL~~dP~kRPTa~ELL~H 593 (720)
||+.||.+|||+.|+++|
T Consensus 332 ~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCCCHHHHHHH
Confidence 999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.66 Aligned_cols=232 Identities=24% Similarity=0.327 Sum_probs=188.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHH-hh-----------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQL-EQ-----------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L-~~-----------~~~~lyLVmEy 416 (720)
...+|++++.||+|+||+||+|.+..+|+.||||++....... .+.++++.+ .. .++..||||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 3568999999999999999999999999999999987554333 334444555 21 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC-----eeeeccccchhccCccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-----VKLADFGMAKHLTGLSY 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~-----VKL~DFGlA~~~~~~~~ 491 (720)
+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||+++.+.....
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9 99999999876678999999999999999999999999999999999999998887 99999999987644322
Q ss_pred --------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhccCCC
Q 005007 492 --------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRTPP 560 (720)
Q Consensus 492 --------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~~~~ 560 (720)
.....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+... .+.+..+......
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLG-------KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred CccccccccCCcCCCccccChHHHcC-------CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 245779999999999873 4578999999999999999999999987433 2333444332222
Q ss_pred CC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 561 IP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 561 iP-----~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+ ..++ ++.+||..||..||.+||++.+|++
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22 2244 9999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=357.32 Aligned_cols=235 Identities=26% Similarity=0.418 Sum_probs=193.4
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~l 410 (720)
....+|+++++||+|+||+||+|.+..++. .||||+++......... +++..+.. .++.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 445799999999999999999999986665 49999997543322222 22222222 24568
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
||||||++||+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999999998766789999999999999999999999999999999999999999999999999998764332
Q ss_pred c----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 491 Y----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 491 ~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ....+..
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAF-------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred cceeeccCCCCcccccCHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence 1 122346778999999975 457889999999999999999 99999988887777776654 4566788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++++.+||.+||..||++|||+.||++
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.99 Aligned_cols=237 Identities=26% Similarity=0.471 Sum_probs=193.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeccCCCChh------HHHHHHHH-hh----------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPK------SAECIKQL-EQ---------- 405 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~-------~tg~~VAVK~l~~~~~~~~------~~~~ik~L-~~---------- 405 (720)
....++|++++.||+|+||+||+|.+. .++..||||+++....... +.++++.+ .+
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344578999999999999999999875 3556799999975432221 12222223 11
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
.++.+||||||+.||+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 2456899999999999999997643 248899999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.+|.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999986644322 233457889999999973 468899999999999999999 99999988
Q ss_pred CcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 546 EGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 546 ~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+.+..+... ...+|..++.++.+||.+||+.||.+|||+.|++++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777666665544 456788899999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=342.06 Aligned_cols=235 Identities=23% Similarity=0.391 Sum_probs=197.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...++|++++.||+|+||+||+|.+. +++.||||++........ ..+++..+.. .++.+|+|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 34568999999999999999999987 477899999976543322 2233333332 2456899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YEL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~ 493 (720)
|+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 999999999998766779999999999999999999999999999999999999999999999999998664432 223
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....|..+++++.+
T Consensus 166 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp STTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CcccccccCCHHHhcC-------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 4457788999999974 457889999999999999999 99999988887777777654 45567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcC
Q 005007 572 FLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~H 593 (720)
+|.+||+.||++|||+.|+++|
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.00 Aligned_cols=241 Identities=39% Similarity=0.685 Sum_probs=192.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEEecc
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLEYVH 418 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmEy~~ 418 (720)
+|....+||+|+||+||+|.+..+++.||||++...... ....+++..+.. .++.+++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556999999999999999999999999998754321 112223333322 2567899999999
Q ss_pred CCCHHHHHHHhcC--CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchhccCcc-cccc
Q 005007 419 PGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 419 gGsL~~~L~~~~~--~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
+++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++...... ....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence 9999999976533 4678999999999999999999999999999999999987 8999999999998765422 2345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHH-HHH--HhccCCCCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFK--VLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~-i~k--i~~~~~~iP~~ls~el~d 571 (720)
..||+.|+|||++.+.. ..++.++|||||||++|||++|+.||........ +.. .......++..+++++.+
T Consensus 183 ~~~~~~y~aPE~~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGP-----RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp CCCCGGGCCHHHHHHGG-----GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred cCCCccccChhhhcCCC-----CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 67999999999997521 2367899999999999999999999976544332 222 234456778889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
||.+||+.||++|||+.|+|+|+||+...
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=361.29 Aligned_cols=236 Identities=26% Similarity=0.445 Sum_probs=188.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------CC------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------DD------ 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------~~------ 408 (720)
.++|++++.||+|+||+||+|.++.+|+.||||++......... .+++..+... .+
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46999999999999999999999999999999999754433221 1222222221 11
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|+||||+. ++|.+++. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 2399999997 78888773 4599999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------- 558 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------- 558 (720)
. .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..++...
T Consensus 197 ~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 197 E--MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----CTTCCCTTSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred C--cCCcccCccccCHHHhcC------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 2 345678999999999863 3468889999999999999999999999877766665554211
Q ss_pred -------------CC--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 -------------PP--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 -------------~~--------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.. ++..+++++++||.+||+.||++|||+.|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00 1235689999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=352.95 Aligned_cols=235 Identities=26% Similarity=0.440 Sum_probs=186.2
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------cCCEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------~~~~l 410 (720)
......+|++++.||+|+||+||+|.+ +|+.||||++.......... +++..+.. .++.+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 344567999999999999999999987 48899999987654433321 22222222 24568
Q ss_pred EEEEEeccCCCHHHHHHHhc--CCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCCeeeeccccchhc
Q 005007 411 YIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997542 23999999999999999999999999 999999999999999999999999999765
Q ss_pred cCcc-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh--ccCCCCCc
Q 005007 487 TGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPE 563 (720)
Q Consensus 487 ~~~~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~--~~~~~iP~ 563 (720)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+. .....+|.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRD-------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262 (309)
T ss_dssp ------------CCTTSCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred cccccccccCCCCccccChhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 4332 2345679999999999863 457889999999999999999999999887777666653 34567788
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+++++.+||.+||..||.+|||+.|+++
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.93 Aligned_cols=238 Identities=22% Similarity=0.382 Sum_probs=186.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhhc---------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQV--------------------- 406 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~~--------------------- 406 (720)
...+|++++.||+|+||+||+|.+..+++.||||++...... ..+...++.+...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 456999999999999999999999999999999998643211 1223333333310
Q ss_pred -----CCEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeec------CCC
Q 005007 407 -----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVD------ASG 473 (720)
Q Consensus 407 -----~~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd------~~g 473 (720)
...+++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ ||+||||||+||||+ ..+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 11689999999 89999999764 34599999999999999999999998 999999999999994 344
Q ss_pred CeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc------
Q 005007 474 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG------ 547 (720)
Q Consensus 474 ~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~------ 547 (720)
.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 176 ~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred eEEEcccccccccCCC--CCCCCCCccccCcHHHhC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 8999999999766432 234579999999999974 4578899999999999999999999976432
Q ss_pred HHHHHHHh------------------------------------------ccCCCCCccCCHHHHHHHHHhhhcCCCCCC
Q 005007 548 PQAMFKVL------------------------------------------NRTPPIPEMLSSEGKDFLLRCFLRNPVERP 585 (720)
Q Consensus 548 ~~~i~ki~------------------------------------------~~~~~iP~~ls~el~dLI~~cL~~dP~kRP 585 (720)
...+..+. .....++..++.++++||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 22222221 112234455678899999999999999999
Q ss_pred CHHHHHcCcccccc
Q 005007 586 SAVELLEHPFIRNA 599 (720)
Q Consensus 586 Ta~ELL~Hpff~~~ 599 (720)
|++|+|+||||+..
T Consensus 327 t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 DAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHhhChhhhcc
Confidence 99999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=356.37 Aligned_cols=237 Identities=26% Similarity=0.403 Sum_probs=193.7
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcE----EEEEEeccCCC------ChhHHHHHHHHhh----------cCCE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPD------DPKSAECIKQLEQ----------VDDH 409 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~----VAVK~l~~~~~------~~~~~~~ik~L~~----------~~~~ 409 (720)
....++|+++++||+|+||+||+|.+..+++. ||+|.+..... ...+...+..+.+ .++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS 88 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCc
Confidence 34567999999999999999999999988876 77776643221 1222333333322 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+++||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 89999999999999999876567999999999999999999999999999999999999999999999999999876543
Q ss_pred c---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 490 S---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 490 ~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
. ......||..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....|..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHF-------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI 241 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT
T ss_pred cccccccCCCCcccccChHHhcc-------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc
Confidence 2 2234567889999999975 457899999999999999999 99999987776666665543 4566778
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++.++.+||.+||..||.+|||+.|++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.66 Aligned_cols=237 Identities=25% Similarity=0.392 Sum_probs=183.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-hHHHHHHHHhhc--------------------------
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQV-------------------------- 406 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-~~~~~ik~L~~~-------------------------- 406 (720)
++|++++.||+|+||+||+|++..+|+.||||++....... ...+++..+...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 47999999999999999999999999999999986421111 111222222211
Q ss_pred -CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 407 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 407 -~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.+.+|+||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 3467999999999999999987666788999999999999999999999999999999999999999999999999976
Q ss_pred ccCc---------------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC-CcHH
Q 005007 486 LTGL---------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQ 549 (720)
Q Consensus 486 ~~~~---------------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~-~~~~ 549 (720)
.... .......||+.|+|||++.+ ...++.++|||||||++|||++ ||... +...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG------TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTS------CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccC------CCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 5421 12234569999999999863 3457889999999999999998 55432 2233
Q ss_pred HHHHHhccCCC----CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 550 AMFKVLNRTPP----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 550 ~i~ki~~~~~~----iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
.+..+...... ++..++..+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 33444443333 344567889999999999999999999999999999754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.44 Aligned_cols=245 Identities=22% Similarity=0.399 Sum_probs=177.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChhH----HHHHHHHhhc--------------CCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKS----AECIKQLEQV--------------DDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------~~~ 409 (720)
...++|++++.||+|+||+||+|.+..++. .||||+++........ .+++..+... .+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999887775 8999998754322221 1222222221 112
Q ss_pred ------EEEEEEeccCCCHHHHHHHhc-----CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 410 ------LYIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 410 ------lyLVmEy~~gGsL~~~L~~~~-----~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
.++||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 389999999999999996542 159999999999999999999999999999999999999999999999
Q ss_pred ccccchhccCcccc---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHH
Q 005007 479 DFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554 (720)
Q Consensus 479 DFGlA~~~~~~~~~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki 554 (720)
|||+++........ ....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+....+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred eccccccccccccccccccccCcccccCchhhcC-------CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999876443222 23446788999999975 457899999999999999999 99999988887777776
Q ss_pred hcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCC-------HHHHHcCccccccccc
Q 005007 555 LNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPS-------AVELLEHPFIRNANYQ 602 (720)
Q Consensus 555 ~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPT-------a~ELL~Hpff~~~~~~ 602 (720)
... ....+..+++++.+||.+||+.||++||| ++++++|+|+......
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 654 45667889999999999999999999999 7788899999765544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.25 Aligned_cols=236 Identities=25% Similarity=0.419 Sum_probs=194.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVm 414 (720)
....++|++++.||+|+||+||+|.+. ++..||||+++....... ..++++.+.. .++.+|+||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 445679999999999999999999876 577899999976543322 2233333332 246689999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
||+.+++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... .
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999999987667799999999999999999999999999999999999999999999999999987644321 2
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 570 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~ 570 (720)
....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....|..+++++.
T Consensus 179 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251 (283)
T ss_dssp TSTTSCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cCCccCcccCCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence 23456788999999985 357889999999999999998 99999988887777777655 4456778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcC
Q 005007 571 DFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+||.+||+.||.+|||+.|+|+|
T Consensus 252 ~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 252 TIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=361.58 Aligned_cols=241 Identities=24% Similarity=0.423 Sum_probs=198.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------------------hhHHHHHHHHhh-------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------------PKSAECIKQLEQ------- 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------------------~~~~~~ik~L~~------- 405 (720)
..++|++++.||+|+||+||+|.+ +|+.||||++...... ....+++..+..
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 346999999999999999999998 8999999988632111 222233333332
Q ss_pred -------cCCEEEEEEEeccCCCHHHH------HHHh-cCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeec
Q 005007 406 -------VDDHLYIYLEYVHPGSINRY------VREH-CRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVD 470 (720)
Q Consensus 406 -------~~~~lyLVmEy~~gGsL~~~------L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd 470 (720)
.++.+|+||||+++|+|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+||||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 25689999999999999998 5432 4679999999999999999999999 9999999999999999
Q ss_pred CCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCc-cccccchhhhHHHHhcCCCCCCCCCc-H
Q 005007 471 ASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL-AVDIWSLGCTVIEMLTGKPPWSEFEG-P 548 (720)
Q Consensus 471 ~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~-asDVWSLG~vLyELLTGk~PF~~~~~-~ 548 (720)
.++.+||+|||++...... ......||+.|+|||++.+ ...++. ++|||||||++|||++|+.||..... .
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcC------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999876443 3345679999999999863 224444 99999999999999999999988766 6
Q ss_pred HHHHHHhccCCCCC-------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 549 QAMFKVLNRTPPIP-------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 549 ~~i~ki~~~~~~iP-------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
+.+..+......+| ..++.++.+||.+||+.||.+|||+.|+|+||||+...+
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 66666666666666 568999999999999999999999999999999986543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=363.50 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=194.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEE-----ECCCCcEEEEEEeccCCCChhHHH---HHHHHhh--------------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAE---CIKQLEQ--------------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~-----d~~tg~~VAVK~l~~~~~~~~~~~---~ik~L~~--------------~~~ 408 (720)
...++|++++.||+|+||+||+|. +..+++.||||+++.......... ++..+.. .++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 345689999999999999999999 456788999999865433222222 2222222 245
Q ss_pred EEEEEEEeccCCCHHHHHHHhc------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC---Ceeeec
Q 005007 409 HLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLAD 479 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g---~VKL~D 479 (720)
..|||||||.||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+| .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 6799999999999999998653 3589999999999999999999999999999999999999555 599999
Q ss_pred cccchhccCc---cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHh
Q 005007 480 FGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 555 (720)
Q Consensus 480 FGlA~~~~~~---~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~ 555 (720)
||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++ |..||......+.+..+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999865322 22234568999999999975 458889999999999999998 999999888777777666
Q ss_pred cc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 556 NR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 556 ~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
.. ....+..++.++.+||.+||+.||.+|||+.||+++.++-
T Consensus 301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 54 4566788999999999999999999999999999987764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=345.09 Aligned_cols=237 Identities=25% Similarity=0.451 Sum_probs=185.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChhH---HHHHHHHhh-------------cCCEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKS---AECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~~---~~~ik~L~~-------------~~~~l 410 (720)
....++|++++.||+|+||+||+|.+..+ +..||||.++........ .+++..+.. .++.+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 90 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence 44567999999999999999999998754 457999988754322211 122222222 24567
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999999998766679999999999999999999999999999999999999999999999999998765433
Q ss_pred cc--ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 491 YE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 491 ~~--~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||......+.+..+... ...++..++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 243 (281)
T ss_dssp --------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred ccccccCCCcccccChhhccc-------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCC
Confidence 22 23456788999999974 457889999999999999996 99999988777777666543 456778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+++.+||.+||..||++|||+.|++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.11 Aligned_cols=235 Identities=26% Similarity=0.442 Sum_probs=196.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
...++|++++.||+|+||+||+|.+. ++..||||+++....... ..+++..+.. .++.+|+|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 34579999999999999999999876 577899999976543332 2223333322 2456899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--cc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--EL 493 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~~ 493 (720)
|+++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 9999999999988766799999999999999999999999999999999999999999999999999986644322 22
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....|..+++++.+
T Consensus 164 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHY-------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp SCCCCGGGCCHHHHHH-------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CCCcCcccCCHHHHhc-------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 3446778999999975 347789999999999999999 99999988887777776654 34557778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcC
Q 005007 572 FLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~H 593 (720)
+|.+||+.||.+|||+.|++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.94 Aligned_cols=237 Identities=24% Similarity=0.443 Sum_probs=195.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCC-------CcEEEEEEeccCCCChh------HHHHHHHH-hh----------
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPK------SAECIKQL-EQ---------- 405 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~t-------g~~VAVK~l~~~~~~~~------~~~~ik~L-~~---------- 405 (720)
....++|++++.||+|+||+||+|.+..+ +..||||+++....... +++.++.+ ..
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44567999999999999999999997543 35799999975533221 22223333 11
Q ss_pred -cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 406 -VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 406 -~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
.++.+||||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 2456899999999999999998753 359999999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999998664432 2234457889999999973 568899999999999999999 99999988
Q ss_pred CcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 546 EGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 546 ~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+....+... ....+..+++++.+||.+||+.||++|||+.|++++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777766666544 556778899999999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=352.59 Aligned_cols=236 Identities=22% Similarity=0.394 Sum_probs=194.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~ 408 (720)
...++|++++.||+|+||+||+|.+. .+++.||||+++........ .+++..+.. .++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34579999999999999999999987 45689999998754322111 122222222 246
Q ss_pred EEEEEEEeccCCCHHHHHHHhc-----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 005007 409 HLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~ 465 (720)
.+||||||+++|+|.+++.... ..+++..++.|+.||++||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 6899999999999999997642 56999999999999999999999999999999999
Q ss_pred ceeecCCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCC
Q 005007 466 NLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 541 (720)
Q Consensus 466 NILLd~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~P 541 (720)
||||+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-------CCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999999999998764332 2234567899999999975 357889999999999999999 9999
Q ss_pred CCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 542 WSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 542 F~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
|.+....+.+..+... ...+|..++.++.+||.+||+.||.+||++.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9988877777766654 346788899999999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.78 Aligned_cols=236 Identities=25% Similarity=0.419 Sum_probs=188.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------C------C
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------D------D 408 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------~------~ 408 (720)
..+|++++.||+|+||+||+|.++.+|+.||||++......... .+++..+... . .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999999999999999999754333221 1222222221 1 1
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 3599999997 68887763 3599999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc-----------
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------- 557 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~----------- 557 (720)
. .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 179 ~--~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 179 E--MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------CCSBCCSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred C--ccccccCcCcCCHHHHhC------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 2 235678999999999863 246788999999999999999999999887766555444321
Q ss_pred --------------------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 --------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 --------------------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
...++..+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 1122346789999999999999999999999999999998653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=361.83 Aligned_cols=237 Identities=25% Similarity=0.432 Sum_probs=195.5
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC------ChhHHHHHHHHhh-----------cCCEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------DPKSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~------~~~~~~~ik~L~~-----------~~~~ly 411 (720)
.....++|++++.||+|+||+||+|.++.+++.||||+++.... ...+.+.++.+.+ .++.+|
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34456799999999999999999999999999999999874321 1122223322221 245689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||||+++|+|.++++.....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999999987766799999999999999999999999999999999999999999999999999986543322
Q ss_pred cc---cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCC
Q 005007 492 EL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566 (720)
Q Consensus 492 ~~---t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls 566 (720)
.. ...+++.|+|||++.+ ..++.++|||||||+||||++ |..||......+....+.. ...+.|..++
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNY-------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred eecCCCCCCCcCcCCHhHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 11 1224677999999974 357889999999999999998 9999998877666655543 3456788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++.+||.+||+.||++|||+.+|++
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.70 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=196.3
Q ss_pred CCCCCCCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhHH---HHHHHHhh-----------
Q 005007 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ----------- 405 (720)
Q Consensus 345 ~~~~~~~~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~----------- 405 (720)
..+......++|++++.||+|+||+||+|.+. .+++.||||+++......... +++..+..
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 34445566789999999999999999999983 456899999997543222111 22222222
Q ss_pred ---cCCEEEEEEEeccCCCHHHHHHHhc-----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcc
Q 005007 406 ---VDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIH 459 (720)
Q Consensus 406 ---~~~~lyLVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVH 459 (720)
.++.+|+||||+.+|+|.+++.... ..+++..++.++.||++||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 2456899999999999999997642 23899999999999999999999999999
Q ss_pred cccCCCceeecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHh
Q 005007 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 536 (720)
Q Consensus 460 RDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELL 536 (720)
|||||+||||+.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIV 246 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHH
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-------CCcCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999986643321 223457888999999975 45788999999999999999
Q ss_pred c-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 537 T-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 537 T-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+ |+.||...........+... ....+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 247 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9 99999987776666555543 456678899999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.28 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=174.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHh---h---------------cCCEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---Q---------------VDDHLY 411 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~---~---------------~~~~ly 411 (720)
....++|++++.||+|+||+||+|.++.+|+.||||+++.........+.+.++. . .++.+|
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 3445799999999999999999999999999999999976543332222222211 1 256789
Q ss_pred EEEEeccCCCHHHHHHH----hcCCCcHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 412 IYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~----~~~~Lse~~i~~i~~QIL~gL~yLHs~-gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
|||||+. |+|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++..
T Consensus 98 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999998 588888753 246799999999999999999999999 9999999999999999999999999999877
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH-HHHHHHhcc-CCCCC--
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR-TPPIP-- 562 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~-~~i~ki~~~-~~~iP-- 562 (720)
..........||+.|+|||++.... ....++.++|||||||++|||++|+.||...... +.+..+... ...++
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSA---SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred ccccccccCCCCccccCceeecccc---CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 6544444557999999999985311 1245788999999999999999999999865432 222222222 22222
Q ss_pred --ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 563 --EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 563 --~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
..+++++.+||.+||..||++|||+.|+|+||||.....
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 358899999999999999999999999999999976543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.56 Aligned_cols=236 Identities=28% Similarity=0.448 Sum_probs=188.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
..++|+++++||+|+||+||+|.+..+++.||||++....... ...+++..+.. .++.+|+|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 3569999999999999999999999999999999885422111 11122222222 2577899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc---
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--- 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~--- 492 (720)
|+.||+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999999999886678999999999999999999999999999999999999999999999999999765432211
Q ss_pred ------------ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH-----HHHHHh
Q 005007 493 ------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-----AMFKVL 555 (720)
Q Consensus 493 ------------~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~-----~i~ki~ 555 (720)
....||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ......
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMING-------RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred cccccccccccccccCCCcceeCHHHhcC-------CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 25679999999999863 567889999999999999999999986532211 111111
Q ss_pred ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 556 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 556 ~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
. ...+..+++++.+||.+||+.||++|||+.|+++ |++.
T Consensus 241 ~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 241 D--RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp H--HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred c--ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 1 2346678899999999999999999999999987 5543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.13 Aligned_cols=235 Identities=28% Similarity=0.447 Sum_probs=186.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEE----EEEEeccCCCChh---HHHHHHHHhh-------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPK---SAECIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~V----AVK~l~~~~~~~~---~~~~ik~L~~-------------~~~~ly 411 (720)
...+|+++++||+|+||+||+|++..+++.| |+|.+........ ..+++..+.. .++..+
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 4568999999999999999999998887765 7776653322111 1222222222 134578
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 99999999999999988777899999999999999999999999999999999999999999999999999987654332
Q ss_pred c---ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 492 E---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 492 ~---~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
. ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp -------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred cccccCCCccccccChHHhcc-------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCC
Confidence 2 23456889999999985 457899999999999999999 99999987766655555433 456677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.++.+||.+||+.||.+||++.|++++
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=352.70 Aligned_cols=233 Identities=18% Similarity=0.254 Sum_probs=187.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC--------CcEEEEEEeccCCCChhHHHHHHHHhh------------------
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRET--------GASCAIKEVDIIPDDPKSAECIKQLEQ------------------ 405 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~t--------g~~VAVK~l~~~~~~~~~~~~ik~L~~------------------ 405 (720)
..++|++++.||+|+||+||+|++..+ ++.||||++........+.+.+..+..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 357999999999999999999999884 889999999765443444444443321
Q ss_pred ---------cCCEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC--
Q 005007 406 ---------VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-- 473 (720)
Q Consensus 406 ---------~~~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-- 473 (720)
.++.+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~ 198 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS 198 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEE
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCc
Confidence 157899999999 99999999764 36799999999999999999999999999999999999999998
Q ss_pred CeeeeccccchhccCcc--------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC
Q 005007 474 VVKLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 545 (720)
Q Consensus 474 ~VKL~DFGlA~~~~~~~--------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~ 545 (720)
.+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-------CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99999999997664322 1234579999999999863 46889999999999999999999999875
Q ss_pred C-cHHHHHHHh----ccCCCCC------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 E-GPQAMFKVL----NRTPPIP------EMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~-~~~~i~ki~----~~~~~iP------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
. ....+.... .....++ ..+++++.+||.+||..||.+|||++||++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 333333222 2222222 246899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.15 Aligned_cols=235 Identities=26% Similarity=0.413 Sum_probs=184.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCCh--hHHHHHHHHhhc----------------CC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDP--KSAECIKQLEQV----------------DD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~~----------------~~ 408 (720)
...++|++++.||+|+||+||+|+ +..+++.||||++....... ...+++..+... ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 456799999999999999999998 66789999999987432111 111222222221 24
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+++||||+++|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 57999999999999999987666799999999999999999999999999999999999999999999999999987644
Q ss_pred cc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH----------------
Q 005007 489 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---------------- 548 (720)
Q Consensus 489 ~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---------------- 548 (720)
.. ......|+..|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-------CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 32 1223446778999999975 45789999999999999999999998642211
Q ss_pred HHHHHHh-ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 549 QAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 549 ~~i~ki~-~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.....+. ......|..+++++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111111 2345667889999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=339.92 Aligned_cols=235 Identities=23% Similarity=0.386 Sum_probs=191.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---------hHHHHHHHHhhc------------CCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------KSAECIKQLEQV------------DDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---------~~~~~ik~L~~~------------~~~ 409 (720)
...++|++.+.||+|+||+||+|++..+++.||||++....... ...+++..+... .+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34579999999999999999999999999999999986543321 112233333321 222
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCC-----eeeecccc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGV-----VKLADFGM 482 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~-----VKL~DFGl 482 (720)
.++||||+++|+|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 96 PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 37999999999999999877678999999999999999999999999 999999999999988776 99999999
Q ss_pred chhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHH--HHHHh--ccC
Q 005007 483 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--MFKVL--NRT 558 (720)
Q Consensus 483 A~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~--i~ki~--~~~ 558 (720)
++.... ......||+.|+|||++.+ ....++.++|||||||++|||++|+.||........ ...+. ...
T Consensus 176 ~~~~~~--~~~~~~g~~~y~aPE~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 176 SQQSVH--SVSGLLGNFQWMAPETIGA-----EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CBCCSS--CEECCCCCCTTSCGGGSSC-----SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred cccccc--cccccCCCccccCchhhcc-----CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 975443 2345679999999998742 134578899999999999999999999987654333 23332 234
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 559 ~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..++..+++++.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5677889999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.84 Aligned_cols=237 Identities=24% Similarity=0.426 Sum_probs=191.8
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCC---h---hHHHHHHHH-hh-----------c
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDD---P---KSAECIKQL-EQ-----------V 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~---~---~~~~~ik~L-~~-----------~ 406 (720)
....++|++++.||+|+||+||+|.+ ..++..||||++...... . .+...+..+ .+ .
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34457999999999999999999997 346678999998743221 1 223333444 21 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcC----------------------CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCR----------------------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 464 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~----------------------~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP 464 (720)
++.+||||||+++|+|.+++..... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4568999999999999999976432 378999999999999999999999999999999
Q ss_pred CceeecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCC
Q 005007 465 ANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 540 (720)
Q Consensus 465 ~NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~ 540 (720)
+||||+.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||||++ |..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-------CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999986643322 223457889999999974 457889999999999999998 999
Q ss_pred CCCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 541 PWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 541 PF~~~~~~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
||.+......+..++.. ....+..+++++.+||.+||..||.+|||+.|+++|
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99887766666555543 445677899999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.69 Aligned_cols=247 Identities=27% Similarity=0.483 Sum_probs=190.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-------HHHHHHHHhh-------------cCCE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------SAECIKQLEQ-------------VDDH 409 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-------~~~~ik~L~~-------------~~~~ 409 (720)
....++|++++.||+|+||+||+|.+. +++.||||++........ ++..+..+.. .++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 345678999999999999999999986 589999999976543322 2333344432 2467
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+||||| +.+++|.+++... ..+++..++.|+.||++||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 899999 5579999999765 6799999999999999999999999999999999999995 589999999999876433
Q ss_pred cc---cccccCCCCCCChHHHHHhhhc----CCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-HHHHHHHhc--cCC
Q 005007 490 SY---ELSLKGSPNWMAPEVIKAVMQK----DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLN--RTP 559 (720)
Q Consensus 490 ~~---~~t~~GTp~YmAPEvl~g~~~~----~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~-~~~i~ki~~--~~~ 559 (720)
.. .....||+.|+|||++.+.... .....++.++|||||||++|||++|+.||..... ...+..+.. ...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 21 2345799999999998642110 0123688899999999999999999999987543 334444443 234
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 ~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.++...+.++.+||.+||..||.+||++.|+|+||||+...
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 56777899999999999999999999999999999997543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.09 Aligned_cols=234 Identities=19% Similarity=0.309 Sum_probs=181.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeccCCCC-hhHHHHHHHHhh------------c------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDD-PKSAECIKQLEQ------------V------ 406 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~t-----g~~VAVK~l~~~~~~-~~~~~~ik~L~~------------~------ 406 (720)
...++|+++++||+|+||+||+|.+..+ ++.||||++...... ..+.+.+..+.. .
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999998765 588999998653211 111112221110 0
Q ss_pred ------------CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec--CC
Q 005007 407 ------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--AS 472 (720)
Q Consensus 407 ------------~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd--~~ 472 (720)
...+||||||+ |++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 13479999999 9999999987767899999999999999999999999999999999999999 88
Q ss_pred CCeeeeccccchhccCcccc--------ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC
Q 005007 473 GVVKLADFGMAKHLTGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 544 (720)
Q Consensus 473 g~VKL~DFGlA~~~~~~~~~--------~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~ 544 (720)
+.+||+|||+++.+...... ....||+.|||||++.+ ..++.++|||||||+||||++|+.||.+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-------VAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-------CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999999766433211 34559999999999863 4588999999999999999999999985
Q ss_pred CCcHHHHHHHhc--cCC---------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 545 FEGPQAMFKVLN--RTP---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 545 ~~~~~~i~ki~~--~~~---------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
............ ... ..+..+++++.+||..||..||.+||++.+|++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 332222221110 000 112467899999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.35 Aligned_cols=237 Identities=25% Similarity=0.443 Sum_probs=190.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCCCChh------HHHHHHHHhh----------cCCEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPK------SAECIKQLEQ----------VDDHL 410 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~---tg~~VAVK~l~~~~~~~~------~~~~ik~L~~----------~~~~l 410 (720)
....++|++++.||+|+||+||+|.+.. ++..||||.+........ +...++.+.+ .++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 87 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 87 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence 4456799999999999999999998654 345699999875432211 1222222321 14557
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 89999999999999998776779999999999999999999999999999999999999999999999999998765432
Q ss_pred c--cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCC
Q 005007 491 Y--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566 (720)
Q Consensus 491 ~--~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls 566 (720)
. .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+.. .....+..++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINF-------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240 (281)
T ss_dssp -----CCCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred ccccccCCCCcceeCchhhcc-------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence 2 223457889999999974 457889999999999999998 9999987766665555543 3456678899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+++.++|.+||..||.+|||+.|++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=370.21 Aligned_cols=233 Identities=23% Similarity=0.363 Sum_probs=191.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHH---HHHhh------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~i---k~L~~------------~~~~lyLVmEy 416 (720)
..++|+++++||+|+||+||+|++..+++.||||+++..........++ +.+.. ..+..||||||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 3579999999999999999999999999999999887655444433333 33332 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee---cCCCCeeeeccccchhccCccc--
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL---d~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+.....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 9 899999998766789999999999999999999999999999999999999 6889999999999987654322
Q ss_pred ------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhccC----
Q 005007 492 ------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRT---- 558 (720)
Q Consensus 492 ------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~~---- 558 (720)
.....||+.|+|||++.+ ..++.++||||||||||||++|+.||.+... .+.+.++....
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred ccccccccccCCCccccCHHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 225679999999999873 4588999999999999999999999987543 23333332211
Q ss_pred -CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 559 -PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 559 -~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..++..+++++.+||.+||..||++||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1223567899999999999999999999998765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.70 Aligned_cols=236 Identities=25% Similarity=0.469 Sum_probs=191.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCChh------HHHHHHHHhh-------------c
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPK------SAECIKQLEQ-------------V 406 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-------------~ 406 (720)
...++|++++.||+|+||+||+|.+ ..+++.||||+++....... +...+..+.. .
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3457999999999999999999985 45778999999975433221 2222333311 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCC---------------CcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 471 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~---------------Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~ 471 (720)
++.+|+||||+++|+|.+++...... +++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 34589999999999999999764322 899999999999999999999999999999999999999
Q ss_pred CCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCc
Q 005007 472 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 547 (720)
Q Consensus 472 ~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~ 547 (720)
++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-------ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999986543221 234557889999999974 457889999999999999998 9999987765
Q ss_pred HHHHHHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 548 PQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 548 ~~~i~ki~--~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+...+ ......+..+++++.++|.+||+.||.+|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55444433 23456678899999999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=343.60 Aligned_cols=238 Identities=24% Similarity=0.407 Sum_probs=195.0
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------c
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------V 406 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~ 406 (720)
.....++|++++.||+|+||+||+|.++ .+++.||||++.......... +++..+.. .
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3445679999999999999999999876 467889999987543322222 22222222 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 456899999999999999997542 45789999999999999999999999999999999999999999999
Q ss_pred eccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHH
Q 005007 478 ADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 553 (720)
Q Consensus 478 ~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~k 553 (720)
+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhcc-------CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 99999986643321 223456889999999974 457889999999999999999 8999998877777666
Q ss_pred Hhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 554 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 554 i~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+... ....+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6544 456678899999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=341.15 Aligned_cols=237 Identities=25% Similarity=0.458 Sum_probs=181.6
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh-------------cCCEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~-------------~~~~ly 411 (720)
.+....+|+++++||+|+||+||+|.+.. .||||+++......... +++..+.. ..+.++
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccE
Confidence 35556799999999999999999998653 59999998665444322 22222322 245679
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC---
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--- 488 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~--- 488 (720)
+||||+.|++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999999976667799999999999999999999999999999999999999999999999999976543
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC------CCCC
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------PPIP 562 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~------~~iP 562 (720)
........||+.|+|||++... ....++.++|||||||++|||++|+.||......+.+..++... ..++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQ----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp --------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccCCCccccCchhhccc----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 2223346799999999998521 12457889999999999999999999998877766665554322 1234
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..+++++.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 568899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.19 Aligned_cols=234 Identities=24% Similarity=0.409 Sum_probs=191.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEE--EEEEeccCCCC---hhHHHHHHHHhh---------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASC--AIKEVDIIPDD---PKSAECIKQLEQ---------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~V--AVK~l~~~~~~---~~~~~~ik~L~~---------------~~~~lyL 412 (720)
.++|++++.||+|+||+||+|.+..++..+ |||.++..... ....+++..+.. .++.+||
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 468999999999999999999999988865 99988743221 112223333322 2567899
Q ss_pred EEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 413 YLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 999999999999997642 36999999999999999999999999999999999999999999999
Q ss_pred eccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc
Q 005007 478 ADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 556 (720)
Q Consensus 478 ~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~ 556 (720)
+|||+++............+++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+..
T Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred cccCcCccccccccccCCCCCccccChhhhcc-------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 99999975543333344567899999999974 357889999999999999998 9999998877776666654
Q ss_pred c-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 ~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
. ....+..+++++++||.+||..||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4 455677889999999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.55 Aligned_cols=233 Identities=21% Similarity=0.355 Sum_probs=189.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCC-------cEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDD 408 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg-------~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~ 408 (720)
..++|++++.||+|+||+||+|.+..++ ..||+|++....... ...+++..+.. .++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4568999999999999999999998877 469999986432211 11222233322 245
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC--------eeeecc
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--------VKLADF 480 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~--------VKL~DF 480 (720)
..|+||||+.||+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 679999999999999999876566999999999999999999999999999999999999998887 999999
Q ss_pred ccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC
Q 005007 481 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP 560 (720)
Q Consensus 481 GlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~ 560 (720)
|++...... ....||+.|+|||++.+ ...++.++|||||||++|||++|..|+..................
T Consensus 166 g~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 166 GISITVLPK---DILQERIPWVPPECIEN------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp CSCTTTSCH---HHHHHTTTTSCHHHHHC------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred cccccccCc---cccCCcCcccCHHHhCC------CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 999765432 23458899999999973 245788999999999999999955444444444455555666777
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 561 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 561 iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 788889999999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=370.36 Aligned_cols=239 Identities=15% Similarity=0.201 Sum_probs=185.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------hHHHHHHHHhh-------------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQ------------------- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------~~~~~ik~L~~------------------- 405 (720)
...|+++++||+|+||+||+|.+..+|+.||||++....... ++..+++.+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346999999999999999999999999999999887332211 11111111110
Q ss_pred -------------c------CCEEEEEEEeccCCCHHHHHHH------hcCCCcHHHHHHHHHHHHHHHHHHHhCCCccc
Q 005007 406 -------------V------DDHLYIYLEYVHPGSINRYVRE------HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460 (720)
Q Consensus 406 -------------~------~~~lyLVmEy~~gGsL~~~L~~------~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHR 460 (720)
. ...++++|+++ +++|.++++. ....+++..+..++.||++||+|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 0 12357777776 5899999852 13458888999999999999999999999999
Q ss_pred ccCCCceeecCCCCeeeeccccchhccCccccccccCCCCCCChHHHHHhhh--cC-CCCCCCccccccchhhhHHHHhc
Q 005007 461 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ--KD-GNPKLALAVDIWSLGCTVIEMLT 537 (720)
Q Consensus 461 DIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~--~~-g~~~~s~asDVWSLG~vLyELLT 537 (720)
||||+||||+.++.+||+|||+++..... ....+| +.|||||++.+... .. ....++.++|||||||+||||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999998765433 345678 99999999964310 00 23457889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 538 GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 538 Gk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|+.||......+....++... ..+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus 313 g~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFRSC----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGSSC----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCCCcchhhhHHHHHhhc----ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999998765544433333322 3578999999999999999999999999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=342.02 Aligned_cols=236 Identities=23% Similarity=0.448 Sum_probs=192.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCCCCh------hHHHHHHHH-hh-----------cC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDP------KSAECIKQL-EQ-----------VD 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d-----~~tg~~VAVK~l~~~~~~~------~~~~~ik~L-~~-----------~~ 407 (720)
...++|++++.||+|+||+||+|.+ ..+++.||||+++...... .+...+..+ .+ .+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456899999999999999999985 4578899999997543321 122233333 11 24
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcC-----------------CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCR-----------------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 470 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~-----------------~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd 470 (720)
+..|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 567999999999999999976532 489999999999999999999999999999999999999
Q ss_pred CCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCC
Q 005007 471 ASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 546 (720)
Q Consensus 471 ~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~ 546 (720)
.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999987654322 223456889999999974 457899999999999999999 999998876
Q ss_pred cHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 547 GPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 547 ~~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
....+..++.. ....+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 65555555433 344567789999999999999999999999999974
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=334.76 Aligned_cols=230 Identities=30% Similarity=0.559 Sum_probs=180.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh--------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~--------------~~~~ly 411 (720)
...+|++.++||+|+||+||+|.+. |+.||||+++...... ...++++.+.. .++.+|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 4569999999999999999999975 8999999886543221 11122222222 245689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC---CcccccCCCceeecC--------CCCeeeecc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN---TIHRDIKGANLLVDA--------SGVVKLADF 480 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g---IVHRDIKP~NILLd~--------~g~VKL~DF 480 (720)
+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999853 57999999999999999999999999 899999999999986 778999999
Q ss_pred ccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--C
Q 005007 481 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--T 558 (720)
Q Consensus 481 GlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~ 558 (720)
|+++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... .
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRA-------SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp CC--------------CCGGGSCHHHHHH-------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 9998665432 235579999999999975 45788999999999999999999999988877766666544 3
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 559 ~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..++..+++++.+||.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 45678899999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.33 Aligned_cols=234 Identities=23% Similarity=0.391 Sum_probs=195.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..++|++++.||+|+||+||+|.+. ++..||||++........ ..+++..+.. .++.+|+||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 4568999999999999999999987 578899999976543322 2223333322 24568999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--cccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELS 494 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~~t 494 (720)
+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 99999999998776779999999999999999999999999999999999999999999999999998764322 1223
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dL 572 (720)
..|++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....|..++.++.++
T Consensus 165 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 165 TKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp TTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccChhhhcC-------CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 457888999999974 357889999999999999999 99999988777777776654 345577789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcC
Q 005007 573 LLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~H 593 (720)
|.+||+.||++|||+.|++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=346.46 Aligned_cols=238 Identities=26% Similarity=0.466 Sum_probs=192.7
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeccCCCChh------HHHHHHHH-hh---------
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPK------SAECIKQL-EQ--------- 405 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~-------~tg~~VAVK~l~~~~~~~~------~~~~ik~L-~~--------- 405 (720)
.....++|++++.||+|+||+||+|.+. .++..||||+++....... +.+.++.+ ..
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3455679999999999999999999976 4678899999875433221 22223333 11
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCcee
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NIL 468 (720)
.++.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 2456899999999999999997643 24899999999999999999999999999999999999
Q ss_pred ecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCC
Q 005007 469 VDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 544 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~ 544 (720)
|+.++.+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-------CCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 99999999999999986654321 233457889999999975 357889999999999999999 9999998
Q ss_pred CCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 545 FEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 545 ~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
....+....+... ....+..++.++.+||.+||..||.+|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 263 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776666555543 456778899999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.79 Aligned_cols=237 Identities=26% Similarity=0.452 Sum_probs=188.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCC----cEEEEEEeccCCCChhHHH---HHHHHhh--------------cCC
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAE---CIKQLEQ--------------VDD 408 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg----~~VAVK~l~~~~~~~~~~~---~ik~L~~--------------~~~ 408 (720)
.....+|++.++||+|+||+||+|.+..++ ..||||+++.......... ++..+.. ..+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 445679999999999999999999987653 4599999875433222222 2222222 246
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+||||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 78999999999999999987667899999999999999999999999999999999999999999999999999987643
Q ss_pred ccc----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCC
Q 005007 489 LSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 562 (720)
Q Consensus 489 ~~~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP 562 (720)
... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ....+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISY-------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272 (333)
T ss_dssp -----------CCCGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccCCCCccccccCchhccc-------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc
Confidence 221 122346788999999873 467889999999999999999 99999988777776666554 45567
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+++++.+||.+||+.||.+||++.|++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.45 Aligned_cols=233 Identities=24% Similarity=0.458 Sum_probs=191.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhHHHHHHHHhhc--------------------------
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQV-------------------------- 406 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~~~~ik~L~~~-------------------------- 406 (720)
.+|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+..+.+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 579999999999999999999999999999999975432 12223333333210
Q ss_pred -CCEEEEEEEeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 407 -DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 407 -~~~lyLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 23379999999999999999754 3579999999999999999999999999999999999999999999999999998
Q ss_pred hccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCcc
Q 005007 485 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM 564 (720)
Q Consensus 485 ~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ 564 (720)
............||+.|+|||++.+ ..++.++|||||||++|||++|..||... ......+. ...++..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~--~~~~~~~ 239 (284)
T 2a19_B 171 SLKNDGKRTRSKGTLRYMSPEQISS-------QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR--DGIISDI 239 (284)
T ss_dssp ESSCCSCCCCCCSCCTTSCHHHHHC-------SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH--TTCCCTT
T ss_pred eccccccccccCCcccccChhhhcc-------CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh--ccccccc
Confidence 7766555556779999999999873 45788999999999999999999887532 12222222 2345677
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
++.++++||.+||..||.+|||+.|+++|.+.-
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 899999999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.57 Aligned_cols=235 Identities=27% Similarity=0.432 Sum_probs=187.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEE----EEEEeccCCCChh---HHHHHHHHhh-------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPK---SAECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~V----AVK~l~~~~~~~~---~~~~ik~L~~-------------~~~~l 410 (720)
....+|+++++||+|+||+||+|.+..+++.| |+|.+........ ..+++..+.. ..+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCc
Confidence 34579999999999999999999999888765 6666643322222 2223333332 13457
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
++||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 89999999999999998877789999999999999999999999999999999999999999999999999998764332
Q ss_pred c---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccC
Q 005007 491 Y---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 565 (720)
Q Consensus 491 ~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~l 565 (720)
. .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244 (327)
T ss_dssp --------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred ccccccCCCccccccCHHHHcC-------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence 2 223446788999999985 457889999999999999999 99999987776666555443 45667789
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.++.+||.+||..||.+||++.|+++
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999997
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.24 Aligned_cols=233 Identities=23% Similarity=0.332 Sum_probs=177.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCCCCh-hHHHHHHH------------Hhh---------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDP-KSAECIKQ------------LEQ--------- 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~---tg~~VAVK~l~~~~~~~-~~~~~ik~------------L~~--------- 405 (720)
...++|++++.||+|+||+||+|.+.. ++..||||++....... .+...+.. +..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345799999999999999999999987 78899999887543211 11111111 111
Q ss_pred -----c----CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC--C
Q 005007 406 -----V----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG--V 474 (720)
Q Consensus 406 -----~----~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g--~ 474 (720)
. ++.+||||||+ |++|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 1 46789999999 99999999765 4799999999999999999999999999999999999998887 9
Q ss_pred eeeeccccchhccCcc--------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC-
Q 005007 475 VKLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF- 545 (720)
Q Consensus 475 VKL~DFGlA~~~~~~~--------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~- 545 (720)
+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-------VALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999997664321 1145679999999999874 45889999999999999999999999642
Q ss_pred CcHHHHHHHh-ccCCCCCc---------cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 EGPQAMFKVL-NRTPPIPE---------MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~~~~~i~ki~-~~~~~iP~---------~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.....+.... .....+|. .+++++++||.+||..||++||++++|++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 265 KDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp TCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2222222211 11122222 68899999999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=337.31 Aligned_cols=236 Identities=25% Similarity=0.452 Sum_probs=196.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVm 414 (720)
.....+|++.+.||+|+||+||+|.+..++..||||++........ ..+++..+.. .++.+|+||
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4456789999999999999999999999999999999975433221 1122222222 246689999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999999999999764 34599999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
.....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+... ....+..+++++
T Consensus 169 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp ETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccCCccccCcCChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 223456889999999975 357889999999999999999 99999887776666555543 456678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||.+||..||.+|||+.|+++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.01 Aligned_cols=235 Identities=25% Similarity=0.413 Sum_probs=186.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCChh---HHHHHHHHhhc----------------C
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK---SAECIKQLEQV----------------D 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~~~---~~~~ik~L~~~----------------~ 407 (720)
....+|++++.||+|+||+||+|+ +..+++.||||+++....... ..+++..+... .
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 345679999999999999999998 677899999999875432221 12223333221 2
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
+.+|+||||+++|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 55899999999999999997776789999999999999999999999999999999999999999999999999998765
Q ss_pred Ccc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC--------------CcHH
Q 005007 488 GLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--------------EGPQ 549 (720)
Q Consensus 488 ~~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~--------------~~~~ 549 (720)
... ......||..|+|||++.+ ..++.++|||||||++|||++|..||... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ-------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC-------CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 432 2234568888999999975 45778999999999999999999986421 1111
Q ss_pred HHHHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 550 AMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 550 ~i~ki~--~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+...+ ......+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 222222 2345667889999999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.09 Aligned_cols=235 Identities=27% Similarity=0.489 Sum_probs=188.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCC---cEEEEEEeccCCCChhHH---HHHHHHhh---------------cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSA---ECIKQLEQ---------------VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg---~~VAVK~l~~~~~~~~~~---~~ik~L~~---------------~~~~ 409 (720)
....+|+++++||+|+||+||+|.+..++ ..||||.++......... +++..+.. .++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 34458999999999999999999976433 468999887644322222 22222221 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
.|+||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 79999999999999999876677999999999999999999999999999999999999999999999999999866433
Q ss_pred cc-----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCC
Q 005007 490 SY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 562 (720)
Q Consensus 490 ~~-----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP 562 (720)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||......+....+... ....|
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred chhccccccCCCCCccccChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 21 223457889999999975 457889999999999999999 77888777666666665544 44557
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
..+++++.++|.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.68 Aligned_cols=232 Identities=25% Similarity=0.451 Sum_probs=192.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh---------------cCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------VDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------~~~~lyLVm 414 (720)
....++|++++.||+|+||+||+|.+. |+.||||+++.........+++..+.. .++.+||||
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 345678999999999999999999875 789999999865443333334443332 133689999
Q ss_pred EeccCCCHHHHHHHhcC-CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||.+|+|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 344 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 344 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--cc
Confidence 99999999999987643 3799999999999999999999999999999999999999999999999999854332 22
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...++..|+|||++.+ ..++.++|||||||+||||++ |+.||......+.+..+..+ ....|..+++++.+
T Consensus 345 ~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 345 TGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --CCCTTTSCHHHHHS-------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CCCCCcceeCHHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 3467899999999973 468899999999999999998 99999987776666666543 55678889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHc
Q 005007 572 FLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~ 592 (720)
||.+||..||.+|||+.+|++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.50 Aligned_cols=232 Identities=16% Similarity=0.287 Sum_probs=190.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHH-HHHHh---h--------------c--CCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLE---Q--------------V--DDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~-ik~L~---~--------------~--~~~l 410 (720)
...++|++++.||+|+||+||+|.+. ++.||||+++.........+. .+++. . . .+.+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 34568999999999999999999985 889999999865544333222 22211 1 1 2568
Q ss_pred EEEEEeccCCCHHHHHHHhcC-CCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 411 YIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
++||||+++|+|.+++..... .+++..++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999976533 5899999999999999999999999 9999999999999999999999998876533
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc--CCCCCccC
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEML 565 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--~~~iP~~l 565 (720)
. ....||+.|+|||++.+.. ...++.++|||||||++|||++|+.||......+....+... ...+|..+
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3kmu_A 165 S----PGRMYAPAWVAPEALQKKP----EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236 (271)
T ss_dssp C----TTCBSCGGGSCHHHHHSCG----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTC
T ss_pred c----cCccCCccccChhhhccCC----CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCC
Confidence 2 3456899999999997421 122345899999999999999999999988877776666543 55678889
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++++.++|.+||+.||++|||++|+++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.00 Aligned_cols=236 Identities=25% Similarity=0.416 Sum_probs=193.3
Q ss_pred CCCCeEEee-EEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCChhHH---HHHHHHhh-------------cCCEEEE
Q 005007 352 KKSQWQKGK-LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k-~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~-------------~~~~lyL 412 (720)
..++|.+.+ .||+|+||+||+|.++ .++..||||+++......... +++..+.. ..+.+|+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~l 86 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 86 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEE
Confidence 446777776 9999999999999864 468889999997643222111 22222222 2456899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~- 491 (720)
||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999999999976666799999999999999999999999999999999999999999999999999987643221
Q ss_pred ---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 492 ---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 492 ---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
.....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ...+|..++
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred eeccccccccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 123456889999999974 357889999999999999998 99999988777776666544 456788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHP 594 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hp 594 (720)
+++.+||.+||..||.+||++.|++++.
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=354.40 Aligned_cols=235 Identities=25% Similarity=0.427 Sum_probs=181.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~---~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~l 410 (720)
....+|+++++||+|+||+||+|+++ .++..||||+++......... +++..+.+ .++.+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34568999999999999999999887 467789999997543322211 22222222 24568
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
||||||+++|+|.+++.+....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999999998776689999999999999999999999999999999999999999999999999998765432
Q ss_pred c----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 491 Y----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 491 ~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
. .....+++.|+|||++.+ ..++.++|||||||+||||++ |+.||......+.+..+... ....+..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 274 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAY-------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274 (373)
T ss_dssp ------------CTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred ccceeccCCCcCCCccChhhhcc-------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 1 112335788999999974 457889999999999999998 99999988777666666543 3455677
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.++.+||.+||+.||.+||++.|+++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=359.48 Aligned_cols=242 Identities=23% Similarity=0.396 Sum_probs=190.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh----------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ----------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~----------------~~~~lyL 412 (720)
...+|+++++||+|+||+||+|.+..+|+.||||+++...... ...+++..+.. ....+||
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3568999999999999999999999999999999987432111 11222222222 1236899
Q ss_pred EEEeccCCCHHHHHHHhc--CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee----cCCCCeeeeccccchhc
Q 005007 413 YLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHL 486 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL----d~~g~VKL~DFGlA~~~ 486 (720)
|||||+||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999999997542 239999999999999999999999999999999999999 77888999999999887
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcC-CCCCCCccccccchhhhHHHHhcCCCCCCCC----CcHHHHHHHhccCCC-
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKD-GNPKLALAVDIWSLGCTVIEMLTGKPPWSEF----EGPQAMFKVLNRTPP- 560 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~-g~~~~s~asDVWSLG~vLyELLTGk~PF~~~----~~~~~i~ki~~~~~~- 560 (720)
..........||+.|+|||++.+..... ....++.++|||||||++|||++|+.||... ...+.+.+++.+.+.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 6666566778999999999987521100 0124677999999999999999999999643 344566666544321
Q ss_pred ------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 561 ------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 561 ------------------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++..++..+.+||.+||+.||++||++.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 113345678899999999999999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.21 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=189.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEE-----ECCCCcEEEEEEeccCCCChhHHH---HHHHHhh--------------cCC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAE---CIKQLEQ--------------VDD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~-----d~~tg~~VAVK~l~~~~~~~~~~~---~ik~L~~--------------~~~ 408 (720)
...++|++++.||+|+||+||+|+ +..++..||||++........... ++..+.. .++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 345799999999999999999998 567889999999864432222222 2222221 245
Q ss_pred EEEEEEEeccCCCHHHHHHHhc------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeec
Q 005007 409 HLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLAD 479 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~D 479 (720)
.+||||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 6799999999999999998653 34899999999999999999999999999999999999984 44699999
Q ss_pred cccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHh
Q 005007 480 FGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 555 (720)
Q Consensus 480 FGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~ 555 (720)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+.
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 99998654322 2234567999999999974 357889999999999999998 999999877766666655
Q ss_pred cc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 556 NR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 556 ~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
.. ....+..++.++.+||.+||+.||.+||++.|+++|.|+-
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 43 4566778999999999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.05 Aligned_cols=237 Identities=25% Similarity=0.422 Sum_probs=190.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCChh--HHHHHHHHhh----------------cC
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK--SAECIKQLEQ----------------VD 407 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~~~--~~~~ik~L~~----------------~~ 407 (720)
....++|++++.||+|+||+||+|+ +..+++.||||++........ ..+++..+.. .+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3456799999999999999999998 567899999999875422111 1222222222 24
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
+.+||||||+++++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 56899999999999999998766679999999999999999999999999999999999999999999999999998664
Q ss_pred Ccc----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH--------------H
Q 005007 488 GLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--------------Q 549 (720)
Q Consensus 488 ~~~----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~--------------~ 549 (720)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-------NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred cCCccceeeccCCccccccCHHHhcc-------CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 332 2223457888999999975 45788999999999999999999998643221 1
Q ss_pred HHHHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 550 AMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 550 ~i~ki~--~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+...+ ......+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222 23455677899999999999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.22 Aligned_cols=232 Identities=25% Similarity=0.445 Sum_probs=185.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh---------------cCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------VDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------~~~~lyLVm 414 (720)
....++|++++.||+|+||+||+|.+. |+.||||+++.........+++..+.. .++.+|+||
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 344579999999999999999999875 889999998755433333333333332 134689999
Q ss_pred EeccCCCHHHHHHHhcC-CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 172 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 172 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--c
Confidence 99999999999976432 38999999999999999999999999999999999999999999999999997654322 2
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 571 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~d 571 (720)
...+++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..+++++.+
T Consensus 173 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 173 TGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred CCCccccccCHHHhCC-------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHH
Confidence 3467899999999974 457889999999999999998 99999987776666666543 45667889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHc
Q 005007 572 FLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~ 592 (720)
+|.+||..||.+|||+.|+++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.63 Aligned_cols=237 Identities=23% Similarity=0.426 Sum_probs=192.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCc-----EEEEEEeccCCCCh------hHHHHHHHH-hh-----------c
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDP------KSAECIKQL-EQ-----------V 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~-----~VAVK~l~~~~~~~------~~~~~ik~L-~~-----------~ 406 (720)
....++|++++.||+|+||+||+|.+..++. .||||.+....... .+...+..+ .+ .
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3446799999999999999999999987665 79999987543221 122233333 11 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHh-------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC
Q 005007 407 DDHLYIYLEYVHPGSINRYVREH-------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 473 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~-------------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g 473 (720)
++.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 45689999999999999999754 23589999999999999999999999999999999999999999
Q ss_pred CeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHH
Q 005007 474 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 549 (720)
Q Consensus 474 ~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~ 549 (720)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-------CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 999999999986543321 223456889999999974 457889999999999999998 999998876666
Q ss_pred HHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 550 AMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 550 ~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+..++.. ....|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 65555433 345577789999999999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.82 Aligned_cols=235 Identities=25% Similarity=0.465 Sum_probs=193.3
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHHHhh-------------cCCEEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ-------------VDDHLYIYLE 415 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~L~~-------------~~~~lyLVmE 415 (720)
....++|++++.||+|+||+||+|.+. ++..||||+++........ .+++..+.. .++.+|+|||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 445578999999999999999999976 5778999999765433222 222222322 1456799999
Q ss_pred eccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 416 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
|+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999999996532 3699999999999999999999999999999999999999999999999999987654332 2
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 570 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~ 570 (720)
....++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ....+..+++++.
T Consensus 168 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp TTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cCCCCccCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 23457889999999974 357889999999999999999 99999988777776666544 3456778999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHc
Q 005007 571 DFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+||.+||..||++|||+.++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.45 Aligned_cols=234 Identities=22% Similarity=0.401 Sum_probs=189.1
Q ss_pred CCCCCeEEee-EEeecCCeEEEEEE--ECCCCcEEEEEEeccCCCChhH----HHHHHHHhh-------------cCCEE
Q 005007 351 PKKSQWQKGK-LIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKS----AECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k-~LG~G~fG~VYla~--d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~-------------~~~~l 410 (720)
....+|++.+ .||+|+||+||+|. +..+++.||||+++........ .+++..+.. .++.+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 92 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW 92 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSE
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCc
Confidence 3456899998 99999999999995 4567889999999765433221 122222222 24568
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999999764 679999999999999999999999999999999999999999999999999998664332
Q ss_pred c----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 491 Y----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 491 ~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
. .....|++.|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ...++..
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 244 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CcccccccCCCCceeeChHHhcc-------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 1 122346788999999974 347789999999999999999 99999988776666655543 4567788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++++.++|.+||..||.+||++.|+++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.73 Aligned_cols=220 Identities=27% Similarity=0.422 Sum_probs=173.9
Q ss_pred CCCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh------------c----CCEEEEEEE
Q 005007 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------V----DDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~-k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~------------~----~~~lyLVmE 415 (720)
..+|.+. ++||+|+||+||+|.+..+++.||||+++.......+.+.+..+.. . ++.+|||||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 3578777 8899999999999999999999999999743222222333222211 1 356899999
Q ss_pred eccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCccc
Q 005007 416 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 416 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~~ 491 (720)
|++||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++....+
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--- 172 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--- 172 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---
Confidence 999999999998753 36999999999999999999999999999999999999998 78999999999865322
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh----ccCCCCC----c
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----NRTPPIP----E 563 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~----~~~~~iP----~ 563 (720)
..++.++|||||||++|||++|+.||...........+. .....++ .
T Consensus 173 -------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (299)
T 3m2w_A 173 -------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227 (299)
T ss_dssp -------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred -------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence 236678999999999999999999997755433322111 1222333 4
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 6899999999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.84 Aligned_cols=236 Identities=26% Similarity=0.434 Sum_probs=179.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHH--Hhh---------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQ--LEQ---------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~--L~~---------------~~~~lyL 412 (720)
..++|++++.||+|+||+||+|.+ +|+.||||++....... .+.+.+.. +.+ ....+|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 356899999999999999999987 58999999986432111 11112222 111 1234789
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH--------hCCCcccccCCCceeecCCCCeeeeccccch
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH--------STNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH--------s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
||||+++|+|.++++. ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||+++
T Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999999999954 57999999999999999999999 9999999999999999999999999999997
Q ss_pred hccCccc-----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC----------CCCCCCC----
Q 005007 485 HLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEF---- 545 (720)
Q Consensus 485 ~~~~~~~-----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG----------k~PF~~~---- 545 (720)
....... .....||+.|+|||++.+..... ...++.++|||||||++|||++| +.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCC-cccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 6544322 22347999999999997421100 01355789999999999999999 8888643
Q ss_pred CcHHHHHHHhc---cCCCCCc-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 EGPQAMFKVLN---RTPPIPE-----MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~~~~~i~ki~~---~~~~iP~-----~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.....+..... ..+.+|. .+++++.+||.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22233333332 2333332 24578999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.36 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=175.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH-HHHHHhh-------------------cCCEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQ-------------------VDDHL 410 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~-~ik~L~~-------------------~~~~l 410 (720)
...++|+++++||+|+||+||+|.+ +++.||||++..........+ .+..+.. ....+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4457999999999999999999976 589999999864321111111 1111100 12356
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC---------CCcccccCCCceeecCCCCeeeeccc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---------NTIHRDIKGANLLVDASGVVKLADFG 481 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~---------gIVHRDIKP~NILLd~~g~VKL~DFG 481 (720)
||||||+++|+|.+++... .+++..++.|+.||+.||.|||++ ||+||||||+||||+.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 8999999999999999763 468999999999999999999999 99999999999999999999999999
Q ss_pred cchhccCc---------cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc-----
Q 005007 482 MAKHLTGL---------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----- 547 (720)
Q Consensus 482 lA~~~~~~---------~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~----- 547 (720)
+++.+... .......||+.|+|||++.+.........++.++|||||||++|||++|..||.....
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99865432 1223457999999999987421111112456789999999999999999776632111
Q ss_pred ------------HHHHHHHh---ccCCCCCcc------CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 548 ------------PQAMFKVL---NRTPPIPEM------LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 548 ------------~~~i~ki~---~~~~~iP~~------ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+.... ...+.+|.. +++++.+||.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11122222 223344443 3458999999999999999999999954
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=349.80 Aligned_cols=235 Identities=26% Similarity=0.480 Sum_probs=182.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCC---cEEEEEEeccCCCChhHHHHHHHHh---h---------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLE---Q---------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg---~~VAVK~l~~~~~~~~~~~~ik~L~---~---------------~~~~l 410 (720)
....|+++++||+|+||+||+|.+..++ ..||||.++............+++. . .++..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3457999999999999999999876432 4689998875444333333222221 1 13567
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|+||||+.+|+|.+++......+++..++.|+.||++||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999999998776779999999999999999999999999999999999999999999999999998664322
Q ss_pred c-----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 005007 491 Y-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 563 (720)
Q Consensus 491 ~-----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~ 563 (720)
. .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||......+....+... ....|.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~ 319 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 319 (373)
T ss_dssp -----------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT
T ss_pred cccccccCCCCCcccccChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 1 123457888999999974 457889999999999999999 78899877665555555543 455678
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+++++.++|.+||..||++|||+.|++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=357.02 Aligned_cols=235 Identities=26% Similarity=0.487 Sum_probs=194.0
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh-------------cCCEEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ-------------VDDHLYIYLE 415 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~-------------~~~~lyLVmE 415 (720)
....++|++++.||+|+||+||+|.+. ++..||||+++....... ..+++..+.. .++.+|||||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence 445678999999999999999999986 477899999975433222 1222333322 1456899999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--c
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--E 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~ 492 (720)
||.+|+|.++|+.. ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... .
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99999999999754 23689999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 570 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~ 570 (720)
....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+... ..+.|..+++++.
T Consensus 343 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp CSSSSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred CCCcccccccCHHHhcc-------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 23446788999999974 458899999999999999999 99999988877777766543 4566788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHc
Q 005007 571 DFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+||.+||..||++|||+++|++
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=335.46 Aligned_cols=237 Identities=23% Similarity=0.390 Sum_probs=184.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCCCChhHH----HHHHHHhhc--------------C-
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSA----ECIKQLEQV--------------D- 407 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~---tg~~VAVK~l~~~~~~~~~~----~~ik~L~~~--------------~- 407 (720)
....++|++++.||+|+||+||+|.+.. ++..||||+++......... +++..+... .
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3455789999999999999999998765 56689999997654443322 122222221 1
Q ss_pred ----CEEEEEEEeccCCCHHHHHHHh-----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 408 ----DHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 408 ----~~lyLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
...|+||||+.+|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 1359999999999999999532 3569999999999999999999999999999999999999999999999
Q ss_pred ccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHH
Q 005007 479 DFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 554 (720)
Q Consensus 479 DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki 554 (720)
|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+....+
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-------RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHS-------SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcC-------CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999987643321 223457889999999973 468889999999999999999 99999988777766666
Q ss_pred hcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 555 LNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 555 ~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
... ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554 456778899999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.06 Aligned_cols=234 Identities=24% Similarity=0.441 Sum_probs=187.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChhHH---HHHHHHhh---------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSA---ECIKQLEQ---------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~~~---~~ik~L~~---------------~~~~l 410 (720)
....|+++++||+|+||+||+|.+..++. .||||.+.......... +++..+.. .++..
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 34478899999999999999999766554 79999987543322211 22222222 12334
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
++||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 89999999999999998766789999999999999999999999999999999999999999999999999997654322
Q ss_pred -----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 005007 491 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 563 (720)
Q Consensus 491 -----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~ 563 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+... ....+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQT-------YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE 251 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT
T ss_pred ccccccCcCCCCCccccChhhhcc-------CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc
Confidence 2234567889999999863 467889999999999999999 55666666655555555433 456678
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+++++.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 89999999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.22 Aligned_cols=236 Identities=20% Similarity=0.341 Sum_probs=168.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hhHHHHHHHHh-h-------------------
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLE-Q------------------- 405 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~-~------------------- 405 (720)
....+|+++++||+|+||+||+|++..+++.||||++...... ..+...+..+. +
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3456899999999999999999999999999999988543211 11222233332 1
Q ss_pred cCCEEEEEEEeccCCCHHHHHHH--hcCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeecCCCCeeeeccc
Q 005007 406 VDDHLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFG 481 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L~~--~~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd~~g~VKL~DFG 481 (720)
....+++||||+. |+|.+++.. ..+.+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 1234799999996 799998865 3456999999999999999999999999 9999999999999999999999999
Q ss_pred cchhccCccc-------------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH
Q 005007 482 MAKHLTGLSY-------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 548 (720)
Q Consensus 482 lA~~~~~~~~-------------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~ 548 (720)
+++....... .....||+.|+|||++... ....++.++|||||||++|||++|+.||......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY----SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp TCBCCSSCC-------------------------------CC----TTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhcc----ccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9987643221 1245699999999998421 1356788999999999999999999999765443
Q ss_pred HHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 549 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 549 ~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+... .....+..++..+.+||.+||+.||.+|||+.|+++|
T Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 260 RIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332221 1223345677889999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.20 Aligned_cols=231 Identities=16% Similarity=0.175 Sum_probs=175.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEE-----EECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDH 409 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla-----~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~ 409 (720)
...++|+++++||+|+||+||+| .+..+++.||||+++..... ..+.++++.+.. .++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 44578999999999999999999 46778999999998753211 112222233221 2567
Q ss_pred EEEEEEeccCCCHHHHHHHh----cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-----------CCC
Q 005007 410 LYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----------SGV 474 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~----~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-----------~g~ 474 (720)
.|||||||+||+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+. ++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence 89999999999999999752 356999999999999999999999999999999999999988 899
Q ss_pred eeeeccccchhcc---CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHH
Q 005007 475 VKLADFGMAKHLT---GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 551 (720)
Q Consensus 475 VKL~DFGlA~~~~---~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i 551 (720)
+||+|||+++.+. ........+||+.|||||++.+ ..++.++||||||||||||++|+.||........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-------KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-------CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-------CCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 9999999996543 3334456789999999999963 4588999999999999999999999964322100
Q ss_pred HHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 552 FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 552 ~ki~~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+....... ..++.+.++|..||+.+|.+|+...+.|.
T Consensus 294 -~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 294 -KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000011111 24678899999999999999965444443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=337.17 Aligned_cols=232 Identities=23% Similarity=0.361 Sum_probs=178.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-Chh----HHHHHHHHhh--------------cCCEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPK----SAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~----~~~~ik~L~~--------------~~~~lyLV 413 (720)
.++|++++.||+|+||+||+|.+..+++.||||++..... +.. ..+++..+.. .++.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4689999999999999999999999999999999875422 111 1122222222 25778999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--c
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--Y 491 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~ 491 (720)
|||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 9999999999999765 679999999999999999999999999999999999999999999999999997665432 2
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSE 568 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~e 568 (720)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... .++..++.+
T Consensus 192 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSE-------SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----CCGGGCCGGGTCC-----------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred ccccCCCcCccCHHHHcC-------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 234579999999998752 4578899999999999999999999987655433333322222 245678999
Q ss_pred HHHHHHHhhhcCCCCCC-CHHHHHc
Q 005007 569 GKDFLLRCFLRNPVERP-SAVELLE 592 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRP-Ta~ELL~ 592 (720)
+.+||.+||+.||++|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 8888875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=360.35 Aligned_cols=236 Identities=24% Similarity=0.452 Sum_probs=195.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHHHhh--------------cCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~L~~--------------~~~~lyLVm 414 (720)
.....+|++++.||+|+||+||+|.++.++..||||+++........ .+++..+.. .++.+||||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 44567899999999999999999999999999999999765433221 222222222 245689999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc-
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE- 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~- 492 (720)
|||.+|+|.++|+.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999999764 345999999999999999999999999999999999999999999999999999876543322
Q ss_pred -ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 493 -LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 493 -~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+... ....|..+++++
T Consensus 376 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 448 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 448 (495)
T ss_dssp CTTCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred cCCCcCCcceeCHhHHhc-------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 23446778999999974 357889999999999999999 99999988776666555443 456678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||.+||+.||.+|||+.||++
T Consensus 449 ~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 449 YELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=363.97 Aligned_cols=234 Identities=24% Similarity=0.409 Sum_probs=189.2
Q ss_pred CCCCeEEee-EEeecCCeEEEEEEECC--CCcEEEEEEeccCCCChh---HHHHHHHHhh-------------cCCEEEE
Q 005007 352 KKSQWQKGK-LIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPK---SAECIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k-~LG~G~fG~VYla~d~~--tg~~VAVK~l~~~~~~~~---~~~~ik~L~~-------------~~~~lyL 412 (720)
...++.+.+ .||+|+||+||+|.++. ++..||||+++....... ..++++.+.. ..+.+||
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l 412 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 412 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEE
Confidence 445666666 89999999999998763 566799999976433222 2223333332 1456899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc-
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 491 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~- 491 (720)
|||||.+|+|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 9999999999999977667799999999999999999999999999999999999999999999999999987643221
Q ss_pred ---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 492 ---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 492 ---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
.....+++.|+|||++.+ ..++.++|||||||+||||++ |+.||......+.+..+..+ ...+|..++
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 565 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 565 (613)
T ss_dssp ---------CCTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred eeeccCCCCccceeCHhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 112345789999999974 468899999999999999998 99999998888877777654 456788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++.+||.+||..||++||++.+|++
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.98 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=180.5
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH-HHHHHHhhc------------------CCE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-ECIKQLEQV------------------DDH 409 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~-~~ik~L~~~------------------~~~ 409 (720)
.....++|+++++||+|+||+||+|++. ++.||||++.......... .++..+... ...
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3445679999999999999999999876 7999999986432111111 111112111 234
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC----------CCcccccCCCceeecCCCCeeeec
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST----------NTIHRDIKGANLLVDASGVVKLAD 479 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~----------gIVHRDIKP~NILLd~~g~VKL~D 479 (720)
+|+||||+++|+|.++++. ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 7999999999999999976 4599999999999999999999999 999999999999999999999999
Q ss_pred cccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---------
Q 005007 480 FGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--------- 547 (720)
Q Consensus 480 FGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--------- 547 (720)
||+++....... .....||+.|+|||++.+.... ...++.++|||||||++|||++|+.||.+...
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF--QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC--CHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred CCcccccccccCccccccCccCccccCHhhccccccc--CcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999977654322 2346799999999998742110 12456789999999999999999999965321
Q ss_pred ------HHHHHHHhcc---CCCCCcc-----CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 548 ------PQAMFKVLNR---TPPIPEM-----LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 548 ------~~~i~ki~~~---~~~iP~~-----ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+...... .+.++.. .++++.+||.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222222211 2222222 2456999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.40 Aligned_cols=234 Identities=26% Similarity=0.452 Sum_probs=182.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC-CCc--EEEEEEeccCCC--ChhH---HHHHHHHhh-------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPD--DPKS---AECIKQLEQ-------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~-tg~--~VAVK~l~~~~~--~~~~---~~~ik~L~~-------------~~~~l 410 (720)
..++|++++.||+|+||+||+|.+.. +++ .||||+++.... .... .+++..+.. ..+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM 95 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCc
Confidence 45689999999999999999998643 333 689998864321 1111 122222222 13447
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 89999999999999998766779999999999999999999999999999999999999999999999999998764432
Q ss_pred c----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CCCCCc
Q 005007 491 Y----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPE 563 (720)
Q Consensus 491 ~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~~iP~ 563 (720)
. .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+... ....+.
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred cchhhhccCCCCceeeCchhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCc
Confidence 2 223457888999999974 357789999999999999999 99999988877777777654 344567
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.++.++.++|.+||..||.+|||+.++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 89999999999999999999999999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.84 Aligned_cols=235 Identities=31% Similarity=0.517 Sum_probs=175.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHHHHHhh--------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~ik~L~~--------------~~~~lyL 412 (720)
...+|++++.||+|+||+||+|.+..+|+.||||++..... .... .+++..+.. .++.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34589999999999999999999999999999999975322 2211 122222222 2567899
Q ss_pred EEEeccCCCHHHHHHH---hcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999964 2456999999999999999999999999999999999999999999999999999866433
Q ss_pred c-ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc--HHHHHHHhccC-CCC-Ccc
Q 005007 490 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLNRT-PPI-PEM 564 (720)
Q Consensus 490 ~-~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~--~~~i~ki~~~~-~~i-P~~ 564 (720)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ......+.... ..+ +..
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp ---------CCSSCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred CccccccCCCeeEeChHHhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence 2 2234579999999999863 4578899999999999999999999975432 23333333322 222 356
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+++++.+||.+||..||.+|||+.+++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=338.97 Aligned_cols=235 Identities=23% Similarity=0.430 Sum_probs=176.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh----------------cC----CEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----------------VD----DHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~----------------~~----~~lyL 412 (720)
.++|+++++||+|+||+||+|.+. ++.||||++....... .......+.. .. +.+|+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccch-hhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 358999999999999999999886 8999999986432111 1111111110 12 67899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCCceeecCCCCeeeeccccch
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~--------gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
||||+++|+|.++++. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++
T Consensus 113 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp EECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999999999965 4699999999999999999999999 99999999999999999999999999997
Q ss_pred hccCcccc-----ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC----------CCCCCCCC---
Q 005007 485 HLTGLSYE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFE--- 546 (720)
Q Consensus 485 ~~~~~~~~-----~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG----------k~PF~~~~--- 546 (720)
.+...... ....||+.|+|||++.+..... ...++.++|||||||++|||++| ..||....
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN-HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTT-CTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCc-cccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 65433221 2457999999999987421100 01111249999999999999999 77775432
Q ss_pred -cHHHHHHHh---ccCCCCCc-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 547 -GPQAMFKVL---NRTPPIPE-----MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 547 -~~~~i~ki~---~~~~~iP~-----~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
....+.... .....+|. .+++++.+||.+||+.||.+|||+.|+++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 222333322 22333443 456789999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.20 Aligned_cols=230 Identities=30% Similarity=0.520 Sum_probs=178.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhc------------CCEEEEEEEeccCC
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV------------DDHLYIYLEYVHPG 420 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~------------~~~lyLVmEy~~gG 420 (720)
.++|++.+.||+|+||+||+|.+. ++.||||++..........+++..+... .+..|+||||++||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 468999999999999999999875 7899999986433222223333333321 34468999999999
Q ss_pred CHHHHHHHhcC--CCcHHHHHHHHHHHHHHHHHHHh---CCCcccccCCCceeecCCCC-eeeeccccchhccCcccccc
Q 005007 421 SINRYVREHCR--DITESIVRNFTRHILNGLAYLHS---TNTIHRDIKGANLLVDASGV-VKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 421 sL~~~L~~~~~--~Lse~~i~~i~~QIL~gL~yLHs---~gIVHRDIKP~NILLd~~g~-VKL~DFGlA~~~~~~~~~~t 494 (720)
+|.+++..... .+++..++.|+.||++||.|||+ +||+||||||+||||+.++. +||+|||++...... ...
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~ 162 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTN 162 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--ccc
Confidence 99999975422 47889999999999999999999 89999999999999998886 799999999765432 234
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH--HHHHHHh-ccCCCCCccCCHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVL-NRTPPIPEMLSSEGKD 571 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~--~~i~ki~-~~~~~iP~~ls~el~d 571 (720)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+. .....++..+++++.+
T Consensus 163 ~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 163 NKGSAAWMAPEVFEG-------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp --CCTTSSCHHHHTC-------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred CCCCCceEChhhhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 469999999999863 46788999999999999999999999865432 2222222 3445667789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcC
Q 005007 572 FLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~H 593 (720)
||.+||+.||.+|||+.|++++
T Consensus 236 li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.30 Aligned_cols=236 Identities=25% Similarity=0.466 Sum_probs=189.8
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh-------------cCCEEEEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ-------------VDDHLYIYL 414 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~-------------~~~~lyLVm 414 (720)
.....++|++.+.||+|+||+||+|.+.. +..||||+++....... ..+++..+.. .++.+||||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~ 257 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 257 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence 34456789999999999999999999875 46799999976443322 1222222222 145689999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
||+.+|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999999753 35699999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
.....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+..+ ..+.|..+++++
T Consensus 338 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 410 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410 (452)
T ss_dssp -----CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred ccCCcccccccCHhHHhc-------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 223456788999999974 357889999999999999999 99999988877777666544 456678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||.+||+.||++|||+++|++
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.72 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=177.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh------------cCCEEEEEEEe
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~------------~~~~lyLVmEy 416 (720)
...+.|.+.++||+|+||+||.+. ..+|+.||||++.....+ ..++..+..+.. .++.+||||||
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 345678889999999999998754 567999999988643211 122233333311 25678999999
Q ss_pred ccCCCHHHHHHHhcC------CCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC-------------CCeee
Q 005007 417 VHPGSINRYVREHCR------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-------------GVVKL 477 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~------~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~-------------g~VKL 477 (720)
|. |+|.+++..... ...+..++.++.||+.||.|||++||+||||||+||||+.+ +.+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 699999975421 12444567899999999999999999999999999999754 48999
Q ss_pred eccccchhccCccc-----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHH
Q 005007 478 ADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 551 (720)
Q Consensus 478 ~DFGlA~~~~~~~~-----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i 551 (720)
+|||+++....... ....+||+.|+|||++.+.........++.++|||||||++|||++ |+.||......+
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 99999987654321 2345799999999999643222223568899999999999999999 999997654433
Q ss_pred HHHhccCCCCC-------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 552 FKVLNRTPPIP-------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 552 ~ki~~~~~~iP-------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..++.....++ ..+++++++||.+||+.||.+|||+.|+|+||||..
T Consensus 248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 23333322221 234588999999999999999999999999999964
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.86 Aligned_cols=236 Identities=25% Similarity=0.360 Sum_probs=182.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLV 413 (720)
....++|++.+.||+|+||+||+|.+. +|+.||||++....... ...+++..+.. .++.+|+|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 345679999999999999999999964 68999999886543221 11122222222 24678999
Q ss_pred EEeccCCCHHHHHHHhc---CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 414 LEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999986532 358999999999999999999999999999999999999999999999999997654321
Q ss_pred ---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH---HHH----HHhcc---
Q 005007 491 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ---AMF----KVLNR--- 557 (720)
Q Consensus 491 ---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~---~i~----ki~~~--- 557 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ... .....
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIK-------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHH-------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccccccCCCccccCHHHhcC-------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 2234568999999999975 357889999999999999999999997533211 110 01111
Q ss_pred -------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 558 -------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 558 -------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...++..++.++.++|.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011223345788999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=355.07 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=181.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChhHHHHHHHHh-h-----------cCCEEEEEEEec
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLE-Q-----------VDDHLYIYLEYV 417 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~~~~~ik~L~-~-----------~~~~lyLVmEy~ 417 (720)
...+|++.++||+|+||+||. ....+|+.||||++.... ....++++++.+. + .++.+|||||||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 345799999999999999764 345679999999986432 1233444444442 1 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---C--CCeeeeccccchhccCc---
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---S--GVVKLADFGMAKHLTGL--- 489 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~--g~VKL~DFGlA~~~~~~--- 489 (720)
. |+|.+++......+.+..++.|+.||+.||.|||++||+||||||+||||+. + ..+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 6 6999999876666777788999999999999999999999999999999953 2 35789999999876533
Q ss_pred -cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhccCCC---CCcc
Q 005007 490 -SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP---IPEM 564 (720)
Q Consensus 490 -~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~~~~---iP~~ 564 (720)
......+||+.|+|||++.+. ....++.++|||||||++|||++ |..||...........+...... .+..
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSED----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred eeeccccCCCcCccChhhhhcc----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 223456799999999998531 12456779999999999999999 99999765443332222221111 1233
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+..+++||.+||+.||.+|||+.|+|+||||....
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 456789999999999999999999999999997543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.39 Aligned_cols=237 Identities=22% Similarity=0.365 Sum_probs=181.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh---hHHHHHHHHhh--------------cCCEEEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~---~~~~~ik~L~~--------------~~~~lyLV 413 (720)
...++|++.++||+|+||+||+|.+. +|+.||||++....... ...+++..+.. ..+..++|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 34578999999999999999999854 68999999987543221 22233333322 24567999
Q ss_pred EEeccCCCHHHHHHHhc---CCCcHHHHHHHHHHHHHHHHHHHhC---CCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 414 LEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHST---NTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIL~gL~yLHs~---gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
|||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 99999999999997642 3499999999999999999999999 99999999999999999999999999998664
Q ss_pred Cc--cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC----CCcHHHHHHHhcc---C
Q 005007 488 GL--SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE----FEGPQAMFKVLNR---T 558 (720)
Q Consensus 488 ~~--~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~----~~~~~~i~ki~~~---~ 558 (720)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ......+...+.. .
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHH-------SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred cccccccccccCCcCccCHHHhcc-------CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 32 22334569999999999975 3578899999999999999999999952 1111111111110 0
Q ss_pred ------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 005007 559 ------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 595 (720)
Q Consensus 559 ------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpf 595 (720)
..++...+.++.+||.+||+.||.+|||+.|+++|-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1122233478999999999999999999999998743
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=334.19 Aligned_cols=238 Identities=21% Similarity=0.292 Sum_probs=180.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh------------------cCCEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ------------------VDDHLY 411 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~------------------~~~~ly 411 (720)
..++|++++.||+|+||+||+|.+..+|+.||||++....... ...+++..+.. ..+.+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3568999999999999999999999999999999886532111 11122222221 123678
Q ss_pred EEEEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 412 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 999999999999999762 46799999999999999999999999999999999999999999999999999875432
Q ss_pred cc----------ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC--CcHHHHHHHhc
Q 005007 489 LS----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--EGPQAMFKVLN 556 (720)
Q Consensus 489 ~~----------~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~--~~~~~i~ki~~ 556 (720)
.. ......||+.|+|||++.+. ....++.++|||||||++|||++|+.||... ........+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQ----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred ccccccccccccccccccCCcccCCHhHhccC----CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 11 11234589999999987531 1123678999999999999999999999531 11111111222
Q ss_pred -cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 -~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+.+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2233345789999999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=358.00 Aligned_cols=236 Identities=25% Similarity=0.466 Sum_probs=194.9
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh-------------cCCEEEEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ-------------VDDHLYIYL 414 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~-------------~~~~lyLVm 414 (720)
.....++|+++++||+|+||+||+|.+.. +..||||+++....... ..+++..+.. .++.+||||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~ 340 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 340 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence 34556789999999999999999999875 46799999976443322 2222333322 145689999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
|||.+|+|.++|... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999999753 35699999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
.....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+... ....+..+++++
T Consensus 421 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 493 (535)
T ss_dssp TCSTTSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccCCcCcccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 223456788999999974 358889999999999999999 99999988877777766544 456678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+||.+||+.||++|||+++|++
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.83 Aligned_cols=229 Identities=29% Similarity=0.444 Sum_probs=180.5
Q ss_pred CeEEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCChhH---HHHHHHHhh----------------cCCEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKS---AECIKQLEQ----------------VDDHLY 411 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~----------------~~~~ly 411 (720)
.|++++.||+|+||+||+|. +..+++.||||+++........ .+++..+.. ....+|
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 34999999999999998875 3457899999999755322211 122222221 136789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
+||||+++|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 112 lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 999999999999999653 59999999999999999999999999999999999999999999999999998765432
Q ss_pred ---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH--------------HHHHH
Q 005007 491 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--------------QAMFK 553 (720)
Q Consensus 491 ---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~--------------~~i~k 553 (720)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKE-------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccCCCCCceeeChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 1234557889999999975 35778999999999999999999999653211 01112
Q ss_pred Hh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 554 VL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 554 i~--~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+ ......+..++.++.+||.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22 2345667889999999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=341.81 Aligned_cols=224 Identities=21% Similarity=0.233 Sum_probs=175.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------------hhHHHHHHHHhh--------------
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQ-------------- 405 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------------~~~~~~ik~L~~-------------- 405 (720)
.++|++++.||+|+||+||+|++ +|+.||||++...... ..++.+++.+..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45899999999999999999998 6899999999764321 122333333431
Q ss_pred ------------------------------------cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Q 005007 406 ------------------------------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 449 (720)
Q Consensus 406 ------------------------------------~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL 449 (720)
.++.+|||||||.+|+|.+.+.+ ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 16789999999999977666644 5689999999999999999
Q ss_pred HHHH-hCCCcccccCCCceeecCCC--------------------CeeeeccccchhccCccccccccCCCCCCChHHHH
Q 005007 450 AYLH-STNTIHRDIKGANLLVDASG--------------------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 508 (720)
Q Consensus 450 ~yLH-s~gIVHRDIKP~NILLd~~g--------------------~VKL~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~ 508 (720)
.||| ++||+||||||+||||+.++ .+||+|||+++..... ..+||+.|||||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 9999999999876542 457999999999986
Q ss_pred HhhhcCCCCCCCccccccchhhh-HHHHhcCCCCCCCCCc-HHHHHHHhcc---CCC----CCccCCHHHHHHHHHhhhc
Q 005007 509 AVMQKDGNPKLALAVDIWSLGCT-VIEMLTGKPPWSEFEG-PQAMFKVLNR---TPP----IPEMLSSEGKDFLLRCFLR 579 (720)
Q Consensus 509 g~~~~~g~~~~s~asDVWSLG~v-LyELLTGk~PF~~~~~-~~~i~ki~~~---~~~----iP~~ls~el~dLI~~cL~~ 579 (720)
+ ..+.++||||||++ .++++.|..||.+... ......+... ... ++..+++++++||++||++
T Consensus 251 g--------~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 251 G--------DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp C--------CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred C--------CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 3 12779999998877 7889999999954221 1122222211 111 1235788999999999998
Q ss_pred CCCCCCCHHHHH-cCcccc
Q 005007 580 NPVERPSAVELL-EHPFIR 597 (720)
Q Consensus 580 dP~kRPTa~ELL-~Hpff~ 597 (720)
| |++|+| +||||+
T Consensus 323 d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 323 S-----SATDLLCQHSLFK 336 (336)
T ss_dssp S-----SHHHHHHHCGGGC
T ss_pred C-----CHHHHHhcCCCcC
Confidence 7 999999 999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=362.11 Aligned_cols=230 Identities=23% Similarity=0.412 Sum_probs=185.8
Q ss_pred CeEE-eeEEeecCCeEEEEEEE--CCCCcEEEEEEeccCCCChh----HHHHHHHHhh-------------cCCEEEEEE
Q 005007 355 QWQK-GKLIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPK----SAECIKQLEQ-------------VDDHLYIYL 414 (720)
Q Consensus 355 ~Y~i-~k~LG~G~fG~VYla~d--~~tg~~VAVK~l~~~~~~~~----~~~~ik~L~~-------------~~~~lyLVm 414 (720)
.+.+ .+.||+|+||+||+|.+ +.+++.||||+++....... ..++++.+.. .++.++|||
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~ 448 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM 448 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEE
Confidence 3444 45899999999999954 45678999999975433322 1222222222 145589999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc---
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--- 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--- 491 (720)
|||.+|+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 449 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 449 EMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp ECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999999999764 6799999999999999999999999999999999999999999999999999987654321
Q ss_pred -cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 005007 492 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 568 (720)
Q Consensus 492 -~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~e 568 (720)
.....||+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+....+... ....|..++++
T Consensus 528 ~~~~~~~t~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 600 (635)
T ss_dssp -------CGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccCCCCceeeeChhhhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 123346788999999974 458899999999999999998 99999998887777766544 45678889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+.+||.+||..||++|||+++|++
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=331.14 Aligned_cols=235 Identities=26% Similarity=0.430 Sum_probs=186.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeccCCCCh--hHHHHHHHHhhc----------------CC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDP--KSAECIKQLEQV----------------DD 408 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~----d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~~----------------~~ 408 (720)
....+|++++.||+|+||+||+|. +..+|+.||||++....... ...+++..+... ..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 345689999999999999999998 46789999999987542211 111222222221 23
Q ss_pred EEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 409 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 409 ~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 57999999999999999987666799999999999999999999999999999999999999999999999999987654
Q ss_pred ccc----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc------------HH---
Q 005007 489 LSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG------------PQ--- 549 (720)
Q Consensus 489 ~~~----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~------------~~--- 549 (720)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..||..... ..
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 322 223457788999999975 3578899999999999999999999864210 00
Q ss_pred HHHHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 550 AMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 550 ~i~ki~--~~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+...+ ......+..+++++.+||.+||..||.+|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111222 2245567889999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.92 Aligned_cols=239 Identities=24% Similarity=0.388 Sum_probs=186.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh-----------cCCEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ-----------VDDHLY 411 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~-----------~~~~ly 411 (720)
....++|++++.||+|+||+||+|.+.. .||||+++..... ..+...++.+.+ .++.++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 4456799999999999999999999864 4999988754321 122222222221 246789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC---
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--- 488 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~--- 488 (720)
+||||++|++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999999987656799999999999999999999999999999999999997 78999999999875431
Q ss_pred ---ccccccccCCCCCCChHHHHHhhhc--CCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC--C
Q 005007 489 ---LSYELSLKGSPNWMAPEVIKAVMQK--DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP--I 561 (720)
Q Consensus 489 ---~~~~~t~~GTp~YmAPEvl~g~~~~--~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~--i 561 (720)
........||+.|+|||++.+.... .....++.++|||||||++|||++|+.||...........+...... .
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence 1222345589999999998642110 01245788999999999999999999999988777776666544332 2
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+..++.++.+||.+||..||.+|||+.++++
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2358899999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.66 Aligned_cols=230 Identities=24% Similarity=0.423 Sum_probs=178.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--Chh----HHHHHHHHhh--------------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPK----SAECIKQLEQ--------------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~----~~~~ik~L~~--------------~~~~lyLV 413 (720)
..|..++.||+|+||+||+|.+ +++.||||++..... ... ..+++..+.. .++.+|+|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 4566779999999999999986 588999999865321 111 1122222222 24568999
Q ss_pred EEeccCCCHHHHHHHh--cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-
Q 005007 414 LEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 490 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~- 490 (720)
|||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 9999999999999743 3459999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHH----HHHhc--------
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM----FKVLN-------- 556 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i----~ki~~-------- 556 (720)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+ ..+..
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccccccCCCcCcCChHHhcC--------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 2234579999999998853 3678999999999999999999999764432211 11111
Q ss_pred ---cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 ---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 ---~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.....+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122334456789999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=358.22 Aligned_cols=235 Identities=25% Similarity=0.451 Sum_probs=191.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChhH---HHHHHHHhh-------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKS---AECIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~~---~~~ik~L~~-------------~~~~ly 411 (720)
....+|++++.||+|+||+||+|.+..+ +..||||.++........ .+++..+.. .++.+|
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 466 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence 3456899999999999999999998654 467999988754332211 122222222 245689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 99999999999999987666799999999999999999999999999999999999999999999999999987654332
Q ss_pred c--ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCH
Q 005007 492 E--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 567 (720)
Q Consensus 492 ~--~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~ 567 (720)
. ....||+.|||||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+... ...+|..+++
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp -------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred eeccCCCCCcceeCHHHhcC-------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 2 23456789999999974 357889999999999999997 99999988887777776654 4567888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.+||.+||..||.+|||+.||++
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.34 Aligned_cols=235 Identities=25% Similarity=0.398 Sum_probs=179.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHH--Hhh-----------cC----CEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQ--LEQ-----------VD----DHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~--L~~-----------~~----~~lyLVm 414 (720)
++|++++.||+|+||+||+|.+ +|+.||||++....... .+.+++.. +.+ .+ ..+|+||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 5899999999999999999988 48999999986432111 11122222 111 12 2789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH--------hCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH--------STNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH--------s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
||+++|+|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||+++..
T Consensus 120 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 120 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp CCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred eecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 99999999999975 46999999999999999999999 899999999999999999999999999999776
Q ss_pred cCcc-----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC----------CCCCCCCC----c
Q 005007 487 TGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFE----G 547 (720)
Q Consensus 487 ~~~~-----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG----------k~PF~~~~----~ 547 (720)
.... ......||+.|+|||++.+..... ...++.++|||||||++|||++| ..||.... .
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccCCcCcccCCHhhhccccccc-ccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 5433 223457999999999986421100 01234689999999999999999 78886542 2
Q ss_pred HHHHHHHh-cc--CCCCCc-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 548 PQAMFKVL-NR--TPPIPE-----MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 548 ~~~i~ki~-~~--~~~iP~-----~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+.+...+ .. .+.++. .+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23333332 22 233443 234688999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=362.96 Aligned_cols=239 Identities=23% Similarity=0.406 Sum_probs=185.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhh-----------------cCCEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQ-----------------VDDHL 410 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~-----------------~~~~l 410 (720)
++|++++.||+|+||+||+|.+..+|+.||||++........ +.+.+..+.+ .++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 689999999999999999999999999999998865432211 1222222221 14567
Q ss_pred EEEEEeccCCCHHHHHHHhc--CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCC---eeeeccccchh
Q 005007 411 YIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKH 485 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~---VKL~DFGlA~~ 485 (720)
|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999999997642 26999999999999999999999999999999999999997765 99999999988
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHH---------H--
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK---------V-- 554 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~k---------i-- 554 (720)
...........||+.|+|||++. ...++.++|||||||++|||++|..||........+.. +
T Consensus 174 ~~~~~~~~~~~gt~~Y~APE~l~-------~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 174 LDQGELCTEFVGTLQYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp TTSCCCCCCCCSCCTTCSSCSSC-------CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccccCCcccCChHHhc-------cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 76666566778999999999875 24678899999999999999999999976432221100 0
Q ss_pred ---hccCC----------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 555 ---LNRTP----------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 555 ---~~~~~----------~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
..+.. .+...+++++.+||.+||..||++|||+.|+|+|+||+..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 01111 1223457899999999999999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.73 Aligned_cols=205 Identities=15% Similarity=0.073 Sum_probs=163.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh--------------cCCEEE
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~--------------~~~~ly 411 (720)
...++|++++.||+|+||+||+|++..+|+.||||++....... ...+++..+.. .++.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34578999999999999999999999999999999997654321 11222222222 356899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||||++|++|.++++. + ..+..+..|+.||+.||+|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999999954 2 4566788999999999999999999999999999999999999998554
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH---HHhccCCC----CCcc
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPP----IPEM 564 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~---ki~~~~~~----iP~~ 564 (720)
|++| ++.++|||||||++|||++|+.||.+......+. +....... ++..
T Consensus 175 ---------~~~~--------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ---------TMPD--------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ---------CCTT--------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ---------ccCC--------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 3332 5668999999999999999999998765433221 11122111 2346
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++++++||.+||+.||++| |+.|+++
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 89999999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=344.13 Aligned_cols=223 Identities=23% Similarity=0.343 Sum_probs=174.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCCCChhHH---HHHHHHhhc--------------CCE----
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSA---ECIKQLEQV--------------DDH---- 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~-tg~~VAVK~l~~~~~~~~~~---~~ik~L~~~--------------~~~---- 409 (720)
..++|+++++||+|+||+||+|.+.. +|+.||||++.......... .++..+... .+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34799999999999999999999986 79999999886432211111 112222211 111
Q ss_pred -EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC
Q 005007 410 -LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 488 (720)
Q Consensus 410 -lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~ 488 (720)
+||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 6999999999999988754 69999999999999999999999999999999999999875 899999999987654
Q ss_pred ccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC-C-CccCC
Q 005007 489 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-I-PEMLS 566 (720)
Q Consensus 489 ~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~-i-P~~ls 566 (720)
. ....||+.|+|||++.+ .++.++||||||||||||++|.+||.+.... .... . ...++
T Consensus 234 ~---~~~~gt~~y~aPE~~~~--------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 294 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRT--------GPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTY 294 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHH--------CSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHC
T ss_pred C---CccCCCccccCHHHHcC--------CCCCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccC
Confidence 3 45679999999999874 2378999999999999999999998652110 0000 0 01246
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
+.+.+||.+||+.||.+||+..+.|.|+|+.
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 7899999999999999999999999898875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-29 Score=290.11 Aligned_cols=211 Identities=16% Similarity=0.062 Sum_probs=130.5
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----h-------HHHHHHHHhh---------------cCCEEEEE
Q 005007 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----K-------SAECIKQLEQ---------------VDDHLYIY 413 (720)
Q Consensus 361 ~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~-------~~~~ik~L~~---------------~~~~lyLV 413 (720)
.++.|++|.++.++..-.|+.||||++....... + ..++++.|.+ .++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 5677888888888888889999999987543211 1 1122333332 35789999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~ 492 (720)
||||+|++|.++|.+. +.+++. .|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 9999999999999765 667664 57899999999999999999999999999999999999999999876543 344
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
.+.+||+.|||||++.+ .+..++|+|++|+++|+|+++..+|. ..+..... ... .+.++
T Consensus 397 ~t~vGTp~YmAPE~l~g--------~~~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~~~~---~~~--~~~~l 455 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE--------NKSWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQEPV---ERW--NFVLL 455 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------------CCCCTTHHHHH--------HHHHTSCG---GGC--SHHHH
T ss_pred cCceechhhccHHHhCC--------CCCCcccccccccchhhhccccchhH--------HHhhcCCC---CCC--cHHHH
Confidence 56789999999999874 34567999999999999987754431 11111100 001 13455
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
+..++..++..|+.......++|.
T Consensus 456 ~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 456 LALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred HHHHhCCCCCCCCChhhhccchhH
Confidence 555666666666655544444444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=247.50 Aligned_cols=171 Identities=15% Similarity=0.195 Sum_probs=124.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------------hhHHHHHHHHhh-----------cCCEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQ-----------VDDHL 410 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------------~~~~~~ik~L~~-----------~~~~l 410 (720)
.+...++||+|+||+||+|. ..+..+|+|++...... .++.+.++.+.+ .++..
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 414 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK 414 (540)
T ss_dssp -----------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred cCCCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence 33556799999999999994 45889999986543221 112222333322 13456
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
|||||||+|++|.+++.+ +..|+.||++||+|||++||+||||||+||||+. .+||+|||+++......
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999999865 5689999999999999999999999999999988 99999999998775432
Q ss_pred c--------cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCC
Q 005007 491 Y--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 543 (720)
Q Consensus 491 ~--------~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~ 543 (720)
. ...++||++|||||++.+... .|+..+|+|+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-----~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLE-----GYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-----HHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHH-----HHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 236789999999999986432 35668899999998888888777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.3e-22 Score=208.00 Aligned_cols=134 Identities=19% Similarity=0.220 Sum_probs=103.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----------------------hhHHHHHHHHhh-----
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----------------------PKSAECIKQLEQ----- 405 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----------------------~~~~~~ik~L~~----- 405 (720)
..|.+++.||+|+||.||+|.+ .+|+.||||+++..... ..+...+..+..
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~ 168 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 168 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe
Confidence 3566779999999999999999 88999999998643211 112222222221
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccc
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA 483 (720)
..+..|+|||||+||+|.+ +. ...+..++.||+.||.|||++||+||||||+||||+ +|.+||+|||++
T Consensus 169 ~~~~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 169 VYAWEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp EEEEETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred EEeccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 1234699999999999987 31 234567999999999999999999999999999999 999999999998
Q ss_pred hhccCccccccccCCCCCCChHHHHH
Q 005007 484 KHLTGLSYELSLKGSPNWMAPEVIKA 509 (720)
Q Consensus 484 ~~~~~~~~~~t~~GTp~YmAPEvl~g 509 (720)
+. +..|+|||++.+
T Consensus 240 ~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 240 VE------------VGEEGWREILER 253 (282)
T ss_dssp EE------------TTSTTHHHHHHH
T ss_pred eE------------CCCCCHHHHHHH
Confidence 63 345899999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=7.9e-20 Score=188.44 Aligned_cols=126 Identities=18% Similarity=0.254 Sum_probs=96.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcE--EEEEEeccCCCC-----------------------------hhHHHHHHHH
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDD-----------------------------PKSAECIKQL 403 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~--VAVK~l~~~~~~-----------------------------~~~~~~ik~L 403 (720)
-|.+++.||+|+||.||+|.+..+|+. ||||+++..... ..+...+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999778999 999987543111 1122223333
Q ss_pred hhcC---------CEEEEEEEeccC-C----CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCcee
Q 005007 404 EQVD---------DHLYIYLEYVHP-G----SINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLL 468 (720)
Q Consensus 404 ~~~~---------~~lyLVmEy~~g-G----sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH-s~gIVHRDIKP~NIL 468 (720)
.... +..+|||||+.+ | .|.+++.. +++..+..++.||+.||.||| ++||+||||||+|||
T Consensus 128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL 203 (258)
T 1zth_A 128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM 203 (258)
T ss_dssp HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence 3211 234799999942 3 67665432 456788999999999999999 999999999999999
Q ss_pred ecCCCCeeeeccccchhc
Q 005007 469 VDASGVVKLADFGMAKHL 486 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~ 486 (720)
|+. .++|+|||+|...
T Consensus 204 l~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 204 YID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ESS--SEEECCCTTCEET
T ss_pred EcC--cEEEEECcccccC
Confidence 988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.4e-17 Score=178.91 Aligned_cols=123 Identities=15% Similarity=0.168 Sum_probs=91.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-------C-------Ch-------------hHHHHHHHHhhc-
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-------D-------DP-------------KSAECIKQLEQV- 406 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-------~-------~~-------------~~~~~ik~L~~~- 406 (720)
-|.++++||+|+||.||+|.+. +|+.||||+++... . .. .+...+..+...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999985 69999999875321 0 00 011122223221
Q ss_pred ---C-----CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-----
Q 005007 407 ---D-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----- 473 (720)
Q Consensus 407 ---~-----~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g----- 473 (720)
. ...+|||||++|+.|.++. ....+..++.||+.+|.|||++|||||||||.||||+++|
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 1 1126999999998875432 2345678899999999999999999999999999998877
Q ss_pred -----Ceeeeccccchh
Q 005007 474 -----VVKLADFGMAKH 485 (720)
Q Consensus 474 -----~VKL~DFGlA~~ 485 (720)
.+.|+||+-+..
T Consensus 248 ~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEEEECCCTTCEE
T ss_pred cccccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=3.6e-10 Score=114.90 Aligned_cols=123 Identities=15% Similarity=0.101 Sum_probs=93.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC-----CCChhHHHHHHHHhh------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII-----PDDPKSAECIKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~-----~~~~~~~~~ik~L~~------------~~~~lyLVmEy 416 (720)
..|++...+|.|+++.||++... +..+++|..... .....+.+.++.+.. ..+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 36889999999999999999743 688999988641 112234445555532 24568999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS------------------------------------------ 454 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs------------------------------------------ 454 (720)
++|.+|.+.+ .+......++.+++++|..||+
T Consensus 92 i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9999987653 1223345788999999999998
Q ss_pred -----------------CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 -----------------TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 -----------------~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876667899999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.4e-09 Score=109.13 Aligned_cols=121 Identities=12% Similarity=0.063 Sum_probs=82.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC--CChhHHHHHHHHhhc-------------CCEEEEEEEeccC
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQV-------------DDHLYIYLEYVHP 419 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~--~~~~~~~~ik~L~~~-------------~~~lyLVmEy~~g 419 (720)
.|.+..+.+.|..+.||++.. .+|..++||...... ....+...++.+... ++..|+||||++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 456654445666799999964 567889999876431 112344455555431 3457999999999
Q ss_pred CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 005007 420 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN------------------------------------------- 456 (720)
Q Consensus 420 GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g------------------------------------------- 456 (720)
.+|. .. ... ...++.++++.|..||+..
T Consensus 100 ~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 100 QDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp EETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 8874 11 111 2255666777777777543
Q ss_pred ---------------CcccccCCCceeecCCCCeeeeccccchh
Q 005007 457 ---------------TIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 457 ---------------IVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
++|+|++|.|||++.++.++|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 89999999999998776778999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=2.5e-09 Score=111.82 Aligned_cols=173 Identities=13% Similarity=0.166 Sum_probs=108.6
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCC---CChhHHHHHHHHhhc--------------CC---EEEEEEEecc
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---DDPKSAECIKQLEQV--------------DD---HLYIYLEYVH 418 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~---~~~~~~~~ik~L~~~--------------~~---~lyLVmEy~~ 418 (720)
.+.|+.|....||++. ..+++|+..... ....+.+.+..+... .+ ..|+||||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3569999999999863 458899764220 111223333344220 11 2478999999
Q ss_pred CCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 005007 419 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------------- 454 (720)
Q Consensus 419 gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-------------------------------------------- 454 (720)
|..|..... ..++..+...++.|+++.|..||.
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 988865432 236777777888888888888885
Q ss_pred --------------CCCcccccCCCceeecC--CCCeeeeccccchhccCccccccccCCCCC---CChHHHHHhhhcCC
Q 005007 455 --------------TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNW---MAPEVIKAVMQKDG 515 (720)
Q Consensus 455 --------------~gIVHRDIKP~NILLd~--~g~VKL~DFGlA~~~~~~~~~~t~~GTp~Y---mAPEvl~g~~~~~g 515 (720)
..++|+|+++.|||++. .+.+.|+||+.+....... .+.....+ ..++.+.......+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHcC
Confidence 13699999999999988 5678999999986532211 11111112 34554433221111
Q ss_pred CCC-------CCccccccchhhhHHHHhcCCCCC
Q 005007 516 NPK-------LALAVDIWSLGCTVIEMLTGKPPW 542 (720)
Q Consensus 516 ~~~-------~s~asDVWSLG~vLyELLTGk~PF 542 (720)
... .....+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 100 111258999999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.7e-08 Score=107.80 Aligned_cols=124 Identities=10% Similarity=0.160 Sum_probs=89.3
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEec--cCC------CChhHHHHHHHHhhc-------------C---CEEEE
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIP------DDPKSAECIKQLEQV-------------D---DHLYI 412 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~--~~~------~~~~~~~~ik~L~~~-------------~---~~lyL 412 (720)
...+.|+.|.++.||++... +..+++|+.. ... ....+...++.+... . +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678999999999998754 4678888765 221 122234445555431 1 34789
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------- 454 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-------------------------------------- 454 (720)
||||++|..|.+.. ...+++.....++.++++.|..||.
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999988774321 2347788888999999999999996
Q ss_pred --------------------CCCcccccCCCceeecCCCC--eeeeccccchh
Q 005007 455 --------------------TNTIHRDIKGANLLVDASGV--VKLADFGMAKH 485 (720)
Q Consensus 455 --------------------~gIVHRDIKP~NILLd~~g~--VKL~DFGlA~~ 485 (720)
..++|+|+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987753 69999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.3e-05 Score=84.06 Aligned_cols=120 Identities=13% Similarity=0.115 Sum_probs=74.4
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCC---CChhHHHHHHHHhhc---------------CCEEEEEEEeccCC
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---DDPKSAECIKQLEQV---------------DDHLYIYLEYVHPG 420 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~---~~~~~~~~ik~L~~~---------------~~~lyLVmEy~~gG 420 (720)
.+.|+.|....||+. |..++||+..... ....+.+.+..+... ++..|+||||++|.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456899999999998 5678888753210 112233344444321 23468999999998
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHS---------------------------------------------- 454 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs---------------------------------------------- 454 (720)
.|....- ..++......++.+|.+.|..||+
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 8765321 123333333444444444444442
Q ss_pred --------------CCCcccccCCCceeecC---CCC-eeeeccccchhc
Q 005007 455 --------------TNTIHRDIKGANLLVDA---SGV-VKLADFGMAKHL 486 (720)
Q Consensus 455 --------------~gIVHRDIKP~NILLd~---~g~-VKL~DFGlA~~~ 486 (720)
..++|+|+++.|||++. ++. +.|+||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999987 455 589999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4.8e-05 Score=77.18 Aligned_cols=120 Identities=16% Similarity=0.110 Sum_probs=76.7
Q ss_pred EEeecCCe-EEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh------------cCCEEEEEEEeccCCCHHHH
Q 005007 361 LIGRGTFG-SVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ------------VDDHLYIYLEYVHPGSINRY 425 (720)
Q Consensus 361 ~LG~G~fG-~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~------------~~~~lyLVmEy~~gGsL~~~ 425 (720)
.+..|..| .||+......+..+.+|.-..... ...+...+..+.. .++..|+|||+++|.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 34455554 799988777788899997642210 1112233333322 25678999999999887766
Q ss_pred HHHhcCCCcHHHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q 005007 426 VREHCRDITESIVRNFTRHILNGLAYLHS--------------------------------------------------- 454 (720)
Q Consensus 426 L~~~~~~Lse~~i~~i~~QIL~gL~yLHs--------------------------------------------------- 454 (720)
.... ......+..++...|.-||.
T Consensus 111 ~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 111 LEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred ccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 5321 11223344455555555552
Q ss_pred C-------CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 455 T-------NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 455 ~-------gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 268999999999999887788999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=6.5e-05 Score=78.24 Aligned_cols=30 Identities=20% Similarity=0.283 Sum_probs=27.3
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=4.7e-05 Score=82.26 Aligned_cols=31 Identities=23% Similarity=0.281 Sum_probs=23.1
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEec
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~ 388 (720)
..+.||.|.++.||++.+..+++.|+||...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~ 64 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAV 64 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEEC
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecc
Confidence 4568999999999999876667889999754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=7.1e-05 Score=79.33 Aligned_cols=31 Identities=19% Similarity=0.184 Sum_probs=26.3
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
..++|+|+++.|||+++++.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999998655689999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00057 Score=69.32 Aligned_cols=122 Identities=19% Similarity=0.076 Sum_probs=83.5
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCceeecCCCCeeeeccccchhccCccccccccCCC
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH-s~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~~GTp 499 (720)
+|.++|+..+..|+|+++|.++.|.+.+|.-+- ...-..+=+-+..|+|..+|.|-+.+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 699999998899999999999999999987762 22222344567999999999998874 2211 1122
Q ss_pred CCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhc
Q 005007 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 579 (720)
Q Consensus 500 ~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~~cL~~ 579 (720)
.+.+||... ...+.+.=|||||++||.-+--..|= ..+..+++++..||..|...
T Consensus 102 ~~~~pe~~~--------~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 102 PPVAGKLGY--------SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -----CCSS--------SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred CCCChhhcc--------ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 356777531 23456788999999999988744321 22345899999999999765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0006 Score=74.48 Aligned_cols=32 Identities=16% Similarity=0.272 Sum_probs=27.9
Q ss_pred HhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 453 Hs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999998776 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.002 Score=66.81 Aligned_cols=29 Identities=21% Similarity=0.240 Sum_probs=24.8
Q ss_pred CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4799999999999 5677889999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0057 Score=63.49 Aligned_cols=127 Identities=14% Similarity=0.153 Sum_probs=70.3
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hhHHHHHHHHhh-------------------cCCEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQ-------------------VDDHLYIY 413 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~~~~~ik~L~~-------------------~~~~lyLV 413 (720)
....+.|+.|....||++... .| .+++|........ ..+...+..|.+ .++..++|
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 345667888998999998753 23 6889987652111 122333444432 12456899
Q ss_pred EEeccCCCHH-----------HH---HHHhcCCCcH-----HHHHHH------------------HHHHHHHHHHHHh--
Q 005007 414 LEYVHPGSIN-----------RY---VREHCRDITE-----SIVRNF------------------TRHILNGLAYLHS-- 454 (720)
Q Consensus 414 mEy~~gGsL~-----------~~---L~~~~~~Lse-----~~i~~i------------------~~QIL~gL~yLHs-- 454 (720)
|||++|..+. .. ++.....+.. .....| ...+.+.++++.+
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999986421 11 1111111100 000000 0113344555552
Q ss_pred -----CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 -----TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 -----~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 368999999999999877666899998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0076 Score=63.14 Aligned_cols=32 Identities=34% Similarity=0.313 Sum_probs=27.5
Q ss_pred CCCcccccCCCceeecCC----CCeeeeccccchhc
Q 005007 455 TNTIHRDIKGANLLVDAS----GVVKLADFGMAKHL 486 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~----g~VKL~DFGlA~~~ 486 (720)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 478999999999999874 68999999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.013 Score=60.95 Aligned_cols=29 Identities=21% Similarity=0.274 Sum_probs=25.0
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4689999999999998 4 899999987743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.02 Score=58.83 Aligned_cols=67 Identities=13% Similarity=0.023 Sum_probs=44.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hhHHHHHHHHhhcC----------CEEEEEEEecc
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQVD----------DHLYIYLEYVH 418 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~~~~----------~~lyLVmEy~~ 418 (720)
.+..-.+.+|.|..+.||++.. .+|+.|.||+....... ..+...++.|.+.. +.-++||||++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~ 93 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVD 93 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCC
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeec
Confidence 3566778999999999999975 46899999976432211 22344455554321 12378999998
Q ss_pred CCC
Q 005007 419 PGS 421 (720)
Q Consensus 419 gGs 421 (720)
++.
T Consensus 94 ~~~ 96 (288)
T 3f7w_A 94 ERP 96 (288)
T ss_dssp CCC
T ss_pred ccC
Confidence 765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.019 Score=60.76 Aligned_cols=64 Identities=11% Similarity=0.150 Sum_probs=42.2
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC--ChhHHHHHHHHhh--------------cCCEEEEEEEeccCC
Q 005007 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQ--------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 357 ~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~--~~~~~~~ik~L~~--------------~~~~lyLVmEy~~gG 420 (720)
...+.|+.|.+..||+... ++..++||....... ...+.+.++.|.. .++..|+||||++|.
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 3457889999999999874 467888997653210 1122334444443 135679999999987
Q ss_pred CH
Q 005007 421 SI 422 (720)
Q Consensus 421 sL 422 (720)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.046 Score=57.90 Aligned_cols=31 Identities=23% Similarity=0.294 Sum_probs=27.5
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888999999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.11 E-value=0.034 Score=61.23 Aligned_cols=31 Identities=10% Similarity=0.035 Sum_probs=24.0
Q ss_pred EeeEEeecCCeEEEEEEECC-------CCcEEEEEEec
Q 005007 358 KGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVD 388 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~-------tg~~VAVK~l~ 388 (720)
..+.|+.|-...||++.... .+..|.+|+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~ 114 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF 114 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeC
Confidence 45678889999999998653 35788899874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.16 Score=56.55 Aligned_cols=64 Identities=11% Similarity=0.021 Sum_probs=37.9
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC----ChhHHHHHHHHhhcC--CEE------EEEEEeccCCC
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----DPKSAECIKQLEQVD--DHL------YIYLEYVHPGS 421 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~----~~~~~~~ik~L~~~~--~~l------yLVmEy~~gGs 421 (720)
..+.|+.|-...+|++.....+..|++|+...... ...+...+..|.... -.+ .+||||++|..
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTNGRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETTEEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCCeEEEEeeCCcc
Confidence 45678889999999998765457888997643211 123445555554321 011 25899998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.40 E-value=0.095 Score=56.94 Aligned_cols=124 Identities=12% Similarity=0.156 Sum_probs=69.1
Q ss_pred eeEEeecCCeEEEEEEECC-------CCcEEEEEEeccCCCCh----hHHHHHHHHhhc----------CCEEEEEEEec
Q 005007 359 GKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDP----KSAECIKQLEQV----------DDHLYIYLEYV 417 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~-------tg~~VAVK~l~~~~~~~----~~~~~ik~L~~~----------~~~lyLVmEy~ 417 (720)
.+.|..|-...+|++.... +++.|.+|+.-...... .+.++++.|... ++ .+||||+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~i 132 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQYI 132 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEECC
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEEe
Confidence 3567778888999987642 35788898753211111 123334444331 22 2899999
Q ss_pred cCCCHH--------------HHHHH-hcC------CC--cHHHHHHHHHHHHH-------------------HHHHHHh-
Q 005007 418 HPGSIN--------------RYVRE-HCR------DI--TESIVRNFTRHILN-------------------GLAYLHS- 454 (720)
Q Consensus 418 ~gGsL~--------------~~L~~-~~~------~L--se~~i~~i~~QIL~-------------------gL~yLHs- 454 (720)
+|..|. +.|.+ +.. .. -+.++..|+.++.. .+++|.+
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 975432 11111 111 11 23566666655432 2344432
Q ss_pred -------CCCcccccCCCceeecCC----CCeeeeccccch
Q 005007 455 -------TNTIHRDIKGANLLVDAS----GVVKLADFGMAK 484 (720)
Q Consensus 455 -------~gIVHRDIKP~NILLd~~----g~VKL~DFGlA~ 484 (720)
..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 258999999999999876 789999998874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.65 E-value=0.17 Score=54.94 Aligned_cols=29 Identities=24% Similarity=0.362 Sum_probs=24.7
Q ss_pred CcccccCCCceee------cCCCCeeeeccccchh
Q 005007 457 TIHRDIKGANLLV------DASGVVKLADFGMAKH 485 (720)
Q Consensus 457 IVHRDIKP~NILL------d~~g~VKL~DFGlA~~ 485 (720)
++|+|+.+.|||+ ++++.++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.01 E-value=0.33 Score=51.49 Aligned_cols=28 Identities=21% Similarity=0.383 Sum_probs=23.8
Q ss_pred CCcccccCCCceeecCCCCeeeeccccch
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.++|+|+++.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999997654 8999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 720 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-60 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-58 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-56 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-42 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-67
Identities = 83/269 (30%), Positives = 129/269 (47%), Gaps = 22/269 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----AECIKQLE------ 404
W+ +G G FG VY N+ET A K +D ++ + + +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+++L+I +E+ G+++ + E R +TES ++ + L+ L YLH IH
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133
Query: 460 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPK 518
RD+K N+L G +KLADFG++ T S G+P WMAPEV+ KD
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR--P 191
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDFLLR 575
D+WSLG T+IEM +PP E + + K+ PP P SS KDFL +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
Query: 576 CFLRNPVERPSAVELLEHPFIRNANYQNL 604
C +N R + +LL+HPF+ + + +
Sbjct: 252 CLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 9e-65
Identities = 70/263 (26%), Positives = 119/263 (45%), Gaps = 28/263 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE--------- 404
++ G+ +G+G FG+VY+ +++ A+K + + E + E
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 405 ----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+Y+ LEY G++ R ++ E + + N L+Y HS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS 124
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
IHRDIK NLL+ ++G +K+ADFG + H S +L G+ +++ PE+I+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIE------ 177
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574
VD+WSLG E L GKPP+ + ++ P+ ++ +D +
Sbjct: 178 -GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 236
Query: 575 RCFLRNPVERPSAVELLEHPFIR 597
R NP +RP E+LEHP+I
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 213 bits (544), Expect = 1e-64
Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 32/273 (11%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----------L 403
++ +++GRG V ++ T A+K +D+ SAE +++ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 404 EQVDDH---------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
+V H ++ + + G + Y+ E ++E R R +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEV 122
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 508
+ LH N +HRD+K N+L+D +KL DFG + L + G+P+++APE+I+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEM 564
D +P VD+WS G + +L G PP+ + + +++ P +
Sbjct: 183 C-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
S KD + R + P +R +A E L HPF +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 8e-62
Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 37/271 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------------- 402
++ IG G++G + G KE+D + +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 403 -------LEQVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYL 452
+++ + LYI +EY G + + + ++ + E V + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 453 HSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEV 506
H + +HRD+K AN+ +D VKL DFG+A+ L S+ + G+P +M+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEML 565
+ DIWSLGC + E+ PP++ F + K+ + IP
Sbjct: 186 MN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596
S E + + R RPS E+LE+P I
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 65/270 (24%), Positives = 110/270 (40%), Gaps = 30/270 (11%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKS----AECIKQLE 404
P W + +G G +G V + NR T + A+K VD+ D P++ K L
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 405 -----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
+ + Y++LEY G + + + E + F ++ G+ YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 120
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 510
HRDIK NLL+D +K++DFG+A + E L G+ ++APE++K
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-- 178
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS 567
A VD+WS G + ML G+ PW + + + + S
Sbjct: 179 ----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
L + + NP R + ++ + +
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-60
Identities = 93/295 (31%), Positives = 142/295 (48%), Gaps = 33/295 (11%)
Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-- 396
I+EK S K ++ + + IG+G G+VY + TG AI+++++ K
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 397 ---AECIKQLE-----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 442
+++ + V D L++ +EY+ GS+ V E C D E +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVC 122
Query: 443 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNW 501
R L L +LHS IHRDIK N+L+ G VKL DFG +T + S + G+P W
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 502 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP- 560
MAPEV+ VDIWSLG IEM+ G+PP+ +A++ + P
Sbjct: 183 MAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
Query: 561 --IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSR 613
PE LS+ +DFL RC + +R SA ELL+H F++ A + P+ ++
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 2e-60
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 31/295 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQLE 404
+ + + IG G+FG+VY + AIK++ +++L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 405 -----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
+ ++ +EY GS + + H + + E + T L GLAYLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
S N IHRD+K N+L+ G+VKL DFG A + + S G+P WMAPEVI A+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEG 189
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 571
+ K VD+WSLG T IE+ KPP A++ + S ++
Sbjct: 190 QYDGK----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 572 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVER 626
F+ C + P +RP++ LL+H F+ + +V M + R + D ++
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQY 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 204 bits (519), Expect = 4e-60
Identities = 66/329 (20%), Positives = 125/329 (37%), Gaps = 38/329 (11%)
Query: 342 HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----- 396
H+++ + + +G G FG V+ T R TG + A K V + K
Sbjct: 23 HVLDH---------YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 73
Query: 397 AECIKQLE-----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 445
+ + L + D+ + + E++ G + V + ++E + R +
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 446 LNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 503
GL ++H N +H D+K N++ S +KL DFG+ HL G+ + A
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 504 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 563
PEV + + D+WS+G +L+G P+ + + V + + +
Sbjct: 194 PEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 564 ----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDK 619
+S +GKDF+ + L +P R + + LEHP++ N + + D
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 620 SHDQVERATRKTESLPDSPETRVRNRKLP 648
+ + L + P
Sbjct: 307 IKTKYDAWPEPLPPLGRISNYSSLRKHRP 335
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 5e-60
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 38/267 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---------------- 402
IGRG+F +VY G + ET A E+ + K+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 403 ------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
+ + + E + G++ Y++ + ++R++ R IL GL +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT 132
Query: 457 T--IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
IHRD+K N+ + +G VK+ D G+A S+ ++ G+P +MAPE+ +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE---- 187
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---RTPPIPEMLSSEGK 570
K +VD+++ G ++EM T + P+SE + +++ + + ++ E K
Sbjct: 188 ----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 571 DFLLRCFLRNPVERPSAVELLEHPFIR 597
+ + C +N ER S +LL H F +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-58
Identities = 60/268 (22%), Positives = 106/268 (39%), Gaps = 33/268 (12%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD 407
Q G+ IG G+FG+VY G A+K +++ P+ + K L +
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 408 -------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
L I ++ S+ ++ + + R G+ YLH+
Sbjct: 63 HVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVM 511
+ IHRD+K N+ + VK+ DFG+A + S L GS WMAPEVI+
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 512 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPIPEML 565
+ + + D+++ G + E++TG+ P+S + ++ R +
Sbjct: 183 KNPYSFQ----SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEH 593
K + C + ERP ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 4e-58
Identities = 60/307 (19%), Positives = 115/307 (37%), Gaps = 28/307 (9%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLE------- 404
+ + +GRG FG V+ + + K V + D +
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 405 ----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
+ + L + E++ I + ++ E + ++ + L +LHS N H
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 461 DIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
DI+ N++ S +K+ +FG A+ L L +P + APEV + +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ-------HDV 179
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSEGKDFLL 574
++ A D+WSLG V +L+G P+ Q + ++N E +S E DF+
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 575 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESL 634
R ++ R +A E L+HP+++ + + +R + +
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
Query: 635 PDSPETR 641
R
Sbjct: 300 SCGGAIR 306
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-58
Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 39/285 (13%)
Query: 351 PKK---SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQV 406
P+K ++ GK++G G+F +V + T AIK ++ + + V
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 407 ------------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 448
D+ LY L Y G + +Y+R E+ R +T I++
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA 120
Query: 449 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPE 505
L YLH IHRD+K N+L++ +++ DFG AK L+ S + S G+ +++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 565
++ + D+W+LGC + +++ G PP+ K++ PE
Sbjct: 181 LLT-------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 233
Query: 566 SSEGKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 604
+ +D + + + + +R E L HPF + ++NL
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 7e-57
Identities = 76/327 (23%), Positives = 146/327 (44%), Gaps = 71/327 (21%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE------- 404
K ++K +G G G V+ +++ +G A K + + + I++L+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 405 ----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
D + I +E++ GS+++ +++ R I E I+ + ++ GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 122
Query: 455 TNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
+ I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ----- 176
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPW------------------------------- 542
++ DIWS+G +++EM G+ P
Sbjct: 177 --GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 543 -------SEFEGPQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERPSAVE 589
+ P A+F++L+ P +P + S E +DF+ +C ++NP ER +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 590 LLEHPFIRNANYQNLSVPMRVFSRINL 616
L+ H FI+ ++ + + + S I L
Sbjct: 295 LMVHAFIKRSDAEEVDFAGWLCSTIGL 321
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQV-------- 406
+ K++G+G+FG V++ ++T AIK + + EC ++V
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 407 -----------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
++L+ +EY++ G + +++ + S + I+ GL +LHS
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK 122
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKD 514
++RD+K N+L+D G +K+ADFGM K G + + G+P+++APE++
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL------ 176
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574
K +VD WS G + EML G+ P+ + + + P P L E KD L+
Sbjct: 177 -GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235
Query: 575 RCFLRNPVERPSAV-ELLEHPFIRNANYQNL 604
+ F+R P +R ++ +HP R N++ L
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFREINWEEL 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 2e-56
Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 32/286 (11%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-------- 404
+ + ++G G F V + ++ T AIK + + K ++
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 405 ---------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
+ HLY+ ++ V G + + E TE +L+ + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 456 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 512
+HRD+K NLL D + ++DFG++K S + G+P ++APEV+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA---- 182
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEMLSSE 568
+ AVD WS+G +L G PP+ + + ++L P + +S
Sbjct: 183 ---QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 569 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 614
KDF+ ++P +R + + L+HP+I + ++ V +I
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 193 bits (491), Expect = 4e-56
Identities = 64/313 (20%), Positives = 127/313 (40%), Gaps = 39/313 (12%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKS----AECIKQLE------ 404
+ + +G G FG V+ + TG K ++ P D + + QL
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 405 -----QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
+ + + LE++ G + + ++E+ V N+ R GL ++H + +H
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 150
Query: 460 RDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
DIK N++ + + VK+ DFG+A L + + APE++
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-------RE 203
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSEGKDFL 573
+ D+W++G +L+G P++ + + + V E +S E KDF+
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 574 LRCFLRNPVERPSAVELLEHPFIRNANYQNLS--VPMRVFSRINLGDKSHDQVERATRKT 631
+ P +R + + LEHP+++ ++ NL+ +P +++I Q +
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKG-DHSNLTSRIPSSRYNKI-------RQKIKEKYAD 315
Query: 632 ESLPDSPETRVRN 644
P R+ N
Sbjct: 316 WPAPQPAIGRIAN 328
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 69/317 (21%), Positives = 121/317 (38%), Gaps = 36/317 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------------- 405
+++G G G V N+ T A+K + P + E + Q
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 406 ---VDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRD 461
L I +E + G + +++ TE + I + YLHS N HRD
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136
Query: 462 IKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 518
+K NLL + + ++KL DFG AK T + + +P ++APEV+ G K
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEK 189
Query: 519 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------TPPIPEMLSSEGK 570
+ D+WSLG + +L G PP+ G + R P +S E K
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 249
Query: 571 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 630
+ P +R + E + HP+I + + P+ + + + V+
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIMQ-STKVPQTPLHTSRVLKEDKERWEDVKEEMTS 308
Query: 631 TESLPDSPETRVRNRKL 647
+ +++ +K+
Sbjct: 309 ALATMRVDYEQIKIKKI 325
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-54
Identities = 65/273 (23%), Positives = 109/273 (39%), Gaps = 38/273 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQ---- 405
P +SQ+Q G L+G G FGSVY G AIK V+ D ++
Sbjct: 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 406 -------------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 446
D + LE P + E + R+F +L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 447 NGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 505
+ + H+ +HRDIK N+L+D + G +KL DFG L + G+ + PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179
Query: 506 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 565
I+ + + +WSLG + +M+ G P+ E +++ + +
Sbjct: 180 WIR------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 227
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
SSE + + C P +RP+ E+ HP++++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 185 bits (470), Expect = 1e-53
Identities = 64/275 (23%), Positives = 121/275 (44%), Gaps = 34/275 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQV------ 406
+Q + +G G+FG V++ +R G A+K + I K E +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 407 ------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 454
+++ ++Y+ G + + + + + + L YLHS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
+ I+RD+K N+L+D +G +K+ DFG AK++ ++Y +L G+P+++APEV+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVS------ 174
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574
++D WS G + EML G P+ + + K+LN P + + KD L
Sbjct: 175 -TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 575 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
R R+ +R ++ HP+ + ++ L
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 183 bits (465), Expect = 2e-52
Identities = 67/279 (24%), Positives = 120/279 (43%), Gaps = 38/279 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----------- 404
+ ++IGRG FG VY +TG A+K +D K E + E
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 405 -----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
D L L+ ++ G ++ ++ +H E+ +R + I+ GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMH 124
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
+ ++RD+K AN+L+D G V+++D G+A + + G+ +MAPEV+
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL------ 177
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPPIPEMLSSEGK 570
+ D +SLGC + ++L G P+ + + L +P+ S E +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237
Query: 571 DFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 604
L R+ R A E+ E PF R+ ++Q +
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 35/261 (13%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE--------- 404
+ + + IG+G FG V +G R G A+K I +D + + +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFLAEASVMTQLRHSN 61
Query: 405 ---------QVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHS 454
+ LYI EY+ GS+ Y+R R + + F+ + + YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 514
N +HRD+ N+LV V K++DFG+ K + S + + K W APE ++
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR------ 173
Query: 515 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKDF 572
K + D+WS G + E+ + G+ P+ + +V P+ +
Sbjct: 174 -EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 573 LLRCFLRNPVERPSAVELLEH 593
+ C+ + RPS ++L E
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 55/269 (20%), Positives = 106/269 (39%), Gaps = 36/269 (13%)
Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD------ 407
K +G G FG+V G + + + A+K + +DP + + ++Q+D
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 408 -------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
+ + +E G +N+Y++++ + + + + G+ YL +N +HR
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 461 DIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQKDGN 516
D+ N+L+ K++DFG++K L + K W APE I
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-------Y 184
Query: 517 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLL 574
K + D+WS G + E + G+ P+ +G + + P E D +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244
Query: 575 RCFLRNPVERPSA---VELLEHPFIRNAN 600
C+ + RP L + + N
Sbjct: 245 LCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQLE-- 404
+ KL+G+GTFG V + + TG A+K + K + ++
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 405 ---------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 455
Q D L +EY + G + ++ TE R + I++ L YLHS
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSR 124
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 514
+ ++RDIK NL++D G +K+ DFG+ K + G+P ++APEV++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE------ 178
Query: 515 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574
+ AVD W LG + EM+ G+ P+ + + +L P LS E K L
Sbjct: 179 -DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 575 RCFLRNPVERPS-----AVELLEHPFIRNANYQNL 604
++P +R A E++EH F + N+Q++
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 27/259 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLE----- 404
S+ + IG G FG V++G AIK + + AE + +L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 405 ------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ + E++ G ++ Y+R + + G+AYL I
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
HRD+ N LV + V+K++DFGM + + + K W +PEV
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-------F 176
Query: 517 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLL 574
+ + D+WS G + E+ + GK P+ + + + P + S+ +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 575 RCFLRNPVERPSAVELLEH 593
C+ P +RP+ LL
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-49
Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 30/265 (11%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKS------AECIKQ 402
++ + + G+ IG G FG V+ G + AIK D A ++Q
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 403 LE----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
+ ++ ++I +E G + +++ + + + + + LAYL
Sbjct: 65 FDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAV 510
S +HRDI N+LV ++ VKL DFG+++++ +Y + K WMAPE I
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN-- 182
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSE 568
+ A D+W G + E+L G P+ + + ++ N P+P
Sbjct: 183 -----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 569 GKDFLLRCFLRNPVERPSAVELLEH 593
+ +C+ +P RP EL
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 5e-49
Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 38/279 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLE---------- 404
+ G+ +G G F V + TG A K + + + +E
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 405 -----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
+ + + LE V G + ++ E +TE F + ILNG+ YLH
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH 130
Query: 454 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 509
S H D+K N+++ V +K+ DFG+A + + ++ G+P ++APE++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 510 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEML 565
L L D+WS+G +L+G P+ + + V
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 604
S+ KDF+ R +++P +R + + L+HP+I+ + Q
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 8e-49
Identities = 58/271 (21%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLE------ 404
S + ++IG G FG V G + G AIK + + + + + +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 405 -----------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
+ I E++ GS++ ++R++ T + R I G+ YL
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
N +HRD+ N+LV+++ V K++DFG+++ L + + + + P A
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 514 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKD 571
K A D+WS G + E+++ G+ P+ + + + + P P S
Sbjct: 206 QYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 572 FLLRCFLRNPVERPSAVELLEH--PFIRNAN 600
+L C+ ++ RP +++ IRN N
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 32/267 (11%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ------ 405
K+++++K K++G G FG+VY G G I + S + K++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 406 --------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
+ + + + + G + YVREH +I + N+ I G+ Y
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL---KGSPNWMAPEVIK 508
L +HRD+ N+LV VK+ DFG+AK L E K WMA E I
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 566
+ D+WS G TV E++T G P+ + + P P + +
Sbjct: 187 -------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLEH 593
+ +++C++ + RP EL+
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIG---TNRETGASCAIKEVDI--IPDDPKSAECIKQLEQV--- 406
++ K++G G +G V++ + +TG A+K + I K+ E + QV
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 407 ----------------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
+ L++ L+Y++ G + ++ + R TE V+ + I+ L
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALE 143
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIK 508
+LH I+RDIK N+L+D++G V L DFG++K E + G+ +MAP++++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM 564
AVD WSLG + E+LTG P++ + ++ R PP P+
Sbjct: 204 GGDSGHDK-----AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 565 LSSEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 604
+S+ KD + R +++P +R A E+ EH F + N+ +L
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-48
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 362 IGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAEC---IKQLEQVD--------- 407
+G G FGSV G R AIK + + + E + + Q+D
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 408 ----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 463
+ L + +E G +++++ +I S V + G+ YL N +HRD+
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136
Query: 464 GANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 519
N+L+ K++DFG++K L + + K W APE I K
Sbjct: 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-------FRKF 189
Query: 520 ALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCF 577
+ D+WS G T+ E L+ G+ P+ + +GP+ M + + P E + C+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 578 LRNPVERPSA---VELLEHPFI 596
+ +RP + + +
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYY 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 3e-48
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 54/293 (18%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------------- 402
+QK + IG GT+G VY N+ TG A+K++ + + +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 -----LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 457
+ ++ LY+ E++H I +++++ +L GLA+ HS
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
+HRD+K NLL++ G +KLADFG+A+ + + + APE++ G
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL------GC 177
Query: 517 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM------------ 564
+ AVDIWSLGC EM+T + + +F++ E+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 565 -----------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
L +G+ L + +P +R SA L HPF ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 7e-48
Identities = 55/281 (19%), Positives = 101/281 (35%), Gaps = 45/281 (16%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV-------- 406
+++ G+ IG G+FG +Y+GT+ G AIK + P+ K + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 407 -------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 459
D+ + +E + S+ R + V +++ + Y+HS N IH
Sbjct: 68 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 460 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSPNWMAPEVIK 508
RD+K N L+ +V + DFG+AK +L G+ + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------PP 560
+ + D+ SLG ++ G PW + K +
Sbjct: 187 -------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 561 IPEMLSSEGKDFLLRCFLRNPVERPSA---VELLEHPFIRN 598
+ + SE +L C ++P +L + F R
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 8e-48
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 30/265 (11%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLE---- 404
+ + + +G G FG V++G A+K + P + A +KQL+
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 405 ------QVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 457
+ +YI EY+ GS+ +++ +T + + + I G+A++ N
Sbjct: 71 VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKDG 515
IHRD++ AN+LV + K+ADFG+A+ + Y K W APE I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN------- 183
Query: 516 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 573
+ D+WS G + E++T G+ P+ P+ + + P+ E +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 574 LRCFLRNPVERPSA---VELLEHPF 595
C+ P +RP+ +LE F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 68/298 (22%), Positives = 111/298 (37%), Gaps = 61/298 (20%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAE--------------- 398
Q++ IG G +G V+ + + G A+K V + +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 399 -----------CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 447
C + L + E+V + + +++ +L
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 507
GL +LHS +HRD+K N+LV +SG +KLADFG+A+ + S+ + + APEV+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----------- 556
A VD+WS+GC EM KP + + K+L+
Sbjct: 188 L-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 557 ----------------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ GKD LL+C NP +R SA L HP+ ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 61/259 (23%), Positives = 99/259 (38%), Gaps = 27/259 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLE----- 404
K +G G FG V G R AIK + A+ + L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 405 ------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
++I EY+ G + Y+RE + + + + YL S +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 516
HRD+ N LV+ GVVK++DFG+++++ Y S K W PEV+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-------Y 175
Query: 517 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLL 574
K + DIW+ G + E+ + GK P+ F + + P + S + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 575 RCFLRNPVERPSAVELLEH 593
C+ ERP+ LL +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-47
Identities = 63/268 (23%), Positives = 103/268 (38%), Gaps = 39/268 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQ------- 405
+ + +G G+FG V G S A+K + PD E + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67
Query: 406 -------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
+ + + E GS+ +R+H + + + G+ YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----KGSPNWMAPEVIK 508
S IHRD+ NLL+ +VK+ DFG+ + L + K W APE +K
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEML 565
+ A D W G T+ EM T G+ PW G Q + K+ P PE
Sbjct: 188 -------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 566 SSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ + +++C+ P +RP+ V L +
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 5e-47
Identities = 56/277 (20%), Positives = 113/277 (40%), Gaps = 39/277 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQ----LEQVD-- 407
+++ G+++G G V++ + A+K + + DP ++ ++
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 408 ----------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 451
YI +EYV ++ V +T L +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNF 126
Query: 452 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPEVI 507
H IHRD+K AN+++ A+ VK+ DFG+A+ + ++ ++ G+ +++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----E 563
+ + D++SLGC + E+LTG+PP++ ++ + P P E
Sbjct: 187 R-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600
LS++ +L+ +NP R + +R N
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-46
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 50/311 (16%)
Query: 337 SAVMPHIMEKPSA---SPKKSQWQKGKLIGRGTFGSVYIGT---NRETGASCAIKEVDII 390
SA+ P +++ P ++IGRG FG VY GT N CA+K ++ I
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66
Query: 391 PDDPKSAECIKQLE------------------QVDDHLYIYLEYVHPGSINRYVREHCRD 432
D + ++ + + + + + L Y+ G + ++R +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 433 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492
T + F + G+ +L S +HRD+ N ++D VK+ADFG+A+ + ++
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 493 L-----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 546
K WMA E ++ K D+WS G + E++T G PP+ +
Sbjct: 187 SVHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239
Query: 547 GPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH------PFIR-- 597
+L R PE + +L+C+ RPS EL+ FI
Sbjct: 240 TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
Query: 598 ----NANYQNL 604
NA Y N+
Sbjct: 300 YVHVNATYVNV 310
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 7e-46
Identities = 65/268 (24%), Positives = 118/268 (44%), Gaps = 29/268 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ-- 405
+ + +G+G FG V++GT T AIK + P++ A+ +K+L
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 406 --------VDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 456
++ +YI EY+ GS+ +++ E + + + + I +G+AY+ N
Sbjct: 74 LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 514
+HRD++ AN+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL------ 187
Query: 515 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDF 572
+ + D+WS G + E+ T G+ P+ + + +V P P D
Sbjct: 188 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246
Query: 573 LLRCFLRNPVERPSAVELLE--HPFIRN 598
+ +C+ + P ERP+ L + +
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (412), Expect = 1e-45
Identities = 49/282 (17%), Positives = 99/282 (35%), Gaps = 47/282 (16%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV--------- 406
++ G+ IG G+FG ++ GTN AIK D P+ + + + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 407 ------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 460
H + ++ + P S+ + R + V + +L + +H + ++R
Sbjct: 67 YYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 125
Query: 461 DIKGANLLVDA-----SGVVKLADFGMAKHL--------TGLSYELSLKGSPNWMAPEVI 507
DIK N L+ + ++ + DFGM K + +L G+ +M+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 508 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-----LNRTPPIP 562
+ ++ + + D+ +LG + L G PW + K ++ P+
Sbjct: 186 ---LGREQSRR----DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 563 EM---LSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRN 598
E+ E ++ P L R
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 58/292 (19%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAEC------IKQLE 404
+ + GK++G G FG V T + +V + + + S+E +K +
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 405 QVDDH---------------LYIYLEYVHPGSINRYVREHCRD----------------- 432
Q+ H +Y+ EY G + Y+R
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 433 -----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487
+T + F + G+ +L + +HRD+ N+LV VVK+ DFG+A+ +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 488 GLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 543
S + + + WMAPE + + D+WS G + E+ + G P+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 544 EFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+K++ P + E + C+ + +RPS L
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 57/289 (19%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE--------------- 404
+G G F +VY ++ T AIK++ + +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 405 ------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
++ + +++ + ++++ +T S ++ + L GL YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 459 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
HRD+K NLL+D +GV+KLADFG+AK + + + APE++
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG--- 179
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP-------------- 560
+ VD+W++GC + E+L P S+ + +F+ L
Sbjct: 180 ---VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 561 -----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
I + D + FL NP R +A + L+ + N
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 76/325 (23%), Positives = 121/325 (37%), Gaps = 58/325 (17%)
Query: 333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK------- 385
S VT+ V + P++ + K+IG G+FG VY ++G AIK
Sbjct: 1 SKVTTVVA--TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR 58
Query: 386 ----EVDII-----PDDPKSAECIKQLEQVDDHLYIYLEYVH-PGSINRYVREHCRD--- 432
E+ I+ + + + D +Y+ L + P ++ R R + R
Sbjct: 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 433 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY 491
+ V+ + + LAY+HS HRDIK NLL+D V+KL DFG AK L
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 551
+S S + APE+I G ++D+WS GC + E+L G+P + G +
Sbjct: 179 NVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 552 FKVLNRTPPIPEM-----------------------------LSSEGKDFLLRCFLRNPV 582
+++ E R P
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 583 ERPSAVELLEHPFIRNANYQNLSVP 607
R + +E H F N+ +P
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKLP 317
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (412), Expect = 3e-45
Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 43/290 (14%)
Query: 344 MEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
E PS + + Q+ + K +G G+FG V + ++E+G A+K +D + +KQ
Sbjct: 30 WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQ 84
Query: 403 LEQVDDHLYIYLEYVHPGSINRYVREHCRD-----------------------ITESIVR 439
+E + I P + +E R
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 440 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 499
+ I+ YLHS + I+RD+K NLL+D G +++ DFG AK + G ++ +L G+P
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTP 202
Query: 500 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 559
+APE+I + AVD W+LG + EM G PP+ + Q K+++
Sbjct: 203 EALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 560 PIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 604
P SS+ KD L + +R ++ H + ++ +
Sbjct: 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-45
Identities = 59/266 (22%), Positives = 107/266 (40%), Gaps = 34/266 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLE----- 404
S + K+IG G FG VY G + + AIK + + + + + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 405 ------------QVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
+ I EY+ G++++++RE + + + R I G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIK 508
+ N +HRD+ N+LV+++ V K++DFG+++ L K W APE I
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLS 566
K A D+WS G + E++T + K +N P P
Sbjct: 187 -------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 567 SEGKDFLLRCFLRNPVERPSAVELLE 592
S +++C+ + RP +++
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-45
Identities = 59/308 (19%), Positives = 112/308 (36%), Gaps = 70/308 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----------- 402
S+++K IG+GTFG V+ +R+TG A+K+V + + +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 403 ---------------LEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 447
+ +Y+ ++ + T S ++ + +LN
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 448 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSPNWM 502
GL Y+H +HRD+K AN+L+ GV+KLADFG+A+ + + + + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 503 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP 559
PE++ G +D+W GC + EM T P +E + ++
Sbjct: 189 PPELLL------GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 560 P-----------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVEL 590
P + D + + + +P +R + +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 591 LEHPFIRN 598
L H F +
Sbjct: 303 LNHDFFWS 310
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (406), Expect = 5e-45
Identities = 59/274 (21%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLE--- 404
+++ +G G +G VY G ++ + A+K + + + A +K+++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 405 --------QVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHST 455
+ YI E++ G++ Y+RE R +++ ++ I + + YL
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 456 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQK 513
N IHRD+ N LV + +VK+ADFG+++ +TG +Y K W APE +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----- 189
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKD 571
K ++ D+W+ G + E+ T ++++L + PE + +
Sbjct: 190 --YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 572 FLLRCFLRNPVERPSAVELLE--HPFIRNANYQN 603
+ C+ NP +RPS E+ + + ++ +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (402), Expect = 2e-44
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 56/291 (19%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------------C 399
++ + IG GT+G VY N G + A+K++ + +D
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 400 IKQLEQV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 456
I +L V L + E++ + ++F +LNG+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDG 515
+HRD+K NLL++ G +K+ADFG+A+ + + + AP+V+ G
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM------G 174
Query: 516 NPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP------------ 560
+ K + +DIWS+GC EM+ G P + SE + +F++L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 561 --------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ L G D L + +P +R +A + LEH + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 8e-44
Identities = 54/301 (17%), Positives = 110/301 (36%), Gaps = 64/301 (21%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE--------- 404
++ IG G +G V + AIK++ +++++
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 405 -----------QVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
++ +YL ++ + + ++ + ++ + F IL GL Y+
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYI 125
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIK 508
HS N +HRD+K +NLL++ + +K+ DFG+A+ + + APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM- 184
Query: 509 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM---- 564
+ ++DIWS+GC + EML+ +P + + +L +
Sbjct: 185 -----LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 565 ---------------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
S+ D L + NP +R + L HP++
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
Query: 598 N 598
Sbjct: 300 Q 300
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 3e-43
Identities = 57/299 (19%), Positives = 106/299 (35%), Gaps = 62/299 (20%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAE 398
+E P ++ + + IG G FG V+ E A+K + A+
Sbjct: 8 LEYP-----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 399 CIKQLE-----------------QVDDHLYIYLEYVHPGSINRYVREHCRD--------- 432
++ V + + EY+ G +N ++R
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 433 --------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478
++ + R + G+AYL +HRD+ N LV + VVK+A
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182
Query: 479 DFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 535
DFG+++++ Y + WM PE I + D+W+ G + E+
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------YNRYTTESDVWAYGVVLWEI 235
Query: 536 LT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592
+ G P+ + ++ V + PE E + + C+ + P +RPS +
Sbjct: 236 FSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-43
Identities = 57/277 (20%), Positives = 103/277 (37%), Gaps = 44/277 (15%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLE------- 404
+ + +IG G FG V ++ G AIK + + +LE
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 405 -----------QVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIV 438
+ +LY+ +EY G++ ++R+ ++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 439 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 498
+F + G+ YL IHRD+ N+LV + V K+ADFG+++ + +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 189
Query: 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-N 556
WMA E + D+WS G + E+++ G P+ + K+
Sbjct: 190 VRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 557 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
P E D + +C+ P ERPS ++L
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 52/291 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVDD-H 409
+++K + IG GT+G+V+ NRET A+K V + DD + L+++ +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 410 LYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNT 457
+ + +H V E C D+ IV++F +L GL + HS N
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 458 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
+HRD+K NLL++ +G +KLA+FG+A+ S + W P + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST- 181
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPP------------- 560
++D+WS GC E+ P + + +F++L
Sbjct: 182 ----SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 561 -------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598
+ L++ G+D L NPV+R SA E L+HP+ +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 71/327 (21%), Positives = 125/327 (38%), Gaps = 68/327 (20%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK-----------------EVDII----- 390
++ ++ + +G G +G+V + TGA AIK E+ ++
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76
Query: 391 PDDPKSAECIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 450
+ + E +DD YL G+ + +H + + E ++ +L GL
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLR 135
Query: 451 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 510
Y+H+ IHRD+K NL V+ +K+ DFG+A+ + + APEVI
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVIL-- 191
Query: 511 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP------- 560
+ VDIWS+GC + EM+TGK + + + + KV P
Sbjct: 192 ----NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 561 ---------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
I S + L + + + +R +A E L HP+ +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 600 NYQNLSVPMRVFSRINLGDKSHDQVER 626
+ ++ + D S D V+R
Sbjct: 308 HDTEDEPQVQKY------DDSFDDVDR 328
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 153 bits (387), Expect = 6e-42
Identities = 58/301 (19%), Positives = 104/301 (34%), Gaps = 67/301 (22%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDH------ 409
+Q + +GRG + V+ N +K + + E IK LE +
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-IKILENLRGGPNIITL 95
Query: 410 -----------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 458
+ E+V+ ++ + +T+ +R + IL L Y HS +
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 459 HRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 517
HRD+K N+++D ++L D+G+A+ S + PE
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE------LLVDYQ 205
Query: 518 KLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR---------------- 557
++D+WSLGC + M+ K P+ ++ + KVL
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 558 ------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599
++S E DFL + + R +A E +EHP+
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325
Query: 600 N 600
Sbjct: 326 V 326
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 58/287 (20%), Positives = 111/287 (38%), Gaps = 52/287 (18%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQV 406
+ + + GK +GRG FG V T + A+K + + + +L+ +
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 407 -------------------DDHLYIYLEYVHPGSINRYVREHCRD--------------- 432
L + +E+ G+++ Y+R +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 433 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492
+T + ++ + G+ +L S IHRD+ N+L+ VVK+ DFG+A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 493 L---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP 548
+ + WMAPE I + + D+WS G + E+ + P+ +
Sbjct: 191 VRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 549 QAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ + L P+ + E +L C+ P +RP+ EL+EH
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 61/295 (20%), Positives = 109/295 (36%), Gaps = 59/295 (20%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + A+K + +
Sbjct: 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 62
Query: 397 AECIKQLE------------------QVDDHLYIYLEYVHPGSINRYVREHCRD------ 432
++ I ++E D LY+ +EY G++ Y++
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122
Query: 433 ---------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 483
++ + + + G+ YL S IHRD+ N+LV V+K+ADFG+A
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 484 KHLTGLSYELSL---KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 540
+ + + Y + WMAPE + + D+WS G + E+ T
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 541 PWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593
+ +FK+L P ++E + C+ P +RP+ +L+E
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 59/304 (19%), Positives = 113/304 (37%), Gaps = 60/304 (19%)
Query: 342 HIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDI 389
++ P+ P +W GK +G G FG V T + + A+K +
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 390 IPDDPKSAECIKQLE------------------QVDDHLYIYLEYVHPGSINRYVREHCR 431
+ + +L+ + + EY G + ++R
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 432 D-----------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 474
+ + +F+ + G+A+L S N IHRD+ N+L+ +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 475 VKLADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 531
K+ DFG+A+ + S + + WMAPE I N D+WS G
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGIF 236
Query: 532 VIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 588
+ E+ + G P+ +K++ PE +E D + C+ +P++RP+
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 589 ELLE 592
++++
Sbjct: 297 QIVQ 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 49/292 (16%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE-- 404
+ + + +G+G+FG VY G + E AIK V+ + E + +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 405 ---------------QVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRN 440
+ +E + G + Y+R + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 441 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKG 497
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 498 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLN 556
WM+PE +K + D+WS G + E+ T + P+ Q + V+
Sbjct: 198 PVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 557 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE------HPFIRNANY 601
P+ + + C+ NP RPS +E++ P R ++
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-39
Identities = 61/308 (19%), Positives = 110/308 (35%), Gaps = 77/308 (25%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ----LEQVD----- 407
Q K IG G G V + + AIK++ + A+ + ++ V+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 408 ---------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 452
+Y+ +E + + ++ + +L G+ +L
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 453 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 512
HS IHRD+K +N++V + +K+ DFG+A+ + + APEVI
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL---- 191
Query: 513 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEML------ 565
VDIWS+GC + EM+ K + + KV+ P PE +
Sbjct: 192 ---GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 566 -----------------------------------SSEGKDFLLRCFLRNPVERPSAVEL 590
+S+ +D L + + +P +R S +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 591 LEHPFIRN 598
L+HP+I
Sbjct: 309 LQHPYINV 316
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 57/288 (19%), Positives = 100/288 (34%), Gaps = 59/288 (20%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQVD---------- 407
+ IG+G FG V+ G + G A+K + E I Q +
Sbjct: 8 QESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 408 --------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS----- 454
L++ +Y GS+ Y+ + +T + +GLA+LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 455 ---TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEV 506
HRD+K N+LV +G +AD G+A + + + G+ +MAPEV
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 507 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------- 558
+ + + + DI+++G E+ E Q + L +
Sbjct: 184 LDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 559 ---------PPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 592
P IP S + C+ N R +A+ + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-36
Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 64/295 (21%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE------------------ 398
Q +G G +GSV + +TG A+K++ A+
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 399 -----CIKQLEQVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 453
+ + + ++ +N V+ C+ +T+ V+ IL GL Y+H
Sbjct: 81 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIH 138
Query: 454 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 513
S + IHRD+K +NL V+ +K+ DFG+A+H + + APE++
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML----- 191
Query: 514 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML-------- 565
VDIWS+GC + E+LTG+ + + + +L L
Sbjct: 192 -NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 566 -----------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597
+ D L + + + +R +A + L H +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (314), Expect = 7e-32
Identities = 64/340 (18%), Positives = 115/340 (33%), Gaps = 95/340 (27%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQVDD------ 408
+ + +G G F +V++ + A+K V ++AE IK L++V+D
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 409 -----------------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 445
H+ + E + + + R I V+ ++ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 446 LNGLAYL-HSTNTIHRDIKGANLLVDASGV------VKLADFGMAKHLTGLSYELSLKGS 498
L GL Y+ IH DIK N+L++ +K+AD G A + + +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 192
Query: 499 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----------- 547
+ +PEV+ DIWS C + E++TG + EG
Sbjct: 193 REYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 548 ---------PQAMFK----------------------------VLNRTPPIPEMLSSEGK 570
P + + VL + + E
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 571 DFLLRCFLRNPVERPSAVELLEHPFIRNA-NYQNLSVPMR 609
DFL +P +R A L+ HP++++ + + VP R
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 345
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 3e-21
Identities = 27/198 (13%), Positives = 55/198 (27%), Gaps = 33/198 (16%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQVDDHLYIYLEYV- 417
GKL+G G +V+ + E C +K + K + + + +
Sbjct: 5 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 418 ---------HPGSINRY------------VREHCRDITESIVRNFTRHILNGLAYLHSTN 456
Y + + IL +A +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 457 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 516
+H D+ N+LV G + + DF + + + L+ I +
Sbjct: 124 IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE-----RDVRNIITYFSRTYR 177
Query: 517 PKLALAVDIWSLGCTVIE 534
+ DI S +++
Sbjct: 178 TE----KDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.39 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=438.97 Aligned_cols=236 Identities=28% Similarity=0.526 Sum_probs=206.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|+++.+|+.||||++.... .. ....+++..+.. .++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999985321 11 111222333332 357899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|||+||+|.++|.+. +.+++..++.|+.||++||+|||++|||||||||+||||+.+|.+||+|||+|+..... ....
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT 163 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence 999999999999765 67999999999999999999999999999999999999999999999999999876543 3346
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|..+++++++||.
T Consensus 164 ~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 164 LCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp TTEEGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred cCCCCcccCHHHHcC-------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 789999999999973 4578899999999999999999999999888888888888888999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHcCccccc
Q 005007 575 RCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 575 ~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
+||+.||++|||++|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=441.36 Aligned_cols=243 Identities=27% Similarity=0.556 Sum_probs=207.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-h---hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-P---KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~---~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
++|+++++||+|+||+||+|+++.+|+.||||+++... .. . +++++++.+.+ .++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986321 11 1 12222222221 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---cc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---~~ 491 (720)
|||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ..
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999999999765 67999999999999999999999999999999999999999999999999999876432 23
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 571 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~d 571 (720)
..+.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|..+++++++
T Consensus 167 ~~~~~GT~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239 (288)
T ss_dssp ---CCCCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred cccccCCccccCceeecc-------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 345789999999999974 4688999999999999999999999999888888888998888999999999999
Q ss_pred HHHHhhhcCCCCCCCHHH------HHcCcccccccccCC
Q 005007 572 FLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 604 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~E------LL~Hpff~~~~~~~l 604 (720)
||.+||+.||.+|||++| +++||||+..+++.+
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 999999999999999987 688999998876654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=441.12 Aligned_cols=238 Identities=36% Similarity=0.600 Sum_probs=203.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
..+|++++.||+|+||+||+|+++.+|+.||||+++...... ...+++..+.. .++.+||||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 458999999999999999999999999999999987543221 12222222222 36789999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
|+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+... ......
T Consensus 99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 999999998865 46999999999999999999999999999999999999999999999999999876543 344567
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---CCCCCccCCHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSSEGKDF 572 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---~~~iP~~ls~el~dL 572 (720)
+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+... ....|..+++++++|
T Consensus 177 ~gt~~Y~aPE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 177 VGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp CSCGGGCCHHHHSS-------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred ccCCCccChhhhcC-------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 89999999999863 45788999999999999999999999988877777766543 344567899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||+.||++|||++|+|+||||+..
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=438.96 Aligned_cols=239 Identities=25% Similarity=0.422 Sum_probs=196.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC---hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~---~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
.++|+++++||+|+||+||+|+++.+|+.||||+++..... ....++++.+.. .++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46899999999999999999999999999999998754321 112223333332 3678999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---ccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYE 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~---~~~ 492 (720)
||+||+|.++|... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999999999654 67999999999999999999999999999999999999999999999999999876432 233
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH-HHhccCC--CCCccCCHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTP--PIPEMLSSEG 569 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~-ki~~~~~--~iP~~ls~el 569 (720)
...+||+.|||||++.+ ...++.++|||||||+||||++|++||.......... .+..... .....+++++
T Consensus 163 ~~~~GT~~Y~APE~~~~------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp CCCCSCGGGSCTHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cceeeCcCccCHhHhcC------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 56789999999999974 3445788999999999999999999997654433333 3333222 2235789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
++||.+||+.||++|||++|+|+||||+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 99999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=435.09 Aligned_cols=243 Identities=33% Similarity=0.579 Sum_probs=206.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-----hhHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-----~~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
+.|++++.||+|+||+||+|+++.+|+.||||+++..... .++++++..+.+ .++.+|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4799999999999999999999999999999998754322 123333333332 367899999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLK 496 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~~ 496 (720)
+||+|.+++.+..+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..... ....+.+
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~ 171 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccc
Confidence 999999998877678999999999999999999999999999999999999999999999999999765432 2334678
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEGKDFL 573 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---~iP~~ls~el~dLI 573 (720)
||+.|||||++.+.. .....|+.++|||||||+||||++|++||.+.+..+.+.++..... ..|..+++++++||
T Consensus 172 Gt~~y~APE~l~~~~--~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 172 GTPYWMAPEVVMCET--SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp SCCTTCCHHHHTTCS--TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccCCHHHHhhcc--cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 999999999986421 1235688999999999999999999999999888888888876543 34568999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccc
Q 005007 574 LRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
.+||+.||++|||++|+|+||||+.
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=444.37 Aligned_cols=241 Identities=31% Similarity=0.514 Sum_probs=210.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC----CCC-hhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDD-PKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~----~~~-~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ... .....+++.+.. .++.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5899999999999999999999999999999998632 111 112223333332 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-ccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~ 493 (720)
|||+||+|.+++.+. +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.... .....
T Consensus 85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 999999999999775 6799999999999999999999999999999999999999999999999999987644 34455
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI 573 (720)
..+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++......+|..+++++++||
T Consensus 164 ~~~GT~~Y~aPE~~~~-------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp CCEECGGGCCGGGGSS-------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cceeCHHHhhhhhccC-------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 6889999999999863 468899999999999999999999999999888888999999999999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 574 LRCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 574 ~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
.+||++||.+|+ +++|+++||||+..++.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 999999999999 49999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=429.87 Aligned_cols=236 Identities=28% Similarity=0.452 Sum_probs=191.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH----HHHHHhh----------------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE----CIKQLEQ----------------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~----~ik~L~~----------------~~~~lyLV 413 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++.........+ +++.+.. .++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 589999999999999999999999999999999976554433222 2222221 13568999
Q ss_pred EEeccCCCHHHHHHHh---cCCCcHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCCceeecCCCCeeeeccccchh
Q 005007 414 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN-----TIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIL~gL~yLHs~g-----IVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
||||+||+|.+++.+. ...+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999642 457999999999999999999999876 99999999999999999999999999998
Q ss_pred ccCc-cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC-CCCCc
Q 005007 486 LTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 563 (720)
Q Consensus 486 ~~~~-~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-~~iP~ 563 (720)
+... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++.... ..+|.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNR-------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236 (269)
T ss_dssp C-----------CCCSCCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred cccCCCccccCCCCcccCCHHHHcC-------CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 7543 33456789999999999863 468899999999999999999999999988888877777554 46788
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 596 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff 596 (720)
.+++++++||.+||+.||.+|||++|||+|||+
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 899999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-52 Score=438.72 Aligned_cols=240 Identities=25% Similarity=0.429 Sum_probs=190.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh------hHHHHHHHHhh-----------cCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQ-----------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~------~~~~~ik~L~~-----------~~~~lyLVm 414 (720)
..++|+++++||+|+||+||+|+++.+|+.||||++....... .++.++..+.+ .++.+||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999999999999999986543221 22333333321 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec---CCCCeeeeccccchhccCccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd---~~g~VKL~DFGlA~~~~~~~~ 491 (720)
|||+||+|.++|.+. +.+++..++.|+.||+.||+|||++|||||||||+|||+. .+|.+||+|||+++.......
T Consensus 87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 999999999999764 6799999999999999999999999999999999999994 578999999999988776666
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC----CccCCH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----PEMLSS 567 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i----P~~ls~ 567 (720)
..+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+....+....+......+ +..+++
T Consensus 166 ~~~~~GT~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQ-------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------CTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred eeeeeeCccccCcHHHcC-------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 667889999999999863 457899999999999999999999999988888888887765544 357899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++||.+||++||++|||++|+|+||||+..
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=439.67 Aligned_cols=242 Identities=28% Similarity=0.546 Sum_probs=195.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHH---HHhh--------------cCCEEEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK---QLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik---~L~~--------------~~~~lyLVm 414 (720)
..++|+++++||+|+||+||+|+++.+|+.||||+++............+ .+.. .++++||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45689999999999999999999999999999999976543322222222 2222 367799999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCCCeeeeccccchhccCccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~ 493 (720)
|||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 84 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~ 161 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 161 (322)
T ss_dssp ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC-
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccc
Confidence 999999999999775 679999999999999999999997 59999999999999999999999999999876542 334
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHH---------------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF--------------------- 552 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~--------------------- 552 (720)
+.+||++|||||++.+ ..|+.++||||||||+|||++|+.||.+.+..+...
T Consensus 162 ~~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp --CCSSCCCCHHHHHC-------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred cccCCccccCchHHcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 6789999999999984 468899999999999999999999997644322110
Q ss_pred ---------------------HHhcc-CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 553 ---------------------KVLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 553 ---------------------ki~~~-~~~iP-~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
.+... .+.++ ..++.+++|||.+||+.||++|||++|+|+||||+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence 01111 11222 2368999999999999999999999999999999865543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-51 Score=442.88 Aligned_cols=241 Identities=26% Similarity=0.440 Sum_probs=208.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----hHHHHHHHHhh-----------cCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----KSAECIKQLEQ-----------VDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----~~~~~ik~L~~-----------~~~~lyLVmEy~ 417 (720)
++|++++.||+|+||+||+|+++.+|+.||||++....... +++.++..+.+ .++.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999999999999999986532211 12222233321 367899999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC--CCCeeeeccccchhccCccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~--~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+||+|.++|.+..+.+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+++.+.......+.
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 999999999766678999999999999999999999999999999999999964 589999999999988776666778
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGKD 571 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~d 571 (720)
.||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+.++......++ ..+++++++
T Consensus 186 ~gT~~Y~aPEv~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 186 TGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp CSCTTTCCHHHHHT-------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred cCcccccCHHHHcC-------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 99999999999974 4678999999999999999999999998888888888887665554 468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
||.+||+.||++|||++|+|+||||+....
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=429.02 Aligned_cols=243 Identities=26% Similarity=0.454 Sum_probs=207.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-----------hHHHHHHHHhh-----------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----------KSAECIKQLEQ-----------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-----------~~~~~ik~L~~-----------~~~~ 409 (720)
..++|++++.||+|+||+||+|+++.+|+.||||+++...... +++.+++.+.+ .++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999999999999999986432111 12222333322 3678
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC----Ceeeeccccchh
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKH 485 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g----~VKL~DFGlA~~ 485 (720)
+|||||||+||+|.++|.+. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+++.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999999775 6799999999999999999999999999999999999998776 599999999988
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC---
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 562 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP--- 562 (720)
........+..||+.|||||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+.++......++
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred cCCCccccccCCCCcccCHHHHcC-------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 776666677889999999999963 4688999999999999999999999999888888888887766554
Q ss_pred -ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 563 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 563 -~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
..+++++++||++||+.||.+|||++|+|+||||+...++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 4689999999999999999999999999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.1e-51 Score=424.23 Aligned_cols=244 Identities=25% Similarity=0.473 Sum_probs=210.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--------------hHHHHHHHHh-h-----------c
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------------KSAECIKQLE-Q-----------V 406 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--------------~~~~~ik~L~-~-----------~ 406 (720)
.++|++++.||+|+||+||+|+++.+|+.||||+++...... ++..++..+. + .
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997654321 1122223332 1 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
++++|||||||+||+|.++|+.. +.+++..++.|+.||++||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 67899999999999999999775 67999999999999999999999999999999999999999999999999999987
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP---- 562 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP---- 562 (720)
.........+||+.|+|||++.+.... ....++.++||||+|||+|||++|+.||.+.+..+.+..++.+...++
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~-~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCCceeeeeccCCCCCHHHhhccccc-cCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 765556667899999999999865432 345689999999999999999999999999888888888877655433
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 563 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 563 ~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 378999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-51 Score=434.27 Aligned_cols=239 Identities=26% Similarity=0.504 Sum_probs=208.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CCh-hHHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDP-KSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~-~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++... ... ...+++..+.. .++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 47999999999999999999999999999999986321 111 11222222322 367899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ..+
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 160 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence 999999999998765 67999999999999999999999999999999999999999999999999999876543 346
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+.+++.....+|..++++++++|.
T Consensus 161 ~~Gt~~Y~APE~l~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 161 LCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp CCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCcccccCHHHHcC-------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 789999999999863 4588899999999999999999999999988899999999989999999999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 575 RCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 575 ~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+||++||.+|+ |++|+|+||||++..++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 99999999996 99999999999887654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-51 Score=441.25 Aligned_cols=239 Identities=22% Similarity=0.380 Sum_probs=207.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh--hHHHHHHHHhh--------------cCCEEEEEEEec
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--KSAECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~--~~~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++...... ...+++..+.. .++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999999999999999987543111 11122222222 367899999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeec--CCCCeeeeccccchhccCccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd--~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+||+|.+++......+++.+++.|+.||+.||+|||++|||||||||+||||+ .+|.|||+|||+|+.+.........
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~ 188 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence 99999998877666799999999999999999999999999999999999997 5789999999999988776666778
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCC----ccCCHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EMLSSEGKD 571 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP----~~ls~el~d 571 (720)
.||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.++......++ ..+++++++
T Consensus 189 ~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 189 TATAEFAAPEIVDR-------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp CSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred cCcccccCHHHHcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 89999999999863 5689999999999999999999999999888888888887665554 468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
||.+||++||.+|||++|+|+||||+..
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=421.00 Aligned_cols=233 Identities=28% Similarity=0.512 Sum_probs=193.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhhc------------------CCEEEE
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQV------------------DDHLYI 412 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~~------------------~~~lyL 412 (720)
-|++.++||+|+||+||+|.++.+++.||||++.......... ++++.+.+. +..+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3478889999999999999999999999999987544332222 222222221 345899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCceeec-CCCCeeeeccccchhccCc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~g--IVHRDIKP~NILLd-~~g~VKL~DFGlA~~~~~~ 489 (720)
|||||+||+|.+++.+. ..+++..++.|+.||++||+|||+++ ||||||||+||||+ .++.+||+|||+++....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 99999999999999765 67999999999999999999999998 99999999999996 578999999999986543
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh-ccC--CCCCccCC
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRT--PPIPEMLS 566 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~-~~~--~~iP~~ls 566 (720)
....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+......+.+.+ ... ..++..++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~--------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TSBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CccCCcccCccccCHHHhC--------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 3345678999999999875 247889999999999999999999998776655554444 332 23456789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVELLEHPFIR 597 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~ 597 (720)
+++++||.+||+.||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=432.67 Aligned_cols=240 Identities=29% Similarity=0.538 Sum_probs=208.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccC----CCCh-hHHHHHHHH----hh-----------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDDP-KSAECIKQL----EQ-----------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~----~~~~-~~~~~ik~L----~~-----------~~~~lyLV 413 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++.. .... ....++..+ .+ .++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999632 1111 111112111 11 36789999
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-ccc
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYE 492 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~ 492 (720)
||||+||+|.++|... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 9999999999999765 67999999999999999999999999999999999999999999999999999866433 334
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 572 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dL 572 (720)
...+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+.++....+.+|..+++++++|
T Consensus 161 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233 (320)
T ss_dssp CCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccCCCCCcCCHHHHcC-------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 45789999999999973 46889999999999999999999999998888888889889999999999999999
Q ss_pred HHHhhhcCCCCCCCHH-HHHcCcccccccc
Q 005007 573 LLRCFLRNPVERPSAV-ELLEHPFIRNANY 601 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~-ELL~Hpff~~~~~ 601 (720)
|.+||++||.+|||+. |+++||||+..++
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 9999999999999996 8999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=436.54 Aligned_cols=239 Identities=29% Similarity=0.493 Sum_probs=209.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CC-hhHHHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD-PKSAECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~-~~~~~~ik~L~~--------------~~~~lyLVm 414 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++... .. ....++++.+.. ..+.+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999999999999999986321 11 112233333332 256789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
||+.||+|..++.+. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... ..+
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 999999999999775 67999999999999999999999999999999999999999999999999999877543 346
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~ls~el~dLI~ 574 (720)
.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+....+.++......+|..+++++.+||+
T Consensus 198 ~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 198 LCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred ccCccccCCHHHHcC-------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 789999999999973 4578999999999999999999999999888888899999999999999999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHcCccccccccc
Q 005007 575 RCFLRNPVERP-----SAVELLEHPFIRNANYQ 602 (720)
Q Consensus 575 ~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~~ 602 (720)
+||++||.+|+ |++|||+||||+..++.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 99999999995 99999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-51 Score=440.63 Aligned_cols=241 Identities=27% Similarity=0.459 Sum_probs=202.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC----CCh----hHHHHHHHHhh--------------cCCEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDP----KSAECIKQLEQ--------------VDDHLY 411 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~----~~~----~~~~~ik~L~~--------------~~~~ly 411 (720)
++|+++++||+|+||+||+|+++.+|+.||||++.... ... .+..++..+.. .++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 58999999999999999999999999999999985321 111 11112222221 357799
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
||||||+||+|.++|.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~ 161 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K 161 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence 999999999999999775 67999999999999999999999999999999999999999999999999999876543 3
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH---HHHHHHhccCCCCCccCCHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSE 568 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~---~~i~ki~~~~~~iP~~ls~e 568 (720)
....+||+.|||||++.. ...|+.++|||||||+||||++|+.||...... +....+......+|..++++
T Consensus 162 ~~~~~GT~~y~APE~~~~------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235 (364)
T ss_dssp CCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred ccccccccccchhHHhhc------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence 345689999999999863 346889999999999999999999999765432 23334445667788899999
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 005007 569 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQ 602 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPT-----a~ELL~Hpff~~~~~~ 602 (720)
+++||.+||++||.+||| ++|+|+||||++.++.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 999999999999999999 7999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-50 Score=425.32 Aligned_cols=238 Identities=31% Similarity=0.555 Sum_probs=201.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-----HHHHHHHhh--------------cCCEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----AECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-----~~~ik~L~~--------------~~~~lyLVm 414 (720)
..|++++.||+|+||+||+|+++.+|+.||||+++........ .++++.+.. .++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999999999999999999765432221 122222222 267899999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccccc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 494 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t 494 (720)
|||.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.... ...
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~ 170 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 170 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCc
Confidence 999999997776554 6799999999999999999999999999999999999999999999999999987644 345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCC--CCccCCHHHHHH
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP--IPEMLSSEGKDF 572 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~--iP~~ls~el~dL 572 (720)
.+||+.|||||++.+. ....|+.++|||||||++|||++|+.||.+....+.+.++...... .+..+++++++|
T Consensus 171 ~~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp CCSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred cccCccccCHHHHhcc----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 6899999999999642 1245888999999999999999999999988888888877755432 345689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 573 LLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 573 I~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
|.+||+.||.+|||++|+|+||||...
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=429.72 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=208.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHHHhh--------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
.++|++++.||+|+||+||+|.++.+|+.||||+++....+... .++++.+.. .++++|||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46899999999999999999999999999999999765432211 122222222 367899999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC--CCeeeeccccchhccCccccccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~--g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+||+|.++|.+....++|.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++...........
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999998765679999999999999999999999999999999999999854 48999999999887766666677
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCc----cCCHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE----MLSSEGKD 571 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~----~ls~el~d 571 (720)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......+.+.+++.....++. .+++++++
T Consensus 164 ~~t~~y~ape~~~~-------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 164 FTAPEYYAPEVHQH-------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp ESCGGGSCHHHHTT-------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred ccccccccchhccC-------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 89999999999863 56889999999999999999999999998888888888888777764 68999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 572 FLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 572 LI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
||.+||++||.+|||++|+|+||||+..
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=414.14 Aligned_cols=234 Identities=28% Similarity=0.495 Sum_probs=198.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCC-----------CChhHHHHHHHHhh-------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----------DDPKSAECIKQLEQ-------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~-----------~~~~~~~~ik~L~~-------------~~ 407 (720)
..++|+++++||+|+||+||+|+++.+|+.||||+++... ....++.+++.+.. .+
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 3568999999999999999999999999999999986421 11234555555541 25
Q ss_pred CEEEEEEEeccC-CCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-CCCeeeeccccchh
Q 005007 408 DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKH 485 (720)
Q Consensus 408 ~~lyLVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-~g~VKL~DFGlA~~ 485 (720)
+.+|+||||+.+ ++|.+++... ..+++..++.|+.||++||+|||++||+||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 678999999986 6788888765 67999999999999999999999999999999999999985 47999999999976
Q ss_pred ccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCCCccC
Q 005007 486 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 565 (720)
Q Consensus 486 ~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~iP~~l 565 (720)
... ....+.+||+.|||||++.+ ...++.++|||||||++|||++|+.||... ..+......++..+
T Consensus 161 ~~~-~~~~~~~GT~~y~aPE~~~~------~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~ 227 (273)
T d1xwsa_ 161 LKD-TVYTDFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV 227 (273)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCC
T ss_pred ccc-ccccccccCCCcCCHHHHcC------CCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCC
Confidence 544 33456789999999999985 345678899999999999999999999753 23556677788899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 566 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 566 s~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
++++++||.+||+.||++|||++|+|+||||++.
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=416.14 Aligned_cols=240 Identities=29% Similarity=0.485 Sum_probs=200.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCC-CcEEEEEEeccCCCC-------hhHHHHHHHHhh-------------------c
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDD-------PKSAECIKQLEQ-------------------V 406 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~t-g~~VAVK~l~~~~~~-------~~~~~~ik~L~~-------------------~ 406 (720)
++|++++.||+|+||+||+|++..+ ++.||||+++..... .+++.+++.|.. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999776 567999998643211 123444454432 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
+..+|++||||.++.+..........+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 23579999999988776666555677999999999999999999999999999999999999999999999999999877
Q ss_pred cCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC--------
Q 005007 487 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------- 558 (720)
Q Consensus 487 ~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~-------- 558 (720)
..........||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.+++...
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~-------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccCCCcccChhhcCcchhcC-------CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 66666677889999999999973 568899999999999999999999999888777766654210
Q ss_pred -------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 -------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 -------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..++..+++++++||.+||++||++|||++|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 012345789999999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=418.53 Aligned_cols=236 Identities=25% Similarity=0.408 Sum_probs=191.2
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC-------hhHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------PKSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~-------~~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
.+++||+|+||+||+|+++.+|+.||||+++..... ....+++..+.. .++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 578999999999999999999999999998653321 112223333322 35679999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc-cccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~-~~~~t~ 495 (720)
|.|+++..++ .....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 9987766555 44577999999999999999999999999999999999999999999999999999876543 334567
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC----------------
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---------------- 559 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---------------- 559 (720)
+||+.|||||++.+ ...|+.++|||||||++|||++|++||.+....+.+.++.....
T Consensus 161 ~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 161 VVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ecChhhccHHHHcc------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 89999999999863 34688999999999999999999999998888777766643100
Q ss_pred -------CC-----CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 -------PI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 -------~i-----P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.. ...+++++++||.+||+.||++|||++|+|+||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00 124688999999999999999999999999999998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=428.60 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=195.4
Q ss_pred CCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHh-h---------------cCCEEEEEEEe
Q 005007 354 SQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-Q---------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~-k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~-~---------------~~~~lyLVmEy 416 (720)
++|++. ++||+|+||+||+|+++.+|+.||||+++......++++++..+. + .++++||||||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 589876 569999999999999999999999999975433333333333222 1 13558999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCcccc
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~~~ 492 (720)
|+||+|.++|.+.+ ..|+|.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+........
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~ 170 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCcc
Confidence 99999999997653 46999999999999999999999999999999999999975 567999999999988776667
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHH----hccCCCCC----cc
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV----LNRTPPIP----EM 564 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki----~~~~~~iP----~~ 564 (720)
...+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+..+....+ ......+| ..
T Consensus 171 ~~~~gt~~y~aPE~~~~-------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 171 TTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCCSCCCSSCCCCCCCG-------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred ccccCCcccCCcHHHcC-------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence 77889999999999864 45788999999999999999999999876554443333 23333444 35
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+++++++||.+||++||++|||+.|+|+||||...
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 89999999999999999999999999999999653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=408.86 Aligned_cols=241 Identities=29% Similarity=0.506 Sum_probs=194.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|+++++||+|+||+||+|+++.+|+.||||+++..... ....++++.+.+ .++++|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999999999999999999654322 122233333332 3678999999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccC-cccccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~-~~~~~t 494 (720)
|+.++.+..+.......+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.... ......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 9975544444444456799999999999999999999999999999999999999999999999999987754 334456
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC---------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------------- 559 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~--------------- 559 (720)
..||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+..+.+.++.....
T Consensus 162 ~~gt~~y~apE~~~~------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp CBCCCTTCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ecccceeeehhhhcc------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 689999999999863 34578899999999999999999999998877776666542100
Q ss_pred ---CC-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 ---PI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 ---~i-----------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.+ ...+++++++||.+||+.||++|||+.|+|+||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 01 124678999999999999999999999999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=416.68 Aligned_cols=242 Identities=27% Similarity=0.418 Sum_probs=199.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhHHHHHHHHhh-----------------cCCEEEEEEEe
Q 005007 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQ-----------------VDDHLYIYLEY 416 (720)
Q Consensus 355 ~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~~~~ik~L~~-----------------~~~~lyLVmEy 416 (720)
+|+.+++||+|+||+||+|+++.+|+.||||+++.... ..+++++++.+.+ .+.++||||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 79999999999999999999999999999999975442 2345555555542 12357999999
Q ss_pred ccCCCHHHHHH--HhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCccccc
Q 005007 417 VHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYEL 493 (720)
Q Consensus 417 ~~gGsL~~~L~--~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~~~~ 493 (720)
|.++.+..+.. .....+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+.......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~ 180 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCC
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccc
Confidence 98654443332 2345799999999999999999999999999999999999999775 89999999998877666677
Q ss_pred cccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc----------------
Q 005007 494 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---------------- 557 (720)
Q Consensus 494 t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~---------------- 557 (720)
+.+||+.|+|||++.+ ...|+.++|||||||++|||++|++||...+..+.+.++...
T Consensus 181 ~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 181 SYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp SCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred cccccccccChHHhhc------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 7889999999999864 356889999999999999999999999988777666655321
Q ss_pred -CCC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 005007 558 -TPP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 602 (720)
Q Consensus 558 -~~~------------iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~~ 602 (720)
... ....+++++++||.+||++||++|||+.|+|+||||+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 001 123478999999999999999999999999999999876443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=401.96 Aligned_cols=237 Identities=24% Similarity=0.432 Sum_probs=190.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH----HHHHHhh-------------cCCEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE----CIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~----~ik~L~~-------------~~~~lyL 412 (720)
+...++|++++.||+|+||+||+|+.. ..||||+++.........+ ++..+.. .++.+||
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEE
Confidence 344678999999999999999999754 3599999976554433322 2222322 2456899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc---
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 489 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~--- 489 (720)
|||||+||+|.++|......+++..+..|+.||++||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999999876677999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC------CCCc
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------PIPE 563 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~------~iP~ 563 (720)
.......||+.|||||++.+. ....|+.++|||||||+||||+||+.||.+......+..++.... .++.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp -----CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred ccccccccCcccCCHHHHhcc----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 223456799999999998631 123588999999999999999999999998777666655553321 3456
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 564 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
.+++++++||.+||+.||++|||+.||+++
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 789999999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-47 Score=397.28 Aligned_cols=237 Identities=26% Similarity=0.464 Sum_probs=191.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|++++.||+|+||+||+|+++ +|+.||||+++..... ....+++..+.. .++.+|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 7899999999754322 222334444433 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+.++.+..+.. ..+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 81 HLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp CCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred eehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 998766666654 44789999999999999999999999999999999999999999999999999998765433 2345
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------------- 558 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~---------------- 558 (720)
..|++.|+|||++.+ ...++.++|||||||++|||++|++||.+.+..+.+.++....
T Consensus 160 ~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ecccchhhhHHHHhC------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 579999999999863 4567899999999999999999999999877766666553210
Q ss_pred -------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 559 -------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 559 -------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
..++..++++++|||++||+.||++|||++|+|+||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123457899999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.55 Aligned_cols=240 Identities=24% Similarity=0.428 Sum_probs=188.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCCh-------hHHHHHHHHhh-------------------c
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------KSAECIKQLEQ-------------------V 406 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~-------~~~~~ik~L~~-------------------~ 406 (720)
.++|++++.||+|+||+||+|+++.+|+.||||++....... +++++++.+.+ .
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 469999999999999999999999999999999986543221 22333333322 1
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
++++|+|||||.++.+..+ ......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999986655544 444578999999999999999999999999999999999999999999999999999765
Q ss_pred cCc-----cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC
Q 005007 487 TGL-----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 561 (720)
Q Consensus 487 ~~~-----~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i 561 (720)
... ......+||++|+|||++.+ ...|+.++|||||||++|||++|++||.+......+..+.......
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccccccceecCHHHhhHHHHcC------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 422 23345679999999999874 3468899999999999999999999998877666555543211100
Q ss_pred C--------------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 005007 562 P--------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 599 (720)
Q Consensus 562 P--------------------------------~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~ 599 (720)
+ ...+++++|||.+||+.||++|||++|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 0 0136788999999999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=408.17 Aligned_cols=236 Identities=24% Similarity=0.425 Sum_probs=193.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCc-----EEEEEEeccCCCCh---h---HHHHHHHH-hh-----------cC
Q 005007 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDP---K---SAECIKQL-EQ-----------VD 407 (720)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~-----~VAVK~l~~~~~~~---~---~~~~ik~L-~~-----------~~ 407 (720)
...++|+++++||+|+||+||+|++..+++ .||||.+....... . +...+..+ .+ .+
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345689999999999999999999876544 69999886433222 1 22223333 11 24
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 465 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~----------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~ 465 (720)
+.+|||||||+||+|.++|+... ..+++..++.|+.||++||+|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 66899999999999999997542 24889999999999999999999999999999999
Q ss_pred ceeecCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCC
Q 005007 466 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 541 (720)
Q Consensus 466 NILLd~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~P 541 (720)
|||++.++.+||+|||+|+....... ..+..||+.|||||++.+ ..|+.++|||||||+||||++ |++|
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-------CCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999999999999987654332 234568999999999984 468899999999999999998 8999
Q ss_pred CCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 542 WSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 542 F~~~~~~~~i~ki~~~--~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
|.+....+.+.+++.. .++.|..+++++++||.+||+.||++|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9988777777777654 456788999999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=399.89 Aligned_cols=235 Identities=25% Similarity=0.446 Sum_probs=184.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCCCChhHHHH---HHHHhh----------------cC
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAEC---IKQLEQ----------------VD 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~-----tg~~VAVK~l~~~~~~~~~~~~---ik~L~~----------------~~ 407 (720)
..++|+++++||+|+||+||+|.+.. +++.||||+++........... +..+.+ .+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 45689999999999999999999754 4578999998754332222211 111211 13
Q ss_pred CEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCC
Q 005007 408 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 472 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~ 472 (720)
+.+++|||||++|+|.++|.... ..+++..++.|+.||++||.|||++|||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 46899999999999999997532 348999999999999999999999999999999999999999
Q ss_pred CCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcH
Q 005007 473 GVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP 548 (720)
Q Consensus 473 g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~ 548 (720)
+++||+|||+|+...... ......||+.|||||++.+ ..++.++|||||||++|||++| .+||......
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-------CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999998764332 2335679999999999985 4688999999999999999986 6789877666
Q ss_pred HHHHHHhc--cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 549 QAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 549 ~~i~ki~~--~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+.+..++. ..+.+|..+++++++||.+||+.||++|||++||++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65555543 4567788999999999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-47 Score=403.89 Aligned_cols=239 Identities=22% Similarity=0.383 Sum_probs=193.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC--hhHHHHHHHHhh--------------cCCEEEEEEEe
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQ--------------VDDHLYIYLEY 416 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~--~~~~~~ik~L~~--------------~~~~lyLVmEy 416 (720)
.++|+++++||+|+||+||+|+++.+|+.||||+++..... .+++++++.+.. ....+|+||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 46899999999999999999999999999999998754321 123334444431 13568999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCC-CeeeeccccchhccCccccccc
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g-~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
|.+++|..+. +.+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...........
T Consensus 114 ~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~ 189 (328)
T d3bqca1 114 VNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 189 (328)
T ss_dssp CCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSC
T ss_pred cCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccccc
Confidence 9999987653 4699999999999999999999999999999999999998655 6999999999887766666778
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHH-HHHHH---hc----------c----
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKV---LN----------R---- 557 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~-~i~ki---~~----------~---- 557 (720)
+||+.|+|||++.+ ...++.++|||||||++|||++|+.||....... ....+ ++ .
T Consensus 190 ~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 190 VASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred ccCccccCcccccC------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 89999999999874 3457889999999999999999999997654322 11111 10 0
Q ss_pred --------------------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 005007 558 --------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 601 (720)
Q Consensus 558 --------------------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~~ 601 (720)
.......++++++|||++||++||++|||++|+|+||||+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 00112347899999999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=394.09 Aligned_cols=241 Identities=24% Similarity=0.432 Sum_probs=197.8
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHHHhh-------------cCCEEEEEE
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ-------------VDDHLYIYL 414 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~L~~-------------~~~~lyLVm 414 (720)
.+...++|++++.||+|+||+||+|.++ ++..||||+++......+. .+++..+.+ .++.+||||
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~ 86 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT 86 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEE
Confidence 3445679999999999999999999976 5788999999765443322 223333332 245679999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--c
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--Y 491 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~ 491 (720)
|||++|+|.+++... ...+++..+..|+.||++||.|||+++|+||||||+||||+.++.+||+|||+|+...... .
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999999987543 3469999999999999999999999999999999999999999999999999998775433 2
Q ss_pred cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 005007 492 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 569 (720)
Q Consensus 492 ~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el 569 (720)
.....||+.|||||++.+ ..++.++|||||||+||||+|| .+||......+.+..+... .+..|..+++++
T Consensus 167 ~~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 239 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239 (272)
T ss_dssp CTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccCCcccccChHHHhC-------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHH
Confidence 334678999999999974 4578899999999999999995 5666666666666666543 566788999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc--Ccccc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE--HPFIR 597 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~--Hpff~ 597 (720)
++||.+||+.||++|||+.||++ |+||.
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999999988 77875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=389.38 Aligned_cols=233 Identities=24% Similarity=0.411 Sum_probs=186.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
.++|++++.||+|+||+||+|.++ +++.||||+++......+ ..++++.+.. .++.+|||||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 468999999999999999999986 577899999875443322 2233333332 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--cccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~~t~ 495 (720)
++|+|.+++......+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 99999999987767799999999999999999999999999999999999999999999999999987654332 2345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.||+.|||||++.+ ..|+.++|||||||+||||+| |++||......+.+..+... ....|..+++++.+||
T Consensus 163 ~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 163 KFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --CTTSCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred ecCcccCChHHhcC-------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 68999999999863 468899999999999999999 57777777766666666554 4567888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcC
Q 005007 574 LRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~H 593 (720)
.+||+.||++|||++|||+|
T Consensus 236 ~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=398.03 Aligned_cols=239 Identities=25% Similarity=0.427 Sum_probs=197.2
Q ss_pred CCCCeEEeeE-EeecCCeEEEEEEECC--CCcEEEEEEeccCCCChhHHH---HHHHHhh-------------cCCEEEE
Q 005007 352 KKSQWQKGKL-IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAE---CIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~-LG~G~fG~VYla~d~~--tg~~VAVK~l~~~~~~~~~~~---~ik~L~~-------------~~~~lyL 412 (720)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++.........+ +++.+.. ..+.+||
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l 85 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 85 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence 3457888885 9999999999998764 455799999975443222111 2222222 2456899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|||||+||+|.+++......+++..+..|+.||++||+|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 999999999999987666789999999999999999999999999999999999999999999999999998765432
Q ss_pred --ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 005007 491 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 566 (720)
Q Consensus 491 --~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls 566 (720)
......||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+....+.+..+..+ .+.+|..++
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 238 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred cccccccccCccccChHHHhC-------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 2234568999999999974 458889999999999999998 99999998887777777654 567889999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHH---HcCcccc
Q 005007 567 SEGKDFLLRCFLRNPVERPSAVEL---LEHPFIR 597 (720)
Q Consensus 567 ~el~dLI~~cL~~dP~kRPTa~EL---L~Hpff~ 597 (720)
+++.+||.+||+.||++|||+.+| |+|.|+.
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999888 6677764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-47 Score=392.61 Aligned_cols=236 Identities=24% Similarity=0.439 Sum_probs=188.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-ChhH----HHHHHHHhhc------------------CCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS----AECIKQLEQV------------------DDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-~~~~----~~~ik~L~~~------------------~~~ 409 (720)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... +... .++++.+... ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4689999999999999999999999999999999975432 2221 1222222221 124
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||+++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 79999999999999999765 67999999999999999999999999999999999999999999999999998755322
Q ss_pred ----cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCCCC----
Q 005007 490 ----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---- 561 (720)
Q Consensus 490 ----~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~~i---- 561 (720)
......+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+.+.+++......
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG-------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237 (277)
T ss_dssp --------------TTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT
T ss_pred cccccccccccCcccccCHHHHcC-------CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh
Confidence 23345689999999999863 468899999999999999999999999988888888877665443
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCC-CHHHHHcCcccc
Q 005007 562 PEMLSSEGKDFLLRCFLRNPVERP-SAVELLEHPFIR 597 (720)
Q Consensus 562 P~~ls~el~dLI~~cL~~dP~kRP-Ta~ELL~Hpff~ 597 (720)
...+++++++||.+||++||.+|| |++++ .|+|++
T Consensus 238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 356899999999999999999999 55555 466654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-47 Score=395.34 Aligned_cols=236 Identities=24% Similarity=0.421 Sum_probs=194.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-HHHHHHHhh--------------cCCEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQ--------------VDDHLYIYL 414 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-~~~ik~L~~--------------~~~~lyLVm 414 (720)
+...++|++++.||+|+||+||+|+++.+|+.||||+++......+. .+++..+.. .++.+||||
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44567899999999999999999999999999999998765444322 222333322 256789999
Q ss_pred EeccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc-
Q 005007 415 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE- 492 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~- 492 (720)
|||++|+|.+++.+. ...+++..++.|+.||++||+|||++|||||||||+||||+.++.+||+|||+++........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999999999753 457999999999999999999999999999999999999999999999999999876543322
Q ss_pred -ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHH
Q 005007 493 -LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEG 569 (720)
Q Consensus 493 -~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~--~~~~iP~~ls~el 569 (720)
....||+.|||||++.+ ..|+.++|||||||++|||++|..||........+.+++. ..+.+|..+++++
T Consensus 173 ~~~~~g~~~y~aPE~~~~-------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp ETTEEECGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred eccccccccccChHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence 23458999999999985 4688999999999999999997666554444444444443 3467788999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 005007 570 KDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 570 ~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++||.+||+.||++|||+.||++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-47 Score=396.81 Aligned_cols=234 Identities=26% Similarity=0.435 Sum_probs=184.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCCCChhHH---HHHHHHhh--------------cCCEEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSA---ECIKQLEQ--------------VDDHLYI 412 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~---~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~~~~lyL 412 (720)
.++|+++++||+|+||+||+|+++.+++ .||||.+.......... ++++.+.. .++.+||
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4689999999999999999999987765 58888876543332222 22222222 2467899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcccc
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 492 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~ 492 (720)
|||||+||+|.+++....+.+++.++..|+.||++||+|||++|||||||||+||||+.++++||+|||+++.+......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999999999877678999999999999999999999999999999999999999999999999999876543221
Q ss_pred ------ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 493 ------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 493 ------~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
....||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+....+.+..+..+ ..+.|..
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257 (299)
T ss_dssp -----------CGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ceeeecccccCCccccCHHHHhc-------CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 12457899999999873 568899999999999999998 89999998887777777654 4567888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+++++.+||.+||+.||++|||+.||+++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=400.59 Aligned_cols=238 Identities=24% Similarity=0.427 Sum_probs=189.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhhc--------------------C
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQV--------------------D 407 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~~--------------------~ 407 (720)
..++|++++.||+|+||+||+|+++.+|+.||||+++........ .++++.+... .
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357999999999999999999999999999999999754433221 1222222221 1
Q ss_pred CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhcc
Q 005007 408 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 487 (720)
Q Consensus 408 ~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~ 487 (720)
.++||||||| |++|..+++. ..+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 2579999999 6788887754 579999999999999999999999999999999999999999999999999998765
Q ss_pred CccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccC---------
Q 005007 488 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------- 558 (720)
Q Consensus 488 ~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~--------- 558 (720)
.. .....||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+....+..+....
T Consensus 173 ~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 173 SE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp SS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred Cc--cccccccccccCHHHHcC------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 43 345679999999999974 3467889999999999999999999998877665554432210
Q ss_pred ----------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 559 ----------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 559 ----------------------~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
..+...+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 012345789999999999999999999999999999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=399.21 Aligned_cols=242 Identities=29% Similarity=0.534 Sum_probs=201.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEE---CCCCcEEEEEEeccCC---------CChhHHHHHHHHhh------------cCCE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIP---------DDPKSAECIKQLEQ------------VDDH 409 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d---~~tg~~VAVK~l~~~~---------~~~~~~~~ik~L~~------------~~~~ 409 (720)
++|++++.||+|+||+||+|++ +.+|+.||||+++... ...++++.++.+.+ ..+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 4579999999885321 22345666666654 2567
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+|+||||+.||+|.+++... +.+.+..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999999999765 67899999999999999999999999999999999999999999999999999876432
Q ss_pred --cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHH----HHHHhccCCCCCc
Q 005007 490 --SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPPIPE 563 (720)
Q Consensus 490 --~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~----i~ki~~~~~~iP~ 563 (720)
....+..|++.|+|||++.+ ....++.++|||||||+||||++|+.||......+. ........+.+|.
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~-----~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRG-----GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTT-----CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred ccccccccccccccchhHHhhc-----CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 33456789999999999964 234578899999999999999999999976543332 2333456677888
Q ss_pred cCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 005007 564 MLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 601 (720)
Q Consensus 564 ~ls~el~dLI~~cL~~dP~kRP-----Ta~ELL~Hpff~~~~~ 601 (720)
.+++++++||.+||+.||++|| |++|+|+||||+..++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 9999999999999999999999 5899999999987654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=399.50 Aligned_cols=241 Identities=22% Similarity=0.387 Sum_probs=187.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh------HHHHHHHHhhc---------------CCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------SAECIKQLEQV---------------DDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~------~~~~ik~L~~~---------------~~~l 410 (720)
...+|++++.||+|+||+||+|+++.+|+.||||+++....... ++++++.+.+. ....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 34689999999999999999999999999999999975443221 22233333220 1122
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
+++|||+.||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++......
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 444566678999999965 469999999999999999999999999999999999999999999999999997654332
Q ss_pred ----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc---------
Q 005007 491 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------- 557 (720)
Q Consensus 491 ----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~--------- 557 (720)
.....+||+.|+|||++.. ...++.++||||+||++|||++|+.||...+..+........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTT------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccceeeccccccceechHHHhhc------CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 2345679999999999853 345788999999999999999999999876655444333210
Q ss_pred -----------------CCC-----CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 558 -----------------TPP-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 558 -----------------~~~-----iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
... +...+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 000 1235688999999999999999999999999999998543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=392.03 Aligned_cols=230 Identities=23% Similarity=0.438 Sum_probs=186.7
Q ss_pred eEEeecCCeEEEEEEEC--CCCcEEEEEEeccCCCChhHH----HHHHHHhh-------------cCCEEEEEEEeccCC
Q 005007 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSA----ECIKQLEQ-------------VDDHLYIYLEYVHPG 420 (720)
Q Consensus 360 k~LG~G~fG~VYla~d~--~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~-------------~~~~lyLVmEy~~gG 420 (720)
++||+|+||+||+|.++ .+++.||||+++....+.... ++++.+.. ..+..|||||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999864 456789999997544333221 22222322 245689999999999
Q ss_pred CHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc----ccccc
Q 005007 421 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----ELSLK 496 (720)
Q Consensus 421 sL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~----~~t~~ 496 (720)
+|.+++++. ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+..... .....
T Consensus 93 ~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 93 PLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred cHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 999999764 6799999999999999999999999999999999999999999999999999987643321 22356
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHHH
Q 005007 497 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLL 574 (720)
Q Consensus 497 GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI~ 574 (720)
||+.|||||++.+ ..++.++|||||||++|||++ |++||.+....+....+.. ..+++|..+++++++||.
T Consensus 172 gt~~y~APE~l~~-------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 172 WPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred CCceecCchhhcC-------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 8999999999985 457889999999999999998 9999999887777766664 456788999999999999
Q ss_pred HhhhcCCCCCCCHHHH---HcCcccc
Q 005007 575 RCFLRNPVERPSAVEL---LEHPFIR 597 (720)
Q Consensus 575 ~cL~~dP~kRPTa~EL---L~Hpff~ 597 (720)
+||+.||++|||++|| |+|+|++
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999998 5666654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=388.35 Aligned_cols=235 Identities=25% Similarity=0.449 Sum_probs=187.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCCCChhHH---HHHHHHhh-------------cCCEEEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSA---ECIKQLEQ-------------VDDHLYI 412 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~t---g~~VAVK~l~~~~~~~~~~---~~ik~L~~-------------~~~~lyL 412 (720)
..++|++++.||+|+||+||+|.+..+ +..||||.++......... +++..+.. .++.+||
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~i 84 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 84 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEE
Confidence 356899999999999999999998754 3568999886544332221 22222222 2567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--
Q 005007 413 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 490 (720)
Q Consensus 413 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-- 490 (720)
|||||.+|+|.+++......+++..++.++.||++||.|||+++||||||||+|||++.++.+||+|||+++......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 999999999999988777789999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 005007 491 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 568 (720)
Q Consensus 491 ~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~e 568 (720)
......||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||......+.+.++..+ ..++|..++++
T Consensus 165 ~~~~~~gt~~y~apE~l~~-------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp ------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred eccceecCcccchhhHhcc-------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2234568999999999984 468899999999999999998 89999998888888777755 46788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+++||.+||..||++|||+.||++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=384.20 Aligned_cols=238 Identities=29% Similarity=0.466 Sum_probs=193.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH----HHHHHHHhh--------------cCCEEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQ--------------VDDHLYIYLE 415 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~----~~~ik~L~~--------------~~~~lyLVmE 415 (720)
++|++++.||+|+||+||+|+++.+|+.||||+++........ .+++..+.. ..+.+++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999999999999999999765443322 223333332 2567899999
Q ss_pred eccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc-cccc
Q 005007 416 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 494 (720)
Q Consensus 416 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~-~~~t 494 (720)
|+.|++|..++.. .+.+++..++.++.||++||+|||++|||||||||+||||+.++.+||+|||+++...... ....
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 9999988888765 4789999999999999999999999999999999999999999999999999998775433 3344
Q ss_pred ccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCC-CCcHHHHHHHhcc----------------
Q 005007 495 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKVLNR---------------- 557 (720)
Q Consensus 495 ~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~-~~~~~~i~ki~~~---------------- 557 (720)
..++++|+|||++.+ ...++.++|||||||++|||++|+.||.. .+..+.+.++...
T Consensus 161 ~~~~~~~~~pe~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 161 EVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred eccccchhhhhHhcc------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 567899999999874 34578899999999999999999998644 3444444443210
Q ss_pred -------------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 558 -------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 558 -------------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
....+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 11123456889999999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=384.21 Aligned_cols=233 Identities=26% Similarity=0.427 Sum_probs=199.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh--------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ--------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~--------------~~~~lyLVmEy~ 417 (720)
.++|+++++||+|+||+||+|+++ +++.||||+++....... ..++++.+.. .++.+|+||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368999999999999999999985 788999999986544332 2233333332 256799999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--cccc
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSL 495 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~--~~t~ 495 (720)
.+|+|.+++......+++..++.|+.||++||+|||++||+||||||+||||+.++.+||+|||+++....... ....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 99999999877777899999999999999999999999999999999999999999999999999987654332 2345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI 573 (720)
.||+.|||||++.+ ..++.++|||||||++|||+| |+.||......+...++... ....|..+++++++||
T Consensus 162 ~~t~~y~aPE~~~~-------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred CCCCCcCCcHHhcC-------CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence 68999999999985 457899999999999999998 89999998888887777654 5577889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcC
Q 005007 574 LRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~H 593 (720)
.+||+.||++|||++|||+|
T Consensus 235 ~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=396.69 Aligned_cols=238 Identities=24% Similarity=0.381 Sum_probs=190.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhH-------HHHHHHHhh----------------cCCE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------AECIKQLEQ----------------VDDH 409 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~-------~~~ik~L~~----------------~~~~ 409 (720)
.++|++++.||+|+||+||+|+++.+|+.||||+++........ +++++.+.+ .+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999999999999999999765433322 222233221 0123
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
.++||||+.||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 4667788889999999954 5699999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhccCC----------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---------- 559 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~~~---------- 559 (720)
...+..||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+.......++....
T Consensus 174 -~~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred -ccccccccccccCchhhcC------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 2345678999999999863 34678899999999999999999999998777666555542211
Q ss_pred -------------CC--------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 005007 560 -------------PI--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 600 (720)
Q Consensus 560 -------------~i--------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~~~ 600 (720)
.. ...++++++|||.+||+.||.+|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 11 124789999999999999999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=389.54 Aligned_cols=233 Identities=27% Similarity=0.440 Sum_probs=190.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCCCChh---HHHHHHHHhh-------------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPK---SAECIKQLEQ-------------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~----~VAVK~l~~~~~~~~---~~~~ik~L~~-------------~~~~lyLV 413 (720)
.+|+++++||+|+||+||+|.+..+|+ .||||+++....... ..++++.+.. .++..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 579999999999999999999988876 588888764332221 1222232322 24567899
Q ss_pred EEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc--
Q 005007 414 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 491 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~-- 491 (720)
|||+.+|+|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence 999999999999988778899999999999999999999999999999999999999999999999999987654332
Q ss_pred -cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 005007 492 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 568 (720)
Q Consensus 492 -~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~-~~~iP~~ls~e 568 (720)
.....||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+....+....+..+ .++.|..++++
T Consensus 169 ~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 241 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241 (317)
T ss_dssp ------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred cccccccCccccChHHHhc-------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 233568999999999985 458899999999999999998 89999988777666666543 46788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 569 GKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 569 l~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
+.+||.+||..||.+|||+.||++|
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=381.86 Aligned_cols=234 Identities=26% Similarity=0.450 Sum_probs=184.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCC----cEEEEEEeccCCCChhHHH---HHHHHhh--------------cCCEE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAE---CIKQLEQ--------------VDDHL 410 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg----~~VAVK~l~~~~~~~~~~~---~ik~L~~--------------~~~~l 410 (720)
..++|+++++||+|+||+||+|.++.++ ..||||+++.........+ ++..+.. .++.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4468999999999999999999987655 4699999975443332222 2222222 24678
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc
Q 005007 411 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 490 (720)
Q Consensus 411 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~ 490 (720)
++|||||.+|+|.+++.+....+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 99999999999999998877889999999999999999999999999999999999999999999999999998764432
Q ss_pred ----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 005007 491 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNR-TPPIPEM 564 (720)
Q Consensus 491 ----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~ki~~~-~~~iP~~ 564 (720)
......||+.|||||++.+ ..++.++|||||||+||||++| .+||......+.+..+..+ .++.|..
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 237 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISY-------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237 (283)
T ss_dssp ---------CCCGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ccceEeccCCCCccccCHHHHcc-------CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchh
Confidence 1223568999999999973 5688999999999999999995 5555555555555555443 5567888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
++.++++||.+||+.||++|||+.||++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=382.09 Aligned_cols=242 Identities=24% Similarity=0.450 Sum_probs=191.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChh-HHHHHHHHhh-------------cCCEEEEEEE
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQ-------------VDDHLYIYLE 415 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~-~~~~ik~L~~-------------~~~~lyLVmE 415 (720)
+...++|++++.||+|+||+||+|+++.+ +.||||+++......+ ..+++..+.. .++.+|+|||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~E 91 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEE
Confidence 34457899999999999999999998765 5799999976544332 2223332322 2456899999
Q ss_pred eccCCCHHHHHHHh-cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc--cc
Q 005007 416 YVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YE 492 (720)
Q Consensus 416 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~--~~ 492 (720)
||.+|+|..++... ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999999988643 3569999999999999999999999999999999999999999999999999998764332 22
Q ss_pred ccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 005007 493 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 570 (720)
Q Consensus 493 ~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~ki~~~-~~~iP~~ls~el~ 570 (720)
....||+.|+|||++.. ..++.++|||||||+||||++| ++||......+.+..+..+ ..+++..++++++
T Consensus 172 ~~~~gt~~y~aPE~~~~-------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 244 (285)
T ss_dssp ----CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ccccccccccChHHHhC-------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHH
Confidence 34568999999999974 4678999999999999999995 5555555555566665543 4578889999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHc--Ccccccc
Q 005007 571 DFLLRCFLRNPVERPSAVELLE--HPFIRNA 599 (720)
Q Consensus 571 dLI~~cL~~dP~kRPTa~ELL~--Hpff~~~ 599 (720)
+||.+||+.||++||++++|++ ++||...
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999987 7788654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=392.68 Aligned_cols=234 Identities=25% Similarity=0.387 Sum_probs=177.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHH----HHHHHHhh--------------------cCCE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQ--------------------VDDH 409 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~----~~ik~L~~--------------------~~~~ 409 (720)
++|+++++||+|+||+||+|+++.+|+.||||++.......... +++..+.. ..++
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 58999999999999999999999999999999997654433221 22222221 1367
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCc
Q 005007 410 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 489 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~ 489 (720)
+|+|||||.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 89999999755 444442 46999999999999999999999999999999999999999999999999999887766
Q ss_pred cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHhcc------------
Q 005007 490 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------ 557 (720)
Q Consensus 490 ~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~~~------------ 557 (720)
......+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+....+.+++..
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~-------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------CCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccccccccccChhhhcC-------CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 66677789999999999973 46788999999999999999999999877665555444311
Q ss_pred ----------CCCC--------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 005007 558 ----------TPPI--------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 598 (720)
Q Consensus 558 ----------~~~i--------------------P~~ls~el~dLI~~cL~~dP~kRPTa~ELL~Hpff~~ 598 (720)
.... +...++++++||++||..||++||||+|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 0113578899999999999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=381.08 Aligned_cols=237 Identities=23% Similarity=0.436 Sum_probs=190.7
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCC-------cEEEEEEeccCCCChhHHHH---HHHHhh-------------
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAEC---IKQLEQ------------- 405 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~~tg-------~~VAVK~l~~~~~~~~~~~~---ik~L~~------------- 405 (720)
.....++|++++.||+|+||+||+|++..++ ..||||+++.........+. +..+..
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4445679999999999999999999876554 47999998765443322221 111211
Q ss_pred --cCCEEEEEEEeccCCCHHHHHHHhc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCcee
Q 005007 406 --VDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 468 (720)
Q Consensus 406 --~~~~lyLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NIL 468 (720)
.++.+|+|||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 2566899999999999999997542 35899999999999999999999999999999999999
Q ss_pred ecCCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCC
Q 005007 469 VDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 544 (720)
Q Consensus 469 Ld~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~ 544 (720)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..|+.++||||||||+|||++ |.+||.+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-------CCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999998765433 2234678999999999974 468999999999999999998 7999988
Q ss_pred CCcHHHHHHHhc-cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 545 FEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 545 ~~~~~~i~ki~~-~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
....+.+..+.. ..+..|..+++++++||.+||+.||.+|||+.|||+
T Consensus 241 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 877766666554 356778899999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=379.57 Aligned_cols=234 Identities=22% Similarity=0.391 Sum_probs=192.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhH---HHHHHHHhh--------------cCCE
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKS---AECIKQLEQ--------------VDDH 409 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~---~~~ik~L~~--------------~~~~ 409 (720)
..++|++++.||+|+||+||+|+++ .+++.||||+++........ .+++..+.. ..+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999875 35688999998754332211 222222222 2456
Q ss_pred EEEEEEeccCCCHHHHHHHhc-----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCc
Q 005007 410 LYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 466 (720)
Q Consensus 410 lyLVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~N 466 (720)
+++||||+.+|+|.++|.... ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 899999999999999996532 248899999999999999999999999999999999
Q ss_pred eeecCCCCeeeeccccchhccCcc---ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCC-CCC
Q 005007 467 LLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPW 542 (720)
Q Consensus 467 ILLd~~g~VKL~DFGlA~~~~~~~---~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk-~PF 542 (720)
|||+.++++||+|||+++...... ...+..||+.|||||++.+ ..|+.++||||||||||||++|. +||
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-------CCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999998764432 2234678999999999985 46889999999999999999984 789
Q ss_pred CCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 543 SEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 543 ~~~~~~~~i~ki~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
.+....+.+..+..+ .+.+|..+++++.+||.+||+.||++|||+.||++
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888887777654 45678899999999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-44 Score=375.93 Aligned_cols=237 Identities=23% Similarity=0.345 Sum_probs=187.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhh---------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~---------------~~~~lyLVmEy~ 417 (720)
.++|++++.||+|+||+||+|+++.+|+.||||++...........+++.+.. .++..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 46899999999999999999999999999999998765544443333333332 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC---CCCeeeeccccchhccCcc----
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~---~g~VKL~DFGlA~~~~~~~---- 490 (720)
+++|.+.+....+.+++..+..++.||+.||+|||++|||||||||+|||++. +..|||+|||+|+.+....
T Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 57787777776678999999999999999999999999999999999999753 4579999999998765432
Q ss_pred ----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcHHHHHHHh---cc-----C
Q 005007 491 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---NR-----T 558 (720)
Q Consensus 491 ----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~~~i~ki~---~~-----~ 558 (720)
......||+.|||||++.+ ..++.++|||||||++|||++|+.||...........+. .. .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTT-------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred eeccccCCcCCCccccCHHHHhC-------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 2245679999999999873 458899999999999999999999998765443332221 11 1
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHH---HHcCcccc
Q 005007 559 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVE---LLEHPFIR 597 (720)
Q Consensus 559 ~~iP~~ls~el~dLI~~cL~~dP~kRPTa~E---LL~Hpff~ 597 (720)
..++..+++++.+||.+||+.||++||++.+ +|+|.|.+
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1234568999999999999999999999875 46676653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=381.15 Aligned_cols=233 Identities=24% Similarity=0.405 Sum_probs=193.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcE--EEEEEeccCCCCh---hHHHHHHHHhh---------------cCCEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDP---KSAECIKQLEQ---------------VDDHLYIY 413 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~--VAVK~l~~~~~~~---~~~~~ik~L~~---------------~~~~lyLV 413 (720)
++|+++++||+|+||+||+|+++.+|.. ||||+++...... ...++++.+.. .++.+|||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999988875 6778775432221 22333333332 25678999
Q ss_pred EEeccCCCHHHHHHHh---------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeee
Q 005007 414 LEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 478 (720)
Q Consensus 414 mEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~ 478 (720)
|||++||+|.++|++. ...+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999999653 2569999999999999999999999999999999999999999999999
Q ss_pred ccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHHHhc-
Q 005007 479 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLN- 556 (720)
Q Consensus 479 DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~ki~~- 556 (720)
|||+++............||..|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+..
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred cccccccccccccccceecCCcccchHHhcc-------CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 9999987665555556779999999999974 4688999999999999999996 567888887777777665
Q ss_pred cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 557 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 557 ~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
..+.+|..+++++++||.+||+.||++|||+.|||+|
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3567788899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=371.81 Aligned_cols=231 Identities=25% Similarity=0.449 Sum_probs=188.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHHHHHHHhhc---------------CCEEEEEEEe
Q 005007 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQV---------------DDHLYIYLEY 416 (720)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~~ik~L~~~---------------~~~lyLVmEy 416 (720)
..++|++++.||+|+||+||+|.++ |..||||+++.........++++.+.+. ++.+||||||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 4468999999999999999999985 7899999997654444334444444331 2458999999
Q ss_pred ccCCCHHHHHHHhc-CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccccccc
Q 005007 417 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 495 (720)
Q Consensus 417 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~~~t~ 495 (720)
+++|+|.++|.+.. ..+++..++.|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..... ....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~ 160 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTG 160 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cccc
Confidence 99999999997542 35899999999999999999999999999999999999999999999999999875432 3345
Q ss_pred cCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHH
Q 005007 496 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 573 (720)
Q Consensus 496 ~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~-~~~~iP~~ls~el~dLI 573 (720)
.+|..|+|||++.+ ..++.++|||||||++|||+| |++||......+.+..+.. ..+++|..+++++++||
T Consensus 161 ~~~~~y~aPE~l~~-------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 161 KLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCChHHHhC-------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 68999999999975 458899999999999999998 8999998888777777764 46778889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcC
Q 005007 574 LRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 574 ~~cL~~dP~kRPTa~ELL~H 593 (720)
.+||..||.+|||+.||+++
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=373.92 Aligned_cols=237 Identities=24% Similarity=0.403 Sum_probs=195.5
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhHH---HHHHHHhh--------------c
Q 005007 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSA---ECIKQLEQ--------------V 406 (720)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~~---~~ik~L~~--------------~ 406 (720)
++...++|++++.||+|+||+||+|.++ .++..||||+++......... ++++.+.+ .
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445679999999999999999999875 246789999997544333222 22232322 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeee
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 477 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL 477 (720)
++.++||||||.+|+|.+++.... ..+++..+..|+.||++||.|||+++|+||||||+||||+.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 567899999999999999986432 24688999999999999999999999999999999999999999999
Q ss_pred eccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcC-CCCCCCCCcHHHHHH
Q 005007 478 ADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFK 553 (720)
Q Consensus 478 ~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTG-k~PF~~~~~~~~i~k 553 (720)
+|||+++....... .....||+.|||||.+.+ ..++.++|||||||+||||+|| ++||.+.+..+.+..
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHcc-------CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999987654322 234468999999999985 4678899999999999999998 588988888888777
Q ss_pred Hhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 554 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 554 i~~~-~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+..+ .+.+|..+++.+.+||.+||+.||.+|||++||++
T Consensus 248 i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7653 55678899999999999999999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=370.99 Aligned_cols=233 Identities=26% Similarity=0.456 Sum_probs=183.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-CC--cEEEEEEeccCCC--ChhH---HHHHHHHhh-------------cCCEEE
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRE-TG--ASCAIKEVDIIPD--DPKS---AECIKQLEQ-------------VDDHLY 411 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~-tg--~~VAVK~l~~~~~--~~~~---~~~ik~L~~-------------~~~~ly 411 (720)
.++|++.+.||+|+||+||+|++.. ++ ..||||+++.... .... .+++..+.. .++.++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~ 86 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 86 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence 4579999999999999999998643 33 3689998864322 1111 122222322 245689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCccc
Q 005007 412 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 491 (720)
Q Consensus 412 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~~ 491 (720)
+|||||++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999999887777899999999999999999999999999999999999999999999999999987644322
Q ss_pred ----cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCCCcHHHHHHHhcc--CCCCCcc
Q 005007 492 ----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEM 564 (720)
Q Consensus 492 ----~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~~~~~~i~ki~~~--~~~iP~~ 564 (720)
.....|+..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+.++... .++.+..
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cceecCccccCcccCCHHHHhC-------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence 223457889999999985 467889999999999999998 89999999888888887655 4466788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 565 LSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 565 ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
+++++++||.+||..||++|||+.||++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=373.20 Aligned_cols=236 Identities=23% Similarity=0.439 Sum_probs=193.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCCCChhHHH------HHHHHhh------------c
Q 005007 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAE------CIKQLEQ------------V 406 (720)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~VYla~d~-----~tg~~VAVK~l~~~~~~~~~~~------~ik~L~~------------~ 406 (720)
+...++|+++++||+|+||+||+|++. .+++.||||+++.........+ .+..+.+ .
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 344579999999999999999999863 5678999999976543322222 2222211 2
Q ss_pred CCEEEEEEEeccCCCHHHHHHHhc-----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceee
Q 005007 407 DDHLYIYLEYVHPGSINRYVREHC-----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 469 (720)
Q Consensus 407 ~~~lyLVmEy~~gGsL~~~L~~~~-----------------~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILL 469 (720)
++.+|||||||++|+|.++|+... ..+++..++.|+.||+.||+|||+++||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 455899999999999999997542 258999999999999999999999999999999999999
Q ss_pred cCCCCeeeeccccchhccCccc---cccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhc-CCCCCCCC
Q 005007 470 DASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 545 (720)
Q Consensus 470 d~~g~VKL~DFGlA~~~~~~~~---~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLT-Gk~PF~~~ 545 (720)
+.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-------CCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654322 234568999999999974 468899999999999999998 77778777
Q ss_pred CcHHHHHHHhc--cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 546 EGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 546 ~~~~~i~ki~~--~~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...+.+.+++. ..+..|..+++++.+||.+||+.||++|||++|||+
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77666666653 345667889999999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-43 Score=366.80 Aligned_cols=232 Identities=20% Similarity=0.284 Sum_probs=188.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH---HHHHHhh------------cCCEEEEEEEec
Q 005007 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQ------------VDDHLYIYLEYV 417 (720)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~---~ik~L~~------------~~~~lyLVmEy~ 417 (720)
.++|++++.||+|+||+||+|++..+|+.||||++..........+ +++.+.. .+...|+||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4689999999999999999999999999999999876554443333 3333332 256789999999
Q ss_pred cCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecC-----CCCeeeeccccchhccCc---
Q 005007 418 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMAKHLTGL--- 489 (720)
Q Consensus 418 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~-----~g~VKL~DFGlA~~~~~~--- 489 (720)
+++|.+++......+++..+..++.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+...
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 69999999877678999999999999999999999999999999999999964 578999999999876432
Q ss_pred -----cccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCc---HHHHHHHhcc----
Q 005007 490 -----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNR---- 557 (720)
Q Consensus 490 -----~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~---~~~i~ki~~~---- 557 (720)
......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+... ...+.++...
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLG-------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cceeecccCceEEchhhcCHHHhcC-------CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 12335679999999999873 4688999999999999999999999975433 2233333221
Q ss_pred -CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 005007 558 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 592 (720)
Q Consensus 558 -~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ELL~ 592 (720)
...++..+++++.++|..|+..+|++||+.+.+.+
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11233568899999999999999999999877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=365.26 Aligned_cols=231 Identities=26% Similarity=0.440 Sum_probs=183.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCC---cEEEEEEeccCCCChhHHHH---HHHHhh---------------cCCEEEEEE
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAEC---IKQLEQ---------------VDDHLYIYL 414 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg---~~VAVK~l~~~~~~~~~~~~---ik~L~~---------------~~~~lyLVm 414 (720)
+...++||+|+||+||+|.+..++ ..||||+++.........+. ++.+.+ .++.+++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 344789999999999999987643 36999999754433322222 222222 246789999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchhccCcc----
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 490 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~~~~~---- 490 (720)
|||++|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999999998776778899999999999999999999999999999999999999999999999998764332
Q ss_pred -ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCC-CcHHHHHHHh-ccCCCCCccCCH
Q 005007 491 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL-NRTPPIPEMLSS 567 (720)
Q Consensus 491 -~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~-~~~~~i~ki~-~~~~~iP~~ls~ 567 (720)
......||+.|+|||++.+ ..++.++|||||||+||||++|..||... ...+....+. +..+..|..+++
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~ 261 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 261 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCH
T ss_pred eecccccccccccChHHHhc-------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcH
Confidence 2223568999999999974 46889999999999999999977766543 3333444444 345667888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 568 EGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 568 el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
++.+||.+||+.||++||++.|+++|
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-41 Score=361.99 Aligned_cols=237 Identities=22% Similarity=0.360 Sum_probs=178.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCC----hhHHHHHHHHhh------------------------
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSAECIKQLEQ------------------------ 405 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~----~~~~~~ik~L~~------------------------ 405 (720)
.+|+++++||+|+||+||+|+++.+|+.||||+++..... .+++..++.+.+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5799999999999999999999999999999999753211 122333333332
Q ss_pred cCCEEEEEEEeccCCCHHHHH--HHhcCCCcHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCceeecCCC------Cee
Q 005007 406 VDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG------VVK 476 (720)
Q Consensus 406 ~~~~lyLVmEy~~gGsL~~~L--~~~~~~Lse~~i~~i~~QIL~gL~yLHs-~gIVHRDIKP~NILLd~~g------~VK 476 (720)
.....+++|+++.++...... ......+++..++.+++||+.||.|||+ +||+||||||+||||+.++ .+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 123456777777655533333 2334679999999999999999999997 8999999999999998765 399
Q ss_pred eeccccchhccCccccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCCcH------HH
Q 005007 477 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QA 550 (720)
Q Consensus 477 L~DFGlA~~~~~~~~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~~~------~~ 550 (720)
|+|||.+..... .....+||+.|+|||++.+ ..|+.++|||||||+++||++|+.||...+.. ..
T Consensus 173 l~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 173 IADLGNACWYDE--HYTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp ECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred Eeeccccccccc--ccccccccccccChhhccc-------cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999976543 2345679999999999873 45788999999999999999999999754321 11
Q ss_pred HHH---Hhcc---------------------------------------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHH
Q 005007 551 MFK---VLNR---------------------------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 588 (720)
Q Consensus 551 i~k---i~~~---------------------------------------~~~iP~~ls~el~dLI~~cL~~dP~kRPTa~ 588 (720)
+.. +++. ...++...+++++|||.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111 1110 1112233467899999999999999999999
Q ss_pred HHHcCcccccc
Q 005007 589 ELLEHPFIRNA 599 (720)
Q Consensus 589 ELL~Hpff~~~ 599 (720)
|+|+||||++.
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99999999854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=356.41 Aligned_cols=235 Identities=24% Similarity=0.335 Sum_probs=175.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCCChhHHH-HHHHHhhc---------------C---CEEEEEE
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQV---------------D---DHLYIYL 414 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~~~~~~~-~ik~L~~~---------------~---~~lyLVm 414 (720)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.........+ ++..+... + ..+||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4799999999999999999986 589999999864321111111 11111110 1 2589999
Q ss_pred EeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHh--------CCCcccccCCCceeecCCCCeeeeccccchhc
Q 005007 415 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHRDIKGANLLVDASGVVKLADFGMAKHL 486 (720)
Q Consensus 415 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs--------~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~~ 486 (720)
|||++|+|.++|++ ..+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999976 469999999999999999999996 69999999999999999999999999999876
Q ss_pred cCcc-----ccccccCCCCCCChHHHHHhhhcCCCCCCCccccccchhhhHHHHhcCCCCCCCCC--------------c
Q 005007 487 TGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------------G 547 (720)
Q Consensus 487 ~~~~-----~~~t~~GTp~YmAPEvl~g~~~~~g~~~~s~asDVWSLG~vLyELLTGk~PF~~~~--------------~ 547 (720)
.... .....+||+.|||||++.+.... ....++.++|||||||+||||+||..||.... .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCT-TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cCCCcceeccccceecccCcCChhhccccccc-cCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 5432 22346799999999998642110 01236778999999999999999998874211 1
Q ss_pred HHHHHHHh-c--cCCCCCccC-----CHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 005007 548 PQAMFKVL-N--RTPPIPEML-----SSEGKDFLLRCFLRNPVERPSAVELLEH 593 (720)
Q Consensus 548 ~~~i~ki~-~--~~~~iP~~l-----s~el~dLI~~cL~~dP~kRPTa~ELL~H 593 (720)
...+.... . ..+.+|..+ ..++.+||.+||+.||++|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22233322 1 123444432 3468999999999999999999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3.7e-23 Score=201.47 Aligned_cols=122 Identities=17% Similarity=0.239 Sum_probs=90.2
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC------------ChhH--------HHHHHHHhhcC--------
Q 005007 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------------DPKS--------AECIKQLEQVD-------- 407 (720)
Q Consensus 356 Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~------------~~~~--------~~~ik~L~~~~-------- 407 (720)
|.++++||+|+||+||+|.+. +|+.||||+++.... .... ..+...+....
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 699999998753211 0000 01111122211
Q ss_pred --CEEEEEEEeccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHHhCCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 408 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 408 --~~lyLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLHs~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
...++||||+++..+ ..+.+..+..++.||+++|.|||++||+||||||+|||++++ .++|+|||+|+.
T Consensus 81 ~~~~~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~ 151 (191)
T d1zara2 81 AWEGNAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVE 151 (191)
T ss_dssp EEETTEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEE
T ss_pred EecCCEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCccc
Confidence 112689999987644 236677788999999999999999999999999999999865 489999999976
Q ss_pred cc
Q 005007 486 LT 487 (720)
Q Consensus 486 ~~ 487 (720)
..
T Consensus 152 ~~ 153 (191)
T d1zara2 152 VG 153 (191)
T ss_dssp TT
T ss_pred CC
Confidence 53
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.77 E-value=4.3e-05 Score=74.69 Aligned_cols=124 Identities=14% Similarity=0.103 Sum_probs=73.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCCC-----ChhHHHHHHHHhh------------cCCEEEEEEEe
Q 005007 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPKSAECIKQLEQ------------VDDHLYIYLEY 416 (720)
Q Consensus 354 ~~Y~i~k~LG~G~fG~VYla~d~~tg~~VAVK~l~~~~~-----~~~~~~~ik~L~~------------~~~~lyLVmEy 416 (720)
..|+..+..+-++.+.||+.. ..+..+.||....... ...+...+..+.. .++..|+|||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 367777665555567999875 3466677887753221 1122333333432 25678999999
Q ss_pred ccCCCHHHHHHHhcCCCcHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 005007 417 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH------------------------------------------- 453 (720)
Q Consensus 417 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIL~gL~yLH------------------------------------------- 453 (720)
++|..+...... ......++.++.+.|..||
T Consensus 92 l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred cccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 998776543211 0011112222222222222
Q ss_pred ----------hC------CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 454 ----------ST------NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 454 ----------s~------gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
+. .++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11 378999999999998777677999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.29 E-value=0.00045 Score=72.68 Aligned_cols=29 Identities=24% Similarity=0.332 Sum_probs=21.8
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEe
Q 005007 359 GKLIGRGTFGSVYIGTNRETGASCAIKEV 387 (720)
Q Consensus 359 ~k~LG~G~fG~VYla~d~~tg~~VAVK~l 387 (720)
.+.||.|....||++.+..+++.|+||.-
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa 59 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQA 59 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecC
Confidence 56789999999999998888889999954
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.88 E-value=0.00093 Score=64.45 Aligned_cols=30 Identities=20% Similarity=0.196 Sum_probs=25.8
Q ss_pred CCcccccCCCceeecCCCCeeeeccccchh
Q 005007 456 NTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 456 gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999998877778999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.55 E-value=0.0043 Score=62.94 Aligned_cols=29 Identities=24% Similarity=0.378 Sum_probs=23.6
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccchh
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 485 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~~ 485 (720)
.++||+|+.+.|||++. + ..|+||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999964 4 45899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.15 E-value=0.015 Score=57.84 Aligned_cols=30 Identities=27% Similarity=0.324 Sum_probs=27.1
Q ss_pred CCCcccccCCCceeecCCCCeeeeccccch
Q 005007 455 TNTIHRDIKGANLLVDASGVVKLADFGMAK 484 (720)
Q Consensus 455 ~gIVHRDIKP~NILLd~~g~VKL~DFGlA~ 484 (720)
.|+||+|+.++|||++.+..+-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999988878999999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.39 E-value=0.1 Score=53.63 Aligned_cols=64 Identities=9% Similarity=0.015 Sum_probs=35.6
Q ss_pred EeeEEeecCCeEEEEEEECC-------CCcEEEEEEeccCCCC---hhHHHHHHHHhhcC---CEE-----EEEEEeccC
Q 005007 358 KGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDD---PKSAECIKQLEQVD---DHL-----YIYLEYVHP 419 (720)
Q Consensus 358 i~k~LG~G~fG~VYla~d~~-------tg~~VAVK~l~~~~~~---~~~~~~ik~L~~~~---~~l-----yLVmEy~~g 419 (720)
.++.|+-|-.=.+|++.... .++.|.+++.-..... ..+..+++.+.+.+ .-+ .+||||++|
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~g~I~efi~g 125 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIPS 125 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCCE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCCceEEEEecc
Confidence 44678888889999998653 3456767665321111 12223333333321 111 468999987
Q ss_pred CC
Q 005007 420 GS 421 (720)
Q Consensus 420 Gs 421 (720)
..
T Consensus 126 ~~ 127 (395)
T d1nw1a_ 126 RP 127 (395)
T ss_dssp EE
T ss_pred cc
Confidence 43
|